<SEC-DOCUMENT>0001144204-13-027117.txt : 20130508
<SEC-HEADER>0001144204-13-027117.hdr.sgml : 20130508
<ACCEPTANCE-DATETIME>20130508170130
ACCESSION NUMBER:		0001144204-13-027117
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20130331
FILED AS OF DATE:		20130508
DATE AS OF CHANGE:		20130508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PHARMATHENE, INC
		CENTRAL INDEX KEY:			0001326190
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				202726770
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32587
		FILM NUMBER:		13825317

	BUSINESS ADDRESS:	
		STREET 1:		ONE PARK PLACE, SUITE 450
		CITY:			ANNAPOLIS
		STATE:			MD
		ZIP:			21401
		BUSINESS PHONE:		410 269 2600

	MAIL ADDRESS:	
		STREET 1:		ONE PARK PLACE, SUITE 450
		CITY:			ANNAPOLIS
		STATE:			MD
		ZIP:			21401

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHCARE ACQUISITION CORP
		DATE OF NAME CHANGE:	20050505
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>v341092_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;10-Q</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(Mark One)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 22px; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings"><B>x</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>QUARTERLY REPORT PURSUANT TO SECTION&nbsp;13 OR 15(d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the quarterly period ended March
31, 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Or</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11px">&nbsp;</TD>
    <TD STYLE="width: 22px"><FONT STYLE="font: 10pt Wingdings"><B>&uml;</B></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TRANSITION REPORT UNDER SECTION&nbsp;13 OR 15(d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number:&nbsp; 001-32587</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PHARMATHENE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 45%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>20-2726770</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of incorporation
        or</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">organization)</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer Identification No.)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>One Park Place, Suite&nbsp;450, Annapolis, MD</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>21401</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(410) 269-2600</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&rsquo;s telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d)&nbsp;of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to
file such reports), and (2)&nbsp;has been subject to such filing requirements for the past 90 days.&nbsp; Yes </FONT><FONT STYLE="font-family: Wingdings">x</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
No </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data file required to be submitted and posted pursuant to Rule&nbsp;405 of Regulation S-T&nbsp;(&sect;232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&nbsp;
Yes&nbsp;</FONT><FONT STYLE="font-family: Wingdings">x</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; No
</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.&nbsp; See the definitions
of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo; in Rule&nbsp;12b-2
of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top; width: 45%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Large Accelerated Filer </FONT><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 10%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 45%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accelerated Filer </FONT><FONT STYLE="font: 10pt Wingdings">x</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Non-Accelerated Filer </FONT><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Smaller Reporting Company </FONT><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Do not check if a smaller reporting company)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule&nbsp;12b-2 of the Act).&nbsp; Yes </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
No </FONT><FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Indicate the number of shares outstanding
of each of the issuer&rsquo;s classes of common stock, as of the latest practicable date:&nbsp;&nbsp;&nbsp; The number of shares
of the registrant&rsquo;s Common Stock, par value $0.0001 per share, outstanding as of May 2, 2013 was 49,460,686.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PHARMATHENE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 91%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Page</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">PART&nbsp;I &mdash; FINANCIAL INFORMATION</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 1.&nbsp;&nbsp;Financial Statements</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 2.&nbsp;&nbsp;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">15</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 3.&nbsp;&nbsp;Quantitative and Qualitative Disclosures about Market Risk</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">21</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 4.&nbsp;&nbsp;Controls and Procedures</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">PART&nbsp;II &mdash; OTHER INFORMATION</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 1.&nbsp;&nbsp;Legal Proceedings</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">22</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 1A.&nbsp;&nbsp;Risk Factors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 2.&nbsp;&nbsp;Unregistered Sales of Equity Securities and Use of Proceeds</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 3.&nbsp;&nbsp;Defaults Upon Senior Securities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 4. Mine Safety Disclosures</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 5.&nbsp;&nbsp;Other Information</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Item 6.&nbsp;&nbsp;Exhibits</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">23</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCFFCC">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certifications</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 1.&nbsp; Financial Statements</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PHARMATHENE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">March 31, 2013<BR> (Unaudited)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">December 31, <BR>
2012</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center">ASSETS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 68%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Cash and cash equivalents</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">12,873,411</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">12,701,517</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Accounts receivable (billed)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,865,916</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,432,641</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Unbilled accounts receivable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,713,797</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,114,442</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Prepaid expenses and other current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">614,388</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">547,245</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">19,067,512</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">19,795,845</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">456,842</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">483,976</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other long-term assets and deferred costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">99,578</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">113,130</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Goodwill</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,348,453</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,348,453</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">21,972,385</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">22,741,404</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: center">LIABILITIES AND STOCKHOLDERS' EQUITY</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Accounts payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,289,627</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,697,280</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Accrued expenses and other liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,294,315</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,328,877</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Deferred revenue</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">874,404</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,381,755</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Current portion of long-term debt</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">999,996</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">749,997</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in">Short-term debt</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,329,233</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,330,507</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total current liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,787,575</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,488,416</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other long-term liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">580,238</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">579,427</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Long-term debt, less current portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,460,417</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,704,108</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Derivative instruments</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,201,390</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,295,613</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,029,620</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">11,067,564</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Stockholders' equity:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Common stock, $0.0001 par value; 100,000,000 shares authorized; 48,416,483 <BR>and 48,352,651 shares issued and outstanding at March 31, 2013 and <BR>December 31, 2012, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,842</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,835</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in">Additional paid-in-capital</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">210,877,892</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">210,495,905</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Accumulated other comprehensive loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(219,012</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(217,328</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Accumulated deficit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(200,720,957</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(198,609,572</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total stockholders'&nbsp;&nbsp;equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9,942,765</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">11,673,840</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total liabilities and stockholders' equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">21,972,385</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">22,741,404</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of the unaudited condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PHARMATHENE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Three&nbsp;months&nbsp;ended&nbsp;March&nbsp;31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2013</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 68%; font: 10pt Times New Roman, Times, Serif; text-align: left">Contract revenue</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">6,475,138</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">6,149,052</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,233,475</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,705,357</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,279,795</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,948,481</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Depreciation and amortization</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">52,602</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">85,910</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total operating expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,565,872</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,739,748</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from operations</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,090,734</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,590,696</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other income (expense):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">783</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,988</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(99,791</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,028</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other income (expense)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,123</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">52,915</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in fair value of derivative instruments</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(905,777</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(991,662</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total other income (expense)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,010,908</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(938,787</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss before income taxes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,101,642</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,529,483</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;Income tax expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(9,743</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(150,405</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,111,385</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,679,888</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic and diluted net loss per share</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.04</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.06</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average shares used in calculation of <BR>basic and diluted net loss per share</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">48,359,181</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">48,269,894</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The accompanying notes are an integral part
of the unaudited condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PHARMATHENE, INC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF OTHER COMPREHENSIVE LOSS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Three&nbsp;months&nbsp;ended&nbsp;March&nbsp;31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2013</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 68%; font: 10pt Times New Roman, Times, Serif; text-align: left">Net Loss</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,111,385</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,679,888</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other comprehensive income (loss):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Foreign currency translation adjustment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,684</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,369</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Comprehensive loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,113,069</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,666,519</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The accompanying notes are an integral part
of the unaudited condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PHARMATHENE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Three months ended March 31,</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2013</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Operating activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 68%; font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,111,385</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,679,888</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 8.65pt">Change in fair value of derivative instruments</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">905,777</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">991,662</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 8.65pt">Depreciation and amortization expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">52,602</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">85,910</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 8.65pt">Gain on the disposal of property and equipment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(66,626</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 8.65pt">Deferred income tax expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,743</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">150,405</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 8.65pt">Non-cash interest expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">32,431</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 8.65pt">Share-based compensation expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">328,581</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">548,664</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 8.65pt">Changes in operating assets and liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 17.3pt">Accounts receivable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">566,725</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,278,062</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 17.3pt">Unbilled accounts receivable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">400,645</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,254,867</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 17.3pt">Prepaid expenses and other current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">39,486</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">137,362</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 17.3pt">Accounts payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(407,653</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(35,280</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 17.3pt">Accrued expenses and other liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">950,800</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">131,338</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 17.3pt">Deferred revenue</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(507,351</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(495,372</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net cash provided by operating activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">260,401</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">791,370</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Investing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Purchase of property and equipment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(25,468</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Proceeds from the sale of property and equipment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">67,400</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net cash provided (used) by investing activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(25,468</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">67,400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Financing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Proceeds from issuance of long-term debt</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,500,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net (repayment of) proceeds from revolving credit agreement</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,274</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">857,808</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred financing costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(220,234</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Controlled equity offering issuance costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(112,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in restricted cash requirements</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Proceeds from issuance of common stock</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">53,413</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Other</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(32,960</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net cash (used) provided by financing activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(60,361</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,204,614</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Effects of exchange rates on cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,678</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,034</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Increases in cash and cash equivalents</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">171,894</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,067,418</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash and cash equivalents, at beginning of period</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,701,517</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">11,236,771</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, at end of period</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">12,873,411</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">15,304,189</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental disclosure of cash flow information</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash paid for interest</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">67,360</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,028</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Noncash financing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Value of warrants issued to lender in connection with loan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">69,876</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The accompanying notes are an integral part
of the unaudited condensed consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PHARMATHENE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Notes to Unaudited Condensed Consolidated Financial Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>March 31, 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 1 - Organization and Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are a biopharmaceutical company focused on developing biodefense
countermeasure applications.&nbsp;&nbsp;We are subject to those risks associated with any biopharmaceutical company that has substantial
expenditures for research and development.&nbsp;&nbsp;There can be no assurance that our research and development projects will
be successful, that products developed will obtain necessary regulatory approval, or that any approved product will be commercially
viable.&nbsp;&nbsp;In addition, we operate in an environment of rapid technological change and are largely dependent on the services
and expertise of our employees, consultants and other third parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historically, we have performed under government contracts and
grants and raised funds from investors&nbsp;to sustain our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 2 - Summary of Significant Accounting Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Basis of Presentation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our unaudited condensed consolidated financial statements include the accounts of PharmAthene, Inc. and
its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. Our
unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles
in the United States (&ldquo;U.S. GAAP&rdquo;).&nbsp;&nbsp;In the opinion of management, the accompanying unaudited condensed consolidated
financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly
our financial position, results of operations and cash flows.&nbsp;&nbsp;The unaudited condensed consolidated balance sheet at
December 31, 2012 has been derived from audited consolidated financial statements at that date.&nbsp;&nbsp;The interim results
of operations are not necessarily indicative of the results that may occur for the full fiscal year.&nbsp;&nbsp; Certain information
and footnote disclosure normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed
or omitted pursuant to instructions, rules and regulations prescribed by the U.S. Securities and Exchange Commission.&nbsp;We believe
that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed
consolidated financial statements are read in conjunction with the Consolidated Financial Statements and Notes included in our
Annual Report on Form 10-K for the year ended December&nbsp;31, 2012, filed with the Securities and Exchange Commission. We currently
operate in one business segment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Use of Estimates</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at
the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.&nbsp;&nbsp;Our
unaudited condensed consolidated financial statements include significant estimates for the expected economic life and value of
our intangible assets, the amount of our net operating losses, our share-based compensation, the value of our financial instruments,
among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly
from those estimates<FONT STYLE="font: 10pt Times New Roman, Times, Serif">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Foreign Currency Translation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The functional currency of our wholly owned foreign subsidiaries
is their local currency.&nbsp;&nbsp;Assets and liabilities of our foreign subsidiaries are translated into United States dollars
based on exchange rates at the end of the reporting period.&nbsp;&nbsp;Income and expense items are translated at the weighted
average exchange rates prevailing during the reporting period.&nbsp; <FONT STYLE="color: black">Translation adjustments for subsidiaries
that have not been sold, substantially liquidated or otherwise disposed of, are accumulated in other comprehensive income (loss),
a component of stockholders&rsquo; equity.&nbsp;&nbsp;</FONT>Foreign currency translation adjustments are the sole component of
accumulated other comprehensive loss at March 31, 2013 and December 31, 2012. <FONT STYLE="color: black">Transaction gains
or losses are included in the determination of net loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Comprehensive Loss and Accumulated Other Comprehensive Income</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Comprehensive loss includes the total of our net loss and all
other changes in equity other than transactions with owners, including (i) changes in equity for cumulative translation adjustments
resulting from the consolidation of foreign subsidiaries as the financial statements of the subsidiaries located outside of the
United States are accounted for using the local currency as the functional currency, and (ii) unrealized gains and losses on short
term available-for-sale investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Cash and Cash Equivalents</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash and cash equivalents are stated at market value.&nbsp;&nbsp;We
consider all highly liquid investments with original maturities of three months or less to be cash equivalents.&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Revolving Line of Credit and Term Loan</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As discussed further in Note 6, we entered into a loan agreement
with General Electric Capital Corporation (&ldquo;GE Capital&rdquo;) in March 2012. As part of that agreement, we issued stock
purchase warrants to GE Capital that expire in March 2022. The fair value of the warrants was charged to additional paid-in-capital,
resulting in a debt discount to the Term Loan at the date of issuance. The debt discount and the financing costs, incurred in connections
with the agreement, are being amortized over the term of the loan using the effective interest method. The amortization of both
the debt discount and deferred financing costs are included in interest expense in the unaudited condensed consolidated statements
of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Significant Customers and Accounts Receivable</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our primary customers are the U.S. Department of Defense (the
&ldquo;DoD&rdquo;) - Chemical Biological Medical Systems (&ldquo;CBMS&rdquo;), and the Biomedical Advanced Research and Development
Authority (&ldquo;BARDA&rdquo;). As of March 31, 2013 and December 31, 2012, the Company&rsquo;s trade receivable and unbilled
receivable balances were comprised solely of receivables from CBMS and BARDA.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Goodwill</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goodwill represents the excess of purchase price over the fair
value of net identifiable assets associated with acquisitions. We review the recoverability of goodwill annually as of December
31<SUP>st</SUP> by comparing our market value (as measured by our stock price multiplied by the number of outstanding shares as
of the end of the year) to the net book value of our equity. If our market value exceeds our net book value, no further analysis
is required. Changes in our business strategy or adverse changes in market conditions could impact the impairment analyses and
require the recognition of an impairment charge equal to the excess of the carrying value over its estimated fair value. We completed
our last annual impairment assessment of goodwill as of December 31, 2012 and determined that there was no impairment as of that
date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Revenue Recognition</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We generate our revenue from<B>&nbsp;</B>different types of
contractual arrangements: cost-plus-fee contracts, cost reimbursable grants and fixed price contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues on cost-plus-fee contracts are recognized in an amount
equal to the costs incurred during the period plus an estimate of the applicable fee earned.&nbsp;&nbsp;The estimate of the applicable
fee earned is determined by reference to the contract:&nbsp;&nbsp;if the contract defines the fee in terms of risk-based milestones
and specifies the fees to be earned upon the completion of each milestone, then the fee is recognized when the related milestones
are earned, as further described below; otherwise, we estimate the fee earned in a given period by using a proportional performance
method based on costs incurred during the period as compared to total estimated project costs and application of the resulting
fraction to the total project fee specified in the contract.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the milestone method of revenue recognition, milestone
payments (including milestone payments for fees) contained in research and development arrangements are recognized as revenue when:
(i)&nbsp;the milestones are achieved; (ii)&nbsp;no further performance obligations with respect to the milestone exist; (iii)&nbsp;collection
is reasonably assured; and (iv)&nbsp;substantive effort was necessary to achieve the milestone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Milestones are considered substantive if all of the following
conditions are met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">it
is commensurate with either our performance to meet the milestone or the enhancement of the value of the delivered item or items
as a result of a specific outcome resulting from our performance to achieve the milestone,</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">it
relates solely to past performance,</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
value of the milestone is reasonable relative to all the deliverables and payment terms (including other potential milestone consideration)
within the arrangement.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If a milestone is deemed not to be substantive, the Company
recognizes the portion of the milestone payment as revenue that correlates to work already performed; the remaining portion of
the milestone payment is deferred and recognized as revenue as the Company completes its performance obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenue on fixed price contracts (without substantive milestones
as described above) is recognized on the percentage-of-completion method.&nbsp;&nbsp;The percentage-of-completion method recognizes
income as the contract progresses (generally related to the costs incurred in providing the services required under the contract).&nbsp;&nbsp;The
use of the percentage-of-completion method depends on the ability to make reasonable dependable estimates and the fact that circumstances
may necessitate frequent revision of estimates does not indicate that the estimates are unreliable for the purpose for which they
are used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of our revenue recognition policies and the billing
provisions contained in our contracts, the timing of customer billings may differ from the timing of recognizing revenue. Amounts
invoiced to customers in excess of revenue recognized are reflected on the balance sheet as deferred revenue. Amounts recognized
as revenue in excess of amounts billed to customers are reflected on the balance sheet as unbilled accounts receivable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We analyze each cost reimbursable grant to determine whether
we should report such reimbursements as revenue or as an offset to our expenses incurred. For the three months ended
March 31, 2013 and 2012, we recorded approximately $0.02 million and $0.5 million, respectively, of costs reimbursed by the government
as an offset to research and development expenses. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Share-Based Compensation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We expense the estimated fair value of share-based awards granted
to employees under our stock compensation plans.&nbsp;&nbsp;The fair value of stock options is determined at the grant date using
an option pricing model.&nbsp;&nbsp;We have estimated the fair value of each stock option award using the Black-Scholes option
pricing model.&nbsp;&nbsp;The Black-Scholes model considers, among other factors, the expected life of the award and the expected
volatility of our stock price. The value of the award that is ultimately expected to vest is recognized as expense on a straight
line basis over the employee&rsquo;s requisite service period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The fair value of restricted stock grants is determined based
on the closing price of our common stock on the award date and is recognized as expense ratably over the requisite service period.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employee share-based compensation expense recognized in the
three months ended March 31, 2013 and 2012 was calculated based on awards ultimately expected to vest and has been reduced for
estimated forfeitures at a rate of approximately 12%, based on historical forfeitures.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Share-based compensation expense for the
three months ended March 31, 2013 and 2012 was:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Three&nbsp;months&nbsp;ended&nbsp;March&nbsp;31,</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2013</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 72%; font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">88,634</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">117,067</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">239,947</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">431,597</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total share-based compensation expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">328,581</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">548,664</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the three months ended March 31, 2013, we granted 60,000
options to employees and consultants and made no restricted stock grants.&nbsp; During the three months ended March 31, 2012, we
granted 15,948 options to employees and made no restricted stock grants.&nbsp; At March 31, 2013, we had total unrecognized share-based
compensation expense related to unvested awards of approximately $2.0 million net of estimated forfeitures, which we expect to
recognize as expense over a weighted-average period of 2.25 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Income Taxes</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We account for income taxes using the asset and liability approach,
which requires the recognition of future tax benefits or liabilities on the temporary differences between the financial reporting
and tax bases of our assets and liabilities. A valuation allowance is established when necessary to reduce deferred tax assets
to the amounts expected to be realized. We also recognize a tax benefit from uncertain tax positions only if it is &ldquo;more
likely than not&rdquo; that the position is sustainable based on its technical merits. Our policy is to recognize interest and
penalties on uncertain tax positions as a component of income tax expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income tax expense was $9,743 and $150,405 during the three
months ended March 31, 2013 and 2012, respectively. Income tax expense is a result of the difference between the treatment of
goodwill for income tax purposes and for U.S. GAAP, resulting in a deferred tax liability, which cannot offset deferred tax assets.
This deferred tax liability is included in our condensed consolidated balance sheet in other long-term liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Basic and Diluted Net Loss Per Share</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Income (loss) per share:</I>&nbsp;&nbsp;Basic income (loss)
per share is computed by dividing consolidated net income (loss) by the weighted average number of common shares outstanding during
the period, excluding unvested restricted stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For periods of net income when the effects are not anti-dilutive,
diluted earnings per share is computed by dividing our net income by the weighted average number of shares outstanding and the
impact of all potential dilutive common shares, consisting&nbsp;&nbsp;primarily of stock options, unvested restricted stock and
stock purchase warrants.&nbsp;&nbsp;The dilutive impact of our dilutive potential common shares resulting from stock options and
stock purchase warrants is determined by applying the treasury stock method.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the periods of net loss, diluted loss per share is calculated
similarly to basic loss per share because the impact of all dilutive potential common shares is anti-dilutive due to the net losses.
A total of approximately 11.6 million and 11.5 million potential dilutive securities have been excluded in the calculation of diluted
net loss per share in the three months ended March 31, 2013 and 2012, respectively, because their inclusion would be anti-dilutive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Recent Accounting Pronouncements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: black">We have evaluated all Accounting
Standards Updates through the date the unaudited condensed consolidated financial statements were issued and believe the adoption
of these will not have a material impact on our results of operations, financial position, or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 3 - Fair Value Measurements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We define fair value as the exchange price that would be received
for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability
in an orderly transaction between market participants at the measurement date.&nbsp;&nbsp;We report assets and liabilities that
are measured at fair value using a three-level fair value hierarchy that prioritizes the inputs used to measure fair value.&nbsp;&nbsp;This
hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs.&nbsp;&nbsp;The three levels of inputs
used to measure fair value are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18px">&nbsp;</TD>
    <TD STYLE="width: 18px"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level 1 &mdash; Quoted prices in active markets for identical assets or liabilities.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18px">&nbsp;</TD>
    <TD STYLE="width: 18px"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level 2 &mdash; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18px">&nbsp;</TD>
    <TD STYLE="width: 18px"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level 3 &mdash; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&nbsp;&nbsp;This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An asset&rsquo;s or liability&rsquo;s level within the fair
value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&nbsp;&nbsp;At each
reporting period, we perform a detailed analysis of our assets and liabilities that are measured at fair value.&nbsp;&nbsp;All
assets and liabilities for which the fair value measurement is based on significant unobservable inputs or instruments which trade
infrequently and therefore have little or no price transparency are classified as Level 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have segregated our financial assets and liabilities that
are measured at fair value into the most appropriate level within the fair value hierarchy based on the inputs used to determine
the fair value at the measurement date in the table below.&nbsp; We have no non-financial assets and liabilities that are measured
at fair value on a recurring basis.&nbsp;&nbsp;As of March 31, 2013 and 2012 we had Level 3 derivative liabilities of approximately
$2.2 million and $2.9 million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table represents the Company&rsquo;s fair value
hierarchy for its financial assets and liabilities measured at fair value on a recurring basis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">As of March 31, 2013</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Level 1</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Level 2</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Level 3</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Balance</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">Liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 44%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">Derivatives instruments</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">-</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">-</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">2,201,390</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">2,201,390</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">As of December 31, 2012</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Level 1</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Level 2</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Level 3</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Balance</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">Liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 44%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">Derivatives instruments</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">-</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">-</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">1,295,613</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">1,295,613</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth a summary of changes in the fair value of the Company&rsquo;s Level 3 liabilities
for the three months ended March 31, 2013:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Description</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Balance&nbsp;as&nbsp;of <BR> December&nbsp;31, <BR> 2012</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Unrealized&nbsp; Losses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Balance&nbsp;as&nbsp;of <BR> March&nbsp;31,&nbsp; <BR> 2013</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 58%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Derivative liabilities related to stock purchase warrants</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,295,613</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">905,777</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,201,390</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth a summary of changes in the fair
value of the Company&rsquo;s Level 3 liabilities for the three months ended March&nbsp;31, 2012:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Description</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Balance&nbsp;as&nbsp;of <BR> December&nbsp;31, <BR> 2011</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Unrealized&nbsp; Losses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Balance&nbsp;as&nbsp;of <BR> March&nbsp;31,&nbsp; <BR> 2012</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 58%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Derivative liabilities related to stock purchase warrants</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,886,652</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">991,662</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,878,314</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At March 31, 2013 and 2012, derivative liabilities are comprised
of warrants to purchase 2,899,991 shares of common stock. The warrants are considered to be derivative liabilities due to the presence
of net settlement features and, as a result, are recorded at fair value at each balance sheet date, with changes in fair value
recorded in the unaudited condensed consolidated statements of operations.&nbsp;&nbsp;The fair value of our warrants is determined
based on the Black-Scholes option pricing model.&nbsp;&nbsp;Use of the Black-Scholes option pricing model requires the use of unobservable
inputs such as the expected term, anticipated volatility and expected dividends.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="7" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Quantitative Information about Level 3 Fair Value Measurements</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right; border-bottom: Black 1pt solid">Fair Value at 3/31/2013</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; border-bottom: Black 1pt solid">Valuation Technique</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; border-bottom: Black 1pt solid">Unobservable Inputs</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">2,201,390</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 42%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">Black-Scholes option pricing model</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">Expected term</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">Expected dividends</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">Anticipated volatility</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in any of the assumptions related to the unobservable
inputs identified above may change the stock purchase warrants&rsquo; fair value; increases in expected term, anticipated volatility
and expected dividends generally result in increases in fair value, while decreases in the unobservable inputs generally result
in decreases in fair value. Gains and losses on the fair value adjustments for these derivative instruments are classified in other
expenses as the change in fair value of derivative instruments in our unaudited condensed consolidated statements of operations.&nbsp;&nbsp;The
$0.9 million change in the market value of derivative instruments during the three-month period ended March 31, 2013 is due primarily
to the change in the closing price of PharmAthene stock, which was $1.12 per share as of December 31, 2012 and $1.70 per share
as of March 28, 2013. The $1.0 million change in the market value of derivative instruments during the three-month period ended
March 31, 2012 is due primarily to the change in the closing price of PharmAthene stock, which was $1.27 per share as of December
30, 2011 and $1.77 per share as of March 30, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Assets Measured at Fair Value on a Nonrecurring Basis</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company measures its long-lived assets, including, property
and equipment and goodwill, at fair value on a nonrecurring basis. These assets are recognized at fair value when they are deemed
to be other-than-temporarily impaired. (see Note 2). As of March 31, 2013, the Company had no other assets or liabilities that
were measured at fair value on a nonrecurring basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 4 - Commitments and Contingencies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>SIGA Litigation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December 2006, we filed a complaint against SIGA Technologies,
Inc. (&ldquo;SIGA&rdquo;) in the Delaware Court of Chancery.&nbsp;&nbsp;The complaint alleged, among other things, that we have
the right to license exclusively development and marketing rights for SIGA&rsquo;s drug candidate, Arestvyr&trade; (Tecovirimat),
pursuant to a merger agreement between the parties that was terminated in 2006.&nbsp;&nbsp;The complaint also alleged that SIGA
failed to negotiate in good faith the terms of such a license pursuant to the terminated merger agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In September 2011, the Court issued an opinion in the case finding
that SIGA had breached certain contractual obligations to us and upholding our claims of promissory estoppel.&nbsp;&nbsp;The Court
awarded us&nbsp;the right to receive&nbsp;50% of all net profits (as defined in the court&rsquo;s final judgment) related to the
sale of Arestvyr&trade; and related products for 10 years following initial commercial sale of the drug once SIGA earns $40 million
in net profits from the sale of Arestvyr&trade;<FONT STYLE="color: #222222"> </FONT>and related products. &nbsp;The Court also
awarded us one-third of our reasonable attorney's fees and expert witness fees, which amounts to approximately $2.4 million plus
interest. In May 2012, the Court issued its final judgment. SIGA has appealed aspects of the decision to the Delaware Supreme Court.
In response, we cross-appealed other aspects of the decision. In January 2013, the Delaware Supreme Court heard oral argument in
the case.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We can provide no assurances that SIGA will not prevail on its
appeal, that we will be successful in our appeal, and that the Delaware Supreme Court will not overturn the trial court&rsquo;s
decision awarding us a 10 year 50% net profit of the sales of Arestvyr&trade;<FONT STYLE="color: #222222"> </FONT>and related products
(once SIGA retains the first $40 million in net profit). We have not yet recorded any amount due from SIGA in relation to this
case.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Vendor Litigation </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">One of our vendors mishandled the storage of certain biological
materials. While we have been engaged in discussions with the vendor to address our concerns, so far we have not come
to agreement. The vendor filed suit against us in Delaware state court seeking a declaration that they are not liable for damages
and seeking damages from us for allegedly not maintaining the required amount and type of insurance. We filed suit against the
vendor in Maryland state court seeking damages related to the loss of the property. We believe we did maintain the appropriate
amount and type of insurance, that in no event did we harm the vendor, and thus their damages claim is without merit. We plan to
vigorously defend against their claims while pursuing our own.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Government Contracting</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payments to the Company on cost-plus-fee contracts are provisional
and are subject to adjustment upon audit by the Defense Contract Audit Agency and BARDA. In our opinion, adjustments that may result
from audits are not expected to have a material effect on our financial position, results of operations, or cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Registration Rights Agreements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We entered into a Registration Rights Agreement with the investors
who participated in the July 2009 private placement of convertible notes and related warrants.&nbsp;&nbsp;We subsequently filed
two registration statements on Form S-3 with the Securities and Exchange Commission to register the shares underlying the convertible
notes and related warrants, which registration statements have been declared effective. We are obligated to maintain the registration
statements effective until the date when all shares underlying the convertible notes and related warrants (and any other securities
issued or issuable with respect to in exchange for such shares) have been sold. The convertible notes were converted or extinguished
in 2010, although the related warrants remain outstanding. The warrants will expire on January 28, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have separate registration rights agreements with investors,
under which we have obligations to keep the corresponding registration statements effective until the registrable securities (as
defined in each agreement) have been sold, and under which we may have separate obligations to file registration statements in
the future on either a demand or &ldquo;piggy-back&rdquo; basis or both.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the terms of the convertible notes, which were converted
or extinguished in 2010, if after the 2nd consecutive business day (other than during an allowable blackout period) on which sales
of all of the securities required to be included on the registration statement cannot be made pursuant to the registration statement
(a &ldquo;Maintenance Failure&rdquo;), we will be required to pay to each selling stockholder a one-time payment of 1.0% of the
aggregate principal amount of the convertible notes relating to the affected shares on the initial day of a Maintenance Failure.
Our total maximum obligation under this provision at March 31, 2013, would be approximately $0.2 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following a Maintenance Failure, we will also be required to
make to each selling stockholder monthly payments of 1.0% of the aggregate principal amount of the convertible notes relating to
the affected shares on every 30th day after the initial day of a Maintenance Failure, in each case prorated for shorter periods
and until the failure is cured. Our total maximum obligation under this provision would be approximate $0.2 million for each month
until the failure, if it occurs, is cured.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 5 - Stockholders&rsquo; Equity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Long-Term Incentive Plan</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In 2007, the Company&rsquo;s stockholders approved the 2007
Long-Term Incentive Compensation Plan (the &ldquo;2007 Plan&rdquo;) which provides for the granting of incentive and non-qualified
stock options, stock appreciation rights, performance units, restricted common awards and performance bonuses (collectively &ldquo;awards&rdquo;)&nbsp;&nbsp;to
Company officers and employees.&nbsp;&nbsp;Additionally, the 2007 Plan authorizes the granting of non-qualified stock options and
restricted stock awards to Company directors and to independent consultants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In 2008, the Company&rsquo;s shareholders approved amendments
to the 2007 Plan, increasing from 3.5 million shares to 4.6 million shares the maximum number of shares authorized for issuance
under the plan and adding an evergreen provision pursuant to which the number of shares authorized for issuance under the plan
will increase automatically in each year, beginning in 2009 and continuing through 2015, according to certain limits set forth
in the 2007 Plan.&nbsp;&nbsp;At March 31, 2013, there are approximately 9.3 million shares approved for issuance under the 2007
plan, of which approximately 2.6 million shares are available to be issued. The Board of Directors in conjunction with management
determines who receives awards, the vesting conditions and the exercise price.&nbsp;&nbsp;Options&nbsp;may have a maximum term
of ten years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><BR>
<I>Warrants Classified as Equity</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the July 2009 private placement, we issued
warrants to purchase an aggregate of 2,572,775 shares of the Company&rsquo;s common stock at an exercise price of $2.50 per share.
The warrants will expire on January 28, 2015.&nbsp;&nbsp;Also outstanding are warrants to purchase an aggregate of 100,778 shares
of common stock at $3.97 per share, which will expire on March 30, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the March 30, 2012, debt financing (see Note
6), we issued warrants to purchase an aggregate of 46,584 shares of the Company&rsquo;s common stock at an exercise price of $1.61
per share to GE Capital Equity Investments, Inc. The relative fair value attributable to the warrants of $69,876 was recorded in
equity during the quarter ended March 31, 2012. The warrants will expire on March 30, 2022.&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Warrants</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At March 31, 2013 and 2012 there were warrants outstanding to
purchase 5,620,128 shares of our common stock, respectively. The warrants outstanding as of March 31, 2013 and 2012 were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Number of Common Shares Underlying Warrants</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Issue Date/Exercisable Date</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Exercise Price</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Expiration Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 22%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">100,778</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">(1)</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 24%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: center">Mar-07 / Mar-07</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 21%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">3.97</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 23%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">Mar-17</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">705,354</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">(2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center">Mar-09 / Sep-09</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">3.00</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">Sep-14</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">2,572,775</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">(1)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center">Jul-09 / Jan-10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">2.50</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">Jan-15</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">500,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">(2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center">Apr-10 / Oct-10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">1.89</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">Oct-15</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">1,323,214</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">(2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center">Jul-10 / Jan-11</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">1.63</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">Jan-17</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">371,423</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">(2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center">Jun-11 / Jun-11</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">3.50</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">Jun-16</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">46,584</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">(1)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; padding-bottom: 1pt">Mar-12 / Mar-12</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">1.61</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right; padding-bottom: 1pt">Mar-22</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">5,620,128</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">(1)</FONT></TD>
    <TD STYLE="width: 92%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">These warrants to purchase common stock are classified as equity.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">(2)</FONT></TD>
    <TD STYLE="width: 92%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: black">These warrants to purchase common stock are classified as derivative liabilities. The fair value of these liabilities (see note 3) is remeasured at the end of every reporting period and the change in fair value is reported in the unaudited condensed consolidated statements of operations as other income (expense).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 6 &ndash; Financing Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Controlled Equity Offering</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 25, 2013, we entered into a controlled equity offering
with a sales agent pursuant to which we may offer and sell, from time to time, through the agent shares of our common stock having
an aggregate offering price of up to $15.0 million. Under the arrangement, the agent may sell shares by any method permitted by
law and deemed to be an &ldquo;at-the-market&rdquo; offering as defined in Rule 415 promulgated under the Securities Act of 1933,
as amended, including sales made directly on NYSE MKT, or any other existing trading market for our Common Stock or to or through
a market maker. We are not obligated to sell any shares under the arrangement. Subject to the terms and conditions of that agreement,
the agent will use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable state
and federal law, rules and regulations and the rules of NYSE MKT, to sell shares from time to time based upon our instructions.
We are obligated to pay the agent a commission of 3.0% of the aggregate gross proceeds from each sale of shares. Total expenses
incurred for the offering, excluding commission payable to the agent, were approximately $277,000. Through March 31, 2013, we sold
19,900 shares of our common stock under this arrangement, which did not settle until April 2013, that resulted in net proceeds
to the company of approximately $33,000. As of March 31, 2013, aggregate gross sales for additional common stock of approximately
$14.97 million remained available under the arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Loan Agreement with GE Capital</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 30, 2012, we entered into a Loan Agreement with GE
Capital. The Loan Agreement provides for a senior secured debt facility including a $2.5 million term loan and a revolving line
of credit of up to $5 million based on our outstanding qualified accounts receivable.&nbsp; On March 30, 2012, the term loan was
funded for an aggregate amount of $2.5 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the terms of the revolving line of credit, the Company
may draw down from the revolving line of credit up to 85% of qualified billed accounts receivable and 80% of qualified unbilled
accounts receivable. As of March 31, 2013, the total amount available to draw was approximately $2.3 million, of which $1.3 million
was drawn and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The fixed interest rate on the term loan is 10.14% per annum.
The revolving line of credit has an adjustable interest rate based upon the 3-month London Interbank Offered Rate (LIBOR), with
a floor of 1.5%, plus 5%. As of March 31, 2013, the interest rate was 6.5%.&nbsp; Both the term loan and the revolving line of
credit mature in September 2015.&nbsp; Payments on the term loan were originally interest-only for the first 10 months, which has
since been extended to 12 months pursuant to terms of the agreement. Subsequently, the term loan will fully amortize over its remaining
term as of March 31, 2013. Principal payments on the term loan are scheduled as follows:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 35%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom"><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Year</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Principal <BR>
Payments</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)"><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: center">2013</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right; width: 15%">$749,997</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White"><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center">2014</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">999,996</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)"><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: center">2015</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">750,007</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White"><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">$2,500,000</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The term loan, net of discount of $39,587, is recorded on the
2013 condensed consolidated balance sheet, net of debt discount, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 54%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: left">Current portion of long-term debt</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">999,996</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Long-term debt, less current portion</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,460,417</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we prepay the term loan and terminate the revolving line of credit prior to the scheduled maturity
date, we are obligated to pay a prepayment premium equal to 3% of the then outstanding principal amount of the term loan if prepaid
during the first two years of the loan and 2% if prepaid during the third year or thereafter. In addition, we are obligated to
pay a final payment fee of 3% of the term loan balance. The final payment fee is being accrued and expensed over the term of the
agreement, using the effective interest method and is included in other long-term liabilities on the condensed consolidated balance
sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our obligations under the Loan Agreement are collateralized
by a security interest in substantially all of our assets. While the security interest does not, except in limited circumstances,
cover our intellectual property, it does cover any proceeds received by us from the use or sale of our intellectual property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the Loan Agreement, we issued GE Capital
warrants to purchase 46,584 shares of the Company&rsquo;s common stock at an exercise price of $1.61 per share. The warrants are
exercisable immediately and subject to customary and standard anti-dilution adjustments. The warrants are classified in equity
and, as a result, the fair value of the warrants was charged to additional paid-in capital resulting in a debt discount at the
date of issuance. The debt discount is being amortized over the term of the loan agreement using the effective interest method.
Financing costs incurred in connection with this agreement are also being amortized over the term of the agreement using the effective
interest method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The fair value of the Company&rsquo;s outstanding borrowings
under its revolving credit facility at March 31, 2013 was consistent with its carrying value as of that date primarily due to the
short term nature of the Revolver&rsquo;s repayment terms. The Company determined the fair value of the Term Loan approximated
its carrying value as of March 31, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 7 &ndash; Subsequent Events </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subsequent to March 31, 2013, we sold 1,030,870 shares of our
common stock under the controlled equity offering, which resulted in net proceeds of approximately $1.63 million. (See Note 6).
A<FONT STYLE="color: black">ggregate gross proceeds of up to approximately $13.29 million remain available under </FONT>the arrangement.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 2.&nbsp; Management&rsquo;s Discussion and Analysis
of Financial Condition and Results of Operations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>This Quarterly Report on Form&nbsp;10-Q contains forward-looking
statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities
Exchange Act of 1934, as amended.&nbsp; This information may involve known and unknown risks, uncertainties and other factors that
are difficult to predict and may cause our actual results, performance or achievements to be materially different from future results,
performance or achievements expressed or implied by any forward-looking statements.&nbsp;&nbsp;These risks, uncertainties and other
factors include, but are not limited to, risk associated with the following:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><I>the reliability of the results of the studies relating to efficacy and safety, and possible adverse effects resulting from the administration, of the Company&rsquo;s product candidates;</I></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>funding delays, reductions in or elimination of U.S. government funding and/or non-renewal of expiring funding for one or more of our development programs;</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>the award of government contracts to our competitors or delays caused by third parties challenging government contract awards to us;</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>unforeseen safety and efficacy issues;</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>challenges related to the development, technology transfer, scale-up, and/or process validation of manufacturing processes for our product candidates; and</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products;</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>as well as risks detailed under the caption
&ldquo;Risk Factors&rdquo; in our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2012, and in our other
reports filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) from time to time thereafter. In particular,
there can be no assurance that the Company will prevail in the appeal to the Delaware Supreme Court of the ruling of the Delaware
Court of Chancery awarding PharmAthene 50% of all net profits (as defined in the court&rsquo;s final judgment) related to the sale
of Arestvyr&trade; (formerly called ST-246&reg;) and related products for 10 years following initial commercial sale of the drug
once SIGA earns $40 million in net profits from the sale of Arestvyr&trade; and related products. Further, the timing and amount
of any future sales and revenues of Arestvyr&trade; is uncertain. Significant additional non-clinical animal studies, human clinical
trials, and manufacturing development work remain to be completed for all our products candidates, including Valortim&reg; and
rBChE, and with FDA&rsquo;s August 2012 clinical hold of SparVax&reg;, it is unclear when, if ever, we can re-initiate human clinical
trials for that product candidate. At this point future government funding to support the development of Valortim&reg; is unlikely
and remains uncertain. It is also uncertain whether any of our product candidates will be shown to be safe and effective and approved
by regulatory authorities for use in humans. Forward-looking statements describe management&rsquo;s current expectations regarding
our future plans, strategies and objectives and are generally identifiable by use of the words &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;should,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend,&rdquo;
&ldquo;project,&rdquo; &ldquo;potential&rdquo; or &ldquo;plan&rdquo; or the negative of these words or other variations on these
words or comparable terminology. Such statements include, but are not limited to:</I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>statements about potential future government contract or grant awards;</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>potential payments under government contracts or grants;</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>potential regulatory approvals;</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>future product advancements; and</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Symbol"><I>&middot;</I></FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>anticipated financial or operational results.</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Forward-looking statements are based on assumptions that
may be incorrect, and we cannot assure you that the projections included in the forward-looking statements will come to pass.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>We have based the forward-looking statements included in
this Quarterly Report on Form&nbsp;10-Q on information available to us on the date of this Quarterly Report, and we assume no obligation
to update any such forward-looking statements, other than as required by law.&nbsp; Although we undertake no obligation to revise
or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to
consult any additional disclosures that we may make directly to you or through reports that we, in the future, may file with the
SEC, including Annual Reports on Form&nbsp;10-K, Quarterly Reports on Form&nbsp;10-Q and Current Reports on Form&nbsp;8-K.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following discussion should be read in conjunction with
our unaudited condensed consolidated financial statements which present our results of operations for the three months ended March
31, 2013 and 2012, as well as our financial positions at March 31, 2013 and December&nbsp;31, 2012, contained elsewhere in this
Quarterly Report on Form&nbsp;10-Q.&nbsp; The following discussion should also be read in conjunction with the Annual Report on
Form&nbsp;10-K for the year ended December&nbsp;31, 2012, filed on March&nbsp;13, 2013, including the consolidated financial statements
contained therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are a biodefense company engaged in the development and commercialization&nbsp;of
next generation medical countermeasures against biological and chemical threats<FONT STYLE="color: black">.&nbsp; Our current biodefense
portfolio includes the following product candidates:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11px">&nbsp;</TD>
    <TD STYLE="width: 11px"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">SparVax<SUP>&reg;</SUP>, a next generation recombinant protective antigen (&ldquo;rPA&rdquo;) anthrax vaccine,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11px">&nbsp;</TD>
    <TD STYLE="width: 11px"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">rBChE (recombinant butyrylcholinesterase) bioscavanger, a medical countermeasure for nerve agent poisoning by organophosphorous compounds, including nerve gases and pesticides, and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11px">&nbsp;</TD>
    <TD STYLE="width: 11px"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Valortim<SUP>&reg;</SUP>, a fully human monoclonal antibody for the prevention and treatment of anthrax infection.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition,&nbsp;we were awarded by the Delaware Court of
Chancery in September 2011&nbsp;the right to receive 50% of all&nbsp;net profits (as defined in the court&rsquo;s final judgment)
related to the sale of SIGA Technologies, Inc.&rsquo;s (SIGA) Arestvyr&trade;<FONT STYLE="color: #222222"> (formerly known as
ST-246<SUP>&reg;</SUP>) </FONT>and related products for 10 years following initial commercial sale of the drug once SIGA earns
$40 million in net profits from the sales of Arestvyr&trade;<FONT STYLE="color: #222222"> </FONT>and related products. In May
2012, the Court issued its final judgment. SIGA has appealed aspects of the decision to the Delaware Supreme Court. In response,
we have cross-appealed other aspects of the decision. In January 2013, the Delaware Supreme Court heard oral argument in the case.
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Critical Accounting Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A &ldquo;critical accounting policy&rdquo; is one that is both
important to the portrayal of our financial condition and results of operations and that requires management&rsquo;s most difficult,
subjective or complex judgments. Such judgments are often the result of a need to make estimates about the effect of matters that
are inherently uncertain. The preparation of our financial statements in conformity with accounting principles generally accepted
in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ materially from those estimates. We believe that the disclosures
provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial
statements are read in conjunction with the Consolidated Financial Statements and Notes included in our Annual Report on Form
10-K for the year ended December&nbsp;31, 2012, filed with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There were no significant changes in critical accounting policies
from those at December 31, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Results of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Revenue</I>&nbsp;</FONT><FONT STYLE="color: black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We recognized revenue of $6.5 million and $6.1 million during
the three months ended March 31, 2013 and 2012, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Three months ended March 31,</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; border-bottom: Black 1pt solid">Revenue ($ in millions)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">2013</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">% Change</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">SparVax<SUP>&reg;</SUP></FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">5.1</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">5.2</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">-1.9</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">rBChE bioscavanger</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">1.4</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">0.8</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">75.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Valortim<SUP>&reg;</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">0.0</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">0.1</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">-100.0</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left; padding-bottom: 2.5pt">Total Revenue</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">6.5</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">6.1</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">6.6</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our revenue was derived primarily from contracts with the U.S.
government for the development of SparVax<SUP>&reg;</SUP>, and our rBChE bioscavanger.&nbsp;Our revenue in the three months ended
March 31, 2013 changed from the comparable period of 2012 primarily due to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our contract for the development of SparVax<SUP>&reg;</SUP>, we recognized approximately $5.1 million
and $5.2 million of revenue for the three months ended March 31, 2013 and 2012, respectively.&nbsp; During the quarter ended March
31, 2013 revenue was primarily attributable to work related to manufacturing process characterization, ongoing stability testing
of bulk drug substance (BDS) and final drug product (FDP), immunopotency assay development, and the completion of a rabbit dose
ranging efficacy study. &nbsp;During the quarter ended March 31, 2012 revenue for the Company's SparVax<SUP>&reg;</SUP> program
was primarily attributable to work related to the manufacture of final drug product of SparVax<SUP>&reg;</SUP> as well as activities
related to the Phase 2 clinical trial planned to commence later in 2012 and the completion of certain activities related to the
development of analytical assays. Milestone revenue for the three months ended March 31, 2013 was $0.07 million and for the three
months ended March 31, 2012 was $0.9 million. <FONT STYLE="font: 10pt Times New Roman, Times, Serif">During the quarter, we submitted
our complete response to the FDA in response to a clinical hold notification for our proposed Phase II clinical trial of SparVax<SUP>&reg;</SUP>.</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We recognized approximately $1.4 million and $0.8 million related to work on our second generation rBChE bioscavanger in the first three months of 2013 and 2012, respectively, under the $5.7 million August 2011 Firm Fixed Price contract with the DoD for the development of the advanced expression system for rBChE. In the first three months of 2012 our activities related to clone generation and initiation of process development, while in the comparable 2013 period we continued with the process development work and focused on material generation for non-clinical studies.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Research and Development Expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our research and development expenses were $5.2 million and
$4.7 million for the three months ended March 31, 2013 and 2012, respectively.&nbsp;&nbsp;These expenses resulted from research
and development activities in both periods related primarily to our SparVax<SUP>&reg;</SUP> and rBChE bioscavanger programs.&nbsp;&nbsp;Direct
expenses included salaries and other costs of personnel, raw materials and supplies, and an allocation of indirect expenses.&nbsp;
We also incurred third-party costs, such as contract research, consulting and clinical development costs for individual projects.&nbsp;
Research and development expenses for the three months ended March 31, 2013 and 2012 were net of cost reimbursements under certain
of our government grants of $0.02 million and $0.5 million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Research and development expenses for the three months ended
March 31, 2013 and 2012 were attributable to research programs as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">Three Months ended&nbsp;March 31,</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; border-bottom: Black 1pt solid">Research and Development Expenses ($ in millions)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">2013</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">% Change</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 58%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">SparVax<SUP>&reg; </SUP>and<SUP> </SUP>Valortim<SUP>&reg;</SUP></FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">4.4</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">4.2</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">4.8</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">rBChE bioscavenger</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">0.8</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">0.4</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">100.0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left; padding-bottom: 1pt">Internal research and development</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">0.0</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">0.1</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">-100.0</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left; padding-bottom: 2.5pt">Total research and development expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">5.2</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">4.7</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">10.6</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the three months ended March 31, 2013, research and development
expenses increased $0.5&nbsp;million from the same period in the prior year, due to increased costs related to our SparVax<SUP>&reg;</SUP>
program, as a result of the completion of a significant number of BDS process characterization activities and the conduct of activities
required to address the FDA clinical hold issues, and our rBChE bioscavanger program. These increases were offset by the reduction
in direct costs related to our Valortim<SUP>&reg;</SUP> program as a result of the completion of work under the contract in the
first quarter of 2012.&nbsp;&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>General and Administrative Expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">General and administrative functions include executive management,
finance and administration, government affairs and regulations, corporate development, human resources, legal, and compliance.&nbsp;
For each function, we may incur expenses such as salaries, supplies and third-party consulting and other external costs and non-cash
expenditures such as expense related to stock option and restricted share awards.&nbsp; An allocation of indirect costs such as
facilities, utilities and other administrative overhead is also included in general and administrative expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Expenses associated with general and administrative functions
were $2.3 million for the three months ended March 31, 2013 and $2.9 million for the three months ended March 31, 2012.&nbsp;&nbsp;The
$0.6 million dollar decrease from the same period in the prior year, was principally due to reduced labor and associated share-based
compensation costs and lower professional and consulting fees.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Depreciation and Amortization</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Depreciation and amortization expenses were approximately $0.1
million for the three months ended March 31, 2013 and 2012, respectively.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Other Income (Expense)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other income (expense) primarily consists of income on our investments,
interest expense on our debt and other financial obligations, changes in fair value of our derivative financial instruments, foreign
currency transaction gains or losses, and the gain on the disposal of property and equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other expense in 2013 was $1.01 million, compared to $0.94 million
in 2012, an increase of $0.07 million. The increase was primarily the result of (i) $0.1 million of additional interest expense
in 2013 generated from our loans with GE Capital, (ii) a $0.07 million gain in 2012 on the disposal of property and equipment,
and (iii) a $0.1 million difference in losses related to the changes in fair value of our derivative instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Income Taxes</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income tax expense was $0.01 million and $0.15 million during
the three months ended March 31, 2013 and 2012, respectively. Income tax expense in 2012 resulted from the difference between the
treatment of goodwill for income tax purposes and for U.S. Generally Accepted Accounting Principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Overview</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our primary source of cash during the first quarter 2013 was
provided by our operating activities. Our future capital requirements will depend on many factors, including, the progress of
our research and development programs; the progress of pre-clinical and clinical testing; the time and cost involved in obtaining
regulatory approval; the cost of filing, prosecuting, defending and enforcing any patent claims and other intellectual property
rights; changes in our existing research relationships; competing technological and marketing developments; our ability to establish
collaborative arrangements and to enter into licensing agreements and contractual arrangements with others; and any future change
in our business strategy.&nbsp; These cash requirements could change materially as a result of shifts in our business and strategy.
The need to raise additional capital will depend on many factors, including but not limited to, our future cash requirements,
future contract funding, whether SIGA prevails in its appeal challenging the trial court ruling awarding us an interest in a portion
of the net profits of Arestvyr&trade;, the timing, amount, and profitability of sales of Arestvyr&trade;, if any (including the
timing of SIGA&rsquo;s recognition of revenue related thereto), and if the trial court ruling is upheld, our ability to collect
our portion of net profits related to Arestvyr&trade;. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the three months ended March 31, 2013 and 2012, we generated positive cash flows from operations, however, historically, we have
not generated positive cash flows from operations.&nbsp; To bridge the gap between payments made to us under our government contracts
and grants and our operating and capital needs, we have had to rely on a variety of financing sources, including the issuance of
equity securities and equity-linked securities and proceeds from loans and other borrowings.&nbsp; On March 25, 2013, we entered
into a controlled equity offering pursuant to which we may offer and sell, from time to time, through a sales agent, shares of
our common stock having an aggregate offering price of up to $15.0 million.</FONT> (<FONT STYLE="font-family: Times New Roman, Times, Serif">See
<I>Financing Activities</I> below</FONT>). <FONT STYLE="font-family: Times New Roman, Times, Serif">For the foreseeable future,
we will continue to need these types of financing vehicles and potentially others to help fund our future operating and capital
requirements.&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Global economic uncertainty continues to make capital markets
more volatile and is threatening to once again tighten the credit markets. As a result, there can be no assurances that we would
be successful in obtaining sufficient financing on commercially reasonable terms or at all. In addition, due&nbsp;to the U.S. government&rsquo;s
continuing substantial efforts to stabilize the economy, the U.S. government may be forced or choose to reduce or delay spending
in the&nbsp;biodefense field, which could decrease the likelihood of future government contract awards, the likelihood that the
government will exercise its right to extend any of its existing contracts with us and/or the likelihood that the government would
procure products from us.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our unaudited condensed consolidated financial statements
have been prepared on a basis which assumes that we will continue as a going concern and which contemplates the realization
of assets and the satisfaction of liabilities and commitments in the normal course of business and do not include any
adjustments that might result if the carrying amount of recorded assets and liabilities are not realized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Sources and Uses of Cash</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash and cash equivalents were $12.9 million and $12.7 million
at March 31, 2013 and December 31, 2012, respectively.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Cash Flows</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table provides information regarding our cash
flows for the three months ended March 31, 2013 and 2012:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 78%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; border-bottom: Black 1pt solid; text-align: center">Three months ended March 31,</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">2013</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: center; border-bottom: Black 1pt solid">2012</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">Net cash provided by (used in):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">Operating activities</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">260,401</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">791,370</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">Investing activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">(25,468</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">67,400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">Financing activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">(60,361</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">3,204,614</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left; padding-bottom: 1pt">Effects of exchange rates on cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">(2,678</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">4,034</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; text-align: left; padding-bottom: 2.5pt">Total increase in net cash</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">171,894</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; color: black; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; color: black; text-align: right">4,067,418</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; color: black; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Operating Activities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net cash provided by operating activities was $0.3 million and
$0.8 million and for the three months ended March 31, 2013 and 2012, respectively.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net cash provided by operating activities during the three months
ended March 31, 2013 reflects our net loss of $2.1 million, adjusted for the increase in the fair value of derivative instruments
of $0.9 million and other noncash expenses of $0.4 million. A decrease in receivables (billed and unbilled) of approximately $1.0
million and an increase in accrued expenses and other liabilities of $1.0 million was partially offset by a decrease in accounts
payable of $0.4 million and deferred revenue of $0.5 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net cash provided by operations during the three months ended
March 31, 2012 reflects our net loss of $2.7 million, adjusted for the increase in the fair value of derivative instruments of
$1.0 million and other noncash expenses of $0.8 million.&nbsp;A decrease in accounts receivable of $3.3 million was partially offset
by an increase in unbilled accounts receivable of $1.3 million.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Investing Activities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There were no significant investing activities during the three
months ended March 31, 2013 and March 31, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Financing Activities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net cash used by financing activities was $0.06 million for
the three months ended March 31, 2013, as compared to, $3.2 million provided by financing activities for the three months ended
March 31, 2012.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net cash used by financing activities for the three months ended
March 31, 2013 was principally the result of issuance costs incurred in connection with the controlled equity offering which were
partially offset from proceeds received from the issuance of common stock in connection with stock option exercises. The majority
of our cash provided by financing for the three months ended March 30, 2012, was a result of us entering into a senior fully-secured
debt facility with GE Capital as described in Note 6 to the unaudited condensed consolidated financial statements, which is included
in Part 1 of this Form 10-Q.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 25, 2013, we entered into a controlled equity offering
pursuant to which we may offer and sell, from time to time, through a sales agent, shares of our common stock having an aggregate
offering price of up to $15.0 million. Under the arrangement, the agent may sell shares by any method permitted by law and deemed
to be an &ldquo;at-the-market&rdquo; offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended,
including sales made directly on NYSE MKT, on any other existing trading market for the Common Stock or to or through a market
maker. We are not obligated to sell any shares under the Sales Agreement. We are obligated to pay the agent a commission of 3.0%
of the aggregate gross proceeds from each sale of shares. See additional discussion in Note 6 to the unaudited condensed consolidated
financial statements which are included in Part 1 of this Form 10-Q.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We do not have any off-balance sheet arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contractual Obligations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following are contractual commitments at March 31, 2013:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Contractual&nbsp;Obligations(1)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Less&nbsp;than&nbsp;1 <BR> Year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">1-3&nbsp;Years</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">3-5&nbsp;Years</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">More&nbsp;than <BR> 5&nbsp;years</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 35%; font: 10pt Times New Roman, Times, Serif; text-align: left">Operating facility leases</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">3,429,900</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">803,500</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,631,200</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">995,200</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development agreements</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,760,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,760,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Term loan, principal payments only</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,500,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">999,996</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,500,004</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total contractual obligations</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">10,689,900</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,563,496</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,131,204</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">995,200</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1)&nbsp;&nbsp;This table does not include any royalty payments
relating to future sales of products subject to license agreements the Company has entered into in relation to its in-licensed
technology, as the timing and likelihood of such payments are not known. In addition, the table does not include the final payment
fee of $75,000 on the term loan, which is being accrued and expensed over the term of the agreement, using the effective interest
method, or the debt discount, which is being amortized over the term of the agreement. The debt discount and final payment accrual
at March 31, 2013 were $39,587 and $32,009 respectively. See additional discussion in Note 6 to the unaudited condensed consolidated
financial statements which are included in Part 1 of this Form 10-Q.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 3.&nbsp; Quantitative and Qualitative Disclosures about
Market Risk.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our exposure to market risk is currently confined to our cash
and cash equivalents and our revolving line of credit.&nbsp;&nbsp;&nbsp;We currently do not hedge interest rate exposure or foreign
currency exchange exposure.&nbsp;&nbsp;We have not used derivative financial instruments for speculation or trading purposes.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s current operations in foreign countries
are minimal. We have closed our active operations in Canada and maintain only nominal operations in the United Kingdom. A 10% change
in exchange rates (against the U.S. dollar) would not have a material impact on earnings, fair values or cash flow.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because of the short-term maturities of our cash and cash equivalents,
we do not believe that an increase in market interest rates would have a significant impact on their realized value.&nbsp;Our term
loan with GE Capital is at a fixed 10.14% rate. Because of the fixed rate, a change in market interest rates would not have a material
impact on interest expense associated with the loan. The interest rate on the revolving line of credit is variable; therefore,
a 1% increase in market interest rates above the interest rate floor of 1.5%, would increase interest expense associated with the
line by $50,000 if the maximum amount of the line ($5.0 million) was drawn for a full year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The change in fair value of our derivative instruments is calculated
utilizing the Black-Scholes model; therefore, a 10% increase/decrease in the closing price of PharmAthene&rsquo;s common stock
at March 31, 2013, would result in a change in fair value of derivative instruments and our earnings of approximately $0.3 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 4.&nbsp;&nbsp;Controls and Procedures.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Evaluation of Disclosure Controls and Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our management, including our principal executive and principal
financial officers, has evaluated the effectiveness of our disclosure controls and procedures as of March&nbsp;31, 2013. Our disclosure
controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in reports we
file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the
time periods specified in the Securities and Exchange Commission&rsquo;s rules and forms, and that such information is accumulated
and communicated to our management, including our principal executive and principal financial officers, to allow timely decisions
regarding required disclosure. Based on that evaluation, our principal executive and principal financial officers have concluded
that our disclosure controls and procedures are effective at the reasonable assurance level.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Changes in Internal Control Over Financial Reporting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our management, including our principal executive and principal
financial officers, has evaluated any changes in our internal control over financial reporting that occurred during the quarterly
period ended March&nbsp;31, 2013, and has concluded that there was no change that occurred during the quarterly period ended March&nbsp;31,
2013 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PART&nbsp;II &mdash; OTHER INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 1.&nbsp; Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Except as noted below, we are not a defendant in any legal
proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December 2006, we filed a complaint against SIGA Technologies,
Inc. (&ldquo;SIGA&rdquo;) in the Delaware Court of Chancery.&nbsp;&nbsp;The complaint alleged, among other things, that we have
the right to license exclusively development and marketing rights for SIGA&rsquo;s drug candidate, Arestvyr&trade; (Tecovirimat),
pursuant to a merger agreement between the parties that was terminated in 2006.&nbsp;&nbsp;The complaint also alleged that SIGA
failed to negotiate in good faith the terms of such a license pursuant to the terminated merger agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In September 2011, the Court issued an opinion in the case finding
that SIGA had breached certain contractual obligations to us and upholding our claims of promissory estoppel.&nbsp;&nbsp;The Court
awarded us&nbsp;the right to receive&nbsp;50% of all net profits (as defined in the court&rsquo;s final judgment) related to the
sale of Arestvyr&trade; and related products for 10 years following initial commercial sale of the drug once SIGA earns $40 million
in net profits from the sale of Arestvyr&trade;<FONT STYLE="color: #222222"> </FONT>and related products. &nbsp;The Court also
awarded us one-third of our reasonable attorney's fees and expert witness fees, which amounts to approximately $2.4 million plus
interest. In May 2012, the Court issued its final judgment. SIGA has appealed aspects of the decision to the Delaware Supreme Court.
In response, we cross-appealed other aspects of the decision. In January 2013, the Delaware Supreme Court heard oral argument in
the case.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We can provide no assurances that SIGA will not prevail on its
appeal, that we will be successful in our appeal, and that the Delaware Supreme Court will not overturn the trial court&rsquo;s
decision awarding us a 10 year 50% net profit of the sales of Arestvyr&trade;<FONT STYLE="color: #222222"> </FONT>and related products
(once SIGA retains the first $40 million in net profit). We have not yet recorded any amount due from SIGA in relation to this
case.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">One of our vendors mishandled the storage of certain biological
materials. While we have been engaged in discussions with the vendor to address our concerns, so far we have not come
to agreement. The vendor filed suit against us in Delaware state court seeking a declaration that they are not liable for damages
and seeking damages from us for allegedly not maintaining the required amount and type of insurance. We filed suit against the
vendor in Maryland state court seeking damages related to the loss of the property. We believe we did maintain the appropriate
amount and type of insurance, that in no event did we harm the vendor, and thus their damages claim is without merit. We plan to
vigorously defend against their claims while pursuing our own.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 1A.&nbsp;&nbsp;Risk Factors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Investing in our securities involves risks.&nbsp; In addition
to the other information in this quarterly report on Form&nbsp;10-Q, stockholders and potential investors should carefully consider
the risks&nbsp;and uncertainties discussed&nbsp;in the section &quot;Item 1A.&nbsp; Risk Factors&quot; in our annual report on
Form 10-K for the year ended December 31, 2012.&nbsp; If any of&nbsp;the risks and&nbsp;uncertainties set forth in our 2012 annual
report on Form 10-K&nbsp;actually&nbsp;materialize, our business, financial condition and/or results of operations could be materially
adversely affected, the trading price of our common stock could decline and a stockholder could lose all or part of his or her
investment. The risks and uncertainties set forth in our 2012 annual report on Form 10-K are not the only ones we face.&nbsp; Additional
risks and uncertainties not presently known to us or that we currently consider immaterial may also impair our business operations.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 2.&nbsp;&nbsp;Unregistered Sales of Equity Securities
and Use of Proceeds</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 3. Default upon Senior Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white">Not
applicable</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 4. Mine Safety Disclosures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 5. Other Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 6.&nbsp; Exhibits.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; border-bottom: black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">No.</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 88%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Description</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.30.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Amendment to Employment Agreement, dated as of December 23, 2010, between the Company and Eric I. Richman (2)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.61</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Controlled Equity Offering<SUP>SM</SUP> Sales Agreement between PharmAthene, Inc. and Cantor Fitzgerald &amp; Co. dated March 25, 2013. (1)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.6</FONT>2</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Employment Agreement, dated as of April 18, 2008, between the
    Company and Francesca Cook.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>31.1</TD>
    <TD>&nbsp;</TD>
    <TD>Certification of Principal Executive Officer Pursuant to SEC Rule&nbsp;13a-14(a)/15d-14(a)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">31.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certification of Principal Financial Officer Pursuant to SEC Rule&nbsp;13a-14(a)/15d-14(a)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">32.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section&nbsp;1350</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">32.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section&nbsp;1350</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(101)</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 90%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The following condensed consolidated financial statements from the PharmAthene, Inc. Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2013, formatted in Extensive Business Reporting Language (&quot;XBRL&quot;): (i) Condensed Consolidated Balance Sheets as of March 31, 2013 and December 31, 2012, (ii) Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2013 and 2012, (iii) Unaudited Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2013 and 2012, (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2013 and 2012, and (v) Notes to consolidated financial statements.*</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.INS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Instance Document*</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.SCH</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Schema Document*</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.CAL</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Calculation Linkbase Document*</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.DEF</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Definition Linkbase Document*</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.LAB</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Label Linkbase Document*</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">101.PRE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Presentation Linkbase Document*</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to the Current Report on Form 8-K filed by the Registrant on March 25, 2013</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to the Current Report on Form 8-K filed by the Registrant on December 30, 2010</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of Section&nbsp;13 or 15(d)&nbsp;of
the Securities Exchange Act of 1934, the Registrant has duly caused the report to be signed on its behalf by the undersigned, thereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">PHARMATHENE, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dated: May 8, 2013</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Eric I. Richman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Eric I. Richman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">President and Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dated: May 8, 2013</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Linda L. Chang</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Linda L. Chang</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.62
<SEQUENCE>2
<FILENAME>v341092_ex10-62.htm
<DESCRIPTION>EXHIBIT 10.62
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 10.62</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EMPLOYMENT AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This <B>EMPLOYMENT</B> <B>AGREEMENT</B> (this &ldquo;<B><U>Agreement</U></B>&rdquo;)
is made and entered into this April 18, 2008 by and between Francesca Cook (the &ldquo;<B><U>Executive</U></B>&rdquo;) and <B>PharmAthene,
Inc.</B>, a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">W I T N E SS E T H:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS</B>, the Company desires to employ
the Executive and the Executive desires to accept employment with the Company subject to the terms and conditions herein agreed
upon:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>NOW, THEREFORE,</B> in consideration
of the foregoing and of the mutual covenants and obligations hereinafter set forth, the parties hereto hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD><B>Employment;</B> <B>Term</B>. The Company hereby agrees to employ the Executive and the Executive hereby accepts employment
with the Company upon the terms and conditions hereinafter set forth for the period commencing on April 18, 2008 (the &ldquo;<B><U>Effective</U></B><U>
<B>Date</B></U>&rdquo;) and ending on the first anniversary of such date. The term of this Agreement shall be automatically extended
for an additional year on each anniversary of the date hereof unless written notice of non-extension is provided by either party
to the other party at least 90 days prior to such anniversary. The period of the Executive&rsquo;s employment under this Agreement,
as it may be terminated or extended from time to time as provided herein is referred to as the &ldquo;<B><U>Employment</U></B><U>
<B>Period</B></U>.&rdquo;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD><B>Position and Duties</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">a.</TD><TD><B>Position and Duties Generally</B>. The Executive shall be employed by the Company in the position of Vice President, Policy
&amp; Government Affairs and shall faithfully render such executive, managerial, administrative and other services as are customarily
associated with and incident to such position and as the Company may from time to time reasonably require consistent with such
position. The Executive shall report to the President and CEO, David P. Wright.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">b.</TD><TD><B>Other Positions</B>. The Executive shall hold such other positions and executive offices with the Company and/or of any
of the Company&rsquo;s subsidiaries or affiliates as may from time to time be authorized by the Board. The Executive shall not
be entitled to any compensation other than the compensation provided for herein for serving during the Employment Period in any
other office or position of the Company or any of its subsidiaries or affiliates, unless the Compensation Committee specifically
approves such additional compensation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">c.</TD><TD><B>Devotion to Employment</B>. Except for vacation time taken in accordance with the Company&rsquo;s vacation policy in effect
from time to time and in accordance with the terms of this Agreement and for absences due to temporary illness, the Executive shall
be a full-time employee of the Company and shall devote full time, attention and efforts during the Employment Period to the business
of the Company and the duties required of him in his position. During the Employment Period, the Executive shall not be engaged
in any other business activity which, in the reasonable judgment of the Board or its designee, conflicts with the duties of the
Executive hereunder, whether or not such activity is pursued for gain, profit or other pecuniary advantage.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 1; Section: Part B -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD><B>Compensation; Reimbursement</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">a.</TD><TD><B>Base Salary</B>. For the Executive&rsquo;s services, the Company shall pay to the Executive an annual base salary of not
less than $231,612.00 per annum, payable in equal periodic installments according to the Company&rsquo;s customary payroll practices,
but no less frequently than monthly. The Executive&rsquo;s base salary shall be subject to review annually by the Compensation
Committee and shall be subject to increase at the option and sole discretion of the Compensation Committee.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">b.</TD><TD><B>Bonus</B>. The Executive shall be eligible to receive at the sole discretion of the Compensation Committee, an annual cash
bonus of up to an additional 30% of the Executive&rsquo;s base salary. In addition, the Executive may be eligible for additional
bonuses at the option and sole discretion of the Compensation Committee based upon the achievement of certain pre-determined performance
milestones.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">c.</TD><TD><B>Benefits</B> <B>Generally</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.2in">i.</TD><TD>In addition to the salary and cash bonus described above, the Executive shall be entitled during the Employment Period to participate
in such employee benefit plans and programs of the Company, and shall be entitled to such other fringe benefits, as are from time
to time made available by the Company generally to employees of the level, position, tenure, salary, age, health and other qualifications
of the Executive including, without limitation, medical, dental and vision insurance coverage for the Executive and the Executive&rsquo;s
dependents, disability, death benefit and life insurance and pension plans.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.2in">ii.</TD><TD>Without limiting the generality of the foregoing, the Executive shall be eligible for such awards, if any, including stock
and stock options under the Company&rsquo;s 2007 Long-Term Incentive Plan or such other plan as the Company may from time to time
put into effect as shall be granted to the Executive by the Compensation Committee or other appropriate designee of the Board acting
in its sole discretion.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.2in">iii.</TD><TD>The Executive acknowledges and agrees that the Company does not guarantee the adoption or continuance of any particular employee
benefit plan and participation by the Executive in any such plan or program shall be subject to the rules and regulations applicable
thereto.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">d.</TD><TD><B>Vacation</B>. The Executive shall be entitled to 20 days of vacation in each calendar year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">e.</TD><TD><B>Expenses</B>. The Company shall reimburse the Executive in accordance with the practices in effect from time to time for
other officers or staff personnel of the Company for all reasonable and necessary business and travel expenses and other disbursements
incurred by the Executive for or on behalf of the Company in the performance of the Executive&rsquo;s duties hereunder, upon presentation
by the Executive to the Company of appropriate supporting documentation.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 2; Section: Part B -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">f.</TD><TD><B>Perquisites</B>. The Executive shall be entitled to those perquisites as the Company shall make available from time to time
to other executive officers of the Company, which shall include, without limitation, the costs associated with the use of an automobile
in an amount not to exceed $1,000 per month and the costs for Executive&rsquo;s use of a cellular telephone and personal digital
assistant to the extent such equipment is used for business purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD><B>Death; Disability.</B> In the event that the Executive dies or is incapacitated or disabled by accident, sickness or otherwise,
so as to render the Executive mentally or physically incapable of performing the services required to be performed by the Executive
under this Agreement for a period that would entitle the Executive to qualify for long-term disability benefits under the Company&rsquo;s
then-current long-term disability insurance program or, in the absence of such a program, for a period of 120 consecutive days
or longer (such condition being herein referred to as a &ldquo;<B><U>Disability</U></B>&rdquo;) then (i) in the case of the Executive&rsquo;s
death, the Executive&rsquo;s employment shall be deemed to terminate on the date of the Executive&rsquo;s death and (ii) in the
case of a Disability, the Company, at its option, may terminate the employment of the Executive under this Agreement immediately
upon giving the Executive notice to that effect. The determination to terminate the Executive in the event of a Disability shall
be made by the Board or the Board&rsquo;s designee. In the case of a Disability, until the Company shall have terminated the Executive&rsquo;s
employment hereunder in accordance with the foregoing, the Executive shall be entitled to receive compensation provided for herein
notwithstanding any such physical or mental disability.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD><B>Termination For Cause</B>. The Company may terminate the employment of the Executive hereunder at any time during the Employment
Period for &ldquo;cause&rdquo; (such termination being herein referred to as a &ldquo;<B><U>Termination for Cause</U></B>&rdquo;)
by giving the Executive notice of such termination, which termination shall be effective on the date of such notice or such later
date as may be specified by the Company. For purposes of this Agreement, &ldquo;<B><U>Cause</U></B>&rdquo; means (i) the Executive&rsquo;s
willful and substantial misconduct that is materially injurious to the Company and is either repeated after written notice from
the Company specifying the misconduct or is continuing and not corrected within 20 days after written notice form the Company specifying
the misconduct, (ii) the Executive&rsquo;s repeated neglect of duties or failure to act which can reasonably be expected to affect
materially and adversely the business or affairs of the Company after written notice from the Company specifying the neglect or
failure to act, (iii) the Executive&rsquo;s material breach of any of the agreements contained in Sections 11, 12, 13 or 14 hereof
or of any of the Company&rsquo;s policies, (iv) the commission by the Executive of any material fraudulent act with respect to
the business and affairs of the Company, (v) the Executive&rsquo;s conviction of (or plea of nolo contendere to) a crime constituting
a felony, (vi) demonstrable gross negligence, or (vii) habitual insobriety or use of illegal drugs by the Executive while performing
the Executive&rsquo;s duties under this Agreement which adversely affects the Executives performance of the Executive&rsquo;s duties
under this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 3; Section: Part B -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.</B></TD><TD><B>Termination Without Cause</B>. The Company may terminate the employment of the Executive hereunder at any time without &ldquo;cause&rdquo;
or fail to extend this Agreement pursuant to the terms hereof (such termination being herein referred to as &ldquo;<B><U>Termination
Without Cause</U></B>&rdquo;) by giving the Executive notice of such termination, upon the giving of which such termination shall
take effect not later than 30 days from the date such notice is given.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.</B></TD><TD><B>Voluntary Termination by Executive</B>. Any termination of the employment of the Executive by the Executive otherwise than
as a result of death or Disability or for Good Reason (as defined below) (such termination being herein referred to as &ldquo;<B><U>Voluntary</U></B><U>
<B>Termination</B></U>&rdquo;). A Voluntary Termination will be deemed to be effective immediately upon such termination.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>8.</B></TD><TD><B>Termination by Executive for Good Reason</B>. Any termination of the employment of the Executive by the Executive for Good
Reason which shall be deemed to be equivalent to a Termination without Cause. For purposes of this Agreement &ldquo;<B><U>Good</U></B><U>
<B>Reason</B></U>&rdquo; means (i) any material breach by the Company of any of its obligations under this Agreement, (ii) any
material reduction in the Executive&rsquo;s duties, authority or responsibilities without the Executive&rsquo;s consent, (iii)
any assignment to the Executive of duties or responsibilities materially inconsistent with the Executive&rsquo;s position and duties
contained in this Agreement without the Executive&rsquo;s consent, (iv) a relocation of the Company&rsquo;s principal executive
offices or the Company determination to require the Executive to be based anywhere other than within 25 miles of the location at
which the Executive on the date hereof performs the Executive&rsquo;s duties; (v) the taking of any action by the Company which
would deprive the Executive of any material benefit plan (including, without limitation, any medical, dental, disability or life
insurance); or (vi) the failure by the Company to obtain the specific assumption of this Agreement by any successor or assignee
of the Company or any person acquiring substantially all of the Company&rsquo;s assets; provided, however, that the Executive may
not terminate the Employment Period for Good Reason unless the Executive first provides the Company with written notice specifying
the Good Reason and providing the Company with 20 days in which to remedy the stated reason.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>9.</B></TD><TD><B>Effect of Termination of Employment</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">a.</TD><TD><B>Voluntary Termination; Termination For Cause</B>. Upon the termination of the Executive&rsquo;s employment as a result of
the Executive&rsquo;s Voluntary Termination or a Termination For Cause, the Executive shall not have any further rights or claims
against the Company under this Agreement except the right to receive (i) the unpaid portion of the base salary provided for in
Section 3(a) hereof, computed on a pro rata basis to the date of termination, (ii) payment of the Executive&rsquo;s accrued but
unpaid amounts and extension of applicable benefits in accordance with the terms of any incentive compensation, retirement, employee
welfare or other employee benefit plans or programs of the Company in which the Executive is then participating in accordance with
the terms of such plans or programs, and (iii) reimbursement for any expenses for which the Executive shall not have theretofore
been reimbursed as provided in Section 3 hereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 4; Section: Part B -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">b.</TD><TD><B>Termination Without Cause; Termination for Good Reason</B>. Upon the termination of the Executive&rsquo;s employment as
a result of a Termination Without Cause or for Good Reason, the Executive shall not have any further rights or claims against the
Company under this Agreement except the right to receive (i) the payments and other rights provided for in Section 9(a) hereof
and (ii) severance payments in the form of a continuation of the Executive&rsquo;s base salary as in effect immediately prior to
such termination for a period of 6 (six) months following the effective date of such termination. To the extent that severance
payments shall be payable under this Agreement such payments shall be in consideration for and only after the Executive executes
a General Release containing terms reasonably satisfactory to the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">c.</TD><TD><B>Death and Disability</B>. Upon the termination of the Executive&rsquo;s employment as a result of death or Disability, neither
the Executive nor the Executive&rsquo;s beneficiaries or estate shall have any further rights or claims against the Company under
this Agreement except the right to receive the payments and other rights provided for in Section 9(a) hereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">d.</TD><TD><B>Forfeiture of Rights</B>. In the event that, subsequent to termination of employment hereunder, the Executive (i) breaches
any of the provisions of Sections 11, 12, 13 or 14 hereof or (ii) makes or facilitates the making of any adverse public statements
or disclosures with respect to the business or securities of the Company, all payments and benefits to which the Executive may
otherwise have been entitled shall immediately terminate and be forfeited, and any portion of such amounts as may have been paid
to the Executive shall forthwith be returned to the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>10.</B></TD><TD><B>Disclosure of Confidential Information</B>. The Executive shall not, directly or indirectly, at any time during or after
the Employment Period, disclose to any person, firm, corporation or other business entity, except as required by law, or use for
any purpose except in the good faith performance of the Executive&rsquo;s duties to the Company, any Confidential Information (as
herein defined). For purposes of this Agreement, &ldquo;<B><U>Confidential Information</U></B>&rdquo; means all trade secrets and
other non-public information of a business, financial , marketing, technical or other nature pertaining to the Company or any subsidiary,
including information of others that the Company or any subsidiary has agreed to keep confidential; provided, however, that Confidential
Information shall not include any information that has entered or enters the public domain (other than through breach of the Executive&rsquo;s
obligations under this Agreement) or which the Executive is required to disclose by law or legal process. Upon the Company&rsquo;s
request at any time, the Executive shall immediately deliver to the Company all materials in the Executive&rsquo;s possession which
contain Confidential Information.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 5; Section: Part B -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>11.</B></TD><TD><B>Restrictive Covenant</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">a.</TD><TD><B>Term of Restrictive Covenant</B>. The Executive hereby acknowledges and recognizes that, during the Employment Period, the
Executive shall be privy to trade secrets and Confidential Information critical to the Company&rsquo;s business and the Executive
further acknowledges and recognizes that the Company would find it extremely difficult or impossible to replace the Executive and,
accordingly, the Executive agrees that, in consideration of the benefits to be received by the Executive hereunder, the Executive
shall not, from and after the date hereof, throughout the Employment Period, and for a period of 12 months following the termination
of the Employment Period (i) directly or indirectly engage in the development, production, marketing or sale of products that compete
(or, upon commercialization, would compete) with products of the Company being developed (so long as such development has not been
abandoned), marketed or sold at the time of the termination of the Employment Period (such business or activity being herein referred
to as a &ldquo;<B><U>Competing</U></B><U> <B>Business</B></U>&rdquo;) whether such engagement shall be as an officer, director,
owner, employee, partner, affiliate or other participant in any Competing Business, (ii) assist others in engaging in any Competing
Business in the manner described in the foregoing clause (i), or (iii) induce other employees of the Company or any subsidiary
thereof to terminate their employment with the Company or any subsidiary thereof or engage in any Competing Business or hire any
employees of the Company or any subsidiary unless such persons have not been employees of the Company for at least 12 months.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">b.</TD><TD><B>Sufficient Consideration</B>. The Executive understands that the foregoing restrictions may limit the ability of the Executive
to earn a livelihood in a business similar to the business of the Company, but nevertheless believes that the Executive has received
and shall receive sufficient consideration and other benefits, as an employee of the Company and as otherwise provided hereunder,
to justify such restrictions which, in any event (given the education, skills and ability of the Executive), the Executive believes
would not prevent the Executive from earning a living.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>12.</B></TD><TD><B>Non-Disparagement</B>. The Executive shall not engage in conduct, through word, act, gesture or other means, or disclose
any information to the public or any third party which (i) directly or indirectly discredits or disparages in whole or in part
the company, its subsidiaries, divisions, affiliates and/or successors as well as the products and the respective officers, directors,
stockholders and employees of each of them; (ii) is detrimental to the reputation, character or standing of these entities, their
products or any of their respective officers, directors, stockholders and/or employees; or (iii) which generally reflects negatively
on the management decisions, strategy or decision-making of these entities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.</B></TD><TD><B>Company Right to Inventions</B>. The Executive shall promptly disclose, grant and assign to the Company, for its sole use
and benefit, any and all inventions, improvements, technical information and suggestions relating in any way to the business of
the Company which the Executive may develop or acquire during the Employment Period (whether or not during usual working hours),
together with all patent applications, letters patent, copyrights and reissues thereof that may at any time be granted for or upon
any such invention, improvement or technical information. In connection therewith: (i) the Executive shall, without charge, but
at the expense of the Company, promptly at all times hereafter execute and deliver such applications, assignments, descriptions
and other instruments as may be necessary or proper in the opinion of the Company to vest title to any such inventions, improvements,
technical information, patent applications, patents, copyrights or reissues thereof in the Company and to enable it to obtain and
maintain the entire right and title thereto throughout the world, and (ii) the Executive shall render to the Company, at its expense
(including a reasonable payment for the time involved in case the Executive is not then in its employ), all such assistance as
it may require in the prosecution of applications for said patents, copyrights or reissues thereof, in the prosecution or defense
of interferences which may be declared involving any said applications, patents or copyrights and in any litigation in which the
Company may be involved relating to any such patents, inventions, improvements or technical information.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 6; Section: Part B -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.</B></TD><TD><B>Enforcement.</B> It is the desire and intent of the parties hereto that the provisions of this Agreement be enforceable
to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought.
Accordingly, to the extent that a restriction contained in this Agreement is more restrictive than permitted by the laws of any
jurisdiction where this Agreement may be subject to review and interpretation, the terms of such restriction, for the purpose only
of the operation of such restriction in such jurisdiction, shall be the maximum restriction allowed by the laws of such jurisdiction
and such restriction shall be deemed to have been revised accordingly herein.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>15.</B></TD><TD><B>Remedies; Survival</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">a.</TD><TD><B>Injunctive Relief</B>. The Executive acknowledges and understands that the provisions of the covenants contained in Sections
11, 12, 13 and 14 hereof, the violation of which cannot be accurately compensated for in damages by an action at law, are of crucial
importance to the Company, and that the breach or threatened breach of the provisions of this Agreement would cause the Company
irreparable harm. In the event of a breach or threatened breach by the Executive of the provisions of Sections 11, 12, 13 or 14
hereof, the Company shall be entitled to an injunction restraining the Executive from such breach. Nothing herein contained shall
be construed as prohibiting the Company from pursuing any other remedies available for any breach or threatened breach of this
Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in">b.</TD><TD><B>Survival</B>. Notwithstanding anything contained in this Agreement to the contrary, the provisions of the Sections 3, 9,
and 11 through 17 hereof shall survive the expiration or earlier termination of this Agreement until, by their terms, such provisions
are no longer operative.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>16.</B></TD><TD><B>Notices.</B> Notices and other communications hereunder shall be in writing and shall be delivered personally or sent by
air courier or first class certified or registered mail, return receipt requested and postage prepaid, addressed as follows:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">if to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">PharmAthene, Inc.<BR>
One Park Place, Suite 450<BR>
Annapolis, Maryland 21401</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 7; Section: Part B -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">with a copy to:<BR>
McCarter &amp; English, LLP<BR>
Four Gateway Center<BR>
100 Mulberry Street<BR>
Newark, New Jersey 07102<BR>
Attention: Jeffrey Baumel, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">if to the Executive to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">with a copy to :</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">All notices and other communications given to any party
hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of delivery, if personally
delivered; on the business day after the date when sent, if sent by air courier; and on the third business day after the date when
sent, if sent by mail, in each case addressed to such party as provided in this Section 16 or in accordance with the latest unrevoked
direction from such party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>17.</B></TD><TD><B>Binding Agreement; Benefit</B>. The provisions of this Agreement shall be binding upon, and shall inure to the benefit of,
the respective heirs, legal representatives and successors of the parties hereto.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>18.</B></TD><TD><B>Governing Law; Jurisdiction</B>. This Agreement shall be governed by, and construed and enforced in accordance with, the
laws of the State of Maryland applicable to contract made and to be performed therein. Any action to enforce any of the provisions
of this Agreement shall be brought in a court of the State of Maryland or in Federal court located within that State. The parties
consent to the jurisdiction of such courts and to the service of process in any manner provided by Maryland law. Each party irrevocably
waives any objection which it may now or hereafter have to the laying of the venue of any such suit, action or proceeding brought
in such court and any claim that such suit, action or proceeding brought in such court has been brought in an inconvenient forum
and agrees that service of process in accordance with the foregoing shall be deemed in every respect effective and valid personal
service of process upon such party.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>19.</B></TD><TD><B>Waiver of Breach</B>. The waiver by either party of a breach of any provision of this Agreement by the other party must
be in writing and shall not operate or be construed as a waiver of any subsequent breach by such other party.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>20.</B></TD><TD><B>Entire Agreement; Amendments</B>. This Agreement contains the entire agreement between the parties with respect to the subject
matter hereof and supersedes all prior agreements or understandings among the parties with respect thereof. This Agreement may
be amended only by an agreement in writing signed by the parties hereto.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>21.</B></TD><TD><B>Headings</B>. The section headings contained in this Agreement are for reference purposes only and shall not affect in any
way the meaning or interpretation of this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>22.</B></TD><TD><B>Severability</B>. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such
jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions
hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision
in any other jurisdiction.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 8; Section: Part B -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>23.</B></TD><TD><B>409A Compliance</B>. The intent of the Executive and the Company is that the severance and other benefits payable to the
Executive under this Agreement not be deemed &ldquo;deferred compensation&rdquo; under, and shall otherwise comply with, Section
409A of the Internal Revenue Code of 1986, as amended. The Executive and the Company agree to use reasonable best efforts to amend
the terms of this Agreement from time to time as may be necessary to avoid the imposition of liability under Section 409A of the
Code in any manner that does not materially alter the substantive rights and obligations of the parties hereunder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>24.</B></TD><TD><B>Executive&rsquo;s Acknowledgement</B>. The Executive acknowledges (a) that the Executive has had the opportunity to consult
with independent counsel of his own choice concerning this Agreement and (b) that the Executive has read and understands the Agreement,
is fully aware of its legal effect and has entered into it freely based on the Executive&rsquo;s own judgment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>25.</B></TD><TD><B>Assignment</B>. This Agreement is personal in its nature and the parties hereto shall not, without the consent of the other,
assign or transfer this Agreement or any rights or obligations hereunder; provided, that the provisions hereof shall inure to the
benefit of, and be binding upon, each successor of the Company, whether by merger, consolidation, transfer of all or substantially
all of its assets or otherwise.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>26.</B></TD><TD><B>Counterparts</B>. This Agreement may be executed in two or more counterparts, each of which shall for all purposes constitute
one agreement which is binding on all of the parties hereto.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 9; Section: Part B -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the parties have
duly executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 5%"><B>EXECUTIVE</B></TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><U>/s/ Francesca Cook</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Francesca Cook</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>PHARMATHENE, INC.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ David P. Wright</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>David P. Wright</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>President and Chief Executive Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 10; Section: Part B; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> of 10</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>v341092_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Certification of Principal Executive
Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Pursuant to SEC Rule&nbsp;13a-14(a)/15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Eric I. Richman, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify">I have reviewed this Form&nbsp;10-Q of PharmAthene,&nbsp;Inc.
for the period ended March 31, 2013;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify">Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: justify">Based on my knowledge, the financial statements, and
other financial information included in this report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods presented in this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">4.</TD><TD STYLE="text-align: justify">The registrant&rsquo;s other certifying officer(s)&nbsp;and
I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f)&nbsp;and 15d-15(f))
for the registrant and have:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statement for external purposes in accordance
with generally accepted accounting principles;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect,
the registrant&rsquo;s internal control over financial reporting; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.</TD><TD STYLE="text-align: justify">The registrant&rsquo;s other certifying officer(s)&nbsp;and
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">All significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.9pt; text-indent: -42.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Dated: May 8, 2013</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: windowtext 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Eric I. Richman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:<B> Eric I. Richman</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:<B> Chief Executive Officer</B></FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>v341092_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Certification of Principal Financial
Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<B>Pursuant to
SEC Rule&nbsp;13a-14(a)/15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Linda L. Chang, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify">I have reviewed this Form&nbsp;10-Q of PharmAthene,&nbsp;Inc.
for the period ended March 31, 2013;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify">Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: justify">Based on my knowledge, the financial statements, and
other financial information included in this report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods presented in this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">4.</TD><TD STYLE="text-align: justify">The registrant&rsquo;s other certifying officer(s)&nbsp;and
I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f)&nbsp;and 15d-15(f))
for the registrant and have:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statement for external purposes in accordance
with generally accepted accounting principles;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect,
the registrant&rsquo;s internal control over financial reporting; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 86.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">5.</TD><TD STYLE="text-align: justify">The registrant&rsquo;s other certifying officer(s)&nbsp;and
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.9pt; text-indent: -42.9pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">All significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Dated: May 8, 2013</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: windowtext 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Linda L. Chang</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:<B> Linda L. Chang</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:<B> Chief Financial Officer</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>v341092_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Certification Pursuant to Section&nbsp;1350
of Chapter&nbsp;63</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>of Title&nbsp;18 of the United States
Code</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.9pt">In connection with the Quarterly Report
on Form 10-Q of PharmAthene,&nbsp;Inc. (the &ldquo;Company&rdquo;) for the period ended March 31, 2013, as filed with the Securities
and Exchange Commission (the &ldquo;Report&rdquo;), I, Eric I. Richman, Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. Section&nbsp;1350, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, that to the best of
my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.9pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 3%; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">1. </FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 96%"><FONT STYLE="font-size: 10pt">The Report fully complies with the requirements of Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Securities Exchange Act of 1934.</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">2. </FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: windowtext 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Eric I. Richman</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Eric I. Richman</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Chief Executive Officer</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">May 8, 2013</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A signed original of this written statement
required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This certification is being furnished pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the
Securities Exchange Act of 1934, or otherwise subject to the liability of that section.&nbsp;&nbsp;This certification will not
be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>v341092_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification Pursuant to Section&nbsp;1350
of Chapter&nbsp;63</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of Title&nbsp;18 of the United States
Code</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.9pt">In connection with the Quarterly Report
on Form 10-Q of PharmAthene,&nbsp;Inc. (the &ldquo;Company&rdquo;) for the period ended March 31, 2013, as filed with the Securities
and Exchange Commission (the &ldquo;Report&rdquo;), I, Linda L. Chang, Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. Section&nbsp;1350, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, that to the best of
my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.9pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">The Report fully complies with the requirements of Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Securities Exchange Act of 1934.</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 2%; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 95%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; border-bottom: windowtext 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Linda L. Chang</FONT></TD>
    <TD STYLE="width: 49%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><B>Linda L. Chang</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><B>Chief Financial Officer</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">May 8, 2013</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A signed original of this written statement
required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This certification is being furnished pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the
Securities Exchange Act of 1934, or otherwise subject to the liability of that section.&nbsp;&nbsp;This certification will not
be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>pip-20130331.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Vintage Filings ("VF")-->
<!--produced on 2013-05-07 @ 7:02 AM-->
<xbrl xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pip="http://www.pharmathene.com/20130331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.xbrl.org/2003/instance">
  <link:schemaRef xlink:type="simple" xlink:href="pip-20130331.xsd" />
  <dei:AmendmentFlag id="AmendmentFlag.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate id="CurrentFiscalYearEndDate.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus id="DocumentFiscalPeriodFocus.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">Q1</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus id="DocumentFiscalYearFocus.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">2013</dei:DocumentFiscalYearFocus>
  <dei:DocumentPeriodEndDate id="DocumentPeriodEndDate.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">2013-03-31</dei:DocumentPeriodEndDate>
  <dei:DocumentType id="DocumentType.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">10-Q</dei:DocumentType>
  <dei:EntityCentralIndexKey id="EntityCentralIndexKey.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">0001326190</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding id="EntityCommonStockSharesOutstanding.13295.0.0.0.0.0.0" contextRef="as-of-2013-05-02.13295.0.0.0.0.0.0.0" unitRef="shares" decimals="0">49460686</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityFilerCategory id="EntityFilerCategory.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityRegistrantName id="EntityRegistrantName.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">PHARMATHENE, INC</dei:EntityRegistrantName>
  <dei:TradingSymbol id="TradingSymbol.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">PIP</dei:TradingSymbol>
  <pip:AccruedExpensesAndOtherCurrentLiabilities id="AccruedExpensesAndOtherCurrentLiabilities.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">3294315</pip:AccruedExpensesAndOtherCurrentLiabilities>
  <pip:AccruedExpensesAndOtherCurrentLiabilities id="AccruedExpensesAndOtherCurrentLiabilities.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">2328877</pip:AccruedExpensesAndOtherCurrentLiabilities>
  <pip:BreachOfContractualCommitmentAwardPeriod id="BreachOfContractualCommitmentAwardPeriod.13408.3241.4187.58137.4956.0.0" contextRef="from-2011-09-01-to-2011-09-30.13408.0.3241.4187.58137.4956.0.0">P10Y</pip:BreachOfContractualCommitmentAwardPeriod>
  <pip:CashEquivalentsMaturityPeriod id="CashEquivalentsMaturityPeriod.13250.58129.872.3241.4187.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.58129.872.3241.4187.0.0">P3M</pip:CashEquivalentsMaturityPeriod>
  <pip:ClassOfWarrantOrRightIssuanceDate id="ClassOfWarrantOrRightIssuanceDate.13250.90121.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90121.967.0.0.0.0">2007-03-01</pip:ClassOfWarrantOrRightIssuanceDate>
  <pip:ClassOfWarrantOrRightIssuanceDate id="ClassOfWarrantOrRightIssuanceDate.13250.90122.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90122.967.0.0.0.0">2009-03-01</pip:ClassOfWarrantOrRightIssuanceDate>
  <pip:ClassOfWarrantOrRightIssuanceDate id="ClassOfWarrantOrRightIssuanceDate.13250.90123.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90123.967.0.0.0.0">2009-07-01</pip:ClassOfWarrantOrRightIssuanceDate>
  <pip:ClassOfWarrantOrRightIssuanceDate id="ClassOfWarrantOrRightIssuanceDate.13250.90124.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90124.967.0.0.0.0">2010-04-01</pip:ClassOfWarrantOrRightIssuanceDate>
  <pip:ClassOfWarrantOrRightIssuanceDate id="ClassOfWarrantOrRightIssuanceDate.13250.90125.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90125.967.0.0.0.0">2010-07-01</pip:ClassOfWarrantOrRightIssuanceDate>
  <pip:ClassOfWarrantOrRightIssuanceDate id="ClassOfWarrantOrRightIssuanceDate.13250.90126.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90126.967.0.0.0.0">2011-06-01</pip:ClassOfWarrantOrRightIssuanceDate>
  <pip:ClassOfWarrantOrRightIssuanceDate id="ClassOfWarrantOrRightIssuanceDate.13250.90127.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90127.967.0.0.0.0">2012-03-01</pip:ClassOfWarrantOrRightIssuanceDate>
  <pip:CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares id="CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.13822.85459.85456.0.0.0.0" contextRef="as-of-2013-03-25.13822.0.85459.85456.0.0.0.0" unitRef="pure" decimals="2">0.03</pip:CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares>
  <pip:CourtAwardedFees id="CourtAwardedFees.13408.58137.4956.0.0.0.0" contextRef="from-2011-09-01-to-2011-09-30.13408.0.58137.4956.0.0.0.0" unitRef="USD" decimals="-5">2400000</pip:CourtAwardedFees>
  <pip:DebtInstrumentInterestRateFloorPercentage id="DebtInstrumentInterestRateFloorPercentage.13421.3014.2887.0.0.0.0" contextRef="as-of-2012-03-30.13421.0.3014.2887.0.0.0.0" unitRef="pure" decimals="3">0.015</pip:DebtInstrumentInterestRateFloorPercentage>
  <pip:DebtInstrumentsMaturityDateMonthAndYear id="DebtInstrumentsMaturityDateMonthAndYear.13250.3014.2887.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.3014.2887.0.0.0.0">2015-09</pip:DebtInstrumentsMaturityDateMonthAndYear>
  <pip:FinalPaymentFeeOfTermLoanBalancePercent id="FinalPaymentFeeOfTermLoanBalancePercent.13250.3055.2887.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.3055.2887.0.0.0.0" unitRef="pure" decimals="2">0.03</pip:FinalPaymentFeeOfTermLoanBalancePercent>
  <pip:LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable id="LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.13250.3014.2887.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.3014.2887.0.0.0.0" unitRef="pure" decimals="2">0.85</pip:LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable>
  <pip:LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl id="LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.13250.3014.2887.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.3014.2887.0.0.0.0" unitRef="pure" decimals="1">0.8</pip:LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl>
  <pip:LongTermDebtPrepaymentPremiumPercentOfPrincipal id="LongTermDebtPrepaymentPremiumPercentOfPrincipal.13250.3055.2887.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.3055.2887.0.0.0.0" unitRef="pure" decimals="2">0.03</pip:LongTermDebtPrepaymentPremiumPercentOfPrincipal>
  <pip:LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo id="LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.13250.3055.2887.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.3055.2887.0.0.0.0" unitRef="pure" decimals="2">0.02</pip:LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo>
  <pip:MaximumValueOfStockIssuableUnderStockOffering id="MaximumValueOfStockIssuableUnderStockOffering.13822.85459.85456.0.0.0.0" contextRef="as-of-2013-03-25.13822.0.85459.85456.0.0.0.0" unitRef="USD" decimals="-5">15000000</pip:MaximumValueOfStockIssuableUnderStockOffering>
  <pip:NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract id="NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.13408.58137.4956.0.0.0.0" contextRef="from-2011-09-01-to-2011-09-30.13408.0.58137.4956.0.0.0.0" unitRef="USD" decimals="-6">40000000</pip:NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract>
  <pip:NotesPayableAggregatePrincipalRepaymentAmount id="NotesPayableAggregatePrincipalRepaymentAmount.13250.58122.3139.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.58122.3139.0.0.0.0" unitRef="USD" decimals="-5">200000</pip:NotesPayableAggregatePrincipalRepaymentAmount>
  <pip:NotesPayableAggregatePrincipalRepaymentAmount id="NotesPayableAggregatePrincipalRepaymentAmount.13250.58120.3139.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.58120.3139.0.0.0.0" unitRef="USD" decimals="-5">200000</pip:NotesPayableAggregatePrincipalRepaymentAmount>
  <pip:PercentageOfAggregatePrincipalAmountRedemption id="PercentageOfAggregatePrincipalAmountRedemption.13250.58122.3139.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.58122.3139.0.0.0.0" unitRef="pure" decimals="2">0.01</pip:PercentageOfAggregatePrincipalAmountRedemption>
  <pip:PercentageOfAggregatePrincipalAmountRedemption id="PercentageOfAggregatePrincipalAmountRedemption.13250.58120.3139.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.58120.3139.0.0.0.0" unitRef="pure" decimals="2">0.01</pip:PercentageOfAggregatePrincipalAmountRedemption>
  <pip:PercentageOfNetProfitAwarded id="PercentageOfNetProfitAwarded.13408.58137.4956.0.0.0.0" contextRef="from-2011-09-01-to-2011-09-30.13408.0.58137.4956.0.0.0.0" unitRef="pure" decimals="1">0.5</pip:PercentageOfNetProfitAwarded>
  <pip:ProceedsFromIssuanceOfLongTermDebtAndWarrants id="ProceedsFromIssuanceOfLongTermDebtAndWarrants.13250.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <pip:ProceedsFromIssuanceOfLongTermDebtAndWarrants id="ProceedsFromIssuanceOfLongTermDebtAndWarrants.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">2500000</pip:ProceedsFromIssuanceOfLongTermDebtAndWarrants>
  <pip:RemainingValueOfStockIssuableUnderStockOffering id="RemainingValueOfStockIssuableUnderStockOffering.13248.85459.85456.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.85459.85456.0.0.0.0" unitRef="USD" decimals="-4">14970000</pip:RemainingValueOfStockIssuableUnderStockOffering>
  <pip:RemainingValueOfStockIssuableUnderStockOffering id="RemainingValueOfStockIssuableUnderStockOffering.14840.5009.5007.0.0.0.0" contextRef="as-of-2013-05-07.14840.0.5009.5007.0.0.0.0" unitRef="USD" decimals="-4">13290000</pip:RemainingValueOfStockIssuableUnderStockOffering>
  <pip:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="pure" decimals="2">0.12</pip:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate>
  <pip:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate id="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="pure" decimals="2">0.12</pip:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate>
  <pip:StockOptionsContractualTerm id="StockOptionsContractualTerm.13250.58153.3871.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.58153.3871.0.0.0.0">P10Y</pip:StockOptionsContractualTerm>
  <pip:SupplementalWarrantIssuedInConnectionWithLongTermDebt id="SupplementalWarrantIssuedInConnectionWithLongTermDebt.13250.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <pip:SupplementalWarrantIssuedInConnectionWithLongTermDebt id="SupplementalWarrantIssuedInConnectionWithLongTermDebt.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">69876</pip:SupplementalWarrantIssuedInConnectionWithLongTermDebt>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.13409.0.0.0.0.0.0" contextRef="from-2009-07-01-to-2009-07-31.13409.0.0.0.0.0.0.0">2015-01-28</pip:WarrantExpirationDate>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.14841.0.0.0.0.0.0" contextRef="from-2012-03-01-to-2012-03-30.14841.0.0.0.0.0.0.0">2022-03-30</pip:WarrantExpirationDate>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.13250.58121.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.58121.967.0.0.0.0">2015-01-28</pip:WarrantExpirationDate>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.13250.58123.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.58123.967.0.0.0.0">2017-03-30</pip:WarrantExpirationDate>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.13250.90121.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90121.967.0.0.0.0">2017-03-30</pip:WarrantExpirationDate>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.13250.90122.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90122.967.0.0.0.0">2014-09-30</pip:WarrantExpirationDate>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.13250.90123.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90123.967.0.0.0.0">2015-01-28</pip:WarrantExpirationDate>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.13250.90124.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90124.967.0.0.0.0">2015-10-31</pip:WarrantExpirationDate>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.13250.90125.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90125.967.0.0.0.0">2017-01-31</pip:WarrantExpirationDate>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.13250.90126.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90126.967.0.0.0.0">2016-06-30</pip:WarrantExpirationDate>
  <pip:WarrantExpirationDate id="WarrantExpirationDate.13250.90127.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90127.967.0.0.0.0">2022-03-30</pip:WarrantExpirationDate>
  <pip:WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement id="WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.13250.3055.2887.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.3055.2887.0.0.0.0" unitRef="shares" decimals="0">46584</pip:WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement>
  <us-gaap:AccountsPayableCurrent id="AccountsPayableCurrent.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">1289627</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent id="AccountsPayableCurrent.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">1697280</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-219012</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-217328</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AdditionalFinancialInformationDisclosureTextBlock id="AdditionalFinancialInformationDisclosureTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;Note 6 - Financing Transactions&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Controlled Equity Offering&lt;/em&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; On March 25, 2013, we entered into a controlled equity offering with a sales agent pursuant to which we may offer and sell, from time to time, through the agent shares of our common stock having an aggregate offering price of up to $15.0 million. Under the arrangement, the agent may sell shares by any method permitted by law and deemed to be an "at-the-market" offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, including sales made directly on NYSE MKT, or any other existing trading market for our Common Stock or to or through a market maker. We are not obligated to sell any shares under the arrangement. Subject to the terms and conditions of that agreement, the agent will use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable state and federal law, rules and regulations and the rules of NYSE MKT, to sell shares from time to time based upon our instructions. We are obligated to pay the agent a commission of 3.0% of the aggregate gross proceeds from each sale of shares. Total expenses incurred for the offering, excluding commission payable to the agent, were approximately $277,000. Through March 31, 2013, we sold 19,900 shares of our common stock under this arrangement, which did not settle until April 2013, that resulted in net proceeds to the company of approximately $33,000. As of March 31, 2013, aggregate gross sales for additional common stock of approximately $14.97 million remained available under the arrangement.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Loan Agreement with GE Capital&lt;/em&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; On March 30, 2012, we entered into a Loan Agreement with GE Capital. The Loan Agreement provides for a senior secured debt facility including a $2.5 million term loan and a revolving line of credit of up to $5 million based on our outstanding qualified accounts receivable. On March 30, 2012, the term loan was funded for an aggregate amount of $2.5 million.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Under the terms of the revolving line of credit, the Company may draw down from the revolving line of credit up to 85% of qualified billed accounts receivable and 80% of qualified unbilled accounts receivable. As of March 31, 2013, the total amount available to draw was approximately $2.3 million, of which $1.3 million was drawn and outstanding.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The fixed interest rate on the term loan is 10.14% per annum. The revolving line of credit has an adjustable interest rate based upon the 3-month London Interbank Offered Rate (LIBOR), with a floor of 1.5%, plus 5%. As of March 31, 2013, the interest rate was 6.5%. Both the term loan and the revolving line of credit mature in September 2015. Payments on the term loan were originally interest-only for the first 10 months, which has since been extended to 12 months pursuant to terms of the agreement. Subsequently, the term loan will fully amortize over its remaining term as of March 31, 2013. Principal payments on the term loan are scheduled as follows:&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 35%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Year&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Principal&lt;br /&gt; Payments&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 15%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2013&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 15%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $749,997&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2014&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 999,996&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2015&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 750,007&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $2,500,000&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The term loan, net of discount of $39,587, is recorded on the 2013 condensed consolidated balance sheet, net of debt discount, as follows:&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 54%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 40%; FONT: 10pt Times New Roman, Times, Serif"&gt; Current portion of long-term debt&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"&gt; 999,996&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; Long-term debt, less current portion&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 1,460,417&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; If we prepay the term loan and terminate the revolving line of credit prior to the scheduled maturity date, we are obligated to pay a prepayment premium equal to 3% of the then outstanding principal amount of the term loan if prepaid during the first two years of the loan and 2% if prepaid during the third year or thereafter. In addition, we are obligated to pay a final payment fee of 3% of the term loan balance. The final payment fee is being accrued and expensed over the term of the agreement, using the effective interest method and is included in other long-term liabilities on the condensed consolidated balance sheet.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Our obligations under the Loan Agreement are collateralized by a security interest in substantially all of our assets. While the security interest does not, except in limited circumstances, cover our intellectual property, it does cover any proceeds received by us from the use or sale of our intellectual property.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In connection with the Loan Agreement, we issued GE Capital warrants to purchase 46,584 shares of the Company&amp;#39;s common stock at an exercise price of $1.61 per share. The warrants are exercisable immediately and subject to customary and standard anti-dilution adjustments. The warrants are classified in equity and, as a result, the fair value of the warrants was charged to additional paid-in capital resulting in a debt discount at the date of issuance. The debt discount is being amortized over the term of the loan agreement using the effective interest method. Financing costs incurred in connection with this agreement are also being amortized over the term of the agreement using the effective interest method.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The fair value of the Company&amp;#39;s outstanding borrowings under its revolving credit facility at March 31, 2013 was consistent with its carrying value as of that date primarily due to the short term nature of the Revolver&amp;#39;s repayment terms. The Company determined the fair value of the Term Loan approximated its carrying value as of March 31, 2013.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="AdditionalPaidInCapitalCommonStock.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">210877892</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="AdditionalPaidInCapitalCommonStock.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">210495905</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.13250.85459.85456.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.85459.85456.0.0.0.0" unitRef="USD" decimals="0">277000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.13250.4381.4617.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.4381.4617.0.0.0.0" unitRef="USD" decimals="0">88634</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.13251.4381.4617.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.4381.4617.0.0.0.0" unitRef="USD" decimals="0">117067</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.13250.2354.4617.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.2354.4617.0.0.0.0" unitRef="USD" decimals="0">239947</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.13251.2354.4617.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.2354.4617.0.0.0.0" unitRef="USD" decimals="0">431597</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">328581</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">548664</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="shares" decimals="-5">11600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="shares" decimals="-5">11500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:Assets id="Assets.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">21972385</us-gaap:Assets>
  <us-gaap:Assets id="Assets.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">22741404</us-gaap:Assets>
  <us-gaap:AssetsCurrent id="AssetsCurrent.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">19067512</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="AssetsCurrent.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">19795845</us-gaap:AssetsCurrent>
  <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock id="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Basis of Presentation&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Our unaudited condensed consolidated financial statements include the accounts of PharmAthene, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. Our unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP"). In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly our financial position, results of operations and cash flows. The unaudited condensed consolidated balance sheet at December 31, 2012 has been derived from audited consolidated financial statements at that date. The interim results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosure normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the U.S. Securities and Exchange Commission. We believe that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial statements are read in conjunction with the Consolidated Financial Statements and Notes included in our Annual Report on Form 10-K for the year ended December 31, 2012, filed with the Securities and Exchange Commission. We currently operate in one business segment.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:BilledContractReceivables id="BilledContractReceivables.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">1865916</us-gaap:BilledContractReceivables>
  <us-gaap:BilledContractReceivables id="BilledContractReceivables.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">2432641</us-gaap:BilledContractReceivables>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">12873411</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">12701517</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.13252.0.0.0.0.0.0" contextRef="as-of-2012-03-31.13252.0.0.0.0.0.0.0" unitRef="USD" decimals="0">15304189</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.13253.0.0.0.0.0.0" contextRef="as-of-2011-12-31.13253.0.0.0.0.0.0.0" unitRef="USD" decimals="0">11236771</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="CashAndCashEquivalentsPeriodIncreaseDecrease.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">171894</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="CashAndCashEquivalentsPeriodIncreaseDecrease.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">4067418</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock id="CashAndCashEquivalentsPolicyTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Cash and Cash Equivalents&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Cash and cash equivalents are stated at market value. We consider all highly liquid investments with original maturities of three months or less to be cash equivalents.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable id="ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.13250.90121.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90121.967.0.0.0.0">2007-03-01</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable id="ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.13250.90122.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90122.967.0.0.0.0">2009-09-01</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable id="ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.13250.90123.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90123.967.0.0.0.0">2010-01-01</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable id="ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.13250.90124.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90124.967.0.0.0.0">2010-10-01</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable id="ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.13250.90125.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90125.967.0.0.0.0">2011-01-01</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable id="ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.13250.90126.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90126.967.0.0.0.0">2011-06-01</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable id="ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.13250.90127.967.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.90127.967.0.0.0.0">2012-03-01</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13248.3055.2887.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.3055.2887.0.0.0.0" unitRef="USD_per_warrants" decimals="2">1.61</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13421.0.0.0.0.0.0" contextRef="as-of-2012-03-30.13421.0.0.0.0.0.0.0" unitRef="USD_per_warrants" decimals="2">1.61</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13248.58121.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.58121.967.0.0.0.0" unitRef="USD_per_warrants" decimals="2">2.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13248.58123.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.58123.967.0.0.0.0" unitRef="USD_per_warrants" decimals="2">3.97</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13248.90121.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90121.967.0.0.0.0" unitRef="USD_per_warrants" decimals="2">3.97</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13248.90122.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90122.967.0.0.0.0" unitRef="USD_per_warrants" decimals="2">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13248.90123.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90123.967.0.0.0.0" unitRef="USD_per_warrants" decimals="2">2.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13248.90124.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90124.967.0.0.0.0" unitRef="USD_per_warrants" decimals="2">1.89</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13248.90125.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90125.967.0.0.0.0" unitRef="USD_per_warrants" decimals="2">1.63</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13248.90126.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90126.967.0.0.0.0" unitRef="USD_per_warrants" decimals="2">3.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.13248.90127.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90127.967.0.0.0.0" unitRef="USD_per_warrants" decimals="2">1.61</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="shares" decimals="0">5620128</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13252.0.0.0.0.0.0" contextRef="as-of-2012-03-31.13252.0.0.0.0.0.0.0" unitRef="shares" decimals="0">5620128</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13421.0.0.0.0.0.0" contextRef="as-of-2012-03-30.13421.0.0.0.0.0.0.0" unitRef="shares" decimals="0">46584</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.58121.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.58121.967.0.0.0.0" unitRef="shares" decimals="0">2572775</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.58123.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.58123.967.0.0.0.0" unitRef="shares" decimals="0">100778</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90121.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90121.967.0.0.0.0" unitRef="shares" decimals="0">100778</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90122.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90122.967.0.0.0.0" unitRef="shares" decimals="0">705354</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90123.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90123.967.0.0.0.0" unitRef="shares" decimals="0">2572775</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90124.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90124.967.0.0.0.0" unitRef="shares" decimals="0">500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90125.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90125.967.0.0.0.0" unitRef="shares" decimals="0">1323214</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90126.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90126.967.0.0.0.0" unitRef="shares" decimals="0">371423</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90127.967.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.90127.967.0.0.0.0" unitRef="shares" decimals="0">46584</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="ClassOfWarrantOrRightOutstanding.13248.2022.1894.58105.1897.5342.2133" contextRef="as-of-2013-03-31.13248.0.2022.1894.58105.1897.5342.2133" unitRef="shares" decimals="0">2899991</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="ClassOfWarrantOrRightOutstanding.13252.2022.1894.58105.1897.5342.2133" contextRef="as-of-2012-03-31.13252.0.2022.1894.58105.1897.5342.2133" unitRef="shares" decimals="0">2899991</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="CommitmentsAndContingenciesDisclosureTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;Note 4 - Commitments and Contingencies&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;SIGA Litigation&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In December 2006, we filed a complaint against SIGA Technologies, Inc. ("SIGA") in the Delaware Court of Chancery. The complaint alleged, among other things, that we have the right to license exclusively development and marketing rights for SIGA&amp;#39;s drug candidate, Arestvyr&amp;trade; (Tecovirimat), pursuant to a merger agreement between the parties that was terminated in 2006. The complaint also alleged that SIGA failed to negotiate in good faith the terms of such a license pursuant to the terminated merger agreement.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In September 2011, the Court issued an opinion in the case finding that SIGA had breached certain contractual obligations to us and upholding our claims of promissory estoppel. The Court awarded us the right to receive 50% of all net profits (as defined in the court&amp;#39;s final judgment) related to the sale of Arestvyr&amp;trade; and related products for 10 years following initial commercial sale of the drug once SIGA earns $40 million in net profits from the sale of Arestvyr&amp;trade; and related products. The Court also awarded us one-third of our reasonable attorney&amp;#39;s fees and expert witness fees, which amounts to approximately $2.4 million plus interest. In May 2012, the Court issued its final judgment. SIGA has appealed aspects of the decision to the Delaware Supreme Court. In response, we cross-appealed other aspects of the decision. In January 2013, the Delaware Supreme Court heard oral argument in the case.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We can provide no assurances that SIGA will not prevail on its appeal, that we will be successful in our appeal, and that the Delaware Supreme Court will not overturn the trial court&amp;#39;s decision awarding us a 10 year 50% net profit of the sales of Arestvyr&amp;trade; and related products (once SIGA retains the first $40 million in net profit). We have not yet recorded any amount due from SIGA in relation to this case.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Vendor Litigation&lt;/em&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; One of our vendors mishandled the storage of certain biological materials. While we have been engaged in discussions with the vendor to address our concerns, so far we have not come to agreement. The vendor filed suit against us in Delaware state court seeking a declaration that they are not liable for damages and seeking damages from us for allegedly not maintaining the required amount and type of insurance. We filed suit against the vendor in Maryland state court seeking damages related to the loss of the property. We believe we did maintain the appropriate amount and type of insurance, that in no event did we harm the vendor, and thus their damages claim is without merit. We plan to vigorously defend against their claims while pursuing our own.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Government Contracting&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Payments to the Company on cost-plus-fee contracts are provisional and are subject to adjustment upon audit by the Defense Contract Audit Agency and BARDA. In our opinion, adjustments that may result from audits are not expected to have a material effect on our financial position, results of operations, or cash flows.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Registration Rights Agreements&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We entered into a Registration Rights Agreement with the investors who participated in the July 2009 private placement of convertible notes and related warrants. We subsequently filed two registration statements on Form S-3 with the Securities and Exchange Commission to register the shares underlying the convertible notes and related warrants, which registration statements have been declared effective. We are obligated to maintain the registration statements effective until the date when all shares underlying the convertible notes and related warrants (and any other securities issued or issuable with respect to in exchange for such shares) have been sold. The convertible notes were converted or extinguished in 2010, although the related warrants remain outstanding. The warrants will expire on January 28, 2015.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We have separate registration rights agreements with investors, under which we have obligations to keep the corresponding registration statements effective until the registrable securities (as defined in each agreement) have been sold, and under which we may have separate obligations to file registration statements in the future on either a demand or "piggy-back" basis or both.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Under the terms of the convertible notes, which were converted or extinguished in 2010, if after the 2nd consecutive business day (other than during an allowable blackout period) on which sales of all of the securities required to be included on the registration statement cannot be made pursuant to the registration statement (a "Maintenance Failure"), we will be required to pay to each selling stockholder a one-time payment of 1.0% of the aggregate principal amount of the convertible notes relating to the affected shares on the initial day of a Maintenance Failure. Our total maximum obligation under this provision at March 31, 2013, would be approximately $0.2 million.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Following a Maintenance Failure, we will also be required to make to each selling stockholder monthly payments of 1.0% of the aggregate principal amount of the convertible notes relating to the affected shares on every 30th day after the initial day of a Maintenance Failure, in each case prorated for shorter periods and until the failure is cured. Our total maximum obligation under this provision would be approximate $0.2 million for each month until the failure, if it occurs, is cured.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="CommonStockCapitalSharesReservedForFutureIssuance.13418.58153.3871.0.0.0.0" contextRef="as-of-2008-12-31.13418.0.58153.3871.0.0.0.0" unitRef="shares" decimals="-5">4600000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="CommonStockCapitalSharesReservedForFutureIssuance.13419.58153.3871.0.0.0.0" contextRef="as-of-2007-12-31.13419.0.58153.3871.0.0.0.0" unitRef="shares" decimals="-5">3500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockParOrStatedValuePerShare id="CommonStockParOrStatedValuePerShare.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="4">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="CommonStockParOrStatedValuePerShare.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="4">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="CommonStockSharesAuthorized.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="shares" decimals="0">100000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="CommonStockSharesAuthorized.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="shares" decimals="0">100000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="CommonStockSharesIssued.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="shares" decimals="0">48416483</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="CommonStockSharesIssued.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="shares" decimals="0">48352651</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="CommonStockSharesOutstanding.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="shares" decimals="0">48416483</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="CommonStockSharesOutstanding.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="shares" decimals="0">48352651</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable id="CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.13248.85459.85456.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.85459.85456.0.0.0.0" unitRef="USD" decimals="0">33000</us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable>
  <us-gaap:CommonStockValue id="CommonStockValue.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">4842</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue id="CommonStockValue.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">4835</us-gaap:CommonStockValue>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock id="ComprehensiveIncomePolicyPolicyTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Comprehensive Loss and Accumulated Other Comprehensive Income&lt;/em&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Comprehensive loss includes the total of our net loss and all other changes in equity other than transactions with owners, including (i) changes in equity for cumulative translation adjustments resulting from the consolidation of foreign subsidiaries as the financial statements of the subsidiaries located outside of the United States are accounted for using the local currency as the functional currency, and (ii) unrealized gains and losses on short term available-for-sale investments.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:ContractsRevenue id="ContractsRevenue.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">6475138</us-gaap:ContractsRevenue>
  <us-gaap:ContractsRevenue id="ContractsRevenue.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">6149052</us-gaap:ContractsRevenue>
  <us-gaap:CostOfReimbursableExpense id="CostOfReimbursableExpense.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="-4">20000</us-gaap:CostOfReimbursableExpense>
  <us-gaap:CostOfReimbursableExpense id="CostOfReimbursableExpense.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">500000</us-gaap:CostOfReimbursableExpense>
  <us-gaap:CurrentIncomeTaxExpenseBenefit id="CurrentIncomeTaxExpenseBenefit.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">9743</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit id="CurrentIncomeTaxExpenseBenefit.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">150405</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate id="DebtInstrumentBasisSpreadOnVariableRate.13421.3014.2887.0.0.0.0" contextRef="as-of-2012-03-30.13421.0.3014.2887.0.0.0.0" unitRef="pure" decimals="2">0.05</us-gaap:DebtInstrumentBasisSpreadOnVariableRate>
  <us-gaap:DebtInstrumentCarryingAmount id="DebtInstrumentCarryingAmount.13249.3055.2887.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.3055.2887.0.0.0.0" unitRef="USD" decimals="0">2500000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount id="DebtInstrumentCarryingAmount.13421.3055.2887.0.0.0.0" contextRef="as-of-2012-03-30.13421.0.3055.2887.0.0.0.0" unitRef="USD" decimals="0">2500000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateEffectivePercentage id="DebtInstrumentInterestRateEffectivePercentage.13248.3014.2887.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.3014.2887.0.0.0.0" unitRef="pure" decimals="3">0.065</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="DebtInstrumentInterestRateStatedPercentage.13421.3055.2887.0.0.0.0" contextRef="as-of-2012-03-30.13421.0.3055.2887.0.0.0.0" unitRef="pure" decimals="4">0.1014</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentPaymentTerms id="DebtInstrumentPaymentTerms.13250.3055.2887.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.3055.2887.0.0.0.0">Payments on the term loan were originally interest-only for the first 10 months, which has since been extended to 12 months pursuant to terms of the agreement. Subsequently, the term loan will fully amortize over its remaining term as of March 31, 2013.</us-gaap:DebtInstrumentPaymentTerms>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="DebtInstrumentUnamortizedDiscount.13248.3055.2887.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.3055.2887.0.0.0.0" unitRef="USD" decimals="0">39587</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:DebtPolicyTextBlock id="DebtPolicyTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Revolving Line of Credit and Term Loan&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; As discussed further in Note 6, we entered into a loan agreement with General Electric Capital Corporation ("GE Capital") in March 2012. As part of that agreement, we issued stock purchase warrants to GE Capital that expire in March 2022. The fair value of the warrants was charged to additional paid-in-capital, resulting in a debt discount to the Term Loan at the date of issuance. The debt discount and the financing costs, incurred in connections with the agreement, are being amortized over the term of the loan using the effective interest method. The amortization of both the debt discount and deferred financing costs are included in interest expense in the unaudited condensed consolidated statements of operations.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="DeferredIncomeTaxExpenseBenefit.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">9743</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="DeferredIncomeTaxExpenseBenefit.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">150405</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredRevenue id="DeferredRevenue.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">874404</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue id="DeferredRevenue.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">1381755</us-gaap:DeferredRevenue>
  <us-gaap:DepreciationAndAmortization id="DepreciationAndAmortization.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">52602</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization id="DepreciationAndAmortization.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">85910</us-gaap:DepreciationAndAmortization>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13248.2024.1894.1906.1887.0.0" xsi:nil="true" contextRef="as-of-2013-03-31.13248.0.2024.1894.1906.1887.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13249.2024.1894.1906.1887.0.0" xsi:nil="true" contextRef="as-of-2012-12-31.13249.0.2024.1894.1906.1887.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13248.2026.1894.1906.1887.0.0" xsi:nil="true" contextRef="as-of-2013-03-31.13248.0.2026.1894.1906.1887.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13249.2026.1894.1906.1887.0.0" xsi:nil="true" contextRef="as-of-2012-12-31.13249.0.2026.1894.1906.1887.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13248.2022.1894.1906.1887.0.0" contextRef="as-of-2013-03-31.13248.0.2022.1894.1906.1887.0.0" unitRef="USD" decimals="0">2201390</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13249.2022.1894.1906.1887.0.0" contextRef="as-of-2012-12-31.13249.0.2022.1894.1906.1887.0.0" unitRef="USD" decimals="0">1295613</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13248.1906.1887.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.1906.1887.0.0.0.0" unitRef="USD" decimals="0">2201390</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13249.1906.1887.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.1906.1887.0.0.0.0" unitRef="USD" decimals="0">1295613</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13248.2022.1894.5342.2133.0.0" contextRef="as-of-2013-03-31.13248.0.2022.1894.5342.2133.0.0" unitRef="USD" decimals="0">2201390</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13249.2022.1894.5342.2133.0.0" contextRef="as-of-2012-12-31.13249.0.2022.1894.5342.2133.0.0" unitRef="USD" decimals="0">1295613</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13252.2022.1894.5342.2133.0.0" contextRef="as-of-2012-03-31.13252.0.2022.1894.5342.2133.0.0" unitRef="USD" decimals="0">2878314</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.13253.2022.1894.5342.2133.0.0" contextRef="as-of-2011-12-31.13253.0.2022.1894.5342.2133.0.0" unitRef="USD" decimals="0">1886652</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:DerivativeLiabilitiesNoncurrent id="DerivativeLiabilitiesNoncurrent.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">2201390</us-gaap:DerivativeLiabilitiesNoncurrent>
  <us-gaap:DerivativeLiabilitiesNoncurrent id="DerivativeLiabilitiesNoncurrent.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">1295613</us-gaap:DerivativeLiabilitiesNoncurrent>
  <us-gaap:EarningsPerShareBasicAndDiluted id="EarningsPerShareBasicAndDiluted.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">-0.04</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="EarningsPerShareBasicAndDiluted.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">-0.06</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerSharePolicyTextBlock id="EarningsPerSharePolicyTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Basic and Diluted Net Loss Per Share&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Income (loss) per share:&lt;/em&gt; Basic income (loss) per share is computed by dividing consolidated net income (loss) by the weighted average number of common shares outstanding during the period, excluding unvested restricted stock.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; For periods of net income when the effects are not anti-dilutive, diluted earnings per share is computed by dividing our net income by the weighted average number of shares outstanding and the impact of all potential dilutive common shares, consisting primarily of stock options, unvested restricted stock and stock purchase warrants. The dilutive impact of our dilutive potential common shares resulting from stock options and stock purchase warrants is determined by applying the treasury stock method.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; For the periods of net loss, diluted loss per share is calculated similarly to basic loss per share because the impact of all dilutive potential common shares is anti-dilutive due to the net losses. A total of approximately 11.6 million and 11.5 million potential dilutive securities have been excluded in the calculation of diluted net loss per share in the three months ended March 31, 2013 and 2012, respectively, because their inclusion would be anti-dilutive.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="EffectOfExchangeRateOnCashAndCashEquivalents.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-2678</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="EffectOfExchangeRateOnCashAndCashEquivalents.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">4034</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="-5">2000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">P2Y3M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:FairValueDisclosuresTextBlock id="FairValueDisclosuresTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;Note 3 - Fair Value Measurements&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We report assets and liabilities that are measured at fair value using a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 18px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Symbol; WIDTH: 18px"&gt;&amp;middot;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;Level 1 - Quoted prices in active markets for identical assets or liabilities.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 1.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 18px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Symbol; WIDTH: 18px"&gt;&amp;middot;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 1.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 18px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Symbol; WIDTH: 18px"&gt;&amp;middot;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; An asset&amp;#39;s or liability&amp;#39;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. At each reporting period, we perform a detailed analysis of our assets and liabilities that are measured at fair value. All assets and liabilities for which the fair value measurement is based on significant unobservable inputs or instruments which trade infrequently and therefore have little or no price transparency are classified as Level 3.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We have segregated our financial assets and liabilities that are measured at fair value into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date in the table below. We have no non-financial assets and liabilities that are measured at fair value on a recurring basis. As of March 31, 2013 and 2012 we had Level 3 derivative liabilities of approximately $2.2 million and $2.9 million, respectively.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following table represents the Company&amp;#39;s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis:&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="14"&gt;As of March 31, 2013&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 1&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 2&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 3&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Balance&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Liabilities&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 44%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Derivatives instruments&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2,201,390&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2,201,390&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="14"&gt;As of December 31, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 1&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 2&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 3&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Balance&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Liabilities&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 44%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Derivatives instruments&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1,295,613&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1,295,613&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following table sets forth a summary of changes in the fair value of the Company&amp;#39;s Level 3 liabilities for the three months ended March 31, 2013:&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif"&gt; Description&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Balance as of&lt;br /&gt; December 31,&lt;br /&gt; 2012&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Unrealized Losses&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Balance as of&lt;br /&gt; March 31,&lt;br /&gt; 2013&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 58%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; Derivative liabilities related to stock purchase warrants&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 1,295,613&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 905,777&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 2,201,390&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following table sets forth a summary of changes in the fair value of the Company&amp;#39;s Level 3 liabilities for the three months ended March 31, 2012:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt; Description&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Balance as of&lt;br /&gt; December 31,&lt;br /&gt; 2011&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Unrealized Losses&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Balance as of&lt;br /&gt; March 31,&lt;br /&gt; 2012&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 58%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; Derivative liabilities related to stock purchase warrants&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 1,886,652&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 991,662&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 2,878,314&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; At March 31, 2013 and 2012, derivative liabilities are comprised of warrants to purchase 2,899,991 shares of common stock. The warrants are considered to be derivative liabilities due to the presence of net settlement features and, as a result, are recorded at fair value at each balance sheet date, with changes in fair value recorded in the unaudited condensed consolidated statements of operations. The fair value of our warrants is determined based on the Black-Scholes option pricing model. Use of the Black-Scholes option pricing model requires the use of unobservable inputs such as the expected term, anticipated volatility and expected dividends.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="7"&gt;Quantitative Information about Level 3 Fair Value Measurements&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Fair Value at 3/31/2013&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Valuation Technique&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Unobservable Inputs&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 20%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2,201,390&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 42%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Black-Scholes option pricing model&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 32%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Expected term&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Expected dividends&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Anticipated volatility&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Changes in any of the assumptions related to the unobservable inputs identified above may change the stock purchase warrants&amp;#39; fair value; increases in expected term, anticipated volatility and expected dividends generally result in increases in fair value, while decreases in the unobservable inputs generally result in decreases in fair value. Gains and losses on the fair value adjustments for these derivative instruments are classified in other expenses as the change in fair value of derivative instruments in our unaudited condensed consolidated statements of operations. The $0.9 million change in the market value of derivative instruments during the three-month period ended March 31, 2013 is due primarily to the change in the closing price of PharmAthene stock, which was $1.12 per share as of December 31, 2012 and $1.70 per share as of March 28, 2013. The $1.0 million change in the market value of derivative instruments during the three-month period ended March 31, 2012 is due primarily to the change in the closing price of PharmAthene stock, which was $1.27 per share as of December 30, 2011 and $1.77 per share as of March 30, 2012.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Assets Measured at Fair Value on a Nonrecurring Basis&lt;/em&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company measures its long-lived assets, including, property and equipment and goodwill, at fair value on a nonrecurring basis. These assets are recognized at fair value when they are deemed to be other-than-temporarily impaired. (see Note 2). As of March 31, 2013, the Company had no other assets or liabilities that were measured at fair value on a nonrecurring basis.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock id="FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="7"&gt;Quantitative Information about Level 3 Fair Value Measurements&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Fair Value at 3/31/2013&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Valuation Technique&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Unobservable Inputs&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 20%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2,201,390&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 42%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Black-Scholes option pricing model&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 32%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Expected term&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Expected dividends&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Anticipated volatility&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock id="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following table sets forth a summary of changes in the fair value of our Level 3 liabilities for the three months ended March 31, 2013:&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif"&gt; Description&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Balance as of&lt;br /&gt; December 31,&lt;br /&gt; 2012&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Unrealized Losses&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Balance as of&lt;br /&gt; March 31,&lt;br /&gt; 2013&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 58%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; Derivative liabilities related to stock purchase warrants&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 1,295,613&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 905,777&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 2,201,390&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following table sets forth a summary of changes in the fair value of the Company&amp;#39;s Level 3 liabilities for the three months ended March 31, 2012:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt; Description&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Balance as of&lt;br /&gt; December 31,&lt;br /&gt; 2011&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Unrealized Losses&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;Balance as of&lt;br /&gt; March 31,&lt;br /&gt; 2012&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 58%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; Derivative liabilities related to stock purchase warrants&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 1,886,652&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 991,662&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 2,878,314&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock id="ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Foreign Currency Translation&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The functional currency of our wholly owned foreign subsidiaries is their local currency. Assets and liabilities of our foreign subsidiaries are translated into United States dollars based on exchange rates at the end of the reporting period. Income and expense items are translated at the weighted average exchange rates prevailing during the reporting period. &lt;font style="COLOR: black"&gt;Translation adjustments for subsidiaries that have not been sold, substantially liquidated or otherwise disposed of, are accumulated in other comprehensive income (loss), a component of stockholders&amp;#39; equity.&lt;/font&gt; Foreign currency translation adjustments are the sole component of accumulated other comprehensive loss at March 31, 2013 and December 31, 2012. &lt;font style="COLOR: black"&gt;Transaction gains or losses are included in the determination of net loss.&lt;/font&gt;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="GainLossOnSaleOfPropertyPlantEquipment.13250.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="GainLossOnSaleOfPropertyPlantEquipment.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">66626</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GeneralAndAdministrativeExpense id="GeneralAndAdministrativeExpense.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">2279795</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="GeneralAndAdministrativeExpense.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">2948481</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:Goodwill id="Goodwill.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">2348453</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Goodwill.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">2348453</us-gaap:Goodwill>
  <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy id="GoodwillAndIntangibleAssetsGoodwillPolicy.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Goodwill&lt;/em&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Goodwill represents the excess of purchase price over the fair value of net identifiable assets associated with acquisitions. We review the recoverability of goodwill annually as of December 31&lt;sup&gt;st&lt;/sup&gt; by comparing our market value (as measured by our stock price multiplied by the number of outstanding shares as of the end of the year) to the net book value of our equity. If our market value exceeds our net book value, no further analysis is required. Changes in our business strategy or adverse changes in market conditions could impact the impairment analyses and require the recognition of an impairment charge equal to the excess of the carrying value over its estimated fair value. We completed our last annual impairment assessment of goodwill as of December 31, 2012 and determined that there was no impairment as of that date.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-2101642</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-2529483</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit id="IncomeTaxExpenseBenefit.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">9743</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit id="IncomeTaxExpenseBenefit.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">150405</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxPolicyTextBlock id="IncomeTaxPolicyTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Income Taxes&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We account for income taxes using the asset and liability approach, which requires the recognition of future tax benefits or liabilities on the temporary differences between the financial reporting and tax bases of our assets and liabilities. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized. We also recognize a tax benefit from uncertain tax positions only if it is "more likely than not" that the position is sustainable based on its technical merits. Our policy is to recognize interest and penalties on uncertain tax positions as a component of income tax expense.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Income tax expense was $9,743 and $150,405 during the three months ended March 31, 2013 and 2012, respectively. Income tax expense is a result of the difference between the treatment of goodwill for income tax purposes and for U.S. GAAP, resulting in a deferred tax liability, which cannot offset deferred tax assets. This deferred tax liability is included in our condensed consolidated balance sheet in other long-term liabilities.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="IncreaseDecreaseInAccountsPayable.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-407653</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="IncreaseDecreaseInAccountsPayable.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-35280</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="IncreaseDecreaseInAccountsReceivable.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-566725</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="IncreaseDecreaseInAccountsReceivable.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-3278062</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities id="IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">950800</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities id="IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">131338</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="IncreaseDecreaseInDeferredRevenue.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-507351</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="IncreaseDecreaseInDeferredRevenue.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-495372</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-39486</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-137362</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInUnbilledReceivables id="IncreaseDecreaseInUnbilledReceivables.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-400645</us-gaap:IncreaseDecreaseInUnbilledReceivables>
  <us-gaap:IncreaseDecreaseInUnbilledReceivables id="IncreaseDecreaseInUnbilledReceivables.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">1254867</us-gaap:IncreaseDecreaseInUnbilledReceivables>
  <us-gaap:InterestExpense id="InterestExpense.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">99791</us-gaap:InterestExpense>
  <us-gaap:InterestExpense id="InterestExpense.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">3028</us-gaap:InterestExpense>
  <us-gaap:InterestPaid id="InterestPaid.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">67360</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="InterestPaid.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">3028</us-gaap:InterestPaid>
  <us-gaap:InvestmentIncomeInterest id="InvestmentIncomeInterest.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">783</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest id="InvestmentIncomeInterest.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">2988</us-gaap:InvestmentIncomeInterest>
  <us-gaap:Liabilities id="Liabilities.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">12029620</us-gaap:Liabilities>
  <us-gaap:Liabilities id="Liabilities.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">11067564</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity id="LiabilitiesAndStockholdersEquity.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">21972385</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="LiabilitiesAndStockholdersEquity.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">22741404</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent id="LiabilitiesCurrent.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">7787575</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="LiabilitiesCurrent.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">7488416</us-gaap:LiabilitiesCurrent>
  <us-gaap:LineOfCreditFacilityBorrowingCapacityDescription id="LineOfCreditFacilityBorrowingCapacityDescription.13250.3014.2887.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.3014.2887.0.0.0.0">Under the terms of the revolving line of credit, the Company may draw down from the revolving line of credit up to 85% of qualified billed accounts receivable and 80% of qualified unbilled accounts receivable.</us-gaap:LineOfCreditFacilityBorrowingCapacityDescription>
  <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity id="LineOfCreditFacilityCurrentBorrowingCapacity.13248.3014.2887.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.3014.2887.0.0.0.0" unitRef="USD" decimals="-5">2300000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding id="LineOfCreditFacilityFairValueOfAmountOutstanding.13248.3014.2887.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.3014.2887.0.0.0.0" unitRef="USD" decimals="-5">1300000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="LineOfCreditFacilityMaximumBorrowingCapacity.13421.3014.2887.0.0.0.0" contextRef="as-of-2012-03-30.13421.0.3014.2887.0.0.0.0" unitRef="USD" decimals="0">5000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LongTermDebtCurrent id="LongTermDebtCurrent.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">999996</us-gaap:LongTermDebtCurrent>
  <us-gaap:LongTermDebtCurrent id="LongTermDebtCurrent.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">749997</us-gaap:LongTermDebtCurrent>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths id="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.13249.3055.2887.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.3055.2887.0.0.0.0" unitRef="USD" decimals="0">749997</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree id="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.13249.3055.2887.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.3055.2887.0.0.0.0" unitRef="USD" decimals="0">750007</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo id="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.13249.3055.2887.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.3055.2887.0.0.0.0" unitRef="USD" decimals="0">999996</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <us-gaap:LongTermDebtNoncurrent id="LongTermDebtNoncurrent.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">1460417</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent id="LongTermDebtNoncurrent.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">1704108</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:MajorCustomersPolicyPolicyTextBlock id="MajorCustomersPolicyPolicyTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Significant Customers and Accounts Receivable&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Our primary customers are the U.S. Department of Defense (the "DoD") - Chemical Biological Medical Systems ("CBMS"), and the Biomedical Advanced Research and Development Authority ("BARDA"). As of March 31, 2013 and December 31, 2012, the Company&amp;#39;s trade receivable and unbilled receivable balances were comprised solely of receivables from CBMS and BARDA.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:MajorCustomersPolicyPolicyTextBlock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="NetCashProvidedByUsedInFinancingActivities.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-60361</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="NetCashProvidedByUsedInFinancingActivities.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">3204614</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="NetCashProvidedByUsedInInvestingActivities.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-25468</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="NetCashProvidedByUsedInInvestingActivities.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">67400</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="NetCashProvidedByUsedInOperatingActivities.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">260401</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="NetCashProvidedByUsedInOperatingActivities.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">791370</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-2111385</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-2679888</us-gaap:NetIncomeLoss>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="NewAccountingPronouncementsPolicyPolicyTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Recent Accounting Pronouncements&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"&gt; We have evaluated all Accounting Standards Updates through the date the unaudited condensed consolidated financial statements were issued and believe the adoption of these will not have a material impact on our results of operations, financial position, or cash flows.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:NonoperatingIncomeExpense id="NonoperatingIncomeExpense.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-1010908</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="NonoperatingIncomeExpense.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-938787</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NumberOfOperatingSegments id="NumberOfOperatingSegments.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="pure" decimals="0">1</us-gaap:NumberOfOperatingSegments>
  <us-gaap:OperatingExpenses id="OperatingExpenses.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">7565872</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="OperatingExpenses.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">7739748</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="OperatingIncomeLoss.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-1090734</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="OperatingIncomeLoss.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-1590696</us-gaap:OperatingIncomeLoss>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock id="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;Note 1 - Organization and Business&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We are a biopharmaceutical company focused on developing biodefense countermeasure applications. We are subject to those risks associated with any biopharmaceutical company that has substantial expenditures for research and development. There can be no assurance that our research and development projects will be successful, that products developed will obtain necessary regulatory approval, or that any approved product will be commercially viable. In addition, we operate in an environment of rapid technological change and are largely dependent on the services and expertise of our employees, consultants and other third parties.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Historically, we have performed under government contracts and grants and raised funds from investors to sustain our operations.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:OtherAssetsNoncurrent id="OtherAssetsNoncurrent.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">99578</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent id="OtherAssetsNoncurrent.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">113130</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax id="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-1684</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax id="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">13369</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-2113069</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-2666519</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherLiabilitiesNoncurrent id="OtherLiabilitiesNoncurrent.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">580238</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="OtherLiabilitiesNoncurrent.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">579427</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherNonoperatingIncomeExpense id="OtherNonoperatingIncomeExpense.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-6123</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense id="OtherNonoperatingIncomeExpense.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">52915</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:PaidInKindInterest id="PaidInKindInterest.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">32431</us-gaap:PaidInKindInterest>
  <us-gaap:PaidInKindInterest id="PaidInKindInterest.13251.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PaymentsOfFinancingCosts id="PaymentsOfFinancingCosts.13250.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PaymentsOfFinancingCosts id="PaymentsOfFinancingCosts.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">220234</us-gaap:PaymentsOfFinancingCosts>
  <us-gaap:PaymentsOfStockIssuanceCosts id="PaymentsOfStockIssuanceCosts.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">112500</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:PaymentsOfStockIssuanceCosts id="PaymentsOfStockIssuanceCosts.13251.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="PaymentsToAcquirePropertyPlantAndEquipment.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">25468</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="PaymentsToAcquirePropertyPlantAndEquipment.13251.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="PrepaidExpenseAndOtherAssetsCurrent.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">614388</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="PrepaidExpenseAndOtherAssetsCurrent.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">547245</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ProceedsFromIssuanceOfCommonStock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">53413</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ProceedsFromIssuanceOfCommonStock.13251.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ProceedsFromIssuanceOfCommonStock.14839.5009.5007.0.0.0.0" contextRef="from-2013-04-01-to-2013-05-07.14839.0.5009.5007.0.0.0.0" unitRef="USD" decimals="-4">1630000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities id="ProceedsFromPaymentsForOtherFinancingActivities.13250.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities id="ProceedsFromPaymentsForOtherFinancingActivities.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-32960</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit id="ProceedsFromRepaymentsOfLinesOfCredit.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-1274</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
  <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit id="ProceedsFromRepaymentsOfLinesOfCredit.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">857808</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
  <us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities id="ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.13250.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities id="ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">100000</us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="ProceedsFromSaleOfPropertyPlantAndEquipment.13250.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="ProceedsFromSaleOfPropertyPlantAndEquipment.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">67400</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentNet id="PropertyPlantAndEquipmentNet.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">456842</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="PropertyPlantAndEquipmentNet.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">483976</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:ResearchAndDevelopmentExpense id="ResearchAndDevelopmentExpense.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">5233475</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="ResearchAndDevelopmentExpense.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">4705357</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="RetainedEarningsAccumulatedDeficit.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-200720957</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="RetainedEarningsAccumulatedDeficit.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-198609572</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RevenueRecognitionPolicyTextBlock id="RevenueRecognitionPolicyTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Revenue Recognition&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We generate our revenue from different types of contractual arrangements: cost-plus-fee contracts, cost reimbursable grants and fixed price contracts.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Revenues on cost-plus-fee contracts are recognized in an amount equal to the costs incurred during the period plus an estimate of the applicable fee earned. The estimate of the applicable fee earned is determined by reference to the contract: if the contract defines the fee in terms of risk-based milestones and specifies the fees to be earned upon the completion of each milestone, then the fee is recognized when the related milestones are earned, as further described below; otherwise, we estimate the fee earned in a given period by using a proportional performance method based on costs incurred during the period as compared to total estimated project costs and application of the resulting fraction to the total project fee specified in the contract.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Under the milestone method of revenue recognition, milestone payments (including milestone payments for fees) contained in research and development arrangements are recognized as revenue when: (i) the milestones are achieved; (ii) no further performance obligations with respect to the milestone exist; (iii) collection is reasonably assured; and (iv) substantive effort was necessary to achieve the milestone.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Milestones are considered substantive if all of the following conditions are met:&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"&gt; &lt;tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"&gt; it is commensurate with either our performance to meet the milestone or the enhancement of the value of the delivered item or items as a result of a specific outcome resulting from our performance to achieve the milestone,&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"&gt; &lt;tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"&gt; it relates solely to past performance,&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"&gt; &lt;tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"&gt; the value of the milestone is reasonable relative to all the deliverables and payment terms (including other potential milestone consideration) within the arrangement.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; If a milestone is deemed not to be substantive, the Company recognizes the portion of the milestone payment as revenue that correlates to work already performed; the remaining portion of the milestone payment is deferred and recognized as revenue as the Company completes its performance obligations.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Revenue on fixed price contracts (without substantive milestones as described above) is recognized on the percentage-of-completion method. The percentage-of-completion method recognizes income as the contract progresses (generally related to the costs incurred in providing the services required under the contract). The use of the percentage-of-completion method depends on the ability to make reasonable dependable estimates and the fact that circumstances may necessitate frequent revision of estimates does not indicate that the estimates are unreliable for the purpose for which they are used.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; As a result of our revenue recognition policies and the billing provisions contained in our contracts, the timing of customer billings may differ from the timing of recognizing revenue. Amounts invoiced to customers in excess of revenue recognized are reflected on the balance sheet as deferred revenue. Amounts recognized as revenue in excess of amounts billed to customers are reflected on the balance sheet as unbilled accounts receivable.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We analyze each cost reimbursable grant to determine whether we should report such reimbursements as revenue or as an offset to our expenses incurred. For the three months ended March 31, 2013 and 2012, we recorded approximately $0.02 million and $0.5 million, respectively, of costs reimbursed by the government as an offset to research and development expenses.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:ScheduleOfDebtTableTextBlock id="ScheduleOfDebtTableTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The term loan, net of discount of $39,587, is recorded on the 2013 condensed consolidated balance sheet, net of debt discount, as follows:&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 54%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 40%; FONT: 10pt Times New Roman, Times, Serif"&gt; Current portion of long-term debt&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"&gt; 999,996&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; Long-term debt, less current portion&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 1,460,417&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Share-based compensation expense for the three months ended March 31, 2013 and 2012 was:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="6"&gt;Three months ended March 31,&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;2013&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;2012&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt" colspan="2"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 72%; FONT: 10pt Times New Roman, Times, Serif"&gt; Research and development&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"&gt; 88,634&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"&gt; 117,067&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; General and administrative&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 239,947&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 431,597&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; Total share-based compensation expense&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 328,581&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 548,664&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock id="ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following table represents the Company&amp;#39;s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis:&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="14"&gt;As of March 31, 2013&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 1&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 2&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 3&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Balance&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Liabilities&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 44%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Derivatives instruments&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2,201,390&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2,201,390&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="14"&gt;As of December 31, 2012&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 1&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 2&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Level 3&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Balance&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Liabilities&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 44%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Derivatives instruments&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; -&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1,295,613&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1,295,613&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock id="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;table style="WIDTH: 35%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Year&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Principal&lt;br /&gt; Payments&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 15%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2013&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 15%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $749,997&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2014&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 999,996&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2015&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 750,007&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $2,500,000&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock id="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; At March 31, 2013 and 2012 there were warrants outstanding to purchase 5,620,128 shares of our common stock, respectively. The warrants outstanding as of March 31, 2013 and 2012 were as follows:&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Number of Common Shares Underlying Warrants&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Issue Date/Exercisable Date&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Exercise Price&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Expiration Date&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 22%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 100,778&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (1)&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 24%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Mar-07 / Mar-07&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 21%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 3.97&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 23%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Mar-17&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 705,354&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (2)&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Mar-09 / Sep-09&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 3.00&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Sep-14&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2,572,775&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (1)&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jul-09 / Jan-10&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2.50&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jan-15&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 500,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (2)&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Apr-10 / Oct-10&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1.89&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Oct-15&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1,323,214&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (2)&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jul-10 / Jan-11&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1.63&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jan-17&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 371,423&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (2)&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jun-11 / Jun-11&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 3.50&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jun-16&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 46,584&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (1)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Mar-12 / Mar-12&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1.61&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Mar-22&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 5,620,128&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 3%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 5%"&gt; (1)&lt;/td&gt; &lt;td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 92%"&gt; These warrants to purchase common stock are classified as equity.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 3%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 5%"&gt; (2)&lt;/td&gt; &lt;td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 92%"&gt; These warrants to purchase common stock are classified as derivative liabilities. The fair value of these liabilities (see note 3) is remeasured at the end of every reporting period and the change in fair value is reported in the unaudited condensed consolidated statements of operations as other income (expense).&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:ShareBasedCompensation id="ShareBasedCompensation.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">328581</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ShareBasedCompensation.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">548664</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.13248.58153.3871.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.58153.3871.0.0.0.0" unitRef="shares" decimals="-5">9300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.13248.58153.3871.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.58153.3871.0.0.0.0" unitRef="shares" decimals="-5">2600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="shares" decimals="0">60000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="shares" decimals="0">15948</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="ShareBasedCompensationOptionAndIncentivePlansPolicy.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Share-Based Compensation&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We expense the estimated fair value of share-based awards granted to employees under our stock compensation plans. The fair value of stock options is determined at the grant date using an option pricing model. We have estimated the fair value of each stock option award using the Black-Scholes option pricing model. The Black-Scholes model considers, among other factors, the expected life of the award and the expected volatility of our stock price. The value of the award that is ultimately expected to vest is recognized as expense on a straight line basis over the employee&amp;#39;s requisite service period.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The fair value of restricted stock grants is determined based on the closing price of our common stock on the award date and is recognized as expense ratably over the requisite service period.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Employee share-based compensation expense recognized in the three months ended March 31, 2013 and 2012 was calculated based on awards ultimately expected to vest and has been reduced for estimated forfeitures at a rate of approximately 12%, based on historical forfeitures.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Share-based compensation expense for the three months ended March 31, 2013 and 2012 was:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="6"&gt;Three months ended March 31,&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;2013&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;2012&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt" colspan="2"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 72%; FONT: 10pt Times New Roman, Times, Serif"&gt; Research and development&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"&gt; 88,634&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"&gt; 117,067&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; General and administrative&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 239,947&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 431,597&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; Total share-based compensation expense&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 328,581&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 548,664&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; During the three months ended March 31, 2013, we granted 60,000 options to employees and consultants and made no restricted stock grants. During the three months ended March 31, 2012, we granted 15,948 options to employees and made no restricted stock grants. At March 31, 2013, we had total unrecognized share-based compensation expense related to unvested awards of approximately $2.0 million net of estimated forfeitures, which we expect to recognize as expense over a weighted-average period of 2.25 years.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:SharePrice id="SharePrice.13249.2022.1894.58105.1897.5342.2133" contextRef="as-of-2012-12-31.13249.0.2022.1894.58105.1897.5342.2133" unitRef="USD_per_share" decimals="2">1.12</us-gaap:SharePrice>
  <us-gaap:SharePrice id="SharePrice.13421.2022.1894.58105.1897.5342.2133" contextRef="as-of-2012-03-30.13421.0.2022.1894.58105.1897.5342.2133" unitRef="USD_per_share" decimals="2">1.77</us-gaap:SharePrice>
  <us-gaap:SharePrice id="SharePrice.13756.2022.1894.58105.1897.5342.2133" contextRef="as-of-2013-03-28.13756.0.2022.1894.58105.1897.5342.2133" unitRef="USD_per_share" decimals="2">1.70</us-gaap:SharePrice>
  <us-gaap:SharePrice id="SharePrice.13757.2022.1894.58105.1897.5342.2133" contextRef="as-of-2011-12-30.13757.0.2022.1894.58105.1897.5342.2133" unitRef="USD_per_share" decimals="2">1.27</us-gaap:SharePrice>
  <us-gaap:ShortTermBorrowings id="ShortTermBorrowings.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">1329233</us-gaap:ShortTermBorrowings>
  <us-gaap:ShortTermBorrowings id="ShortTermBorrowings.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">1330507</us-gaap:ShortTermBorrowings>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="SignificantAccountingPoliciesTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;Note 2 - Summary of Significant Accounting Policies&lt;/strong&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Basis of Presentation&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Our unaudited condensed consolidated financial statements include the accounts of PharmAthene, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. Our unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP"). In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly our financial position, results of operations and cash flows. The unaudited condensed consolidated balance sheet at December 31, 2012 has been derived from audited consolidated financial statements at that date. The interim results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosure normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the U.S. Securities and Exchange Commission. We believe that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial statements are read in conjunction with the Consolidated Financial Statements and Notes included in our Annual Report on Form 10-K for the year ended December 31, 2012, filed with the Securities and Exchange Commission. We currently operate in one business segment.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Use of Estimates&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our unaudited condensed consolidated financial statements include significant estimates for the expected economic life and value of our intangible assets, the amount of our net operating losses, our share-based compensation, the value of our financial instruments, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates&lt;font style="FONT: 10pt Times New Roman, Times, Serif"&gt;.&lt;/font&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Foreign Currency Translation&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The functional currency of our wholly owned foreign subsidiaries is their local currency. Assets and liabilities of our foreign subsidiaries are translated into United States dollars based on exchange rates at the end of the reporting period. Income and expense items are translated at the weighted average exchange rates prevailing during the reporting period. &lt;font style="COLOR: black"&gt;Translation adjustments for subsidiaries that have not been sold, substantially liquidated or otherwise disposed of, are accumulated in other comprehensive income (loss), a component of stockholders&amp;#39; equity.&lt;/font&gt; Foreign currency translation adjustments are the sole component of accumulated other comprehensive loss at March 31, 2013 and December 31, 2012. &lt;font style="COLOR: black"&gt;Transaction gains or losses are included in the determination of net loss.&lt;/font&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Comprehensive Loss and Accumulated Other Comprehensive Income&lt;/em&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Comprehensive loss includes the total of our net loss and all other changes in equity other than transactions with owners, including (i) changes in equity for cumulative translation adjustments resulting from the consolidation of foreign subsidiaries as the financial statements of the subsidiaries located outside of the United States are accounted for using the local currency as the functional currency, and (ii) unrealized gains and losses on short term available-for-sale investments.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Cash and Cash Equivalents&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Cash and cash equivalents are stated at market value. We consider all highly liquid investments with original maturities of three months or less to be cash equivalents.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Revolving Line of Credit and Term Loan&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; As discussed further in Note 6, we entered into a loan agreement with General Electric Capital Corporation ("GE Capital") in March 2012. As part of that agreement, we issued stock purchase warrants to GE Capital that expire in March 2022. The fair value of the warrants was charged to additional paid-in-capital, resulting in a debt discount to the Term Loan at the date of issuance. The debt discount and the financing costs, incurred in connections with the agreement, are being amortized over the term of the loan using the effective interest method. The amortization of both the debt discount and deferred financing costs are included in interest expense in the unaudited condensed consolidated statements of operations.&lt;/p&gt; &lt;p style="TEXT-INDENT: 9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Significant Customers and Accounts Receivable&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Our primary customers are the U.S. Department of Defense (the "DoD") - Chemical Biological Medical Systems ("CBMS"), and the Biomedical Advanced Research and Development Authority ("BARDA"). As of March 31, 2013 and December 31, 2012, the Company&amp;#39;s trade receivable and unbilled receivable balances were comprised solely of receivables from CBMS and BARDA.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Goodwill&lt;/em&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Goodwill represents the excess of purchase price over the fair value of net identifiable assets associated with acquisitions. We review the recoverability of goodwill annually as of December 31&lt;sup&gt;st&lt;/sup&gt; by comparing our market value (as measured by our stock price multiplied by the number of outstanding shares as of the end of the year) to the net book value of our equity. If our market value exceeds our net book value, no further analysis is required. Changes in our business strategy or adverse changes in market conditions could impact the impairment analyses and require the recognition of an impairment charge equal to the excess of the carrying value over its estimated fair value. We completed our last annual impairment assessment of goodwill as of December 31, 2012 and determined that there was no impairment as of that date.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Revenue Recognition&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We generate our revenue from different types of contractual arrangements: cost-plus-fee contracts, cost reimbursable grants and fixed price contracts.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Revenues on cost-plus-fee contracts are recognized in an amount equal to the costs incurred during the period plus an estimate of the applicable fee earned. The estimate of the applicable fee earned is determined by reference to the contract: if the contract defines the fee in terms of risk-based milestones and specifies the fees to be earned upon the completion of each milestone, then the fee is recognized when the related milestones are earned, as further described below; otherwise, we estimate the fee earned in a given period by using a proportional performance method based on costs incurred during the period as compared to total estimated project costs and application of the resulting fraction to the total project fee specified in the contract.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Under the milestone method of revenue recognition, milestone payments (including milestone payments for fees) contained in research and development arrangements are recognized as revenue when: (i) the milestones are achieved; (ii) no further performance obligations with respect to the milestone exist; (iii) collection is reasonably assured; and (iv) substantive effort was necessary to achieve the milestone.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Milestones are considered substantive if all of the following conditions are met:&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"&gt; &lt;tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"&gt; it is commensurate with either our performance to meet the milestone or the enhancement of the value of the delivered item or items as a result of a specific outcome resulting from our performance to achieve the milestone,&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"&gt; &lt;tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"&gt; it relates solely to past performance,&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"&gt; &lt;tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 0.25in"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"&gt; &amp;middot;&lt;/td&gt; &lt;td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"&gt; the value of the milestone is reasonable relative to all the deliverables and payment terms (including other potential milestone consideration) within the arrangement.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; If a milestone is deemed not to be substantive, the Company recognizes the portion of the milestone payment as revenue that correlates to work already performed; the remaining portion of the milestone payment is deferred and recognized as revenue as the Company completes its performance obligations.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Revenue on fixed price contracts (without substantive milestones as described above) is recognized on the percentage-of-completion method. The percentage-of-completion method recognizes income as the contract progresses (generally related to the costs incurred in providing the services required under the contract). The use of the percentage-of-completion method depends on the ability to make reasonable dependable estimates and the fact that circumstances may necessitate frequent revision of estimates does not indicate that the estimates are unreliable for the purpose for which they are used.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; As a result of our revenue recognition policies and the billing provisions contained in our contracts, the timing of customer billings may differ from the timing of recognizing revenue. Amounts invoiced to customers in excess of revenue recognized are reflected on the balance sheet as deferred revenue. Amounts recognized as revenue in excess of amounts billed to customers are reflected on the balance sheet as unbilled accounts receivable.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We analyze each cost reimbursable grant to determine whether we should report such reimbursements as revenue or as an offset to our expenses incurred. For the three months ended March 31, 2013 and 2012, we recorded approximately $0.02 million and $0.5 million, respectively, of costs reimbursed by the government as an offset to research and development expenses.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Share-Based Compensation&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We expense the estimated fair value of share-based awards granted to employees under our stock compensation plans. The fair value of stock options is determined at the grant date using an option pricing model. We have estimated the fair value of each stock option award using the Black-Scholes option pricing model. The Black-Scholes model considers, among other factors, the expected life of the award and the expected volatility of our stock price. The value of the award that is ultimately expected to vest is recognized as expense on a straight line basis over the employee&amp;#39;s requisite service period.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The fair value of restricted stock grants is determined based on the closing price of our common stock on the award date and is recognized as expense ratably over the requisite service period.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Employee share-based compensation expense recognized in the three months ended March 31, 2013 and 2012 was calculated based on awards ultimately expected to vest and has been reduced for estimated forfeitures at a rate of approximately 12%, based on historical forfeitures.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Share-based compensation expense for the three months ended March 31, 2013 and 2012 was:&lt;/p&gt; &lt;p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="6"&gt;Three months ended March 31,&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;2013&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2"&gt;2012&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt" colspan="2"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 72%; FONT: 10pt Times New Roman, Times, Serif"&gt; Research and development&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"&gt; 88,634&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"&gt; 117,067&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; General and administrative&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 239,947&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 431,597&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; Total share-based compensation expense&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 328,581&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; $&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"&gt; 548,664&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; During the three months ended March 31, 2013, we granted 60,000 options to employees and consultants and made no restricted stock grants. During the three months ended March 31, 2012, we granted 15,948 options to employees and made no restricted stock grants. At March 31, 2013, we had total unrecognized share-based compensation expense related to unvested awards of approximately $2.0 million net of estimated forfeitures, which we expect to recognize as expense over a weighted-average period of 2.25 years.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Income Taxes&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; We account for income taxes using the asset and liability approach, which requires the recognition of future tax benefits or liabilities on the temporary differences between the financial reporting and tax bases of our assets and liabilities. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized. We also recognize a tax benefit from uncertain tax positions only if it is "more likely than not" that the position is sustainable based on its technical merits. Our policy is to recognize interest and penalties on uncertain tax positions as a component of income tax expense.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Income tax expense was $9,743 and $150,405 during the three months ended March 31, 2013 and 2012, respectively. Income tax expense is a result of the difference between the treatment of goodwill for income tax purposes and for U.S. GAAP, resulting in a deferred tax liability, which cannot offset deferred tax assets. This deferred tax liability is included in our condensed consolidated balance sheet in other long-term liabilities.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Basic and Diluted Net Loss Per Share&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Income (loss) per share:&lt;/em&gt; Basic income (loss) per share is computed by dividing consolidated net income (loss) by the weighted average number of common shares outstanding during the period, excluding unvested restricted stock.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; For periods of net income when the effects are not anti-dilutive, diluted earnings per share is computed by dividing our net income by the weighted average number of shares outstanding and the impact of all potential dilutive common shares, consisting primarily of stock options, unvested restricted stock and stock purchase warrants. The dilutive impact of our dilutive potential common shares resulting from stock options and stock purchase warrants is determined by applying the treasury stock method.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; For the periods of net loss, diluted loss per share is calculated similarly to basic loss per share because the impact of all dilutive potential common shares is anti-dilutive due to the net losses. A total of approximately 11.6 million and 11.5 million potential dilutive securities have been excluded in the calculation of diluted net loss per share in the three months ended March 31, 2013 and 2012, respectively, because their inclusion would be anti-dilutive.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Recent Accounting Pronouncements&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"&gt; We have evaluated all Accounting Standards Updates through the date the unaudited condensed consolidated financial statements were issued and believe the adoption of these will not have a material impact on our results of operations, financial position, or cash flows.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:StockholdersEquity id="StockholdersEquity.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">9942765</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">11673840</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="StockholdersEquityNoteDisclosureTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;Note 5 - Stockholders&amp;#39; Equity&lt;/strong&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Long-Term Incentive Plan&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In 2007, the Company&amp;#39;s stockholders approved the 2007 Long-Term Incentive Compensation Plan (the "2007 Plan") which provides for the granting of incentive and non-qualified stock options, stock appreciation rights, performance units, restricted common awards and performance bonuses (collectively "awards") to Company officers and employees. Additionally, the 2007 Plan authorizes the granting of non-qualified stock options and restricted stock awards to Company directors and to independent consultants.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In 2008, the Company&amp;#39;s shareholders approved amendments to the 2007 Plan, increasing from 3.5 million shares to 4.6 million shares the maximum number of shares authorized for issuance under the plan and adding an evergreen provision pursuant to which the number of shares authorized for issuance under the plan will increase automatically in each year, beginning in 2009 and continuing through 2015, according to certain limits set forth in the 2007 Plan. At March 31, 2013, there are approximately 9.3 million shares approved for issuance under the 2007 plan, of which approximately 2.6 million shares are available to be issued. The Board of Directors in conjunction with management determines who receives awards, the vesting conditions and the exercise price. Options may have a maximum term of ten years.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;br /&gt; &lt;em&gt;Warrants Classified as Equity&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In connection with the July 2009 private placement, we issued warrants to purchase an aggregate of 2,572,775 shares of the Company&amp;#39;s common stock at an exercise price of $2.50 per share. The warrants will expire on January 28, 2015. Also outstanding are warrants to purchase an aggregate of 100,778 shares of common stock at $3.97 per share, which will expire on March 30, 2017.&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In connection with the March 30, 2012, debt financing (see Note 6), we issued warrants to purchase an aggregate of 46,584 shares of the Company&amp;#39;s common stock at an exercise price of $1.61 per share to GE Capital Equity Investments, Inc. The relative fair value attributable to the warrants of $69,876 was recorded in equity during the quarter ended March 31, 2012. The warrants will expire on March 30, 2022.&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Warrants&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; At March 31, 2013 and 2012 there were warrants outstanding to purchase 5,620,128 shares of our common stock, respectively. The warrants outstanding as of March 31, 2013 and 2012 were as follows:&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Number of Common Shares Underlying Warrants&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Issue Date/Exercisable Date&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2"&gt;Exercise Price&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Expiration Date&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 22%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 100,778&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (1)&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; WIDTH: 24%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Mar-07 / Mar-07&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 21%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 3.97&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; WIDTH: 23%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Mar-17&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 705,354&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (2)&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Mar-09 / Sep-09&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 3.00&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Sep-14&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2,572,775&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (1)&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jul-09 / Jan-10&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 2.50&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jan-15&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 500,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (2)&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Apr-10 / Oct-10&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1.89&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Oct-15&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1,323,214&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (2)&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jul-10 / Jan-11&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1.63&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jan-17&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 371,423&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (2)&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jun-11 / Jun-11&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 3.50&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Jun-16&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 46,584&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; (1)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Mar-12 / Mar-12&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; $&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 1.61&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; Mar-22&lt;/td&gt; &lt;/tr&gt; &lt;tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; 5,620,128&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt; &amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 3%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 5%"&gt; (1)&lt;/td&gt; &lt;td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 92%"&gt; These warrants to purchase common stock are classified as equity.&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"&gt; &lt;tr style="VERTICAL-ALIGN: top"&gt; &lt;td style="WIDTH: 3%"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 5%"&gt; (2)&lt;/td&gt; &lt;td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 92%"&gt; These warrants to purchase common stock are classified as derivative liabilities. The fair value of these liabilities (see note 3) is remeasured at the end of every reporting period and the change in fair value is reported in the unaudited condensed consolidated statements of operations as other income (expense).&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.13250.85459.85456.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.85459.85456.0.0.0.0" unitRef="shares" decimals="0">19900</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.14839.5009.5007.0.0.0.0" contextRef="from-2013-04-01-to-2013-05-07.14839.0.5009.5007.0.0.0.0" unitRef="shares" decimals="0">1030870</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SubsequentEventsTextBlock id="SubsequentEventsTextBlock.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;strong&gt;Note 7 - Subsequent Events&lt;/strong&gt;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt;&amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Subsequent to March 31, 2013, we sold 1,030,870 shares of our common stock under the controlled equity offering, which resulted in net proceeds of approximately $1.63 million. (See Note 6). A&lt;font style="COLOR: black"&gt;ggregate gross proceeds of up to approximately $13.29 million remain available under&lt;/font&gt; the arrangement.&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:UnbilledContractsReceivable id="UnbilledContractsReceivable.13248.0.0.0.0.0.0" contextRef="as-of-2013-03-31.13248.0.0.0.0.0.0.0" unitRef="USD" decimals="0">3713797</us-gaap:UnbilledContractsReceivable>
  <us-gaap:UnbilledContractsReceivable id="UnbilledContractsReceivable.13249.0.0.0.0.0.0" contextRef="as-of-2012-12-31.13249.0.0.0.0.0.0.0" unitRef="USD" decimals="0">4114442</us-gaap:UnbilledContractsReceivable>
  <us-gaap:UnrealizedGainLossOnDerivatives id="UnrealizedGainLossOnDerivatives.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-905777</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives id="UnrealizedGainLossOnDerivatives.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="USD" decimals="0">-991662</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives id="UnrealizedGainLossOnDerivatives.13250.2022.1894.5342.2133.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.2022.1894.5342.2133.0.0" unitRef="USD" decimals="0">-905777</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives id="UnrealizedGainLossOnDerivatives.13251.2022.1894.5342.2133.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.2022.1894.5342.2133.0.0" unitRef="USD" decimals="0">-991662</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UseOfEstimates id="UseOfEstimates.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;em&gt;Use of Estimates&lt;/em&gt;&lt;/p&gt; &lt;p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &amp;nbsp;&lt;/p&gt; &lt;p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our unaudited condensed consolidated financial statements include significant estimates for the expected economic life and value of our intangible assets, the amount of our net operating losses, our share-based compensation, the value of our financial instruments, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates&lt;font style="FONT: 10pt Times New Roman, Times, Serif"&gt;.&lt;/font&gt;&lt;/p&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="WeightedAverageNumberOfShareOutstandingBasicAndDiluted.13250.0.0.0.0.0.0" contextRef="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0" unitRef="shares" decimals="0">48359181</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="WeightedAverageNumberOfShareOutstandingBasicAndDiluted.13251.0.0.0.0.0.0" contextRef="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0" unitRef="shares" decimals="0">48269894</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <xbrli:unit id="shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USD_per_warrants">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>pip:warrants</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="USD_per_share">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:context id="from-2013-04-01-to-2013-05-07.14839.0.5009.5007.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-04-01</xbrli:startDate>
      <xbrli:endDate>2013-05-08</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.90127.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheSevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.90126.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheSixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.90125.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheFiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.90124.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheFourMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.90123.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheThreeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.90122.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.90121.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.85459.85456.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="pip:EquityOfferingAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:EquityOfferingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.58153.3871.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:StockIncentivePlanTwentyZeroSevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.58129.872.3241.4187.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:LiquidityArrangementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.58123.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:GroupTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.58122.3139.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:GroupThreeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.58121.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:GroupOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.58120.3139.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:GroupFourMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.4381.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.3055.2887.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LoansPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.3014.2887.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.2354.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.2022.1894.5342.2133.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-01-01-to-2013-03-31.13250.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-03-01-to-2012-03-30.14841.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-03-01</xbrli:startDate>
      <xbrli:endDate>2012-03-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-03-31.13251.0.4381.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-03-31.13251.0.2354.4617.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-03-31.13251.0.2022.1894.5342.2133.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-01-01-to-2012-03-31.13251.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-09-01-to-2011-09-30.13408.0.58137.4956.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:PharmAtheneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-09-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-09-01-to-2011-09-30.13408.0.3241.4187.58137.4956.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:PharmAtheneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-09-01</xbrli:startDate>
      <xbrli:endDate>2011-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2009-07-01-to-2009-07-31.13409.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-07-01</xbrli:startDate>
      <xbrli:endDate>2009-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-05-07.14840.0.5009.5007.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-05-08</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-05-02.13295.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-05-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.90127.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheSevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.90126.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheSixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.90125.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheFiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.90124.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheFourMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.90123.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheThreeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.90122.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.90121.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:WarrantTrancheOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.85459.85456.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="pip:EquityOfferingAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:EquityOfferingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.58153.3871.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:StockIncentivePlanTwentyZeroSevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.58123.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:GroupTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.58121.967.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:GroupOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.3055.2887.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LoansPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.3014.2887.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.2026.1894.1906.1887.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.2024.1894.1906.1887.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.2022.1894.58105.1897.5342.2133">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:DerivativeLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.2022.1894.5342.2133.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.2022.1894.1906.1887.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.1906.1887.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-31.13248.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-28.13756.0.2022.1894.58105.1897.5342.2133">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:DerivativeLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-03-25.13822.0.85459.85456.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="pip:EquityOfferingAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:EquityOfferingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-03-25</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-12-31.13249.0.2026.1894.1906.1887.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-12-31.13249.0.2024.1894.1906.1887.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-12-31.13249.0.2022.1894.58105.1897.5342.2133">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:DerivativeLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-12-31.13249.0.2022.1894.5342.2133.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-12-31.13249.0.2022.1894.1906.1887.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-12-31.13249.0.1906.1887.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-12-31.13249.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-03-31.13252.0.2022.1894.58105.1897.5342.2133">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:DerivativeLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-03-31.13252.0.2022.1894.5342.2133.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-03-31.13252.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-03-30.13421.0.3055.2887.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LoansPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-03-30.13421.0.3014.2887.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-03-30.13421.0.2022.1894.58105.1897.5342.2133">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:DerivativeLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-03-30.13421.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-31.13253.0.2022.1894.5342.2133.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-31.13253.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-12-30.13757.0.2022.1894.58105.1897.5342.2133">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:DerivativeLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2008-12-31.13418.0.58153.3871.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:StockIncentivePlanTwentyZeroSevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2007-12-31.13419.0.58153.3871.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001326190</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">pip:StockIncentivePlanTwentyZeroSevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2007-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:footnote xlink:type="resource" xlink:label="Footnote_241_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">These warrants to purchase common stock are classified as equity.</link:footnote>
    <link:footnote xlink:type="resource" xlink:label="Footnote_242_lbl" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">These warrants to purchase common stock are classified as derivative liabilities. The fair value of these liabilities (see note 3) is remeasured at the end of every reporting period and the change in fair value is reported in the unaudited condensed consolidated statements of operations as other income (expense).</link:footnote>
    <link:loc xlink:type="locator" xlink:href="#ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90121.967.0.0.0.0" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90121.967.0.0.0.0_loc" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90121.967.0.0.0.0_loc" xlink:to="Footnote_241_lbl" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="#ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90122.967.0.0.0.0" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90122.967.0.0.0.0_loc" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90122.967.0.0.0.0_loc" xlink:to="Footnote_242_lbl" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="#ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90123.967.0.0.0.0" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90123.967.0.0.0.0_loc" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90123.967.0.0.0.0_loc" xlink:to="Footnote_241_lbl" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="#ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90124.967.0.0.0.0" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90124.967.0.0.0.0_loc" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90124.967.0.0.0.0_loc" xlink:to="Footnote_242_lbl" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="#ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90125.967.0.0.0.0" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90125.967.0.0.0.0_loc" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90125.967.0.0.0.0_loc" xlink:to="Footnote_242_lbl" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="#ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90126.967.0.0.0.0" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90126.967.0.0.0.0_loc" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90126.967.0.0.0.0_loc" xlink:to="Footnote_242_lbl" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="#ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90127.967.0.0.0.0" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90127.967.0.0.0.0_loc" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.13248.90127.967.0.0.0.0_loc" xlink:to="Footnote_241_lbl" order="1.0" />
  </link:footnoteLink>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>pip-20130331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Vintage Filings ("VF")-->
<!--produced on 2013-05-07 @ 7:02 AM-->
<xsd:schema targetNamespace="http://www.pharmathene.com/20130331" elementFormDefault="qualified" xmlns:pip="http://www.pharmathene.com/20130331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:href="pip-20130331_cal.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:href="pip-20130331_def.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="pip-20130331_lab.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="pip-20130331_pre.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:roleType roleURI="http://www.pharmathene.com/role/CommitmentsAndContingencies" id="pip-cac" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>104 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/CommitmentsAndContingenciesDetails" id="pip-cacd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40401 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheets" id="pip-ccbs" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="pip-ccbsp" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/DocumentAndEntityInformation" id="pip-daei" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/FinancingTransactions" id="pip-ft" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>106 - Disclosure - Financing Transactions</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/FinancingTransactionsDetails" id="pip-ftd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40601 - Disclosure - Financing Transactions (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/FinancingTransactionsTables" id="pip-ftt" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>306 - Disclosure - Financing Transactions (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/FairValueMeasurements" id="pip-fvm" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>103 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/FairValueMeasurementsNarrativeDetails" id="pip-fvmnd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40303 - Disclosure - Fair Value Measurements (Narrative) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/FairValueMeasurementsSummaryOfChangesInFairValueOfOurLevelThreeLiabilitiesDetails" id="pip-fvmsocifvoolld" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40302 - Disclosure - Fair Value Measurements (Summary of Changes in Fair Value of Our Level 3 Liabilities) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/FairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueDetails" id="pip-fvmsolmafvd1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40301 - Disclosure - Fair Value Measurements (Schedule of Liabilities Measured at Fair Value) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/FairValueMeasurementsTables" id="pip-fvmt" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/OrganizationAndBusiness" id="pip-oab" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>101 - Disclosure - Organization and Business</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/StockholdersEquity" id="pip-se" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>105 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/SubsequentEvents" id="pip-se123" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>107 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/SubsequentEventsDetails" id="pip-sed1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40701 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/StockholdersEquityNarrativeDetails" id="pip-send1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40501 - Disclosure - Stockholders' Equity (Narrative) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/StockholdersEquityScheduleOfWarrantsDetails" id="pip-sesowd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40502 - Disclosure - Stockholders' Equity (Schedule of Warrants) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/StockholdersEquityTables" id="pip-set1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>305 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPolicies" id="pip-sosap" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" id="pip-sosapnd1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesPolicy" id="pip-sosapp" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>202 - Disclosure - Summary of Significant Accounting Policies (Policy)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfSharebasedCompensationExpenseDetails" id="pip-sosapsosced" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40202 - Disclosure - Summary of Significant Accounting Policies (Schedule of Share-based Compensation Expense) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesTables" id="pip-sosapt" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>302 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" id="pip-uccsocf" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" id="pip-uccsoo" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOtherComprehensiveLoss" id="pip-uccsoocl" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" id="pip-uccsoop" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2012-01-31" schemaLocation="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2012-01-31" schemaLocation="http://xbrl.sec.gov/invest/2012/invest-2012-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2012-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2012-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2012/elts/us-types-2012-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2012-01-31" schemaLocation="http://xbrl.sec.gov/country/2012/country-2012-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:element name="AccruedExpensesAndOtherCurrentLiabilities" id="pip_AccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="BreachOfContractualCommitmentAwardPeriod" id="pip_BreachOfContractualCommitmentAwardPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="CashEquivalentsMaturityPeriod" id="pip_CashEquivalentsMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="ClassOfWarrantOrRightIssuanceDate" id="pip_ClassOfWarrantOrRightIssuanceDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType" />
  <xsd:element name="CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares" id="pip_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="CommitmentAndContingenciesTable" id="pip_CommitmentAndContingenciesTable" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" />
  <xsd:element name="CommitmentsAndContingenciesLineItems" id="pip_CommitmentsAndContingenciesLineItems" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="CourtAwardedFees" id="pip_CourtAwardedFees" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="DebtInstrumentInterestRateFloorPercentage" id="pip_DebtInstrumentInterestRateFloorPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="DebtInstrumentsMaturityDateMonthAndYear" id="pip_DebtInstrumentsMaturityDateMonthAndYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:gYearMonthItemType" />
  <xsd:element name="DerivativeLiabilitiesMember" id="pip_DerivativeLiabilitiesMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="pip_DocumentAndEntityInformationAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="EquityOfferingAxis" id="pip_EquityOfferingAxis" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" />
  <xsd:element name="EquityOfferingDomain" id="pip_EquityOfferingDomain" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="EquityOfferingLineItems" id="pip_EquityOfferingLineItems" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="EquityOfferingMember" id="pip_EquityOfferingMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="EquityOfferingTable" id="pip_EquityOfferingTable" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" />
  <xsd:element name="FairValueMeasurementsLineItems" id="pip_FairValueMeasurementsLineItems" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="FairValueMeasurementsTable" id="pip_FairValueMeasurementsTable" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" />
  <xsd:element name="FinalPaymentFeeOfTermLoanBalancePercent" id="pip_FinalPaymentFeeOfTermLoanBalancePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="GroupFourMember" id="pip_GroupFourMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="GroupOneMember" id="pip_GroupOneMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="GroupThreeMember" id="pip_GroupThreeMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="GroupTwoMember" id="pip_GroupTwoMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable" id="pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl" id="pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="LiquidityArrangementsMember" id="pip_LiquidityArrangementsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="LongTermDebtPrepaymentPremiumPercentOfPrincipal" id="pip_LongTermDebtPrepaymentPremiumPercentOfPrincipal" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo" id="pip_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="MaximumValueOfStockIssuableUnderStockOffering" id="pip_MaximumValueOfStockIssuableUnderStockOffering" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract" id="pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="NonCashFinancingActivityAbstract" id="pip_NonCashFinancingActivityAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="NotesPayableAggregatePrincipalRepaymentAmount" id="pip_NotesPayableAggregatePrincipalRepaymentAmount" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation" id="pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="PercentageOfAggregatePrincipalAmountRedemption" id="pip_PercentageOfAggregatePrincipalAmountRedemption" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="PercentageOfNetProfitAwarded" id="pip_PercentageOfNetProfitAwarded" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="PharmAtheneMember" id="pip_PharmAtheneMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ProceedsFromIssuanceOfCommonStockAndWarrants" id="pip_ProceedsFromIssuanceOfCommonStockAndWarrants" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="ProceedsFromIssuanceOfLongTermDebtAndWarrants" id="pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="RemainingValueOfStockIssuableUnderStockOffering" id="pip_RemainingValueOfStockIssuableUnderStockOffering" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate" id="pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="SignificantAccountingPoliciesLineItems" id="pip_SignificantAccountingPoliciesLineItems" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="SignificantAccountingPoliciesTable" id="pip_SignificantAccountingPoliciesTable" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" />
  <xsd:element name="StockholdersEquityLineItems" id="pip_StockholdersEquityLineItems" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="StockholdersEquityTable" id="pip_StockholdersEquityTable" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" />
  <xsd:element name="StockIncentivePlanTwentyZeroSevenMember" id="pip_StockIncentivePlanTwentyZeroSevenMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="StockIssuedValueConvertibleNotesAndStockPurchaseWarrants" id="pip_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="StockOptionsContractualTerm" id="pip_StockOptionsContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="SupplementalWarrantIssuedInConnectionWithLongTermDebt" id="pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="WarrantExpirationDate" id="pip_WarrantExpirationDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType" />
  <xsd:element name="WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement" id="pip_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="WarrantTrancheFiveMember" id="pip_WarrantTrancheFiveMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="WarrantTrancheFourMember" id="pip_WarrantTrancheFourMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="WarrantTrancheOneMember" id="pip_WarrantTrancheOneMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="WarrantTrancheSevenMember" id="pip_WarrantTrancheSevenMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="WarrantTrancheSixMember" id="pip_WarrantTrancheSixMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="WarrantTrancheThreeMember" id="pip_WarrantTrancheThreeMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="WarrantTrancheTwoMember" id="pip_WarrantTrancheTwoMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>pip-20130331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Vintage Filings ("VF")-->
<!--produced on 2013-05-07 @ 7:02 AM-->
<link:linkbase xmlns:pip="http://www.pharmathene.com/20130331" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://www.pharmathene.com/role/DocumentAndEntityInformation" xlink:href="pip-20130331.xsd#pip-daei" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheets" xlink:href="pip-20130331.xsd#pip-ccbs" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="pip-20130331.xsd#pip-ccbsp" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="pip-20130331.xsd#pip-uccsoo" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOtherComprehensiveLoss" xlink:href="pip-20130331.xsd#pip-uccsoocl" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="pip-20130331.xsd#pip-uccsocf" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/OrganizationAndBusiness" xlink:href="pip-20130331.xsd#pip-oab" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="pip-20130331.xsd#pip-sosap" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurements" xlink:href="pip-20130331.xsd#pip-fvm" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CommitmentsAndContingencies" xlink:href="pip-20130331.xsd#pip-cac" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquity" xlink:href="pip-20130331.xsd#pip-se" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FinancingTransactions" xlink:href="pip-20130331.xsd#pip-ft" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesPolicy" xlink:href="pip-20130331.xsd#pip-sosapp" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="pip-20130331.xsd#pip-sosapt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsTables" xlink:href="pip-20130331.xsd#pip-fvmt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FinancingTransactionsTables" xlink:href="pip-20130331.xsd#pip-ftt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="pip-20130331.xsd#pip-sosapnd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfSharebasedCompensationExpenseDetails" xlink:href="pip-20130331.xsd#pip-sosapsosced" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsSummaryOfChangesInFairValueOfOurLevelThreeLiabilitiesDetails" xlink:href="pip-20130331.xsd#pip-fvmsocifvoolld" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="pip-20130331.xsd#pip-fvmnd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CommitmentsAndContingenciesDetails" xlink:href="pip-20130331.xsd#pip-cacd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquityNarrativeDetails" xlink:href="pip-20130331.xsd#pip-send1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:href="pip-20130331.xsd#pip-uccsoop" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SubsequentEvents" xlink:href="pip-20130331.xsd#pip-se123" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FinancingTransactionsDetails" xlink:href="pip-20130331.xsd#pip-ftd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueDetails" xlink:href="pip-20130331.xsd#pip-fvmsolmafvd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SubsequentEventsDetails" xlink:href="pip-20130331.xsd#pip-sed1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquityScheduleOfWarrantsDetails" xlink:href="pip-20130331.xsd#pip-sesowd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquityTables" xlink:href="pip-20130331.xsd#pip-set1" xlink:type="simple" />
  <link:calculationLink xlink:title="002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS" xlink:role="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:label="loc_AssetsCurrent.5874.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6556.14.6" order="1.01000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_BilledContractReceivables.6094.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BilledContractReceivables" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_BilledContractReceivables.6094.14.6" order="1.02000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_UnbilledContractsReceivable.17122.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_UnbilledContractsReceivable.17122.14.6" order="1.03000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PrepaidExpenseAndOtherAssetsCurrent.14234.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_PrepaidExpenseAndOtherAssetsCurrent.14234.14.6" order="1.04000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.5874.14.6" xlink:to="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.14.6" order="1.05000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_Assets.5880.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Assets.5880.14.6" xlink:to="loc_AssetsCurrent.5874.14.6" order="1.06000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.14697.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Assets.5880.14.6" xlink:to="loc_PropertyPlantAndEquipmentNet.14697.14.6" order="1.07000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13227.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Assets.5880.14.6" xlink:to="loc_OtherAssetsNoncurrent.13227.14.6" order="1.08000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_Goodwill.10311.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Assets.5880.14.6" xlink:to="loc_Goodwill.10311.14.6" order="1.09000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LiabilitiesCurrent.11668.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:loc xlink:label="loc_AccountsPayableCurrent.5468.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_AccountsPayableCurrent.5468.14.6" order="1.10000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccruedExpensesAndOtherCurrentLiabilities.58092.14.6" xlink:href="pip-20130331.xsd#pip_AccruedExpensesAndOtherCurrentLiabilities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_AccruedExpensesAndOtherCurrentLiabilities.58092.14.6" order="1.11000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtCurrent.12288.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_LongTermDebtCurrent.12288.14.6" order="1.12000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ShortTermBorrowings.16437.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_ShortTermBorrowings.16437.14.6" order="1.13000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenue.7581.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.11668.14.6" xlink:to="loc_DeferredRevenue.7581.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_Liabilities.11702.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Liabilities.11702.14.6" xlink:to="loc_LiabilitiesCurrent.11668.14.6" order="1.14000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherLiabilitiesNoncurrent.13448.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Liabilities.11702.14.6" xlink:to="loc_OtherLiabilitiesNoncurrent.13448.14.6" order="1.15000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtNoncurrent.12289.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Liabilities.11702.14.6" xlink:to="loc_LongTermDebtNoncurrent.12289.14.6" order="1.16000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesNoncurrent.8124.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Liabilities.11702.14.6" xlink:to="loc_DerivativeLiabilitiesNoncurrent.8124.14.6" order="1.17000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.11731.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesAndStockholdersEquity.11731.14.6" xlink:to="loc_Liabilities.11702.14.6" order="1.18000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquity.16667.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesAndStockholdersEquity.11731.14.6" xlink:to="loc_StockholdersEquity.16667.14.6" order="1.23000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CommonStockValue.6874.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.16667.14.6" xlink:to="loc_CommonStockValue.6874.14.6" order="1.19000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AdditionalPaidInCapitalCommonStock.5617.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.16667.14.6" xlink:to="loc_AdditionalPaidInCapitalCommonStock.5617.14.6" order="1.20000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.5579.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.16667.14.6" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.5579.14.6" order="1.21000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15457.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.16667.14.6" xlink:to="loc_RetainedEarningsAccumulatedDeficit.15457.14.6" order="1.22000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" xlink:role="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.12898.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" xlink:to="loc_NonoperatingIncomeExpense.12898.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingIncomeLoss.13080.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" xlink:to="loc_OperatingIncomeLoss.13080.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:loc xlink:label="loc_CurrentIncomeTaxExpenseBenefit.7281.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetIncomeLoss.12771.14.6" xlink:to="loc_CurrentIncomeTaxExpenseBenefit.7281.14.6" order="1.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:calculationArc xlink:from="loc_NetIncomeLoss.12771.14.6" xlink:to="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherNonoperatingIncomeExpense.13446.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.12898.14.6" xlink:to="loc_OtherNonoperatingIncomeExpense.13446.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.12898.14.6" xlink:to="loc_UnrealizedGainLossOnDerivatives.17162.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.58133.14.6" xlink:href="pip-20130331.xsd#pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.12898.14.6" xlink:to="loc_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.58133.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_GainLossOnDispositionOfAssets.10190.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.12898.14.6" xlink:to="loc_GainLossOnDispositionOfAssets.10190.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_InterestExpense.11178.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.12898.14.6" xlink:to="loc_InterestExpense.11178.14.6" order="5.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_InvestmentIncomeInterest.11436.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.12898.14.6" xlink:to="loc_InvestmentIncomeInterest.11436.14.6" order="6.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingExpenses.13060.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15293.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingExpenses.13060.14.6" xlink:to="loc_ResearchAndDevelopmentExpense.15293.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10284.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingExpenses.13060.14.6" xlink:to="loc_GeneralAndAdministrativeExpense.10284.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingExpenses.13060.14.6" xlink:to="loc_DepreciationAndAmortization.8044.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ContractsRevenue.7028.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingIncomeLoss.13080.14.6" xlink:to="loc_ContractsRevenue.7028.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:calculationArc xlink:from="loc_OperatingIncomeLoss.13080.14.6" xlink:to="loc_OperatingExpenses.13060.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE LOSS" xlink:role="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13148.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.13305.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTax.13148.14.6" xlink:to="loc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.13305.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTax.13148.14.6" xlink:to="loc_NetIncomeLoss.12771.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" xlink:role="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:loc xlink:label="loc_EffectOfExchangeRateOnCashAndCashEquivalents.8714.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.14.6" xlink:to="loc_EffectOfExchangeRateOnCashAndCashEquivalents.8714.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.14.6" xlink:to="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivities.12731.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.14.6" xlink:to="loc_NetCashProvidedByUsedInInvestingActivities.12731.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.14.6" xlink:to="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivities.12731.14.6" xlink:to="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PaymentsToAcquirePropertyPlantAndEquipment.13779.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivities.12731.14.6" xlink:to="loc_PaymentsToAcquirePropertyPlantAndEquipment.13779.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromPaymentsForOtherFinancingActivities.14363.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromPaymentsForOtherFinancingActivities.14363.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStockAndWarrants.58138.14.6" xlink:href="pip-20130331.xsd#pip_ProceedsFromIssuanceOfCommonStockAndWarrants" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromIssuanceOfCommonStockAndWarrants.58138.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.14.6" order="5.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PaymentsOfFinancingCosts.13844.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_PaymentsOfFinancingCosts.13844.14.6" order="6.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfLinesOfCredit.14422.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromRepaymentsOfLinesOfCredit.14422.14.6" order="7.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfLongTermDebtAndWarrants.58140.14.6" xlink:href="pip-20130331.xsd#pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromIssuanceOfLongTermDebtAndWarrants.58140.14.6" order="8.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14449.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PaymentsOfStockIssuanceCosts.13770.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.14.6" xlink:to="loc_PaymentsOfStockIssuanceCosts.13770.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.10775.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.10775.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayable.10805.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInAccountsPayable.10805.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.14.6" order="3.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInUnbilledReceivables.11010.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInUnbilledReceivables.11010.14.6" order="4.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.10853.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInAccountsReceivable.10853.14.6" order="5.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PaidInKindInterest.13591.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaidInKindInterest" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_PaidInKindInterest.13591.14.6" order="6.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredIncomeTaxExpenseBenefit.7621.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_DeferredIncomeTaxExpenseBenefit.7621.14.6" order="7.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensation.16244.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_ShareBasedCompensation.16244.14.6" order="8.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.14.6" order="9.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_DepreciationAndAmortization.8044.14.6" order="10.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_UnrealizedGainLossOnDerivatives.17162.14.6" order="11.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_NetIncomeLoss.12771.14.6" order="12.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.10850.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.14.6" xlink:to="loc_IncreaseDecreaseInDeferredRevenue.10850.14.6" order="13.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40601 - Disclosure - Financing Transactions (Details)" xlink:role="http://www.pharmathene.com/role/FinancingTransactionsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DebtInstrumentCarryingAmount.7362.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.12271.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_DebtInstrumentCarryingAmount.7362.14.6" xlink:to="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.12271.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.12273.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_DebtInstrumentCarryingAmount.7362.14.6" xlink:to="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.12273.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.12282.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_DebtInstrumentCarryingAmount.7362.14.6" xlink:to="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.12282.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>pip-20130331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Vintage Filings ("VF")-->
<!--produced on 2013-05-07 @ 7:02 AM-->
<link:linkbase xmlns:pip="http://www.pharmathene.com/20130331" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://www.pharmathene.com/role/DocumentAndEntityInformation" xlink:href="pip-20130331.xsd#pip-daei" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheets" xlink:href="pip-20130331.xsd#pip-ccbs" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="pip-20130331.xsd#pip-ccbsp" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="pip-20130331.xsd#pip-uccsoo" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOtherComprehensiveLoss" xlink:href="pip-20130331.xsd#pip-uccsoocl" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="pip-20130331.xsd#pip-uccsocf" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/OrganizationAndBusiness" xlink:href="pip-20130331.xsd#pip-oab" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="pip-20130331.xsd#pip-sosap" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurements" xlink:href="pip-20130331.xsd#pip-fvm" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CommitmentsAndContingencies" xlink:href="pip-20130331.xsd#pip-cac" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquity" xlink:href="pip-20130331.xsd#pip-se" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FinancingTransactions" xlink:href="pip-20130331.xsd#pip-ft" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesPolicy" xlink:href="pip-20130331.xsd#pip-sosapp" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="pip-20130331.xsd#pip-sosapt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsTables" xlink:href="pip-20130331.xsd#pip-fvmt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FinancingTransactionsTables" xlink:href="pip-20130331.xsd#pip-ftt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="pip-20130331.xsd#pip-sosapnd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfSharebasedCompensationExpenseDetails" xlink:href="pip-20130331.xsd#pip-sosapsosced" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsSummaryOfChangesInFairValueOfOurLevelThreeLiabilitiesDetails" xlink:href="pip-20130331.xsd#pip-fvmsocifvoolld" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="pip-20130331.xsd#pip-fvmnd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CommitmentsAndContingenciesDetails" xlink:href="pip-20130331.xsd#pip-cacd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquityNarrativeDetails" xlink:href="pip-20130331.xsd#pip-send1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:href="pip-20130331.xsd#pip-uccsoop" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SubsequentEvents" xlink:href="pip-20130331.xsd#pip-se123" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FinancingTransactionsDetails" xlink:href="pip-20130331.xsd#pip-ftd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueDetails" xlink:href="pip-20130331.xsd#pip-fvmsolmafvd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SubsequentEventsDetails" xlink:href="pip-20130331.xsd#pip-sed1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquityScheduleOfWarrantsDetails" xlink:href="pip-20130331.xsd#pip-sesowd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquityTables" xlink:href="pip-20130331.xsd#pip-set1" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:definitionLink xlink:title="40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)" xlink:role="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_CashAndCashEquivalentsAxis.872.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CashAndCashEquivalentsAxis.872.8.6" xlink:to="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAxis.872.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CashAndCashEquivalentsAxis.872.6.6" xlink:to="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4187.6.6" xlink:to="loc_RangeMember.4188.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4188.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MaximumMember.3241.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4188.7.6" xlink:to="loc_MaximumMember.3241.7.6" order="1.15000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" />
    <link:loc xlink:label="loc_LiquidityArrangementsMember.58129.7.6" xlink:href="pip-20130331.xsd#pip_LiquidityArrangementsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.7.6" xlink:to="loc_LiquidityArrangementsMember.58129.7.6" order="1.14000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SignificantAccountingPoliciesLineItems.58149.9.6" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTable.58150.9.6" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.9.6" xlink:to="loc_SignificantAccountingPoliciesTable.58150.9.6" order="100.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_SignificantAccountingPoliciesLineItems.58149.7.6" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_NumberOfOperatingSegments.12967.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.7.6" xlink:to="loc_NumberOfOperatingSegments.12967.7.6" order="1.02000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CashEquivalentsMaturityPeriod.58094.7.6" xlink:href="pip-20130331.xsd#pip_CashEquivalentsMaturityPeriod" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.7.6" xlink:to="loc_CashEquivalentsMaturityPeriod.58094.7.6" order="1.04000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CostOfReimbursableExpense.7169.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostOfReimbursableExpense" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.7.6" xlink:to="loc_CostOfReimbursableExpense.7169.7.6" order="1.06000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.58147.7.6" xlink:href="pip-20130331.xsd#pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.58147.7.6" order="1.07000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.7.6" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.7.6" order="1.10000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.7.6" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.7.6" order="1.11000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxExpenseBenefit.10688.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.7.6" xlink:to="loc_IncomeTaxExpenseBenefit.10688.7.6" order="1.12000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.7.6" xlink:to="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.7.6" order="1.13000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.7.6" order="7.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTable.58150.5.6" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesTable" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAxis.872.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesTable.58150.5.6" xlink:to="loc_CashAndCashEquivalentsAxis.872.5.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SignificantAccountingPoliciesTable.58150.5.6" xlink:to="loc_RangeAxis.4187.5.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40202 - Disclosure - Summary of Significant Accounting Policies (Schedule of Share-based Compensation Expense) (Details)" xlink:role="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.9.6" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.9.6" order="100.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5724.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.7.6" xlink:to="loc_AllocatedShareBasedCompensationExpense.5724.7.6" order="1.04000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4381.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.7.6" xlink:to="loc_ResearchAndDevelopmentExpenseMember.4381.7.6" order="1.02000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2354.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.7.6" xlink:to="loc_GeneralAndAdministrativeExpenseMember.2354.7.6" order="1.03000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.8.6" xlink:to="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.6.6" xlink:to="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.5.6" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.5.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40302 - Disclosure - Fair Value Measurements (Summary of Changes in Fair Value of Our Level 3 Liabilities) (Details)" xlink:role="http://www.pharmathene.com/role/FairValueMeasurementsSummaryOfChangesInFairValueOfOurLevelThreeLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.6.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:to="loc_FairValueInputsLevel3Member.2022.7.6" order="1.02000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.9.6" xlink:to="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.7.6" xlink:to="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.7.6" xlink:to="loc_UnrealizedGainLossOnDerivatives.17162.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.5.6" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis.1894.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_FinancialInstrumentAxis.2133.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.5.6" xlink:to="loc_FinancialInstrumentAxis.2133.5.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_FinancialInstrumentAxis.2133.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FinancialInstrumentAxis.2133.6.6" xlink:to="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_WarrantMember.5342.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.7.6" xlink:to="loc_WarrantMember.5342.7.6" order="1.03000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40303 - Disclosure - Fair Value Measurements (Narrative) (Details)" xlink:role="http://www.pharmathene.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.8.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.6.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByLiabilityClassAxis.1897.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByLiabilityClassAxis.1897.8.6" xlink:to="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByLiabilityClassAxis.1897.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByLiabilityClassAxis.1897.6.6" xlink:to="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesMember.58105.7.6" xlink:href="pip-20130331.xsd#pip_DerivativeLiabilitiesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.7.6" xlink:to="loc_DerivativeLiabilitiesMember.58105.7.6" order="1.04000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:to="loc_FairValueInputsLevel3Member.2022.7.6" order="1.06000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FinancialInstrumentAxis.2133.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FinancialInstrumentAxis.2133.8.6" xlink:to="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_FinancialInstrumentAxis.2133.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FinancialInstrumentAxis.2133.6.6" xlink:to="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_WarrantMember.5342.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.7.6" xlink:to="loc_WarrantMember.5342.7.6" order="1.05000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsLineItems.58117.9.6" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsTable.58118.9.6" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsLineItems.58117.9.6" xlink:to="loc_FairValueMeasurementsTable.58118.9.6" order="100.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsLineItems.58117.7.6" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightOutstanding.6757.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsLineItems.58117.7.6" xlink:to="loc_ClassOfWarrantOrRightOutstanding.6757.7.6" order="1.01000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsLineItems.58117.7.6" xlink:to="loc_UnrealizedGainLossOnDerivatives.17162.7.6" order="1.02000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SharePrice.16294.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsLineItems.58117.7.6" xlink:to="loc_SharePrice.16294.7.6" order="3.02000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsTable.58118.5.6" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsTable" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsTable.58118.5.6" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis.1894.5.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_FinancialInstrumentAxis.2133.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsTable.58118.5.6" xlink:to="loc_FinancialInstrumentAxis.2133.5.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByLiabilityClassAxis.1897.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsTable.58118.5.6" xlink:to="loc_FairValueByLiabilityClassAxis.1897.5.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40401 - Disclosure - Commitments and Contingencies (Details)" xlink:role="http://www.pharmathene.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended">
    <link:loc xlink:label="loc_LossContingenciesByNatureOfContingencyAxis.3139.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_LossContingencyNatureDomain.3148.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LossContingenciesByNatureOfContingencyAxis.3139.8.6" xlink:to="loc_LossContingencyNatureDomain.3148.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_LossContingenciesByNatureOfContingencyAxis.3139.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_LossContingencyNatureDomain.3148.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LossContingenciesByNatureOfContingencyAxis.3139.6.6" xlink:to="loc_LossContingencyNatureDomain.3148.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_LossContingencyNatureDomain.3148.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_GroupThreeMember.58122.7.6" xlink:href="pip-20130331.xsd#pip_GroupThreeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LossContingencyNatureDomain.3148.7.6" xlink:to="loc_GroupThreeMember.58122.7.6" order="1.12000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_GroupFourMember.58120.7.6" xlink:href="pip-20130331.xsd#pip_GroupFourMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LossContingencyNatureDomain.3148.7.6" xlink:to="loc_GroupFourMember.58120.7.6" order="1.13000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4187.8.6" xlink:to="loc_RangeMember.4188.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4187.6.6" xlink:to="loc_RangeMember.4188.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4188.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MaximumMember.3241.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4188.7.6" xlink:to="loc_MaximumMember.3241.7.6" order="1.10000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SegmentDomain.4780.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SegmentDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_PharmAtheneMember.58137.7.6" xlink:href="pip-20130331.xsd#pip_PharmAtheneMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SegmentDomain.4780.7.6" xlink:to="loc_PharmAtheneMember.58137.7.6" order="1.09000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementBusinessSegmentsAxis.4956.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_SegmentDomain.4780.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SegmentDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementBusinessSegmentsAxis.4956.8.6" xlink:to="loc_SegmentDomain.4780.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementBusinessSegmentsAxis.4956.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_SegmentDomain.4780.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SegmentDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementBusinessSegmentsAxis.4956.6.6" xlink:to="loc_SegmentDomain.4780.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_CommitmentAndContingenciesTable.58096.5.6" xlink:href="pip-20130331.xsd#pip_CommitmentAndContingenciesTable" xlink:type="locator" />
    <link:loc xlink:label="loc_StatementBusinessSegmentsAxis.4956.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentAndContingenciesTable.58096.5.6" xlink:to="loc_StatementBusinessSegmentsAxis.4956.5.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_LossContingenciesByNatureOfContingencyAxis.3139.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentAndContingenciesTable.58096.5.6" xlink:to="loc_LossContingenciesByNatureOfContingencyAxis.3139.5.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentAndContingenciesTable.58096.5.6" xlink:to="loc_RangeAxis.4187.5.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_CommitmentsAndContingenciesLineItems.58097.9.6" xlink:href="pip-20130331.xsd#pip_CommitmentsAndContingenciesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_CommitmentAndContingenciesTable.58096.9.6" xlink:href="pip-20130331.xsd#pip_CommitmentAndContingenciesTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.9.6" xlink:to="loc_CommitmentAndContingenciesTable.58096.9.6" order="100.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_CommitmentsAndContingenciesLineItems.58097.7.6" xlink:href="pip-20130331.xsd#pip_CommitmentsAndContingenciesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_PercentageOfNetProfitAwarded.58135.7.6" xlink:href="pip-20130331.xsd#pip_PercentageOfNetProfitAwarded" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.7.6" xlink:to="loc_PercentageOfNetProfitAwarded.58135.7.6" order="1.02000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_BreachOfContractualCommitmentAwardPeriod.58093.7.6" xlink:href="pip-20130331.xsd#pip_BreachOfContractualCommitmentAwardPeriod" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.7.6" xlink:to="loc_BreachOfContractualCommitmentAwardPeriod.58093.7.6" order="1.03000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.58130.7.6" xlink:href="pip-20130331.xsd#pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.7.6" xlink:to="loc_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.58130.7.6" order="1.04000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CourtAwardedFees.58099.7.6" xlink:href="pip-20130331.xsd#pip_CourtAwardedFees" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.7.6" xlink:to="loc_CourtAwardedFees.58099.7.6" order="1.05000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantExpirationDate.58158.7.6" xlink:href="pip-20130331.xsd#pip_WarrantExpirationDate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.7.6" xlink:to="loc_WarrantExpirationDate.58158.7.6" order="1.06000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PercentageOfAggregatePrincipalAmountRedemption.58134.7.6" xlink:href="pip-20130331.xsd#pip_PercentageOfAggregatePrincipalAmountRedemption" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.7.6" xlink:to="loc_PercentageOfAggregatePrincipalAmountRedemption.58134.7.6" order="1.07000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_NotesPayableAggregatePrincipalRepaymentAmount.58132.7.6" xlink:href="pip-20130331.xsd#pip_NotesPayableAggregatePrincipalRepaymentAmount" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.7.6" xlink:to="loc_NotesPayableAggregatePrincipalRepaymentAmount.58132.7.6" order="1.08000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40501 - Disclosure - Stockholders' Equity (Narrative) (Details)" xlink:role="http://www.pharmathene.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_GroupOneMember.58121.7.6" xlink:href="pip-20130331.xsd#pip_GroupOneMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:to="loc_GroupOneMember.58121.7.6" order="1.10000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_GroupTwoMember.58123.7.6" xlink:href="pip-20130331.xsd#pip_GroupTwoMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:to="loc_GroupTwoMember.58123.7.6" order="1.11000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.967.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightAxis.967.6.6" xlink:to="loc_ClassOfWarrantOrRightDomain.964.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.967.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightAxis.967.8.6" xlink:to="loc_ClassOfWarrantOrRightDomain.964.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIncentivePlanTwentyZeroSevenMember.58153.7.6" xlink:href="pip-20130331.xsd#pip_StockIncentivePlanTwentyZeroSevenMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameDomain.3870.7.6" xlink:to="loc_StockIncentivePlanTwentyZeroSevenMember.58153.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameAxis.3871.6.6" xlink:to="loc_PlanNameDomain.3870.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PlanNameAxis.3871.8.6" xlink:to="loc_PlanNameDomain.3870.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityLineItems.58151.9.6" xlink:href="pip-20130331.xsd#pip_StockholdersEquityLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquityTable.58152.9.6" xlink:href="pip-20130331.xsd#pip_StockholdersEquityTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityLineItems.58151.9.6" xlink:to="loc_StockholdersEquityTable.58152.9.6" order="100.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityLineItems.58151.7.6" xlink:href="pip-20130331.xsd#pip_StockholdersEquityLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockCapitalSharesReservedForFutureIssuance.6881.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityLineItems.58151.7.6" xlink:to="loc_CommonStockCapitalSharesReservedForFutureIssuance.6881.7.6" order="1.02000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityLineItems.58151.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.7.6" order="1.04000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityLineItems.58151.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.7.6" order="1.05000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityLineItems.58151.7.6" xlink:to="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.7.6" order="1.06000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityLineItems.58151.7.6" xlink:to="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.7.6" order="1.07000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantExpirationDate.58158.7.6" xlink:href="pip-20130331.xsd#pip_WarrantExpirationDate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityLineItems.58151.7.6" xlink:to="loc_WarrantExpirationDate.58158.7.6" order="1.08000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockOptionsContractualTerm.58154.7.6" xlink:href="pip-20130331.xsd#pip_StockOptionsContractualTerm" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityLineItems.58151.7.6" xlink:to="loc_StockOptionsContractualTerm.58154.7.6" order="4.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.7.6" xlink:href="pip-20130331.xsd#pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityLineItems.58151.7.6" xlink:to="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.7.6" order="8.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityTable.58152.5.6" xlink:href="pip-20130331.xsd#pip_StockholdersEquityTable" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.967.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityTable.58152.5.6" xlink:to="loc_ClassOfWarrantOrRightAxis.967.5.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityTable.58152.5.6" xlink:to="loc_PlanNameAxis.3871.5.6" order="10.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40601 - Disclosure - Financing Transactions (Details)" xlink:role="http://www.pharmathene.com/role/FinancingTransactionsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DebtInstrumentLineItems.1279.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DebtInstrumentTable.1280.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.9.6" xlink:to="loc_DebtInstrumentTable.1280.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentLineItems.1279.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_LineOfCreditFacilityMaximumBorrowingCapacity.11955.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LineOfCreditFacilityMaximumBorrowingCapacity.11955.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LineOfCreditFacilityCurrentBorrowingCapacity.11992.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LineOfCreditFacilityCurrentBorrowingCapacity.11992.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LineOfCreditFacilityFairValueOfAmountOutstanding.11964.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LineOfCreditFacilityFairValueOfAmountOutstanding.11964.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityDescription.11991.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityBorrowingCapacityDescription" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LineOfCreditFacilityBorrowingCapacityDescription.11991.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.85398.7.6" xlink:href="pip-20130331.xsd#pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.85398.7.6" order="8.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.85399.7.6" xlink:href="pip-20130331.xsd#pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.85399.7.6" order="9.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentInterestRateStatedPercentage.7491.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentInterestRateStatedPercentage.7491.7.6" order="10.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.7.6" order="11.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentMaturityDate.7446.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentMaturityDate.7446.7.6" order="14.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentInterestRateEffectivePercentage.7445.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentInterestRateEffectivePercentage.7445.7.6" order="13.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentIssuanceDate1.7367.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentIssuanceDate1.7367.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.12282.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.12282.7.6" order="15.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.12273.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.12273.7.6" order="16.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.12271.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.12271.7.6" order="17.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipal.85400.7.6" xlink:href="pip-20130331.xsd#pip_LongTermDebtPrepaymentPremiumPercentOfPrincipal" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipal.85400.7.6" order="18.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.85401.7.6" xlink:href="pip-20130331.xsd#pip_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.85401.7.6" order="20.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.85402.7.6" xlink:href="pip-20130331.xsd#pip_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.85402.7.6" order="21.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.7.6" order="23.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.85403.7.6" xlink:href="pip-20130331.xsd#pip_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.85403.7.6" order="24.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.16610.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.16610.7.6" order="25.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.16635.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.16635.7.6" order="26.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentConvertibleConversionPrice1.7392.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentConvertibleConversionPrice1.7392.7.6" order="27.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_InducedConversionOfConvertibleDebtExpense.11067.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_InducedConversionOfConvertibleDebtExpense.11067.7.6" order="28.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ConvertibleLongTermNotesPayable.7099.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_ConvertibleLongTermNotesPayable.7099.7.6" order="29.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_InterestExpenseDebt.11271.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_InterestExpenseDebt.11271.7.6" order="30.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtCurrent.12288.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LongTermDebtCurrent.12288.7.6" order="31.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtNoncurrent.12289.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LongTermDebtNoncurrent.12289.7.6" order="32.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtFairValue.12213.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_LongTermDebtFairValue.12213.7.6" order="33.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FinalPaymentFeeOfTermLoanBalancePercent.85404.7.6" xlink:href="pip-20130331.xsd#pip_FinalPaymentFeeOfTermLoanBalancePercent" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_FinalPaymentFeeOfTermLoanBalancePercent.85404.7.6" order="22.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentInterestRateFloorPercentage.85405.7.6" xlink:href="pip-20130331.xsd#pip_DebtInstrumentInterestRateFloorPercentage" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentInterestRateFloorPercentage.85405.7.6" order="12.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentCarryingAmount.7362.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentCarryingAmount.7362.7.6" order="16.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentPaymentTerms.7453.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentPaymentTerms.7453.7.6" order="5.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentsMaturityDateMonthAndYear.58104.7.6" xlink:href="pip-20130331.xsd#pip_DebtInstrumentsMaturityDateMonthAndYear" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentsMaturityDateMonthAndYear.58104.7.6" order="6.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentUnamortizedDiscount.7464.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentLineItems.1279.7.6" xlink:to="loc_DebtInstrumentUnamortizedDiscount.7464.7.6" order="29.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtInstrumentTable.1280.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" />
    <link:loc xlink:label="loc_LongtermDebtTypeAxis.2887.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DebtInstrumentTable.1280.5.6" xlink:to="loc_LongtermDebtTypeAxis.2887.5.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_LongtermDebtTypeDomain.2885.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_LineOfCreditMember.3014.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongtermDebtTypeDomain.2885.7.6" xlink:to="loc_LineOfCreditMember.3014.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LoansPayableMember.3055.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LoansPayableMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongtermDebtTypeDomain.2885.7.6" xlink:to="loc_LoansPayableMember.3055.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongtermDebtTypeAxis.2887.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_LongtermDebtTypeDomain.2885.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongtermDebtTypeAxis.2887.6.6" xlink:to="loc_LongtermDebtTypeDomain.2885.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_LongtermDebtTypeAxis.2887.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_LongtermDebtTypeDomain.2885.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongtermDebtTypeAxis.2887.8.6" xlink:to="loc_LongtermDebtTypeDomain.2885.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingAxis.85456.8.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityOfferingDomain.85458.8.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingAxis.85456.8.6" xlink:to="loc_EquityOfferingDomain.85458.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingAxis.85456.6.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityOfferingDomain.85458.6.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingAxis.85456.6.6" xlink:to="loc_EquityOfferingDomain.85458.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingDomain.85458.7.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityOfferingMember.85459.7.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingDomain.85458.7.6" xlink:to="loc_EquityOfferingMember.85459.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingTable.85460.5.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingTable" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityOfferingAxis.85456.5.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingTable.85460.5.6" xlink:to="loc_EquityOfferingAxis.85456.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingLineItems.85461.9.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityOfferingTable.85460.9.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingLineItems.85461.9.6" xlink:to="loc_EquityOfferingTable.85460.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingLineItems.85461.7.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_MaximumValueOfStockIssuableUnderStockOffering.85462.7.6" xlink:href="pip-20130331.xsd#pip_MaximumValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingLineItems.85461.7.6" xlink:to="loc_MaximumValueOfStockIssuableUnderStockOffering.85462.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.85463.7.6" xlink:href="pip-20130331.xsd#pip_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingLineItems.85461.7.6" xlink:to="loc_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.85463.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingLineItems.85461.7.6" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14449.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingLineItems.85461.7.6" xlink:to="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.7.6" xlink:href="pip-20130331.xsd#pip_RemainingValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingLineItems.85461.7.6" xlink:to="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.7.6" order="8.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingLineItems.85461.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16628.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5652.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityOfferingLineItems.85461.7.6" xlink:to="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5652.7.6" order="3.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40301 - Disclosure - Fair Value Measurements (Schedule of Liabilities Measured at Fair Value) (Details)" xlink:role="http://www.pharmathene.com/role/FairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueByMeasurementFrequencyAxis.1887.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.1917.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByMeasurementFrequencyAxis.1887.8.6" xlink:to="loc_FairValueMeasurementFrequencyDomain.1917.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByMeasurementFrequencyAxis.1887.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.1917.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByMeasurementFrequencyAxis.1887.6.6" xlink:to="loc_FairValueMeasurementFrequencyDomain.1917.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.8.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.6.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.1917.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsRecurringMember.1906.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementFrequencyDomain.1917.7.6" xlink:to="loc_FairValueMeasurementsRecurringMember.1906.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueByMeasurementFrequencyAxis.1887.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.5.6" xlink:to="loc_FairValueByMeasurementFrequencyAxis.1887.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.5.6" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis.1894.5.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2024.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:to="loc_FairValueInputsLevel1Member.2024.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2026.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:to="loc_FairValueInputsLevel2Member.2026.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.7.6" xlink:to="loc_FairValueInputsLevel3Member.2022.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.9.6" xlink:to="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.7.6" xlink:to="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40701 - Disclosure - Subsequent Events (Details)" xlink:role="http://www.pharmathene.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_SubsequentEventTypeDomain.5005.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventMember.5009.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventTypeDomain.5005.7.6" xlink:to="loc_SubsequentEventMember.5009.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventLineItems.5006.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventTable.5008.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventLineItems.5006.9.6" xlink:to="loc_SubsequentEventTable.5008.9.6" order="3.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventLineItems.5006.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventLineItems.5006.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16628.7.6" order="4.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.7.6" xlink:href="pip-20130331.xsd#pip_RemainingValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventLineItems.5006.7.6" xlink:to="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.7.6" order="5.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventLineItems.5006.7.6" xlink:to="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.7.6" order="6.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventLineItems.5006.7.6" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14449.7.6" order="7.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventTypeAxis.5007.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventTypeDomain.5005.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventTypeAxis.5007.6.6" xlink:to="loc_SubsequentEventTypeDomain.5005.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventTypeAxis.5007.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventTypeDomain.5005.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventTypeAxis.5007.8.6" xlink:to="loc_SubsequentEventTypeDomain.5005.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventTable.5008.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventTypeAxis.5007.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventTable.5008.5.6" xlink:to="loc_SubsequentEventTypeAxis.5007.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40502 - Disclosure - Stockholders' Equity (Schedule of Warrants) (Details)" xlink:role="http://www.pharmathene.com/role/StockholdersEquityScheduleOfWarrantsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_ClassOfWarrantOrRightTable.959.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.967.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightTable.959.5.6" xlink:to="loc_ClassOfWarrantOrRightAxis.967.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantsTransferred.961.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightTable.959.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_WarrantsTransferred.961.9.6" xlink:to="loc_ClassOfWarrantOrRightTable.959.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantsTransferred.961.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_WarrantsTransferred.961.7.6" xlink:to="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightIssuanceDate.87420.7.6" xlink:href="pip-20130331.xsd#pip_ClassOfWarrantOrRightIssuanceDate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_WarrantsTransferred.961.7.6" xlink:to="loc_ClassOfWarrantOrRightIssuanceDate.87420.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.6763.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_WarrantsTransferred.961.7.6" xlink:to="loc_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.6763.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_WarrantsTransferred.961.7.6" xlink:to="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.7.6" order="8.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantExpirationDate.58158.7.6" xlink:href="pip-20130331.xsd#pip_WarrantExpirationDate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_WarrantsTransferred.961.7.6" xlink:to="loc_WarrantExpirationDate.58158.7.6" order="9.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_WarrantTrancheOneMember.90121.7.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheOneMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:to="loc_WarrantTrancheOneMember.90121.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantTrancheTwoMember.90122.7.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheTwoMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:to="loc_WarrantTrancheTwoMember.90122.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantTrancheThreeMember.90123.7.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheThreeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:to="loc_WarrantTrancheThreeMember.90123.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantTrancheFourMember.90124.7.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheFourMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:to="loc_WarrantTrancheFourMember.90124.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantTrancheFiveMember.90125.7.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheFiveMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:to="loc_WarrantTrancheFiveMember.90125.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantTrancheSixMember.90126.7.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheSixMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:to="loc_WarrantTrancheSixMember.90126.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantTrancheSevenMember.90127.7.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheSevenMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.7.6" xlink:to="loc_WarrantTrancheSevenMember.90127.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.967.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightAxis.967.8.6" xlink:to="loc_ClassOfWarrantOrRightDomain.964.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.967.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightAxis.967.6.6" xlink:to="loc_ClassOfWarrantOrRightDomain.964.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>pip-20130331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Vintage Filings ("VF")-->
<!--produced on 2013-05-07 @ 7:02 AM-->
<link:linkbase xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-roles-2012-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/changeLabel2012" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-roles-2012-01-31.xsd#changeLabel2012" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/fragmentDocumentation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-roles-2012-01-31.xsd#fragmentDocumentation" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/fragmentLabel" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-roles-2012-01-31.xsd#fragmentLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/deprecatedLabel" xlink:href="http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd#deprecatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/deprecatedDateLabel" xlink:href="http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd#deprecatedDateLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:label="loc_AmendmentFlag.144.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AmendmentFlag.144.11.6" xlink:to="dei_AmendmentFlag_lbl.267514" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_AmendmentFlag_lbl.267514" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_AmendmentFlag_lbl.267514">Amendment Flag</link:label>
    <link:loc xlink:label="loc_AmendmentFlag.144.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AmendmentFlag.144.11.7" xlink:to="dei_AmendmentFlag_lbl.267515" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_AmendmentFlag_lbl.267515" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_AmendmentFlag_lbl.267515">Amendment Flag</link:label>
    <link:loc xlink:label="loc_CurrentFiscalYearEndDate.155.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CurrentFiscalYearEndDate.155.11.6" xlink:to="dei_CurrentFiscalYearEndDate_lbl.267604" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_CurrentFiscalYearEndDate_lbl.267604" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl.267604">Current Fiscal Year End Date</link:label>
    <link:loc xlink:label="loc_CurrentFiscalYearEndDate.155.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CurrentFiscalYearEndDate.155.11.7" xlink:to="dei_CurrentFiscalYearEndDate_lbl.267605" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_CurrentFiscalYearEndDate_lbl.267605" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl.267605">Current Fiscal Year End Date</link:label>
    <link:loc xlink:label="loc_DocumentFiscalPeriodFocus.208.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentFiscalPeriodFocus.208.11.6" xlink:to="dei_DocumentFiscalPeriodFocus_lbl.267675" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_DocumentFiscalPeriodFocus_lbl.267675" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl.267675">Document Fiscal Period Focus</link:label>
    <link:loc xlink:label="loc_DocumentFiscalPeriodFocus.208.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentFiscalPeriodFocus.208.11.7" xlink:to="dei_DocumentFiscalPeriodFocus_lbl.267676" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_DocumentFiscalPeriodFocus_lbl.267676" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl.267676">Document Fiscal Period Focus</link:label>
    <link:loc xlink:label="loc_DocumentFiscalYearFocus.207.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentFiscalYearFocus.207.11.6" xlink:to="dei_DocumentFiscalYearFocus_lbl.267677" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_DocumentFiscalYearFocus_lbl.267677" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl.267677">Document Fiscal Year Focus</link:label>
    <link:loc xlink:label="loc_DocumentFiscalYearFocus.207.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentFiscalYearFocus.207.11.7" xlink:to="dei_DocumentFiscalYearFocus_lbl.267678" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_DocumentFiscalYearFocus_lbl.267678" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl.267678">Document Fiscal Year Focus</link:label>
    <link:loc xlink:label="loc_DocumentPeriodEndDate.161.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentPeriodEndDate.161.11.6" xlink:to="dei_DocumentPeriodEndDate_lbl.267681" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_DocumentPeriodEndDate_lbl.267681" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl.267681">Document Period End Date</link:label>
    <link:loc xlink:label="loc_DocumentPeriodEndDate.161.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentPeriodEndDate.161.11.7" xlink:to="dei_DocumentPeriodEndDate_lbl.267682" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_DocumentPeriodEndDate_lbl.267682" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl.267682">Document Period End Date</link:label>
    <link:loc xlink:label="loc_DocumentType.212.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentType" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentType.212.11.6" xlink:to="dei_DocumentType_lbl.267683" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_DocumentType_lbl.267683" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_DocumentType_lbl.267683">Document Type</link:label>
    <link:loc xlink:label="loc_DocumentType.212.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentType" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentType.212.11.7" xlink:to="dei_DocumentType_lbl.267684" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_DocumentType_lbl.267684" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_DocumentType_lbl.267684">Document Type</link:label>
    <link:loc xlink:label="loc_EntityCentralIndexKey.188.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityCentralIndexKey.188.11.6" xlink:to="dei_EntityCentralIndexKey_lbl.267701" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_EntityCentralIndexKey_lbl.267701" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl.267701">Entity Central Index Key</link:label>
    <link:loc xlink:label="loc_EntityCentralIndexKey.188.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityCentralIndexKey.188.11.7" xlink:to="dei_EntityCentralIndexKey_lbl.267702" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_EntityCentralIndexKey_lbl.267702" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl.267702">Entity Central Index Key</link:label>
    <link:loc xlink:label="loc_EntityCommonStockSharesOutstanding.192.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityCommonStockSharesOutstanding.192.11.6" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl.267703" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_EntityCommonStockSharesOutstanding_lbl.267703" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl.267703">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:label="loc_EntityCommonStockSharesOutstanding.192.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityCommonStockSharesOutstanding.192.11.7" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl.267704" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_EntityCommonStockSharesOutstanding_lbl.267704" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl.267704">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:label="loc_EntityFilerCategory.185.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityFilerCategory.185.11.6" xlink:to="dei_EntityFilerCategory_lbl.267707" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_EntityFilerCategory_lbl.267707" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_EntityFilerCategory_lbl.267707">Entity Filer Category</link:label>
    <link:loc xlink:label="loc_EntityFilerCategory.185.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityFilerCategory.185.11.7" xlink:to="dei_EntityFilerCategory_lbl.267708" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_EntityFilerCategory_lbl.267708" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_EntityFilerCategory_lbl.267708">Entity Filer Category</link:label>
    <link:loc xlink:label="loc_EntityRegistrantName.187.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityRegistrantName.187.11.6" xlink:to="dei_EntityRegistrantName_lbl.267709" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_EntityRegistrantName_lbl.267709" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_EntityRegistrantName_lbl.267709">Entity Registrant Name</link:label>
    <link:loc xlink:label="loc_EntityRegistrantName.187.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityRegistrantName.187.11.7" xlink:to="dei_EntityRegistrantName_lbl.267710" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_EntityRegistrantName_lbl.267710" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_EntityRegistrantName_lbl.267710">Entity Registrant Name</link:label>
    <link:loc xlink:label="loc_TradingSymbol.177.11.6" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_TradingSymbol" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TradingSymbol.177.11.6" xlink:to="dei_TradingSymbol_lbl.268067" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_TradingSymbol_lbl.268067" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="dei_TradingSymbol_lbl.268067">Trading Symbol</link:label>
    <link:loc xlink:label="loc_TradingSymbol.177.11.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_TradingSymbol" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TradingSymbol.177.11.7" xlink:to="dei_TradingSymbol_lbl.268068" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="dei_TradingSymbol_lbl.268068" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="dei_TradingSymbol_lbl.268068">Trading Symbol</link:label>
    <link:loc xlink:label="loc_DocumentAndEntityInformationAbstract.58115.11.6" xlink:href="pip-20130331.xsd#pip_DocumentAndEntityInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.11.6" xlink:to="lab_DocumentAndEntityInformationAbstract.267673" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentAndEntityInformationAbstract.267673" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentAndEntityInformationAbstract.267673">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:label="loc_DocumentAndEntityInformationAbstract.58115.11.12" xlink:href="pip-20130331.xsd#pip_DocumentAndEntityInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.11.12" xlink:to="pip_DocumentDocumentandEntityInformationAbstract_lbl.267672" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_DocumentDocumentandEntityInformationAbstract_lbl.267672" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_DocumentDocumentandEntityInformationAbstract_lbl.267672">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:label="loc_AccruedExpensesAndOtherCurrentLiabilities.58092.11.6" xlink:href="pip-20130331.xsd#pip_AccruedExpensesAndOtherCurrentLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccruedExpensesAndOtherCurrentLiabilities.58092.11.6" xlink:to="pip_AccruedExpensesAndOtherCurrentLiabilities_lbl.267504" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_AccruedExpensesAndOtherCurrentLiabilities_lbl.267504" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_AccruedExpensesAndOtherCurrentLiabilities_lbl.267504">Accrued Expenses And Other Current Liabilities</link:label>
    <link:loc xlink:label="loc_AccruedExpensesAndOtherCurrentLiabilities.58092.11.7" xlink:href="pip-20130331.xsd#pip_AccruedExpensesAndOtherCurrentLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccruedExpensesAndOtherCurrentLiabilities.58092.11.7" xlink:to="pip_AccruedExpensesAndOtherCurrentLiabilities_lbl.267505" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_AccruedExpensesAndOtherCurrentLiabilities_lbl.267505" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_AccruedExpensesAndOtherCurrentLiabilities_lbl.267505">Accrued expenses and other liabilities</link:label>
    <link:loc xlink:label="loc_AccruedExpensesAndOtherCurrentLiabilities.58092.11.12" xlink:href="pip-20130331.xsd#pip_AccruedExpensesAndOtherCurrentLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccruedExpensesAndOtherCurrentLiabilities.58092.11.12" xlink:to="pip_AccruedExpensesAndOtherCurrentLiabilities_lbl.267503" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_AccruedExpensesAndOtherCurrentLiabilities_lbl.267503" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_AccruedExpensesAndOtherCurrentLiabilities_lbl.267503">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Also includes the aggregate carrying amount, as of the balance sheet date, of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:label="loc_AccountsPayableCurrent.5468.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableCurrent.5468.11.6" xlink:to="us-gaap_AccountsPayableCurrent_lbl.267501" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AccountsPayableCurrent_lbl.267501" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl.267501">Accounts Payable Current</link:label>
    <link:loc xlink:label="loc_AccountsPayableCurrent.5468.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableCurrent.5468.11.7" xlink:to="us-gaap_AccountsPayableCurrent_lbl.267502" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AccountsPayableCurrent_lbl.267502" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl.267502">Accounts payable</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.5579.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.5579.11.6" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl.267506" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl.267506" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl.267506">Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.5579.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.5579.11.7" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl.267507" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl.267507" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl.267507">Accumulated other comprehensive loss</link:label>
    <link:loc xlink:label="loc_AdditionalPaidInCapitalCommonStock.5617.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalPaidInCapitalCommonStock.5617.11.6" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl.267508" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl.267508" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalCommonStock_lbl.267508">Additional Paid In Capital Common Stock</link:label>
    <link:loc xlink:label="loc_AdditionalPaidInCapitalCommonStock.5617.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalPaidInCapitalCommonStock.5617.11.7" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl.267509" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl.267509" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalCommonStock_lbl.267509">Additional paid-in-capital</link:label>
    <link:loc xlink:label="loc_Assets.5880.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Assets.5880.11.6" xlink:to="us-gaap_Assets_lbl.267518" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_Assets_lbl.267518" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_Assets_lbl.267518">Assets</link:label>
    <link:loc xlink:label="loc_Assets.5880.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Assets.5880.11.9" xlink:to="us-gaap_Assets_lbl.267519" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_Assets_lbl.267519" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_Assets_lbl.267519">Total assets</link:label>
    <link:loc xlink:label="loc_AssetsAbstract.595.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsAbstract.595.11.6" xlink:to="us-gaap_AssetsAbstract_lbl.267520" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AssetsAbstract_lbl.267520" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl.267520">Assets [Abstract]</link:label>
    <link:loc xlink:label="loc_AssetsAbstract.595.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsAbstract.595.11.7" xlink:to="us-gaap_AssetsAbstract_lbl.267521" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AssetsAbstract_lbl.267521" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl.267521">ASSETS</link:label>
    <link:loc xlink:label="loc_AssetsCurrent.5874.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrent.5874.11.6" xlink:to="us-gaap_AssetsCurrent_lbl.267522" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AssetsCurrent_lbl.267522" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl.267522">Assets Current</link:label>
    <link:loc xlink:label="loc_AssetsCurrent.5874.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrent.5874.11.9" xlink:to="us-gaap_AssetsCurrent_lbl.267523" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AssetsCurrent_lbl.267523" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl.267523">Total current assets</link:label>
    <link:loc xlink:label="loc_AssetsCurrentAbstract.592.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrentAbstract.592.11.6" xlink:to="us-gaap_AssetsCurrentAbstract_lbl.267524" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AssetsCurrentAbstract_lbl.267524" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl.267524">Assets Current [Abstract]</link:label>
    <link:loc xlink:label="loc_AssetsCurrentAbstract.592.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrentAbstract.592.11.7" xlink:to="us-gaap_AssetsCurrentAbstract_lbl.267525" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AssetsCurrentAbstract_lbl.267525" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl.267525">Current assets:</link:label>
    <link:loc xlink:label="loc_BilledContractReceivables.6094.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BilledContractReceivables" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BilledContractReceivables.6094.11.6" xlink:to="us-gaap_BilledContractReceivables_lbl.267528" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_BilledContractReceivables_lbl.267528" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_BilledContractReceivables_lbl.267528">Billed Contract Receivables</link:label>
    <link:loc xlink:label="loc_BilledContractReceivables.6094.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BilledContractReceivables" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BilledContractReceivables.6094.11.7" xlink:to="us-gaap_BilledContractReceivables_lbl.267529" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_BilledContractReceivables_lbl.267529" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_BilledContractReceivables_lbl.267529">Accounts receivable (billed)</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.6" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267537" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267537" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267537">Cash And Cash Equivalents At Carrying Value</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.7" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267540" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267540" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267540">Cash and cash equivalents</link:label>
    <link:loc xlink:label="loc_CommonStockValue.6874.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValue.6874.11.6" xlink:to="us-gaap_CommonStockValue_lbl.267586" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockValue_lbl.267586" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl.267586">Common Stock Value</link:label>
    <link:loc xlink:label="loc_CommonStockValue.6874.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValue.6874.11.7" xlink:to="us-gaap_CommonStockValue_lbl.267587" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockValue_lbl.267587" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl.267587">Common stock, $0.0001 par value; 100,000,000 shares authorized; 48,416,483 and 48,352,651 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively</link:label>
    <link:loc xlink:label="loc_DeferredRevenue.7581.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenue.7581.11.6" xlink:to="us-gaap_DeferredRevenue_lbl.267632" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DeferredRevenue_lbl.267632" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_DeferredRevenue_lbl.267632">Deferred Revenue</link:label>
    <link:loc xlink:label="loc_DeferredRevenue.7581.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenue.7581.11.7" xlink:to="us-gaap_DeferredRevenue_lbl.267633" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DeferredRevenue_lbl.267633" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_DeferredRevenue_lbl.267633">Deferred revenue</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesNoncurrent.8124.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesNoncurrent.8124.11.6" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl.267643" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl.267643" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_DerivativeLiabilitiesNoncurrent_lbl.267643">Derivative Liabilities Noncurrent</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesNoncurrent.8124.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesNoncurrent.8124.11.7" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl.267644" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl.267644" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_DerivativeLiabilitiesNoncurrent_lbl.267644">Derivative instruments</link:label>
    <link:loc xlink:label="loc_Goodwill.10311.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Goodwill.10311.11.6" xlink:to="us-gaap_Goodwill_lbl.267749" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_Goodwill_lbl.267749" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_Goodwill_lbl.267749">Goodwill</link:label>
    <link:loc xlink:label="loc_Goodwill.10311.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Goodwill.10311.11.7" xlink:to="us-gaap_Goodwill_lbl.267750" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_Goodwill_lbl.267750" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_Goodwill_lbl.267750">Goodwill</link:label>
    <link:loc xlink:label="loc_Liabilities.11702.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Liabilities.11702.11.6" xlink:to="us-gaap_Liabilities_lbl.267799" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_Liabilities_lbl.267799" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_Liabilities_lbl.267799">Liabilities</link:label>
    <link:loc xlink:label="loc_Liabilities.11702.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Liabilities.11702.11.9" xlink:to="us-gaap_Liabilities_lbl.267800" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_Liabilities_lbl.267800" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_Liabilities_lbl.267800">Total liabilities</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.11731.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquity.11731.11.6" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl.267801" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl.267801" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl.267801">Liabilities And Stockholders Equity</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.11731.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquity.11731.11.9" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl.267802" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl.267802" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl.267802">Total liabilities and stockholders' equity</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.2940.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.11.6" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl.267803" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl.267803" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl.267803">Liabilities And Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.2940.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.11.7" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl.267804" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl.267804" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl.267804">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrent.11668.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrent.11668.11.6" xlink:to="us-gaap_LiabilitiesCurrent_lbl.267805" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LiabilitiesCurrent_lbl.267805" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl.267805">Liabilities Current</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrent.11668.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrent.11668.11.9" xlink:to="us-gaap_LiabilitiesCurrent_lbl.267806" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LiabilitiesCurrent_lbl.267806" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl.267806">Total current liabilities</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.2935.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.11.6" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl.267807" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl.267807" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl.267807">Liabilities Current [Abstract]</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.2935.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.11.7" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl.267808" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl.267808" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl.267808">Current liabilities:</link:label>
    <link:loc xlink:label="loc_LongTermDebtCurrent.12288.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtCurrent.12288.11.6" xlink:to="us-gaap_LongTermDebtCurrent_lbl.267837" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LongTermDebtCurrent_lbl.267837" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl.267837">Long Term Debt Current</link:label>
    <link:loc xlink:label="loc_LongTermDebtCurrent.12288.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtCurrent.12288.11.7" xlink:to="us-gaap_LongTermDebtCurrent_lbl.267838" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LongTermDebtCurrent_lbl.267838" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl.267838">Current portion of long-term debt</link:label>
    <link:loc xlink:label="loc_LongTermDebtNoncurrent.12289.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtNoncurrent.12289.11.6" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl.267847" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LongTermDebtNoncurrent_lbl.267847" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LongTermDebtNoncurrent_lbl.267847">Long Term Debt Noncurrent</link:label>
    <link:loc xlink:label="loc_LongTermDebtNoncurrent.12289.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtNoncurrent.12289.11.7" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl.267848" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LongTermDebtNoncurrent_lbl.267848" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_LongTermDebtNoncurrent_lbl.267848">Long-term debt, less current portion</link:label>
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13227.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAssetsNoncurrent.13227.11.6" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl.267895" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OtherAssetsNoncurrent_lbl.267895" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl.267895">Other Assets Noncurrent</link:label>
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13227.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAssetsNoncurrent.13227.11.7" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl.267896" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OtherAssetsNoncurrent_lbl.267896" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl.267896">Other long-term assets and deferred costs</link:label>
    <link:loc xlink:label="loc_OtherLiabilitiesNoncurrent.13448.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherLiabilitiesNoncurrent.13448.11.6" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl.267907" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl.267907" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl.267907">Other Liabilities Noncurrent</link:label>
    <link:loc xlink:label="loc_OtherLiabilitiesNoncurrent.13448.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherLiabilitiesNoncurrent.13448.11.7" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl.267908" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl.267908" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl.267908">Other long-term liabilities</link:label>
    <link:loc xlink:label="loc_PrepaidExpenseAndOtherAssetsCurrent.14234.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PrepaidExpenseAndOtherAssetsCurrent.14234.11.6" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl.267927" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl.267927" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl.267927">Prepaid Expense And Other Assets Current</link:label>
    <link:loc xlink:label="loc_PrepaidExpenseAndOtherAssetsCurrent.14234.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PrepaidExpenseAndOtherAssetsCurrent.14234.11.7" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl.267928" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl.267928" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl.267928">Prepaid expenses and other current assets</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.14697.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentNet.14697.11.6" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl.267946" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl.267946" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl.267946">Property Plant And Equipment Net</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.14697.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentNet.14697.11.7" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl.267947" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl.267947" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl.267947">Property and equipment, net</link:label>
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.11.6" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl.267962" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl.267962" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl.267962">Restricted Cash And Cash Equivalents At Carrying Value</link:label>
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.11.7" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl.267963" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl.267963" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl.267963">Restricted cash</link:label>
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15457.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RetainedEarningsAccumulatedDeficit.15457.11.6" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl.267966" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl.267966" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl.267966">Retained Earnings Accumulated Deficit</link:label>
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15457.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RetainedEarningsAccumulatedDeficit.15457.11.7" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl.267967" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl.267967" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl.267967">Accumulated deficit</link:label>
    <link:loc xlink:label="loc_ShortTermBorrowings.16437.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShortTermBorrowings.16437.11.6" xlink:to="us-gaap_ShortTermBorrowings_lbl.268012" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShortTermBorrowings_lbl.268012" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShortTermBorrowings_lbl.268012">Short Term Borrowings</link:label>
    <link:loc xlink:label="loc_ShortTermBorrowings.16437.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShortTermBorrowings.16437.11.7" xlink:to="us-gaap_ShortTermBorrowings_lbl.268013" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShortTermBorrowings_lbl.268013" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShortTermBorrowings_lbl.268013">Short-term debt</link:label>
    <link:loc xlink:label="loc_StatementOfFinancialPositionAbstract.4958.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.11.6" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl.268030" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl.268030" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract_lbl.268030">CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]</link:label>
    <link:loc xlink:label="loc_StockholdersEquity.16667.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquity.16667.11.6" xlink:to="us-gaap_StockholdersEquity_lbl.268036" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StockholdersEquity_lbl.268036" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl.268036">Stockholders Equity</link:label>
    <link:loc xlink:label="loc_StockholdersEquity.16667.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquity.16667.11.9" xlink:to="us-gaap_StockholdersEquity_lbl.268037" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StockholdersEquity_lbl.268037" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl.268037">Total stockholders' equity</link:label>
    <link:loc xlink:label="loc_StockholdersEquityAbstract.4986.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityAbstract.4986.11.6" xlink:to="us-gaap_StockholdersEquityAbstract_lbl.268038" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StockholdersEquityAbstract_lbl.268038" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl.268038">Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityAbstract.4986.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityAbstract.4986.11.7" xlink:to="us-gaap_StockholdersEquityAbstract_lbl.268039" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StockholdersEquityAbstract_lbl.268039" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl.268039">Stockholders' equity:</link:label>
    <link:loc xlink:label="loc_UnbilledContractsReceivable.17122.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnbilledContractsReceivable.17122.11.6" xlink:to="us-gaap_UnbilledContractsReceivable_lbl.268071" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_UnbilledContractsReceivable_lbl.268071" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_UnbilledContractsReceivable_lbl.268071">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:label="loc_UnbilledContractsReceivable.17122.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnbilledContractsReceivable.17122.11.7" xlink:to="us-gaap_UnbilledContractsReceivable_lbl.268072" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_UnbilledContractsReceivable_lbl.268072" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_UnbilledContractsReceivable_lbl.268072">Unbilled accounts receivable</link:label>
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.6878.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockParOrStatedValuePerShare.6878.11.6" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl.267574" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl.267574" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl.267574">Common Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.6878.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockParOrStatedValuePerShare.6878.11.7" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl.267575" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl.267575" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl.267575">Common stock, par value</link:label>
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.6879.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesAuthorized.6879.11.6" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl.267579" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockSharesAuthorized_lbl.267579" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl.267579">Common Stock Shares Authorized</link:label>
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.6879.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesAuthorized.6879.11.7" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl.267580" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockSharesAuthorized_lbl.267580" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl.267580">Common stock, shares authorized</link:label>
    <link:loc xlink:label="loc_CommonStockSharesIssued.6875.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesIssued.6875.11.6" xlink:to="us-gaap_CommonStockSharesIssued_lbl.267581" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockSharesIssued_lbl.267581" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl.267581">Common Stock Shares Issued</link:label>
    <link:loc xlink:label="loc_CommonStockSharesIssued.6875.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesIssued.6875.11.8" xlink:to="us-gaap_CommonStockSharesIssued_lbl.267583" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockSharesIssued_lbl.267583" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl.267583">Common stock, shares issued</link:label>
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.6864.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesOutstanding.6864.11.6" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl.267584" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockSharesOutstanding_lbl.267584" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl.267584">Common Stock Shares Outstanding</link:label>
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.6864.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesOutstanding.6864.11.7" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl.267585" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockSharesOutstanding_lbl.267585" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl.267585">Common stock, shares outstanding</link:label>
    <link:loc xlink:label="loc_CurrentIncomeTaxExpenseBenefit.7281.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CurrentIncomeTaxExpenseBenefit.7281.11.6" xlink:to="lab_CurrentIncomeTaxExpenseBenefit.3403" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CurrentIncomeTaxExpenseBenefit.3403" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CurrentIncomeTaxExpenseBenefit.3403">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:label="loc_CurrentIncomeTaxExpenseBenefit.7281.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CurrentIncomeTaxExpenseBenefit.7281.11.42" xlink:to="lab_CurrentIncomeTaxExpenseBenefit42.466644" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CurrentIncomeTaxExpenseBenefit42.466644" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_CurrentIncomeTaxExpenseBenefit42.466644">Income tax expense</link:label>
    <link:loc xlink:label="loc_GainLossOnDispositionOfAssets.10190.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnDispositionOfAssets.10190.11.6" xlink:to="lab_GainLossOnDispositionOfAssets.7718" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnDispositionOfAssets.7718" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnDispositionOfAssets.7718">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:label="loc_GainLossOnDispositionOfAssets.10190.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnDispositionOfAssets.10190.11.7" xlink:to="lab_GainLossOnDispositionOfAssets.466592" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnDispositionOfAssets.466592" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnDispositionOfAssets.466592">Gain on the sale of assets held for sale</link:label>
    <link:loc xlink:label="loc_InterestExpense.11178.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestExpense.11178.11.42" xlink:to="lab_InterestExpense.268174" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestExpense.268174" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_InterestExpense.268174">Interest expense</link:label>
    <link:loc xlink:label="loc_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.58133.11.6" xlink:href="pip-20130331.xsd#pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.58133.11.6" xlink:to="lab_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.267904" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.267904" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.267904">Other Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation</link:label>
    <link:loc xlink:label="loc_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.58133.11.8" xlink:href="pip-20130331.xsd#pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.58133.11.8" xlink:to="pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation_lbl.267906" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation_lbl.267906" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation_lbl.267906">Realization of cumulative translation adjustment</link:label>
    <link:loc xlink:label="loc_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.58133.11.12" xlink:href="pip-20130331.xsd#pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.58133.11.12" xlink:to="pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation_lbl.267903" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation_lbl.267903" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation_lbl.267903">Income statement impact of the reclassification adjustment for translation gain (loss) realized upon the sale or complete or substantially complete liquidation of an investment in a foreign entity.</link:label>
    <link:loc xlink:label="loc_ContractsRevenue.7028.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ContractsRevenue.7028.11.6" xlink:to="us-gaap_ContractsRevenue_lbl.267590" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ContractsRevenue_lbl.267590" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ContractsRevenue_lbl.267590">Contracts Revenue</link:label>
    <link:loc xlink:label="loc_ContractsRevenue.7028.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ContractsRevenue.7028.11.7" xlink:to="us-gaap_ContractsRevenue_lbl.267591" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ContractsRevenue_lbl.267591" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ContractsRevenue_lbl.267591">Contract revenue</link:label>
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DepreciationAndAmortization.8044.11.7" xlink:to="us-gaap_DepreciationAndAmortization_lbl.267635" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DepreciationAndAmortization_lbl.267635" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_DepreciationAndAmortization_lbl.267635">Depreciation and amortization</link:label>
    <link:loc xlink:label="loc_EarningsPerShareBasicAndDiluted.8698.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerShareBasicAndDiluted.8698.11.6" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl.267685" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl.267685" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDiluted_lbl.267685">Earnings Per Share Basic And Diluted</link:label>
    <link:loc xlink:label="loc_EarningsPerShareBasicAndDiluted.8698.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerShareBasicAndDiluted.8698.11.7" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl.267686" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl.267686" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDiluted_lbl.267686">Basic and diluted net loss per share</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10284.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpense.10284.11.6" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl.267745" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl.267745" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpense_lbl.267745">General And Administrative Expense</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10284.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpense.10284.11.7" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl.267746" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl.267746" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpense_lbl.267746">General and administrative</link:label>
    <link:loc xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.11.6" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl.267766" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl.267766" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl.267766">Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments</link:label>
    <link:loc xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.11.9" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl.267767" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl.267767" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl.267767">Net loss before income taxes</link:label>
    <link:loc xlink:label="loc_IncomeStatementAbstract.2519.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeStatementAbstract.2519.11.6" xlink:to="us-gaap_IncomeStatementAbstract_lbl.267768" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncomeStatementAbstract_lbl.267768" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract_lbl.267768">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]</link:label>
    <link:loc xlink:label="loc_InterestExpense.11178.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestExpense.11178.11.6" xlink:to="us-gaap_InterestExpense_lbl.267786" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_InterestExpense_lbl.267786" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_InterestExpense_lbl.267786">Interest Expense</link:label>
    <link:loc xlink:label="loc_InvestmentIncomeInterest.11436.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InvestmentIncomeInterest.11436.11.6" xlink:to="us-gaap_InvestmentIncomeInterest_lbl.267795" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_InvestmentIncomeInterest_lbl.267795" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_InvestmentIncomeInterest_lbl.267795">Investment Income Interest</link:label>
    <link:loc xlink:label="loc_InvestmentIncomeInterest.11436.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InvestmentIncomeInterest.11436.11.7" xlink:to="us-gaap_InvestmentIncomeInterest_lbl.267796" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_InvestmentIncomeInterest_lbl.267796" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_InvestmentIncomeInterest_lbl.267796">Interest income</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.12771.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.12771.11.9" xlink:to="us-gaap_NetIncomeLoss_lbl.267871" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetIncomeLoss_lbl.267871" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl.267871">Net loss</link:label>
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.12898.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonoperatingIncomeExpense.12898.11.6" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl.267878" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NonoperatingIncomeExpense_lbl.267878" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl.267878">Nonoperating Income Expense</link:label>
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.12898.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonoperatingIncomeExpense.12898.11.9" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl.267879" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NonoperatingIncomeExpense_lbl.267879" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl.267879">Total other income (expense)</link:label>
    <link:loc xlink:label="loc_NonoperatingIncomeExpenseAbstract.3452.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.11.6" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl.267880" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl.267880" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpenseAbstract_lbl.267880">Nonoperating Income Expense [Abstract]</link:label>
    <link:loc xlink:label="loc_NonoperatingIncomeExpenseAbstract.3452.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.11.7" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl.267881" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl.267881" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpenseAbstract_lbl.267881">Other income (expense):</link:label>
    <link:loc xlink:label="loc_OperatingExpenses.13060.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingExpenses.13060.11.6" xlink:to="us-gaap_OperatingExpenses_lbl.267887" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OperatingExpenses_lbl.267887" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl.267887">Operating Expenses</link:label>
    <link:loc xlink:label="loc_OperatingExpenses.13060.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingExpenses.13060.11.9" xlink:to="us-gaap_OperatingExpenses_lbl.267888" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OperatingExpenses_lbl.267888" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl.267888">Total operating expenses</link:label>
    <link:loc xlink:label="loc_OperatingExpensesAbstract.3531.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingExpensesAbstract.3531.11.6" xlink:to="us-gaap_OperatingExpensesAbstract_lbl.267889" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OperatingExpensesAbstract_lbl.267889" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl.267889">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:label="loc_OperatingExpensesAbstract.3531.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingExpensesAbstract.3531.11.7" xlink:to="us-gaap_OperatingExpensesAbstract_lbl.267890" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OperatingExpensesAbstract_lbl.267890" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl.267890">Operating expenses:</link:label>
    <link:loc xlink:label="loc_OperatingIncomeLoss.13080.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingIncomeLoss.13080.11.6" xlink:to="us-gaap_OperatingIncomeLoss_lbl.267891" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OperatingIncomeLoss_lbl.267891" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl.267891">Operating Income Loss</link:label>
    <link:loc xlink:label="loc_OperatingIncomeLoss.13080.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingIncomeLoss.13080.11.9" xlink:to="us-gaap_OperatingIncomeLoss_lbl.267892" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OperatingIncomeLoss_lbl.267892" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl.267892">Loss from operations</link:label>
    <link:loc xlink:label="loc_OtherNonoperatingIncomeExpense.13446.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherNonoperatingIncomeExpense.13446.11.6" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl.267909" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl.267909" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpense_lbl.267909">Other Nonoperating Income Expense</link:label>
    <link:loc xlink:label="loc_OtherNonoperatingIncomeExpense.13446.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherNonoperatingIncomeExpense.13446.11.7" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl.267910" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl.267910" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpense_lbl.267910">Other income (expense)</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15293.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpense.15293.11.6" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl.267958" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl.267958" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpense_lbl.267958">Research And Development Expense</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15293.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpense.15293.11.7" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl.267959" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl.267959" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpense_lbl.267959">Research and development</link:label>
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnrealizedGainLossOnDerivatives.17162.11.7" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl.268075" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl.268075" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_UnrealizedGainLossOnDerivatives_lbl.268075">Change in fair value of derivative instruments</link:label>
    <link:loc xlink:label="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.11.6" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl.268084" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl.268084" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl.268084">Weighted Average Number Of Share Outstanding Basic And Diluted</link:label>
    <link:loc xlink:label="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.11.7" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl.268085" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl.268085" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl.268085">Weighted average shares used in calculation of basic and diluted net loss per share</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13148.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTax.13148.11.6" xlink:to="lab_OtherComprehensiveIncomeLossNetOfTax.12468" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeLossNetOfTax.12468" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeLossNetOfTax.12468">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13148.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTax.13148.11.9" xlink:to="lab_OtherComprehensiveIncomeLossNetOfTax.466881" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeLossNetOfTax.466881" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeLossNetOfTax.466881">Comprehensive loss</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.3648.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.3648.11.6" xlink:to="lab_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.12814" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.12814" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.12814">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.3648.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.3648.11.7" xlink:to="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.466877" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.466877" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.466877">Other comprehensive income (loss):</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.12771.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.12771.11.7" xlink:to="us-gaap_NetIncomeLoss_lbl.267870" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetIncomeLoss_lbl.267870" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl.267870">Net Loss</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.13305.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.13305.11.6" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl.267897" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl.267897" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl.267897">Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.13305.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.13305.11.7" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl.267898" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl.267898" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl.267898">Foreign currency translation adjustment</link:label>
    <link:loc xlink:label="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.11.6" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl.268032" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl.268032" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl.268032">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE LOSS [Abstract]</link:label>
    <link:loc xlink:label="loc_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.7483.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.7483.11.6" xlink:to="lab_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.3663" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.3663" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.3663">Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction</link:label>
    <link:loc xlink:label="loc_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.7483.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.7483.11.7" xlink:to="lab_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.490090" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.490090" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.490090">Deferred financing costs not paid as of March 31st</link:label>
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.11.42" xlink:to="lab_GainLossOnSaleOfPropertyPlantEquipment42.268190" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnSaleOfPropertyPlantEquipment42.268190" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnSaleOfPropertyPlantEquipment42.268190">Gain on the disposal of property and equipment</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.10853.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsReceivable.10853.11.42" xlink:to="lab_IncreaseDecreaseInAccountsReceivable42.268191" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInAccountsReceivable42.268191" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInAccountsReceivable42.268191">Accounts receivable</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.10850.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInDeferredRevenue.10850.11.6" xlink:to="lab_IncreaseDecreaseInDeferredRevenue.8782" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInDeferredRevenue.8782" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInDeferredRevenue.8782">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.10850.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInDeferredRevenue.10850.11.7" xlink:to="lab_IncreaseDecreaseInDeferredRevenue.466890" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInDeferredRevenue.466890" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInDeferredRevenue.466890">Deferred revenue</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.11.42" xlink:to="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets42.268194" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets42.268194" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets42.268194">Prepaid expenses and other current assets</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInUnbilledReceivables.11010.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInUnbilledReceivables.11010.11.42" xlink:to="lab_IncreaseDecreaseInUnbilledReceivables.268192" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInUnbilledReceivables.268192" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInUnbilledReceivables.268192">Unbilled accounts receivable</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.12771.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.12771.11.8" xlink:to="lab_NetIncomeLoss.490099" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetIncomeLoss.490099" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetIncomeLoss.490099">Net loss</link:label>
    <link:loc xlink:label="loc_PaymentsOfStockIssuanceCosts.13770.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsOfStockIssuanceCosts.13770.11.6" xlink:to="lab_PaymentsOfStockIssuanceCosts.13507" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsOfStockIssuanceCosts.13507" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsOfStockIssuanceCosts.13507">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:label="loc_PaymentsOfStockIssuanceCosts.13770.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsOfStockIssuanceCosts.13770.11.42" xlink:to="lab_PaymentsOfStockIssuanceCosts.512246" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsOfStockIssuanceCosts.512246" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsOfStockIssuanceCosts.512246">Controlled equity offering issuance costs</link:label>
    <link:loc xlink:label="loc_PaymentsToAcquirePropertyPlantAndEquipment.13779.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsToAcquirePropertyPlantAndEquipment.13779.11.42" xlink:to="lab_PaymentsToAcquirePropertyPlantAndEquipment42.268201" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsToAcquirePropertyPlantAndEquipment42.268201" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsToAcquirePropertyPlantAndEquipment42.268201">Purchase of property and equipment</link:label>
    <link:loc xlink:label="loc_PaymentsOfFinancingCosts.13844.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsOfFinancingCosts.13844.11.42" xlink:to="PaymentsOfFinancingCosts.270367" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="PaymentsOfFinancingCosts.270367" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="PaymentsOfFinancingCosts.270367">Deferred financing costs</link:label>
    <link:loc xlink:label="loc_NonCashFinancingActivityAbstract.58131.11.6" xlink:href="pip-20130331.xsd#pip_NonCashFinancingActivityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonCashFinancingActivityAbstract.58131.11.6" xlink:to="pip_NonCashFinancingActivityAbstract_lbl.267876" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_NonCashFinancingActivityAbstract_lbl.267876" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_NonCashFinancingActivityAbstract_lbl.267876">Non Cash Financing Activity [Abstract]</link:label>
    <link:loc xlink:label="loc_NonCashFinancingActivityAbstract.58131.11.7" xlink:href="pip-20130331.xsd#pip_NonCashFinancingActivityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonCashFinancingActivityAbstract.58131.11.7" xlink:to="pip_NonCashFinancingActivityAbstract_lbl.267877" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_NonCashFinancingActivityAbstract_lbl.267877" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_NonCashFinancingActivityAbstract_lbl.267877">Noncash financing activities</link:label>
    <link:loc xlink:label="loc_NonCashFinancingActivityAbstract.58131.11.12" xlink:href="pip-20130331.xsd#pip_NonCashFinancingActivityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonCashFinancingActivityAbstract.58131.11.12" xlink:to="pip_NonCashFinancingActivityAbstract_lbl.267875" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_NonCashFinancingActivityAbstract_lbl.267875" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_NonCashFinancingActivityAbstract_lbl.267875">Non Cash Financing Activity [Abstract]</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStockAndWarrants.58138.11.6" xlink:href="pip-20130331.xsd#pip_ProceedsFromIssuanceOfCommonStockAndWarrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStockAndWarrants.58138.11.6" xlink:to="pip_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl.267930" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl.267930" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl.267930">Proceeds From Issuance Of Common Stock And Warrants</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStockAndWarrants.58138.11.7" xlink:href="pip-20130331.xsd#pip_ProceedsFromIssuanceOfCommonStockAndWarrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStockAndWarrants.58138.11.7" xlink:to="pip_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl.267931" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl.267931" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl.267931">Proceeds from issuance of common stock and warrants</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStockAndWarrants.58138.11.12" xlink:href="pip-20130331.xsd#pip_ProceedsFromIssuanceOfCommonStockAndWarrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStockAndWarrants.58138.11.12" xlink:to="pip_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl.267929" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl.267929" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl.267929">Proceeds from the issuance of common stock or common stock and warrants.</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfLongTermDebtAndWarrants.58140.11.6" xlink:href="pip-20130331.xsd#pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfLongTermDebtAndWarrants.58140.11.6" xlink:to="pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants_lbl.267936" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants_lbl.267936" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants_lbl.267936">Proceeds From Issuance Of Long Term Debt And Warrants</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfLongTermDebtAndWarrants.58140.11.7" xlink:href="pip-20130331.xsd#pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfLongTermDebtAndWarrants.58140.11.7" xlink:to="pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants_lbl.267937" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants_lbl.267937" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants_lbl.267937">Proceeds from issuance of long-term debt</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfLongTermDebtAndWarrants.58140.11.12" xlink:href="pip-20130331.xsd#pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfLongTermDebtAndWarrants.58140.11.12" xlink:to="pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants_lbl.267935" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants_lbl.267935" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants_lbl.267935">Proceeds from Issuance of Long Term Debt and Warrants</link:label>
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.11.6" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267510" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267510" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267510">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.11.7" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267511" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267511" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267511">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.10" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267539" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267539" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267539">Cash and cash equivalents, at beginning of period</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6556.11.11" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267538" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267538" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl.267538">Cash and cash equivalents, at end of period</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.11.6" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl.267543" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl.267543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl.267543">Cash And Cash Equivalents Period Increase Decrease</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.11.9" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl.267544" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl.267544" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl.267544">Increases in cash and cash equivalents</link:label>
    <link:loc xlink:label="loc_DeferredIncomeTaxExpenseBenefit.7621.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredIncomeTaxExpenseBenefit.7621.11.6" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl.267630" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl.267630" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl.267630">Deferred Income Tax Expense Benefit</link:label>
    <link:loc xlink:label="loc_DeferredIncomeTaxExpenseBenefit.7621.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredIncomeTaxExpenseBenefit.7621.11.7" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl.267631" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl.267631" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl.267631">Deferred income tax expenses</link:label>
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DepreciationAndAmortization.8044.11.6" xlink:to="us-gaap_DepreciationAndAmortization_lbl.267634" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DepreciationAndAmortization_lbl.267634" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_DepreciationAndAmortization_lbl.267634">Depreciation And Amortization</link:label>
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DepreciationAndAmortization.8044.11.8" xlink:to="us-gaap_DepreciationAndAmortization_lbl.267636" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DepreciationAndAmortization_lbl.267636" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_DepreciationAndAmortization_lbl.267636">Depreciation and amortization expense</link:label>
    <link:loc xlink:label="loc_EffectOfExchangeRateOnCashAndCashEquivalents.8714.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EffectOfExchangeRateOnCashAndCashEquivalents.8714.11.6" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl.267689" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl.267689" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl.267689">Effect Of Exchange Rate On Cash And Cash Equivalents</link:label>
    <link:loc xlink:label="loc_EffectOfExchangeRateOnCashAndCashEquivalents.8714.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EffectOfExchangeRateOnCashAndCashEquivalents.8714.11.7" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl.267690" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl.267690" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl.267690">Effects of exchange rates on cash</link:label>
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.11.6" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl.267744" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl.267744" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl.267744">Gain Loss On Sale Of Property Plant Equipment</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayable.10805.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsPayable.10805.11.6" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl.267774" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl.267774" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayable_lbl.267774">Increase Decrease In Accounts Payable</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayable.10805.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsPayable.10805.11.7" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl.267775" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl.267775" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayable_lbl.267775">Accounts payable</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.10853.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsReceivable.10853.11.6" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl.267776" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl.267776" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl.267776">Increase Decrease In Accounts Receivable</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.10775.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.10775.11.6" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl.267777" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl.267777" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl.267777">Increase Decrease In Accrued Liabilities And Other Operating Liabilities</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.10775.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.10775.11.7" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl.267778" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl.267778" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl.267778">Accrued expenses and other liabilities</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.11.6" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl.267779" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl.267779" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl.267779">Increase Decrease In Operating Capital [Abstract]</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.11.7" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl.267780" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl.267780" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl.267780">Changes in operating assets and liabilities:</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.11.6" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl.267781" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl.267781" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl.267781">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInUnbilledReceivables.11010.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInUnbilledReceivables.11010.11.6" xlink:to="us-gaap_IncreaseDecreaseInUnbilledReceivables_lbl.267782" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncreaseDecreaseInUnbilledReceivables_lbl.267782" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInUnbilledReceivables_lbl.267782">Increase Decrease In Unbilled Receivables</link:label>
    <link:loc xlink:label="loc_InterestPaid.11342.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestPaid" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestPaid.11342.11.6" xlink:to="us-gaap_InterestPaid_lbl.267787" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_InterestPaid_lbl.267787" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_InterestPaid_lbl.267787">Interest Paid</link:label>
    <link:loc xlink:label="loc_InterestPaid.11342.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestPaid" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestPaid.11342.11.7" xlink:to="us-gaap_InterestPaid_lbl.267788" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_InterestPaid_lbl.267788" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_InterestPaid_lbl.267788">Cash paid for interest</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivities.12740.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.11.6" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl.267857" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl.267857" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl.267857">Net Cash Provided By Used In Financing Activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivities.12740.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivities.12740.11.9" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl.267858" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl.267858" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl.267858">Net cash (used) provided by financing activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.11.6" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl.267859" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl.267859" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl.267859">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.11.7" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl.267860" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl.267860" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl.267860">Financing activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivities.12731.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivities.12731.11.6" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl.267861" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl.267861" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl.267861">Net Cash Provided By Used In Investing Activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivities.12731.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivities.12731.11.9" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl.267862" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl.267862" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl.267862">Net cash provided (used) by investing activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.11.6" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl.267863" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl.267863" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl.267863">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.11.7" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl.267864" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl.267864" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl.267864">Investing activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivities.12778.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.11.6" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl.267865" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl.267865" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl.267865">Net Cash Provided By Used In Operating Activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivities.12778.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivities.12778.11.9" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl.267866" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl.267866" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl.267866">Net cash provided by operating activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.11.6" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267867" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267867" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267867">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.11.7" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267868" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267868" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl.267868">Operating activities</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.12771.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.12771.11.6" xlink:to="us-gaap_NetIncomeLoss_lbl.267869" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NetIncomeLoss_lbl.267869" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl.267869">Net Income Loss</link:label>
    <link:loc xlink:label="loc_PaidInKindInterest.13591.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaidInKindInterest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaidInKindInterest.13591.11.6" xlink:to="us-gaap_PaidInKindInterest_lbl.267911" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_PaidInKindInterest_lbl.267911" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_PaidInKindInterest_lbl.267911">Paid In Kind Interest</link:label>
    <link:loc xlink:label="loc_PaidInKindInterest.13591.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaidInKindInterest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaidInKindInterest.13591.11.7" xlink:to="us-gaap_PaidInKindInterest_lbl.267912" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_PaidInKindInterest_lbl.267912" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_PaidInKindInterest_lbl.267912">Non-cash interest expense</link:label>
    <link:loc xlink:label="loc_PaymentsOfFinancingCosts.13844.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsOfFinancingCosts.13844.11.6" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl.267913" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl.267913" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_PaymentsOfFinancingCosts_lbl.267913">Payments Of Financing Costs</link:label>
    <link:loc xlink:label="loc_PaymentsToAcquirePropertyPlantAndEquipment.13779.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsToAcquirePropertyPlantAndEquipment.13779.11.6" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl.267914" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl.267914" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl.267914">Payments To Acquire Property Plant And Equipment</link:label>
    <link:loc xlink:label="loc_ProceedsFromPaymentsForOtherFinancingActivities.14363.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromPaymentsForOtherFinancingActivities.14363.11.6" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl.267938" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl.267938" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl.267938">Proceeds From Payments For Other Financing Activities</link:label>
    <link:loc xlink:label="loc_ProceedsFromPaymentsForOtherFinancingActivities.14363.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromPaymentsForOtherFinancingActivities.14363.11.7" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl.267939" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl.267939" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl.267939">Other</link:label>
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfLinesOfCredit.14422.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromRepaymentsOfLinesOfCredit.14422.11.6" xlink:to="us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_lbl.267940" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_lbl.267940" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_lbl.267940">Proceeds From Repayments Of Lines Of Credit</link:label>
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfLinesOfCredit.14422.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromRepaymentsOfLinesOfCredit.14422.11.7" xlink:to="us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_lbl.267941" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_lbl.267941" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_lbl.267941">Net (repayment of) proceeds from revolving credit agreement</link:label>
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.11.6" xlink:to="us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_lbl.267942" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_lbl.267942" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_lbl.267942">Proceeds From Repayments Of Restricted Cash Financing Activities</link:label>
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.11.7" xlink:to="us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_lbl.267943" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_lbl.267943" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities_lbl.267943">Change in restricted cash requirements</link:label>
    <link:loc xlink:label="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.11.6" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl.267944" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl.267944" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl.267944">Proceeds From Sale Of Property Plant And Equipment</link:label>
    <link:loc xlink:label="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.11.7" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl.267945" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl.267945" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl.267945">Proceeds from the sale of property and equipment</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensation.16244.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensation.16244.11.6" xlink:to="us-gaap_ShareBasedCompensation_lbl.267996" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShareBasedCompensation_lbl.267996" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl.267996">Share Based Compensation</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensation.16244.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensation.16244.11.7" xlink:to="us-gaap_ShareBasedCompensation_lbl.267997" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShareBasedCompensation_lbl.267997" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl.267997">Share-based compensation expense</link:label>
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.11.6" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl.268028" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl.268028" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract_lbl.268028">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:loc xlink:label="loc_SupplementalCashFlowInformationAbstract.5043.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5043.11.6" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl.268054" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl.268054" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl.268054">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:label="loc_SupplementalCashFlowInformationAbstract.5043.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5043.11.7" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl.268055" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl.268055" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl.268055">Supplemental disclosure of cash flow information</link:label>
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.11.6" xlink:to="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.270413" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.270413" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.270413">Organization and Business [Abstract]</link:label>
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13128.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13128.11.6" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl.267893" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl.267893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl.267893">Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13128.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13128.11.7" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl.267894" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl.267894" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl.267894">Organization and Business</link:label>
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountingPoliciesAbstract.385.11.6" xlink:to="lab_AccountingPoliciesAbstract.270475" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountingPoliciesAbstract.270475" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccountingPoliciesAbstract.270475">Summary of Significant Accounting Policies [Abstract]</link:label>
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTextBlock.16463.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SignificantAccountingPoliciesTextBlock.16463.11.6" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl.268022" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl.268022" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_SignificantAccountingPoliciesTextBlock_lbl.268022">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTextBlock.16463.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SignificantAccountingPoliciesTextBlock.16463.11.7" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl.268023" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl.268023" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_SignificantAccountingPoliciesTextBlock_lbl.268023">Summary of Significant Accounting Policies</link:label>
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.1951.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueDisclosuresAbstract.1951.11.6" xlink:to="lab_FairValueDisclosuresAbstract.270479" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueDisclosuresAbstract.270479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueDisclosuresAbstract.270479">Fair Value Measurements [Abstract]</link:label>
    <link:loc xlink:label="loc_FairValueDisclosuresTextBlock.9267.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueDisclosuresTextBlock.9267.11.6" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl.267721" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl.267721" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl.267721">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:label="loc_FairValueDisclosuresTextBlock.9267.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueDisclosuresTextBlock.9267.11.7" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl.267722" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl.267722" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl.267722">Fair Value Measurements</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract.1025.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract.1025.11.6" xlink:to="lab_CommitmentsAndContingenciesDisclosureAbstract.270480" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommitmentsAndContingenciesDisclosureAbstract.270480" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommitmentsAndContingenciesDisclosureAbstract.270480">Commitments and Contingencies [Abstract]</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureTextBlock.6838.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingenciesDisclosureTextBlock.6838.11.6" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl.267567" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl.267567" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl.267567">Commitments And Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureTextBlock.6838.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingenciesDisclosureTextBlock.6838.11.7" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl.267568" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl.267568" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl.267568">Commitments and Contingencies</link:label>
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.4988.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityNoteAbstract.4988.11.6" xlink:to="lab_StockholdersEquityNoteAbstract.270481" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquityNoteAbstract.270481" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquityNoteAbstract.270481">Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityNoteDisclosureTextBlock.16673.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityNoteDisclosureTextBlock.16673.11.6" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl.268043" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl.268043" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl.268043">Stockholders Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityNoteDisclosureTextBlock.16673.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityNoteDisclosureTextBlock.16673.11.7" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl.268044" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl.268044" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl.268044">Stockholders' Equity</link:label>
    <link:loc xlink:label="loc_AdditionalFinancialInformationDisclosureTextBlock.5621.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalFinancialInformationDisclosureTextBlock.5621.11.7" xlink:to="AdditionalFinancialInformationDisclosureTextBlock.490091" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="AdditionalFinancialInformationDisclosureTextBlock.490091" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="AdditionalFinancialInformationDisclosureTextBlock.490091">Financing Transactions</link:label>
    <link:loc xlink:label="loc_AdditionalFinancialInformationDisclosureTextBlock.5621.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalFinancialInformationDisclosureTextBlock.5621.11.6" xlink:to="lab_AdditionalFinancialInformationDisclosureTextBlock.678" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdditionalFinancialInformationDisclosureTextBlock.678" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AdditionalFinancialInformationDisclosureTextBlock.678">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_DebtDisclosureAbstract.1283.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtDisclosureAbstract.1283.11.6" xlink:to="lab_DebtDisclosureAbstract.270482" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtDisclosureAbstract.270482" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtDisclosureAbstract.270482">Financing Transactions [Abstract]</link:label>
    <link:loc xlink:label="loc_ComprehensiveIncomePolicyPolicyTextBlock.6916.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComprehensiveIncomePolicyPolicyTextBlock.6916.11.6" xlink:to="lab_ComprehensiveIncomePolicyPolicyTextBlock.2824" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComprehensiveIncomePolicyPolicyTextBlock.2824" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ComprehensiveIncomePolicyPolicyTextBlock.2824">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_ComprehensiveIncomePolicyPolicyTextBlock.6916.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComprehensiveIncomePolicyPolicyTextBlock.6916.11.7" xlink:to="lab_ComprehensiveIncomePolicyPolicyTextBlock.490092" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComprehensiveIncomePolicyPolicyTextBlock.490092" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ComprehensiveIncomePolicyPolicyTextBlock.490092">Comprehensive Loss and Accumulated Other Comprehensive Income</link:label>
    <link:loc xlink:label="loc_GoodwillAndIntangibleAssetsGoodwillPolicy.10327.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GoodwillAndIntangibleAssetsGoodwillPolicy.10327.11.6" xlink:to="lab_GoodwillAndIntangibleAssetsGoodwillPolicy.7939" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GoodwillAndIntangibleAssetsGoodwillPolicy.7939" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GoodwillAndIntangibleAssetsGoodwillPolicy.7939">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_GoodwillAndIntangibleAssetsGoodwillPolicy.10327.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GoodwillAndIntangibleAssetsGoodwillPolicy.10327.11.7" xlink:to="lab_GoodwillAndIntangibleAssetsGoodwillPolicy.490093" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GoodwillAndIntangibleAssetsGoodwillPolicy.490093" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_GoodwillAndIntangibleAssetsGoodwillPolicy.490093">Goodwill</link:label>
    <link:loc xlink:label="loc_MajorCustomersPolicyPolicyTextBlock.12409.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MajorCustomersPolicyPolicyTextBlock.12409.11.6" xlink:to="lab_MajorCustomersPolicyPolicyTextBlock.11216" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MajorCustomersPolicyPolicyTextBlock.11216" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MajorCustomersPolicyPolicyTextBlock.11216">Major Customers, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_MajorCustomersPolicyPolicyTextBlock.12409.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MajorCustomersPolicyPolicyTextBlock.12409.11.7" xlink:to="lab_MajorCustomersPolicyPolicyTextBlock.270488" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MajorCustomersPolicyPolicyTextBlock.270488" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MajorCustomersPolicyPolicyTextBlock.270488">Significant Customers and Accounts Receivable</link:label>
    <link:loc xlink:label="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.11.6" xlink:to="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.11883" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.11883" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.11883">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.11.7" xlink:to="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.270485" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.270485" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.270485">Recent Accounting Pronouncements</link:label>
    <link:loc xlink:label="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.11.6" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl.267526" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl.267526" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl.267526">Basis Of Presentation And Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:label="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.11.7" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl.267527" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl.267527" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl.267527">Basis of Presentation</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsPolicyTextBlock.6571.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsPolicyTextBlock.6571.11.6" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl.267545" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl.267545" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl.267545">Cash And Cash Equivalents Policy [Text Block]</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsPolicyTextBlock.6571.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsPolicyTextBlock.6571.11.7" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl.267546" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl.267546" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl.267546">Cash and Cash Equivalents</link:label>
    <link:loc xlink:label="loc_DebtPolicyTextBlock.7444.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtPolicyTextBlock.7444.11.6" xlink:to="us-gaap_DebtPolicyTextBlock_lbl.267626" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DebtPolicyTextBlock_lbl.267626" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_DebtPolicyTextBlock_lbl.267626">Debt Policy [Text Block]</link:label>
    <link:loc xlink:label="loc_DebtPolicyTextBlock.7444.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtPolicyTextBlock.7444.11.7" xlink:to="us-gaap_DebtPolicyTextBlock_lbl.267627" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DebtPolicyTextBlock_lbl.267627" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_DebtPolicyTextBlock_lbl.267627">Revolving Line of Credit and Term Loan</link:label>
    <link:loc xlink:label="loc_EarningsPerSharePolicyTextBlock.8704.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerSharePolicyTextBlock.8704.11.6" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl.267687" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl.267687" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_EarningsPerSharePolicyTextBlock_lbl.267687">Earnings Per Share Policy [Text Block]</link:label>
    <link:loc xlink:label="loc_EarningsPerSharePolicyTextBlock.8704.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerSharePolicyTextBlock.8704.11.7" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl.267688" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl.267688" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_EarningsPerSharePolicyTextBlock_lbl.267688">Basic and Diluted Net Loss Per Share</link:label>
    <link:loc xlink:label="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10010.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10010.11.6" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl.267742" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl.267742" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl.267742">Foreign Currency Transactions And Translations Policy [Text Block]</link:label>
    <link:loc xlink:label="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10010.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10010.11.7" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl.267743" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl.267743" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl.267743">Foreign Currency Translation</link:label>
    <link:loc xlink:label="loc_IncomeTaxPolicyTextBlock.10751.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxPolicyTextBlock.10751.11.6" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl.267772" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl.267772" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl.267772">Income Tax Policy [Text Block]</link:label>
    <link:loc xlink:label="loc_IncomeTaxPolicyTextBlock.10751.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxPolicyTextBlock.10751.11.7" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl.267773" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl.267773" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl.267773">Income Taxes</link:label>
    <link:loc xlink:label="loc_RevenueRecognitionPolicyTextBlock.15515.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RevenueRecognitionPolicyTextBlock.15515.11.6" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl.267968" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl.267968" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_RevenueRecognitionPolicyTextBlock_lbl.267968">Revenue Recognition Policy [Text Block]</link:label>
    <link:loc xlink:label="loc_RevenueRecognitionPolicyTextBlock.15515.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RevenueRecognitionPolicyTextBlock.15515.11.7" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl.267969" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl.267969" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_RevenueRecognitionPolicyTextBlock_lbl.267969">Revenue Recognition</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16373.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16373.11.6" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl.268010" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl.268010" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl.268010">Share Based Compensation Option And Incentive Plans Policy</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16373.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16373.11.7" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl.268011" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl.268011" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl.268011">Share-Based Compensation</link:label>
    <link:loc xlink:label="loc_UseOfEstimates.17234.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UseOfEstimates.17234.11.6" xlink:to="us-gaap_UseOfEstimates_lbl.268077" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_UseOfEstimates_lbl.268077" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl.268077">Use Of Estimates</link:label>
    <link:loc xlink:label="loc_UseOfEstimates.17234.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UseOfEstimates.17234.11.7" xlink:to="us-gaap_UseOfEstimates_lbl.268078" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_UseOfEstimates_lbl.268078" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl.268078">Use of Estimates</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.11.6" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl.267979" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl.267979" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl.267979">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.11.7" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl.267980" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl.267980" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl.267980">Schedule of Share-based Compensation Expense</link:label>
    <link:loc xlink:label="loc_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.9256.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.9256.11.6" xlink:to="lab_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.6331" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.6331" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.6331">Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.9256.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.9256.11.7" xlink:to="lab_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.490095" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.490095" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.490095">Schedule of Quantitative Information about Level 3 Fair Value Measurements</link:label>
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.11.6" xlink:to="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.6652" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.6652" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.6652">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.11.7" xlink:to="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.490094" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.490094" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.490094">Summary of Changes in Fair Value of Level 3 Liabilities</link:label>
    <link:loc xlink:label="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.11.6" xlink:to="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.16543" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.16543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.16543">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.11.7" xlink:to="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.490114" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.490114" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.490114">Schedule of Liabilities Measured at Fair Value</link:label>
    <link:loc xlink:label="loc_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock.15773.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock.15773.11.6" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl.267973" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl.267973" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl.267973">Schedule Of Derivative Liabilities At Fair Value Table [Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock.15773.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock.15773.11.7" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl.267974" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl.267974" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl.267974">Summary of Fair Value Hierarchy for Financial Assets and Liabilities</link:label>
    <link:loc xlink:label="loc_ScheduleOfDebtTableTextBlock.15760.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfDebtTableTextBlock.15760.11.6" xlink:to="lab_ScheduleOfDebtTableTextBlock.16595" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfDebtTableTextBlock.16595" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfDebtTableTextBlock.16595">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfDebtTableTextBlock.15760.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfDebtTableTextBlock.15760.11.7" xlink:to="lab_ScheduleOfDebtTableTextBlock7.466750" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfDebtTableTextBlock7.466750" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfDebtTableTextBlock7.466750">Term Loan, Net of Debt Discount</link:label>
    <link:loc xlink:label="loc_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.15767.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.15767.11.6" xlink:to="lab_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.16605" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.16605" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.16605">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.15767.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.15767.11.7" xlink:to="lab_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.466748" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.466748" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.466748">Principal Payments On The Term Loan</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAxis.872.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAxis.872.11.6" xlink:to="lab_CashAndCashEquivalentsAxis.2205" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsAxis.2205" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsAxis.2205">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.11.6" xlink:to="lab_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.15956" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.15956" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.15956">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.17448" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.17448" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.17448">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.467377" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.467377" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.467377">Share options granted to employees</link:label>
    <link:loc xlink:label="loc_CashEquivalentsMaturityPeriod.58094.11.6" xlink:href="pip-20130331.xsd#pip_CashEquivalentsMaturityPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashEquivalentsMaturityPeriod.58094.11.6" xlink:to="pip_CashEquivalentsMaturityPeriod_lbl.267548" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CashEquivalentsMaturityPeriod_lbl.267548" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_CashEquivalentsMaturityPeriod_lbl.267548">Cash Equivalents Maturity Period</link:label>
    <link:loc xlink:label="loc_CashEquivalentsMaturityPeriod.58094.11.7" xlink:href="pip-20130331.xsd#pip_CashEquivalentsMaturityPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashEquivalentsMaturityPeriod.58094.11.7" xlink:to="pip_CashEquivalentsMaturityPeriod_lbl.267549" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CashEquivalentsMaturityPeriod_lbl.267549" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_CashEquivalentsMaturityPeriod_lbl.267549">Cash liquidity maturity period</link:label>
    <link:loc xlink:label="loc_CashEquivalentsMaturityPeriod.58094.11.12" xlink:href="pip-20130331.xsd#pip_CashEquivalentsMaturityPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashEquivalentsMaturityPeriod.58094.11.12" xlink:to="pip_CashEquivalentsMaturityPeriod_lbl.267547" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CashEquivalentsMaturityPeriod_lbl.267547" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_CashEquivalentsMaturityPeriod_lbl.267547">Cash Equivalents, Maturity Period</link:label>
    <link:loc xlink:label="loc_LiquidityArrangementsMember.58129.11.6" xlink:href="pip-20130331.xsd#pip_LiquidityArrangementsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiquidityArrangementsMember.58129.11.6" xlink:to="pip_LiquidityArrangementsMember_lbl.267830" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_LiquidityArrangementsMember_lbl.267830" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_LiquidityArrangementsMember_lbl.267830">Liquidity Arrangements [Member]</link:label>
    <link:loc xlink:label="loc_LiquidityArrangementsMember.58129.11.7" xlink:href="pip-20130331.xsd#pip_LiquidityArrangementsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiquidityArrangementsMember.58129.11.7" xlink:to="pip_LiquidityArrangementsMember_lbl.267831" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_LiquidityArrangementsMember_lbl.267831" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_LiquidityArrangementsMember_lbl.267831">Liquidity Arrangements [Member]</link:label>
    <link:loc xlink:label="loc_LiquidityArrangementsMember.58129.11.12" xlink:href="pip-20130331.xsd#pip_LiquidityArrangementsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiquidityArrangementsMember.58129.11.12" xlink:to="pip_LiquidityArrangementsMember_lbl.267829" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_LiquidityArrangementsMember_lbl.267829" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_LiquidityArrangementsMember_lbl.267829">Liquidity Arrangements [Member]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.58147.11.6" xlink:href="pip-20130331.xsd#pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.58147.11.6" xlink:to="pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate_lbl.267999" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate_lbl.267999" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate_lbl.267999">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Annual Forfeiture Rate</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.58147.11.7" xlink:href="pip-20130331.xsd#pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.58147.11.7" xlink:to="pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate_lbl.268000" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate_lbl.268000" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate_lbl.268000">Share-based compensation forfeitures rate</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.58147.11.12" xlink:href="pip-20130331.xsd#pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.58147.11.12" xlink:to="pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate_lbl.267998" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate_lbl.267998" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate_lbl.267998">Share based Compensation Arrangement by Share based Payment Award, Fair Value Assumptions, Annual Forfeiture Rate</link:label>
    <link:loc xlink:label="loc_SignificantAccountingPoliciesLineItems.58149.11.6" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.11.6" xlink:to="pip_SignificantAccountingPoliciesLineItems_lbl.268017" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_SignificantAccountingPoliciesLineItems_lbl.268017" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_SignificantAccountingPoliciesLineItems_lbl.268017">Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:label="loc_SignificantAccountingPoliciesLineItems.58149.11.12" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.11.12" xlink:to="pip_SignificantAccountingPoliciesLineItems_lbl.268016" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_SignificantAccountingPoliciesLineItems_lbl.268016" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_SignificantAccountingPoliciesLineItems_lbl.268016">Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:label="loc_SignificantAccountingPoliciesLineItems.58149.11.7" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.11.7" xlink:to="pip_SignificantAccountingPoliciesLineItems_lbl.268018" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_SignificantAccountingPoliciesLineItems_lbl.268018" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_SignificantAccountingPoliciesLineItems_lbl.268018">Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTable.58150.11.6" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SignificantAccountingPoliciesTable.58150.11.6" xlink:to="pip_SignificantAccountingPoliciesTable_lbl.268020" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_SignificantAccountingPoliciesTable_lbl.268020" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_SignificantAccountingPoliciesTable_lbl.268020">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTable.58150.11.7" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SignificantAccountingPoliciesTable.58150.11.7" xlink:to="pip_SignificantAccountingPoliciesTable_lbl.268021" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_SignificantAccountingPoliciesTable_lbl.268021" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_SignificantAccountingPoliciesTable_lbl.268021">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTable.58150.11.12" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SignificantAccountingPoliciesTable.58150.11.12" xlink:to="pip_SignificantAccountingPoliciesTable_lbl.268019" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_SignificantAccountingPoliciesTable_lbl.268019" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_SignificantAccountingPoliciesTable_lbl.268019">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:label="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.11.6" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl.267516" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl.267516" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl.267516">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</link:label>
    <link:loc xlink:label="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.11.7" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl.267517" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl.267517" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl.267517">Anti-dilutive securities excluded from computation of earnings per share</link:label>
    <link:loc xlink:label="loc_CostOfReimbursableExpense.7169.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostOfReimbursableExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CostOfReimbursableExpense.7169.11.6" xlink:to="us-gaap_CostOfReimbursableExpense_lbl.267592" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CostOfReimbursableExpense_lbl.267592" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CostOfReimbursableExpense_lbl.267592">Cost Of Reimbursable Expense</link:label>
    <link:loc xlink:label="loc_CostOfReimbursableExpense.7169.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostOfReimbursableExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CostOfReimbursableExpense.7169.11.7" xlink:to="us-gaap_CostOfReimbursableExpense_lbl.267593" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CostOfReimbursableExpense_lbl.267593" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CostOfReimbursableExpense_lbl.267593">Cost reimbursed to offset research and development expenses</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.11.6" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl.267695" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl.267695" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl.267695">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.11.7" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl.267696" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl.267696" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl.267696">Unrecognized share-based compensation expense related to unvested awards</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.11.6" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl.267697" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl.267697" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl.267697">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.11.7" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl.267698" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl.267698" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl.267698">Unrecognized share-based compensation expense related to unvested awards expected to be recognized in the period</link:label>
    <link:loc xlink:label="loc_IncomeTaxExpenseBenefit.10688.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxExpenseBenefit.10688.11.6" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl.267770" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl.267770" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl.267770">Income Tax Expense Benefit</link:label>
    <link:loc xlink:label="loc_IncomeTaxExpenseBenefit.10688.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxExpenseBenefit.10688.11.7" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl.267771" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl.267771" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl.267771">Income tax expense</link:label>
    <link:loc xlink:label="loc_NumberOfOperatingSegments.12967.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NumberOfOperatingSegments.12967.11.6" xlink:to="us-gaap_NumberOfOperatingSegments_lbl.267885" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NumberOfOperatingSegments_lbl.267885" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_NumberOfOperatingSegments_lbl.267885">Number Of Operating Segments</link:label>
    <link:loc xlink:label="loc_NumberOfOperatingSegments.12967.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NumberOfOperatingSegments.12967.11.7" xlink:to="us-gaap_NumberOfOperatingSegments_lbl.267886" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_NumberOfOperatingSegments_lbl.267886" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_NumberOfOperatingSegments_lbl.267886">Number of operating segment</link:label>
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5724.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AllocatedShareBasedCompensationExpense.5724.11.6" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl.267512" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl.267512" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl.267512">Allocated Share Based Compensation Expense</link:label>
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5724.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AllocatedShareBasedCompensationExpense.5724.11.7" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl.267513" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl.267513" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl.267513">Total share-based compensation expense</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.11.6" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl.267691" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl.267691" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl.267691">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.11.7" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl.267692" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl.267692" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl.267692">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.11.6" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_lbl.267693" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_lbl.267693" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_lbl.267693">Employee Service Share Based Compensation Allocation Of Recognized Period Costs Report Line [Domain]</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.11.7" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_lbl.267694" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_lbl.267694" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_lbl.267694">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2354.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpenseMember.2354.11.6" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl.267747" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl.267747" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpenseMember_lbl.267747">General And Administrative Expense [Member]</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2354.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpenseMember.2354.11.7" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl.267748" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl.267748" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpenseMember_lbl.267748">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4381.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpenseMember.4381.11.6" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl.267960" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl.267960" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseMember_lbl.267960">Research And Development Expense [Member]</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4381.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpenseMember.4381.11.7" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl.267961" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl.267961" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseMember_lbl.267961">Research and Development [Member]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.11.6" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_lbl.267975" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_lbl.267975" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_lbl.267975">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs By Report Line [Axis]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.11.7" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_lbl.267976" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_lbl.267976" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_lbl.267976">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.11.6" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl.267977" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl.267977" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl.267977">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.11.7" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl.267978" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl.267978" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl.267978">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.11.6" xlink:to="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.6675" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.6675" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.6675">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.11.6" xlink:to="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.6699" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.6699" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.6699">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.11.7" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.369463" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.369463" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.369463">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:label="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.11.6" xlink:to="us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure_lbl.267637" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure_lbl.267637" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure_lbl.267637">Derivative Financial Instruments Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:label="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.11.10" xlink:to="us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure_lbl.267639" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure_lbl.267639" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure_lbl.267639">Beginning Balance</link:label>
    <link:loc xlink:label="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.11.11" xlink:to="us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure_lbl.267638" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure_lbl.267638" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure_lbl.267638">Ending Balance</link:label>
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnrealizedGainLossOnDerivatives.17162.11.8" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl.268076" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl.268076" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_UnrealizedGainLossOnDerivatives_lbl.268076">Unrealized Gains (Losses)</link:label>
    <link:loc xlink:label="loc_SharePrice.16294.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharePrice.16294.11.6" xlink:to="lab_SharePrice.17475" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharePrice.17475" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharePrice.17475">Share Price</link:label>
    <link:loc xlink:label="loc_SharePrice.16294.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharePrice.16294.11.7" xlink:to="lab_SharePrice.490101" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharePrice.490101" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharePrice.490101">Closing stock price, per share</link:label>
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.11.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnrealizedGainLossOnDerivatives.17162.11.42" xlink:to="lab_UnrealizedGainLossOnDerivatives.268189" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UnrealizedGainLossOnDerivatives.268189" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_UnrealizedGainLossOnDerivatives.268189">Change in fair value of derivative instruments</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesMember.58105.11.6" xlink:href="pip-20130331.xsd#pip_DerivativeLiabilitiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesMember.58105.11.6" xlink:to="pip_DerivativeLiabilitiesMember_lbl.267641" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_DerivativeLiabilitiesMember_lbl.267641" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_DerivativeLiabilitiesMember_lbl.267641">Derivative Liabilities [Member]</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesMember.58105.11.7" xlink:href="pip-20130331.xsd#pip_DerivativeLiabilitiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesMember.58105.11.7" xlink:to="pip_DerivativeLiabilitiesMember_lbl.267642" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_DerivativeLiabilitiesMember_lbl.267642" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_DerivativeLiabilitiesMember_lbl.267642">Derivative Liabilities [Member]</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesMember.58105.11.12" xlink:href="pip-20130331.xsd#pip_DerivativeLiabilitiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesMember.58105.11.12" xlink:to="pip_DerivativeLiabilitiesMember_lbl.267640" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_DerivativeLiabilitiesMember_lbl.267640" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_DerivativeLiabilitiesMember_lbl.267640">Derivative Liabilities [Member]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsLineItems.58117.11.6" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsLineItems.58117.11.6" xlink:to="pip_FairValueMeasurementsLineItems_lbl.267735" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_FairValueMeasurementsLineItems_lbl.267735" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_FairValueMeasurementsLineItems_lbl.267735">Fair Value Measurements [Line Items]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsLineItems.58117.11.12" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsLineItems.58117.11.12" xlink:to="pip_FairValueMeasurementsLineItems_lbl.267734" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_FairValueMeasurementsLineItems_lbl.267734" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_FairValueMeasurementsLineItems_lbl.267734">Fair Value Measurements [Line Items]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsLineItems.58117.11.7" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsLineItems.58117.11.7" xlink:to="pip_FairValueMeasurementsLineItems_lbl.267736" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_FairValueMeasurementsLineItems_lbl.267736" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_FairValueMeasurementsLineItems_lbl.267736">Fair Value Measurements [Line Items]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsTable.58118.11.6" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsTable.58118.11.6" xlink:to="pip_FairValueMeasurementsTable_lbl.267738" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_FairValueMeasurementsTable_lbl.267738" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_FairValueMeasurementsTable_lbl.267738">Fair Value Measurements [Table]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsTable.58118.11.7" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsTable.58118.11.7" xlink:to="pip_FairValueMeasurementsTable_lbl.267739" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_FairValueMeasurementsTable_lbl.267739" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_FairValueMeasurementsTable_lbl.267739">Fair Value Measurements [Table]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsTable.58118.11.12" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsTable.58118.11.12" xlink:to="pip_FairValueMeasurementsTable_lbl.267737" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_FairValueMeasurementsTable_lbl.267737" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_FairValueMeasurementsTable_lbl.267737">Fair Value Measurements [Table]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightOutstanding.6757.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightOutstanding.6757.11.6" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl.267559" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl.267559" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightOutstanding_lbl.267559">Class Of Warrant Or Right Outstanding</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightOutstanding.6757.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightOutstanding.6757.11.7" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl.267560" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl.267560" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightOutstanding_lbl.267560">Warrants to purchase common stock</link:label>
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.11.6" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl.267717" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl.267717" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl.267717">Fair Value By Fair Value Hierarchy Level [Axis]</link:label>
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.11.7" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl.267718" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl.267718" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl.267718">Fair Value, Hierarchy [Axis]</link:label>
    <link:loc xlink:label="loc_FairValueByLiabilityClassAxis.1897.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueByLiabilityClassAxis.1897.11.6" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl.267719" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl.267719" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueByLiabilityClassAxis_lbl.267719">Fair Value By Liability Class [Axis]</link:label>
    <link:loc xlink:label="loc_FairValueByLiabilityClassAxis.1897.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueByLiabilityClassAxis.1897.11.7" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl.267720" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl.267720" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueByLiabilityClassAxis_lbl.267720">Liability Class [Axis]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel3Member.2022.11.6" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl.267726" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueInputsLevel3Member_lbl.267726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueInputsLevel3Member_lbl.267726">Fair Value Inputs Level 3 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel3Member.2022.11.7" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl.267727" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueInputsLevel3Member_lbl.267727" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueInputsLevel3Member_lbl.267727">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.11.6" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl.267730" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl.267730" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl.267730">Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain]</link:label>
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.11.7" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl.267731" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl.267731" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl.267731">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.11.6" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl.267732" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl.267732" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl.267732">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.11.7" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl.267733" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl.267733" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl.267733">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:label="loc_FinancialInstrumentAxis.2133.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FinancialInstrumentAxis.2133.11.6" xlink:to="us-gaap_FinancialInstrumentAxis_lbl.267740" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FinancialInstrumentAxis_lbl.267740" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_FinancialInstrumentAxis_lbl.267740">Financial Instrument [Axis]</link:label>
    <link:loc xlink:label="loc_FinancialInstrumentAxis.2133.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FinancialInstrumentAxis.2133.11.7" xlink:to="us-gaap_FinancialInstrumentAxis_lbl.267741" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_FinancialInstrumentAxis_lbl.267741" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_FinancialInstrumentAxis_lbl.267741">Financial Instrument [Axis]</link:label>
    <link:loc xlink:label="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.11.6" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl.268069" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl.268069" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl.268069">Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]</link:label>
    <link:loc xlink:label="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.11.7" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl.268070" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl.268070" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl.268070">Types of Financial Instruments [Domain]</link:label>
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnrealizedGainLossOnDerivatives.17162.11.6" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl.268073" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl.268073" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_UnrealizedGainLossOnDerivatives_lbl.268073">Unrealized Gain Loss On Derivatives</link:label>
    <link:loc xlink:label="loc_WarrantMember.5342.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantMember.5342.11.6" xlink:to="us-gaap_WarrantMember_lbl.268082" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_WarrantMember_lbl.268082" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_WarrantMember_lbl.268082">Warrant [Member]</link:label>
    <link:loc xlink:label="loc_WarrantMember.5342.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantMember.5342.11.7" xlink:to="us-gaap_WarrantMember_lbl.268083" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_WarrantMember_lbl.268083" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_WarrantMember_lbl.268083">Warrants [Member]</link:label>
    <link:loc xlink:label="loc_MaximumMember.3241.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumMember.3241.11.6" xlink:to="lab_MaximumMember.11410.512266" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MaximumMember.11410.512266" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MaximumMember.11410.512266">Maximum [Member]</link:label>
    <link:loc xlink:label="loc_RangeAxis.4187.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RangeAxis.4187.11.6" xlink:to="lab_RangeAxis.15198.512263" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RangeAxis.15198.512263" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RangeAxis.15198.512263">Range [Axis]</link:label>
    <link:loc xlink:label="loc_RangeMember.4188.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RangeMember.4188.11.7" xlink:to="lab_RangeMember.147960" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RangeMember.147960" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RangeMember.147960">Range [Domain]</link:label>
    <link:loc xlink:label="loc_RangeMember.4188.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RangeMember.4188.11.6" xlink:to="lab_RangeMember.15199.512264" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RangeMember.15199.512264" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RangeMember.15199.512264">Range [Domain]</link:label>
    <link:loc xlink:label="loc_WarrantExpirationDate.58158.11.6" xlink:href="pip-20130331.xsd#pip_WarrantExpirationDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantExpirationDate.58158.11.6" xlink:to="lab_WarrantExpirationDate.268080" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantExpirationDate.268080" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantExpirationDate.268080">Warrant Expiration Date</link:label>
    <link:loc xlink:label="loc_BreachOfContractualCommitmentAwardPeriod.58093.11.6" xlink:href="pip-20130331.xsd#pip_BreachOfContractualCommitmentAwardPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BreachOfContractualCommitmentAwardPeriod.58093.11.6" xlink:to="pip_BreachOfContractualCommitmentAwardPeriod_lbl.267531" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_BreachOfContractualCommitmentAwardPeriod_lbl.267531" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_BreachOfContractualCommitmentAwardPeriod_lbl.267531">Breach Of Contractual Commitment Award Period</link:label>
    <link:loc xlink:label="loc_BreachOfContractualCommitmentAwardPeriod.58093.11.7" xlink:href="pip-20130331.xsd#pip_BreachOfContractualCommitmentAwardPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BreachOfContractualCommitmentAwardPeriod.58093.11.7" xlink:to="pip_BreachOfContractualCommitmentAwardPeriod_lbl.267532" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_BreachOfContractualCommitmentAwardPeriod_lbl.267532" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_BreachOfContractualCommitmentAwardPeriod_lbl.267532">SIGA breach of contractual obligation award period following initial commercial sale</link:label>
    <link:loc xlink:label="loc_BreachOfContractualCommitmentAwardPeriod.58093.11.12" xlink:href="pip-20130331.xsd#pip_BreachOfContractualCommitmentAwardPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BreachOfContractualCommitmentAwardPeriod.58093.11.12" xlink:to="pip_BreachOfContractualCommitmentAwardPeriod_lbl.267530" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_BreachOfContractualCommitmentAwardPeriod_lbl.267530" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_BreachOfContractualCommitmentAwardPeriod_lbl.267530">Breach of contractual commitment award period - number of years following initial commercial sale of ArestvyrTM.</link:label>
    <link:loc xlink:label="loc_CommitmentAndContingenciesTable.58096.11.6" xlink:href="pip-20130331.xsd#pip_CommitmentAndContingenciesTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentAndContingenciesTable.58096.11.6" xlink:to="pip_CommitmentAndContingenciesTable_lbl.267565" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CommitmentAndContingenciesTable_lbl.267565" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_CommitmentAndContingenciesTable_lbl.267565">Commitment And Contingencies [Table]</link:label>
    <link:loc xlink:label="loc_CommitmentAndContingenciesTable.58096.11.7" xlink:href="pip-20130331.xsd#pip_CommitmentAndContingenciesTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentAndContingenciesTable.58096.11.7" xlink:to="pip_CommitmentAndContingenciesTable_lbl.267566" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CommitmentAndContingenciesTable_lbl.267566" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_CommitmentAndContingenciesTable_lbl.267566">Commitment And Contingencies [Table]</link:label>
    <link:loc xlink:label="loc_CommitmentAndContingenciesTable.58096.11.12" xlink:href="pip-20130331.xsd#pip_CommitmentAndContingenciesTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentAndContingenciesTable.58096.11.12" xlink:to="pip_CommitmentAndContingenciesTable_lbl.267564" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CommitmentAndContingenciesTable_lbl.267564" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_CommitmentAndContingenciesTable_lbl.267564">Commitment And Contingencies [Table]</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingenciesLineItems.58097.11.6" xlink:href="pip-20130331.xsd#pip_CommitmentsAndContingenciesLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.11.6" xlink:to="pip_CommitmentsAndContingenciesLineItems_lbl.267570" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CommitmentsAndContingenciesLineItems_lbl.267570" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_CommitmentsAndContingenciesLineItems_lbl.267570">Commitments And Contingencies [Line Items]</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingenciesLineItems.58097.11.7" xlink:href="pip-20130331.xsd#pip_CommitmentsAndContingenciesLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.11.7" xlink:to="pip_CommitmentsAndContingenciesLineItems_lbl.267571" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CommitmentsAndContingenciesLineItems_lbl.267571" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_CommitmentsAndContingenciesLineItems_lbl.267571">Commitments and Contingencies [Line Items]</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingenciesLineItems.58097.11.12" xlink:href="pip-20130331.xsd#pip_CommitmentsAndContingenciesLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.11.12" xlink:to="pip_CommitmentsAndContingenciesLineItems_lbl.267569" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CommitmentsAndContingenciesLineItems_lbl.267569" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_CommitmentsAndContingenciesLineItems_lbl.267569">Commitments and Contingencies [Line Items]</link:label>
    <link:loc xlink:label="loc_CourtAwardedFees.58099.11.6" xlink:href="pip-20130331.xsd#pip_CourtAwardedFees" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CourtAwardedFees.58099.11.6" xlink:to="pip_CourtAwardedFees_lbl.267595" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CourtAwardedFees_lbl.267595" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_CourtAwardedFees_lbl.267595">Court Awarded Fees</link:label>
    <link:loc xlink:label="loc_CourtAwardedFees.58099.11.7" xlink:href="pip-20130331.xsd#pip_CourtAwardedFees" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CourtAwardedFees.58099.11.7" xlink:to="pip_CourtAwardedFees_lbl.267596" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CourtAwardedFees_lbl.267596" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_CourtAwardedFees_lbl.267596">Awarded 1/3 reasonable attorney's fees and expert witness fees, plus interest.</link:label>
    <link:loc xlink:label="loc_CourtAwardedFees.58099.11.12" xlink:href="pip-20130331.xsd#pip_CourtAwardedFees" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CourtAwardedFees.58099.11.12" xlink:to="pip_CourtAwardedFees_lbl.267594" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_CourtAwardedFees_lbl.267594" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_CourtAwardedFees_lbl.267594">Court awarded fees.</link:label>
    <link:loc xlink:label="loc_GroupFourMember.58120.11.6" xlink:href="pip-20130331.xsd#pip_GroupFourMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupFourMember.58120.11.6" xlink:to="pip_GroupFourMember_lbl.267755" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupFourMember_lbl.267755" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_GroupFourMember_lbl.267755">Group Four [Member]</link:label>
    <link:loc xlink:label="loc_GroupFourMember.58120.11.7" xlink:href="pip-20130331.xsd#pip_GroupFourMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupFourMember.58120.11.7" xlink:to="pip_GroupFourMember_lbl.267756" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupFourMember_lbl.267756" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_GroupFourMember_lbl.267756">Every 30 days until failure is cured [Member]</link:label>
    <link:loc xlink:label="loc_GroupFourMember.58120.11.12" xlink:href="pip-20130331.xsd#pip_GroupFourMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupFourMember.58120.11.12" xlink:to="pip_GroupFourMember_lbl.267754" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupFourMember_lbl.267754" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_GroupFourMember_lbl.267754">Group Four [Member]</link:label>
    <link:loc xlink:label="loc_GroupThreeMember.58122.11.6" xlink:href="pip-20130331.xsd#pip_GroupThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupThreeMember.58122.11.6" xlink:to="pip_GroupThreeMember_lbl.267761" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupThreeMember_lbl.267761" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_GroupThreeMember_lbl.267761">Group Three [Member]</link:label>
    <link:loc xlink:label="loc_GroupThreeMember.58122.11.7" xlink:href="pip-20130331.xsd#pip_GroupThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupThreeMember.58122.11.7" xlink:to="pip_GroupThreeMember_lbl.267762" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupThreeMember_lbl.267762" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_GroupThreeMember_lbl.267762">Initial Maximum Maintenance Failure Obligation [Member]</link:label>
    <link:loc xlink:label="loc_GroupThreeMember.58122.11.12" xlink:href="pip-20130331.xsd#pip_GroupThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupThreeMember.58122.11.12" xlink:to="pip_GroupThreeMember_lbl.267760" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupThreeMember_lbl.267760" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_GroupThreeMember_lbl.267760">Initial maximum maintenance failure obligation and additional maximum obligation every 30th daily after initial maintenance failure.</link:label>
    <link:loc xlink:label="loc_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.58130.11.6" xlink:href="pip-20130331.xsd#pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.58130.11.6" xlink:to="pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract_lbl.267873" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract_lbl.267873" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract_lbl.267873">Net Profit Retention From Sales Before Distribution For Breach Of Contract</link:label>
    <link:loc xlink:label="loc_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.58130.11.7" xlink:href="pip-20130331.xsd#pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.58130.11.7" xlink:to="pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract_lbl.267874" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract_lbl.267874" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract_lbl.267874">SIGA net profits (as defined in court's final judgement) before distribution for breach of contract</link:label>
    <link:loc xlink:label="loc_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.58130.11.12" xlink:href="pip-20130331.xsd#pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.58130.11.12" xlink:to="pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract_lbl.267872" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract_lbl.267872" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract_lbl.267872">Net profit on ArestvyrTM (as defined in court's final judgement) before distribution for breach of contract.</link:label>
    <link:loc xlink:label="loc_NotesPayableAggregatePrincipalRepaymentAmount.58132.11.6" xlink:href="pip-20130331.xsd#pip_NotesPayableAggregatePrincipalRepaymentAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NotesPayableAggregatePrincipalRepaymentAmount.58132.11.6" xlink:to="pip_NotesPayableAggregatePrincipalRepaymentAmount_lbl.267883" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_NotesPayableAggregatePrincipalRepaymentAmount_lbl.267883" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_NotesPayableAggregatePrincipalRepaymentAmount_lbl.267883">Notes Payable Aggregate Principal Repayment Amount</link:label>
    <link:loc xlink:label="loc_NotesPayableAggregatePrincipalRepaymentAmount.58132.11.7" xlink:href="pip-20130331.xsd#pip_NotesPayableAggregatePrincipalRepaymentAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NotesPayableAggregatePrincipalRepaymentAmount.58132.11.7" xlink:to="pip_NotesPayableAggregatePrincipalRepaymentAmount_lbl.267884" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_NotesPayableAggregatePrincipalRepaymentAmount_lbl.267884" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_NotesPayableAggregatePrincipalRepaymentAmount_lbl.267884">Aggregate principal amount of obligation</link:label>
    <link:loc xlink:label="loc_NotesPayableAggregatePrincipalRepaymentAmount.58132.11.12" xlink:href="pip-20130331.xsd#pip_NotesPayableAggregatePrincipalRepaymentAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NotesPayableAggregatePrincipalRepaymentAmount.58132.11.12" xlink:to="pip_NotesPayableAggregatePrincipalRepaymentAmount_lbl.267882" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_NotesPayableAggregatePrincipalRepaymentAmount_lbl.267882" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_NotesPayableAggregatePrincipalRepaymentAmount_lbl.267882">Initial maximum maintenance failure obligation and additional maximum obligation every 30th daily after initial maintenance failure.</link:label>
    <link:loc xlink:label="loc_PercentageOfAggregatePrincipalAmountRedemption.58134.11.6" xlink:href="pip-20130331.xsd#pip_PercentageOfAggregatePrincipalAmountRedemption" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentageOfAggregatePrincipalAmountRedemption.58134.11.6" xlink:to="pip_PercentageOfAggregatePrincipalAmountRedemption_lbl.267916" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_PercentageOfAggregatePrincipalAmountRedemption_lbl.267916" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_PercentageOfAggregatePrincipalAmountRedemption_lbl.267916">Percentage Of Aggregate Principal Amount Redemption</link:label>
    <link:loc xlink:label="loc_PercentageOfAggregatePrincipalAmountRedemption.58134.11.7" xlink:href="pip-20130331.xsd#pip_PercentageOfAggregatePrincipalAmountRedemption" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentageOfAggregatePrincipalAmountRedemption.58134.11.7" xlink:to="pip_PercentageOfAggregatePrincipalAmountRedemption_lbl.267917" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_PercentageOfAggregatePrincipalAmountRedemption_lbl.267917" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_PercentageOfAggregatePrincipalAmountRedemption_lbl.267917">Percentage of aggregate principal amount of convertible Notes</link:label>
    <link:loc xlink:label="loc_PercentageOfAggregatePrincipalAmountRedemption.58134.11.12" xlink:href="pip-20130331.xsd#pip_PercentageOfAggregatePrincipalAmountRedemption" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentageOfAggregatePrincipalAmountRedemption.58134.11.12" xlink:to="pip_PercentageOfAggregatePrincipalAmountRedemption_lbl.267915" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_PercentageOfAggregatePrincipalAmountRedemption_lbl.267915" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_PercentageOfAggregatePrincipalAmountRedemption_lbl.267915">Percentage of aggregate principal amount of convertible notes relating to the affected shares.</link:label>
    <link:loc xlink:label="loc_PercentageOfNetProfitAwarded.58135.11.6" xlink:href="pip-20130331.xsd#pip_PercentageOfNetProfitAwarded" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentageOfNetProfitAwarded.58135.11.6" xlink:to="pip_PercentageOfNetProfitAwarded_lbl.267919" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_PercentageOfNetProfitAwarded_lbl.267919" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_PercentageOfNetProfitAwarded_lbl.267919">Percentage Of Net Profit Awarded</link:label>
    <link:loc xlink:label="loc_PercentageOfNetProfitAwarded.58135.11.7" xlink:href="pip-20130331.xsd#pip_PercentageOfNetProfitAwarded" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentageOfNetProfitAwarded.58135.11.7" xlink:to="pip_PercentageOfNetProfitAwarded_lbl.267920" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_PercentageOfNetProfitAwarded_lbl.267920" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_PercentageOfNetProfitAwarded_lbl.267920">SIGA breach of contractual obligation awarded, percentage of net profits (as defined in court's final judgement)</link:label>
    <link:loc xlink:label="loc_PercentageOfNetProfitAwarded.58135.11.12" xlink:href="pip-20130331.xsd#pip_PercentageOfNetProfitAwarded" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentageOfNetProfitAwarded.58135.11.12" xlink:to="pip_PercentageOfNetProfitAwarded_lbl.267918" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_PercentageOfNetProfitAwarded_lbl.267918" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_PercentageOfNetProfitAwarded_lbl.267918">Percentage of net profits (as defined in court's final judgement) awarded on the sales of ArestvyrTM and related products.</link:label>
    <link:loc xlink:label="loc_PharmAtheneMember.58137.11.6" xlink:href="pip-20130331.xsd#pip_PharmAtheneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PharmAtheneMember.58137.11.6" xlink:to="pip_PharmAtheneMember_lbl.267925" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_PharmAtheneMember_lbl.267925" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_PharmAtheneMember_lbl.267925">Pharm Athene [Member]</link:label>
    <link:loc xlink:label="loc_PharmAtheneMember.58137.11.7" xlink:href="pip-20130331.xsd#pip_PharmAtheneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PharmAtheneMember.58137.11.7" xlink:to="pip_PharmAtheneMember_lbl.267926" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_PharmAtheneMember_lbl.267926" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_PharmAtheneMember_lbl.267926">PharmAthene [Member]</link:label>
    <link:loc xlink:label="loc_PharmAtheneMember.58137.11.12" xlink:href="pip-20130331.xsd#pip_PharmAtheneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PharmAtheneMember.58137.11.12" xlink:to="pip_PharmAtheneMember_lbl.267924" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_PharmAtheneMember_lbl.267924" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_PharmAtheneMember_lbl.267924">PharmAthene [Member]</link:label>
    <link:loc xlink:label="loc_WarrantExpirationDate.58158.11.7" xlink:href="pip-20130331.xsd#pip_WarrantExpirationDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantExpirationDate.58158.11.7" xlink:to="pip_WarrantExpirationDate_lbl.268081" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_WarrantExpirationDate_lbl.268081" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_WarrantExpirationDate_lbl.268081">Warrant expiration date</link:label>
    <link:loc xlink:label="loc_WarrantExpirationDate.58158.11.12" xlink:href="pip-20130331.xsd#pip_WarrantExpirationDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantExpirationDate.58158.11.12" xlink:to="pip_WarrantExpirationDate_lbl.268079" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_WarrantExpirationDate_lbl.268079" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_WarrantExpirationDate_lbl.268079">Warrant, Expiration Date</link:label>
    <link:loc xlink:label="loc_LossContingenciesByNatureOfContingencyAxis.3139.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LossContingenciesByNatureOfContingencyAxis.3139.11.6" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl.267851" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl.267851" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl.267851">Loss Contingencies By Nature Of Contingency [Axis]</link:label>
    <link:loc xlink:label="loc_LossContingenciesByNatureOfContingencyAxis.3139.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LossContingenciesByNatureOfContingencyAxis.3139.11.7" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl.267852" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl.267852" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl.267852">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:label="loc_LossContingencyNatureDomain.3148.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LossContingencyNatureDomain.3148.11.6" xlink:to="us-gaap_LossContingencyNatureDomain_lbl.267853" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LossContingencyNatureDomain_lbl.267853" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LossContingencyNatureDomain_lbl.267853">Loss Contingency Nature [Domain]</link:label>
    <link:loc xlink:label="loc_LossContingencyNatureDomain.3148.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LossContingencyNatureDomain.3148.11.7" xlink:to="us-gaap_LossContingencyNatureDomain_lbl.267854" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LossContingencyNatureDomain_lbl.267854" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_LossContingencyNatureDomain_lbl.267854">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:label="loc_MaximumMember.3241.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumMember.3241.11.7" xlink:to="us-gaap_MaximumMember_lbl.267856" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_MaximumMember_lbl.267856" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_MaximumMember_lbl.267856">Maximum [Member]</link:label>
    <link:loc xlink:label="loc_RangeAxis.4187.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RangeAxis.4187.11.7" xlink:to="us-gaap_RangeAxis_lbl.267952" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_RangeAxis_lbl.267952" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_RangeAxis_lbl.267952">Range [Axis]</link:label>
    <link:loc xlink:label="loc_SegmentDomain.4780.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SegmentDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SegmentDomain.4780.11.6" xlink:to="us-gaap_SegmentDomain_lbl.267991" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_SegmentDomain_lbl.267991" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_SegmentDomain_lbl.267991">Segment [Domain]</link:label>
    <link:loc xlink:label="loc_SegmentDomain.4780.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SegmentDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SegmentDomain.4780.11.7" xlink:to="us-gaap_SegmentDomain_lbl.267992" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_SegmentDomain_lbl.267992" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_SegmentDomain_lbl.267992">Segment [Domain]</link:label>
    <link:loc xlink:label="loc_StatementBusinessSegmentsAxis.4956.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementBusinessSegmentsAxis.4956.11.6" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl.268024" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl.268024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_StatementBusinessSegmentsAxis_lbl.268024">Statement Business Segments [Axis]</link:label>
    <link:loc xlink:label="loc_StatementBusinessSegmentsAxis.4956.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementBusinessSegmentsAxis.4956.11.7" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl.268025" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl.268025" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_StatementBusinessSegmentsAxis_lbl.268025">Business Segments [Axis]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.11.8" xlink:to="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.512286" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.512286" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.512286">Warrants issued to purchase shares of common stock</link:label>
    <link:loc xlink:label="loc_PlanNameAxis.3871.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PlanNameAxis.3871.11.6" xlink:to="lab_PlanNameAxis.13737" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PlanNameAxis.13737" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PlanNameAxis.13737">Plan Name [Axis]</link:label>
    <link:loc xlink:label="loc_PlanNameAxis.3871.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PlanNameAxis.3871.11.7" xlink:to="lab_PlanNameAxis.155144" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PlanNameAxis.155144" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PlanNameAxis.155144">Plan Name [Axis]</link:label>
    <link:loc xlink:label="loc_PlanNameDomain.3870.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PlanNameDomain.3870.11.6" xlink:to="lab_PlanNameDomain.13729" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PlanNameDomain.13729" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PlanNameDomain.13729">Plan Name [Domain]</link:label>
    <link:loc xlink:label="loc_PlanNameDomain.3870.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PlanNameDomain.3870.11.7" xlink:to="lab_PlanNameDomain.155147" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PlanNameDomain.155147" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PlanNameDomain.155147">Plan Name [Domain]</link:label>
    <link:loc xlink:label="loc_GroupOneMember.58121.11.6" xlink:href="pip-20130331.xsd#pip_GroupOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupOneMember.58121.11.6" xlink:to="pip_GroupOneMember_lbl.267758" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupOneMember_lbl.267758" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_GroupOneMember_lbl.267758">Group One [Member]</link:label>
    <link:loc xlink:label="loc_GroupOneMember.58121.11.7" xlink:href="pip-20130331.xsd#pip_GroupOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupOneMember.58121.11.7" xlink:to="pip_GroupOneMember_lbl.267759" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupOneMember_lbl.267759" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_GroupOneMember_lbl.267759">Expiration 2015 [Member]</link:label>
    <link:loc xlink:label="loc_GroupOneMember.58121.11.12" xlink:href="pip-20130331.xsd#pip_GroupOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupOneMember.58121.11.12" xlink:to="pip_GroupOneMember_lbl.267757" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupOneMember_lbl.267757" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_GroupOneMember_lbl.267757">Group One [Member]</link:label>
    <link:loc xlink:label="loc_GroupTwoMember.58123.11.6" xlink:href="pip-20130331.xsd#pip_GroupTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupTwoMember.58123.11.6" xlink:to="pip_GroupTwoMember_lbl.267764" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupTwoMember_lbl.267764" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_GroupTwoMember_lbl.267764">Group Two [Member]</link:label>
    <link:loc xlink:label="loc_GroupTwoMember.58123.11.7" xlink:href="pip-20130331.xsd#pip_GroupTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupTwoMember.58123.11.7" xlink:to="pip_GroupTwoMember_lbl.267765" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupTwoMember_lbl.267765" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_GroupTwoMember_lbl.267765">Expiration 2017 [Member]</link:label>
    <link:loc xlink:label="loc_GroupTwoMember.58123.11.12" xlink:href="pip-20130331.xsd#pip_GroupTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GroupTwoMember.58123.11.12" xlink:to="pip_GroupTwoMember_lbl.267763" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_GroupTwoMember_lbl.267763" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_GroupTwoMember_lbl.267763">Group Two [Member]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityLineItems.58151.11.6" xlink:href="pip-20130331.xsd#pip_StockholdersEquityLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityLineItems.58151.11.6" xlink:to="pip_StockholdersEquityLineItems_lbl.268041" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockholdersEquityLineItems_lbl.268041" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_StockholdersEquityLineItems_lbl.268041">Stockholders Equity [Line Items]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityLineItems.58151.11.12" xlink:href="pip-20130331.xsd#pip_StockholdersEquityLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityLineItems.58151.11.12" xlink:to="pip_StockholdersEquityLineItems_lbl.268040" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockholdersEquityLineItems_lbl.268040" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_StockholdersEquityLineItems_lbl.268040">Stockholders Equity [Line Items]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityLineItems.58151.11.7" xlink:href="pip-20130331.xsd#pip_StockholdersEquityLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityLineItems.58151.11.7" xlink:to="pip_StockholdersEquityLineItems_lbl.268042" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockholdersEquityLineItems_lbl.268042" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_StockholdersEquityLineItems_lbl.268042">Stockholders Equity [Line Items]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityTable.58152.11.6" xlink:href="pip-20130331.xsd#pip_StockholdersEquityTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityTable.58152.11.6" xlink:to="pip_StockholdersEquityTable_lbl.268046" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockholdersEquityTable_lbl.268046" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_StockholdersEquityTable_lbl.268046">Stockholders Equity [Table]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityTable.58152.11.7" xlink:href="pip-20130331.xsd#pip_StockholdersEquityTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityTable.58152.11.7" xlink:to="pip_StockholdersEquityTable_lbl.268047" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockholdersEquityTable_lbl.268047" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_StockholdersEquityTable_lbl.268047">Stockholders' Equity [Table]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityTable.58152.11.12" xlink:href="pip-20130331.xsd#pip_StockholdersEquityTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityTable.58152.11.12" xlink:to="pip_StockholdersEquityTable_lbl.268045" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockholdersEquityTable_lbl.268045" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_StockholdersEquityTable_lbl.268045">Stockholders' Equity [Table]</link:label>
    <link:loc xlink:label="loc_StockIncentivePlanTwentyZeroSevenMember.58153.11.6" xlink:href="pip-20130331.xsd#pip_StockIncentivePlanTwentyZeroSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIncentivePlanTwentyZeroSevenMember.58153.11.6" xlink:to="pip_StockIncentivePlanTwentyZeroSevenMember_lbl.268049" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockIncentivePlanTwentyZeroSevenMember_lbl.268049" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_StockIncentivePlanTwentyZeroSevenMember_lbl.268049">Stock Incentive Plan Twenty Zero Seven [Member]</link:label>
    <link:loc xlink:label="loc_StockIncentivePlanTwentyZeroSevenMember.58153.11.7" xlink:href="pip-20130331.xsd#pip_StockIncentivePlanTwentyZeroSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIncentivePlanTwentyZeroSevenMember.58153.11.7" xlink:to="pip_StockIncentivePlanTwentyZeroSevenMember_lbl.268050" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockIncentivePlanTwentyZeroSevenMember_lbl.268050" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_StockIncentivePlanTwentyZeroSevenMember_lbl.268050">2007 Long Term Incentive Plan [Member]</link:label>
    <link:loc xlink:label="loc_StockIncentivePlanTwentyZeroSevenMember.58153.11.12" xlink:href="pip-20130331.xsd#pip_StockIncentivePlanTwentyZeroSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIncentivePlanTwentyZeroSevenMember.58153.11.12" xlink:to="pip_StockIncentivePlanTwentyZeroSevenMember_lbl.268048" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockIncentivePlanTwentyZeroSevenMember_lbl.268048" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_StockIncentivePlanTwentyZeroSevenMember_lbl.268048">Stock Incentive Plan 2007 [Member]</link:label>
    <link:loc xlink:label="loc_StockOptionsContractualTerm.58154.11.6" xlink:href="pip-20130331.xsd#pip_StockOptionsContractualTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockOptionsContractualTerm.58154.11.6" xlink:to="pip_StockOptionsContractualTerm_lbl.268052" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockOptionsContractualTerm_lbl.268052" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_StockOptionsContractualTerm_lbl.268052">Stock Options Contractual Term</link:label>
    <link:loc xlink:label="loc_StockOptionsContractualTerm.58154.11.7" xlink:href="pip-20130331.xsd#pip_StockOptionsContractualTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockOptionsContractualTerm.58154.11.7" xlink:to="pip_StockOptionsContractualTerm_lbl.268053" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockOptionsContractualTerm_lbl.268053" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_StockOptionsContractualTerm_lbl.268053">Options award term</link:label>
    <link:loc xlink:label="loc_StockOptionsContractualTerm.58154.11.12" xlink:href="pip-20130331.xsd#pip_StockOptionsContractualTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockOptionsContractualTerm.58154.11.12" xlink:to="pip_StockOptionsContractualTerm_lbl.268051" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_StockOptionsContractualTerm_lbl.268051" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_StockOptionsContractualTerm_lbl.268051">Stock Options Contractual Term</link:label>
    <link:loc xlink:label="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.11.6" xlink:href="pip-20130331.xsd#pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.11.6" xlink:to="pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt_lbl.268057" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt_lbl.268057" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt_lbl.268057">Supplemental Warrant Issued In Connection With Long Term Debt</link:label>
    <link:loc xlink:label="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.11.7" xlink:href="pip-20130331.xsd#pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.11.7" xlink:to="pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt_lbl.268058" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt_lbl.268058" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt_lbl.268058">Value of warrants issued to lender in connection with loan</link:label>
    <link:loc xlink:label="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.11.12" xlink:href="pip-20130331.xsd#pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.11.12" xlink:to="pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt_lbl.268056" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt_lbl.268056" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt_lbl.268056">Supplemental warrant issued in connection with long-term debt</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.967.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightAxis.967.11.6" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl.267550" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl.267550" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightAxis_lbl.267550">Class Of Warrant Or Right [Axis]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.967.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightAxis.967.11.7" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl.267551" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl.267551" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightAxis_lbl.267551">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.11.6" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl.267552" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl.267552" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightDomain_lbl.267552">Class Of Warrant Or Right [Domain]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.11.7" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl.267553" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl.267553" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightDomain_lbl.267553">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.11.6" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl.267557" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl.267557" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl.267557">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights</link:label>
    <link:loc xlink:label="loc_CommonStockCapitalSharesReservedForFutureIssuance.6881.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockCapitalSharesReservedForFutureIssuance.6881.11.6" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl.267572" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl.267572" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl.267572">Common Stock Capital Shares Reserved For Future Issuance</link:label>
    <link:loc xlink:label="loc_CommonStockCapitalSharesReservedForFutureIssuance.6881.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockCapitalSharesReservedForFutureIssuance.6881.11.7" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl.267573" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl.267573" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl.267573">Common stock reserved</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.11.6" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl.268001" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl.268001" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl.268001">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.11.7" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl.268002" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl.268002" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl.268002">Shares approved for issuance</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.11.6" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl.268003" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl.268003" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl.268003">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.11.7" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl.268004" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl.268004" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl.268004">Shares available to be issued</link:label>
    <link:loc xlink:label="loc_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.10593.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.10593.11.6" xlink:to="lab_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.8358" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.8358" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.8358">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:label="loc_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.10593.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.10593.11.7" xlink:to="lab_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.466679" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.466679" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.466679">Impairment charges</link:label>
    <link:loc xlink:label="loc_SubsequentEventsAbstract.5004.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventsAbstract.5004.11.6" xlink:to="lab_SubsequentEventsAbstract.490111" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventsAbstract.490111" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventsAbstract.490111">Subsequent Event [Abstract]</link:label>
    <link:loc xlink:label="loc_SubsequentEventsTextBlock.16697.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventsTextBlock.16697.11.6" xlink:to="lab_SubsequentEventsTextBlock.18084" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventsTextBlock.18084" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventsTextBlock.18084">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:label="loc_SubsequentEventsTextBlock.16697.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventsTextBlock.16697.11.7" xlink:to="lab_SubsequentEventsTextBlock.134775" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventsTextBlock.134775" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventsTextBlock.134775">Subsequent Events</link:label>
    <link:loc xlink:label="loc_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.85463.11.7" xlink:href="pip-20130331.xsd#pip_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.85463.11.7" xlink:to="CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.471383" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.471383" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.471383">Commission owed to sales agent, expressed as percentage of aggregate gross proceeds from each sale of shares of common stock</link:label>
    <link:loc xlink:label="loc_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.85463.11.12" xlink:href="pip-20130331.xsd#pip_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.85463.11.12" xlink:to="CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.471382" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.471382" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.471382">Commission owed to sales agent, expressed as percentage of aggregate gross proceeds from each sale of shares.</link:label>
    <link:loc xlink:label="loc_EquityOfferingAxis.85456.11.12" xlink:href="pip-20130331.xsd#pip_EquityOfferingAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOfferingAxis.85456.11.12" xlink:to="EquityOfferingAxis.471352" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="EquityOfferingAxis.471352" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="EquityOfferingAxis.471352">Equity Offering [Axis]</link:label>
    <link:loc xlink:label="loc_EquityOfferingDomain.85458.11.12" xlink:href="pip-20130331.xsd#pip_EquityOfferingDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOfferingDomain.85458.11.12" xlink:to="EquityOfferingDomain.471355" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="EquityOfferingDomain.471355" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="EquityOfferingDomain.471355">Equity Offering [Domain]</link:label>
    <link:loc xlink:label="loc_EquityOfferingLineItems.85461.11.12" xlink:href="pip-20130331.xsd#pip_EquityOfferingLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOfferingLineItems.85461.11.12" xlink:to="EquityOfferingLineItems.471363" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="EquityOfferingLineItems.471363" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="EquityOfferingLineItems.471363">Equity Offering [Line Items]</link:label>
    <link:loc xlink:label="loc_EquityOfferingMember.85459.11.12" xlink:href="pip-20130331.xsd#pip_EquityOfferingMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOfferingMember.85459.11.12" xlink:to="EquityOfferingMember.471358" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="EquityOfferingMember.471358" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="EquityOfferingMember.471358">Equity Offering [Member]</link:label>
    <link:loc xlink:label="loc_EquityOfferingTable.85460.11.12" xlink:href="pip-20130331.xsd#pip_EquityOfferingTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOfferingTable.85460.11.12" xlink:to="EquityOfferingTable.471361" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="EquityOfferingTable.471361" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="EquityOfferingTable.471361">Equity Offering [Table]</link:label>
    <link:loc xlink:label="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5652.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5652.11.6" xlink:to="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.735" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.735" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.735">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:label="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5652.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5652.11.7" xlink:to="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts7.514563" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts7.514563" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts7.514563">Equity offering, issuance costs</link:label>
    <link:loc xlink:label="loc_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.85463.11.6" xlink:href="pip-20130331.xsd#pip_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.85463.11.6" xlink:to="lab_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.471365" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.471365" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.471365">Commission Owed To Sales Agent Expressed As Percentage Of Aggregate Gross Proceeds From Each Sale Of Shares</link:label>
    <link:loc xlink:label="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.11.6" xlink:to="lab_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.2754" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.2754" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.2754">Common Stock, Share Subscribed but Unissued, Subscriptions Receivable</link:label>
    <link:loc xlink:label="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.11.7" xlink:to="lab_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.490096" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.490096" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.490096">Common stock - receivable</link:label>
    <link:loc xlink:label="loc_ConvertibleLongTermNotesPayable.7099.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConvertibleLongTermNotesPayable.7099.11.6" xlink:to="lab_ConvertibleLongTermNotesPayable.3110" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConvertibleLongTermNotesPayable.3110" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ConvertibleLongTermNotesPayable.3110">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:label="loc_ConvertibleLongTermNotesPayable.7099.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConvertibleLongTermNotesPayable.7099.11.7" xlink:to="lab_ConvertibleLongTermNotesPayable.470454" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConvertibleLongTermNotesPayable.470454" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ConvertibleLongTermNotesPayable.470454">Convertible note payable, cash paid</link:label>
    <link:loc xlink:label="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.11.8" xlink:to="lab_DebtInstrumentBasisSpreadOnVariableRate.150647" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentBasisSpreadOnVariableRate.150647" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentBasisSpreadOnVariableRate.150647">Loan payable, interest rate spread</link:label>
    <link:loc xlink:label="loc_DebtInstrumentCarryingAmount.7362.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentCarryingAmount.7362.11.9" xlink:to="lab_DebtInstrumentCarryingAmount.141890" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentCarryingAmount.141890" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentCarryingAmount.141890">Total</link:label>
    <link:loc xlink:label="loc_DebtInstrumentConvertibleConversionPrice1.7392.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentConvertibleConversionPrice1.7392.11.6" xlink:to="lab_DebtInstrumentConvertibleConversionPrice1.3559" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentConvertibleConversionPrice1.3559" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentConvertibleConversionPrice1.3559">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:label="loc_DebtInstrumentConvertibleConversionPrice1.7392.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentConvertibleConversionPrice1.7392.11.7" xlink:to="lab_DebtInstrumentConvertibleConversionPrice1.138546" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentConvertibleConversionPrice1.138546" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentConvertibleConversionPrice1.138546">Debt conversion, price per share</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateEffectivePercentage.7445.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateEffectivePercentage.7445.11.6" xlink:to="lab_DebtInstrumentInterestRateEffectivePercentage.3619" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateEffectivePercentage.3619" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateEffectivePercentage.3619">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateEffectivePercentage.7445.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateEffectivePercentage.7445.11.8" xlink:to="lab_DebtInstrumentInterestRateEffectivePercentage.1872697.311576" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateEffectivePercentage.1872697.311576" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateEffectivePercentage.1872697.311576">Incremental borrowing rate used to calculate discount</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateFloorPercentage.85405.11.6" xlink:href="pip-20130331.xsd#pip_DebtInstrumentInterestRateFloorPercentage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateFloorPercentage.85405.11.6" xlink:to="lab_DebtInstrumentInterestRateFloorPercentage.470444" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateFloorPercentage.470444" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateFloorPercentage.470444">Debt Instrument Interest Rate Floor Percentage</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateFloorPercentage.85405.11.7" xlink:href="pip-20130331.xsd#pip_DebtInstrumentInterestRateFloorPercentage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateFloorPercentage.85405.11.7" xlink:to="lab_DebtInstrumentInterestRateFloorPercentage.470446" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateFloorPercentage.470446" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateFloorPercentage.470446">Variable interest rate, with floor of 1.5%</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateFloorPercentage.85405.11.12" xlink:href="pip-20130331.xsd#pip_DebtInstrumentInterestRateFloorPercentage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateFloorPercentage.85405.11.12" xlink:to="lab_DebtInstrumentInterestRateFloorPercentage.470445" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateFloorPercentage.470445" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateFloorPercentage.470445">The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date, which accrues interest at a rate subject to change from time to time, however, with a floor of 1.5%.</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateStatedPercentage.7491.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateStatedPercentage.7491.11.6" xlink:to="lab_DebtInstrumentInterestRateStatedPercentage.3675" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateStatedPercentage.3675" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateStatedPercentage.3675">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:label="loc_DebtInstrumentInterestRateStatedPercentage.7491.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentInterestRateStatedPercentage.7491.11.7" xlink:to="lab_DebtInstrumentInterestRateStatedPercentage.470449" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentInterestRateStatedPercentage.470449" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentInterestRateStatedPercentage.470449">Fixed interest rate</link:label>
    <link:loc xlink:label="loc_DebtInstrumentIssuanceDate1.7367.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentIssuanceDate1.7367.11.6" xlink:to="lab_DebtInstrumentIssuanceDate1.3530" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentIssuanceDate1.3530" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentIssuanceDate1.3530">Debt Instrument, Issuance Date</link:label>
    <link:loc xlink:label="loc_DebtInstrumentLineItems.1279.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentLineItems.1279.11.6" xlink:to="lab_DebtInstrumentLineItems.3528" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentLineItems.3528" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentLineItems.3528">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:label="loc_DebtInstrumentMaturityDate.7446.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentMaturityDate.7446.11.6" xlink:to="lab_DebtInstrumentMaturityDate.3621" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentMaturityDate.3621" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentMaturityDate.3621">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:label="loc_DebtInstrumentMaturityDate.7446.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentMaturityDate.7446.11.8" xlink:to="lab_DebtInstrumentMaturityDate.137222" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentMaturityDate.137222" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentMaturityDate.137222">Debt instrument, maturity date</link:label>
    <link:loc xlink:label="loc_DebtInstrumentTable.1280.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentTable.1280.11.6" xlink:to="lab_DebtInstrumentTable.3529" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentTable.3529" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentTable.3529">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:label="loc_DebtInstrumentUnamortizedDiscount.7464.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentUnamortizedDiscount.7464.11.6" xlink:to="lab_DebtInstrumentUnamortizedDiscount.3641" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentUnamortizedDiscount.3641" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentUnamortizedDiscount.3641">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:label="loc_DebtInstrumentUnamortizedDiscount.7464.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentUnamortizedDiscount.7464.11.7" xlink:to="lab_DebtInstrumentUnamortizedDiscount.512277" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DebtInstrumentUnamortizedDiscount.512277" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DebtInstrumentUnamortizedDiscount.512277">Debt discount</link:label>
    <link:loc xlink:label="loc_EquityOfferingAxis.85456.11.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOfferingAxis.85456.11.6" xlink:to="lab_EquityOfferingAxis.471350" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityOfferingAxis.471350" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquityOfferingAxis.471350">Equity Offering [Axis]</link:label>
    <link:loc xlink:label="loc_EquityOfferingDomain.85458.11.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOfferingDomain.85458.11.6" xlink:to="lab_EquityOfferingDomain.471353" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityOfferingDomain.471353" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquityOfferingDomain.471353">Equity Offering [Domain]</link:label>
    <link:loc xlink:label="loc_EquityOfferingLineItems.85461.11.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOfferingLineItems.85461.11.6" xlink:to="lab_EquityOfferingLineItems.471362" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityOfferingLineItems.471362" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquityOfferingLineItems.471362">Equity Offering [Line Items]</link:label>
    <link:loc xlink:label="loc_EquityOfferingMember.85459.11.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOfferingMember.85459.11.6" xlink:to="lab_EquityOfferingMember.471356" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityOfferingMember.471356" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquityOfferingMember.471356">Equity Offering [Member]</link:label>
    <link:loc xlink:label="loc_EquityOfferingTable.85460.11.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOfferingTable.85460.11.6" xlink:to="lab_EquityOfferingTable.471360" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityOfferingTable.471360" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquityOfferingTable.471360">Equity Offering [Table]</link:label>
    <link:loc xlink:label="loc_FinalPaymentFeeOfTermLoanBalancePercent.85404.11.6" xlink:href="pip-20130331.xsd#pip_FinalPaymentFeeOfTermLoanBalancePercent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FinalPaymentFeeOfTermLoanBalancePercent.85404.11.6" xlink:to="lab_FinalPaymentFeeOfTermLoanBalancePercent.470441" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FinalPaymentFeeOfTermLoanBalancePercent.470441" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FinalPaymentFeeOfTermLoanBalancePercent.470441">Final Payment Fee Of Term Loan Balance Percent</link:label>
    <link:loc xlink:label="loc_FinalPaymentFeeOfTermLoanBalancePercent.85404.11.7" xlink:href="pip-20130331.xsd#pip_FinalPaymentFeeOfTermLoanBalancePercent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FinalPaymentFeeOfTermLoanBalancePercent.85404.11.7" xlink:to="lab_FinalPaymentFeeOfTermLoanBalancePercent.470443" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FinalPaymentFeeOfTermLoanBalancePercent.470443" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FinalPaymentFeeOfTermLoanBalancePercent.470443">Final payment fee payable on term loan balance, percent</link:label>
    <link:loc xlink:label="loc_FinalPaymentFeeOfTermLoanBalancePercent.85404.11.12" xlink:href="pip-20130331.xsd#pip_FinalPaymentFeeOfTermLoanBalancePercent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FinalPaymentFeeOfTermLoanBalancePercent.85404.11.12" xlink:to="lab_FinalPaymentFeeOfTermLoanBalancePercent.470442" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FinalPaymentFeeOfTermLoanBalancePercent.470442" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_FinalPaymentFeeOfTermLoanBalancePercent.470442">Final payment fee payable on term loan balance, percent.</link:label>
    <link:loc xlink:label="loc_InducedConversionOfConvertibleDebtExpense.11067.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InducedConversionOfConvertibleDebtExpense.11067.11.6" xlink:to="lab_InducedConversionOfConvertibleDebtExpense.9112" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InducedConversionOfConvertibleDebtExpense.9112" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InducedConversionOfConvertibleDebtExpense.9112">Induced Conversion of Convertible Debt Expense</link:label>
    <link:loc xlink:label="loc_InducedConversionOfConvertibleDebtExpense.11067.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InducedConversionOfConvertibleDebtExpense.11067.11.7" xlink:to="lab_InducedConversionOfConvertibleDebtExpense.470453" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InducedConversionOfConvertibleDebtExpense.470453" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_InducedConversionOfConvertibleDebtExpense.470453">Early Conversion offer expense</link:label>
    <link:loc xlink:label="loc_InterestExpenseDebt.11271.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestExpenseDebt.11271.11.6" xlink:to="lab_InterestExpenseDebt.9431" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestExpenseDebt.9431" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InterestExpenseDebt.9431">Interest Expense, Debt</link:label>
    <link:loc xlink:label="loc_InterestExpenseDebt.11271.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestExpenseDebt.11271.11.7" xlink:to="lab_InterestExpenseDebt.470455" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestExpenseDebt.470455" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_InterestExpenseDebt.470455">Interest expense related to convertible notes</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityDescription.11991.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityBorrowingCapacityDescription" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityBorrowingCapacityDescription.11991.11.6" xlink:to="lab_LineOfCreditFacilityBorrowingCapacityDescription.10562" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityBorrowingCapacityDescription.10562" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityBorrowingCapacityDescription.10562">Line of Credit Facility, Borrowing Capacity, Description</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityDescription.11991.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityBorrowingCapacityDescription" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityBorrowingCapacityDescription.11991.11.7" xlink:to="lab_LineOfCreditFacilityBorrowingCapacityDescription.470448" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityBorrowingCapacityDescription.470448" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityBorrowingCapacityDescription.470448">Line of credit borrowing capacity description</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.85398.11.6" xlink:href="pip-20130331.xsd#pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.85398.11.6" xlink:to="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.470423" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.470423" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.470423">Line Of Credit Facility Borrowing Capacity Percent Of Qualified Billed Accounts Receivable</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.85398.11.7" xlink:href="pip-20130331.xsd#pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.85398.11.7" xlink:to="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.470425" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.470425" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.470425">Line of credit facility borrowing capacity, qualified billed accounts receivable, percent</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.85398.11.12" xlink:href="pip-20130331.xsd#pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.85398.11.12" xlink:to="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.470424" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.470424" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.470424">Line Of Credit Facility Borrowing Capacity Percent Of Qualified Billed Accounts Receivable.</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.85399.11.6" xlink:href="pip-20130331.xsd#pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.85399.11.6" xlink:to="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.470426" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.470426" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.470426">Line Of Credit Facility Borrowing Capacity Percent Of Qualified Unbilled Accounts Receivabl</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.85399.11.7" xlink:href="pip-20130331.xsd#pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.85399.11.7" xlink:to="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.470428" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.470428" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.470428">Line of credit facility borrowing capacity, qualified unbilled accounts receivable, percent</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.85399.11.12" xlink:href="pip-20130331.xsd#pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.85399.11.12" xlink:to="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.470427" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.470427" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.470427">Line Of Credit Facility Borrowing Capacity Percent Of Qualified Unbilled Accounts Receivable.</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityCurrentBorrowingCapacity.11992.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityCurrentBorrowingCapacity.11992.11.6" xlink:to="lab_LineOfCreditFacilityCurrentBorrowingCapacity.10563" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityCurrentBorrowingCapacity.10563" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityCurrentBorrowingCapacity.10563">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityCurrentBorrowingCapacity.11992.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityCurrentBorrowingCapacity.11992.11.8" xlink:to="lab_LineOfCreditFacilityCurrentBorrowingCapacity.145684" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityCurrentBorrowingCapacity.145684" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityCurrentBorrowingCapacity.145684">Current borrowing capacity</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityFairValueOfAmountOutstanding.11964.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityFairValueOfAmountOutstanding.11964.11.6" xlink:to="lab_LineOfCreditFacilityFairValueOfAmountOutstanding.10531" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityFairValueOfAmountOutstanding.10531" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityFairValueOfAmountOutstanding.10531">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityFairValueOfAmountOutstanding.11964.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityFairValueOfAmountOutstanding.11964.11.8" xlink:to="lab_LineOfCreditFacilityFairValueOfAmountOutstanding.470447" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditFacilityFairValueOfAmountOutstanding.470447" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditFacilityFairValueOfAmountOutstanding.470447">Line of Credit Facility, Amount Outstanding</link:label>
    <link:loc xlink:label="loc_LineOfCreditMember.3014.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditMember.3014.11.6" xlink:to="lab_LineOfCreditMember.10553" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LineOfCreditMember.10553" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LineOfCreditMember.10553">Line of Credit [Member]</link:label>
    <link:loc xlink:label="loc_LoansPayableMember.3055.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LoansPayableMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LoansPayableMember.3055.11.6" xlink:to="lab_LoansPayableMember.10770" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LoansPayableMember.10770" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LoansPayableMember.10770">Loans Payable [Member]</link:label>
    <link:loc xlink:label="loc_LongTermDebtFairValue.12213.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtFairValue.12213.11.6" xlink:to="lab_LongTermDebtFairValue.10897" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtFairValue.10897" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtFairValue.10897">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:label="loc_LongTermDebtFairValue.12213.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtFairValue.12213.11.7" xlink:to="lab_LongTermDebtFairValue.146770" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtFairValue.146770" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtFairValue.146770">Long-term borrowings</link:label>
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.12282.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.12282.11.6" xlink:to="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.11008" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.11008" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.11008">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.12282.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.12282.11.8" xlink:to="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.1873024.311239" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.1873024.311239" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.1873024.311239">2013</link:label>
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.12271.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.12271.11.8" xlink:to="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.470450" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.470450" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.470450">2015</link:label>
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.12273.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.12273.11.8" xlink:to="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.1873025.311247" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.1873025.311247" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.1873025.311247">2014</link:label>
    <link:loc xlink:label="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipal.85400.11.6" xlink:href="pip-20130331.xsd#pip_LongTermDebtPrepaymentPremiumPercentOfPrincipal" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipal.85400.11.6" xlink:to="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipal.470429" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipal.470429" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipal.470429">Long Term Debt Prepayment Premium Percent Of Principal</link:label>
    <link:loc xlink:label="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipal.85400.11.7" xlink:href="pip-20130331.xsd#pip_LongTermDebtPrepaymentPremiumPercentOfPrincipal" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipal.85400.11.7" xlink:to="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipal.470431" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipal.470431" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipal.470431">Prepayment premium, if paid within the first two years of the term loan, percent</link:label>
    <link:loc xlink:label="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipal.85400.11.12" xlink:href="pip-20130331.xsd#pip_LongTermDebtPrepaymentPremiumPercentOfPrincipal" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipal.85400.11.12" xlink:to="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipal.470430" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipal.470430" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipal.470430">Prepayment premium, if paid within the first two years of the term loan, percent.</link:label>
    <link:loc xlink:label="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.85401.11.6" xlink:href="pip-20130331.xsd#pip_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.85401.11.6" xlink:to="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.470432" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.470432" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.470432">Long Term Debt Prepayment Premium Percent Of Principal Period Two</link:label>
    <link:loc xlink:label="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.85401.11.7" xlink:href="pip-20130331.xsd#pip_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.85401.11.7" xlink:to="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.470434" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.470434" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.470434">Prepayment premium, if paid after the first two years of the term loan, percent</link:label>
    <link:loc xlink:label="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.85401.11.12" xlink:href="pip-20130331.xsd#pip_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.85401.11.12" xlink:to="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.470433" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.470433" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.470433">Prepayment premium, if paid after the first two years of the term loan, percent.</link:label>
    <link:loc xlink:label="loc_LongtermDebtTypeAxis.2887.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongtermDebtTypeAxis.2887.11.6" xlink:to="lab_LongtermDebtTypeAxis.9963" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongtermDebtTypeAxis.9963" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongtermDebtTypeAxis.9963">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:label="loc_LongtermDebtTypeDomain.2885.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongtermDebtTypeDomain.2885.11.6" xlink:to="lab_LongtermDebtTypeDomain.9961" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongtermDebtTypeDomain.9961" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongtermDebtTypeDomain.9961">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:label="loc_MaximumValueOfStockIssuableUnderStockOffering.85462.11.6" xlink:href="pip-20130331.xsd#pip_MaximumValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumValueOfStockIssuableUnderStockOffering.85462.11.6" xlink:to="lab_MaximumValueOfStockIssuableUnderStockOffering.471364" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MaximumValueOfStockIssuableUnderStockOffering.471364" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MaximumValueOfStockIssuableUnderStockOffering.471364">Maximum Value Of Stock Issuable Under Stock Offering</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStock.14449.11.6" xlink:to="lab_ProceedsFromIssuanceOfCommonStock.14546" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOfCommonStock.14546" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOfCommonStock.14546">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStock.14449.11.7" xlink:to="lab_ProceedsFromIssuanceOfCommonStock.490089" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOfCommonStock.490089" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOfCommonStock.490089">Proceeds from issuance of common stock</link:label>
    <link:loc xlink:label="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.11.6" xlink:href="pip-20130331.xsd#pip_RemainingValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.11.6" xlink:to="lab_RemainingValueOfStockIssuableUnderStockOffering.490102" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RemainingValueOfStockIssuableUnderStockOffering.490102" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RemainingValueOfStockIssuableUnderStockOffering.490102">Remaining Value Of Stock Issuable Under Stock Offering</link:label>
    <link:loc xlink:label="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.11.12" xlink:href="pip-20130331.xsd#pip_RemainingValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.11.12" xlink:to="lab_RemainingValueOfStockIssuableUnderStockOffering12.490103" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RemainingValueOfStockIssuableUnderStockOffering12.490103" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_RemainingValueOfStockIssuableUnderStockOffering12.490103">The remaining value of common stock issuable under the controlled equity offering.</link:label>
    <link:loc xlink:label="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.11.7" xlink:href="pip-20130331.xsd#pip_RemainingValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.11.7" xlink:to="lab_RemainingValueOfStockIssuableUnderStockOffering7.490104" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RemainingValueOfStockIssuableUnderStockOffering7.490104" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RemainingValueOfStockIssuableUnderStockOffering7.490104">Amount remaining available under the arrangement</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.16635.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.16635.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.17985" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.17985" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.17985">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesNewIssues.16628.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesNewIssues.17977" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesNewIssues.17977" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesNewIssues.17977">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesNewIssues.16628.11.7" xlink:to="lab_StockIssuedDuringPeriodSharesNewIssues.490112" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesNewIssues.490112" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesNewIssues.490112">Number of shares sold</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.16610.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.16610.11.6" xlink:to="lab_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.17951" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.17951" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.17951">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:label="loc_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.85403.11.6" xlink:href="pip-20130331.xsd#pip_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.85403.11.6" xlink:to="lab_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.470438" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.470438" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.470438">Stock Issued Value Convertible Notes And Stock Purchase Warrants</link:label>
    <link:loc xlink:label="loc_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.85403.11.7" xlink:href="pip-20130331.xsd#pip_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.85403.11.7" xlink:to="lab_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.470440" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.470440" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.470440">Stock issued of convertible notes and stock purchase warrants, Value</link:label>
    <link:loc xlink:label="loc_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.85403.11.12" xlink:href="pip-20130331.xsd#pip_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.85403.11.12" xlink:to="lab_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.470439" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.470439" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.470439">Stock Issued Value Convertible Notes And Stock Purchase Warrants.</link:label>
    <link:loc xlink:label="loc_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.85402.11.6" xlink:href="pip-20130331.xsd#pip_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.85402.11.6" xlink:to="lab_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.470435" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.470435" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.470435">Warrants Issued To Purchase Common Stock In Connection To Loan Agreement</link:label>
    <link:loc xlink:label="loc_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.85402.11.7" xlink:href="pip-20130331.xsd#pip_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.85402.11.7" xlink:to="lab_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.470437" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.470437" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.470437">Warrants issued to purchase common stock, in connection to loan agreement</link:label>
    <link:loc xlink:label="loc_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.85402.11.12" xlink:href="pip-20130331.xsd#pip_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.85402.11.12" xlink:to="lab_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.470436" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.470436" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.470436">Warrants Issued To Purchase Common Stock In Connection To Loan Agreement.</link:label>
    <link:loc xlink:label="loc_MaximumValueOfStockIssuableUnderStockOffering.85462.11.7" xlink:href="pip-20130331.xsd#pip_MaximumValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumValueOfStockIssuableUnderStockOffering.85462.11.7" xlink:to="MaximumValueOfStockIssuableUnderStockOffering.471368" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="MaximumValueOfStockIssuableUnderStockOffering.471368" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="MaximumValueOfStockIssuableUnderStockOffering.471368">The maximum value of common stock issuable under the controlled equity offering</link:label>
    <link:loc xlink:label="loc_MaximumValueOfStockIssuableUnderStockOffering.85462.11.12" xlink:href="pip-20130331.xsd#pip_MaximumValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumValueOfStockIssuableUnderStockOffering.85462.11.12" xlink:to="MaximumValueOfStockIssuableUnderStockOffering.471367" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="MaximumValueOfStockIssuableUnderStockOffering.471367" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="MaximumValueOfStockIssuableUnderStockOffering.471367">The maximum value of common stock issuable under the controlled equity offering.</link:label>
    <link:loc xlink:label="loc_DebtInstrumentsMaturityDateMonthAndYear.58104.11.6" xlink:href="pip-20130331.xsd#pip_DebtInstrumentsMaturityDateMonthAndYear" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentsMaturityDateMonthAndYear.58104.11.6" xlink:to="pip_DebtInstrumentsMaturityDateMonthAndYear_lbl.267624" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_DebtInstrumentsMaturityDateMonthAndYear_lbl.267624" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="pip_DebtInstrumentsMaturityDateMonthAndYear_lbl.267624">Debt Instruments Maturity Date Month And Year</link:label>
    <link:loc xlink:label="loc_DebtInstrumentsMaturityDateMonthAndYear.58104.11.7" xlink:href="pip-20130331.xsd#pip_DebtInstrumentsMaturityDateMonthAndYear" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentsMaturityDateMonthAndYear.58104.11.7" xlink:to="pip_DebtInstrumentsMaturityDateMonthAndYear_lbl.267625" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_DebtInstrumentsMaturityDateMonthAndYear_lbl.267625" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="pip_DebtInstrumentsMaturityDateMonthAndYear_lbl.267625">Term loan and line of credit, maturity date</link:label>
    <link:loc xlink:label="loc_DebtInstrumentsMaturityDateMonthAndYear.58104.11.12" xlink:href="pip-20130331.xsd#pip_DebtInstrumentsMaturityDateMonthAndYear" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentsMaturityDateMonthAndYear.58104.11.12" xlink:to="pip_DebtInstrumentsMaturityDateMonthAndYear_lbl.267623" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="pip_DebtInstrumentsMaturityDateMonthAndYear_lbl.267623" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="pip_DebtInstrumentsMaturityDateMonthAndYear_lbl.267623">Debt Instruments Maturity Date Month and Year</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.11.6" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl.267554" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl.267554" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl.267554">Class Of Warrant Or Right Exercise Price Of Warrants Or Rights</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.11.8" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl.267556" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl.267556" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl.267556">Warrant exercise price</link:label>
    <link:loc xlink:label="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.11.6" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate_lbl.267609" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate_lbl.267609" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_DebtInstrumentBasisSpreadOnVariableRate_lbl.267609">Debt Instrument Basis Spread On Variable Rate</link:label>
    <link:loc xlink:label="loc_DebtInstrumentCarryingAmount.7362.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentCarryingAmount.7362.11.6" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl.267611" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl.267611" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_DebtInstrumentCarryingAmount_lbl.267611">Debt Instrument Carrying Amount</link:label>
    <link:loc xlink:label="loc_DebtInstrumentPaymentTerms.7453.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentPaymentTerms.7453.11.8" xlink:to="us-gaap_DebtInstrumentPaymentTerms.470456" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DebtInstrumentPaymentTerms.470456" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_DebtInstrumentPaymentTerms.470456">Term loan, payment terms</link:label>
    <link:loc xlink:label="loc_DebtInstrumentPaymentTerms.7453.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DebtInstrumentPaymentTerms.7453.11.6" xlink:to="us-gaap_DebtInstrumentPaymentTerms_lbl.267615" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl.267615" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_DebtInstrumentPaymentTerms_lbl.267615">Debt Instrument Payment Terms</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityMaximumBorrowingCapacity.11955.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityMaximumBorrowingCapacity.11955.11.6" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl.267823" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl.267823" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl.267823">Line Of Credit Facility Maximum Borrowing Capacity</link:label>
    <link:loc xlink:label="loc_LineOfCreditFacilityMaximumBorrowingCapacity.11955.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LineOfCreditFacilityMaximumBorrowingCapacity.11955.11.7" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl.267824" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl.267824" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl.267824">Line of credit facility, maximum borrowing capacity</link:label>
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.12271.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.12271.11.6" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl.267841" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl.267841" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl.267841">Long Term Debt Maturities Repayments Of Principal In Year Three</link:label>
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.12273.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.12273.11.6" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl.267843" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl.267843" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl.267843">Long Term Debt Maturities Repayments Of Principal In Year Two</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.16635.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.16635.11.7" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl.470452" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl.470452" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl.470452">Conversion of July 2009 Convertible Debt (in shares)</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.16610.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.16610.11.7" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl.470451" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl.470451" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl.470451">Conversion of July 2009 Convertible Debt</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2024.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel1Member.2024.11.7" xlink:to="FairValueInputsLevel1Member.141121" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="FairValueInputsLevel1Member.141121" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="FairValueInputsLevel1Member.141121">Level 1 [Member]</link:label>
    <link:loc xlink:label="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.11.8" xlink:to="lab_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.490097" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.490097" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.490097">Derivatives</link:label>
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.11.6" xlink:to="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.6333" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.6333" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.6333">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.11.6" xlink:to="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.6255" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.6255" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.6255">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:label="loc_FairValueByMeasurementFrequencyAxis.1887.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueByMeasurementFrequencyAxis.1887.11.6" xlink:to="lab_FairValueByMeasurementFrequencyAxis.6080" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueByMeasurementFrequencyAxis.6080" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueByMeasurementFrequencyAxis.6080">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2024.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel1Member.2024.11.6" xlink:to="lab_FairValueInputsLevel1Member.6601" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel1Member.6601" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel1Member.6601">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2026.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel2Member.2026.11.6" xlink:to="lab_FairValueInputsLevel2Member.6625" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel2Member.6625" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel2Member.6625">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2026.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel2Member.2026.11.7" xlink:to="lab_FairValueInputsLevel2Member.138285" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel2Member.138285" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel2Member.138285">Level 2 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.1917.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementFrequencyDomain.1917.11.6" xlink:to="lab_FairValueMeasurementFrequencyDomain.6232" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementFrequencyDomain.6232" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementFrequencyDomain.6232">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsRecurringMember.1906.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsRecurringMember.1906.11.6" xlink:to="lab_FairValueMeasurementsRecurringMember.6172" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementsRecurringMember.6172" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementsRecurringMember.6172">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsRecurringMember.1906.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsRecurringMember.1906.11.7" xlink:to="lab_FairValueMeasurementsRecurringMember.143475" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementsRecurringMember.143475" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementsRecurringMember.143475">Recurring [Member]</link:label>
    <link:loc xlink:label="loc_SubsequentEventLineItems.5006.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventLineItems.5006.11.6" xlink:to="lab_SubsequentEventLineItems.18100" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventLineItems.18100" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventLineItems.18100">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:label="loc_SubsequentEventMember.5009.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventMember.5009.11.6" xlink:to="lab_SubsequentEventMember.18109" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventMember.18109" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventMember.18109">Subsequent Event [Member]</link:label>
    <link:loc xlink:label="loc_SubsequentEventTable.5008.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventTable.5008.11.6" xlink:to="lab_SubsequentEventTable.18108" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventTable.18108" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventTable.18108">Subsequent Event [Table]</link:label>
    <link:loc xlink:label="loc_SubsequentEventTypeAxis.5007.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventTypeAxis.5007.11.6" xlink:to="lab_SubsequentEventTypeAxis.18104" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventTypeAxis.18104" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventTypeAxis.18104">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:label="loc_SubsequentEventTypeDomain.5005.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventTypeDomain.5005.11.6" xlink:to="lab_SubsequentEventTypeDomain.18097" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventTypeDomain.18097" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventTypeDomain.18097">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightIssuanceDate.87420.11.12" xlink:href="pip-20130331.xsd#pip_ClassOfWarrantOrRightIssuanceDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightIssuanceDate.87420.11.12" xlink:to="ClassOfWarrantOrRightIssuanceDate.490106" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ClassOfWarrantOrRightIssuanceDate.490106" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="ClassOfWarrantOrRightIssuanceDate.490106">Class Of Warrant Or Right, Issuance Date.</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.6763.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.6763.11.6" xlink:to="lab_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.2535" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.2535" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.2535">Class of Warrant or Right, Date from which Warrants or Rights Exercisable</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.6763.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.6763.11.7" xlink:to="lab_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.512276" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.512276" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.512276">Exercisable Date</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.11.51" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.11.51" xlink:to="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights51.512275" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights51.512275" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights51.512275">Exercise Price</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightIssuanceDate.87420.11.6" xlink:href="pip-20130331.xsd#pip_ClassOfWarrantOrRightIssuanceDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightIssuanceDate.87420.11.6" xlink:to="lab_ClassOfWarrantOrRightIssuanceDate.490105" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightIssuanceDate.490105" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightIssuanceDate.490105">Class Of Warrant Or Right Issuance Date</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightIssuanceDate.87420.11.7" xlink:href="pip-20130331.xsd#pip_ClassOfWarrantOrRightIssuanceDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightIssuanceDate.87420.11.7" xlink:to="lab_ClassOfWarrantOrRightIssuanceDate7.490107" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightIssuanceDate7.490107" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightIssuanceDate7.490107">Issue Date</link:label>
    <link:loc xlink:label="loc_WarrantsTransferred.961.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsTransferred.961.11.6" xlink:to="lab_ClassOfWarrantOrRightLineItems.2519" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightLineItems.2519" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightLineItems.2519">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightTable.959.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightTable.959.11.6" xlink:to="lab_ClassOfWarrantOrRightTable.2514" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightTable.2514" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightTable.2514">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:label="loc_WarrantExpirationDate.58158.11.8" xlink:href="pip-20130331.xsd#pip_WarrantExpirationDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantExpirationDate.58158.11.8" xlink:to="lab_WarrantExpirationDate8.514559" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantExpirationDate8.514559" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantExpirationDate8.514559">Expiration Date</link:label>
    <link:loc xlink:label="loc_WarrantTrancheFiveMember.90125.11.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheFiveMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheFiveMember.90125.11.6" xlink:to="lab_WarrantTrancheFiveMember.512269" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantTrancheFiveMember.512269" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantTrancheFiveMember.512269">Warrant Tranche Five [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheFiveMember.90125.11.12" xlink:href="pip-20130331.xsd#pip_WarrantTrancheFiveMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheFiveMember.90125.11.12" xlink:to="lab_WarrantTrancheFiveMember12.512270" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantTrancheFiveMember12.512270" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantTrancheFiveMember12.512270">Warrant Tranche Five [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheFourMember.90124.11.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheFourMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheFourMember.90124.11.6" xlink:to="lab_WarrantTrancheFourMember.512268" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantTrancheFourMember.512268" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantTrancheFourMember.512268">Warrant Tranche Four [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheOneMember.90121.11.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheOneMember.90121.11.6" xlink:to="lab_WarrantTrancheOneMember.512254" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantTrancheOneMember.512254" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantTrancheOneMember.512254">Warrant Tranche One [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheSevenMember.90127.11.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheSevenMember.90127.11.6" xlink:to="lab_WarrantTrancheSevenMember.512273" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantTrancheSevenMember.512273" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantTrancheSevenMember.512273">Warrant Tranche Seven [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheSevenMember.90127.11.12" xlink:href="pip-20130331.xsd#pip_WarrantTrancheSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheSevenMember.90127.11.12" xlink:to="lab_WarrantTrancheSevenMember12.512274" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantTrancheSevenMember12.512274" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantTrancheSevenMember12.512274">Warrant Tranche Seven [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheSixMember.90126.11.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheSixMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheSixMember.90126.11.6" xlink:to="lab_WarrantTrancheSixMember.512271" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantTrancheSixMember.512271" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantTrancheSixMember.512271">Warrant Tranche Six [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheSixMember.90126.11.12" xlink:href="pip-20130331.xsd#pip_WarrantTrancheSixMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheSixMember.90126.11.12" xlink:to="lab_WarrantTrancheSixMember12.512272" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantTrancheSixMember12.512272" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantTrancheSixMember12.512272">Warrant Tranche Six [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheThreeMember.90123.11.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheThreeMember.90123.11.6" xlink:to="lab_WarrantTrancheThreeMember.512260" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantTrancheThreeMember.512260" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantTrancheThreeMember.512260">Warrant Tranche Three [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheTwoMember.90122.11.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheTwoMember.90122.11.6" xlink:to="lab_WarrantTrancheTwoMember.512257" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantTrancheTwoMember.512257" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantTrancheTwoMember.512257">Warrant Tranche Two [Member]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.11.7" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl.267558" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl.267558" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl.267558">Number of Common Shares Underlying Warrants</link:label>
    <link:loc xlink:label="loc_WarrantTrancheOneMember.90121.11.12" xlink:href="pip-20130331.xsd#pip_WarrantTrancheOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheOneMember.90121.11.12" xlink:to="WarrantOneMember.150929.512256" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="WarrantOneMember.150929.512256" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="WarrantOneMember.150929.512256">Warrant One [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheOneMember.90121.11.7" xlink:href="pip-20130331.xsd#pip_WarrantTrancheOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheOneMember.90121.11.7" xlink:to="WarrantOneMember.150930.512255" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="WarrantOneMember.150930.512255" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="WarrantOneMember.150930.512255">Warrant Tranche One [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheThreeMember.90123.11.12" xlink:href="pip-20130331.xsd#pip_WarrantTrancheThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheThreeMember.90123.11.12" xlink:to="WarrantThreeMember.150935.512262" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="WarrantThreeMember.150935.512262" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="WarrantThreeMember.150935.512262">Warrant Three [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheThreeMember.90123.11.7" xlink:href="pip-20130331.xsd#pip_WarrantTrancheThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheThreeMember.90123.11.7" xlink:to="WarrantThreeMember.150936.512261" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="WarrantThreeMember.150936.512261" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="WarrantThreeMember.150936.512261">Warrant Tranche Three [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheTwoMember.90122.11.12" xlink:href="pip-20130331.xsd#pip_WarrantTrancheTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheTwoMember.90122.11.12" xlink:to="WarrantTwoMember.150932.512259" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="WarrantTwoMember.150932.512259" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="WarrantTwoMember.150932.512259">Warrant Two [Member]</link:label>
    <link:loc xlink:label="loc_WarrantTrancheTwoMember.90122.11.7" xlink:href="pip-20130331.xsd#pip_WarrantTrancheTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantTrancheTwoMember.90122.11.7" xlink:to="WarrantTwoMember.150933.512258" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="WarrantTwoMember.150933.512258" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="WarrantTwoMember.150933.512258">Warrant Tranche Two [Member]</link:label>
    <link:loc xlink:label="loc_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock.15940.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock.15940.11.6" xlink:to="lab_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock.16875" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock.16875" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock.16875">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock.15940.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock.15940.11.7" xlink:to="lab_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock7.512278" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock7.512278" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock7.512278">Summary of Warrants Outstanding</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>pip-20130331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Vintage Filings ("VF")-->
<!--produced on 2013-05-07 @ 7:02 AM-->
<link:linkbase xmlns:pip="http://www.pharmathene.com/20130331" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://www.pharmathene.com/role/DocumentAndEntityInformation" xlink:href="pip-20130331.xsd#pip-daei" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheets" xlink:href="pip-20130331.xsd#pip-ccbs" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="pip-20130331.xsd#pip-ccbsp" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="pip-20130331.xsd#pip-uccsoo" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOtherComprehensiveLoss" xlink:href="pip-20130331.xsd#pip-uccsoocl" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="pip-20130331.xsd#pip-uccsocf" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/OrganizationAndBusiness" xlink:href="pip-20130331.xsd#pip-oab" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="pip-20130331.xsd#pip-sosap" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurements" xlink:href="pip-20130331.xsd#pip-fvm" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CommitmentsAndContingencies" xlink:href="pip-20130331.xsd#pip-cac" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquity" xlink:href="pip-20130331.xsd#pip-se" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FinancingTransactions" xlink:href="pip-20130331.xsd#pip-ft" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesPolicy" xlink:href="pip-20130331.xsd#pip-sosapp" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="pip-20130331.xsd#pip-sosapt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsTables" xlink:href="pip-20130331.xsd#pip-fvmt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FinancingTransactionsTables" xlink:href="pip-20130331.xsd#pip-ftt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="pip-20130331.xsd#pip-sosapnd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfSharebasedCompensationExpenseDetails" xlink:href="pip-20130331.xsd#pip-sosapsosced" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsSummaryOfChangesInFairValueOfOurLevelThreeLiabilitiesDetails" xlink:href="pip-20130331.xsd#pip-fvmsocifvoolld" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="pip-20130331.xsd#pip-fvmnd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/CommitmentsAndContingenciesDetails" xlink:href="pip-20130331.xsd#pip-cacd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquityNarrativeDetails" xlink:href="pip-20130331.xsd#pip-send1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:href="pip-20130331.xsd#pip-uccsoop" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SubsequentEvents" xlink:href="pip-20130331.xsd#pip-se123" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FinancingTransactionsDetails" xlink:href="pip-20130331.xsd#pip-ftd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/FairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueDetails" xlink:href="pip-20130331.xsd#pip-fvmsolmafvd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/SubsequentEventsDetails" xlink:href="pip-20130331.xsd#pip-sed1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquityScheduleOfWarrantsDetails" xlink:href="pip-20130331.xsd#pip-sesowd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pharmathene.com/role/StockholdersEquityTables" xlink:href="pip-20130331.xsd#pip-set1" xlink:type="simple" />
  <link:presentationLink xlink:title="001 - Document - Document and Entity Information" xlink:role="http://www.pharmathene.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:label="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:href="pip-20130331.xsd#pip_DocumentAndEntityInformationAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DocumentType.212.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentType" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_DocumentType.212.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AmendmentFlag.144.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_AmendmentFlag.144.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DocumentPeriodEndDate.161.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_DocumentPeriodEndDate.161.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DocumentFiscalYearFocus.207.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_DocumentFiscalYearFocus.207.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DocumentFiscalPeriodFocus.208.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_DocumentFiscalPeriodFocus.208.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TradingSymbol.177.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_TradingSymbol" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_TradingSymbol.177.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EntityRegistrantName.187.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_EntityRegistrantName.187.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EntityCentralIndexKey.188.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_EntityCentralIndexKey.188.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CurrentFiscalYearEndDate.155.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_CurrentFiscalYearEndDate.155.12.7" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EntityFilerCategory.185.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_EntityFilerCategory.185.12.7" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EntityCommonStockSharesOutstanding.192.12.7" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.58115.12.7" xlink:to="loc_EntityCommonStockSharesOutstanding.192.12.7" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS" xlink:role="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:label="loc_AssetsCurrentAbstract.592.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_BilledContractReceivables.6094.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BilledContractReceivables" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_BilledContractReceivables.6094.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_UnbilledContractsReceivable.17122.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_UnbilledContractsReceivable.17122.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PrepaidExpenseAndOtherAssetsCurrent.14234.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_PrepaidExpenseAndOtherAssetsCurrent.14234.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.7" xlink:to="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15340.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AssetsCurrentAbstract.592.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AssetsCurrent.5874.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.592.12.9" xlink:to="loc_AssetsCurrent.5874.12.9" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_AssetsAbstract.595.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.7" xlink:to="loc_AssetsCurrentAbstract.592.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.14697.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.7" xlink:to="loc_PropertyPlantAndEquipmentNet.14697.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13227.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.7" xlink:to="loc_OtherAssetsNoncurrent.13227.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_Goodwill.10311.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.7" xlink:to="loc_Goodwill.10311.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AssetsAbstract.595.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_Assets.5880.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.595.12.9" xlink:to="loc_Assets.5880.12.9" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AccountsPayableCurrent.5468.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_AccountsPayableCurrent.5468.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccruedExpensesAndOtherCurrentLiabilities.58092.12.7" xlink:href="pip-20130331.xsd#pip_AccruedExpensesAndOtherCurrentLiabilities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_AccruedExpensesAndOtherCurrentLiabilities.58092.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermDebtCurrent.12288.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_LongTermDebtCurrent.12288.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShortTermBorrowings.16437.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_ShortTermBorrowings.16437.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.2935.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LiabilitiesCurrent.11668.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.9" xlink:to="loc_LiabilitiesCurrent.11668.12.9" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_DeferredRevenue.7581.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.2935.12.7" xlink:to="loc_DeferredRevenue.7581.12.7" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_LiabilitiesCurrentAbstract.2935.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherLiabilitiesNoncurrent.13448.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_OtherLiabilitiesNoncurrent.13448.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermDebtNoncurrent.12289.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_LongTermDebtNoncurrent.12289.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesNoncurrent.8124.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_DerivativeLiabilitiesNoncurrent.8124.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_Liabilities.11702.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.9" xlink:to="loc_Liabilities.11702.12.9" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_StockholdersEquityAbstract.4986.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" xlink:to="loc_StockholdersEquityAbstract.4986.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.11731.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.9" xlink:to="loc_LiabilitiesAndStockholdersEquity.11731.12.9" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_AssetsAbstract.595.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_LiabilitiesAndStockholdersEquityAbstract.2940.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockValue.6874.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.7" xlink:to="loc_CommonStockValue.6874.12.7" order="1.02000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AdditionalPaidInCapitalCommonStock.5617.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.7" xlink:to="loc_AdditionalPaidInCapitalCommonStock.5617.12.7" order="2.03000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.5579.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.7" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax.5579.12.7" order="3.04000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15457.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.7" xlink:to="loc_RetainedEarningsAccumulatedDeficit.15457.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityAbstract.4986.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquity.16667.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityAbstract.4986.12.9" xlink:to="loc_StockholdersEquity.16667.12.9" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" xlink:role="http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:label="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.6878.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_CommonStockParOrStatedValuePerShare.6878.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.6879.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_CommonStockSharesAuthorized.6879.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfFinancialPositionAbstract.4958.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockSharesIssued.6875.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.8" xlink:to="loc_CommonStockSharesIssued.6875.12.8" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.6864.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.4958.12.7" xlink:to="loc_CommonStockSharesOutstanding.6864.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" xlink:role="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:label="loc_IncomeStatementAbstract.2519.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingIncomeLoss.13080.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.9" xlink:to="loc_OperatingIncomeLoss.13080.12.9" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_IncomeStatementAbstract.2519.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ContractsRevenue.7028.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_ContractsRevenue.7028.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OperatingExpensesAbstract.3531.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_OperatingExpensesAbstract.3531.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.9" xlink:to="loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.10659.12.9" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.9" xlink:to="loc_NetIncomeLoss.12771.12.9" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_EarningsPerShareBasicAndDiluted.8698.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_EarningsPerShareBasicAndDiluted.8698.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17395.12.7" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeStatementAbstract.2519.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CurrentIncomeTaxExpenseBenefit.7281.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.42" xlink:to="loc_CurrentIncomeTaxExpenseBenefit.7281.12.42" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_InvestmentIncomeInterest.11436.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" xlink:to="loc_InvestmentIncomeInterest.11436.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpenseAbstract.3452.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_InterestExpense.11178.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.42" xlink:to="loc_InterestExpense.11178.12.42" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpenseAbstract.3452.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.58133.12.8" xlink:href="pip-20130331.xsd#pip_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.8" xlink:to="loc_OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation.58133.12.8" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" xlink:to="loc_UnrealizedGainLossOnDerivatives.17162.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherNonoperatingIncomeExpense.13446.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" xlink:to="loc_OtherNonoperatingIncomeExpense.13446.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpenseAbstract.3452.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.12898.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.9" xlink:to="loc_NonoperatingIncomeExpense.12898.12.9" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_GainLossOnDispositionOfAssets.10190.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonoperatingIncomeExpenseAbstract.3452.12.7" xlink:to="loc_GainLossOnDispositionOfAssets.10190.12.7" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15293.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingExpensesAbstract.3531.12.7" xlink:to="loc_ResearchAndDevelopmentExpense.15293.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10284.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingExpensesAbstract.3531.12.7" xlink:to="loc_GeneralAndAdministrativeExpense.10284.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OperatingExpensesAbstract.3531.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingExpenses.13060.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingExpensesAbstract.3531.12.9" xlink:to="loc_OperatingExpenses.13060.12.9" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingExpensesAbstract.3531.12.7" xlink:to="loc_DepreciationAndAmortization.8044.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE LOSS" xlink:role="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.3648.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.13305.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.3648.12.7" xlink:to="loc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.13305.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.12.7" xlink:to="loc_NetIncomeLoss.12771.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.12.7" xlink:to="loc_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract.3648.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13148.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.4960.12.9" xlink:to="loc_OtherComprehensiveIncomeLossNetOfTax.13148.12.9" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" xlink:role="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.42" xlink:to="loc_UnrealizedGainLossOnDerivatives.17162.12.42" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DepreciationAndAmortization.8044.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.8" xlink:to="loc_DepreciationAndAmortization.8044.12.8" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.42" xlink:to="loc_GainLossOnSaleOfPropertyPlantEquipment.10196.12.42" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensation.16244.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" xlink:to="loc_ShareBasedCompensation.16244.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DeferredIncomeTaxExpenseBenefit.7621.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" xlink:to="loc_DeferredIncomeTaxExpenseBenefit.7621.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PaidInKindInterest.13591.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaidInKindInterest" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" xlink:to="loc_PaidInKindInterest.13591.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" xlink:to="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.10853.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.42" xlink:to="loc_IncreaseDecreaseInAccountsReceivable.10853.12.42" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInUnbilledReceivables.11010.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.42" xlink:to="loc_IncreaseDecreaseInUnbilledReceivables.11010.12.42" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.42" xlink:to="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.10932.12.42" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayable.10805.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.7" xlink:to="loc_IncreaseDecreaseInAccountsPayable.10805.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.10775.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.7" xlink:to="loc_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.10775.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.10850.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncreaseDecreaseInOperatingCapitalAbstract.2616.12.7" xlink:to="loc_IncreaseDecreaseInDeferredRevenue.10850.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfLongTermDebtAndWarrants.58140.12.7" xlink:href="pip-20130331.xsd#pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromIssuanceOfLongTermDebtAndWarrants.58140.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfLinesOfCredit.14422.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromRepaymentsOfLinesOfCredit.14422.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_PaymentsOfFinancingCosts.13844.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.42" xlink:to="loc_PaymentsOfFinancingCosts.13844.12.42" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities.14388.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStockAndWarrants.58138.12.7" xlink:href="pip-20130331.xsd#pip_ProceedsFromIssuanceOfCommonStockAndWarrants" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromIssuanceOfCommonStockAndWarrants.58138.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromPaymentsForOtherFinancingActivities.14363.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromPaymentsForOtherFinancingActivities.14363.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivities.12740.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.9" xlink:to="loc_NetCashProvidedByUsedInFinancingActivities.12740.12.9" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14449.12.7" order="5.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PaymentsOfStockIssuanceCosts.13770.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.42" xlink:to="loc_PaymentsOfStockIssuanceCosts.13770.12.42" order="3.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_PaymentsToAcquirePropertyPlantAndEquipment.13779.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.42" xlink:to="loc_PaymentsToAcquirePropertyPlantAndEquipment.13779.12.42" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.7" xlink:to="loc_ProceedsFromSaleOfPropertyPlantAndEquipment.14507.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivities.12731.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.9" xlink:to="loc_NetCashProvidedByUsedInInvestingActivities.12731.12.9" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetIncomeLoss.12771.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.8" xlink:to="loc_NetIncomeLoss.12771.12.8" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.7" xlink:to="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.480.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivities.12778.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.9" xlink:to="loc_NetCashProvidedByUsedInOperatingActivities.12778.12.9" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3386.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3385.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3365.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EffectOfExchangeRateOnCashAndCashEquivalents.8714.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_EffectOfExchangeRateOnCashAndCashEquivalents.8714.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.9" xlink:to="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6589.12.9" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.10" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.10" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.4955.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.11" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6556.12.11" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_SupplementalCashFlowInformationAbstract.5043.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_SupplementalCashFlowInformationAbstract.5043.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NonCashFinancingActivityAbstract.58131.12.7" xlink:href="pip-20130331.xsd#pip_NonCashFinancingActivityAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.4955.12.7" xlink:to="loc_NonCashFinancingActivityAbstract.58131.12.7" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_InterestPaid.11342.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestPaid" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5043.12.7" xlink:to="loc_InterestPaid.11342.12.7" order="1.02000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.7483.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5043.12.7" xlink:to="loc_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.7483.12.7" order="2.02000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.12.7" xlink:href="pip-20130331.xsd#pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NonCashFinancingActivityAbstract.58131.12.7" xlink:to="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.12.7" order="1.39000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="101 - Disclosure - Organization and Business" xlink:role="http://www.pharmathene.com/role/OrganizationAndBusiness" xlink:type="extended">
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13128.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract.3564.12.7" xlink:to="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13128.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="102 - Disclosure - Summary of Significant Accounting Policies" xlink:role="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTextBlock.16463.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_SignificantAccountingPoliciesTextBlock.16463.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="103 - Disclosure - Fair Value Measurements" xlink:role="http://www.pharmathene.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.1951.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueDisclosuresTextBlock.9267.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.1951.12.7" xlink:to="loc_FairValueDisclosuresTextBlock.9267.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="104 - Disclosure - Commitments and Contingencies" xlink:role="http://www.pharmathene.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract.1025.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureTextBlock.6838.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract.1025.12.7" xlink:to="loc_CommitmentsAndContingenciesDisclosureTextBlock.6838.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="105 - Disclosure - Stockholders' Equity" xlink:role="http://www.pharmathene.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.4988.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquityNoteDisclosureTextBlock.16673.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.4988.12.7" xlink:to="loc_StockholdersEquityNoteDisclosureTextBlock.16673.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="106 - Disclosure - Financing Transactions" xlink:role="http://www.pharmathene.com/role/FinancingTransactions" xlink:type="extended">
    <link:loc xlink:label="loc_DebtDisclosureAbstract.1283.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AdditionalFinancialInformationDisclosureTextBlock.5621.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_AdditionalFinancialInformationDisclosureTextBlock.5621.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="202 - Disclosure - Summary of Significant Accounting Policies (Policy)" xlink:role="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesPolicy" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock.6085.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_UseOfEstimates.17234.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_UseOfEstimates.17234.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10010.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10010.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsPolicyTextBlock.6571.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_CashAndCashEquivalentsPolicyTextBlock.6571.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtPolicyTextBlock.7444.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_DebtPolicyTextBlock.7444.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RevenueRecognitionPolicyTextBlock.15515.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_RevenueRecognitionPolicyTextBlock.15515.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16373.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16373.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeTaxPolicyTextBlock.10751.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_IncomeTaxPolicyTextBlock.10751.12.7" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EarningsPerSharePolicyTextBlock.8704.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_EarningsPerSharePolicyTextBlock.8704.12.7" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.12785.12.7" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MajorCustomersPolicyPolicyTextBlock.12409.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_MajorCustomersPolicyPolicyTextBlock.12409.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ComprehensiveIncomePolicyPolicyTextBlock.6916.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_ComprehensiveIncomePolicyPolicyTextBlock.6916.12.7" order="5.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GoodwillAndIntangibleAssetsGoodwillPolicy.10327.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_GoodwillAndIntangibleAssetsGoodwillPolicy.10327.12.7" order="8.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="302 - Disclosure - Summary of Significant Accounting Policies (Tables)" xlink:role="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.15869.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="303 - Disclosure - Fair Value Measurements (Tables)" xlink:role="http://www.pharmathene.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.1951.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock.15773.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.1951.12.7" xlink:to="loc_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock.15773.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.1951.12.7" xlink:to="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock.9490.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.9256.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.1951.12.7" xlink:to="loc_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock.9256.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.1951.12.7" xlink:to="loc_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock.15717.12.7" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="306 - Disclosure - Financing Transactions (Tables)" xlink:role="http://www.pharmathene.com/role/FinancingTransactionsTables" xlink:type="extended">
    <link:loc xlink:label="loc_DebtDisclosureAbstract.1283.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.15767.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock.15767.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfDebtTableTextBlock.15760.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.7" xlink:to="loc_ScheduleOfDebtTableTextBlock.15760.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)" xlink:role="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTable.58150.12.7" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_SignificantAccountingPoliciesTable.58150.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAxis.872.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CashAndCashEquivalentsAxis.872.12.6" xlink:to="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4187.12.6" xlink:to="loc_RangeMember.4188.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4188.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MaximumMember.3241.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4188.12.7" xlink:to="loc_MaximumMember.3241.12.7" order="1.15000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" />
    <link:loc xlink:label="loc_LiquidityArrangementsMember.58129.12.7" xlink:href="pip-20130331.xsd#pip_LiquidityArrangementsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember.4413.12.7" xlink:to="loc_LiquidityArrangementsMember.58129.12.7" order="1.14000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SignificantAccountingPoliciesLineItems.58149.12.7" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_NumberOfOperatingSegments.12967.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.12.7" xlink:to="loc_NumberOfOperatingSegments.12967.12.7" order="1.02000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CashEquivalentsMaturityPeriod.58094.12.7" xlink:href="pip-20130331.xsd#pip_CashEquivalentsMaturityPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.12.7" xlink:to="loc_CashEquivalentsMaturityPeriod.58094.12.7" order="3.04000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CostOfReimbursableExpense.7169.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostOfReimbursableExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.12.7" xlink:to="loc_CostOfReimbursableExpense.7169.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.58147.12.7" xlink:href="pip-20130331.xsd#pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate.58147.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.12.7" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.8820.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.12.7" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.8813.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeTaxExpenseBenefit.10688.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.12.7" xlink:to="loc_IncomeTaxExpenseBenefit.10688.12.7" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.12.7" xlink:to="loc_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.5816.12.7" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesLineItems.58149.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.16275.12.7" order="7.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTable.58150.12.6" xlink:href="pip-20130331.xsd#pip_SignificantAccountingPoliciesTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesTable.58150.12.6" xlink:to="loc_CashAndCashEquivalentsAxis.872.12.6" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4187.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesTable.58150.12.7" xlink:to="loc_RangeAxis.4187.12.7" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_SignificantAccountingPoliciesTable.58150.12.7" xlink:to="loc_SignificantAccountingPoliciesLineItems.58149.12.7" order="100.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40202 - Disclosure - Summary of Significant Accounting Policies (Schedule of Share-based Compensation Expense) (Details)" xlink:role="http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.385.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.385.12.7" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5724.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.12.7" xlink:to="loc_AllocatedShareBasedCompensationExpense.5724.12.7" order="1.04000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4381.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.12.7" xlink:to="loc_ResearchAndDevelopmentExpenseMember.4381.12.7" order="1.02000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2354.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.12.7" xlink:to="loc_GeneralAndAdministrativeExpenseMember.2354.12.7" order="1.03000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.12.7" xlink:to="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain.1715.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.12.7" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis.4617.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4618.12.7" xlink:to="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1710.12.7" order="100.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40302 - Disclosure - Fair Value Measurements (Summary of Changes in Fair Value of Our Level 3 Liabilities) (Details)" xlink:role="http://www.pharmathene.com/role/FairValueMeasurementsSummaryOfChangesInFairValueOfOurLevelThreeLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.7" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:to="loc_FairValueInputsLevel3Member.2022.12.7" order="1.02000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.1951.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.1951.12.6" xlink:to="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.12.10" xlink:to="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.12.10" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.12.8" xlink:to="loc_UnrealizedGainLossOnDerivatives.17162.12.8" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.12.11" xlink:to="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.12.11" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.12.7" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FinancialInstrumentAxis.2133.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.12.7" xlink:to="loc_FinancialInstrumentAxis.2133.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable.2044.12.7" xlink:to="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems.2039.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FinancialInstrumentAxis.2133.12.7" xlink:to="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantMember.5342.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.12.7" xlink:to="loc_WarrantMember.5342.12.7" order="1.03000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40303 - Disclosure - Fair Value Measurements (Narrative) (Details)" xlink:role="http://www.pharmathene.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.7" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueByLiabilityClassAxis.1897.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueByLiabilityClassAxis.1897.12.7" xlink:to="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesMember.58105.12.7" xlink:href="pip-20130331.xsd#pip_DerivativeLiabilitiesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain.1929.12.7" xlink:to="loc_DerivativeLiabilitiesMember.58105.12.7" order="1.04000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:to="loc_FairValueInputsLevel3Member.2022.12.7" order="1.06000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.1951.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsTable.58118.12.7" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.1951.12.7" xlink:to="loc_FairValueMeasurementsTable.58118.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FinancialInstrumentAxis.2133.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FinancialInstrumentAxis.2133.12.7" xlink:to="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantMember.5342.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain.5144.12.7" xlink:to="loc_WarrantMember.5342.12.7" order="1.05000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueMeasurementsLineItems.58117.12.7" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightOutstanding.6757.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsLineItems.58117.12.7" xlink:to="loc_ClassOfWarrantOrRightOutstanding.6757.12.7" order="1.01000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueMeasurementsLineItems.58117.12.42" xlink:href="pip-20130331.xsd#pip_FairValueMeasurementsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_UnrealizedGainLossOnDerivatives.17162.12.42" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsLineItems.58117.12.42" xlink:to="loc_UnrealizedGainLossOnDerivatives.17162.12.42" order="2.02000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_SharePrice.16294.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsLineItems.58117.12.7" xlink:to="loc_SharePrice.16294.12.7" order="3.02000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsTable.58118.12.7" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.7" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsTable.58118.12.7" xlink:to="loc_FinancialInstrumentAxis.2133.12.7" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsTable.58118.12.7" xlink:to="loc_FairValueByLiabilityClassAxis.1897.12.7" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsTable.58118.12.7" xlink:to="loc_FairValueMeasurementsLineItems.58117.12.7" order="100.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40401 - Disclosure - Commitments and Contingencies (Details)" xlink:role="http://www.pharmathene.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended">
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract.1025.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CommitmentAndContingenciesTable.58096.12.7" xlink:href="pip-20130331.xsd#pip_CommitmentAndContingenciesTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract.1025.12.7" xlink:to="loc_CommitmentAndContingenciesTable.58096.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LossContingenciesByNatureOfContingencyAxis.3139.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_LossContingencyNatureDomain.3148.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LossContingenciesByNatureOfContingencyAxis.3139.12.7" xlink:to="loc_LossContingencyNatureDomain.3148.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GroupThreeMember.58122.12.7" xlink:href="pip-20130331.xsd#pip_GroupThreeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LossContingencyNatureDomain.3148.12.7" xlink:to="loc_GroupThreeMember.58122.12.7" order="1.12000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GroupFourMember.58120.12.7" xlink:href="pip-20130331.xsd#pip_GroupFourMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LossContingencyNatureDomain.3148.12.7" xlink:to="loc_GroupFourMember.58120.12.7" order="1.13000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RangeAxis.4187.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4188.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4187.12.7" xlink:to="loc_RangeMember.4188.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MaximumMember.3241.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4188.12.7" xlink:to="loc_MaximumMember.3241.12.7" order="1.10000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SegmentDomain.4780.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SegmentDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_PharmAtheneMember.58137.12.7" xlink:href="pip-20130331.xsd#pip_PharmAtheneMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SegmentDomain.4780.12.7" xlink:to="loc_PharmAtheneMember.58137.12.7" order="1.09000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementBusinessSegmentsAxis.4956.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementBusinessSegmentsAxis.4956.12.7" xlink:to="loc_SegmentDomain.4780.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_CommitmentAndContingenciesTable.58096.12.7" xlink:to="loc_StatementBusinessSegmentsAxis.4956.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_CommitmentAndContingenciesTable.58096.12.7" xlink:to="loc_LossContingenciesByNatureOfContingencyAxis.3139.12.7" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_CommitmentAndContingenciesTable.58096.12.7" xlink:to="loc_RangeAxis.4187.12.7" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommitmentsAndContingenciesLineItems.58097.12.7" xlink:href="pip-20130331.xsd#pip_CommitmentsAndContingenciesLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentAndContingenciesTable.58096.12.7" xlink:to="loc_CommitmentsAndContingenciesLineItems.58097.12.7" order="100.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PercentageOfNetProfitAwarded.58135.12.7" xlink:href="pip-20130331.xsd#pip_PercentageOfNetProfitAwarded" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.12.7" xlink:to="loc_PercentageOfNetProfitAwarded.58135.12.7" order="1.02000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_BreachOfContractualCommitmentAwardPeriod.58093.12.7" xlink:href="pip-20130331.xsd#pip_BreachOfContractualCommitmentAwardPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.12.7" xlink:to="loc_BreachOfContractualCommitmentAwardPeriod.58093.12.7" order="2.03000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.58130.12.7" xlink:href="pip-20130331.xsd#pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.12.7" xlink:to="loc_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract.58130.12.7" order="3.04000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CourtAwardedFees.58099.12.7" xlink:href="pip-20130331.xsd#pip_CourtAwardedFees" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.12.7" xlink:to="loc_CourtAwardedFees.58099.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantExpirationDate.58158.12.7" xlink:href="pip-20130331.xsd#pip_WarrantExpirationDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.12.7" xlink:to="loc_WarrantExpirationDate.58158.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PercentageOfAggregatePrincipalAmountRedemption.58134.12.7" xlink:href="pip-20130331.xsd#pip_PercentageOfAggregatePrincipalAmountRedemption" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.12.7" xlink:to="loc_PercentageOfAggregatePrincipalAmountRedemption.58134.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NotesPayableAggregatePrincipalRepaymentAmount.58132.12.7" xlink:href="pip-20130331.xsd#pip_NotesPayableAggregatePrincipalRepaymentAmount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesLineItems.58097.12.7" xlink:to="loc_NotesPayableAggregatePrincipalRepaymentAmount.58132.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40501 - Disclosure - Stockholders' Equity (Narrative) (Details)" xlink:role="http://www.pharmathene.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_GroupOneMember.58121.12.7" xlink:href="pip-20130331.xsd#pip_GroupOneMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.12.7" xlink:to="loc_GroupOneMember.58121.12.7" order="1.10000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GroupTwoMember.58123.12.7" xlink:href="pip-20130331.xsd#pip_GroupTwoMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.12.7" xlink:to="loc_GroupTwoMember.58123.12.7" order="2.11000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.967.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightAxis.967.12.7" xlink:to="loc_ClassOfWarrantOrRightDomain.964.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PlanNameDomain.3870.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIncentivePlanTwentyZeroSevenMember.58153.12.7" xlink:href="pip-20130331.xsd#pip_StockIncentivePlanTwentyZeroSevenMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PlanNameDomain.3870.12.7" xlink:to="loc_StockIncentivePlanTwentyZeroSevenMember.58153.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PlanNameAxis.3871.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PlanNameAxis.3871.12.7" xlink:to="loc_PlanNameDomain.3870.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.4988.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquityTable.58152.12.7" xlink:href="pip-20130331.xsd#pip_StockholdersEquityTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.4988.12.7" xlink:to="loc_StockholdersEquityTable.58152.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityLineItems.58151.12.7" xlink:href="pip-20130331.xsd#pip_StockholdersEquityLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockCapitalSharesReservedForFutureIssuance.6881.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityLineItems.58151.12.7" xlink:to="loc_CommonStockCapitalSharesReservedForFutureIssuance.6881.12.7" order="1.02000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockOptionsContractualTerm.58154.12.7" xlink:href="pip-20130331.xsd#pip_StockOptionsContractualTerm" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityLineItems.58151.12.7" xlink:to="loc_StockOptionsContractualTerm.58154.12.7" order="4.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityLineItems.58151.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16337.12.7" order="3.04000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityLineItems.58151.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16333.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityLineItems.58151.12.8" xlink:href="pip-20130331.xsd#pip_StockholdersEquityLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityLineItems.58151.12.8" xlink:to="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.12.8" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityLineItems.58151.12.8" xlink:to="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.12.8" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_WarrantExpirationDate.58158.12.7" xlink:href="pip-20130331.xsd#pip_WarrantExpirationDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityLineItems.58151.12.7" xlink:to="loc_WarrantExpirationDate.58158.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.12.7" xlink:href="pip-20130331.xsd#pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityLineItems.58151.12.7" xlink:to="loc_SupplementalWarrantIssuedInConnectionWithLongTermDebt.58155.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StockholdersEquityTable.58152.12.7" xlink:to="loc_ClassOfWarrantOrRightAxis.967.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StockholdersEquityTable.58152.12.7" xlink:to="loc_StockholdersEquityLineItems.58151.12.7" order="100.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StockholdersEquityTable.58152.12.7" xlink:to="loc_PlanNameAxis.3871.12.7" order="10.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)" xlink:role="http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="extended">
    <link:loc xlink:label="loc_IncomeStatementAbstract.2519.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.10593.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2519.12.7" xlink:to="loc_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill.10593.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="107 - Disclosure - Subsequent Events" xlink:role="http://www.pharmathene.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:label="loc_SubsequentEventsAbstract.5004.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventsTextBlock.16697.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventsAbstract.5004.12.7" xlink:to="loc_SubsequentEventsTextBlock.16697.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40601 - Disclosure - Financing Transactions (Details)" xlink:role="http://www.pharmathene.com/role/FinancingTransactionsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DebtInstrumentLineItems.1279.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_LineOfCreditFacilityMaximumBorrowingCapacity.11955.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_LineOfCreditFacilityMaximumBorrowingCapacity.11955.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentLineItems.1279.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_LineOfCreditFacilityCurrentBorrowingCapacity.11992.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.8" xlink:to="loc_LineOfCreditFacilityCurrentBorrowingCapacity.11992.12.8" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_LineOfCreditFacilityFairValueOfAmountOutstanding.11964.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.8" xlink:to="loc_LineOfCreditFacilityFairValueOfAmountOutstanding.11964.12.8" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityDescription.11991.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditFacilityBorrowingCapacityDescription" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_LineOfCreditFacilityBorrowingCapacityDescription.11991.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.85398.12.7" xlink:href="pip-20130331.xsd#pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable.85398.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.85399.12.7" xlink:href="pip-20130331.xsd#pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl.85399.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentInterestRateStatedPercentage.7491.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_DebtInstrumentInterestRateStatedPercentage.7491.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.8" xlink:to="loc_DebtInstrumentBasisSpreadOnVariableRate.7414.12.8" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentMaturityDate.7446.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.8" xlink:to="loc_DebtInstrumentMaturityDate.7446.12.8" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentInterestRateEffectivePercentage.7445.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.8" xlink:to="loc_DebtInstrumentInterestRateEffectivePercentage.7445.12.8" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentLineItems.1279.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DebtInstrumentIssuanceDate1.7367.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.6" xlink:to="loc_DebtInstrumentIssuanceDate1.7367.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.12282.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.8" xlink:to="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.12282.12.8" order="14.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.12273.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.8" xlink:to="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo.12273.12.8" order="15.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.12271.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.8" xlink:to="loc_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.12271.12.8" order="16.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipal.85400.12.7" xlink:href="pip-20130331.xsd#pip_LongTermDebtPrepaymentPremiumPercentOfPrincipal" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipal.85400.12.7" order="18.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.85401.12.7" xlink:href="pip-20130331.xsd#pip_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo.85401.12.7" order="19.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.85402.12.7" xlink:href="pip-20130331.xsd#pip_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement.85402.12.7" order="21.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.8" xlink:to="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.12.8" order="22.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.85403.12.7" xlink:href="pip-20130331.xsd#pip_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_StockIssuedValueConvertibleNotesAndStockPurchaseWarrants.85403.12.7" order="23.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.16610.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.16610.12.7" order="24.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.16635.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities.16635.12.7" order="25.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentConvertibleConversionPrice1.7392.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_DebtInstrumentConvertibleConversionPrice1.7392.12.7" order="26.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_InducedConversionOfConvertibleDebtExpense.11067.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InducedConversionOfConvertibleDebtExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_InducedConversionOfConvertibleDebtExpense.11067.12.7" order="27.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ConvertibleLongTermNotesPayable.7099.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_ConvertibleLongTermNotesPayable.7099.12.7" order="28.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_InterestExpenseDebt.11271.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_InterestExpenseDebt.11271.12.7" order="29.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermDebtCurrent.12288.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_LongTermDebtCurrent.12288.12.7" order="30.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermDebtNoncurrent.12289.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_LongTermDebtNoncurrent.12289.12.7" order="31.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermDebtFairValue.12213.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_LongTermDebtFairValue.12213.12.7" order="32.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FinalPaymentFeeOfTermLoanBalancePercent.85404.12.7" xlink:href="pip-20130331.xsd#pip_FinalPaymentFeeOfTermLoanBalancePercent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_FinalPaymentFeeOfTermLoanBalancePercent.85404.12.7" order="20.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentInterestRateFloorPercentage.85405.12.7" xlink:href="pip-20130331.xsd#pip_DebtInstrumentInterestRateFloorPercentage" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_DebtInstrumentInterestRateFloorPercentage.85405.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentLineItems.1279.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DebtInstrumentCarryingAmount.7362.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.9" xlink:to="loc_DebtInstrumentCarryingAmount.7362.12.9" order="16.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_DebtInstrumentPaymentTerms.7453.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.8" xlink:to="loc_DebtInstrumentPaymentTerms.7453.12.8" order="5.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentsMaturityDateMonthAndYear.58104.12.7" xlink:href="pip-20130331.xsd#pip_DebtInstrumentsMaturityDateMonthAndYear" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_DebtInstrumentsMaturityDateMonthAndYear.58104.12.7" order="6.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentUnamortizedDiscount.7464.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentLineItems.1279.12.7" xlink:to="loc_DebtInstrumentUnamortizedDiscount.7464.12.7" order="29.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DebtInstrumentTable.1280.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentTable.1280.12.6" xlink:to="loc_DebtInstrumentLineItems.1279.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_LongtermDebtTypeAxis.2887.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtInstrumentTable.1280.12.6" xlink:to="loc_LongtermDebtTypeAxis.2887.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DebtDisclosureAbstract.1283.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.6" xlink:to="loc_DebtInstrumentTable.1280.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingTable.85460.12.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DebtDisclosureAbstract.1283.12.6" xlink:to="loc_EquityOfferingTable.85460.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_LongtermDebtTypeDomain.2885.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_LineOfCreditMember.3014.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LineOfCreditMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongtermDebtTypeDomain.2885.12.6" xlink:to="loc_LineOfCreditMember.3014.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_LoansPayableMember.3055.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LoansPayableMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongtermDebtTypeDomain.2885.12.6" xlink:to="loc_LoansPayableMember.3055.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_LongtermDebtTypeAxis.2887.12.6" xlink:to="loc_LongtermDebtTypeDomain.2885.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingAxis.85456.12.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityOfferingDomain.85458.12.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityOfferingAxis.85456.12.6" xlink:to="loc_EquityOfferingDomain.85458.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingMember.85459.12.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityOfferingDomain.85458.12.6" xlink:to="loc_EquityOfferingMember.85459.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_EquityOfferingTable.85460.12.6" xlink:to="loc_EquityOfferingAxis.85456.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingLineItems.85461.12.6" xlink:href="pip-20130331.xsd#pip_EquityOfferingLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityOfferingTable.85460.12.6" xlink:to="loc_EquityOfferingLineItems.85461.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOfferingLineItems.85461.12.7" xlink:href="pip-20130331.xsd#pip_EquityOfferingLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_MaximumValueOfStockIssuableUnderStockOffering.85462.12.7" xlink:href="pip-20130331.xsd#pip_MaximumValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityOfferingLineItems.85461.12.7" xlink:to="loc_MaximumValueOfStockIssuableUnderStockOffering.85462.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.85463.12.7" xlink:href="pip-20130331.xsd#pip_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityOfferingLineItems.85461.12.7" xlink:to="loc_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares.85463.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityOfferingLineItems.85461.12.7" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14449.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityOfferingLineItems.85461.12.7" xlink:to="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.12.7" xlink:href="pip-20130331.xsd#pip_RemainingValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityOfferingLineItems.85461.12.7" xlink:to="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityOfferingLineItems.85461.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16628.12.7" order="5.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5652.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityOfferingLineItems.85461.12.7" xlink:to="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5652.12.7" order="3.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40301 - Disclosure - Fair Value Measurements (Schedule of Liabilities Measured at Fair Value) (Details)" xlink:role="http://www.pharmathene.com/role/FairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueByMeasurementFrequencyAxis.1887.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.1917.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueByMeasurementFrequencyAxis.1887.12.6" xlink:to="loc_FairValueMeasurementFrequencyDomain.1917.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.1917.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsRecurringMember.1906.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementFrequencyDomain.1917.12.7" xlink:to="loc_FairValueMeasurementsRecurringMember.1906.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.12.6" xlink:to="loc_FairValueByMeasurementFrequencyAxis.1887.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.12.6" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis.1894.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.12.6" xlink:to="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.12.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2024.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:to="loc_FairValueInputsLevel1Member.2024.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2026.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:to="loc_FairValueInputsLevel2Member.2026.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2022.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.1937.12.7" xlink:to="loc_FairValueInputsLevel3Member.2022.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.1949.12.8" xlink:to="loc_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure.8102.12.8" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.1951.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.1951.12.6" xlink:to="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.1924.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40701 - Disclosure - Subsequent Events (Details)" xlink:role="http://www.pharmathene.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_SubsequentEventsAbstract.5004.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventTable.5008.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventsAbstract.5004.12.6" xlink:to="loc_SubsequentEventTable.5008.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventTypeDomain.5005.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventMember.5009.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventTypeDomain.5005.12.6" xlink:to="loc_SubsequentEventMember.5009.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventLineItems.5006.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16628.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventLineItems.5006.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16628.12.7" order="4.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.12.7" xlink:href="pip-20130331.xsd#pip_RemainingValueOfStockIssuableUnderStockOffering" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventLineItems.5006.12.7" xlink:to="loc_RemainingValueOfStockIssuableUnderStockOffering.87419.12.7" order="5.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventLineItems.5006.12.7" xlink:to="loc_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable.6888.12.7" order="6.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14449.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventLineItems.5006.12.7" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14449.12.7" order="7.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SubsequentEventTypeAxis.5007.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventTypeAxis.5007.12.6" xlink:to="loc_SubsequentEventTypeDomain.5005.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_SubsequentEventTable.5008.12.6" xlink:to="loc_SubsequentEventTypeAxis.5007.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventLineItems.5006.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventTable.5008.12.6" xlink:to="loc_SubsequentEventLineItems.5006.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40502 - Disclosure - Stockholders' Equity (Schedule of Warrants) (Details)" xlink:role="http://www.pharmathene.com/role/StockholdersEquityScheduleOfWarrantsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_ClassOfWarrantOrRightTable.959.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.967.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightTable.959.12.6" xlink:to="loc_ClassOfWarrantOrRightAxis.967.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantsTransferred.961.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightTable.959.12.6" xlink:to="loc_WarrantsTransferred.961.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantsTransferred.961.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsTransferred.961.12.7" xlink:to="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.6765.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightIssuanceDate.87420.12.7" xlink:href="pip-20130331.xsd#pip_ClassOfWarrantOrRightIssuanceDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsTransferred.961.12.7" xlink:to="loc_ClassOfWarrantOrRightIssuanceDate.87420.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.6763.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsTransferred.961.12.7" xlink:to="loc_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable.6763.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsTransferred.961.12.51" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.12.51" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsTransferred.961.12.51" xlink:to="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights.6764.12.51" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel" />
    <link:loc xlink:label="loc_WarrantsTransferred.961.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_WarrantExpirationDate.58158.12.8" xlink:href="pip-20130331.xsd#pip_WarrantExpirationDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsTransferred.961.12.8" xlink:to="loc_WarrantExpirationDate.58158.12.8" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_WarrantTrancheOneMember.90121.12.7" xlink:href="pip-20130331.xsd#pip_WarrantTrancheOneMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.12.7" xlink:to="loc_WarrantTrancheOneMember.90121.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantTrancheTwoMember.90122.12.7" xlink:href="pip-20130331.xsd#pip_WarrantTrancheTwoMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.12.7" xlink:to="loc_WarrantTrancheTwoMember.90122.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantTrancheThreeMember.90123.12.7" xlink:href="pip-20130331.xsd#pip_WarrantTrancheThreeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.12.7" xlink:to="loc_WarrantTrancheThreeMember.90123.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.964.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_WarrantTrancheFourMember.90124.12.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheFourMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.12.6" xlink:to="loc_WarrantTrancheFourMember.90124.12.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantTrancheFiveMember.90125.12.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheFiveMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.12.6" xlink:to="loc_WarrantTrancheFiveMember.90125.12.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantTrancheSixMember.90126.12.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheSixMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.12.6" xlink:to="loc_WarrantTrancheSixMember.90126.12.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantTrancheSevenMember.90127.12.6" xlink:href="pip-20130331.xsd#pip_WarrantTrancheSevenMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.964.12.6" xlink:to="loc_WarrantTrancheSevenMember.90127.12.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightAxis.967.12.6" xlink:to="loc_ClassOfWarrantOrRightDomain.964.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.4988.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.4988.12.6" xlink:to="loc_ClassOfWarrantOrRightTable.959.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="305 - Disclosure - Stockholders' Equity (Tables)" xlink:role="http://www.pharmathene.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.4988.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock.15940.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.4988.12.7" xlink:to="loc_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock.15940.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ECNAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stockholders' Equity (Narrative) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="3">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2009</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>2007 Long Term Incentive Plan [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008

</div>
          <div>2007 Long Term Incentive Plan [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007

</div>
          <div>2007 Long Term Incentive Plan [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>Expiration 2015 [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>Expiration 2017 [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_StockholdersEquityLineItems', window );"><strong>Stockholders Equity [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,600,000<span></span></td>
        <td class="nump">3,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares approved for issuance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available to be issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_StockOptionsContractualTerm', window );">Options award term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase shares of common stock</a></td>
        <td class="nump">46,584<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,620,128<span></span></td>
        <td class="nump">5,620,128<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,572,775<span></span></td>
        <td class="nump">100,778<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrant exercise price</a></td>
        <td class="nump">1.61<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2.50<span></span></td>
        <td class="nump">3.97<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_WarrantExpirationDate', window );">Warrant expiration date</a></td>
        <td class="text">Mar. 30,
         2022<span></span></td>
        <td class="text">Jan. 28,
         2015<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jan. 28,
         2015<span></span></td>
        <td class="text">Mar. 30,
         2017<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt', window );">Value of warrants issued to lender in connection with loan</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 69,876<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_StockholdersEquityLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_StockholdersEquityLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_StockOptionsContractualTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock Options Contractual Term</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_StockOptionsContractualTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Supplemental warrant issued in connection with long-term debt</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_WarrantExpirationDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrant, Expiration Date</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_WarrantExpirationDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exercise price of each class of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The specified number of securities that each class of warrants or rights outstanding give the holder the right but not the obligation to purchase from the issuer at a specific price, on or before a certain date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate number of common shares reserved for future issuance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Note 3 - Fair Value Measurements</strong></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We report assets and liabilities that are measured at fair value using a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 18px">&nbsp;</td> <td style="FONT: 10pt Symbol; WIDTH: 18px">&middot;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">Level 1 - Quoted prices in active markets for identical assets or liabilities.</td> </tr> </table> <p style="TEXT-INDENT: 1.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 18px">&nbsp;</td> <td style="FONT: 10pt Symbol; WIDTH: 18px">&middot;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</td> </tr> </table> <p style="TEXT-INDENT: 1.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 18px">&nbsp;</td> <td style="FONT: 10pt Symbol; WIDTH: 18px">&middot;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> An asset&#39;s or liability&#39;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. At each reporting period, we perform a detailed analysis of our assets and liabilities that are measured at fair value. All assets and liabilities for which the fair value measurement is based on significant unobservable inputs or instruments which trade infrequently and therefore have little or no price transparency are classified as Level 3.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We have segregated our financial assets and liabilities that are measured at fair value into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date in the table below. We have no non-financial assets and liabilities that are measured at fair value on a recurring basis. As of March 31, 2013 and 2012 we had Level 3 derivative liabilities of approximately $2.2 million and $2.9 million, respectively.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table represents the Company&#39;s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis:</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="14">As of March 31, 2013</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 1</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 2</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 3</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Balance</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Liabilities</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 44%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Derivatives instruments</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> -</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> -</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2,201,390</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2,201,390</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="14">As of December 31, 2012</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 1</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 2</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 3</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Balance</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Liabilities</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 44%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Derivatives instruments</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> -</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> -</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1,295,613</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1,295,613</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table sets forth a summary of changes in the fair value of the Company&#39;s Level 3 liabilities for the three months ended March 31, 2013:</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif"> Description</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Balance as of<br /> December 31,<br /> 2012</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Unrealized Losses</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Balance as of<br /> March 31,<br /> 2013</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="WIDTH: 58%; FONT-SIZE: 10pt">&nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Derivative liabilities related to stock purchase warrants</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 1,295,613</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 905,777</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 2,201,390</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table sets forth a summary of changes in the fair value of the Company&#39;s Level 3 liabilities for the three months ended March 31, 2012:</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT: 10pt Times New Roman, Times, Serif"> Description</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Balance as of<br /> December 31,<br /> 2011</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Unrealized Losses</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Balance as of<br /> March 31,<br /> 2012</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="WIDTH: 58%; FONT-SIZE: 10pt">&nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Derivative liabilities related to stock purchase warrants</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 1,886,652</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 991,662</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 2,878,314</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> At March 31, 2013 and 2012, derivative liabilities are comprised of warrants to purchase 2,899,991 shares of common stock. The warrants are considered to be derivative liabilities due to the presence of net settlement features and, as a result, are recorded at fair value at each balance sheet date, with changes in fair value recorded in the unaudited condensed consolidated statements of operations. The fair value of our warrants is determined based on the Black-Scholes option pricing model. Use of the Black-Scholes option pricing model requires the use of unobservable inputs such as the expected term, anticipated volatility and expected dividends.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="7">Quantitative Information about Level 3 Fair Value Measurements</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Fair Value at 3/31/2013</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Valuation Technique</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Unobservable Inputs</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 20%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2,201,390</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 42%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Black-Scholes option pricing model</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 32%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Expected term</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Expected dividends</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Anticipated volatility</td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Changes in any of the assumptions related to the unobservable inputs identified above may change the stock purchase warrants&#39; fair value; increases in expected term, anticipated volatility and expected dividends generally result in increases in fair value, while decreases in the unobservable inputs generally result in decreases in fair value. Gains and losses on the fair value adjustments for these derivative instruments are classified in other expenses as the change in fair value of derivative instruments in our unaudited condensed consolidated statements of operations. The $0.9 million change in the market value of derivative instruments during the three-month period ended March 31, 2013 is due primarily to the change in the closing price of PharmAthene stock, which was $1.12 per share as of December 31, 2012 and $1.70 per share as of March 28, 2013. The $1.0 million change in the market value of derivative instruments during the three-month period ended March 31, 2012 is due primarily to the change in the closing price of PharmAthene stock, which was $1.27 per share as of December 30, 2011 and $1.77 per share as of March 30, 2012.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Assets Measured at Fair Value on a Nonrecurring Basis</em></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company measures its long-lived assets, including, property and equipment and goodwill, at fair value on a nonrecurring basis. These assets are recognized at fair value when they are deemed to be other-than-temporarily impaired. (see Note 2). As of March 31, 2013, the Company had no other assets or liabilities that were measured at fair value on a nonrecurring basis.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13504-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 15C, 15D<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 133<br><br> -Paragraph 44A, 44B<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 15A<br><br> -Subparagraph a-d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 3, 10, 14, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13433-108611<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 159<br><br> -Paragraph 17-22, 27, 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13537-108611<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 15B<br><br> -Subparagraph a, b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 157<br><br> -Paragraph 32, 33, 34<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19207-110258<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 30<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
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M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].1$5.4T5$7T-/
M3E-/3$E$051%1%]"04Q!3D-%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0T].1$5.4T5$7T-/3E-/3$E$051%1%]"04Q!3D-%,3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970P,RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E5.055$251%
M1%]#3TY$14Y3141?0T].4T],241!5#PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P-"YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/E5.055$251%1%]#3TY$14Y3141?0T].4T],241!
M5#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,#4N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y53D%5
M1$E4141?0T].1$5.4T5$7T-/3E-/3$E$050R/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^3W)G86YI>F%T:6]N7V%N9%]"=7-I;F5S
M<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970P-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-U;6UA
M<GE?;V9?4VEG;FEF:6-A;G1?06-C;W5N=#PO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P."YH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/D9A:7)?5F%L=65?365A<W5R96UE;G1S/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`Y+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]M;6ET;65N
M='-?86YD7T-O;G1I;F=E;F-I97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3`N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y3=&]C:VAO;&1E<G-?17%U:71Y/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#$Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^1FEN86YC:6YG7U1R86YS86-T
M:6]N<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970Q,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-U
M8G-E<75E;G1?179E;G1S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$S+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^4W5M;6%R>5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT,3PO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970Q-"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-U;6UA<GE?;V9?
M4VEG;FEF:6-A;G1?06-C;W5N=#(\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,34N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y&86ER7U9A;'5E7TUE87-U<F5M96YT<U]486)L97,\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,38N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=&]C:VAO
M;&1E<G-?17%U:71Y7U1A8FQE<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/D9I;F%N8VEN9U]4<F%N<V%C=&EO;G-?5&%B;&5S/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#$X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4W5M;6%R>5]O
M9E]3:6=N:69I8V%N=%]!8V-O=6YT,SPO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q.2YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/E-U;6UA<GE?;V9?4VEG;FEF:6-A;G1?06-C;W5N
M=#0\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,C`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y&86ER
M7U9A;'5E7TUE87-U<F5M96YT<U]38VAE9'4\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C$N:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y&86ER7U9A;'5E7TUE87-U<F5M96YT<U]3
M=6UM87(\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,C(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y&
M86ER7U9A;'5E7TUE87-U<F5M96YT<U].87)R870\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C,N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#;VUM:71M96YT<U]A;F1?0V]N=&EN
M9V5N8VEE<U\\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,C0N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y3=&]C:VAO;&1E<G-?17%U:71Y7TYA<G)A=&EV95\\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M,C4N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=&]C:VAO;&1E<G-?17%U:71Y
M7U-C:&5D=6QE7V\\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,C8N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y&:6YA;F-I;F=?5')A;G-A8W1I;VYS7T1E=&%I;',\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,C<N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=6)S97%U96YT7T5V96YT
M<U]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#(X+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@/"]X.D5X8V5L5V]R:W-H965T<SX-"B`@/'@Z4W1Y
M;&5S:&5E="!(4F5F/3-$(E=O<FMS:&5E=',O<F5P;W)T+F-S<R(O/@T*("`\
M>#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0<F]T96-T
M4W1R=6-T=7)E/D9A;'-E/"]X.E!R;W1E8W13=')U8W1U<F4^#0H@(#QX.E!R
M;W1E8W17:6YD;W=S/D9A;'-E/"]X.E!R;W1E8W17:6YD;W=S/@T*(#PO>#I%
M>&-E;%=O<FMB;V]K/@T*/"]X;6P^/"%;96YD:69=+2T^#0H\+VAE860^#0H@
M(#QB;V1Y/@T*("`@/'`^5&AI<R!P86=E('-H;W5L9"!B92!O<&5N960@=VET
M:"!-:6-R;W-O9G0@17AC96P@6%`@;W(@;F5W97(N/"]P/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y-6)?-60S-U\T
M-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V.%]A-#EB7S(R9&4P9#%B9#=C-2]7
M;W)K<VAE971S+U-H965T,#$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4Q0T%%/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/D1O8W5M96YT(&%N9"!%;G1I='D@26YF;W)M871I
M;VX\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q
M,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87D@,#(L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^1&]C=6UE;G0@86YD($5N=&ET>2!);F9O<FUA=&EO;B!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O
M8W5M96YT(%1Y<&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C$P
M+5$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D%M96YD;65N="!&;&%G/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#YF86QS93QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1&]C=6UE;G0@4&5R:6]D($5N9"!$871E/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#Y-87(@,S$L#0H)"3(P,3,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M
M96YT($9I<V-A;"!996%R($9O8W5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y$;V-U;65N="!&:7-C86P@4&5R:6]D($9O8W5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y1,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5')A9&EN9R!3>6UB
M;VP\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/E!)4#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y
M(%)E9VES=')A;G0@3F%M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^4$A!4DU!5$A%3D4L($E.0SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y($-E;G1R86P@26YD97@@2V5Y
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XP,#`Q,S(V,3DP/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M=7)R96YT($9I<V-A;"!996%R($5N9"!$871E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XM+3$R+3,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@1FEL97(@0V%T96=O<GD\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/D%C8V5L97)A=&5D($9I
M;&5R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%;G1I='D@0V]M;6]N(%-T;V-K+"!3:&%R97,@3W5T<W1A;F1I;F<\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0Y+#0V,"PV.#8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V$V,3=A.35B
M7S5D,S=?-#8V.%]A-#EB7S(R9&4P9#%B9#=C-0T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B]A-C$W83DU8E\U9#,W7S0V-CA?830Y8E\R,F1E,&0Q
M8F0W8S4O5V]R:W-H965T<R]3:&5E=#`R+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%445!1SX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#3TY$14Y3140@0T].4T],241!5$5$
M($)!3$%.0T4@4TA%1513("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-U<G)E;G0@
M87-S971S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$R+#@W,RPT,3$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$R+#<P,2PU,3<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C
M8V]U;G1S(')E8V5I=F%B;&4@*&)I;&QE9"D\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L.#8U+#DQ-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-#,R+#8T,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^56YB:6QL960@86-C
M;W5N=',@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,RPW,3,L-SDW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-"PQ,30L-#0R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&5X<&5N<V5S(&%N9"!O
M=&AE<B!C=7)R96YT(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-C$T+#,X.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4T-RPR-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!C=7)R96YT(&%S<V5T<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DL,#8W+#4Q,CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Y+#<Y
M-2PX-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!R;W!E<G1Y(&%N9"!E<75I<&UE;G0L(&YE=#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#4V+#@T,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0X,RPY-S8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R(&QO
M;F<M=&5R;2!A<W-E=',@86YD(&1E9F5R<F5D(&-O<W1S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XY.2PU-S@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3,L,3,P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y';V]D=VEL;#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPS-#@L-#4S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPS-#@L
M-#4S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5&]T86P@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,2PY-S(L,S@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C(L-S0Q+#0P-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#=7)R96YT(&QI
M86)I;&ET:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y!8V-O=6YT<R!P87EA8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#(X.2PV,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#8Y-RPR.#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@97AP96YS
M97,@86YD(&]T:&5R(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#(Y-"PS,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR+#,R."PX-S<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E9F5R<F5D(')E=F5N
M=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@W-"PT,#0\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,X
M,2PW-34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-U<G)E;G0@<&]R=&EO;B!O9B!L;VYG+71E<FT@9&5B=#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3DY+#DY-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<T.2PY.3<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H
M;W)T+71E<FT@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PS,CDL,C,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PS,S`L-3`W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@8W5R<F5N="!L:6%B:6QI=&EE
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPW.#<L-3<U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPT
M.#@L-#$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y/=&AE<B!L;VYG+71E<FT@;&EA8FEL:71I97,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4X,"PR,S@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-SDL-#(W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG+71E
M<FT@9&5B="P@;&5S<R!C=7)R96YT('!O<G1I;VX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L-#8P+#0Q-SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-S`T+#$P.#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV
M92!I;G-T<G5M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,BPR,#$L,SDP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PR.34L-C$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@;&EA8FEL:71I97,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#`R.2PV,C`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,2PP-C<L-38T
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/E-T;V-K:&]L9&5R<R<@97%U:71Y.CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL("0P
M+C`P,#$@<&%R('9A;'5E.R`Q,#`L,#`P+#`P,"!S:&%R97,@875T:&]R:7IE
M9#L@-#@L-#$V+#0X,R!A;F0@-#@L,S4R+#8U,2!S:&%R97,@:7-S=65D(&%N
M9"!O=71S=&%N9&EN9R!A="!-87)C:"`S,2P@,C`Q,R!A;F0@1&5C96UB97(@
M,S$L(#(P,3(L(')E<W!E8W1I=F5L>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-"PX-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XT+#@S-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^061D:71I;VYA;"!P86ED+6EN+6-A<&ET
M86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Q,"PX-S<L.#DR
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,C$P+#0Y-2PY,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D%C8W5M=6QA=&5D(&]T:&5R(&-O;7!R96AE;G-I=F4@
M;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C$Y+#`Q,BD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R
M,3<L,S(X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^06-C=6UU;&%T960@9&5F:6-I=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,C`P+#<R,"PY-3<I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3DX+#8P.2PU-S(I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T
M86P@<W1O8VMH;VQD97)S)R!E<75I='D\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/CDL.30R+#<V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$Q+#8W,RPX-#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!L:6%B:6QI
M=&EE<R!A;F0@<W1O8VMH;VQD97)S)R!E<75I='D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,C$L.3<R+#,X-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C(L-S0Q+#0P-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y-6)?
M-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V.%]A-#EB7S(R9&4P9#%B
M9#=C-2]7;W)K<VAE971S+U-H965T,#,N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4V1D%#/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D-/3D1%3E-%1"!#3TY33TQ)1$%4140@
M0D%,04Y#12!32$5%5%,@*%!A<F5N=&AE=&EC86PI("A54T0@)"D\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@
M,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D-/3D1%3E-%1"!#3TY33TQ)1$%4140@0D%,04Y#12!32$5%5%,@
M6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('!A<B!V86QU93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`P,#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`P,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T
M;V-K+"!S:&%R97,@875T:&]R:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3`P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,#`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K
M+"!S:&%R97,@:7-S=65D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT."PT,38L-#@S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-#@L,S4R+#8U,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!S:&%R97,@
M;W5T<W1A;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0X
M+#0Q-BPT.#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT."PS-3(L-C4Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
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M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P15E3044^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M54Y!541)5$5$($-/3D1%3E-%1"!#3TY33TQ)1$%4140@4U1!5$5-14Y44R!/
M1B!/4$52051)3TY3("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E5.055$251%1"!#3TY$14Y3140@
M0T].4T],241!5$5$(%-4051%345.5%,@3T8@3U!%4D%424].4R!;06)S=')A
M8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-O;G1R86-T(')E=F5N=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-BPT-S4L,3,X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`V+#$T.2PP-3(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3W!E<F%T:6YG
M(&5X<&5N<V5S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y297-E87)C:"!A;F0@9&5V96QO<&UE;G0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C4L,C,S+#0W-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L-S`U+#,U-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V5N97)A
M;"!A;F0@861M:6YI<W1R871I=F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(L,C<Y+#<Y-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(L.30X+#0X,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5P<F5C:6%T:6]N(&%N9"!A
M;6]R=&EZ871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4R
M+#8P,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C@U+#DQ,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E1O=&%L(&]P97)A=&EN9R!E>'!E;G-E<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPU-C4L.#<R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPW,SDL-S0X/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3&]S<R!F<F]M(&]P97)A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#$L,#DP+#<S-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@Q+#4Y,"PV.38I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]T:&5R(&EN
M8V]M92`H97AP96YS92DZ/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DEN=&5R97-T(&EN8V]M93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-S@S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,BPY.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T(&5X<&5N<V4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DY+#<Y,2D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#`R."D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T
M:&5R(&EN8V]M92`H97AP96YS92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#8L,3(S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4R+#DQ-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0VAA;F=E(&EN(&9A:7(@=F%L=64@;V8@
M9&5R:79A=&EV92!I;G-T<G5M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH.3`U+#<W-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@Y.3$L-C8R*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&]T:&5R(&EN8V]M
M92`H97AP96YS92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L
M,#$P+#DP."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Y,S@L-S@W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S(&)E9F]R92!I;F-O;64@=&%X
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L,3`Q+#8T,BD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R
M+#4R.2PT.#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y);F-O;64@=&%X(&5X<&5N<V4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#DL-S0S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#$U,"PT,#4I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPQ,3$L,S@U*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPV
M-SDL.#@X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0F%S:6,@86YD(&1I;'5T960@;F5T(&QO<W,@<&5R('-H87)E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,#0I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C`V
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5V5I9VAT960@879E<F%G92!S:&%R97,@=7-E9"!I;B!C86QC=6QA=&EO
M;B!O9B!B87-I8R!A;F0@9&EL=71E9"!N970@;&]S<R!P97(@<VAA<F4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0X+#,U.2PQ.#$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT."PR-CDL
M.#DT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M149&04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^54Y!541)5$5$($-/3D1%
M3E-%1"!#3TY33TQ)1$%4140@4U1!5$5-14Y44R!/1B!/5$A%4B!#3TU04D5(
M14Y3259%($Q/4U,@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^54Y!541)5$5$($-/3D1%3E-%1"!#
M3TY33TQ)1$%4140@4U1!5$5-14Y44R!/1B!/5$A%4B!#3TU04D5(14Y3259%
M($Q/4U,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.970@3&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XD("@R+#$Q,2PS.#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@R+#8W.2PX.#@I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]T
M:&5R(&-O;7!R96AE;G-I=F4@:6YC;VUE("AL;W-S*3H\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG;B!C=7)R96YC
M>2!T<F%N<VQA=&EO;B!A9&IU<W1M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q+#8X-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,RPS-CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUP<F5H96YS:79E(&QO<W,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPQ,3,L,#8Y*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M,BPV-C8L-3$Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?838Q-V$Y-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V
M.%]A-#EB7S(R9&4P9#%B9#=C-2]7;W)K<VAE971S+U-H965T,#8N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$4U5T%'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E5.055$251%
M1"!#3TY$14Y3140@0T].4T],241!5$5$(%-4051%345.5%,@3T8@0T%32"!&
M3$]74R`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^36%R+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY/<&5R871I;F<@86-T:79I=&EE<SPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R+#$Q,2PS.#4I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R
M+#8W.2PX.#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D%D:G5S=&UE;G1S('1O(')E8V]N8VEL92!N
M970@;&]S<R!T;R!N970@8V%S:"!U<V5D(&EN(&]P97)A=&EN9R!A8W1I=FET
M:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#:&%N9V4@:6X@9F%I<B!V86QU92!O9B!D97)I=F%T:79E(&EN<W1R=6UE
M;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,#4L-S<W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3DQ
M+#8V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX@97AP96YS93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3(L-C`R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#4L.3$P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'
M86EN(&]N('1H92!D:7-P;W-A;"!O9B!P<F]P97)T>2!A;F0@97%U:7!M96YT
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V
M-BPV,C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y$969E<G)E9"!I;F-O;64@=&%X(&5X<&5N<V5S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+#<T,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U,"PT,#4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO;BUC87-H
M(&EN=&5R97-T(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C,R+#0S,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F4M8F%S960@8V]M<&5N<V%T
M:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,R
M."PU.#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XU-#@L-C8T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-H86YG97,@:6X@;W!E<F%T:6YG(&%S
M<V5T<R!A;F0@;&EA8FEL:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U;G1S(')E8V5I=F%B;&4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4V-BPW,C4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#(W."PP-C(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5N
M8FEL;&5D(&%C8V]U;G1S(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0P,"PV-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@Q+#(U-"PX-C<I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&5X<&5N
M<V5S(&%N9"!O=&AE<B!C=7)R96YT(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,SDL-#@V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3,W+#,V,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C;W5N=',@<&%Y86)L
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#`W+#8U,RD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S-2PR
M.#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!8V-R=65D(&5X<&5N<V5S(&%N9"!O=&AE<B!L:6%B:6QI=&EE<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.34P+#@P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S,2PS,S@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D1E9F5R<F5D(')E=F5N=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#4P-RPS-3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-#DU+#,W,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@8V%S:"!P<F]V:61E9"!B>2!O
M<&5R871I;F<@86-T:79I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C8P+#0P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C<Y,2PS-S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^26YV97-T:6YG(&%C=&EV
M:71I97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4'5R8VAA<V4@;V8@<')O<&5R='D@86YD(&5Q=6EP;65N=#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C4L-#8X*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4')O8V5E9',@9G)O;2!T:&4@<V%L92!O9B!P<F]P97)T>2!A;F0@97%U:7!M
M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XV-RPT,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y.970@8V%S:"!P<F]V:61E9"`H=7-E9"D@8GD@:6YV97-T
M:6YG(&%C=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(U+#0V."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XV-RPT,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1FEN86YC:6YG(&%C=&EV:71I97,\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M8V5E9',@9G)O;2!I<W-U86YC92!O9B!L;VYG+71E<FT@9&5B=#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPU,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.970@*')E<&%Y;65N="!O9BD@<')O8V5E9',@9G)O;2!R979O;'9I;F<@
M8W)E9&ET(&%G<F5E;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,2PR-S0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.#4W+#@P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1&5F97)R960@9FEN86YC:6YG(&-O<W1S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,C`L
M,C,T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V]N=')O;&QE9"!E<75I='D@;V9F97)I;F<@:7-S=6%N8V4@8V]S
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$Q,BPU,#`I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#:&%N9V4@:6X@<F5S=')I8W1E9"!C87-H(')E<75I<F5M
M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!I<W-U86YC92!O9B!C;VUM;VX@
M<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4S+#0Q,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W1H97(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#,R+#DV,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@8V%S:"`H=7-E9"D@<')O
M=FED960@8GD@9FEN86YC:6YG(&%C=&EV:71I97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#8P+#,V,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#(P-"PV,30\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5F9F5C=',@;V8@
M97AC:&%N9V4@<F%T97,@;VX@8V%S:#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,BPV-S@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-"PP,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);F-R96%S97,@:6X@8V%S:"!A;F0@
M8V%S:"!E<75I=F%L96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3<Q+#@Y-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0L,#8W+#0Q.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT
M<RP@870@8F5G:6YN:6YG(&]F('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3(L-S`Q+#4Q-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q+#(S-BPW-S$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@86YD(&-A
M<V@@97%U:79A;&5N=',L(&%T(&5N9"!O9B!P97)I;V0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$R+#@W,RPT,3$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PS,#0L,3@Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E-U<'!L96UE;G1A;"!D:7-C;&]S=7)E(&]F(&-A<V@@9FQO=R!I;F9O
M<FUA=&EO;CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#87-H('!A:60@9F]R(&EN=&5R97-T/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XV-RPS-C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS+#`R.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;VYC87-H(&9I
M;F%N8VEN9R!A8W1I=FET:65S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E9A;'5E(&]F('=A<G)A;G1S(&ES<W5E9"!T;R!L
M96YD97(@:6X@8V]N;F5C=&EO;B!W:71H(&QO86X\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-CDL.#<V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
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M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/D]R9V%N:7IA=&EO;B!A;F0@0G5S:6YE<W,\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY/
M<F=A;FEZ871I;VX@86YD($)U<VEN97-S(%M!8G-T<F%C=%T\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W)G86YI>F%T:6]N
M(&%N9"!"=7-I;F5S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N
M,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT
M;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I
M=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`\<W1R;VYG/DYO=&4@,2`M($]R9V%N:7IA=&EO;B!A;F0@0G5S:6YE
M<W,\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I
M;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
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M=&AI<F0@<&%R=&EE<RX\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-
M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B!(:7-T;W)I8V%L;'DL('=E(&AA=F4@<&5R9F]R;65D
M('5N9&5R(&=O=F5R;FUE;G0@8V]N=')A8W1S(&%N9"!G<F%N=',@86YD(')A
M:7-E9"!F=6YD<R!F<F]M(&EN=F5S=&]R<R!T;R!S=7-T86EN(&]U<B!O<&5R
M871I;VYS+CPO<#X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y
M-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V.%]A-#EB7S(R9&4P
M9#%B9#=C-2]7;W)K<VAE971S+U-H965T,#@N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT
M($%C8V]U;G1I;F<@4&]L:6-I97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT
M($%C8V]U;G1I;F<@4&]L:6-I97,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F(%-I9VYI
M9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O
M+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N
M=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B
M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@<W1Y;&4]
M,T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@/'-T<F]N9SY.;W1E(#(@+2!3=6UM87)Y(&]F
M(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,\+W-T<F]N9SX\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@
M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\96T^
M0F%S:7,@;V8@4')E<V5N=&%T:6]N/"]E;3X\+W`^(#QP('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\
M<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
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M(%-T871E<R`H(E4N4RX@1T%!4"(I+B!);B!T:&4@;W!I;FEO;B!O9B!M86YA
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M9"!C;VYS;VQI9&%T960@8F%L86YC92!S:&5E="!A="!$96-E;6)E<B`S,2P@
M,C`Q,B!H87,@8F5E;B!D97)I=F5D(&9R;VT@875D:71E9"!C;VYS;VQI9&%T
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M9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$R+"!F:6QE9"!W
M:71H('1H92!396-U<FET:65S(&%N9"!%>&-H86YG92!#;VUM:7-S:6]N+B!7
M92!C=7)R96YT;'D@;W!E<F%T92!I;B!O;F4@8G5S:6YE<W,@<V5G;65N="X\
M+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@
M<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/&5M/E5S92!O9B!%<W1I;6%T97,\
M+V5M/CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T
M(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^(%1H92!P<F5P87)A=&EO;B!O9B!F:6YA;F-I86P@<W1A=&5M96YT<R!I
M;B!C;VYF;W)M:71Y('=I=&@@52Y3+B!'04%0(')E<75I<F5S(&UA;F%G96UE
M;G0@=&\@;6%K92!E<W1I;6%T97,@86YD(&%S<W5M<'1I;VYS('1H870@869F
M96-T('1H92!R97!O<G1E9"!A;6]U;G1S(&]F(&%S<V5T<R!A;F0@;&EA8FEL
M:71I97,L(&1I<V-L;W-U<F4@;V8@8V]N=&EN9V5N="!A<W-E=',@86YD(&QI
M86)I;&ET:65S(&%T('1H92!D871E(&]F('1H92!F:6YA;F-I86P@<W1A=&5M
M96YT<RP@86YD('1H92!R97!O<G1E9"!A;6]U;G1S(&]F(')E=F5N=65S(&%N
M9"!E>'!E;G-E<R!D=7)I;F<@=&AE(')E<&]R=&EN9R!P97)I;V0N($]U<B!U
M;F%U9&ET960@8V]N9&5N<V5D(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A
M=&5M96YT<R!I;F-L=61E('-I9VYI9FEC86YT(&5S=&EM871E<R!F;W(@=&AE
M(&5X<&5C=&5D(&5C;VYO;6EC(&QI9F4@86YD('9A;'5E(&]F(&]U<B!I;G1A
M;F=I8FQE(&%S<V5T<RP@=&AE(&%M;W5N="!O9B!O=7(@;F5T(&]P97)A=&EN
M9R!L;W-S97,L(&]U<B!S:&%R92UB87-E9"!C;VUP96YS871I;VXL('1H92!V
M86QU92!O9B!O=7(@9FEN86YC:6%L(&EN<W1R=6UE;G1S+"!A;6]N9R!O=&AE
M<B!T:&EN9W,N($)E8V%U<V4@;V8@=&AE('5S92!O9B!E<W1I;6%T97,@:6YH
M97)E;G0@:6X@=&AE(&9I;F%N8VEA;"!R97!O<G1I;F<@<')O8V5S<RP@86-T
M=6%L(')E<W5L=',@8V]U;&0@9&EF9F5R('-I9VYI9FEC86YT;'D@9G)O;2!T
M:&]S92!E<W1I;6%T97,\9F]N="!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXN/"]F;VYT/CPO<#X@/'`@<W1Y
M;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-
M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B`\96T^1F]R96EG;B!#=7)R96YC>2!4<F%N<VQA=&EO
M;CPO96T^/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!
M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
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M<&5R:6]D+B`\9F]N="!S='EL93TS1"=#3TQ/4CH@8FQA8VLG/E1R86YS;&%T
M:6]N(&%D:G5S=&UE;G1S(&9O<B!S=6)S:61I87)I97,@=&AA="!H879E(&YO
M="!B965N('-O;&0L('-U8G-T86YT:6%L;'D@;&EQ=6ED871E9"!O<B!O=&AE
M<G=I<V4@9&ES<&]S960@;V8L(&%R92!A8V-U;75L871E9"!I;B!O=&AE<B!C
M;VUP<F5H96YS:79E(&EN8V]M92`H;&]S<RDL(&$@8V]M<&]N96YT(&]F('-T
M;V-K:&]L9&5R<R8C,SD[(&5Q=6ET>2X\+V9O;G0^($9O<F5I9VX@8W5R<F5N
M8WD@=')A;G-L871I;VX@861J=7-T;65N=',@87)E('1H92!S;VQE(&-O;7!O
M;F5N="!O9B!A8V-U;75L871E9"!O=&AE<B!C;VUP<F5H96YS:79E(&QO<W,@
M870@36%R8V@@,S$L(#(P,3,@86YD($1E8V5M8F5R(#,Q+"`R,#$R+B`\9F]N
M="!S='EL93TS1"=#3TQ/4CH@8FQA8VLG/E1R86YS86-T:6]N(&=A:6YS(&]R
M(&QO<W-E<R!A<F4@:6YC;'5D960@:6X@=&AE(&1E=&5R;6EN871I;VX@;V8@
M;F5T(&QO<W,N/"]F;VYT/CPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@
M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\96T^
M0V]M<')E:&5N<VEV92!,;W-S(&%N9"!!8V-U;75L871E9"!/=&AE<B!#;VUP
M<F5H96YS:79E($EN8V]M93PO96T^/"]P/B`\<"!S='EL93TS1"=-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
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M<G0@=&5R;2!A=F%I;&%B;&4M9F]R+7-A;&4@:6YV97-T;65N=',N/"]P/B`\
M<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE
M/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^(#QE;3Y#87-H(&%N9"!#87-H($5Q=6EV86QE
M;G1S/"]E;3X\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B!#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S(&%R92!S=&%T960@
M870@;6%R:V5T('9A;'5E+B!792!C;VYS:61E<B!A;&P@:&EG:&QY(&QI<75I
M9"!I;G9E<W1M96YT<R!W:71H(&]R:6=I;F%L(&UA='5R:71I97,@;V8@=&AR
M964@;6]N=&AS(&]R(&QE<W,@=&\@8F4@8V%S:"!E<75I=F%L96YT<RX\+W`^
M(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@
M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\96T^
M4F5V;VQV:6YG($QI;F4@;V8@0W)E9&ET(&%N9"!497)M($QO86X\+V5M/CPO
M<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^($%S
M(&1I<V-U<W-E9"!F=7)T:&5R(&EN($YO=&4@-BP@=V4@96YT97)E9"!I;G1O
M(&$@;&]A;B!A9W)E96UE;G0@=VET:"!'96YE<F%L($5L96-T<FEC($-A<&ET
M86P@0V]R<&]R871I;VX@*")'12!#87!I=&%L(BD@:6X@36%R8V@@,C`Q,BX@
M07,@<&%R="!O9B!T:&%T(&%G<F5E;65N="P@=V4@:7-S=65D('-T;V-K('!U
M<F-H87-E('=A<G)A;G1S('1O($=%($-A<&ET86P@=&AA="!E>'!I<F4@:6X@
M36%R8V@@,C`R,BX@5&AE(&9A:7(@=F%L=64@;V8@=&AE('=A<G)A;G1S('=A
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M<RX\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`Y<'0[($U!4D=)3CH@
M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M/&5M/E-I9VYI9FEC86YT($-U<W1O;65R<R!A;F0@06-C;W5N=',@4F5C96EV
M86)L93PO96T^/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@3W5R('!R:6UA<GD@8W5S=&]M97)S(&%R92!T:&4@52Y3+B!$
M97!A<G1M96YT(&]F($1E9F5N<V4@*'1H92`B1&]$(BD@+2!#:&5M:6-A;"!"
M:6]L;V=I8V%L($UE9&EC86P@4WES=&5M<R`H(D-"35,B*2P@86YD('1H92!"
M:6]M961I8V%L($%D=F%N8V5D(%)E<V5A<F-H(&%N9"!$979E;&]P;65N="!!
M=71H;W)I='D@*")"05)$02(I+B!!<R!O9B!-87)C:"`S,2P@,C`Q,R!A;F0@
M1&5C96UB97(@,S$L(#(P,3(L('1H92!#;VUP86YY)B,S.3MS('1R861E(')E
M8V5I=F%B;&4@86YD('5N8FEL;&5D(')E8V5I=F%B;&4@8F%L86YC97,@=V5R
M92!C;VUP<FES960@<V]L96QY(&]F(')E8V5I=F%B;&5S(&9R;VT@0T)-4R!A
M;F0@0D%21$$N/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@/&5M/D=O;V1W:6QL/"]E;3X\+W`^(#QP('-T>6QE/3-$)TU!
M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B!';V]D=VEL;"!R97!R97-E;G1S('1H92!E>&-E<W,@;V8@<'5R8VAA
M<V4@<')I8V4@;W9E<B!T:&4@9F%I<B!V86QU92!O9B!N970@:61E;G1I9FEA
M8FQE(&%S<V5T<R!A<W-O8VEA=&5D('=I=&@@86-Q=6ES:71I;VYS+B!792!R
M979I97<@=&AE(')E8V]V97)A8FEL:71Y(&]F(&=O;V1W:6QL(&%N;G5A;&QY
M(&%S(&]F($1E8V5M8F5R(#,Q/'-U<#YS=#PO<W5P/B!B>2!C;VUP87)I;F<@
M;W5R(&UA<FME="!V86QU92`H87,@;65A<W5R960@8GD@;W5R('-T;V-K('!R
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M<R!O9B!$96-E;6)E<B`S,2P@,C`Q,B!A;F0@9&5T97)M:6YE9"!T:&%T('1H
M97)E('=A<R!N;R!I;7!A:7)M96YT(&%S(&]F('1H870@9&%T92X\+W`^(#QP
M('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4]
M,T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@/&5M/E)E=F5N=64@4F5C;V=N:71I;VX\+V5M
M/CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M5V4@9V5N97)A=&4@;W5R(')E=F5N=64@9G)O;2!D:69F97)E;G0@='EP97,@
M;V8@8V]N=')A8W1U86P@87)R86YG96UE;G1S.B!C;W-T+7!L=7,M9F5E(&-O
M;G1R86-T<RP@8V]S="!R96EM8G5R<V%B;&4@9W)A;G1S(&%N9"!F:7AE9"!P
M<FEC92!C;VYT<F%C=',N/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@
M,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
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M;VYT<F%C="X\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
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M;VYS('=I=&@@<F5S<&5C="!T;R!T:&4@;6EL97-T;VYE(&5X:7-T.R`H:6EI
M*2!C;VQL96-T:6]N(&ES(')E87-O;F%B;'D@87-S=7)E9#L@86YD("AI=BD@
M<W5B<W1A;G1I=F4@969F;W)T('=A<R!N96-E<W-A<GD@=&\@86-H:65V92!T
M:&4@;6EL97-T;VYE+CPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!-:6QE<W1O
M;F5S(&%R92!C;VYS:61E<F5D('-U8G-T86YT:79E(&EF(&%L;"!O9B!T:&4@
M9F]L;&]W:6YG(&-O;F1I=&EO;G,@87)E(&UE=#H\+W`^(#QP('-T>6QE/3-$
M)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)TU!
M4D=)3BU43U`Z(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@34%21TE.+4)/5%1/33H@,'!X)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y;&4],T0G5$585"U!3$E'3CH@
M:G5S=&EF>3L@5D525$E#04PM04Q)1TXZ('1O<"<^(#QT9"!S='EL93TS1"=7
M24142#H@,"XR-6EN)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F=#L@=VED=&@Z(#`N,C5I;CLG/B`F;6ED9&]T.SPO=&0^(#QT
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M;F-E('1O(&%C:&EE=F4@=&AE(&UI;&5S=&]N92P\+W1D/B`\+W1R/B`\+W1A
M8FQE/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QT
M86)L92!S='EL93TS1"=-05)'24XM5$]0.B`P<'@[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($U!4D=)3BU"3U143TTZ(#!P
M>"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%9%4E1)0T%,+4%,24=..B!T;W`G
M/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#`N,C5I;B<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`P+C(U:6X[)SX@
M)FUI9&1O=#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+4%,24=..B!J=7-T:69Y
M)SX@:70@<F5L871E<R!S;VQE;'D@=&\@<&%S="!P97)F;W)M86YC92P\+W1D
M/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F
M;F)S<#L\+W`^(#QT86)L92!S='EL93TS1"=-05)'24XM5$]0.B`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($U!4D=)
M3BU"3U143TTZ(#!P>"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$
M,#X@/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%9%4E1)0T%,
M+4%,24=..B!T;W`G/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#`N,C5I;B<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H
M.B`P+C(U:6X[)SX@)FUI9&1O=#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+4%,
M24=..B!J=7-T:69Y)SX@=&AE('9A;'5E(&]F('1H92!M:6QE<W1O;F4@:7,@
M<F5A<V]N86)L92!R96QA=&EV92!T;R!A;&P@=&AE(&1E;&EV97)A8FQE<R!A
M;F0@<&%Y;65N="!T97)M<R`H:6YC;'5D:6YG(&]T:&5R('!O=&5N=&EA;"!M
M:6QE<W1O;F4@8V]N<VED97)A=&EO;BD@=VET:&EN('1H92!A<G)A;F=E;65N
M="X\+W1D/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=415A4+4E.1$5.
M5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4]
M,T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
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M;G,N/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@
M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
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M:"!T:&5Y(&%R92!U<V5D+CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$
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M96EV86)L92X\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
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M<')O>&EM871E;'D@)#`N,#(@;6EL;&EO;B!A;F0@)#`N-2!M:6QL:6]N+"!R
M97-P96-T:79E;'DL(&]F(&-O<W1S(')E:6UB=7)S960@8GD@=&AE(&=O=F5R
M;FUE;G0@87,@86X@;V9F<V5T('1O(')E<V5A<F-H(&%N9"!D979E;&]P;65N
M="!E>'!E;G-E<RX\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I
M;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`\96T^4VAA<F4M0F%S960@0V]M<&5N<V%T:6]N/"]E;3X\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!7
M92!E>'!E;G-E('1H92!E<W1I;6%T960@9F%I<B!V86QU92!O9B!S:&%R92UB
M87-E9"!A=V%R9',@9W)A;G1E9"!T;R!E;7!L;WEE97,@=6YD97(@;W5R('-T
M;V-K(&-O;7!E;G-A=&EO;B!P;&%N<RX@5&AE(&9A:7(@=F%L=64@;V8@<W1O
M8VL@;W!T:6]N<R!I<R!D971E<FUI;F5D(&%T('1H92!G<F%N="!D871E('5S
M:6YG(&%N(&]P=&EO;B!P<FEC:6YG(&UO9&5L+B!792!H879E(&5S=&EM871E
M9"!T:&4@9F%I<B!V86QU92!O9B!E86-H('-T;V-K(&]P=&EO;B!A=V%R9"!U
M<VEN9R!T:&4@0FQA8VLM4V-H;VQE<R!O<'1I;VX@<')I8VEN9R!M;V1E;"X@
M5&AE($)L86-K+5-C:&]L97,@;6]D96P@8V]N<VED97)S+"!A;6]N9R!O=&AE
M<B!F86-T;W)S+"!T:&4@97AP96-T960@;&EF92!O9B!T:&4@87=A<F0@86YD
M('1H92!E>'!E8W1E9"!V;VQA=&EL:71Y(&]F(&]U<B!S=&]C:R!P<FEC92X@
M5&AE('9A;'5E(&]F('1H92!A=V%R9"!T:&%T(&ES('5L=&EM871E;'D@97AP
M96-T960@=&\@=F5S="!I<R!R96-O9VYI>F5D(&%S(&5X<&5N<V4@;VX@82!S
M=')A:6=H="!L:6YE(&)A<VES(&]V97(@=&AE(&5M<&QO>65E)B,S.3MS(')E
M<75I<VET92!S97)V:6-E('!E<FEO9"X\+W`^(#QP('-T>6QE/3-$)U1%6%0M
M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S
M='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!4:&4@9F%I<B!V86QU92!O9B!R97-T
M<FEC=&5D('-T;V-K(&=R86YT<R!I<R!D971E<FUI;F5D(&)A<V5D(&]N('1H
M92!C;&]S:6YG('!R:6-E(&]F(&]U<B!C;VUM;VX@<W1O8VL@;VX@=&AE(&%W
M87)D(&1A=&4@86YD(&ES(')E8V]G;FEZ960@87,@97AP96YS92!R871A8FQY
M(&]V97(@=&AE(')E<75I<VET92!S97)V:6-E('!E<FEO9"X\+W`^(#QP('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB
M<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
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M(#$R)2P@8F%S960@;VX@:&ES=&]R:6-A;"!F;W)F96ET=7)E<RX\+W`^(#QP
M('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@4VAA<F4M
M8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4@9F]R('1H92!T:')E92!M;VYT
M:',@96YD960@36%R8V@@,S$L(#(P,3,@86YD(#(P,3(@=V%S.CPO<#X@/'`@
M<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\=&%B;&4@<W1Y;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%
M4BU#3TQ,05!313H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V]L<W!A;CTS
M1#8^5&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q+#PO=&0^(#QT9"!S='EL
M93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)
M1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C
M96YT97([($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G(&-O;'-P86X],T0R/C(P,3,\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V]L
M<W!A;CTS1#(^,C`Q,CPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W1D/B`\+W1R
M/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U325I%.B`Q,'!T)R!C;VQS<&%N
M/3-$,CX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@8V]L
M<W!A;CTS1#(^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P="<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]5
M3D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z
M(#<R)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^(%)E<V5A<F-H(&%N9"!D979E;&]P;65N=#PO=&0^(#QT9"!S='EL93TS
M1"=724142#H@,B4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!R:6=H=#L@5TE$5$@Z(#$P)3L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^(#@X+#8S-#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^("0\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q,"4[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`Q,3<L,#8W/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO
M=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET
M93L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@1V5N97)A;"!A;F0@861M:6YI<W1R871I=F4\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L
M:60[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@,C,Y+#DT-SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@
M<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=.
M.B!R:6=H=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^(#0S,2PU.3<\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^("9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$
M+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T
M=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!4;W1A;"!S:&%R
M92UB87-E9"!C;VUP96YS871I;VX@97AP96YS93PO=&0^(#QT9"!S='EL93TS
M1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@,S(X+#4X,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`U
M-#@L-C8T/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S
M<#L\+W1D/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^($1U
M<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$S+"!W
M92!G<F%N=&5D(#8P+#`P,"!O<'1I;VYS('1O(&5M<&QO>65E<R!A;F0@8V]N
M<W5L=&%N=',@86YD(&UA9&4@;F\@<F5S=')I8W1E9"!S=&]C:R!G<F%N=',N
M($1U<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$R
M+"!W92!G<F%N=&5D(#$U+#DT."!O<'1I;VYS('1O(&5M<&QO>65E<R!A;F0@
M;6%D92!N;R!R97-T<FEC=&5D('-T;V-K(&=R86YT<RX@070@36%R8V@@,S$L
M(#(P,3,L('=E(&AA9"!T;W1A;"!U;G)E8V]G;FEZ960@<VAA<F4M8F%S960@
M8V]M<&5N<V%T:6]N(&5X<&5N<V4@<F5L871E9"!T;R!U;G9E<W1E9"!A=V%R
M9',@;V8@87!P<F]X:6UA=&5L>2`D,BXP(&UI;&QI;VX@;F5T(&]F(&5S=&EM
M871E9"!F;W)F96ET=7)E<RP@=VAI8V@@=V4@97AP96-T('1O(')E8V]G;FEZ
M92!A<R!E>'!E;G-E(&]V97(@82!W96EG:'1E9"UA=F5R86=E('!E<FEO9"!O
M9B`R+C(U('EE87)S+CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N
M-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!
M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^(#QE;3Y);F-O;64@5&%X97,\+V5M/CPO<#X@/'`@<W1Y
M;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S
M<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P
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M/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@
M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M26YC;VUE('1A>"!E>'!E;G-E('=A<R`D.2PW-#,@86YD("0Q-3`L-#`U(&1U
M<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$S(&%N
M9"`R,#$R+"!R97-P96-T:79E;'DN($EN8V]M92!T87@@97AP96YS92!I<R!A
M(')E<W5L="!O9B!T:&4@9&EF9F5R96YC92!B971W965N('1H92!T<F5A=&UE
M;G0@;V8@9V]O9'=I;&P@9F]R(&EN8V]M92!T87@@<'5R<&]S97,@86YD(&9O
M<B!5+E,N($=!05`L(')E<W5L=&EN9R!I;B!A(&1E9F5R<F5D('1A>"!L:6%B
M:6QI='DL('=H:6-H(&-A;FYO="!O9F9S970@9&5F97)R960@=&%X(&%S<V5T
M<RX@5&AI<R!D969E<G)E9"!T87@@;&EA8FEL:71Y(&ES(&EN8VQU9&5D(&EN
M(&]U<B!C;VYD96YS960@8V]N<V]L:61A=&5D(&)A;&%N8V4@<VAE970@:6X@
M;W1H97(@;&]N9RUT97)M(&QI86)I;&ET:65S+CPO<#X@/'`@<W1Y;&4],T0G
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B`\96T^0F%S:6,@86YD($1I;'5T960@3F5T($QO<W,@4&5R(%-H
M87)E/"]E;3X\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B`\96T^26YC;VUE("AL;W-S*2!P97(@<VAA<F4Z/"]E;3X@0F%S
M:6,@:6YC;VUE("AL;W-S*2!P97(@<VAA<F4@:7,@8V]M<'5T960@8GD@9&EV
M:61I;F<@8V]N<V]L:61A=&5D(&YE="!I;F-O;64@*&QO<W,I(&)Y('1H92!W
M96EG:'1E9"!A=F5R86=E(&YU;6)E<B!O9B!C;VUM;VX@<VAA<F5S(&]U='-T
M86YD:6YG(&1U<FEN9R!T:&4@<&5R:6]D+"!E>&-L=61I;F<@=6YV97-T960@
M<F5S=')I8W1E9"!S=&]C:RX\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4
M.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS
M1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
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M=&AE('1R96%S=7)Y('-T;V-K(&UE=&AO9"X\+W`^(#QP('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\
M<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
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M87)C:"`S,2P@,C`Q,R!A;F0@,C`Q,BP@<F5S<&5C=&EV96QY+"!B96-A=7-E
M('1H96ER(&EN8VQU<VEO;B!W;W5L9"!B92!A;G1I+61I;'5T:79E+CPO<#X@
M/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QE;3Y2
M96-E;G0@06-C;W5N=&EN9R!0<F]N;W5N8V5M96YT<SPO96T^/"]P/B`\<"!S
M='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N
M8G-P.SPO<#X@/'`@<W1Y;&4],T0G0T],3U(Z(&)L86-K.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!-05)'24XZ(#!P="`P
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M=W,N/"]P/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
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M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,CX\<W1R;VYG/D9A:7(@5F%L=64@365A<W5R96UE;G1S/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M1F%I<B!686QU92!-96%S=7)E;65N=',@6T%B<W1R86-T73PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER(%9A;'5E($UE
M87-U<F5M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M
M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4
M<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ
M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\
M(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B`\<W1R;VYG/DYO=&4@,R`M($9A:7(@5F%L=64@365A<W5R96UE;G1S/"]S
M=')O;F<^/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!
M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
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M=7)E(&9A:7(@=F%L=64@87)E(&%S(&9O;&QO=W,Z/"]P/B`\<"!S='EL93TS
M1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO
M<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Q,#`E.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ
M('1O<"<^(#QT9"!S='EL93TS1"=724142#H@,3AP>"<^)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@4WEM8F]L.R!724142#H@,3AP>"<^
M)FUI9&1O=#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^3&5V96P@,2`M(%%U;W1E9"!P<FEC
M97,@:6X@86-T:79E(&UA<FME=',@9F]R(&ED96YT:6-A;"!A<W-E=',@;W(@
M;&EA8FEL:71I97,N/"]T9#X@/"]T<CX@/"]T86)L93X@/'`@<W1Y;&4],T0G
M5$585"U)3D1%3E0Z(#$N-7!T.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^
M(#QT86)L92!S='EL93TS1"=724142#H@,3`P)3L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=..B!T
M;W`G/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'@G/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4.B`Q,'!T(%-Y;6)O;#L@5TE$5$@Z(#$X<'@G/B9M
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M<CX@/"]T86)L93X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#$N-7!T.R!-
M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QT86)L92!S='EL93TS1"=72414
M2#H@,3`P)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T
M>6QE/3-$)U9%4E1)0T%,+4%,24=..B!T;W`G/B`\=&0@<W1Y;&4],T0G5TE$
M5$@Z(#$X<'@G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T
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M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z
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M3&5V96P@,RX\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
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M<R!O9B!-87)C:"`S,2P@,C`Q,R!A;F0@,C`Q,B!W92!H860@3&5V96P@,R!D
M97)I=F%T:79E(&QI86)I;&ET:65S(&]F(&%P<')O>&EM871E;'D@)#(N,B!M
M:6QL:6]N(&%N9"`D,BXY(&UI;&QI;VXL(')E<W!E8W1I=F5L>2X\+W`^(#QP
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!4:&4@9F]L
M;&]W:6YG('1A8FQE(')E<')E<V5N=',@=&AE($-O;7!A;GDF(S,Y.W,@9F%I
M<B!V86QU92!H:65R87)C:'D@9F]R(&ET<R!F:6YA;F-I86P@87-S971S(&%N
M9"!L:6%B:6QI=&EE<R!M96%S=7)E9"!A="!F86ER('9A;'5E(&]N(&$@<F5C
M=7)R:6YG(&)A<VES.CPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\=&%B;&4@<W1Y;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%
M4BU#3TQ,05!313H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q
M<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)R!C;VQS
M<&%N/3-$,30^07,@;V8@36%R8V@@,S$L(#(P,3,\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T
M9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG
M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG(&-O
M;'-P86X],T0R/DQE=F5L(#$\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L
M:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)R!C;VQS<&%N/3-$
M,CY,979E;"`R/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q
M<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4
M+4%,24=..B!C96YT97([($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<@8V]L<W!A;CTS1#(^3&5V96P@
M,SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@
M8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG(&-O;'-P86X],T0R/D)A;&%N8V4\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=.
M.B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@3&EA8FEL:71I
M97,\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0M4TE:
M13H@,3!P="<@8V]L<W!A;CTS1#(^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!R:6=H=#L@1D].5"U325I%.B`Q,'!T)R!C;VQS<&%N/3-$,CX@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-)
M6D4Z(#$P<'0G(&-O;'-P86X],T0R/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0[($9/3E0M4TE:13H@,3!P="<@8V]L<W!A;CTS1#(^
M("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N
M8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2
M.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`T-"4[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2
M.B!B;&%C:R<^($1E<FEV871I=F5S(&EN<W1R=6UE;G1S/"]T9#X@/'1D('-T
M>6QE/3-$)U=)1%1(.B`R)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@
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M:68[($-/3$]2.B!B;&%C:R<^("0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0[(%=)1%1(.B`Q,"4[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("T\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(E.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/
M4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`D/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@,3`E.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`R+#(P,2PS.3`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`D/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M.R!724142#H@,3`E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`R+#(P,2PS.3`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`F;F)S<#L\+W1D/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=4
M15A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@
M/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B`F;F)S<#L\+W`^(#QT86)L92!S='EL93TS1"=724142#H@,3`P)3L@0D]2
M1$52+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D
M:6YG/3-$,#X@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG
M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG(&-O
M;'-P86X],T0Q-#Y!<R!O9B!$96-E;6)E<B`S,2P@,C`Q,CPO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S
M<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ(&)O
M='1O;2<^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C
M:R<@8V]L<W!A;CTS1#(^3&5V96P@,3PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P
M="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG(&-O;'-P
M86X],T0R/DQE=F5L(#(\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[
M(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)R!C;VQS<&%N/3-$,CY,
M979E;"`S/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/
M3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,
M24=..B!C96YT97([($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[($-/3$]2.B!B;&%C:R<@8V]L<W!A;CTS1#(^0F%L86YC93PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`F;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G5D525$E#04PM
M04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!,:6%B
M:6QI=&EE<SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].
M5"U325I%.B`Q,'!T)R!C;VQS<&%N/3-$,CX@)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-)6D4Z(#$P<'0G(&-O;'-P86X]
M,T0R/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)SXF
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/
M3E0M4TE:13H@,3!P="<@8V]L<W!A;CTS1#(^("9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U325I%.B`Q,'!T)R!C;VQS<&%N
M/3-$,CX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M="<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M
M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#0T
M)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M0T],3U(Z(&)L86-K)SX@1&5R:79A=&EV97,@:6YS=')U;65N=',\+W1D/B`\
M=&0@<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/
M4CH@8FQA8VLG/B`D/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT.R!724142#H@,3`E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`M/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`R)3L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K
M)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%=)1%1(.B`Q)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
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M(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("0\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q,"4[($9/
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M3$]2.B!B;&%C:R<^("0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0[(%=)1%1(.B`Q,"4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
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M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@5&AE(&9O;&QO=VEN9R!T86)L92!S971S(&9O<G1H(&$@
M<W5M;6%R>2!O9B!C:&%N9V5S(&EN('1H92!F86ER('9A;'5E(&]F('1H92!#
M;VUP86YY)B,S.3MS($QE=F5L(#,@;&EA8FEL:71I97,@9F]R('1H92!T:')E
M92!M;VYT:',@96YD960@36%R8V@@,S$L(#(P,3,Z/"]P/B`\<"!S='EL93TS
M1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO
M<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Q,#`E.R!"3U)$15(M0T],3$%0
M4T4Z(&-O;&QA<'-E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/B`\
M='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@1&5S8W)I<'1I;VX\+W1D/B`\=&0@
M<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C;VQS<&%N/3-$
M,CY"86QA;F-E(&%S(&]F/&)R("\^($1E8V5M8F5R(#,Q+#QB<B`O/B`R,#$R
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O
M;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-O;'-P86X],T0R/E5N<F5A;&EZ960@
M3&]S<V5S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-O;'-P86X],T0R/D)A;&%N
M8V4@87,@;V8\8G(@+SX@36%R8V@@,S$L/&)R("\^(#(P,3,\+W1D/B`\=&0@
M<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)0T%,
M+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#4X)3L@1D].
M5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z
M(#(E.R!&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/3E0M4TE:13H@,3!P
M="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M=#L@5TE$5$@Z(#$P)3L@1D].5"U325I%.B`Q,'!T)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].
M5"U325I%.B`Q,'!T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(
M.B`R)3L@1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4+5-)6D4Z(#$P
M<'0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0[(%=)1%1(.B`Q,"4[($9/3E0M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/
M3E0M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=72414
M2#H@,B4[($9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5"U325I%.B`Q
M,'!T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT.R!724142#H@,3`E.R!&3TY4+5-)6D4Z(#$P<'0G/B`F;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&
M3TY4+5-)6D4Z(#$P<'0G/B`F;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4]
M,T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SX@1&5R:79A=&EV92!L:6%B:6QI=&EE<R!R96QA=&5D('1O('-T;V-K('!U
M<F-H87-E('=A<G)A;G1S/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^(#$L,CDU+#8Q,SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#DP-2PW-S<\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("0\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`R+#(P,2PS.3`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO=&0^
M(#PO='(^(#PO=&%B;&4^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I
M;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B!4:&4@9F]L;&]W:6YG('1A8FQE('-E=',@9F]R=&@@82!S
M=6UM87)Y(&]F(&-H86YG97,@:6X@=&AE(&9A:7(@=F%L=64@;V8@=&AE($-O
M;7!A;GDF(S,Y.W,@3&5V96P@,R!L:6%B:6QI=&EE<R!F;W(@=&AE('1H<F5E
M(&UO;G1H<R!E;F1E9"!-87)C:"`S,2P@,C`Q,CH\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P+C5I;CL@34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\=&%B;&4@<W1Y;&4],T0G5TE$5$@Z
M(#$P,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'
M3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!$97-C<FEP=&EO;CPO=&0^(#QT9"!S
M='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-O;'-P86X],T0R
M/D)A;&%N8V4@87,@;V8\8G(@+SX@1&5C96UB97(@,S$L/&)R("\^(#(P,3$\
M+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L
M:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<@8V]L<W!A;CTS1#(^56YR96%L:7IE9"!,
M;W-S97,\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q
M<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V]L<W!A;CTS1#(^0F%L86YC
M92!A<R!O9CQB<B`O/B!-87)C:"`S,2P\8G(@+SX@,C`Q,CPO=&0^(#QT9"!S
M='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G5D525$E#04PM
M04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=724142#H@-3@E.R!&3TY4
M+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=724142#H@
M,B4[($9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5"U325I%.B`Q,'!T
M)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M.R!724142#H@,3`E.R!&3TY4+5-)6D4Z(#$P<'0G/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4
M+5-)6D4Z(#$P<'0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z
M(#(E.R!&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/3E0M4TE:13H@,3!P
M="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M=#L@5TE$5$@Z(#$P)3L@1D].5"U325I%.B`Q,'!T)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].
M5"U325I%.B`Q,'!T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(
M.B`R)3L@1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4+5-)6D4Z(#$P
M<'0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0[(%=)1%1(.B`Q,"4[($9/3E0M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/
M3E0M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS
M1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B!$97)I=F%T:79E(&QI86)I;&ET:65S(')E;&%T960@=&\@<W1O8VL@<'5R
M8VAA<V4@=V%R<F%N=',\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`D/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@,2PX.#8L-C4R/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`D/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@.3DQ+#8V,CPO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#(L.#<X+#,Q-#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@
M/"]T<CX@/"]T86)L93X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN
M.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^($%T($UA<F-H(#,Q+"`R,#$S(&%N9"`R,#$R+"!D97)I=F%T
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M('9O;&%T:6QI='D@86YD(&5X<&5C=&5D(&1I=FED96YD<RX\+W`^(#QP('-T
M>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE
M/3-$)U=)1%1(.B`Q,#`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y;&4],T0G5D52
M5$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].
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M86QU92!A="`S+S,Q+S(P,3,\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L
M:60[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M($-/3$]2.B!B;&%C:R<^(%9A;'5A=&EO;B!496-H;FEQ=64\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P
M="!S;VQI9#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@0T],3U(Z(&)L86-K)SX@56YO8G-E<G9A8FQE($EN<'5T<SPO=&0^
M(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T
M+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z
M(#(P)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@0T],3U(Z(&)L86-K)SX@,BPR,#$L,SDP/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`R)3L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)
M1%1(.B`T,B4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[($-/3$]2.B!B;&%C:R<^($)L86-K+5-C:&]L97,@;W!T:6]N('!R
M:6-I;F<@;6]D96P\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
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M9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U325I%.B`Q,'!T
M)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K
M)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/
M3$]2.B!B;&%C:R<^($5X<&5C=&5D(&1I=FED96YD<SPO=&0^(#PO='(^(#QT
M<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I
M.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[($9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-)6D4Z(#$P<'0G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&
M3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],
M3U(Z(&)L86-K)SX@06YT:6-I<&%T960@=F]L871I;&ET>3PO=&0^(#PO='(^
M(#PO=&%B;&4^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO
M<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I
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M<F-H(#,Q+"`R,#$S(&ES(&1U92!P<FEM87)I;'D@=&\@=&AE(&-H86YG92!I
M;B!T:&4@8VQO<VEN9R!P<FEC92!O9B!0:&%R;4%T:&5N92!S=&]C:RP@=VAI
M8V@@=V%S("0Q+C$R('!E<B!S:&%R92!A<R!O9B!$96-E;6)E<B`S,2P@,C`Q
M,B!A;F0@)#$N-S`@<&5R('-H87)E(&%S(&]F($UA<F-H(#(X+"`R,#$S+B!4
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M($1E8V5M8F5R(#,P+"`R,#$Q(&%N9"`D,2XW-R!P97(@<VAA<F4@87,@;V8@
M36%R8V@@,S`L(#(P,3(N/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QE;3Y!
M<W-E=',@365A<W5R960@870@1F%I<B!686QU92!O;B!A($YO;G)E8W5R<FEN
M9R!"87-I<SPO96T^/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F
M;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@
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M*'-E92!.;W1E(#(I+B!!<R!O9B!-87)C:"`S,2P@,C`Q,RP@=&AE($-O;7!A
M;GD@:&%D(&YO(&]T:&5R(&%S<V5T<R!O<B!L:6%B:6QI=&EE<R!T:&%T('=E
M<F4@;65A<W5R960@870@9F%I<B!V86QU92!O;B!A(&YO;G)E8W5R<FEN9R!B
M87-I<RX\+W`^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
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M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^0V]M;6ET;65N=',@86YD($-O;G1I;F=E
M;F-I97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S
M,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY#;VUM:71M96YT<R!A;F0@0V]N=&EN9V5N8VEE<R!;06)S=')A
M8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-O;6UI=&UE;G1S(&%N9"!#;VYT:6YG96YC:65S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O
M5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O
M=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN
M9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP('-T
M>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^(#QS=')O;F<^3F]T92`T("T@0V]M;6ET
M;65N=',@86YD($-O;G1I;F=E;F-I97,\+W-T<F]N9SX\+W`^(#QP('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[
M/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\96T^4TE'02!,:71I
M9V%T:6]N/"]E;3X\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I
M;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B!);B!$96-E;6)E<B`R,#`V+"!W92!F:6QE9"!A(&-O;7!L
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M('1H870@=V%S('1E<FUI;F%T960@:6X@,C`P-BX@5&AE(&-O;7!L86EN="!A
M;'-O(&%L;&5G960@=&AA="!324=!(&9A:6QE9"!T;R!N96=O=&EA=&4@:6X@
M9V]O9"!F86ET:"!T:&4@=&5R;7,@;V8@<W5C:"!A(&QI8V5N<V4@<'5R<W5A
M;G0@=&\@=&AE('1E<FUI;F%T960@;65R9V5R(&%G<F5E;65N="X\+W`^(#QP
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!);B!397!T
M96UB97(@,C`Q,2P@=&AE($-O=7)T(&ES<W5E9"!A;B!O<&EN:6]N(&EN('1H
M92!C87-E(&9I;F1I;F<@=&AA="!324=!(&AA9"!B<F5A8VAE9"!C97)T86EN
M(&-O;G1R86-T=6%L(&]B;&EG871I;VYS('1O('5S(&%N9"!U<&AO;&1I;F<@
M;W5R(&-L86EM<R!O9B!P<F]M:7-S;W)Y(&5S=&]P<&5L+B!4:&4@0V]U<G0@
M87=A<F1E9"!U<R!T:&4@<FEG:'0@=&\@<F5C96EV92`U,"4@;V8@86QL(&YE
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M:71N97-S(&9E97,L('=H:6-H(&%M;W5N=',@=&\@87!P<F]X:6UA=&5L>2`D
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M=6UE;G0@:6X@=&AE(&-A<V4N/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@
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M)B,S.3MS(&1E8VES:6]N(&%W87)D:6YG('5S(&$@,3`@>65A<B`U,"4@;F5T
M('!R;V9I="!O9B!T:&4@<V%L97,@;V8@07)E<W1V>7(F=')A9&4[(&%N9"!R
M96QA=&5D('!R;V1U8W1S("AO;F-E(%-)1T$@<F5T86EN<R!T:&4@9FER<W0@
M)#0P(&UI;&QI;VX@:6X@;F5T('!R;V9I="DN(%=E(&AA=F4@;F]T('EE="!R
M96-O<F1E9"!A;GD@86UO=6YT(&1U92!F<F]M(%-)1T$@:6X@<F5L871I;VX@
M=&\@=&AI<R!C87-E+CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N
M-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!
M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^(#QE;3Y696YD;W(@3&ET:6=A=&EO;CPO96T^/"]P/B`\
M<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE
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M;F<@;W5R(&]W;BX\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB
M<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\96T^1V]V97)N
M;65N="!#;VYT<F%C=&EN9SPO96T^/"]P/B`\<"!S='EL93TS1"=415A4+4E.
M1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y
M;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
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M<&5R871I;VYS+"!O<B!C87-H(&9L;W=S+CPO<#X@/'`@<W1Y;&4],T0G34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`\96T^4F5G:7-T<F%T:6]N(%)I9VAT<R!!9W)E96UE;G1S/"]E;3X\
M+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!7
M92!E;G1E<F5D(&EN=&\@82!296=I<W1R871I;VX@4FEG:'1S($%G<F5E;65N
M="!W:71H('1H92!I;G9E<W1O<G,@=VAO('!A<G1I8VEP871E9"!I;B!T:&4@
M2G5L>2`R,#`Y('!R:79A=&4@<&QA8V5M96YT(&]F(&-O;G9E<G1I8FQE(&YO
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M<F5L871E9"!W87)R86YT<R`H86YD(&%N>2!O=&AE<B!S96-U<FET:65S(&ES
M<W5E9"!O<B!I<W-U86)L92!W:71H(')E<W!E8W0@=&\@:6X@97AC:&%N9V4@
M9F]R('-U8V@@<VAA<F5S*2!H879E(&)E96X@<V]L9"X@5&AE(&-O;G9E<G1I
M8FQE(&YO=&5S('=E<F4@8V]N=F5R=&5D(&]R(&5X=&EN9W5I<VAE9"!I;B`R
M,#$P+"!A;'1H;W5G:"!T:&4@<F5L871E9"!W87)R86YT<R!R96UA:6X@;W5T
M<W1A;F1I;F<N(%1H92!W87)R86YT<R!W:6QL(&5X<&ER92!O;B!*86YU87)Y
M(#(X+"`R,#$U+CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN
M.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^(%=E(&AA=F4@<V5P87)A=&4@<F5G:7-T<F%T:6]N(')I9VAT
M<R!A9W)E96UE;G1S('=I=&@@:6YV97-T;W)S+"!U;F1E<B!W:&EC:"!W92!H
M879E(&]B;&EG871I;VYS('1O(&ME97`@=&AE(&-O<G)E<W!O;F1I;F<@<F5G
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M;W(@(G!I9V=Y+6)A8VLB(&)A<VES(&]R(&)O=&@N/"]P/B`\<"!S='EL93TS
M1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO
M<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@56YD97(@=&AE('1E<FUS
M(&]F('1H92!C;VYV97)T:6)L92!N;W1E<RP@=VAI8V@@=V5R92!C;VYV97)T
M960@;W(@97AT:6YG=6ES:&5D(&EN(#(P,3`L(&EF(&%F=&5R('1H92`R;F0@
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M<&%Y;65N="!O9B`Q+C`E(&]F('1H92!A9V=R96=A=&4@<')I;F-I<&%L(&%M
M;W5N="!O9B!T:&4@8V]N=F5R=&EB;&4@;F]T97,@<F5L871I;F<@=&\@=&AE
M(&%F9F5C=&5D('-H87)E<R!O;B!T:&4@:6YI=&EA;"!D87D@;V8@82!-86EN
M=&5N86YC92!&86EL=7)E+B!/=7(@=&]T86P@;6%X:6UU;2!O8FQI9V%T:6]N
M('5N9&5R('1H:7,@<')O=FES:6]N(&%T($UA<F-H(#,Q+"`R,#$S+"!W;W5L
M9"!B92!A<'!R;WAI;6%T96QY("0P+C(@;6EL;&EO;BX\+W`^(#QP('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[
M/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!&;VQL;W=I;F<@82!-
M86EN=&5N86YC92!&86EL=7)E+"!W92!W:6QL(&%L<V\@8F4@<F5Q=6ER960@
M=&\@;6%K92!T;R!E86-H('-E;&QI;F<@<W1O8VMH;VQD97(@;6]N=&AL>2!P
M87EM96YT<R!O9B`Q+C`E(&]F('1H92!A9V=R96=A=&4@<')I;F-I<&%L(&%M
M;W5N="!O9B!T:&4@8V]N=F5R=&EB;&4@;F]T97,@<F5L871I;F<@=&\@=&AE
M(&%F9F5C=&5D('-H87)E<R!O;B!E=F5R>2`S,'1H(&1A>2!A9G1E<B!T:&4@
M:6YI=&EA;"!D87D@;V8@82!-86EN=&5N86YC92!&86EL=7)E+"!I;B!E86-H
M(&-A<V4@<')O<F%T960@9F]R('-H;W)T97(@<&5R:6]D<R!A;F0@=6YT:6P@
M=&AE(&9A:6QU<F4@:7,@8W5R960N($]U<B!T;W1A;"!M87AI;75M(&]B;&EG
M871I;VX@=6YD97(@=&AI<R!P<F]V:7-I;VX@=V]U;&0@8F4@87!P<F]X:6UA
M=&4@)#`N,B!M:6QL:6]N(&9O<B!E86-H(&UO;G1H('5N=&EL('1H92!F86EL
M=7)E+"!I9B!I="!O8V-U<G,L(&ES(&-U<F5D+CPO<#X@/"$M+45N9$9R86=M
M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?838Q-V$Y-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D
M,6)D-V,U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B
M7S5D,S=?-#8V.%]A-#EB7S(R9&4P9#%B9#=C-2]7;W)K<VAE971S+U-H965T
M,3$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3
M=&]C:VAO;&1E<G,G($5Q=6ET>3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-T;V-K:&]L9&5R<R<@17%U:71Y(%M!
M8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4W1O8VMH;VQD97)S)R!%<75I='D\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O
M+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N
M=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B
M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@<W1Y;&4]
M,T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@/'-T<F]N9SY.;W1E(#4@+2!3=&]C:VAO;&1E
M<G,F(S,Y.R!%<75I='D\+W-T<F]N9SX\+W`^(#QP('-T>6QE/3-$)TU!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B`\96T^3&]N9RU497)M($EN8V5N=&EV92!0;&%N/"]E;3X\+W`^(#QP('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB
M<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!);B`R,#`W+"!T
M:&4@0V]M<&%N>28C,SD[<R!S=&]C:VAO;&1E<G,@87!P<F]V960@=&AE(#(P
M,#<@3&]N9RU497)M($EN8V5N=&EV92!#;VUP96YS871I;VX@4&QA;B`H=&AE
M("(R,#`W(%!L86XB*2!W:&EC:"!P<F]V:61E<R!F;W(@=&AE(&=R86YT:6YG
M(&]F(&EN8V5N=&EV92!A;F0@;F]N+7%U86QI9FEE9"!S=&]C:R!O<'1I;VYS
M+"!S=&]C:R!A<'!R96-I871I;VX@<FEG:'1S+"!P97)F;W)M86YC92!U;FET
M<RP@<F5S=')I8W1E9"!C;VUM;VX@87=A<F1S(&%N9"!P97)F;W)M86YC92!B
M;VYU<V5S("AC;VQL96-T:79E;'D@(F%W87)D<R(I('1O($-O;7!A;GD@;V9F
M:6-E<G,@86YD(&5M<&QO>65E<RX@061D:71I;VYA;&QY+"!T:&4@,C`P-R!0
M;&%N(&%U=&AO<FEZ97,@=&AE(&=R86YT:6YG(&]F(&YO;BUQ=6%L:69I960@
M<W1O8VL@;W!T:6]N<R!A;F0@<F5S=')I8W1E9"!S=&]C:R!A=V%R9',@=&\@
M0V]M<&%N>2!D:7)E8W1O<G,@86YD('1O(&EN9&5P96YD96YT(&-O;G-U;'1A
M;G1S+CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T
M(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^($EN(#(P,#@L('1H92!#;VUP86YY)B,S.3MS('-H87)E:&]L9&5R<R!A
M<'!R;W9E9"!A;65N9&UE;G1S('1O('1H92`R,#`W(%!L86XL(&EN8W)E87-I
M;F<@9G)O;2`S+C4@;6EL;&EO;B!S:&%R97,@=&\@-"XV(&UI;&QI;VX@<VAA
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M(&)E9VEN;FEN9R!I;B`R,#`Y(&%N9"!C;VYT:6YU:6YG('1H<F]U9V@@,C`Q
M-2P@86-C;W)D:6YG('1O(&-E<G1A:6X@;&EM:71S('-E="!F;W)T:"!I;B!T
M:&4@,C`P-R!0;&%N+B!!="!-87)C:"`S,2P@,C`Q,RP@=&AE<F4@87)E(&%P
M<')O>&EM871E;'D@.2XS(&UI;&QI;VX@<VAA<F5S(&%P<')O=F5D(&9O<B!I
M<W-U86YC92!U;F1E<B!T:&4@,C`P-R!P;&%N+"!O9B!W:&EC:"!A<'!R;WAI
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M('EE87)S+CPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/&)R("\^
M(#QE;3Y787)R86YT<R!#;&%S<VEF:65D(&%S($5Q=6ET>3PO96T^/"]P/B`\
M<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P
M>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@26X@8V]N
M;F5C=&EO;B!W:71H('1H92!*=6QY(#(P,#D@<')I=F%T92!P;&%C96UE;G0L
M('=E(&ES<W5E9"!W87)R86YT<R!T;R!P=7)C:&%S92!A;B!A9V=R96=A=&4@
M;V8@,BPU-S(L-S<U('-H87)E<R!O9B!T:&4@0V]M<&%N>28C,SD[<R!C;VUM
M;VX@<W1O8VL@870@86X@97AE<F-I<V4@<')I8V4@;V8@)#(N-3`@<&5R('-H
M87)E+B!4:&4@=V%R<F%N=',@=VEL;"!E>'!I<F4@;VX@2F%N=6%R>2`R."P@
M,C`Q-2X@06QS;R!O=71S=&%N9&EN9R!A<F4@=V%R<F%N=',@=&\@<'5R8VAA
M<V4@86X@86=G<F5G871E(&]F(#$P,"PW-S@@<VAA<F5S(&]F(&-O;6UO;B!S
M=&]C:R!A="`D,RXY-R!P97(@<VAA<F4L('=H:6-H('=I;&P@97AP:7)E(&]N
M($UA<F-H(#,P+"`R,#$W+CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$
M)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^($EN(&-O;FYE8W1I;VX@=VET:"!T:&4@36%R8V@@
M,S`L(#(P,3(L(&1E8G0@9FEN86YC:6YG("AS964@3F]T92`V*2P@=V4@:7-S
M=65D('=A<G)A;G1S('1O('!U<F-H87-E(&%N(&%G9W)E9V%T92!O9B`T-BPU
M.#0@<VAA<F5S(&]F('1H92!#;VUP86YY)B,S.3MS(&-O;6UO;B!S=&]C:R!A
M="!A;B!E>&5R8VES92!P<FEC92!O9B`D,2XV,2!P97(@<VAA<F4@=&\@1T4@
M0V%P:71A;"!%<75I='D@26YV97-T;65N=',L($EN8RX@5&AE(')E;&%T:79E
M(&9A:7(@=F%L=64@871T<FEB=71A8FQE('1O('1H92!W87)R86YT<R!O9B`D
M-CDL.#<V('=A<R!R96-O<F1E9"!I;B!E<75I='D@9'5R:6YG('1H92!Q=6%R
M=&5R(&5N9&5D($UA<F-H(#,Q+"`R,#$R+B!4:&4@=V%R<F%N=',@=VEL;"!E
M>'!I<F4@;VX@36%R8V@@,S`L(#(P,C(N/"]P/B`\<"!S='EL93TS1"=-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T
M(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^(#QE;3Y787)R86YT<SPO96T^/"]P/B`\<"!S='EL93TS1"=415A4+4E.
M1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]P/B`\<"!S='EL
M93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B!!="!-87)C:"`S,2P@,C`Q,R!A;F0@,C`Q
M,B!T:&5R92!W97)E('=A<G)A;G1S(&]U='-T86YD:6YG('1O('!U<F-H87-E
M(#4L-C(P+#$R."!S:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C:RP@<F5S<&5C
M=&EV96QY+B!4:&4@=V%R<F%N=',@;W5T<W1A;F1I;F<@87,@;V8@36%R8V@@
M,S$L(#(P,3,@86YD(#(P,3(@=V5R92!A<R!F;VQL;W=S.CPO<#X@/'`@<W1Y
M;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\=&%B;&4@<W1Y;&4]
M,T0G5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-E;&QS
M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL93TS1"=615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG(&-O;'-P86X],T0R/DYU;6)E<B!O9B!#;VUM;VX@4VAA<F5S(%5N
M9&5R;'EI;F<@5V%R<F%N=',\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L
M:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@27-S=64@1&%T
M92]%>&5R8VES86)L92!$871E/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)
M1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@0T],3U(Z(&)L86-K)R!C;VQS<&%N/3-$,CY%>&5R8VES92!0
M<FEC93PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/
M4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'
M3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!%>'!I<F%T:6]N($1A=&4\+W1D/B`\
M+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR
M-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5TE$
M5$@Z(#(R)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@0T],3U(Z(&)L86-K)SX@,3`P+#<W.#PO=&0^(#QT9"!S='EL93TS
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M1%1(.B`R-"4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[($-/3$]2.B!B;&%C:R<^($UA<BTP-R`O($UA<BTP-SPO=&0^(#QT
M9"!S='EL93TS1"=724142#H@,B4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2
M.B!B;&%C:R<^("0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0[(%=)1%1(.B`R,24[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#,N.3<\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0[(%=)1%1(.B`R,R4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^($UA<BTQ-SPO=&0^(#PO='(^
M(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET93L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#<P-2PS-30\+W1D/B`\=&0@
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M.2`O(%-E<"TP.3PO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L
M86-K)SX@)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],
M3U(Z(&)L86-K)SX@,RXP,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],
M3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!397`M,30\+W1D/B`\+W1R/B`\='(@
M<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#(L-3<R+#<W-3PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG
M/B`H,2D\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K
M)SX@2G5L+3`Y("\@2F%N+3$P/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C
M:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#
M3TQ/4CH@8FQA8VLG/B`D/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B`R+C4P/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^($IA;BTQ-3PO=&0^(#PO
M='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET93L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#4P,"PP,#`\+W1D/B`\
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M<BTQ,"`O($]C="TQ,#PO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z
M(&)L86-K)SX@)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M0T],3U(Z(&)L86-K)SX@,2XX.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!/8W0M,34\+W1D/B`\+W1R/B`\
M='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T
M*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#$L,S(S+#(Q
M-#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`H,BD\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[
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M969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!#3TQ/4CH@8FQA8VLG/B`D/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`Q+C8S/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^($IA;BTQ-SPO=&0^
M(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET93L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#,W,2PT,C,\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M*#(I/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^
M($IU;BTQ,2`O($IU;BTQ,3PO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],
M3U(Z(&)L86-K)SX@)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@0T],3U(Z(&)L86-K)SX@,RXU,#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!*=6XM,38\+W1D/B`\+W1R
M/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L
M,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#
M3TQ/4CH@8FQA8VLG/B`T-BPU.#0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M*#$I/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2
M.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97([(%!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^($UA
M<BTQ,B`O($UA<BTQ,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L
M86-K)SX@)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@
M4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@,2XV,3PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@
M,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!#3TQ/4CH@8FQA8VLG/B!-87(M,C(\+W1D/B`\+W1R/B`\='(@<W1Y;&4]
M,T0G0D%#2T=23U5.1"U#3TQ/4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B
M;W1T;VTG/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU
M<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU
M<'0@9&]U8FQE.R!415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@-2PV
M,C`L,3(X/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R+C5P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R+C5P=#L@1D].5"U325I%
M.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#(N-7!T.R!&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0[($9/3E0M4TE:13H@,3!P
M="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@1D].5"U325I%.B`Q,'!T)SX@)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$
M24Y'+4)/5%1/33H@,BXU<'0[($9/3E0M4TE:13H@,3!P="<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/
M5%1/33H@,BXU<'0[($9/3E0M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0[($9/3E0M4TE:13H@
M,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R+C5P=#L@1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\+W1R/B`\
M+W1A8FQE/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Q
M,#`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ
M('1O<"<^(#QT9"!S='EL93TS1"=724142#H@,R4G/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=#3TQ/4CH@8FQA8VL[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(%=)1%1(.B`U)2<^("@Q*3PO=&0^(#QT
M9"!S='EL93TS1"=#3TQ/4CH@8FQA8VL[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(%=)1%1(.B`Y,B4G/B!4:&5S92!W87)R
M86YT<R!T;R!P=7)C:&%S92!C;VUM;VX@<W1O8VL@87)E(&-L87-S:69I960@
M87,@97%U:71Y+CPO=&0^(#PO='(^(#PO=&%B;&4^(#QP('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\
M=&%B;&4@<W1Y;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!313H@
M8V]L;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S
M='EL93TS1"=615)424-!3"U!3$E'3CH@=&]P)SX@/'1D('-T>6QE/3-$)U=)
M1%1(.B`S)2<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T-/3$]2.B!B;&%C
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M:65S+B!4:&4@9F%I<B!V86QU92!O9B!T:&5S92!L:6%B:6QI=&EE<R`H<V5E
M(&YO=&4@,RD@:7,@<F5M96%S=7)E9"!A="!T:&4@96YD(&]F(&5V97)Y(')E
M<&]R=&EN9R!P97)I;V0@86YD('1H92!C:&%N9V4@:6X@9F%I<B!V86QU92!I
M<R!R97!O<G1E9"!I;B!T:&4@=6YA=61I=&5D(&-O;F1E;G-E9"!C;VYS;VQI
M9&%T960@<W1A=&5M96YT<R!O9B!O<&5R871I;VYS(&%S(&]T:&5R(&EN8V]M
M92`H97AP96YS92DN/"]T9#X@/"]T<CX@/"]T86)L93X@/"$M+45N9$9R86=M
M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?838Q-V$Y-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D
M,6)D-V,U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B
M7S5D,S=?-#8V.%]A-#EB7S(R9&4P9#%B9#=C-2]7;W)K<VAE971S+U-H965T
M,3(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY&
M:6YA;F-I;F<@5')A;G-A8W1I;VYS/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1FEN86YC:6YG(%1R86YS86-T:6]N
M<R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D9I;F%N8VEN9R!4<F%N<V%C=&EO;G,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M
M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z
M+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA
M;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@
M<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/'-T<F]N9SY.;W1E(#8@+2!&:6YA
M;F-I;F<@5')A;G-A8W1I;VYS/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=4
M15A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@
M/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/&5M/D-O;G1R;VQL960@17%U
M:71Y($]F9F5R:6YG/"]E;3X\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T
M(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@3VX@
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M9"!B>2!L87<@86YD(&1E96UE9"!T;R!B92!A;B`B870M=&AE+6UA<FME="(@
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M=&5L>2`D,C<W+#`P,"X@5&AR;W5G:"!-87)C:"`S,2P@,C`Q,RP@=V4@<V]L
M9"`Q.2PY,#`@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@=6YD97(@=&AI
M<R!A<G)A;F=E;65N="P@=VAI8V@@9&ED(&YO="!S971T;&4@=6YT:6P@07!R
M:6P@,C`Q,RP@=&AA="!R97-U;'1E9"!I;B!N970@<')O8V5E9',@=&\@=&AE
M(&-O;7!A;GD@;V8@87!P<F]X:6UA=&5L>2`D,S,L,#`P+B!!<R!O9B!-87)C
M:"`S,2P@,C`Q,RP@86=G<F5G871E(&=R;W-S('-A;&5S(&9O<B!A9&1I=&EO
M;F%L(&-O;6UO;B!S=&]C:R!O9B!A<'!R;WAI;6%T96QY("0Q-"XY-R!M:6QL
M:6]N(')E;6%I;F5D(&%V86EL86)L92!U;F1E<B!T:&4@87)R86YG96UE;G0N
M/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP
M('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QE;3Y,;V%N($%G<F5E;65N="!W
M:71H($=%($-A<&ET86P\+V5M/CPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!/
M;B!-87)C:"`S,"P@,C`Q,BP@=V4@96YT97)E9"!I;G1O(&$@3&]A;B!!9W)E
M96UE;G0@=VET:"!'12!#87!I=&%L+B!4:&4@3&]A;B!!9W)E96UE;G0@<')O
M=FED97,@9F]R(&$@<V5N:6]R('-E8W5R960@9&5B="!F86-I;&ET>2!I;F-L
M=61I;F<@82`D,BXU(&UI;&QI;VX@=&5R;2!L;V%N(&%N9"!A(')E=F]L=FEN
M9R!L:6YE(&]F(&-R961I="!O9B!U<"!T;R`D-2!M:6QL:6]N(&)A<V5D(&]N
M(&]U<B!O=71S=&%N9&EN9R!Q=6%L:69I960@86-C;W5N=',@<F5C96EV86)L
M92X@3VX@36%R8V@@,S`L(#(P,3(L('1H92!T97)M(&QO86X@=V%S(&9U;F1E
M9"!F;W(@86X@86=G<F5G871E(&%M;W5N="!O9B`D,BXU(&UI;&QI;VXN/"]P
M/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T
M>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^(%5N9&5R('1H92!T97)M<R!O9B!T:&4@
M<F5V;VQV:6YG(&QI;F4@;V8@8W)E9&ET+"!T:&4@0V]M<&%N>2!M87D@9')A
M=R!D;W=N(&9R;VT@=&AE(')E=F]L=FEN9R!L:6YE(&]F(&-R961I="!U<"!T
M;R`X-24@;V8@<75A;&EF:65D(&)I;&QE9"!A8V-O=6YT<R!R96-E:79A8FQE
M(&%N9"`X,"4@;V8@<75A;&EF:65D('5N8FEL;&5D(&%C8V]U;G1S(')E8V5I
M=F%B;&4N($%S(&]F($UA<F-H(#,Q+"`R,#$S+"!T:&4@=&]T86P@86UO=6YT
M(&%V86EL86)L92!T;R!D<F%W('=A<R!A<'!R;WAI;6%T96QY("0R+C,@;6EL
M;&EO;BP@;V8@=VAI8V@@)#$N,R!M:6QL:6]N('=A<R!D<F%W;B!A;F0@;W5T
M<W1A;F1I;F<N/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@5&AE(&9I>&5D(&EN=&5R97-T(')A=&4@;VX@=&AE('1E<FT@
M;&]A;B!I<R`Q,"XQ-"4@<&5R(&%N;G5M+B!4:&4@<F5V;VQV:6YG(&QI;F4@
M;V8@8W)E9&ET(&AA<R!A;B!A9&IU<W1A8FQE(&EN=&5R97-T(')A=&4@8F%S
M960@=7!O;B!T:&4@,RUM;VYT:"!,;VYD;VX@26YT97)B86YK($]F9F5R960@
M4F%T92`H3$E"3U(I+"!W:71H(&$@9FQO;W(@;V8@,2XU)2P@<&QU<R`U)2X@
M07,@;V8@36%R8V@@,S$L(#(P,3,L('1H92!I;G1E<F5S="!R871E('=A<R`V
M+C4E+B!";W1H('1H92!T97)M(&QO86X@86YD('1H92!R979O;'9I;F<@;&EN
M92!O9B!C<F5D:70@;6%T=7)E(&EN(%-E<'1E;6)E<B`R,#$U+B!087EM96YT
M<R!O;B!T:&4@=&5R;2!L;V%N('=E<F4@;W)I9VEN86QL>2!I;G1E<F5S="UO
M;FQY(&9O<B!T:&4@9FER<W0@,3`@;6]N=&AS+"!W:&EC:"!H87,@<VEN8V4@
M8F5E;B!E>'1E;F1E9"!T;R`Q,B!M;VYT:',@<'5R<W5A;G0@=&\@=&5R;7,@
M;V8@=&AE(&%G<F5E;65N="X@4W5B<V5Q=65N=&QY+"!T:&4@=&5R;2!L;V%N
M('=I;&P@9G5L;'D@86UO<G1I>F4@;W9E<B!I=',@<F5M86EN:6YG('1E<FT@
M87,@;V8@36%R8V@@,S$L(#(P,3,N(%!R:6YC:7!A;"!P87EM96YT<R!O;B!T
M:&4@=&5R;2!L;V%N(&%R92!S8VAE9'5L960@87,@9F]L;&]W<SH\+W`^(#QP
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!
M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(
M.B`S-24[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'
M3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/
M3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],
M3U(Z(&)L86-K)R!C;VQS<&%N/3-$,CY996%R/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^
M(%!R:6YC:7!A;#QB<B`O/B!087EM96YT<SPO=&0^(#PO='(^(#QT<B!S='EL
M93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U=)1%1(.B`Q)3L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],
M3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@5TE$5$@Z(#$U)3L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],
M3U(Z(&)L86-K)SX@,C`Q,SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
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M3U(Z(&)L86-K)SX@)#<T.2PY.3<\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G
M0D%#2T=23U5.1"U#3TQ/4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T
M;VTG/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B
M;&%C:R<^(#(P,30\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B
M;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@0T],3U(Z(&)L86-K)SX@.3DY+#DY-CPO=&0^(#PO='(^(#QT<B!S='EL
M93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M8V5N=&5R.R!0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`R,#$U
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O
M;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@-S4P+#`P-SPO
M=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET
M93L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,BXU<'0[($9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]4
M5$]-.B`R+C5P=#L@1D].5"U325I%.B`Q,'!T)SX@)FYB<W`[/"]T9#X@/'1D
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M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`D,BPU,#`L,#`P
M/"]T9#X@/"]T<CX@/"]T86)L93X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$
M)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^(%1H92!T97)M(&QO86XL(&YE="!O9B!D:7-C;W5N
M="!O9B`D,SDL-3@W+"!I<R!R96-O<F1E9"!O;B!T:&4@,C`Q,R!C;VYD96YS
M960@8V]N<V]L:61A=&5D(&)A;&%N8V4@<VAE970L(&YE="!O9B!D96)T(&1I
M<V-O=6YT+"!A<R!F;VQL;W=S.CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%
M3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QT86)L92!S
M='EL93TS1"=724142#H@-30E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y;&4],T0G
M0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D525$E#04PM
M04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!724142#H@-#`E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@0W5R<F5N="!P;W)T:6]N(&]F(&QO;F<M=&5R;2!D96)T
M/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`R)3L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`D/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@,3`E.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@.3DY+#DY
M-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@
M,24[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B`F;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#
M3TQ/4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^($QO;F<M=&5R;2!D96)T+"!L97-S(&-U
M<G)E;G0@<&]R=&EO;CPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^("0\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`Q+#0V,"PT,3<\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO=&0^(#PO='(^(#PO=&%B;&4^(#QP
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!)9B!W92!P
M<F5P87D@=&AE('1E<FT@;&]A;B!A;F0@=&5R;6EN871E('1H92!R979O;'9I
M;F<@;&EN92!O9B!C<F5D:70@<')I;W(@=&\@=&AE('-C:&5D=6QE9"!M871U
M<FET>2!D871E+"!W92!A<F4@;V)L:6=A=&5D('1O('!A>2!A('!R97!A>6UE
M;G0@<')E;6EU;2!E<75A;"!T;R`S)2!O9B!T:&4@=&AE;B!O=71S=&%N9&EN
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M;VYD96YS960@8V]N<V]L:61A=&5D(&)A;&%N8V4@<VAE970N/"]P/B`\<"!S
M='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$
M)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^($]U<B!O8FQI9V%T:6]N<R!U;F1E<B!T:&4@3&]A
M;B!!9W)E96UE;G0@87)E(&-O;&QA=&5R86QI>F5D(&)Y(&$@<V5C=7)I='D@
M:6YT97)E<W0@:6X@<W5B<W1A;G1I86QL>2!A;&P@;V8@;W5R(&%S<V5T<RX@
M5VAI;&4@=&AE('-E8W5R:71Y(&EN=&5R97-T(&1O97,@;F]T+"!E>&-E<'0@
M:6X@;&EM:71E9"!C:7)C=6US=&%N8V5S+"!C;W9E<B!O=7(@:6YT96QL96-T
M=6%L('!R;W!E<G1Y+"!I="!D;V5S(&-O=F5R(&%N>2!P<F]C965D<R!R96-E
M:79E9"!B>2!U<R!F<F]M('1H92!U<V4@;W(@<V%L92!O9B!O=7(@:6YT96QL
M96-T=6%L('!R;W!E<G1Y+CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$
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M:6YT97)E<W0@;65T:&]D+CPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@
M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].
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M<G)Y:6YG('9A;'5E(&%S(&]F($UA<F-H(#,Q+"`R,#$S+CPO<#X@/"$M+45N
M9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y-6)?-60S-U\T-C8X7V$T.6)?
M,C)D93!D,6)D-V,U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V$V
M,3=A.35B7S5D,S=?-#8V.%]A-#EB7S(R9&4P9#%B9#=C-2]7;W)K<VAE971S
M+U-H965T,3,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY3=6)S97%U96YT($5V96YT<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U8G-E<75E;G0@179E;G0@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3=6)S97%U96YT($5V96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$
M(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO
M<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^
M/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=-
M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B`\<W1R;VYG/DYO=&4@-R`M(%-U8G-E<75E;G0@179E
M;G1S/"]S=')O;F<^/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N
M8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@4W5B<V5Q=65N
M="!T;R!-87)C:"`S,2P@,C`Q,RP@=V4@<V]L9"`Q+#`S,"PX-S`@<VAA<F5S
M(&]F(&]U<B!C;VUM;VX@<W1O8VL@=6YD97(@=&AE(&-O;G1R;VQL960@97%U
M:71Y(&]F9F5R:6YG+"!W:&EC:"!R97-U;'1E9"!I;B!N970@<')O8V5E9',@
M;V8@87!P<F]X:6UA=&5L>2`D,2XV,R!M:6QL:6]N+B`H4V5E($YO=&4@-BDN
M($$\9F]N="!S='EL93TS1"=#3TQ/4CH@8FQA8VLG/F=G<F5G871E(&=R;W-S
M('!R;V-E961S(&]F('5P('1O(&%P<')O>&EM871E;'D@)#$S+C(Y(&UI;&QI
M;VX@<F5M86EN(&%V86EL86)L92!U;F1E<CPO9F]N=#X@=&AE(&%R<F%N9V5M
M96YT+CPO<#X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y-6)?
M-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V.%]A-#EB7S(R9&4P9#%B
M9#=C-2]7;W)K<VAE971S+U-H965T,30N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5"3T%#/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-U;6UA<GD@;V8@4VEG;FEF:6-A;G0@
M06-C;W5N=&EN9R!0;VQI8VEE<R`H4&]L:6-Y*3QB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U;6UA<GD@;V8@4VEG
M;FEF:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<R!;06)S=')A8W1=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A<VES(&]F
M(%!R97-E;G1A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N
M,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT
M;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I
M=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`\96T^0F%S:7,@;V8@4')E<V5N=&%T:6]N/"]E;3X\+W`^(#QP('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB
M<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
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M:&4@56YI=&5D(%-T871E<R`H(E4N4RX@1T%!4"(I+B!);B!T:&4@;W!I;FEO
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M;6)E<B`S,2P@,C`Q,B!H87,@8F5E;B!D97)I=F5D(&9R;VT@875D:71E9"!C
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M;W)M(#$P+4L@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$R
M+"!F:6QE9"!W:71H('1H92!396-U<FET:65S(&%N9"!%>&-H86YG92!#;VUM
M:7-S:6]N+B!792!C=7)R96YT;'D@;W!E<F%T92!I;B!O;F4@8G5S:6YE<W,@
M<V5G;65N="X\+W`^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E5S92!O9B!%<W1I;6%T97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-
M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12
M+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^
M(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@<W1Y;&4],T0G34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@/&5M/E5S92!O9B!%<W1I;6%T97,\+V5M/CPO<#X@/'`@<W1Y
M;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S
M<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P
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M9F]N="!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXN/"]F;VYT/CPO<#X@/"$M+45N9$9R86=M96YT+2T^/"]D
M:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1F]R96EG;B!#=7)R96YC>2!4<F%N<VQA=&EO;CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!0
M54),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.
M(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A
M;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N
M="TM/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\96T^1F]R96EG;B!#
M=7)R96YC>2!4<F%N<VQA=&EO;CPO96T^/"]P/B`\<"!S='EL93TS1"=415A4
M+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@
M<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@5&AE(&9U;F-T:6]N86P@8W5R<F5N
M8WD@;V8@;W5R('=H;VQL>2!O=VYE9"!F;W)E:6=N('-U8G-I9&EA<FEE<R!I
M<R!T:&5I<B!L;V-A;"!C=7)R96YC>2X@07-S971S(&%N9"!L:6%B:6QI=&EE
M<R!O9B!O=7(@9F]R96EG;B!S=6)S:61I87)I97,@87)E('1R86YS;&%T960@
M:6YT;R!5;FET960@4W1A=&5S(&1O;&QA<G,@8F%S960@;VX@97AC:&%N9V4@
M<F%T97,@870@=&AE(&5N9"!O9B!T:&4@<F5P;W)T:6YG('!E<FEO9"X@26YC
M;VUE(&%N9"!E>'!E;G-E(&ET96US(&%R92!T<F%N<VQA=&5D(&%T('1H92!W
M96EG:'1E9"!A=F5R86=E(&5X8VAA;F=E(')A=&5S('!R979A:6QI;F<@9'5R
M:6YG('1H92!R97!O<G1I;F<@<&5R:6]D+B`\9F]N="!S='EL93TS1"=#3TQ/
M4CH@8FQA8VLG/E1R86YS;&%T:6]N(&%D:G5S=&UE;G1S(&9O<B!S=6)S:61I
M87)I97,@=&AA="!H879E(&YO="!B965N('-O;&0L('-U8G-T86YT:6%L;'D@
M;&EQ=6ED871E9"!O<B!O=&AE<G=I<V4@9&ES<&]S960@;V8L(&%R92!A8V-U
M;75L871E9"!I;B!O=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H;&]S<RDL
M(&$@8V]M<&]N96YT(&]F('-T;V-K:&]L9&5R<R8C,SD[(&5Q=6ET>2X\+V9O
M;G0^($9O<F5I9VX@8W5R<F5N8WD@=')A;G-L871I;VX@861J=7-T;65N=',@
M87)E('1H92!S;VQE(&-O;7!O;F5N="!O9B!A8V-U;75L871E9"!O=&AE<B!C
M;VUP<F5H96YS:79E(&QO<W,@870@36%R8V@@,S$L(#(P,3,@86YD($1E8V5M
M8F5R(#,Q+"`R,#$R+B`\9F]N="!S='EL93TS1"=#3TQ/4CH@8FQA8VLG/E1R
M86YS86-T:6]N(&=A:6YS(&]R(&QO<W-E<R!A<F4@:6YC;'5D960@:6X@=&AE
M(&1E=&5R;6EN871I;VX@;V8@;F5T(&QO<W,N/"]F;VYT/CPO<#X@/"$M+45N
M9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M<')E:&5N<VEV92!,;W-S
M(&%N9"!!8V-U;75L871E9"!/=&AE<B!#;VUP<F5H96YS:79E($EN8V]M93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M+41/0U194$4@:'1M
M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO
M+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M
M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G
M;65N="TM/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\96T^0V]M<')E
M:&5N<VEV92!,;W-S(&%N9"!!8V-U;75L871E9"!/=&AE<B!#;VUP<F5H96YS
M:79E($EN8V]M93PO96T^/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@0V]M<')E
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M;2!A=F%I;&%B;&4M9F]R+7-A;&4@:6YV97-T;65N=',N/"]P/B`\(2TM16YD
M1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!#87-H($5Q=6EV
M86QE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#
M5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS
M:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$
M+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3
M=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QE
M;3Y#87-H(&%N9"!#87-H($5Q=6EV86QE;G1S/"]E;3X\+W`^(#QP('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[
M/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!#87-H(&%N9"!C87-H
M(&5Q=6EV86QE;G1S(&%R92!S=&%T960@870@;6%R:V5T('9A;'5E+B!792!C
M;VYS:61E<B!A;&P@:&EG:&QY(&QI<75I9"!I;G9E<W1M96YT<R!W:71H(&]R
M:6=I;F%L(&UA='5R:71I97,@;V8@=&AR964@;6]N=&AS(&]R(&QE<W,@=&\@
M8F4@8V%S:"!E<75I=F%L96YT<RX\+W`^(#PA+2U%;F1&<F%G;65N="TM/CPO
M9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)E=F]L=FEN9R!,:6YE(&]F($-R961I="!A;F0@5&5R
M;2!,;V%N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#
M5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS
M:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$
M+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3
M=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QE
M;3Y2979O;'9I;F<@3&EN92!O9B!#<F5D:70@86YD(%1E<FT@3&]A;CPO96T^
M/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@
M,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M07,@9&ES8W5S<V5D(&9U<G1H97(@:6X@3F]T92`V+"!W92!E;G1E<F5D(&EN
M=&\@82!L;V%N(&%G<F5E;65N="!W:71H($=E;F5R86P@16QE8W1R:6,@0V%P
M:71A;"!#;W)P;W)A=&EO;B`H(D=%($-A<&ET86PB*2!I;B!-87)C:"`R,#$R
M+B!!<R!P87)T(&]F('1H870@86=R965M96YT+"!W92!I<W-U960@<W1O8VL@
M<'5R8VAA<V4@=V%R<F%N=',@=&\@1T4@0V%P:71A;"!T:&%T(&5X<&ER92!I
M;B!-87)C:"`R,#(R+B!4:&4@9F%I<B!V86QU92!O9B!T:&4@=V%R<F%N=',@
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M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VEG
M;FEF:6-A;G0@0W5S=&]M97)S(&%N9"!!8V-O=6YT<R!296-E:79A8FQE/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#5%E012!H=&UL
M(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O
M14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT
M<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M
M96YT+2T^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QE;3Y3:6=N:69I
M8V%N="!#=7-T;VUE<G,@86YD($%C8V]U;G1S(%)E8V5I=F%B;&4\+V5M/CPO
M<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@
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M+"`R,#$R+"!T:&4@0V]M<&%N>28C,SD[<R!T<F%D92!R96-E:79A8FQE(&%N
M9"!U;F)I;&QE9"!R96-E:79A8FQE(&)A;&%N8V5S('=E<F4@8V]M<')I<V5D
M('-O;&5L>2!O9B!R96-E:79A8FQE<R!F<F]M($-"35,@86YD($)!4D1!+CPO
M<#X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V]O9'=I;&P\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT
M;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L
M+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ
M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A
M9VUE;G0M+3X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/&5M/D=O;V1W
M:6QL/"]E;3X\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[
M/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
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M/'-U<#YS=#PO<W5P/B!B>2!C;VUP87)I;F<@;W5R(&UA<FME="!V86QU92`H
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M;G0@87-S97-S;65N="!O9B!G;V]D=VEL;"!A<R!O9B!$96-E;6)E<B`S,2P@
M,C`Q,B!A;F0@9&5T97)M:6YE9"!T:&%T('1H97)E('=A<R!N;R!I;7!A:7)M
M96YT(&%S(&]F('1H870@9&%T92X\+W`^(#PA+2U%;F1&<F%G;65N="TM/CPO
M9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)E=F5N=64@4F5C;V=N:71I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M
M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z
M+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA
M;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@
M<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@/&5M/E)E=F5N=64@4F5C;V=N:71I
M;VX\+V5M/CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-
M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@5V4@9V5N97)A=&4@;W5R(')E=F5N=64@9G)O;2!D:69F97)E;G0@
M='EP97,@;V8@8V]N=')A8W1U86P@87)R86YG96UE;G1S.B!C;W-T+7!L=7,M
M9F5E(&-O;G1R86-T<RP@8V]S="!R96EM8G5R<V%B;&4@9W)A;G1S(&%N9"!F
M:7AE9"!P<FEC92!C;VYT<F%C=',N/"]P/B`\<"!S='EL93TS1"=415A4+4E.
M1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y
M;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
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M('1H92!C;VYT<F%C="X\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-
M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
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M.R`H:6EI*2!C;VQL96-T:6]N(&ES(')E87-O;F%B;'D@87-S=7)E9#L@86YD
M("AI=BD@<W5B<W1A;G1I=F4@969F;W)T('=A<R!N96-E<W-A<GD@=&\@86-H
M:65V92!T:&4@;6EL97-T;VYE+CPO<#X@/'`@<W1Y;&4],T0G34%21TE..B`P
M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!-
M:6QE<W1O;F5S(&%R92!C;VYS:61E<F5D('-U8G-T86YT:79E(&EF(&%L;"!O
M9B!T:&4@9F]L;&]W:6YG(&-O;F1I=&EO;G,@87)E(&UE=#H\+W`^(#QP('-T
M>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE
M/3-$)TU!4D=)3BU43U`Z(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@34%21TE.+4)/5%1/33H@,'!X)R!C96QL<W!A
M8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y;&4],T0G5$585"U!
M3$E'3CH@:G5S=&EF>3L@5D525$E#04PM04Q)1TXZ('1O<"<^(#QT9"!S='EL
M93TS1"=724142#H@,"XR-6EN)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#`N,C5I;CLG/B`F;6ED9&]T.SPO
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M<F9O<FUA;F-E('1O(&%C:&EE=F4@=&AE(&UI;&5S=&]N92P\+W1D/B`\+W1R
M/B`\+W1A8FQE/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\
M+W`^(#QT86)L92!S='EL93TS1"=-05)'24XM5$]0.B`P<'@[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($U!4D=)3BU"3U14
M3TTZ(#!P>"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%9%4E1)0T%,+4%,24=.
M.B!T;W`G/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#`N,C5I;B<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`P+C(U
M:6X[)SX@)FUI9&1O=#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!415A4+4%,24=..B!J
M=7-T:69Y)SX@:70@<F5L871E<R!S;VQE;'D@=&\@<&%S="!P97)F;W)M86YC
M92P\+W1D/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`F;F)S<#L\+W`^(#QT86)L92!S='EL93TS1"=-05)'24XM5$]0.B`P
M<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M($U!4D=)3BU"3U143TTZ(#!P>"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D
M:6YG/3-$,#X@/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU<W1I9GD[(%9%
M4E1)0T%,+4%,24=..B!T;W`G/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#`N,C5I
M;B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[
M('=I9'1H.B`P+C(U:6X[)SX@)FUI9&1O=#L\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!4
M15A4+4%,24=..B!J=7-T:69Y)SX@=&AE('9A;'5E(&]F('1H92!M:6QE<W1O
M;F4@:7,@<F5A<V]N86)L92!R96QA=&EV92!T;R!A;&P@=&AE(&1E;&EV97)A
M8FQE<R!A;F0@<&%Y;65N="!T97)M<R`H:6YC;'5D:6YG(&]T:&5R('!O=&5N
M=&EA;"!M:6QE<W1O;F4@8V]N<VED97)A=&EO;BD@=VET:&EN('1H92!A<G)A
M;F=E;65N="X\+W1D/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL93TS1"=415A4
M+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@
M<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
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M:6=A=&EO;G,N/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[
M($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
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M<B!W:&EC:"!T:&5Y(&%R92!U<V5D+CPO<#X@/'`@<W1Y;&4],T0G5$585"U)
M3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T
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M=',@<F5C96EV86)L92X\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-
M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
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M9&5D(&%P<')O>&EM871E;'D@)#`N,#(@;6EL;&EO;B!A;F0@)#`N-2!M:6QL
M:6]N+"!R97-P96-T:79E;'DL(&]F(&-O<W1S(')E:6UB=7)S960@8GD@=&AE
M(&=O=F5R;FUE;G0@87,@86X@;V9F<V5T('1O(')E<V5A<F-H(&%N9"!D979E
M;&]P;65N="!E>'!E;G-E<RX\+W`^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV
M/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E-H87)E+4)A<V5D($-O;7!E;G-A=&EO;CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!054),24,@
M(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T
M<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO
M;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\
M<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`\96T^4VAA<F4M0F%S960@0V]M
M<&5N<V%T:6]N/"]E;3X\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-
M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
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M<&QO>65E)B,S.3MS(')E<75I<VET92!S97)V:6-E('!E<FEO9"X\+W`^(#QP
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z
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M<FEO9"X\+W`^(#QP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\<"!S='EL93TS1"=-05)'24XZ(#!P
M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
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M96ET=7)E<RX\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P
M.SPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@34%21TE.
M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@4VAA<F4M8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4@9F]R
M('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@,S$L(#(P,3,@86YD(#(P
M,3(@=V%S.CPO<#X@/'`@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S=&EF>3L@
M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\=&%B;&4@<W1Y;&4],T0G5TE$
M5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL93TS1"=615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ
M(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<@8V]L<W!A;CTS1#8^5&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q
M+#PO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4]
M,T0G5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED
M.R!415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G(&-O;'-P86X],T0R/C(P,3,\+W1D/B`\=&0@
M<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M
M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<@8V]L<W!A;CTS1#(^,C`Q,CPO=&0^(#QT9"!S='EL93TS
M1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF
M;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ
M(&)O='1O;2<^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U325I%
M.B`Q,'!T)R!C;VQS<&%N/3-$,CX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P="<@8V]L<W!A;CTS1#(^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T
M>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%
M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@5TE$5$@Z(#<R)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^(%)E<V5A<F-H(&%N9"!D979E;&]P;65N=#PO
M=&0^(#QT9"!S='EL93TS1"=724142#H@,B4[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$P)3L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#@X+#8S-#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("0\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q,"4[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`Q
M,3<L,#8W/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)
M1%1(.B`Q)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^("9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/
M54Y$+4-/3$]2.B!W:&ET93L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@1V5N97)A;"!A;F0@861M:6YI
M<W1R871I=F4\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@,C,Y+#DT-SPO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O
M;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^(#0S,2PU.3<\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL
M93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)4
M24-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B!4;W1A;"!S:&%R92UB87-E9"!C;VUP96YS871I;VX@97AP96YS93PO
M=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P
M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@,S(X+#4X,3PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R+C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`D/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$58
M5"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B`U-#@L-C8T/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`F;F)S<#L\+W1D/B`\+W1R/B`\+W1A8FQE/B`\<"!S='EL
M93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!
M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^($1U<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D($UA
M<F-H(#,Q+"`R,#$S+"!W92!G<F%N=&5D(#8P+#`P,"!O<'1I;VYS('1O(&5M
M<&QO>65E<R!A;F0@8V]N<W5L=&%N=',@86YD(&UA9&4@;F\@<F5S=')I8W1E
M9"!S=&]C:R!G<F%N=',N($1U<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D
M($UA<F-H(#,Q+"`R,#$R+"!W92!G<F%N=&5D(#$U+#DT."!O<'1I;VYS('1O
M(&5M<&QO>65E<R!A;F0@;6%D92!N;R!R97-T<FEC=&5D('-T;V-K(&=R86YT
M<RX@070@36%R8V@@,S$L(#(P,3,L('=E(&AA9"!T;W1A;"!U;G)E8V]G;FEZ
M960@<VAA<F4M8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4@<F5L871E9"!T
M;R!U;G9E<W1E9"!A=V%R9',@;V8@87!P<F]X:6UA=&5L>2`D,BXP(&UI;&QI
M;VX@;F5T(&]F(&5S=&EM871E9"!F;W)F96ET=7)E<RP@=VAI8V@@=V4@97AP
M96-T('1O(')E8V]G;FEZ92!A<R!E>'!E;G-E(&]V97(@82!W96EG:'1E9"UA
M=F5R86=E('!E<FEO9"!O9B`R+C(U('EE87)S+CPO<#X@/"$M+45N9$9R86=M
M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^26YC;VUE(%1A>&5S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B
M+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P
M.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N
M86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP
M('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^(#QE;3Y);F-O;64@5&%X97,\+V5M
M/CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ
M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P
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M=&%X(&5X<&5N<V4N/"]P/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU
M:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'`@<W1Y;&4],T0G34%2
M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@26YC;VUE('1A>"!E>'!E;G-E('=A<R`D.2PW-#,@86YD
M("0Q-3`L-#`U(&1U<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D($UA<F-H
M(#,Q+"`R,#$S(&%N9"`R,#$R+"!R97-P96-T:79E;'DN($EN8V]M92!T87@@
M97AP96YS92!I<R!A(')E<W5L="!O9B!T:&4@9&EF9F5R96YC92!B971W965N
M('1H92!T<F5A=&UE;G0@;V8@9V]O9'=I;&P@9F]R(&EN8V]M92!T87@@<'5R
M<&]S97,@86YD(&9O<B!5+E,N($=!05`L(')E<W5L=&EN9R!I;B!A(&1E9F5R
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M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%S:6,@86YD($1I
M;'5T960@3F5T($QO<W,@4&5R(%-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$
M5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S
M+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M
M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP('-T>6QE/3-$
M)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^(#QE;3Y"87-I8R!A;F0@1&EL=71E9"!.970@3&]S
M<R!097(@4VAA<F4\+V5M/CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$
M)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^(#QE;3Y);F-O;64@*&QO<W,I('!E<B!S:&%R93H\
M+V5M/B!"87-I8R!I;F-O;64@*&QO<W,I('!E<B!S:&%R92!I<R!C;VUP=71E
M9"!B>2!D:79I9&EN9R!C;VYS;VQI9&%T960@;F5T(&EN8V]M92`H;&]S<RD@
M8GD@=&AE('=E:6=H=&5D(&%V97)A9V4@;G5M8F5R(&]F(&-O;6UO;B!S:&%R
M97,@;W5T<W1A;F1I;F<@9'5R:6YG('1H92!P97)I;V0L(&5X8VQU9&EN9R!U
M;G9E<W1E9"!R97-T<FEC=&5D('-T;V-K+CPO<#X@/'`@<W1Y;&4],T0G5$58
M5"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP
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M<'!L>6EN9R!T:&4@=')E87-U<GD@<W1O8VL@;65T:&]D+CPO<#X@/'`@<W1Y
M;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S
M<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^($9O<B!T:&4@<&5R
M:6]D<R!O9B!N970@;&]S<RP@9&EL=71E9"!L;W-S('!E<B!S:&%R92!I<R!C
M86QC=6QA=&5D('-I;6EL87)L>2!T;R!B87-I8R!L;W-S('!E<B!S:&%R92!B
M96-A=7-E('1H92!I;7!A8W0@;V8@86QL(&1I;'5T:79E('!O=&5N=&EA;"!C
M;VUM;VX@<VAA<F5S(&ES(&%N=&DM9&EL=71I=F4@9'5E('1O('1H92!N970@
M;&]S<V5S+B!!('1O=&%L(&]F(&%P<')O>&EM871E;'D@,3$N-B!M:6QL:6]N
M(&%N9"`Q,2XU(&UI;&QI;VX@<&]T96YT:6%L(&1I;'5T:79E('-E8W5R:71I
M97,@:&%V92!B965N(&5X8VQU9&5D(&EN('1H92!C86QC=6QA=&EO;B!O9B!D
M:6QU=&5D(&YE="!L;W-S('!E<B!S:&%R92!I;B!T:&4@=&AR964@;6]N=&AS
M(&5N9&5D($UA<F-H(#,Q+"`R,#$S(&%N9"`R,#$R+"!R97-P96-T:79E;'DL
M(&)E8V%U<V4@=&AE:7(@:6YC;'5S:6]N('=O=6QD(&)E(&%N=&DM9&EL=71I
M=F4N/"]P/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296-E
M;G0@06-C;W5N=&EN9R!0<F]N;W5N8V5M96YT<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S
M0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W
M=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T
M9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL
M93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B`\96T^4F5C96YT($%C8V]U;G1I;F<@4')O
M;F]U;F-E;65N=',\+V5M/CPO<#X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z
M(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$
M)T-/3$]2.B!B;&%C:SL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@34%21TE..B`P<'0@,'!X)SX@5V4@:&%V92!E=F%L=6%T
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M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?838Q-V$Y-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D
M,6)D-V,U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B
M7S5D,S=?-#8V.%]A-#EB7S(R9&4P9#%B9#=C-2]7;W)K<VAE971S+U-H965T
M,34N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3
M=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,@*%1A
M8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S
M,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L
M:6-I97,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y38VAE9'5L92!O9B!3:&%R92UB87-E9"!#;VUP96YS
M871I;VX@17AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N
M,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT
M;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I
M=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S='EL93TS1"=415A4+4%,24=.
M.B!J=7-T:69Y.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!3:&%R92UB87-E9"!C;VUP96YS
M871I;VX@97AP96YS92!F;W(@=&AE('1H<F5E(&UO;G1H<R!E;F1E9"!-87)C
M:"`S,2P@,C`Q,R!A;F0@,C`Q,B!W87,Z/"]P/B`\<"!S='EL93TS1"=415A4
M+4%,24=..B!J=7-T:69Y.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QT
M86)L92!S='EL93TS1"=724142#H@,3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C
M;VQL87!S93L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T
M>6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S
M;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C;VQS<&%N/3-$-CY4:')E92!M;VYT
M:',@96YD960@36%R8V@@,S$L/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO=&0^
M(#PO='(^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V]L<W!A;CTS
M1#(^,C`Q,SPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C;VQS<&%N/3-$,CXR,#$R
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS
M1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT.R!&3TY4+5-)6D4Z(#$P<'0G(&-O;'-P86X],T0R/B`F;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)R!C;VQS<&%N/3-$,CXF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\
M+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B
M*#(P-"PR-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@-S(E.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@4F5S96%R8V@@
M86YD(&1E=F5L;W!M96YT/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`R)3L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!72414
M2#H@,24[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`D/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!7
M24142#H@,3`E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SX@.#@L-C,T/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=72414
M2#H@,B4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX@)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H=#L@5TE$5$@Z(#$P)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^(#$Q-RPP-C<\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@/"]T<CX@/'1R
M('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!'
M96YE<F%L(&%N9"!A9&UI;FES=')A=&EV93PO=&0^(#QT9"!S='EL93TS1"=&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T
M('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'
M3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B`R,SDL.30W/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@-#,Q+#4Y
M-SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T
M9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R
M,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^(%1O=&%L('-H87)E+6)A<V5D(&-O;7!E
M;G-A=&EO;B!E>'!E;G-E/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C5P="!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`D/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`S
M,C@L-3@Q/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@
M;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^("0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#4T."PV-C0\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P.SPO=&0^(#PO='(^
M(#PO=&%B;&4^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
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M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%2T@^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^1F%I<B!686QU92!-96%S=7)E;65N=',@
M*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R
M+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY&86ER(%9A;'5E($UE87-U<F5M96YT<R!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C
M:&5D=6QE(&]F($QI86)I;&ET:65S($UE87-U<F5D(&%T($9A:7(@5F%L=64\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT
M;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L
M+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ
M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A
M9VUE;G0M+3X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@5&AE(&9O;&QO
M=VEN9R!T86)L92!R97!R97-E;G1S('1H92!#;VUP86YY)B,S.3MS(&9A:7(@
M=F%L=64@:&EE<F%R8VAY(&9O<B!I=',@9FEN86YC:6%L(&%S<V5T<R!A;F0@
M;&EA8FEL:71I97,@;65A<W5R960@870@9F%I<B!V86QU92!O;B!A(')E8W5R
M<FEN9R!B87-I<SH\+W`^(#QP('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N
M8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`Q,#`E.R!"3U)$15(M
M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT
M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T
M('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<@8V]L<W!A
M;CTS1#$T/D%S(&]F($UA<F-H(#,Q+"`R,#$S/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^
M(#PO='(^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q
M<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)R!C;VQS
M<&%N/3-$,CY,979E;"`Q/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED
M.R!415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<@8V]L<W!A;CTS1#(^
M3&5V96P@,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#
M3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!
M3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG(&-O;'-P86X],T0R/DQE=F5L(#,\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L
M86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E
M;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@0T],3U(Z(&)L86-K)R!C;VQS<&%N/3-$,CY"86QA;F-E/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N
M8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@
M8F]T=&]M)SX@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^($QI86)I;&ET:65S
M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-)6D4Z
M(#$P<'0G(&-O;'-P86X],T0R/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0[($9/3E0M4TE:13H@,3!P="<@8V]L<W!A;CTS1#(^("9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U325I%
M.B`Q,'!T)R!C;VQS<&%N/3-$,CX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT.R!&3TY4+5-)6D4Z(#$P<'0G(&-O;'-P86X],T0R/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)SXF;F)S
M<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@
M<F=B*#(P-"PR-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@-#0E.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
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M:R<^("0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)
M1%1(.B`Q,"4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[($-/3$]2.B!B;&%C:R<^("T\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z
M(#$E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!#3TQ/4CH@8FQA8VLG/B`D/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT.R!724142#H@,3`E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`M/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L
M86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`R)3L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z
M(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$P)3L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K
M)SX@,BPR,#$L,SDP/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%=)1%1(.B`Q)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)U=)1%1(.B`R)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L
M86-K)SX@)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@
M5TE$5$@Z(#$P)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@0T],3U(Z(&)L86-K)SX@,BPR,#$L,SDP/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K
M)SX@)FYB<W`[/"]T9#X@/"]T<CX@/"]T86)L93X@/'`@<W1Y;&4],T0G5$58
M5"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@
M)FYB<W`[/"]P/B`\=&%B;&4@<W1Y;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%
M4BU#3TQ,05!313H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`^(#QT<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@
M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q
M<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)R!C;VQS
M<&%N/3-$,30^07,@;V8@1&5C96UB97(@,S$L(#(P,3(\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[
M/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T
M;VTG/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K
M)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG
M(&-O;'-P86X],T0R/DQE=F5L(#$\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@
M<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)R!C;VQS<&%N
M/3-$,CY,979E;"`R/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O;&ED.R!4
M15A4+4%,24=..B!C96YT97([($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<@8V]L<W!A;CTS1#(^3&5V
M96P@,SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/
M4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'
M3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG(&-O;'-P86X],T0R/D)A;&%N8V4\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K
M)SX@)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,
M24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@3&EA8FEL
M:71I97,\+W1D/B`\=&0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T)SXF;F)S
M<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0M
M4TE:13H@,3!P="<@8V]L<W!A;CTS1#(^("9N8G-P.SPO=&0^(#QT9"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H=#L@1D].5"U325I%.B`Q,'!T)R!C;VQS<&%N/3-$
M,CX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4
M+5-)6D4Z(#$P<'0G(&-O;'-P86X],T0R/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0[($9/3E0M4TE:13H@,3!P="<@8V]L<W!A;CTS
M1#(^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G
M/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/
M3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M
M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`T-"4[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/
M3$]2.B!B;&%C:R<^($1E<FEV871I=F5S(&EN<W1R=6UE;G1S/"]T9#X@/'1D
M('-T>6QE/3-$)U=)1%1(.B`R)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].
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M4V5R:68[($-/3$]2.B!B;&%C:R<^("0\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q,"4[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("T\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/
M4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(E
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#
M3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`D/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@,3`E.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`Q+#(Y-2PV,3,\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/
M4CH@8FQA8VLG/B`D/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT.R!724142#H@,3`E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`Q+#(Y-2PV,3,\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`F;F)S<#L\+W1D/B`\+W1R/B`\+W1A8FQE/B`\(2TM16YD1G)A
M9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F($-H86YG97,@:6X@
M1F%I<B!686QU92!O9B!,979E;"`S($QI86)I;&ET:65S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B
M+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P
M.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N
M86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QP
M('-T>6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^(%1H92!F;VQL;W=I;F<@=&%B;&4@
M<V5T<R!F;W)T:"!A('-U;6UA<GD@;V8@8VAA;F=E<R!I;B!T:&4@9F%I<B!V
M86QU92!O9B!O=7(@3&5V96P@,R!L:6%B:6QI=&EE<R!F;W(@=&AE('1H<F5E
M(&UO;G1H<R!E;F1E9"!-87)C:"`S,2P@,C`Q,SH\+W`^(#QP('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P
M/B`\=&%B;&4@<W1Y;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!3
M13H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT
M<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!$97-C<FEP=&EO;CPO=&0^(#QT9"!S
M='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-O;'-P86X],T0R
M/D)A;&%N8V4@87,@;V8\8G(@+SX@1&5C96UB97(@,S$L/&)R("\^(#(P,3(\
M+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L
M:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<@8V]L<W!A;CTS1#(^56YR96%L:7IE9"!,
M;W-S97,\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q
M<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V]L<W!A;CTS1#(^0F%L86YC
M92!A<R!O9CQB<B`O/B!-87)C:"`S,2P\8G(@+SX@,C`Q,SPO=&0^(#QT9"!S
M='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF;F)S<#L\+W1D/B`\+W1R/B`\='(@<W1Y;&4],T0G5D525$E#04PM
M04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=724142#H@-3@E.R!&3TY4
M+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=724142#H@
M,B4[($9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5"U325I%.B`Q,'!T
M)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M.R!724142#H@,3`E.R!&3TY4+5-)6D4Z(#$P<'0G/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4
M+5-)6D4Z(#$P<'0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z
M(#(E.R!&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/3E0M4TE:13H@,3!P
M="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M=#L@5TE$5$@Z(#$P)3L@1D].5"U325I%.B`Q,'!T)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].
M5"U325I%.B`Q,'!T)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(
M.B`R)3L@1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4+5-)6D4Z(#$P
M<'0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0[(%=)1%1(.B`Q,"4[($9/3E0M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/
M3E0M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS
M1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR,#0I.R!615)424-!
M3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B!$97)I=F%T:79E(&QI86)I;&ET:65S(')E;&%T960@=&\@<W1O8VL@<'5R
M8VAA<V4@=V%R<F%N=',\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`D/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX@,2PR.34L-C$S/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`D/"]T9#X@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@.3`U+#<W-SPO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#(L,C`Q+#,Y,#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@
M/"]T<CX@/"]T86)L93X@/'`@<W1Y;&4],T0G5$585"U)3D1%3E0Z(#`N-6EN
M.R!-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QP('-T>6QE/3-$)TU!4D=)
M3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^(%1H92!F;VQL;W=I;F<@=&%B;&4@<V5T<R!F;W)T:"!A('-U
M;6UA<GD@;V8@8VAA;F=E<R!I;B!T:&4@9F%I<B!V86QU92!O9B!T:&4@0V]M
M<&%N>28C,SD[<R!,979E;"`S(&QI86)I;&ET:65S(&9O<B!T:&4@=&AR964@
M;6]N=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$R.CPO<#X@/'`@<W1Y;&4],T0G
M5$585"U!3$E'3CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'
M24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B`F;F)S<#L\+W`^(#QT86)L92!S='EL93TS1"=724142#H@
M,3`P)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V5L;'-P86-I;F<],T0P
M(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=.
M.B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^($1E<V-R:7!T:6]N/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<@8V]L<W!A;CTS1#(^
M0F%L86YC92!A<R!O9CQB<B`O/B!$96-E;6)E<B`S,2P\8G(@+SX@,C`Q,3PO
M=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI
M9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)R!C;VQS<&%N/3-$,CY5;G)E86QI>F5D($QO
M<W-E<SPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P
M="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C;VQS<&%N/3-$,CY"86QA;F-E
M(&%S(&]F/&)R("\^($UA<F-H(#,Q+#QB<B`O/B`R,#$R/"]T9#X@/'1D('-T
M>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS1"=615)424-!3"U!
M3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U=)1%1(.B`U."4[($9/3E0M
M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`R
M)3L@1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4+5-)6D4Z(#$P<'0G
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[
M(%=)1%1(.B`Q,"4[($9/3E0M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/3E0M
M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=724142#H@
M,B4[($9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].5"U325I%.B`Q,'!T
M)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M.R!724142#H@,3`E.R!&3TY4+5-)6D4Z(#$P<'0G/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4
M+5-)6D4Z(#$P<'0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z
M(#(E.R!&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/3E0M4TE:13H@,3!P
M="<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M=#L@5TE$5$@Z(#$P)3L@1D].5"U325I%.B`Q,'!T)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)3L@1D].
M5"U325I%.B`Q,'!T)SX@)FYB<W`[/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$
M)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,
M+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M($1E<FEV871I=F4@;&EA8FEL:71I97,@<F5L871E9"!T;R!S=&]C:R!P=7)C
M:&%S92!W87)R86YT<SPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^("0\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B`Q+#@X-BPV-3(\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("0\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`Y.3$L-C8R/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`D/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@,BPX-S@L,S$T/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B`F;F)S<#L\+W1D/B`\
M+W1R/B`\+W1A8FQE/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y38VAE9'5L92!O9B!1=6%N=&ET871I=F4@26YF;W)M871I;VX@86)O=70@
M3&5V96P@,R!&86ER(%9A;'5E($UE87-U<F5M96YT<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO
M+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO
M+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L
M+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\=&%B
M;&4@<W1Y;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!313H@8V]L
M;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL
M93TS1"=615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N
M=&5R.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!#3TQ/4CH@8FQA8VLG(&-O;'-P86X],T0W/E%U86YT:71A=&EV92!);F9O
M<FUA=&EO;B!A8F]U="!,979E;"`S($9A:7(@5F%L=64@365A<W5R96UE;G1S
M/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T
M;VTG/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O
M;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)R!C;VQS<&%N/3-$
M,CY&86ER(%9A;'5E(&%T(#,O,S$O,C`Q,SPO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@0T],3U(Z(&)L86-K)SX@5F%L=6%T:6]N(%1E8VAN:7%U93PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,7!T('-O;&ED.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!5;F]B<V5R=F%B;&4@26YP
M=71S/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z
M(')G8B@R,#0L,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`D/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M.R!724142#H@,C`E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`R+#(P,2PS.3`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@5TE$5$@Z(#0R)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@0FQA8VLM4V-H;VQE<R!O
M<'1I;VX@<')I8VEN9R!M;V1E;#PO=&0^(#QT9"!S='EL93TS1"=724142#H@
M,B4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!724142#H@,S(E.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!%>'!E8W1E
M9"!T97)M/"]T9#X@/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],
M3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4TE:13H@,3!P="<^)FYB<W`[
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M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/
M4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@0T],3U(Z(&)L86-K)SX@17AP96-T960@9&EV:61E;F1S/"]T9#X@
M/"]T<CX@/'1R('-T>6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L
M,C4U+#(P-"D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0M4TE:
M13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2
M.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B!!;G1I8VEP871E9"!V;VQA=&EL:71Y/"]T
M9#X@/"]T<CX@/"]T86)L93X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO
M9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M838Q-V$Y-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V.%]A-#EB
M7S(R9&4P9#%B9#=C-2]7;W)K<VAE971S+U-H965T,3<N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3=&]C:VAO;&1E<G,G($5Q
M=6ET>2`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/E-T;V-K:&]L9&5R<R<@17%U:71Y(%M!8G-T<F%C
M=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4W5M;6%R>2!O9B!787)R86YT<R!/=71S=&%N9&EN9SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO
M+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO
M+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L
M+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\<"!S
M='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!!="!-87)C:"`S,2P@,C`Q,R!A;F0@
M,C`Q,B!T:&5R92!W97)E('=A<G)A;G1S(&]U='-T86YD:6YG('1O('!U<F-H
M87-E(#4L-C(P+#$R."!S:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C:RP@<F5S
M<&5C=&EV96QY+B!4:&4@=V%R<F%N=',@;W5T<W1A;F1I;F<@87,@;V8@36%R
M8V@@,S$L(#(P,3,@86YD(#(P,3(@=V5R92!A<R!F;VQL;W=S.CPO<#X@/'`@
M<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P/B`\=&%B;&4@<W1Y
M;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT<B!S='EL93TS1"=6
M15)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/
M4CH@8FQA8VLG(&-O;'-P86X],T0R/DYU;6)E<B!O9B!#;VUM;VX@4VAA<F5S
M(%5N9&5R;'EI;F<@5V%R<F%N=',\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@
M<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@27-S=64@
M1&%T92]%>&5R8VES86)L92!$871E/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M
M04Q)1TXZ(&-E;G1E<CL@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@0T],3U(Z(&)L86-K)R!C;VQS<&%N/3-$,CY%>&5R8VES
M92!0<FEC93PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T
M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#
M3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI9#L@5$585"U!
M3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!%>'!I<F%T:6]N($1A=&4\+W1D
M/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P
M-"PR-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^
M("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@
M5TE$5$@Z(#(R)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@0T],3U(Z(&)L86-K)SX@,3`P+#<W.#PO=&0^(#QT9"!S='EL
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M(%=)1%1(.B`R-"4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^($UA<BTP-R`O($UA<BTP-SPO=&0^
M(#QT9"!S='EL93TS1"=724142#H@,B4[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/
M3$]2.B!B;&%C:R<^("0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0[(%=)1%1(.B`R,24[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#,N.3<\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0[(%=)1%1(.B`R,R4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^($UA<BTQ-SPO=&0^(#PO
M='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET93L@5D52
M5$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#<P-2PS-30\+W1D/B`\
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M<BTP.2`O(%-E<"TP.3PO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z
M(&)L86-K)SX@)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M0T],3U(Z(&)L86-K)SX@,RXP,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!397`M,30\+W1D/B`\+W1R/B`\
M='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T
M*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#(L-3<R+#<W
M-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`H,2D\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L
M86-K)SX@2G5L+3`Y("\@2F%N+3$P/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B
M;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!#3TQ/4CH@8FQA8VLG/B`D/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`R+C4P/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^($IA;BTQ-3PO=&0^
M(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET93L@
M5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#4P,"PP,#`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M*#(I/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^
M($%P<BTQ,"`O($]C="TQ,#PO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG
M/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],
M3U(Z(&)L86-K)SX@)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@0T],3U(Z(&)L86-K)SX@,2XX.3PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!/8W0M,34\+W1D/B`\+W1R
M/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L
M,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#$L,S(S
M+#(Q-#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@
M8FQA8VLG/B`H,BD\+W1D/B`\=&0@<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z
M(&)L86-K)SX@2G5L+3$P("\@2F%N+3$Q/"]T9#X@/'1D('-T>6QE/3-$)T9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2
M.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B`D/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`Q+C8S/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^($IA;BTQ-SPO
M=&0^(#PO='(^(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET
M93L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#,W,2PT,C,\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5#H@,3!P
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M:R<^($IU;BTQ,2`O($IU;BTQ,3PO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M0T],3U(Z(&)L86-K)SX@)#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@0T],3U(Z(&)L86-K)SX@,RXU,#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!*=6XM,38\+W1D/B`\
M+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR
M-34L,C`T*3L@5D525$E#04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ
M(&QE9G0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[($-/3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@<V]L:60[(%1%6%0M04Q)1TXZ(')I
M9VAT.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!#3TQ/4CH@8FQA8VLG/B`T-BPU.#0\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K
M)SX@*#$I/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`Q<'0[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/
M3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!C96YT97([(%!!1$1)3D<M0D]45$]-.B`Q<'0[($9/3E0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^
M($UA<BTQ,B`O($UA<BTQ,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
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M33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/
M33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B!-87(M,C(\+W1D/B`\+W1R/B`\='(@<W1Y
M;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@=VAI=&4[(%9%4E1)0T%,+4%,24=.
M.B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F
M;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,BXU<'0@9&]U8FQE.R!415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M-2PV,C`L,3(X/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R+C5P=#L@1D].5"U3
M25I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#(N-7!T.R!&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0[($9/3E0M4TE:13H@
M,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%!!1$1)3D<M0D]45$]-.B`R+C5P=#L@1D].5"U325I%.B`Q,'!T)SX@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0
M041$24Y'+4)/5%1/33H@,BXU<'0[($9/3E0M4TE:13H@,3!P="<^("9N8G-P
M.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'
M+4)/5%1/33H@,BXU<'0[($9/3E0M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,BXU<'0[($9/3E0M4TE:
M13H@,3!P="<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R+C5P=#L@1D].5"U325I%.B`Q,'!T)SXF;F)S<#L\+W1D/B`\+W1R
M/B`\+W1A8FQE/B`\<"!S='EL93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!
M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^("9N8G-P.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(
M.B`Q,#`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)
M1TXZ('1O<"<^(#QT9"!S='EL93TS1"=724142#H@,R4G/B9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=#3TQ/4CH@8FQA8VL[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%=)1%1(.B`U)2<^("@Q*3PO=&0^
M(#QT9"!S='EL93TS1"=#3TQ/4CH@8FQA8VL[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(%=)1%1(.B`Y,B4G/B!4:&5S92!W
M87)R86YT<R!T;R!P=7)C:&%S92!C;VUM;VX@<W1O8VL@87)E(&-L87-S:69I
M960@87,@97%U:71Y+CPO=&0^(#PO='(^(#PO=&%B;&4^(#QP('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P+C5I;CL@34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]P
M/B`\=&%B;&4@<W1Y;&4],T0G5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!3
M13H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT
M<B!S='EL93TS1"=615)424-!3"U!3$E'3CH@=&]P)SX@/'1D('-T>6QE/3-$
M)U=)1%1(.B`S)2<^)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T-/3$]2.B!B
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M;&ET:65S+B!4:&4@9F%I<B!V86QU92!O9B!T:&5S92!L:6%B:6QI=&EE<R`H
M<V5E(&YO=&4@,RD@:7,@<F5M96%S=7)E9"!A="!T:&4@96YD(&]F(&5V97)Y
M(')E<&]R=&EN9R!P97)I;V0@86YD('1H92!C:&%N9V4@:6X@9F%I<B!V86QU
M92!I<R!R97!O<G1E9"!I;B!T:&4@=6YA=61I=&5D(&-O;F1E;G-E9"!C;VYS
M;VQI9&%T960@<W1A=&5M96YT<R!O9B!O<&5R871I;VYS(&%S(&]T:&5R(&EN
M8V]M92`H97AP96YS92DN/"]T9#X@/"]T<CX@/"]T86)L93X@/"$M+45N9$9R
M86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y-6)?-60S-U\T-C8X7V$T.6)?,C)D
M93!D,6)D-V,U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V$V,3=A
M.35B7S5D,S=?-#8V.%]A-#EB7S(R9&4P9#%B9#=C-2]7;W)K<VAE971S+U-H
M965T,3@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$4R1CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY&:6YA;F-I;F<@5')A;G-A8W1I;VYS("A486)L97,I/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1FEN86YC:6YG
M(%1R86YS86-T:6]N<R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R:6YC:7!A;"!087EM96YT<R!/;B!4
M:&4@5&5R;2!,;V%N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP
M(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M
M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV
M/CPA+2U3=&%R=$9R86=M96YT+2T^(#QT86)L92!S='EL93TS1"=724142#H@
M,S4E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)R!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P/B`\='(@<W1Y;&4],T0G5D525$E#04PM04Q)1TXZ
M(&)O='1O;2<^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,7!T.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/
M4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2
M.B!B;&%C:R<@8V]L<W!A;CTS1#(^665A<CPO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@
M)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#%P="!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B!0
M<FEN8VEP86P\8G(@+SX@4&%Y;65N=',\+W1D/B`\+W1R/B`\='(@<W1Y;&4]
M,T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D525$E#
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M9"!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%=)1%1(.B`Q-24[($9/
M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2
M.B!B;&%C:R<^(#(P,3,\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@5TE$5$@Z(#$E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@
M<W1Y;&4],T0G5TE$5$@Z(#(E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)1%1(.B`Q-24[($9/
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M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`R,#$T/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[($-/
M3$]2.B!B;&%C:R<^("9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA
M8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M($-/3$]2.B!B;&%C:R<^(#DY.2PY.38\+W1D/B`\+W1R/B`\='(@<W1Y;&4]
M,T0G0D%#2T=23U5.1"U#3TQ/4CH@<F=B*#(P-"PR-34L,C`T*3L@5D525$E#
M04PM04Q)1TXZ(&)O='1O;2<^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L
M86-K)SX@)FYB<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E
M;G1E<CL@4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@,C`Q-3PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/
M5%1/33H@,7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)FYB<W`[/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P="!S;VQI
M9#L@5$585"U!3$E'3CH@<FEG:'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[($-/3$]2.B!B;&%C:R<^(#<U,"PP,#<\+W1D
M/B`\+W1R/B`\='(@<W1Y;&4],T0G0D%#2T=23U5.1"U#3TQ/4CH@=VAI=&4[
M(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#(N-7!T.R!&3TY4+5-)6D4Z(#$P<'0G/B9N8G-P.SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,BXU<'0[($9/3E0M4TE:13H@,3!P="<^("9N8G-P.SPO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU"3U143TTZ(#(N
M-7!T.R!&3TY4+5-)6D4Z(#$P<'0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#(N-7!T.R!&
M3TY4+5-)6D4Z(#$P<'0G/B`F;F)S<#L\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#(N-7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!#3TQ/4CH@8FQA8VLG/B`F;F)S<#L\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,BXU<'0@9&]U8FQE
M.R!415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@0T],3U(Z(&)L86-K)SX@)#(L-3`P+#`P,#PO
M=&0^(#PO='(^(#PO=&%B;&4^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\
M+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E1E<FT@3&]A;BP@3F5T(&]F($1E8G0@1&ES8V]U;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CPA+2U$3T-465!%(&AT;6P@4%5"
M3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@
M(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS
M:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M
M+3X@/'`@<W1Y;&4],T0G34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@5&AE('1E<FT@;&]A;BP@
M;F5T(&]F(&1I<V-O=6YT(&]F("0S.2PU.#<L(&ES(')E8V]R9&5D(&]N('1H
M92`R,#$S(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@8F%L86YC92!S:&5E="P@
M;F5T(&]F(&1E8G0@9&ES8V]U;G0L(&%S(&9O;&QO=W,Z/"]P/B`\<"!S='EL
M93TS1"=415A4+4E.1$5.5#H@,"XU:6X[($U!4D=)3CH@,'!T(#!P>#L@1D].
M5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^("9N8G-P
M.SPO<#X@/'1A8FQE('-T>6QE/3-$)U=)1%1(.B`U-"4[($)/4D1%4BU#3TQ,
M05!313H@8V]L;&%P<V4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^
M(#QT<B!S='EL93TS1"="04-+1U)/54Y$+4-/3$]2.B!R9V(H,C`T+#(U-2PR
M,#0I.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`T,"4[($9/3E0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B!#=7)R96YT('!O<G1I;VX@;V8@
M;&]N9RUT97)M(&1E8G0\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(E.R!&
M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB
M<W`[/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(
M.B`Q)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^("0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0[(%=)
M1%1(.B`Q,"4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B`Y.3DL.3DV/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%=)1%1(.B`Q)3L@1D].5#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^("9N8G-P.SPO=&0^(#PO='(^(#QT<B!S='EL93TS
M1"="04-+1U)/54Y$+4-/3$]2.B!W:&ET93L@5D525$E#04PM04Q)1TXZ(&)O
M='1O;2<^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@3&]N9RUT97)M
M(&1E8G0L(&QE<W,@8W5R<F5N="!P;W)T:6]N/"]T9#X@/'1D('-T>6QE/3-$
M)T9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B9N
M8G-P.SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^(#$L-#8P+#0Q-SPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX@)FYB<W`[/"]T9#X@/"]T
M<CX@/"]T86)L93X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y
M-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V.%]A-#EB7S(R9&4P
M9#%B9#=C-2]7;W)K<VAE971S+U-H965T,3DN:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5&3$%%
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-U;6UA<GD@;V8@4VEG;FEF:6-A
M;G0@06-C;W5N=&EN9R!0;VQI8VEE<R`H3F%R<F%T:79E*2`H1&5T86EL<RD@
M*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N
M(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA
M<BX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4VEG;FEF:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<R!;
M3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3G5M8F5R(&]F(&]P97)A=&EN9R!S96=M96YT/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;W-T(')E:6UB=7)S960@=&\@
M;V9F<V5T(')E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E;G-E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-H87)E+6)A<V5D(&-O;7!E;G-A=&EO;B!F;W)F96ET=7)E<R!R871E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BXP,"4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BXP,"4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H
M87)E(&]P=&EO;G,@9W)A;G1E9"!T;R!E;7!L;WEE97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C8P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#DT.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^56YR96-O9VYI>F5D
M('-H87)E+6)A<V5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E(')E;&%T960@=&\@
M=6YV97-T960@87=A<F1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E5N<F5C;V=N:7IE9"!S:&%R92UB87-E9"!C;VUP96YS
M871I;VX@97AP96YS92!R96QA=&5D('1O('5N=F5S=&5D(&%W87)D<R!E>'!E
M8W1E9"!T;R!B92!R96-O9VYI>F5D(&EN('1H92!P97)I;V0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/C(@>65A<G,@,R!M;VYT:',\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN8V]M
M92!T87@@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`Y+#<T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,34P+#0P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06YT:2UD:6QU=&EV92!S96-U<FET:65S(&5X
M8VQU9&5D(&9R;VT@8V]M<'5T871I;VX@;V8@96%R;FEN9W,@<&5R('-H87)E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,2PV,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$L
M-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3&EQ=6ED:71Y($%R<F%N9V5M96YT<R!;365M8F5R72!\($UA
M>&EM=6T@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(%M,
M:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#87-H(&QI<75I9&ET>2!M871U<FET>2!P97)I;V0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/C,@;6]N=&AS/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13)"044^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^4W5M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O=6YT
M:6YG(%!O;&EC:65S("A38VAE9'5L92!O9B!3:&%R92UB87-E9"!#;VUP96YS
M871I;VX@17AP96YS92D@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5M<&QO>65E
M(%-E<G9I8V4@4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N+"!!;&QO8V%T:6]N
M(&]F(%)E8V]G;FEZ960@4&5R:6]D($-O<W1S(%M,:6YE($ET96US73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!S
M:&%R92UB87-E9"!C;VUP96YS871I;VX@97AP96YS93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`S,C@L-3@Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U-#@L-C8T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-E87)C
M:"!A;F0@1&5V96QO<&UE;G0@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY%;7!L;WEE92!397)V:6-E(%-H87)E
M+6)A<V5D($-O;7!E;G-A=&EO;BP@06QL;V-A=&EO;B!O9B!296-O9VYI>F5D
M(%!E<FEO9"!#;W-T<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@<VAA<F4M8F%S960@8V]M
M<&5N<V%T:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C@X+#8S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$Q-RPP-C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D=E;F5R86P@86YD($%D;6EN:7-T<F%T:79E
M($5X<&5N<V4@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY%;7!L;WEE92!397)V:6-E(%-H87)E+6)A<V5D($-O
M;7!E;G-A=&EO;BP@06QL;V-A=&EO;B!O9B!296-O9VYI>F5D(%!E<FEO9"!#
M;W-T<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5&]T86P@<VAA<F4M8F%S960@8V]M<&5N<V%T:6]N
M(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C,Y
M+#DT-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-#,Q+#4Y-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?838Q-V$Y-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?
M-#8V.%]A-#EB7S(R9&4P9#%B9#=C-2]7;W)K<VAE971S+U-H965T,C$N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$5'3$%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D9A:7(@
M5F%L=64@365A<W5R96UE;G1S("A38VAE9'5L92!O9B!,:6%B:6QI=&EE<R!-
M96%S=7)E9"!A="!&86ER(%9A;'5E*2`H1&5T86EL<RD@*%)E8W5R<FEN9R!;
M365M8F5R72P@55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E+"!!<W-E
M=',@86YD($QI86)I;&ET:65S($UE87-U<F5D(&]N(%)E8W5R<FEN9R!A;F0@
M3F]N<F5C=7)R:6YG($)A<VES(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#(P,2PS.3`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L,CDU
M+#8Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3&5V96P@,2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@5F%L=64L($%S<V5T<R!A;F0@3&EA
M8FEL:71I97,@365A<W5R960@;VX@4F5C=7)R:6YG(&%N9"!.;VYR96-U<G)I
M;F<@0F%S:7,@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I=F5S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE
M=F5L(#(@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY&86ER(%9A;'5E+"!!<W-E=',@86YD($QI86)I;&ET:65S
M($UE87-U<F5D(&]N(%)E8W5R<FEN9R!A;F0@3F]N<F5C=7)R:6YG($)A<VES
M(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y$97)I=F%T:79E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER(%9A;'5E
M+"!);G!U=',L($QE=F5L(#,@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E+"!!<W-E=',@86YD
M($QI86)I;&ET:65S($UE87-U<F5D(&]N(%)E8W5R<FEN9R!A;F0@3F]N<F5C
M=7)R:6YG($)A<VES(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#(P,2PS.3`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L,CDU+#8Q,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y
M-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V.%]A-#EB7S(R9&4P
M9#%B9#=C-2]7;W)K<VAE971S+U-H965T,C(N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4R3D%#
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D9A:7(@5F%L=64@365A<W5R96UE
M;G1S("A3=6UM87)Y(&]F($-H86YG97,@:6X@1F%I<B!686QU92!O9B!/=7(@
M3&5V96P@,R!,:6%B:6QI=&EE<RD@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9A
M:7(@5F%L=64L($QI86)I;&ET:65S($UE87-U<F5D(&]N(%)E8W5R<FEN9R!"
M87-I<RP@56YO8G-E<G9A8FQE($EN<'5T(%)E8V]N8VEL:6%T:6]N(%M,:6YE
M($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y5;G)E86QI>F5D($=A:6YS("A,;W-S97,I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#DP-2PW-S<I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Y.3$L-C8R*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F%I<B!6
M86QU92P@26YP=71S+"!,979E;"`S(%M-96UB97)=('P@5V%R<F%N=',@6TUE
M;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY&86ER(%9A;'5E+"!,:6%B:6QI=&EE<R!-96%S=7)E9"!O;B!296-U<G)I
M;F<@0F%S:7,L(%5N;V)S97)V86)L92!);G!U="!296-O;F-I;&EA=&EO;B!;
M3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0F5G:6YN:6YG($)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L,CDU+#8Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.#@V+#8U,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^56YR96%L:7IE9"!'
M86EN<R`H3&]S<V5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M.3`U+#<W-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Y.3$L-C8R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^16YD:6YG($)A;&%N8V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,BPR,#$L,SDP/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#@W."PS,30\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
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M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%4#)!13X-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY&86ER(%9A;'5E($UE87-U<F5M96YT
M<R`H3F%R<F%T:79E*2`H1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$-#XS($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DUA<BX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CY&86ER(%9A;'5E+"!);G!U=',L($QE
M=F5L(#,@6TUE;6)E<ET\8G(^5V%R<F%N=',@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,CQB<CY&86ER
M(%9A;'5E+"!);G!U=',L($QE=F5L(#,@6TUE;6)E<ET\8G(^5V%R<F%N=',@
M6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R
M+B`S,2P@,C`Q,SQB<CY&86ER(%9A;'5E+"!);G!U=',L($QE=F5L(#,@6TUE
M;6)E<ET\8G(^5V%R<F%N=',@6TUE;6)E<ET\8G(^1&5R:79A=&EV92!,:6%B
M:6QI=&EE<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y-87(N(#(X+"`R,#$S/&)R/D9A:7(@5F%L=64L($EN<'5T<RP@3&5V
M96P@,R!;365M8F5R73QB<CY787)R86YT<R!;365M8F5R73QB<CY$97)I=F%T
M:79E($QI86)I;&ET:65S(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^1F%I<B!686QU92P@26YP
M=71S+"!,979E;"`S(%M-96UB97)=/&)R/E=A<G)A;G1S(%M-96UB97)=/&)R
M/D1E<FEV871I=F4@3&EA8FEL:71I97,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,CQB<CY&86ER(%9A
M;'5E+"!);G!U=',L($QE=F5L(#,@6TUE;6)E<ET\8G(^5V%R<F%N=',@6TUE
M;6)E<ET\8G(^1&5R:79A=&EV92!,:6%B:6QI=&EE<R!;365M8F5R73QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,P+"`R,#$R/&)R
M/D9A:7(@5F%L=64L($EN<'5T<RP@3&5V96P@,R!;365M8F5R73QB<CY787)R
M86YT<R!;365M8F5R73QB<CY$97)I=F%T:79E($QI86)I;&ET:65S(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S`L
M(#(P,3$\8G(^1F%I<B!686QU92P@26YP=71S+"!,979E;"`S(%M-96UB97)=
M/&)R/E=A<G)A;G1S(%M-96UB97)=/&)R/D1E<FEV871I=F4@3&EA8FEL:71I
M97,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^1F%I<B!686QU92!-96%S=7)E;65N=',@6TQI;F4@271E
M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E=A<G)A;G1S('1O('!U<F-H87-E(&-O;6UO;B!S=&]C:SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPX.3DL.3DQ/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPX.3DL.3DQ/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#:&%N
M9V4@:6X@9F%I<B!V86QU92!O9B!D97)I=F%T:79E(&EN<W1R=6UE;G1S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#DP-2PW-S<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#DY,2PV
M-C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#DP-2PW-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#DY,2PV-C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-L;W-I;F<@<W1O8VL@<')I8V4L('!E
M<B!S:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+C<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$N,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$N-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#$N,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
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M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%5U5!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#
M;VUM:71M96YT<R!A;F0@0V]N=&EN9V5N8VEE<R`H1&5T86EL<RD@*%531"`D
M*3QB<CY);B!-:6QL:6]N<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CXQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*=6PN(#,Q+"`R,#`Y/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^26YI=&EA;"!-87AI;75M($UA
M:6YT96YA;F-E($9A:6QU<F4@3V)L:6=A=&EO;B!;365M8F5R73QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/D5V
M97)Y(#,P(&1A>7,@=6YT:6P@9F%I;'5R92!I<R!C=7)E9"!;365M8F5R73QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$Q
M/&)R/E!H87)M071H96YE(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3$\8G(^4&AA<FU!=&AE;F4@6TUE
M;6)E<ET\8G(^36%X:6UU;2!;365M8F5R73QB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#;VUM:71M96YT<R!A;F0@0V]N
M=&EN9V5N8VEE<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4TE'02!B<F5A8V@@;V8@8V]N=')A8W1U
M86P@;V)L:6=A=&EO;B!A=V%R9&5D+"!P97)C96YT86=E(&]F(&YE="!P<F]F
M:71S("AA<R!D969I;F5D(&EN(&-O=7)T)W,@9FEN86P@:G5D9V5M96YT*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`N,#`E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y324=!(&)R
M96%C:"!O9B!C;VYT<F%C='5A;"!O8FQI9V%T:6]N(&%W87)D('!E<FEO9"!F
M;VQL;W=I;F<@:6YI=&EA;"!C;VUM97)C:6%L('-A;&4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/C$P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y324=!(&YE="!P<F]F:71S
M("AA<R!D969I;F5D(&EN(&-O=7)T)W,@9FEN86P@:G5D9V5M96YT*2!B969O
M<F4@9&ES=')I8G5T:6]N(&9O<B!B<F5A8V@@;V8@8V]N=')A8W0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%W87)D960@,2\S(')E
M87-O;F%B;&4@871T;W)N97DG<R!F965S(&%N9"!E>'!E<G0@=VET;F5S<R!F
M965S+"!P;'5S(&EN=&5R97-T+CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,BXT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y787)R86YT(&5X<&ER871I;VX@9&%T93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^36%R(#,P+`T*"0DR,#(R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^2F%N(#(X+`T*
M"0DR,#$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y097)C96YT86=E(&]F(&%G9W)E9V%T92!P<FEN8VEP86P@86UO
M=6YT(&]F(&-O;G9E<G1I8FQE($YO=&5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!9V=R96=A=&4@<')I;F-I<&%L(&%M
M;W5N="!O9B!O8FQI9V%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#`N,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,"XR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14-.04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4W1O
M8VMH;VQD97)S)R!%<75I='D@*$YA<G)A=&EV92D@*$1E=&%I;',I("A54T0@
M)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#(^,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXS($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/DUA<BX@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5L+B`S,2P@,C`P.3QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CXR,#`W($QO;F<@5&5R
M;2!);F-E;G1I=F4@4&QA;B!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`X/&)R/C(P,#<@3&]N9R!497)M
M($EN8V5N=&EV92!0;&%N(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#<\8G(^,C`P-R!,;VYG(%1E<FT@
M26YC96YT:79E(%!L86X@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CY%>'!I<F%T:6]N(#(P,34@
M6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R
M+B`S,2P@,C`Q,SQB<CY%>'!I<F%T:6]N(#(P,3<@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W1O8VMH
M;VQD97)S($5Q=6ET>2!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K(')E<V5R=F5D
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#8P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#4P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-H87)E<R!A<'!R;W9E9"!F;W(@:7-S=6%N8V4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/CDL,S`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5S(&%V86EL
M86)L92!T;R!B92!I<W-U960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(L-C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A=V%R9"!T97)M/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XQ,"!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@:7-S=65D
M('1O('!U<F-H87-E('-H87)E<R!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C0V+#4X-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-C(P+#$R.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-C(P+#$R
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(L-3<R+#<W-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$P,"PW-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G0@97AE<F-I<V4@<')I8V4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$N-C$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+C4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+CDW/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R
M86YT(&5X<&ER871I;VX@9&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^36%R(#,P+`T*"0DR,#(R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^2F%N(#(X+`T*"0DR,#$U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^2F%N(#(X+`T*
M"0DR,#$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^36%R(#,P+`T*"0DR,#$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y686QU92!O9B!W87)R86YT<R!I<W-U
M960@=&\@;&5N9&5R(&EN(&-O;FYE8W1I;VX@=VET:"!L;V%N/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8Y+#@W-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y
M-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V.%]A-#EB7S(R9&4P
M9#%B9#=C-2]7;W)K<VAE971S+U-H965T,C8N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5)24%'
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-T;V-K:&]L9&5R<R<@17%U:71Y
M("A38VAE9'5L92!O9B!787)R86YT<RD@*$1E=&%I;',I/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C$@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$T/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S`L(#(P,3(\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`S,2P@,C`P.3QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P
M,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#(^36%R+B`S,2P@,C`Q,SQB<CY787)R86YT(%1R86YC:&4@3VYE(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0R/DUA<BX@,S$L(#(P,3,\8G(^5V%R<F%N="!4<F%N8VAE(%1W;R!;365M
M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CY-87(N(#,Q+"`R,#$S/&)R/E=A<G)A;G0@5')A;F-H92!4:')E92!;
M365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,CY-87(N(#,Q+"`R,#$S/&)R/E=A<G)A;G0@5')A;F-H92!&;W5R
M(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0R/DUA<BX@,S$L(#(P,3,\8G(^5V%R<F%N="!4<F%N8VAE($9I
M=F4@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#(^36%R+B`S,2P@,C`Q,SQB<CY787)R86YT(%1R86YC:&4@
M4VEX(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0R/DUA<BX@,S$L(#(P,3,\8G(^5V%R<F%N="!4<F%N8VAE
M(%-E=F5N(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D-L87-S(&]F(%=A<G)A;G0@;W(@4FEG:'0@6TQI
M;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O
M9B!#;VUM;VX@4VAA<F5S(%5N9&5R;'EI;F<@5V%R<F%N=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C0V+#4X-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-C(P+#$R.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-C(P+#$R
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$P,"PW-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$9FX^/'-U<#Y;,5T\+W-U<#X\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C<P-2PS-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/'-U<#Y;,ET\+W-U<#X\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L-3<R+#<W-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\<W5P/ELQ73PO<W5P/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\<W5P/ELR73PO<W5P/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS,C,L,C$T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CQS=7`^6S)=/"]S
M=7`^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-S$L-#(S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CQS=7`^
M6S)=/"]S=7`^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-BPU
M.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^
M/'-U<#Y;,5T\+W-U<#X\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^27-S=64@1&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M36%R(#$L#0H)"3(P,#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y-
M87(@,2P-"@D),C`P.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DIU
M;"`Q+`T*"0DR,#`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^07!R
M(#$L#0H)"3(P,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y*=6P@
M,2P-"@D),C`Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DIU;B`Q
M+`T*"0DR,#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^36%R(#$L
M#0H)"3(P,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C
M:7-A8FQE($1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DUA
M<B`Q+`T*"0DR,#`W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^4V5P
M(#$L#0H)"3(P,#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y*86X@
M,2P-"@D),C`Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/D]C="`Q
M+`T*"0DR,#$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^2F%N(#$L
M#0H)"3(P,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y*=6X@,2P-
M"@D),C`Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DUA<B`Q+`T*
M"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES
M92!0<FEC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XV,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,N
M.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,BXU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2XX.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$N-C,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+C4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ+C8Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y%>'!I<F%T:6]N($1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/DUA<B`S,"P-"@D),C`R,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/DIA;B`R."P-"@D),C`Q-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DUA<B`S
M,"P-"@D),C`Q-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/E-E<"`S
M,"P-"@D),C`Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DIA;B`R
M."P-"@D),C`Q-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/D]C="`S
M,2P-"@D),C`Q-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DIA;B`S
M,2P-"@D),C`Q-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DIU;B`S
M,"P-"@D),C`Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DUA<B`S
M,"P-"@D),C`R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1D(&-O;'-P86X],T0Q.3X\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1&EN;F5R1F]O=&YO=&4^#0H@("`@("`@(#QT9"!V86QI
M9VX],T1T;W`^6S%=/"]T9#X-"B`@("`@("`@/'1D(&-O;'-P86X],T0Q."!V
M86QI9VX],T1T;W`^5&AE<V4@=V%R<F%N=',@=&\@<'5R8VAA<V4@8V]M;6]N
M('-T;V-K(&%R92!C;&%S<VEF:65D(&%S(&5Q=6ET>2X\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1&EN;F5R1F]O=&YO=&4^#0H@("`@
M("`@(#QT9"!V86QI9VX],T1T;W`^6S)=/"]T9#X-"B`@("`@("`@/'1D(&-O
M;'-P86X],T0Q."!V86QI9VX],T1T;W`^5&AE<V4@=V%R<F%N=',@=&\@<'5R
M8VAA<V4@8V]M;6]N('-T;V-K(&%R92!C;&%S<VEF:65D(&%S(&1E<FEV871I
M=F4@;&EA8FEL:71I97,N(%1H92!F86ER('9A;'5E(&]F('1H97-E(&QI86)I
M;&ET:65S("AS964@;F]T92`S*2!I<R!R96UE87-U<F5D(&%T('1H92!E;F0@
M;V8@979E<GD@<F5P;W)T:6YG('!E<FEO9"!A;F0@=&AE(&-H86YG92!I;B!F
M86ER('9A;'5E(&ES(')E<&]R=&5D(&EN('1H92!U;F%U9&ET960@8V]N9&5N
M<V5D(&-O;G-O;&ED871E9"!S=&%T96UE;G1S(&]F(&]P97)A=&EO;G,@87,@
M;W1H97(@:6YC;VUE("AE>'!E;G-E*2X\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?838Q-V$Y-6)?-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V
M.%]A-#EB7S(R9&4P9#%B9#=C-2]7;W)K<VAE971S+U-H965T,C<N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5.2T1)/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D9I;F%N8VEN
M9R!4<F%N<V%C=&EO;G,@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,3X\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3X\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S
M,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N
M(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M36%R+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y-87(N(#,Q+"`R,#$S/&)R/D5Q=6ET>2!/9F9E<FEN9R!;365M8F5R73QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#(U+"`R,#$S
M/&)R/D5Q=6ET>2!/9F9E<FEN9R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/DQI;F4@;V8@0W)E
M9&ET(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DUA<BX@,S`L(#(P,3(\8G(^3&EN92!O9B!#<F5D:70@6TUE;6)E<ET\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB
M<CY,;V%N<R!087EA8FQE(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA<BX@,S`L(#(P,3(\8G(^3&]A;G,@4&%Y86)L92!;
M365M8F5R73QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY$96)T($EN<W1R=6UE;G0@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQI;F4@;V8@8W)E
M9&ET(&9A8VEL:71Y+"!M87AI;75M(&)O<G)O=VEN9R!C87!A8VET>3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+#`P,"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E
M;G0@8F]R<F]W:6YG(&-A<&%C:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#,P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DQI;F4@;V8@0W)E9&ET($9A8VEL:71Y+"!!
M;6]U;G0@3W5T<W1A;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,S`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5&5R;2!L;V%N+"!P87EM96YT('1E<FUS/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y087EM96YT<R!O;B!T:&4@=&5R
M;2!L;V%N('=E<F4@;W)I9VEN86QL>2!I;G1E<F5S="UO;FQY(&9O<B!T:&4@
M9FER<W0@,3`@;6]N=&AS+"!W:&EC:"!H87,@<VEN8V4@8F5E;B!E>'1E;F1E
M9"!T;R`Q,B!M;VYT:',@<'5R<W5A;G0@=&\@=&5R;7,@;V8@=&AE(&%G<F5E
M;65N="X@4W5B<V5Q=65N=&QY+"!T:&4@=&5R;2!L;V%N('=I;&P@9G5L;'D@
M86UO<G1I>F4@;W9E<B!I=',@<F5M86EN:6YG('1E<FT@87,@;V8@36%R8V@@
M,S$L(#(P,3,N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y,:6YE(&]F(&-R961I="!B;W)R;W=I;F<@8V%P86-I='D@
M9&5S8W)I<'1I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/E5N
M9&5R('1H92!T97)M<R!O9B!T:&4@<F5V;VQV:6YG(&QI;F4@;V8@8W)E9&ET
M+"!T:&4@0V]M<&%N>2!M87D@9')A=R!D;W=N(&9R;VT@=&AE(')E=F]L=FEN
M9R!L:6YE(&]F(&-R961I="!U<"!T;R`X-24@;V8@<75A;&EF:65D(&)I;&QE
M9"!A8V-O=6YT<R!R96-E:79A8FQE(&%N9"`X,"4@;V8@<75A;&EF:65D('5N
M8FEL;&5D(&%C8V]U;G1S(')E8V5I=F%B;&4N/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y497)M(&QO86X@86YD(&QI
M;F4@;V8@8W)E9&ET+"!M871U<FET>2!D871E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XR,#$U+3`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,:6YE(&]F(&-R961I="!F86-I;&ET
M>2!B;W)R;W=I;F<@8V%P86-I='DL('%U86QI9FEE9"!B:6QL960@86-C;W5N
M=',@<F5C96EV86)L92P@<&5R8V5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.#4N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y,:6YE(&]F(&-R961I="!F86-I;&ET>2!B;W)R
M;W=I;F<@8V%P86-I='DL('%U86QI9FEE9"!U;F)I;&QE9"!A8V-O=6YT<R!R
M96-E:79A8FQE+"!P97)C96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XX,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D9I>&5D(&EN=&5R97-T(')A=&4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$P+C$T)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5F%R:6%B;&4@:6YT97)E<W0@
M<F%T92P@=VET:"!F;&]O<B!O9B`Q+C4E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+C4P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3&]A;B!P87EA8FQE+"!I;G1E<F5S="!R871E
M('-P<F5A9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2XP,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DEN8W)E;65N=&%L(&)O<G)O=VEN9R!R871E('5S960@=&\@8V%L8W5L871E
M(&1I<V-O=6YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+C4P
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^,C`Q,SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S0Y+#DY
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^,C`Q-#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3DY+#DY
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^,C`Q-3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S4P+#`P
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E1O=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#4P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!R97!A>6UE;G0@<')E;6EU;2P@:68@<&%I9"!W
M:71H:6X@=&AE(&9I<G-T('1W;R!Y96%R<R!O9B!T:&4@=&5R;2!L;V%N+"!P
M97)C96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+C`P)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4')E<&%Y;65N="!P<F5M:75M+"!I9B!P86ED(&%F=&5R('1H92!F:7)S="!T
M=V\@>65A<G,@;V8@=&AE('1E<FT@;&]A;BP@<&5R8V5N=#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BXP,"4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9I;F%L('!A>6UE;G0@9F5E
M('!A>6%B;&4@;VX@=&5R;2!L;V%N(&)A;&%N8V4L('!E<F-E;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,N,#`E/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT<R!I<W-U
M960@=&\@<'5R8VAA<V4@8V]M;6]N('-T;V-K+"!I;B!C;VYN96-T:6]N('1O
M(&QO86X@86=R965M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT-BPU.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E=A<G)A;G0@97AE<F-I<V4@<')I8V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$N-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C8Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$96)T(&1I<V-O=6YT/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.2PU.#<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E;G0@
M<&]R=&EO;B!O9B!L;VYG+71E<FT@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.3DY+#DY-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C<T.2PY.3<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!D96)T+"!L
M97-S(&-U<G)E;G0@<&]R=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PT-C`L-#$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PW,#0L,3`X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5Q=6ET>2!/9F9E
M<FEN9R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5&AE(&UA>&EM=6T@=F%L=64@;V8@8V]M;6]N('-T
M;V-K(&ES<W5A8FQE('5N9&5R('1H92!C;VYT<F]L;&5D(&5Q=6ET>2!O9F9E
M<FEN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L,#`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V]M;6ES<VEO;B!O=V5D('1O('-A;&5S(&%G96YT+"!E>'!R97-S960@
M87,@<&5R8V5N=&%G92!O9B!A9V=R96=A=&4@9W)O<W,@<')O8V5E9',@9G)O
M;2!E86-H('-A;&4@;V8@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RXP,"4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5Q=6ET>2!O9F9E<FEN
M9RP@:7-S=6%N8V4@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(W-RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@:7-S=6%N8V4@;V8@8V]M;6]N
M('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,RPT,3,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:R`M(')E8V5I=F%B;&4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,S+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3G5M8F5R(&]F('-H
M87)E<R!S;VQD/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.2PY
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D%M;W5N="!R96UA:6YI;F<@879A:6QA8FQE('5N9&5R('1H92!A<G)A
M;F=E;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q-"PY
M-S`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
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M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P155(04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4W5B<V5Q=65N="!%
M=F5N=',@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%Y(#`X+"`R,#$S/&)R/E-U
M8G-E<75E;G0@179E;G0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5B<V5Q=65N="!%=F5N="!;3&EN
M92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3G5M8F5R(&]F('-H87)E<R!S;VQD/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#`S,"PX-S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W5N="!R96UA:6YI;F<@879A
M:6QA8FQE('5N9&5R('1H92!A<G)A;F=E;65N=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q,RPR.3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M(&ES
M<W5A;F-E(&]F(&-O;6UO;B!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`U,RPT,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-C,P+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y-6)?
M-60S-U\T-C8X7V$T.6)?,C)D93!D,6)D-V,U#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V$V,3=A.35B7S5D,S=?-#8V.%]A-#EB7S(R9&4P9#%B
M9#=C-2]7;W)K<VAE971S+V9I;&5L:7-T+GAM;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\]
M,T0B=7)N.G-C:&5M87,M;6EC<F]S;V9T+6-O;3IO9F9I8V4Z;V9F:6-E(CX-
M"B`\;SI-86EN1FEL92!(4F5F/3-$(BXN+U=O<FMB;V]K+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970P,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,#(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`S
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P-"YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,#4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#`V+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P
M-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#@N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`Y+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970Q,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,3$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$R+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970Q,RYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,30N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#$U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-BYH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3<N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#$X+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970Q.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C`N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(Q+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970R,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,C,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(T+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R-2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,C8N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#(W+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R."YH=&UL
M(B\^#0H\+WAM;#X-"BTM+2TM+3U?3F5X=%!A<G1?838Q-V$Y-6)?-60S-U\T
9-C8X7V$T.6)?,C)D93!D,6)D-V,U+2T-"@``
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EUHAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Subsequent Events (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>May 08, 2013

</div>
          <div>Subsequent Event [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares sold</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,030,870<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_RemainingValueOfStockIssuableUnderStockOffering', window );">Amount remaining available under the arrangement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 13,290,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
        <td class="nump">$ 53,413<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 1,630,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_RemainingValueOfStockIssuableUnderStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The remaining value of common stock issuable under the controlled equity offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_RemainingValueOfStockIssuableUnderStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Note 2 - Summary of Significant Accounting Policies</strong></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Basis of Presentation</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Our unaudited condensed consolidated financial statements include the accounts of PharmAthene, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. Our unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP"). In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly our financial position, results of operations and cash flows. The unaudited condensed consolidated balance sheet at December 31, 2012 has been derived from audited consolidated financial statements at that date. The interim results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosure normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the U.S. Securities and Exchange Commission. We believe that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial statements are read in conjunction with the Consolidated Financial Statements and Notes included in our Annual Report on Form 10-K for the year ended December 31, 2012, filed with the Securities and Exchange Commission. We currently operate in one business segment.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Use of Estimates</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our unaudited condensed consolidated financial statements include significant estimates for the expected economic life and value of our intangible assets, the amount of our net operating losses, our share-based compensation, the value of our financial instruments, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates<font style="FONT: 10pt Times New Roman, Times, Serif">.</font></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Foreign Currency Translation</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The functional currency of our wholly owned foreign subsidiaries is their local currency. Assets and liabilities of our foreign subsidiaries are translated into United States dollars based on exchange rates at the end of the reporting period. Income and expense items are translated at the weighted average exchange rates prevailing during the reporting period. <font style="COLOR: black">Translation adjustments for subsidiaries that have not been sold, substantially liquidated or otherwise disposed of, are accumulated in other comprehensive income (loss), a component of stockholders&#39; equity.</font> Foreign currency translation adjustments are the sole component of accumulated other comprehensive loss at March 31, 2013 and December 31, 2012. <font style="COLOR: black">Transaction gains or losses are included in the determination of net loss.</font></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Comprehensive Loss and Accumulated Other Comprehensive Income</em></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Comprehensive loss includes the total of our net loss and all other changes in equity other than transactions with owners, including (i) changes in equity for cumulative translation adjustments resulting from the consolidation of foreign subsidiaries as the financial statements of the subsidiaries located outside of the United States are accounted for using the local currency as the functional currency, and (ii) unrealized gains and losses on short term available-for-sale investments.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Cash and Cash Equivalents</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Cash and cash equivalents are stated at market value. We consider all highly liquid investments with original maturities of three months or less to be cash equivalents.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Revolving Line of Credit and Term Loan</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> As discussed further in Note 6, we entered into a loan agreement with General Electric Capital Corporation ("GE Capital") in March 2012. As part of that agreement, we issued stock purchase warrants to GE Capital that expire in March 2022. The fair value of the warrants was charged to additional paid-in-capital, resulting in a debt discount to the Term Loan at the date of issuance. The debt discount and the financing costs, incurred in connections with the agreement, are being amortized over the term of the loan using the effective interest method. The amortization of both the debt discount and deferred financing costs are included in interest expense in the unaudited condensed consolidated statements of operations.</p> <p style="TEXT-INDENT: 9pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Significant Customers and Accounts Receivable</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Our primary customers are the U.S. Department of Defense (the "DoD") - Chemical Biological Medical Systems ("CBMS"), and the Biomedical Advanced Research and Development Authority ("BARDA"). As of March 31, 2013 and December 31, 2012, the Company&#39;s trade receivable and unbilled receivable balances were comprised solely of receivables from CBMS and BARDA.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Goodwill</em></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Goodwill represents the excess of purchase price over the fair value of net identifiable assets associated with acquisitions. We review the recoverability of goodwill annually as of December 31<sup>st</sup> by comparing our market value (as measured by our stock price multiplied by the number of outstanding shares as of the end of the year) to the net book value of our equity. If our market value exceeds our net book value, no further analysis is required. Changes in our business strategy or adverse changes in market conditions could impact the impairment analyses and require the recognition of an impairment charge equal to the excess of the carrying value over its estimated fair value. We completed our last annual impairment assessment of goodwill as of December 31, 2012 and determined that there was no impairment as of that date.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Revenue Recognition</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We generate our revenue from different types of contractual arrangements: cost-plus-fee contracts, cost reimbursable grants and fixed price contracts.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Revenues on cost-plus-fee contracts are recognized in an amount equal to the costs incurred during the period plus an estimate of the applicable fee earned. The estimate of the applicable fee earned is determined by reference to the contract: if the contract defines the fee in terms of risk-based milestones and specifies the fees to be earned upon the completion of each milestone, then the fee is recognized when the related milestones are earned, as further described below; otherwise, we estimate the fee earned in a given period by using a proportional performance method based on costs incurred during the period as compared to total estimated project costs and application of the resulting fraction to the total project fee specified in the contract.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Under the milestone method of revenue recognition, milestone payments (including milestone payments for fees) contained in research and development arrangements are recognized as revenue when: (i) the milestones are achieved; (ii) no further performance obligations with respect to the milestone exist; (iii) collection is reasonably assured; and (iv) substantive effort was necessary to achieve the milestone.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Milestones are considered substantive if all of the following conditions are met:</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"> &middot;</td> <td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"> it is commensurate with either our performance to meet the milestone or the enhancement of the value of the delivered item or items as a result of a specific outcome resulting from our performance to achieve the milestone,</td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"> &middot;</td> <td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"> it relates solely to past performance,</td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"> &middot;</td> <td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"> the value of the milestone is reasonable relative to all the deliverables and payment terms (including other potential milestone consideration) within the arrangement.</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> If a milestone is deemed not to be substantive, the Company recognizes the portion of the milestone payment as revenue that correlates to work already performed; the remaining portion of the milestone payment is deferred and recognized as revenue as the Company completes its performance obligations.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Revenue on fixed price contracts (without substantive milestones as described above) is recognized on the percentage-of-completion method. The percentage-of-completion method recognizes income as the contract progresses (generally related to the costs incurred in providing the services required under the contract). The use of the percentage-of-completion method depends on the ability to make reasonable dependable estimates and the fact that circumstances may necessitate frequent revision of estimates does not indicate that the estimates are unreliable for the purpose for which they are used.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> As a result of our revenue recognition policies and the billing provisions contained in our contracts, the timing of customer billings may differ from the timing of recognizing revenue. Amounts invoiced to customers in excess of revenue recognized are reflected on the balance sheet as deferred revenue. Amounts recognized as revenue in excess of amounts billed to customers are reflected on the balance sheet as unbilled accounts receivable.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We analyze each cost reimbursable grant to determine whether we should report such reimbursements as revenue or as an offset to our expenses incurred. For the three months ended March 31, 2013 and 2012, we recorded approximately $0.02 million and $0.5 million, respectively, of costs reimbursed by the government as an offset to research and development expenses.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Share-Based Compensation</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We expense the estimated fair value of share-based awards granted to employees under our stock compensation plans. The fair value of stock options is determined at the grant date using an option pricing model. We have estimated the fair value of each stock option award using the Black-Scholes option pricing model. The Black-Scholes model considers, among other factors, the expected life of the award and the expected volatility of our stock price. The value of the award that is ultimately expected to vest is recognized as expense on a straight line basis over the employee&#39;s requisite service period.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The fair value of restricted stock grants is determined based on the closing price of our common stock on the award date and is recognized as expense ratably over the requisite service period.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Employee share-based compensation expense recognized in the three months ended March 31, 2013 and 2012 was calculated based on awards ultimately expected to vest and has been reduced for estimated forfeitures at a rate of approximately 12%, based on historical forfeitures.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Share-based compensation expense for the three months ended March 31, 2013 and 2012 was:</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="6">Three months ended March 31,</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">2013</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">2012</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt" colspan="2">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 72%; FONT: 10pt Times New Roman, Times, Serif"> Research and development</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"> 88,634</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"> 117,067</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> General and administrative</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 239,947</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 431,597</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Total share-based compensation expense</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 328,581</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 548,664</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> During the three months ended March 31, 2013, we granted 60,000 options to employees and consultants and made no restricted stock grants. During the three months ended March 31, 2012, we granted 15,948 options to employees and made no restricted stock grants. At March 31, 2013, we had total unrecognized share-based compensation expense related to unvested awards of approximately $2.0 million net of estimated forfeitures, which we expect to recognize as expense over a weighted-average period of 2.25 years.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Income Taxes</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We account for income taxes using the asset and liability approach, which requires the recognition of future tax benefits or liabilities on the temporary differences between the financial reporting and tax bases of our assets and liabilities. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized. We also recognize a tax benefit from uncertain tax positions only if it is "more likely than not" that the position is sustainable based on its technical merits. Our policy is to recognize interest and penalties on uncertain tax positions as a component of income tax expense.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Income tax expense was $9,743 and $150,405 during the three months ended March 31, 2013 and 2012, respectively. Income tax expense is a result of the difference between the treatment of goodwill for income tax purposes and for U.S. GAAP, resulting in a deferred tax liability, which cannot offset deferred tax assets. This deferred tax liability is included in our condensed consolidated balance sheet in other long-term liabilities.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Basic and Diluted Net Loss Per Share</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Income (loss) per share:</em> Basic income (loss) per share is computed by dividing consolidated net income (loss) by the weighted average number of common shares outstanding during the period, excluding unvested restricted stock.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> For periods of net income when the effects are not anti-dilutive, diluted earnings per share is computed by dividing our net income by the weighted average number of shares outstanding and the impact of all potential dilutive common shares, consisting primarily of stock options, unvested restricted stock and stock purchase warrants. The dilutive impact of our dilutive potential common shares resulting from stock options and stock purchase warrants is determined by applying the treasury stock method.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> For the periods of net loss, diluted loss per share is calculated similarly to basic loss per share because the impact of all dilutive potential common shares is anti-dilutive due to the net losses. A total of approximately 11.6 million and 11.5 million potential dilutive securities have been excluded in the calculation of diluted net loss per share in the three months ended March 31, 2013 and 2012, respectively, because their inclusion would be anti-dilutive.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Recent Accounting Pronouncements</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> We have evaluated all Accounting Standards Updates through the date the unaudited condensed consolidated financial statements were issued and believe the adoption of these will not have a material impact on our results of operations, financial position, or cash flows.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 22<br><br> -Paragraph 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EQEAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 12,873,411<span></span></td>
        <td class="nump">$ 12,701,517<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BilledContractReceivables', window );">Accounts receivable (billed)</a></td>
        <td class="nump">1,865,916<span></span></td>
        <td class="nump">2,432,641<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled accounts receivable</a></td>
        <td class="nump">3,713,797<span></span></td>
        <td class="nump">4,114,442<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">614,388<span></span></td>
        <td class="nump">547,245<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">19,067,512<span></span></td>
        <td class="nump">19,795,845<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
        <td class="nump">456,842<span></span></td>
        <td class="nump">483,976<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets and deferred costs</a></td>
        <td class="nump">99,578<span></span></td>
        <td class="nump">113,130<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
        <td class="nump">2,348,453<span></span></td>
        <td class="nump">2,348,453<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">21,972,385<span></span></td>
        <td class="nump">22,741,404<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump">1,289,627<span></span></td>
        <td class="nump">1,697,280<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other liabilities</a></td>
        <td class="nump">3,294,315<span></span></td>
        <td class="nump">2,328,877<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
        <td class="nump">874,404<span></span></td>
        <td class="nump">1,381,755<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
        <td class="nump">999,996<span></span></td>
        <td class="nump">749,997<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
        <td class="nump">1,329,233<span></span></td>
        <td class="nump">1,330,507<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">7,787,575<span></span></td>
        <td class="nump">7,488,416<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
        <td class="nump">580,238<span></span></td>
        <td class="nump">579,427<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
        <td class="nump">1,460,417<span></span></td>
        <td class="nump">1,704,108<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative instruments</a></td>
        <td class="nump">2,201,390<span></span></td>
        <td class="nump">1,295,613<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
        <td class="nump">12,029,620<span></span></td>
        <td class="nump">11,067,564<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 100,000,000 shares authorized; 48,416,483 and 48,352,651 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively</a></td>
        <td class="nump">4,842<span></span></td>
        <td class="nump">4,835<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in-capital</a></td>
        <td class="nump">210,877,892<span></span></td>
        <td class="nump">210,495,905<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated other comprehensive loss</a></td>
        <td class="num">(219,012)<span></span></td>
        <td class="num">(217,328)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
        <td class="num">(200,720,957)<span></span></td>
        <td class="num">(198,609,572)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
        <td class="nump">9,942,765<span></span></td>
        <td class="nump">11,673,840<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
        <td class="nump">$ 21,972,385<span></span></td>
        <td class="nump">$ 22,741,404<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_AccruedExpensesAndOtherCurrentLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Also includes the aggregate carrying amount, as of the balance sheet date, of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_AccruedExpensesAndOtherCurrentLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 52<br><br><br><br> -Paragraph 12, 13<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 130<br><br><br><br> -Paragraph 17, 18, 19, 22, 23, 24, 25, 26<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e637-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Principles Board Opinion (APB)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 10<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=SL7669646-108580<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 52<br><br><br><br> -Paragraph 31<br><br><br><br> -Subparagraph a<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e681-108580<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 133<br><br><br><br> -Paragraph 45<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32022-110900<br><br><br><br><br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=SL7669686-108580<br><br><br><br><br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapitalCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Concepts (CON)<br><br><br><br> -Number 6<br><br><br><br> -Paragraph 25<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BilledContractReceivables">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3(c))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BilledContractReceivables</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 8, 9<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 7, 26<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 7<br><br><br><br> -Footnote 1<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6600647&amp;loc=d3e214044-122780<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of after one year or beyond the normal operating cycle, if longer, net of the effects of master netting arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name FASB Staff Position (FSP)<br><br><br><br> -Number FIN39-1<br><br><br><br> -Paragraph 10A, 10B<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13433-108611<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 107<br><br><br><br> -Paragraph 10<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 7<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 133<br><br><br><br> -Paragraph 4, 17<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13495-108611<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 142<br><br><br><br> -Paragraph 45<br><br><br><br> -Subparagraph e<br><br><br><br> -Clause 1<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=14024403&amp;loc=d3e13816-109267<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 141R<br><br><br><br> -Paragraph 68<br><br><br><br> -Subparagraph l<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 141R<br><br><br><br> -Paragraph 34<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 142<br><br><br><br> -Paragraph 43<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 142<br><br><br><br> -Paragraph 45<br><br><br><br> -Subparagraph e<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 141R<br><br><br><br> -Paragraph 72<br><br><br><br> -Subparagraph d<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Goodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount of long-term debt, net of unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 22<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 24<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 4<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph b, c<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Principles Board Opinion (APB)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 10<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),16(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 16<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph 2, 3<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShortTermBorrowings</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph A3<br><br><br><br> -Appendix A<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 4, 21<br><br><br><br> -Chapter 11<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3(c)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph c(3)<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 912<br><br><br><br> -SubTopic 310<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6471842&amp;loc=d3e55302-109406<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnbilledContractsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001144204-13-027117-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001144204-13-027117-xbrl.zip
M4$L#!!0````(`#V(J$+(%(K\27X``![-!``0`!P`<&EP+3(P,3,P,S,Q+GAM
M;%54"0`#1KV*44:]BE%U>`L``00E#@``!#D!``#L7>MS&S>2_WY5]S\@/'LK
MJ2*I&;XIV]FE7HXJ>D6BD\U]`V=`$NMY[6!&C_WKKQO`O,@A38H<24Y=',OB
M#-#H_J'1:*`;X,>_/[H.N6>AX+[WJ68VC1IAGN7;W)M]JGVY:XSNCL_/:T1$
MU+.IXWOL4\WS:W__^;__Z^,/C<9QR&C$;#)Y(K]S+Z(S1LZX`W4%^;'V^UGM
MIT9#EPQ"WXXM*.I[I&68[8;1;1A]\@_2/S1:9'2I"CY.0H<`1YXX!"I?/]7F
M410<'AP\/#PT\5W3#V<'+<-H'^#K"16LIHL'/"B4#N8T=&DT9QYK6KY[@&T:
M[;:9E$=J?`U][J'(5DK_<1ZY3J'\0UN6-H?#X8%\FQ9=8KU0%-\F16V6\2#;
M%\QJSOS[`WB!++<:AMG(F(Y%8T9I)NB4BHFDK%^45.'"[[3,_CI)50E=81-(
MH*<(^8AR'`IKSEQZRZ9$RG48/06@(8*[@8/0R6?SD$T_U:"#&DDG-!^%72,'
MB@Z(>CARF6?#W^C,H3/"[4^UPI.FV6YUC6;N3XU8OA>QQ^@6:4]#WVTHK3+Q
M_\C7G]J`Q')EJ/[SE#J"?3Q8:CSCZ3@.0WS(A46=/QD-3SW[!+1=LK?J906<
M-AK0IVU3\;JJW8SM$]^*W;3(#0NY;Y_!,R'Y7OFV`L9_TSRO;',5TRC7*I;3
M=Q4PC._+6$[;7&9829/7C-(W%3&KWA=9+K2[S/`8!FB!3WQ0`7NFT?BMR!@V
ME/%SZD4\>CJ&YR%USCV;/?[*GB1CI6\JX-`PH$"K9PX-Q6=INTL,^Z[K>W>1
M;WV]@QF&B>LXDG,CS'EY[M<40VZ&W=6B4-'PIXUTCFPME\<:L<=5<2'IUXC-
M+.Z"4?M4`]DZPT[/Z`UZ!<G6\+0H)DSB+#P&!9KY8;Y7"L\KZ).193%H0?H4
MLJV\`(7&%SF^93,NH.>\Z(JZ+,=R\44%/-_\,KJ]'(U_.;TZK9/SJ^,\R\7&
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M;`Y[_5WLT#(1<%Z,/I8R3"W<M_BI4L#6/@1L+0DX?#,"MO<A8+M,P/[;$+"S
M#P$[BP*""VMTWH:`W7T(V"T3\(WT8&\?`O:6!(0*O;<A8'\?`O:7!&P]U\C@
M_"APT^_Z@=EC_PYF%3&:P<P"3@2L#02S1P+F%HO)7;WKZ6@V"]D,:'P.?2%N
M0M]BS!9GP/HIS+U8_7JJEA4*FNKH`R(#,+>#;J<[E#][F[B6H/VJGE%>,W6U
M@CAD>5^K!2O%IM'6"%<G5KYOXE"Y+<P^8RF@Q8?:02HZ1<]ULLJHK/(]&UU0
MO(Z!_R68%#G+!#EAD^C<@_6/7/^?`U<@9W0+:)PYOA]F.*D-B4U+(]O@4+0-
ML]-$)_B;'C8.)$/7,LKJK>S\MNS\9'FQ,8>K($B]-AR,E\#L'%QUW%TJ`6!E
M66T1OB'^9D9EF0@:E2ZH1YG$*UG*Y#WC'G5NZ)/</&.@W&,6NA<^]8ZH@U9(
M8R3EW;!L*F^WNP=YEXAL-O`WY#4#XH)[4.HX9#:/SJB%ZZ^G(S\,_0=8?!_3
M`!Y)YQUK74]_@R4+GW)F'W''`1MB67X,>-\RBX'#/W'4"-DSS6H5Z1O`#O28
MVK-,.W?`%V]23GJ7'EA)]+6ZP)1=L%,/K)0IUP6^-\-Q@E;D)F2!&C[PF\MC
M-Z5X$W+/X@'5"&]7YTT8ARUY?C9`:JT_?O"?@U1:^74A:ST+LI3Y#+M+^LC=
MV/V=.C'Z4+BM+5U=,`)?/)N%\LGU=`HU]=;\5C4J]C)+G"JS:^2\JJV8S5"Y
M8@"B/\56(H`0'%7T-:6;>L2F?LA.<#^:3V+YR@\7M\XD4+L2>3W?M%?[6;FF
M"8R[BI)#UH^8``\`>R#UZE,%O4U4>.2B-50P;E,CMZ78:K;-]G"785E&9:T_
MGT=L&ZY?`QYC+_`L4JD8GM(U85I-E;YE-G,#5$2)SW957DY_RNVZWH+8CNG7
MP:=B!:H<G]2FZ47W$AJ+!5[.'I?ZF=UET1<YS`F:VR))MJZNIWEW`=:<>H=+
M[8QL5:,LLOHH^*''G4\U6.:R70.M"X9$9X0)7I8/!G;%//CGY<6=3*)J9"EG
M!R^+AUF4H`R`5@&`5@X`<ST`Q:!E-V=)M^(S`^06H.(>.#U;>'Y;UM%!Z"U]
MOUSP>CO?KP.^7V?8SY#9DMT7QJ8SZ,"8-HPA_OC6YIO.\]2U2NNMQ:7=&NX!
M%[G#>D0%LX]]%V/D%*WK"%5KQG"Z/GK*BNA='FF9SB@/96,C:$799#'R/%@#
M@Z\X93P">W>;A`,J;V7_:2'?F+5,O5JK7+*_9E=59%??3%?)P:9*YE(OT'HK
MD%>_S[RQ;KO9'O3-712ZA$HN.60-%SE1XB!P)#S4T5,.VA5FGWM0QV,65O^#
M1_/\]*2$?$[-[\X+>0U\7LPKZ0T'_9Y6EN=PF\&DJYP^!CR4XRX-%9>^D3[U
MFB0Q+6:2:*'$5)^DF`N5L^B-V6CIS=W2=G=@&*;QS?JEO=@OQG)EQ7!+OZ^&
MX735MW,:TS*1RM%.F=\Y@V>9"#+?KQSYZA+(7HCY:I+#S(Y:55?,?#6)7R^@
M\Q4F=74;IB$/353*?$4)6WUUN*MBYBM*QNIA,E;E.E]-HM5S)BFA7(>Q?Q.'
MUAS\[=P)C+P_,?8QD6`T"YGT//)2/I/$2X7XRL^>]+J#3@&G9TJA`-5'&P^3
M.+/>>]>Y[4E6?LFKRH\>F*W!L-?J?SQ8S^(^Q*CR)('9&_9;`V-K,6(W=O"@
MCCIJ`(O-D,UAO<GOV;EG^2Z[\(6`I2/C,T^1L)[&H`W"42M2^U^QD`GZ5RRZ
MGH[I8X+!ONE6K@>-EHDVHP#@OH7XOM&O4GT!_7X;G9&70]^V.9:C#F:%>1;'
MXX)3'X^;XU3`A>7X(@[9&&0\<L#&*6RWK57!(;"_.=&''QJ-D^OC\9\WIP0/
MK9.;+T<7Y\>DUC@X^*-]?'!P,CXA__QE?'E!8*U&)"R:[X.#TZL:*=E!&-^J
M`_`F5M:_-J)<S:8=V372:/QM%GU`'FQ^C[^2W.^:M;N(AM%92&<(OZH@2P5$
M1$\.^U2['-U^/K\Z)$80P=_'#^3L^FI\2$S\/.8N$^2*/9!;WZ5>73VHDSL6
M\FDMI26B$%;O^!&#N:1'&D1WB3=3`E,Y'0DL?)"5EA^#99;&I_\<-\ZO3DZ1
M$5AJ<>\#V95-Z@8?O(D(5C:Z!QR8B[_*/3$?,[D('B^*GDBR?RZ;5H6JXJ)J
M,:\]<DG!YR"M;EU>.U$G#XPPF;EK$^Y%/J%R4&D$F$+`3P(D#SR:0PF!^2*$
M8IXW">(08U41@;H/<PZT@:)+=25"/9L(YCAU@N.31,`2EL1_ZR2:AWX\F\._
M3%-3'A34)7X<`B?H%X'L:#3F]!Y9H!X4U8'BC+$@Y!9^)'&`Y-^971BL+G<<
M#'43&0M1K60;O_5<L\@O<IFT/WF"=IZ(RZ*Y;Y.`A2Z/]+T>#GV00MGHE-G8
MV(0A4S4:-8!@PZ7A5Q;5,M:H@+)3[DF`R6WL,-(QN\"Q#U9Y)H_VQBE_=\S"
MC&(\7SFR(A3('+:AEX`(Q6L9F%T'*I83RP/6JA]<:C-B\Q"<1N<)[Q.Y^O/N
ME%S^.JX3/Y1R^&CW"7OD(L)JD3KR2A2K!(RN1%MYH42ZH5@31,.?NH]H4MRE
M7UG8)'\@F(QX/G`Y<;@2!*I(&+%1#65<AGV3W,63?P'#4A?@'2B@*R2NH'UJ
M8I!:$,UI!'VD/>!\ESU`YY)8,*DD+,3Y`Z0/&15@83%#F$U!L`CT'R@*D%Q5
M`OWED0"V8:)Q4B2DEDHP`]P/!UU2S-`@<+@ER8D(%0X?3AE(!)5!$^HDC!U=
M%E0R5A.F^HRLJK<@1]8E"40:GJ510?`6%U")`+H">X7+='-E@%/4"X@'H+P9
M+E0"H@YE8,OMIO%>(<ER`V>&QR]0!V7(67&!F5X2!2RNV&N2L1^!J$R?I$7=
M0P?!EDJ#)!,UKT.91"US#`3*9TZZ6;*(-@=D`&Q#_Q$<EXA!Q[UK]?MUPS"@
M1:UPRE"US9RA$KYCPX"H#PUCG:5(5(Z+XGA7YLGFMM1:P:((.`//GCMD!`;$
MT0U)G0/:L1.I,>N!UJ=0:4F@P4`.K>FB(#!<I1PCR=RB%(M=H+0.T:2I0U24
M9KD%L],<]A/K!IQB%!@XI?>4.Q+M\C'WO4Y:V=R,RV&2;0S(T?SYE!S3@(.6
M_I7FY[8A%:95-C^O1P$'$%LL`^ISS^U$T4#U/0Z_")QL&$YE$Y@%=*I[;GJA
M,"J;W531T$83!PE+TPB*=^\[<DYV0/]03RV9-)^;AK/*RJIIF^;G+@GY=Y)`
M3ZA>9P/A]$A&&2+)?*%X>8"I<8H*KVQ2P3V@*KL2^,D+\MT.A,R-4=.EMNJK
M^D$A=:P-%;HX=@C.B^T_>'K:65-9]^"@*R>/K)/4(8>ROI):,3`6RL?>ZAJK
M;*244,X[N@,SRP8L22&PUQ<GD&8[Z>$Z4E76_IV9/9:UL+K2X)P6KE2)[W$M
M@^-_RA^5P9!'\D@HG65O8>C`_&AB&/(]>K@`B1>[RGJL5(HYP@[HR1T!=0ZK
MT$3.=\&FV@T73\6!-?)L>"1/"$ZH]U4MJ:"D3$#Y\>+\Z/KVIWJRNICBX4'I
M^C:[[^LD<&)!NN_7*4N1">SE7A-K'('CNR!SZIFM$M'%,WU($B`-(N9.`!H,
MDS2)S@X1RT!*?\8/^0Q/Q3E/*3\-WX-/B:LTY2&P:,*Z!$$1B3^"F`HPNH`>
M8QZX49'T\U'5S98N6UAE%09_ZAM+EUK`@@U^=YZ6K"1ZR],8F8,Q%4;\/\#P
M/8C&Y8C4>62J`BW!&:1/CR4%*W%`UQ1OP+-C.>)QNG$<_T$<OJGA]9*-1GKM
M(!O^X_QD_,LA:7???R"@\2>GMXWCZXN+T<W=Z2'X?(Y#`\&V:)I8L)`0>"`-
M+Z<TU.<`_4CU.>,B3%CX_?1V?'X\NFB,+LX_@[P3/XI\-U?23DK>C$Y.SJ\^
M-XZNQ^/K2^`GB#9G[0,!P:YO@;Y#K:^E&$5V2:,:E:1-61M;1L^?VV#:L.LT
MZY9TBY[-$P(.V'F8+X:<X+G=U8R]"AI_]2Z0K:=V!=F8A.1`/=4V9I'/@R@L
MT>JCT?&OGV^OOUR=-'0#X6SR8\OHU%O=;AW^_>D#V5SS]3`UWU</=AY,ATWA
M_2LUGO1DTGQWQ_9QSGBC8NNF6B^,<(B7C^P/X'?]SK`^'/:?.T#`]XC8-J/B
MY8?":^C_CCK?>4ORO8)V[]+D<(@*W7L-B_\J$^VR0KPZ&\DHV#LCN(!Z\TB\
M>7=K#X.LWS7JAO%RL\8BIJUF-T&U<7?^OZ=*#EES/V-F30//-6I5-E&-$&OH
MO;@NR[:)[<>P$-Z[.K]KU;L&:K2Q3J,/Y"K\C>P^[&%S+]UPJ<O0E#\E-A=6
MNM7='M:[@WX=M_="9OGR2+3>JD&W7$98,9HG8ZW2S*COK%`W-Q$Q9RS**&-L
M("%??VM[.F7;*]W.ZVVO[-<M6;E,ZAA;K!X4Y22Q,L#-/Q49=GQOUI"ZA)V\
MUP73"Z^`M3%XUD)L>RA7.*J5R+0:PLJF[.<O5!2UBX):U8&&$,0JJM_NBY8=
M7(8JM6H[VF:]TS/J'7/)']L?^YLIT%]IACR?8LP\D)=HE05_,)G+PSC1VC!0
M$'*5`H6ELIB&JV]\)#AGRN!\:3H.U>WKX+N\Q0N3Z3#ER"?M-"$'OX^I$`T/
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M6R;VH5:H)+D(?#,F3[)CLDO`PN@)/&!-3A7$+(@TC4ME(2@Q8I'E0V!&(:;&
MZ#2XE<3_4AD#,-2M]-21"L,OZX`T`ER>7,JE&Y&'Y*X=M`CZ/!/I]&`)TLGE
MZ.4R4:0T_],>?A#%/#=,],3P-^9R"I9E]+XSFSU39BA(<LI^I*VB8NHZ*A_!
M=<%^JY00F=69Y9E:,33DTE"_D-_@%Z)9B'C#YHZ\\DZG-LC84TE+%MXHKA);
M0"UU=C3040FZ.FE0Q=ZGE(?D'B^02.1/*6&"`N`4SI0=S27^H75N`&5+@ZL(
MRJMI@+7B8@P!0[*V2H2679,9V&+1S+CJX/\*BZKFBW34;V!5F[FS`I8OHER*
M*"_3*LS)+%@5Z@A_,^:VXZN:H?(RR3M+JK,\=/).PR2YG38QX"JI(_%LM$>3
M)OB!WA23.Y1"EF1)6Z"Q3TA",4.SE&RI=#!$83AQ&&EVG*;XBCETHNHW3Z72
M:!EN)4,LS`F1^4@RIT5I;I*P9C/EJC%[Q7B2%ZM(&Y7+!+-7,[Z0T;+0@3\T
M&J>>73QJ(XOD#^<D'W*GJ[8]QK3J[-0-#/US3UO5W('0A<-2JXI5?JJO91J#
M?G\P;)7)OHJK*H6M]-ND3*,S[`Z-[B["IA/)V%]1.;VPB]G)C6_'RH9*&)Y/
M0!]W^^:-;9N=F=OJ^C9$K]^7=Y3M`XH%4!T80CC*RZ]UTE_XI>#;J*B6L=,>
MF,U.S]SI9'@)D34@#0:]=B>'T4;LO@0:YJ9HK+]M:#LT3+-O]/IO$0ZCV6IW
M.SLK1PF1M=]F-QQVWB0<YJ9PK->.[>#`;S0<ODDX]GH>>?WW.@ZZ`_,M0O!B
M]Y)U.X->;U>3"8L]M=:[9]E9R]-'M26$5Z\BB3B2%*ZGIS3$O&C\"B/92.ZZ
M[KU0JE*'EB\CD;?JFSU]Y^Q>(7G[*%>DIJM0[KX`RG(W3<&D-M:J7P,,^ZWV
M(.\5RX8WX:M2=[W5[Y@=H[,)7X4;9O)/JK\?9P@N3K=P,4J^_>V9K?06G&%_
MV!UTEKJZE%FPO5S@UY,P@5=%RDM#//N.SSP^Y1;U(GV%#FCTC>]P"S2_>!G(
M+@3^_UZ0BNX%44=I9=?@]DF^<^1>R/JCMM_C/CB&0V*/QK:*-I1'?J;)/H^Z
M$D`=A=)!);5/F9QT1-#`>+LC#/.Q.CGWK*:*0N$F\-QWG*>&_X`;7!@Q@>F!
MAOA5V62$UP-DNJ^V-I,#YU'N0A9)3$>B!%Z0D9PAPX")1Z-T$U9S+R_#>+Z0
M60,RD*CW>%'<T);!,+EQ.`-90Q7YL3"`DYW]S`4X'7F7@(3KBR<9N<-V!/FQ
M]J5YUR2?1Z.;VD\R""EO&0BXI[-6H.MHX0(/2R.#U'?K/(Q4Y?;_TYLCD#*T
MK.^,"''V5C=[Y,NJPWSR2@P&O2$PSH`A$35JY/8EWLX!X&<\!+[0\56UT:^N
M,PA82+/NM:B8XY'(![T]^DT1"Y%)W.P]`7[D,4:]]=F21PYE/]J@^Q@$D^&O
M'-UO`"8C#WH76'$E592[J^30%X4DR'!Y1M(&[99;]^DY9E57DI8WR%@6PI4<
MGXSQ"",7%O""\>HF.69A1$&+>+;AJB[H\/W(PZN,['3[]?_:>_?FMI%<;_BK
M\/4S4V5728I$W3-GIDJQDQSO)G&>.-EY]ORS18DMF3L4J>7%CLZG?P%T-]FD
M2-VIFSFUM9$ELB]H-!I``S^(Q;/GB>O?0-Q$+TQP&7]'_*GLAW@I,'-5@,6H
M.9LJBD<>:`BRRLBSAOQ2DK8&=J5`PN`;H#(^(:2#%M=>)5B0(6QZ]LPX]>A>
M*)J\+_/_30WO]RV>J&F8&)`0D.,>,5U$)FU,2L&ZC,-E0%\VXV@I+QBU`$_[
M:W!C-O]XN-J&E$[_#IW4S>.MVD3D6.<R0C0!I*#:0\G[?.`7#M*N?6,8:X2W
M^!]@1G`$5/\>L1*%._`LVX7-48$A8Z1'-)8UZ2\BG'"/$^-3"K'KP,+@;17&
M0/ELDH7#L>7%PRXJ4TI[HP1]B04?UX[D*GSNK\7KR[U.N]_H*%/.&\K^YE.H
ME=)JZIU68^/YW,()`$N+_R`BV;-AXPX8!+?BDHNJ%/"BR.L\>0@<T&ZSU5`F
MNM:XBI]TH?:2WJTWVHWNJ4VZK:\UZ=@8TC>9=+M9;S5Z_9.;='.-23?BE4X^
MO_*J0F]VNMTBV)N7]00S`6',&!Q-].^2N6>_<%C/=*,+'-!:18WLD1Z:*`?S
M5;?JG2[LC`*I@F?Z/.E%6>O)TEU2J+L$B4]Z(GU0EN%"72;1?,E.9?%\.1A,
M0!H\V7,$'DGQ.%Q?1ML:@Y70ZGZR)D^@.=L6O(^*_#,3=C57PR6TC@R_MF10
MH<>81,@!U9XR#3@@9WHT>U*ZU]IAJ>V+(8,/8P']_N!]@ZGZ`0+DH]/_3_0:
M2%AX_F/@OU?C&7%?[]1$X95'ZEU>WD8ATTX#/EWZ%5/\!"L8]5\%_0JJOU+G
M[UP^_0HJ`5.O$@DOGWX%5:%IO!;^*Z@03@,+X;P&^A53BT>6ESL<_0+Q-%;J
MQB+%Z<9RJ;;J1>%K6E&H)]=#M:PV#]AH_YHQ[U\R"R-5,1233)83<-78CTNV
MEK[$MDTY>NJ+S[\F4B&OK*B`F,MA&>^M2S:]UJY?`MF6*'%+R=;<CFSP6O?<
MR;;"]LHE6\9[KXUL2TRNI633MR5;_>PWZ0I+:RG9MMRDER#;5AA82\G6VHYL
MC5KB[N1LR;;$KEI*MO:V9.LT+X%L2\RII63K;"O;+F.3+K&BEI*MNS6W%:_N
M?@DQ".5A'`>;W!H8'/!NOCX%UV]CSR$`F65/VQVT-WHK*+?^F$^2B'N\77^U
M1-RGY;JL`.\%D[`HBS:3G'J[JW>[[5=!T'W;NID$;=3KW>YE[_&BC.#73L]]
M6\>9].S6V\WVY0O0(LSF5RU`BS"HL[6D5*[E!=-SWY9VM@!MZDV]\3IV_+YM
M\$R"-KN-EK[*97$9]-RW<7X:&OV#@K:52R_E(3$UO0XG+4;'HE)8;^/';JT-
M%DQ-;S2;:U)G52,K#IM>'_Y;Y<!0AEX0-<#RW8H::>/YN-3`E!\>F(A1@"YE
MUS`'<VLRD+XX;39ZI0S.+2@XUP\\UYG@GY@TIK6TJJ:L#`_85=>&PC_CERXI
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M\$5Z^*XD"G^/:#XV:$V@2X=-W,`2*903US7Q-Z62*P5_^R&F6T=42A1(%<^)
M8:3'?VG0O8DZM0U9]1F94J#U&DZ40"^8=X09-&.+'^'Q$CP9IC;TF(%PY]I(
M9%>/1'XB)M6J6-%`Z)!+SG#VY-K4%.;?CF"5^1+-X+2"(;C>7`.6<V<S9DN(
M3QP=;A],P0W]).,+:&:MS6M)8WX`%B.!UL8(G'"-19S9F(!!Y72P/87E.;KX
MOT.3CI0;:-&6H.4$42K`G;-V`D_*YH]#CV8X$KNJ41?0ZKS^"<?DM1#CFF",
M\0((DYQ%TY2`C1O/Q;QQ(BZ\#%3[I56/RE'#Z-6)11C4FXXO053:7#%E78=5
M.<:[0+/&#",XGZE@=Q"XGL-46-DQ$VG.B+SN$10LY2[C]Q'&P93#6Z!P2)?@
M;D63H[+-$I27@!P^&W.E@GN"0VGZB46K28ZD.M_,X`6%9VP41'C2J-GY5)C>
M34KDQQ`A]T47U#6,808\RQ'[1Y[K^]6H52Z/<]JFM_]F."'".<0%I[.[TIX8
M`DJ['L+W>Y.0A*6RX\X6)A[3=0Q'H@AHCHM([J''84=B\4%%IA$K`&B"%=LQ
M^1Y7EI,Z/NOHN2%#$8YX$./0EKG[\DE>I5L`&>00.^H-P:*#T!/%J#V^(Y,"
M(6(5VAF$%()XW6)/DZ2)=Z+D`=R&_D9RXCK>[1Y#X>DKQ1ER=_X-Y4.1`H#3
MF<,/4=TF1'P1E2`08YE$!+5O.;S[B/\M?SF/G>/A%JNJ_V"."4)X(V7UU&?W
MX$0E!IYI>CZ";(`2:=H"\QH.33"+>%D2<1H/+5)+1SP9CB&W1P45I!K),8"<
MB3'A1R0B@82$5.''L!:\2X$_[Z&,I\,;.=A#C!(X1L:P-5X4SH1SCM!"E)KS
MW^.6N$KMAU:L2],)$.]?R@;D>U/S&?N+,'1P;]J&)SA9[/EY!!F#%3E@:G@"
MF\849L2/)_FZ_(XV1LA/:J%:PH%$N"6H<\KR]H0R\Y_00F@7L:U(U,QG'$+?
M$5*-=F3&A!3"67B@>7-;U!)8F)@<64KW`(,_.F2B6A(J?LL+(K>8T;`YQA$>
MLS./5.)EPQ8B%J6+JT%C*#6@+5I#;ZJ,7DI8KGI9,6U)><-R`<@G;HAH^IX5
MT`!!>R=1\VQ-7,\-?3)'QM"<2ATKTO]>B"5)+9>:H?OBG"LL?RR)/N)QX]#1
M+I$[8'X7:CO+,NR2>R4VO^M0L8<J*GE5K-XCC02>]DN*@L]+6B"CT>:/"W'$
MN%E@.N"AC!!"$O/H#GG*9Q%QM0'].D#'#*_<\6[P[6Y`BADQ%;=L*BH:5PPA
MQ3&E%'RK&(P*-=R1V)DDXHQ(HHJR$CC-C0"[*IB%K`!VG>O)%'/[-S:Q_$!(
M9W%A$%6$N=2<=A!V5`B93D]R@2PE0WRF\L1U/,A?GESN&L%B7D%LJ?XMM-&.
MJ/<1".^9BFC8QH@W@Z>\ZZ`R:^&1YQ"ZE:IGR@!%$L<(&0A'&8><XD<5EO_R
MU)$JD%L2!^NQVMP$VHK;X]BD*,@B2OI0G1%[+@_5]<8M#<B\,<;*"]<)X-6H
MO@O->:$$6>*4S&LVKA&#<%AV7#2'<,S0O;#+I+1KDG`H%,F0]&.:"N,6E04L
M:8#M$.G1&A6B$*L(2:JC[D)>+3Z<&X4>OFN;THV6'M0+\Z*O>6_L)QY)(>B2
MT@G7J(-\M/%$GSP)6J5F`8:5825JT:7*'Y&Y!3+3PC50;.(>P::U+\KND.:8
MCRB`R"D)UA*NUD@+%DIUM/DKH@H/9W:I0*=<9W\Q-A-<YG'O!)FEF_"P?)9*
MX,9<E_*/H3<O'FN:J;@BF!HO'IS)^:<&C^(F=Z@25S'DQ7]@!!;WL,"HIM@;
M<.C5S)I,YM4A%G+6AAQAUL.:I$\7Q4<_HG)ZD=LZ4[!4(MJOMY6ML49%&GE-
M9X=#+@('$(-$>(,F+..UO&T`W5U4?31(YKDOQ#=42QOU_!DA$=W@>O&Q1-X/
M4;]/J=9GD5DCS"B.MQ*!,+K+9#%ZD5#U&B*/F8M.^YRWK@WMZC-*>N80#.<'
MP[*!MZYN*JHW21T1E?YT.>_[S+9QWE1E#AW5Q(OD%X4%BVI0PA0;M7I4M]*8
MP):9B"I7F24Y%R4Q=\C@Z<&G8]"F11M2U,%SA);`W<:X/DA?+6-N'*8W<`.R
M\W]:TW"J;,*H3J/EQ[KV8ETO((\;VB82)^6HK==TZ8NZJ`WW(?+-9U(UYA=1
M=2[!-!P$=0G7$-(0D&\FK:+#\`P8\G#0-NMPQB#+Q#M_'4:J1&<`W?D`%W@<
MEQ65#2S5!FWQO2_N<J+C9<P;0&<`['IF;L.26?R7X#X:!PV/B+O8/0D[],DB
M%K!?B4>S)T"GC<(S%J-!1.DO6<2*UNP;\YGWS$S0MS_0(2@+6D4!(1N]A2D/
M#0I';S=KS5ZWL3RZJMZK2EQ#?*V>^>**\A6M=(V0C0=]/$KUUZ=45Z%4?SM*
M-1=B3_=&J:^&]^`1XK%)`)*R%$B:-GG/[1_GE;+DB`XJ&5I7?\"3]03^R.K1
M%3OMO2*]'F3:G$L&(=AH'I5`34TW_?LA4O@:=?%?YA33(]KOU/:W@L5/[5Y<
M8F=-B_]VB-5J]5J-3JO77#(C/IC]S*;@!8*)M/5..WMW;3";A5C5)0^<R"HM
M#3_=;7+'7[2U)_<8#D4UA'=A\,/AOC3QY8P\$3%@>N;D-VE`K.3*>JFY'+!I
MB=1F<ZGLV63LN614@+-37Q8.`0]<KF?.+@L*>^T1%XG?CJR[P8AG'GMB#D9E
MWCMX+<XA8#-!F==\N`S]+A:765T&[1/>PJ.Y.P"S<AIR7_@#N<J2#_(%*SS8
MI'B8YL2L*`A!N.QXB!(WZT4T"H8FV9)"Y/XCRO!K"G+PHM<DF&N*<S%1EHJ#
M-K\XC"QVZ@>/J&OK)J,1]`"(1<"Q44,BL$F]TN47KMA,%">9*&R%@X>FF#5Q
M$N6TL/A[;IT?Z==4GQ=%1>DJ!*/=Q#/),E540(<76!'.%/2Z3D2(!T;G\'HP
M>&4M^A=%;I2?N//]V@*RA(['#)NT8PJFH%]P#;@+B#PUY$36#(RL0[E?A5ZK
M%"JJX&7OSRVREM!*RT41!/`-8T\B29[\\K#%"3JM;KO15)/!4\/9=@8'JR30
M:;3Z];:^_@S\X&'\C5G38>@1G*=:UC?WUP.N2K5%H-=)]2=G6/N;VV'6"UU"
MBQZA]2;'ZT?QS?;=^"D>>L<<AC&I-,.ECQQV8_6[+=6&63JR(B9ZL/W7:-=;
M]?9V4[UC0W@0*[^A]*6*78\S+'SVX/P##AODA6^4Y@)S7O-9`8#3K#=:ZR#D
MIF%S,MZ+YCX+DQXNG3Q<RM37'.(R&LB2.$J)YV4/"#6^(#S@!5R&U,Y=-K+]
M3I(OZ7J37%S2HTSR7J1VX(J_E]$)7YDWPFITDRR>7O%&A/V\'F<OKO7ZG-TD
MSN[DLO:*D:Y+%N[_79LFZ<<+Y(LT0<B9W:BKF`_KCW,9.40`Z7<*?UB<OOJS
M.()63'>]4VRQD3^B4%9Q"T_*M.V"Z4)1%[+$#%4(Y7.MNHX]C\N/4A)'HR[J
MS<B0#4Q0`LU_)*/N?P:\KF3@:@U=UJ9)Q#FHD2!*)/VC$L]728\0KZRQ_BDE
M@W@!V`F4]4+9-3QRBXP/L@^H\60@0"UO657Z+UO&'X[LU\1KT1RQEO%4L8#N
M::=:O]WKYDTU8W"+,\YRX&1\7_IJ"O75@&'CVL_(T9\LGB-SZS$,`D>C&'E5
M^P2[XD*#CP>^S-=!QT+HD8O%<JC8K<:3UU/!R20BC&0T\D=>A%M[;\/AY5DC
M35Q&:[>N-W-%A-7UU<?W\@>>V,[%!AXF-1P(1C!S464$<0\T!A';2N$Q*-]&
M3QA>$D6+PL#BMOG[(G94Z477>8PIUL;FE<&D7(RC3D&<0=/>A(M4PS0%W\+8
M++-J.=41[Z.B.(BPP#%(AF%`E"1A):)K(N;19)%DBFX<\P!=2OSY3MF?ZKL\
M52;R($$'F/O`/5MH#,@RQ@Y3W5\)\5XAA]&04622%$-<A$>27DR=5C-V)L6!
MG_)8TJ8L>')%.+!H+/*`80BE2&!-3P&3=6BTJ7G0T-0BRE%'3%K7_,1<6>LY
MZ5B+TR+VY)3*$,1I"<YGN,RT7/',,8WH%4,K9JY'LZ.WFJWJEDM]5_B=5J_;
M:M5;BQ/(=,.M.^!"2Q(W>XUN.X/D.2,&4WYDR4+B`U6P\-'G_G[83=/6.W5=
MG53NN/8[P8/ME%Z[WZAO-4%**8*SXH.\ZXC57_^390PMFX*W/\!Y2]>:<8BC
MH,#V#<2(9RT.S]7HUSOPB:ON5]I/WWKK6/;O5]`<6Q_Y++NQ)/%^3FW'?PL=
M_)ZA`.OU>N/-__O\Z7'T!'92%?-4\9R_TMZ<&O'ZNQ$O+25>%_&(\SK[Y+SL
MQBZ2>/W=B)?!>:^(>"K*8VJ^&\([+J56THF+[?039\3VLS@U@O8W)&@&^VU,
MT(;>;W<:S<LD:"])B`UX,^.]U\N5ZQ(QS8^;$?'".5&!;Y68K5O)RM3;KY<K
M-R-HOJQ<GZ"7S*%)E.*U")H+3[P^A_:ZO6;RZNUR"-K<D*"-F$/;S6TYM-?K
M=-IZL015WOKB<D=P="FV])G"'55+)%[F@(J98:&>K7P1M,8,WQL>7I?Z,B<+
M`UE&`\>\L^PP$)DO*YXIV..5G7&F7_U1A4<50;%BE,5,NS@_V-)I=_8T[:PK
MWA7/E->]A5[WTO+1%95DQ2\LX"'ZL"`:K<B%7O;&1.#7(-HUQGS?8$8^!P!X
MJTQ<XX2RLI^DS'AW.B,"#N<:K*9E\DL^Y8H.0_N3#0C8M1>&J#8(B_C,"'/2
MH?H9')0*DV$B0`(EYTP@BA"6(6$(5#A:.4=8I:ATAHA)/EY!!_*Z^,(0)V+\
M!*"50E]"EXJO<&/@.<,)K*J)K`[G544S!=,S(8366%*9I"%Z6KV$&6LG;[6M
MZ0Q1]@30R\P-8+L3J(088'+Y*\1.ED_W[#/$B_<LF]`G>"2`.Q-`>+FKS^$[
ML\,&Q.V[[#D>&DXX^CH>8Y(S4QDBB0$MZQ7);#(.&,\);<QF,0Q8@(C9H3<7
MKXO;]TOCX7@/1WR,\B%F3TH(2K*F88]$ZI1O32W;\&Q"W1F2F$H]/V0C(_19
M!LNM7%?+3VX90D(6`1URG`QX9Q!G,27A;AJ-6B<"'$%&@"_:,5#Y(LLK.$<*
MH.[/.$2"(WKSZ8O("TFG*'E*H96(.'SR&),A@3Q*,!FF1V/C".D"(HZJ/E14
MXED>C]5(P:NH]-E3N,4*I2BE99&,>QA+"$&,$WUP;@W_"6%5X)_W_PE!0[<Y
M0ABJ7!N\<-C[Y:K>4:M';C+00]/D8%?2K7JSM1>23&>V.V<,A,^S-6)2>V<F
M)IPQQZ?=],459\<`P=K][[BIU=\QH>:+&_R3P6A'[L2),"4*:[U8DQV3AO0T
M&D5A<SG0@GRELP1.%O$5/M<H=I4RNRS`=ONJ_[/Y^0`KE3F?Y/)E^*O\I&F[
M](G2L#U,N;&F5D4\-D_C``>?2:%4()0OL]#8GTS@D*H!OB(;.@*]!1MBQ$1E
M$*G-B`)`/*\:8W5!OPL0#1-C?DGSPX4?$XZC+?Q]<\3AA6:M@#<9U>F*H?A<
M1/#SP?XRGPU*7'%#7U30BK(\HJ[B=C&:&#0\C["!U3SWJ`Z6:"/">Z:*<CR^
M>!HO-<4:$XRQQV:8SDU]B4SOV&LI@JV]Z%T3VU(HR&.##:Y.5FVL"*;^_&2!
M\0=:Y9PW!--W497]7Y'H;SE@3OK0B,`\Y'TH#:`-!AIWW`QA_47OHQJ*!MD0
MX<PX]@IOD<J16<[BHZ&S\#"W\[@^3!/P>1F#%4/C6?>R`I/_]A0V2\#A=WG'
M?][???]O;+3^ZP8=:"-FVSZ81+"NJ&W1WS,,=>=_QWUYLJ-_O/_V_?YV\*DZ
M^'3_$685N#/E,3,]GM[L9Q;,1&!FO*,,^W$^';HV;.2L9J:6:;K!>@VM)O`G
M8N,&R,G_&[J\IHXUXC`1!@]_YYN,5_BP3+38$&5!["%EP\(6JJ4']2;PE,^X
M8BN8!NS#65`RS5DPC0Y,\[`@CA1HDO^D."HVXP77540Q03_U*&&D<L]&GK!>
MX,_?,MJ(V76M!B6G1P<!.0VIE]^P!5>D!-$\HX<4(4M%*/!X(G!Q=R@@7X=S
M]2%Q:,&A9)3[Y37M%U1&?RR>R3$G^>$,]1/.,<"6`6<IQY4\0[R(JE%4IHU>
ML\!&&0.;Q^E6BXE=V?*:JQP1()&L=85;"'6=J6N"BE")TIDP[T@661'^6%&K
ME;MYQ0X+L(BK]9]0ZE2HCZB#S%),=MX)9Z*;#X16K=3(4Y5>Y6NN8&)*FP3V
MS](U8?F&://*[&I8&<P@XR^C0]:9<Q*+"E7^"G91].::-@@X1#37F^GF0=PV
MO9#3>HR%33#C+^`E9`VP!^=44X#?'&RG:$._MIWW+HIUG@">/_`$458P'A4)
MB4-29-M8:Q"^'WM1I1=Q;>,QQ+KBWNG$%A7V%%HI8(]P`"HL*H!USJ%_JJ(I
MSKWF15UBQ#4[!`B[F:K=M*6Y14FV9,J1[:A48EMO9R2V1<K$B6Z=TJ_G6(_1
M30*OW<!@EZFU(^%_3G7G">,="9K@H4>7NU2=@[*!%V`%HOL*7N3$E'P%\Y+A
M.(F>%RYF?M$5)'AL#+[HRR^2ER`7Q:N4]!R5*N"KZ6&:E\]X];*HTII:FC>+
MNTB]%,5SEZ[Z!HN=:U<?7KU[]_#M[OVWZNW#IT^#KX_OWX)":]O&S&>'U?R&
M;A"XTRSE#T=1?;S_G_=\*&LK@%\'=W?W7SY6WSU\__[P&5Y&]7G=*?VF`4$>
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MG,;.>^VK4+I_2_=OZ?XMW8WE/,YV'J7[MW1`E,["<D7+%;V`%6U4]'Z[TED6
MEE:N;+FR!W7_GF,@LR^R-(,GS=#\<#HU/`*(4BI_9^<&+88\RWCR=.;%6F@Z
M)YX>?/+N[9W,7ZEA^B//(@2NY2KWVDT>VZ>0YT7@91=Q'$-/>R,F'_N[$S\L
M]WWOG1SG3=\?CL<,FR!^/A'.5TFYG3DSDI-IMEQR0.Z)%KLZNH0(;?=^733X
MUUV%E"*UJ_LA4UU(-[JQVI6C`NW<[OY&6Y*Q)..QR7@<!]RF2E!F,J3'.'1F
MX&HYN*0'/)AVG>-F=MUF;6]EO>VDOI<T[]?;E6ZW6U+\8!3?*D1M7S0_V4BT
MRW5/Z,O=$V*9_QWZ@36>"\N@]%GLZQZ\=$\L=4\L"=,JC>S2/7$L]T3Q7K/2
M/7'F!F%)QI*,IT/&TCUQ^89;H]+K=2J=]I+#J326]^V>Z#<JG4Y)\4.Z)WK=
M7J79:)7NB3V"<`;Y!8!R(/0(R]&=SCR+4`7'<1$K$-21B(;5ZO<KL$NBPE]Q
M%3>JP$:>D>A5WJCC6]`I%_E#EC<`I?82QZL;,5DORF>(0TE@A6-F!%AI`B=4
M017?$-6Y*M29QT:(IY\&HS,$SN=0F`;^$^,(Q:Q",(NJCT9Y+6I-N&Y"QPA-
MBU!B7<=DCL\_Q47P_`#^X3B;B!`Z8YY!1<(X69*>'\20S"L49BC(CN_06*H^
MCIY<&^E-3H4D@&U-^^%'SJ35CVN(^6DA#9=CZ4?8U;RL`@(FXAK"("M4%@H+
M$N`WSR[6JK(E;&_T)!658X[IYR(LEGZF@UK*N6DK71K)_PUQ50.^,^\=Q+XE
M[M6,H1L&D4]R6;F1/1J\FQ!BPX-G1?J.,D&0&\TWS<:;D\$4//&DJEWZ1XIS
M?OLNX;5?T>P3N.GW)']/P^8[9GRN?IGP#*<5>=W:M??5&L=I$Z"Y:^_O5=UH
MVUW[\@2*Y>[NF8)2WG:S-`^9O[?+>X=EO[VP7*1DG\9I4;+@JV'!0:8)N(V'
MY=2]*;>Q<P"KC<0%9\*IJ`&N^+2YGV#1F.:EFGB=C*%+99WFPNU`[^3YPF50
MB.(]^`T+VF#M<#ZF74QS;<(<YAFV/1=N%&PPT7K<;07/*!O]-\K/>=/-:C?Q
MHEH.Y:-AB4+JO.*V='VH'AP3(U:X:T5$PO@)5Y):XR15EP1ZXY6M</X.MB^<
M&H+\2:</5MS.;A;;";U=O4"_U.-*%,H(J"H'KX*T:AQFZ$4EY*E4(P4#B=(U
MV?6_+>Y?`ZT,^K!X-?4D!>@O(#\5P:%2+S"`KT^&-QW`3XY@T(JH'_,"%/RE
M46OH2C%R(QN,B9??:-2Z]85G^2#U'A^D(`]6;CTL>?2BR*-WEY"G3GTW(O(L
M/BL&R1_4#^Y%VV?96C;%CP->0>2S4C%$<;90Q9`OKA,7#7F'14-H5/S]<Z7`
M]SC(3Y9+\:FXBNTZDZI-%6EY=96*J%4&LZ]H6!"(>5)V_R>T9N0"Q[\FKFN^
MP":I9%5=<50:BBH[WTE>RA(NPE,N*IPGFW@!=D9VY^6=3`:23'KN28I6L?1A
M%03<S/7X9K%@9A:L9TV[]AF#)0R8IM]D5_:IJ!&/5-K'<85TSJS@)@KXLA55
MA3*FG%K+_Z]:?>^8R>K,](A:SUG^$=?@7EKE.J=D-G??*.@WJF=5<:Q^QP,S
MIZCV=FV49;>5LMOE+4!Y"U#>`IR9'[R\!2AO`<I;@/(6H+P%*%VPI0NVO`4H
M6?"T67#G6X!=[?+M#.4<RUUI1CJI'IQOTK%`[BA51:.^X6?7&<%;O)ML<WZ/
M#9<VOF+CGUP^+UX0E.!B1W2=E.!B);C8\>E;9N\>,'NW!!?;6BE^+?F2)1E+
M,IX.&<OLW?T<3*><UUB"BY7@8I=/\1)<K`076USF$EQL,_.@=$^4X&*E>^(L
M*%>"BY4&86E7EV2\9#*6[HG+-]Q*<+$27.SR*7ZJX&*[!KWL,9PD%0GC>LR:
M.+?0$'-&<PKS,$:4O3AP3/K3IO?]KZ!<PP/)<)=MWRYC6@J(:<&V>-Z<6!=-
M+HRF+`5QVO+TNK/UH87.B"^*-I(SE\!K3R[F)KLO"+<V%N3QPZ%OF9;AH29A
M48JPY6G`GTH#F-7&<^@P6UG1/$3#F6UA(ET@2$[YR*">_'`HA?@1<X5]S42/
ME.?'R&_LI\@]]>AW(^`H;(XI_7H>F[E>0.FHE-A:T^Z=D3ME4:*W`TH/=#%=
MZ%ZT]<)0HN+?SPR8D*6[G'GLV8#900]*1NUBM[AJ8]BK<N$68@059EM(XTZ0
MB5+]GF`XFN,&VI`Q!TUXLT)/!1C51PGEMO6?4&1:0PN4._AB83*XY<]<#E[(
MP0"-T2B<AI+F(LN0,`[9$Y"'YPT3S:XQ[_P&WJ*?70?3+('.I$("IYC,4Q+Q
M,1,SF//\0IPX\9O<8A&C!3FSIL7`?'_79LG>U.%FC17'B(N7@>RXD'2][K)P
MZ:Q-*`$?,R]Y_CT.DB>BQN"'$I^03TD@,^+S24JD]O.V)]VV)TGR.$-@`71P
M/3B/ALT>QE]%1NU7&[CI?911BV?7>H]F'50_?>NM8]F_7P5>R'8]M[00Y`*]
M^^/Q#MJ>VH[_%GKX/>,LTNOUQIO_]_G3X^B)38TJYL"C;^I*>W,(*C16']=Z
M8MJZ,NW&\FF;;&1-#=M'S_H?'="9.S%KK#?$%`4X&@6PSL`$%K;\P"/;\;V4
MDSCUY<_L7T59-F==[_:[_;8RZ^6C*V:Z!UMBO=_JM7J-;:<KDN'YO,0?.(96
M+W\"AE]UQZDE2CZ_:LQ-&'.[J8Q9]+SNX/IK#$ZOPO_$X/K%#0[H?.^`\)A8
M8"UP!4?^Q.5K8O0KGR[5^4+5>4GL-53WW?HL7$N/-@>HE83Y'$BTX1'S2:>.
M_'<"=`5TU8R+;E1%),`270-+H`O?=T<6:50$\VR,X'S@2^O7M#]1G7VV8(!<
MLQUAZURC)T-!@FR`BN6$I'HN0-P@,?R0".,'1"3QES:<D_IFD.:,ED$"O>8:
M6HKP+.!1?$`X+&F>H`<&ULRV^*\X/">D+LG,"/"@QYMGB<+-QY6R$.;,\&XD
MD@U2:.BZ?R4S%80JJ]V/%X>(:\!,GWY(OEU!S(YQZ''4#M@D<]\B@TD`2X-1
MH$!FX?O#T+<<7%&2XVPR1UW3,('</E-#&,0`$%>)+Q)\#&V3$$9&W&SA8","
M"`6[9MP6$WU'2SEQ+*FH&H[Z%G3GH;7S'UA229V8WPCGQ_"\.5)7T`IY#M%:
MF!^`A$5F4L&K_N1JO,U(;X?)VH8?")9)C!8U:W\JE/V8MY:@)BF0X&0;(<$9
M@0O!`B2:YD,W.*;YGJ!/UA;WR3.%FZ&HH7T`,7\+8M]R0J#F0X2#]8ZAE<R?
M^V[\9/YGRW$]8,1[O)P%*E./:BOOB4\_L^#)A5^>F32F\%0Z8'^'U0&K>J/>
MZ+3T>$4..-77M:8'4W2K>AMUW>;)K"DT*'3J=Z!RCZU`H?_";X?E_WZWM4"G
MA2'M9TX'6_]&N]ZJM[>=59;//>_'4@<O5`<7SE;:CQ?J0O^3/*ANB%570%T3
MKM(`9ZR%OG0(DZ:=\(:#FCR;>:XQ>I)PB(F"(RGE;!QB/1=L5AMRYE^`@!-H
MH!)R;JZ9UGC,T#$(/PY9\,*8B'ZU',,!?=]6W-0X,FJ<@$>%WFMD^O!KVH"4
M.N&TQ0!<BO6R2/4#N\+RG]"20(`\AZ'&B(,!%1)4WG"$'E(8%=6Y@?Y$%T+!
M-*9(1U_!:B5`/1F%1UHDR`@WAN73#)4F&FY7$"PCY@4&.F3AIYDK+!D@$*+P
MC364=+YV-87C`N;U%T,@2U"NT9U^%6F0T7OXK!_ZV![93-'=`RY!0.A+>/,Q
M!8Z`8U)[`+K-A#/`Y[.60[7$040$!3EFV'+=\D9,A7L2WN^8O>3M12[@Y3EN
MION%Z7&0T'X%3CF!`=JN5^!P6,`O798MKM1U@@5`WK*>8=EK6?U9<;$D:>G$
M&RFQCP+@RV#!4DD*`;3,\;J%[R+\[4?ML:9]'`R^5D0O.`O$3$YNC$A,2.DP
M`EO)Q:[&*$DR-A&B5U*!I*Q6<%KJ505N[QQ<WF3UI^A&B$`XT=!*R(+]V%!Y
MI_/"`4_`R'<"(/G>&7#!ZW\UYAQ5F9_TRY\ZL'G2JG<[[:2&MGQ\Q4WZ</I[
MLZWWZ@7,^1N<)];S&M..'SSP<K<[G:[>7F?J\1"+GOT!UUWO]NH=?>_3]T)F
M*M$\8,H]H%`2UI\S47[+)\T&C1S8A&O7>_55VV6#T9\J00]G/S8;S6;O<`2]
M$V?N-_;,G#!O=Z:>.K1@JG>;[<8RFJ3&5]RD#R>/6OUVL[M4'&TXZ:]@,AF6
M*=\2_@C).R+H*9L2Z[QZ8)YH]EN]SC+JK#/F4R#9X3BJT>PVEQ]P^Z#9#P=$
MCXU<*0_)/!)E/'EP!;?>:2W5>#+&6#P!#G?8Z&W81=T="<!=`VKH2>J[`ZLD
M_6X_<5@DQK+=X`^V(LVZWMMP[%]AQR8&CE\<EN0=$"SUQ6'C0#8=\Y$IG35D
M>;W"37WYI!A^]H^')7\W>=V4/:1]S>J`(6.]WJ;32NO^*36^T'"QAE[7^QU=
MV0>Y:OBJ8189.-9HU#O==J>UV3!!!WA48J7Y_6-Z[)D/%1^FU^AW]6:OG3FA
MS"$5-<M"X_WT;JO1JF<OVV:SY#'707I>XNO"UZO;[77;W>SE$F/89>A%+D*W
MU>NU&IU-ANZPA_$MZ-)6\,$8D3_[G>MY!/QR:R#:2#!7X#[$Q#9[29P7S7JC
M5=-[O>XN1\YB(W_\<$P1DH<N=#].3WEV[6>\`;!AO(140R-.UG_"&HBF9[QH
MIOOB\#NN92]KX0POGGKM7_$[#.#B!?ZX#BIO*S$.+7(GXN5$KYYZ/G3RWZBI
MR[<9I5<OKN""A49R%S;O!;&M5BQJ[F;,>"^/KZMMC":NXW_+*9,WU-54B=(:
M'\8#NB=]4"(<\RBS[*7#4J>Q#G66#7<UA3X;/ZUI.%V?;_)>@#FV],;:E.'*
M65V\M1%E0#2TZVL0)F^D*:*XSN0[R)<[-@P24G[Q^\)/J#[^ITKYQ3'L-OAB
MSR@8?'?+P7\V@M"CX^P;FQES"BK#!!S+P1(`]KWS!<;Y_879S^PSO[-.3W/C
M%L0$F_5V>[NMO/#>EL39>.0[D/&?S/"^T]7_QO2+7CTLX7"K;TNX:,B[4NS%
MW9)>+^Y!J;5,@*P[X'Q:?7&=48Z0B7\JWMQM=>JM1@Y+Q./8QS0*-8>[,(MZ
M;[-I?#;^[7JWH1^X4S"W>.1'5NCF&L^549R%1G$^6A,'3(*1`5P6+039#/(R
M7XL]VQ<:YDEQ?53X>JZ-8AJ(5!H*ZKH#4>1%`6%X_X/>\&O\_>K.O;NZT:K:
M[1.;4KS@.\NUW0E]_`R*'O[[./<)B.#ZZO;=Y\<K3+3'J$QX'1Z>BH<&YC-&
M9YE`<9]1D!O/;']FMLL3E`=A\$2![]#0N\&WN\%53I'A[)SXA.FIX*$"DYHL
M;3-&)J+RO8@?\WDY8DK.MS#(#%/Y;<H8\Y1+';)F<;[4'HUW3T%E:\B-I$#Z
MPH);PW_ZZKE8)LQ\-_\!P[YW/O!P66<RP+#!V-^X_N,'OI#KU)L=Y>YF_7$>
MDAR'NZ+0ZZU.HU48/;A/?6UZ9#Q^Z'RI=JO36TF.C'$>DAR'@TWHME3;>\_4
MB(*)UJ-&QN,'!E0`=;2^6G9DC/.0Y#@8<W3[C69W-7>L0XXX]4S../[FX`F3
MC4;BJB<QF,U'?L"TP$ZWW^OUUASYB]!.86%@Q1P7LRS(4LRW-39]J30\"C4\
MT*I`C39:$BVY)J=J:Z@H4IL4#DT-+$HP([0OQI.N\#[&ME6:/**#W/!,7_LQ
M,PF4+'CRW'#RQ)-7X!OZ$#I&:!*:6D[B1YP7YB/<&L\S)B7>\OT0^P4-?<AL
M"XP-GJYEB@+6_#8+DW4P`P;35&C$AH8X`)XE,OQ'`>8Z8>8)3WSA>691`F]%
M&8!,@:I@DML(1*XVMMV7?:6;;+K+4X(%GI<"GPL?-?`I]]<#"_E&O5'OJRZ9
MW('M;W:'.PCZS5ZWU]U\<H0.\C".#NQ'-HG3Z7-_+7+I9J''TMXT95YY0TK.
M*_I9S)K/9^';`P=4M3OMGAI\O3">[2=Q.`VPV^QW6[W-)Y'2FC*^/[A`Z->[
MS5;&3/(TJ$WG<L`@[':_WE'O!E;/Q9L8CO6_=-+<1H<>_#%PS*\<4XG^?!A_
MD(?08W0(WEG^R'81A2BI+>Z[T5*;+$B;]`,XY"?XYQ<7M*&&5M74M>.N1P&^
MQ.&IHA=.2J_<`U0!`KYJ0\N=/1G>U!BQ,""W\DB$&HW=42CRVTWN4T8-$YXW
MA3N;U";F"50NQ#``5<F(H<*P`S\<_ILA$!5F];OPDF?Y?V7`C$%_^2,1,+>^
M"FO+D[1!B0T]48W+4[W@9NP%QV1H<C\;#B((."[V'GJ4V$PM"S4T\V5MYKDX
M`9_KLT.<T0B!#,:A7>&OPQ-FB$^(UVA.\*P[I#3^&/?`8Q,$JW4]@?<`2CPI
MM=0*SI-_"^^+)J,^@1!3YHTXFN\S`;9APKJ&U;2X;OS"A/K,*('<T9CS;`'C
MRBL(SYA9)L<HB"X;!'@QSAB7RD:4+VC?9$A8>H\GMR,HNC42>>M(=B]`]&")
MB#:=V>Z<(7^A"0'*O.$(I`B>+1X\61Y,";9V1I;X66^B_[9\6$VDI3VG)2!3
M!^@#[#BEJ#F,])L@'!I?")3@GC$2Y)EX$:4\@^Y%QO"&N`>QR,WH>@0<(4`G
MB-ZQE;0G$VC?1U?JM(TSG5(7U)F_'"`6J=U5=;BL0>P^@V(#SIN-9GWS*=RJ
MV-@*_%4N<'02-WH007)_8<'#^+OQ,Z;!WIL^M$+<Z;52!-W[E"YA10Z8M=WL
M]$]G1=:F[Y'X5P>94%^78(>:_B'O`CJ==F/WZ2O9!UF2/O/GP@^L=J^N-],G
M5N90]CFC(@^P=K??TKM;SFBY4W+Y(X<.OFCHS=0LUW1.[F>F!]N`;;W?:&\W
M4\P/O7?^;A%B;IPQN?CU8=<..+JI^%X7A[/++%+KLD8UC*V7:2_5,+Y&4;51
M8,RMZPM/>=Z/6>MU\G4_MI_IX;)X=3@.6BIK9H\J;V*4UWCO^R$2(&MRBP\<
M=NLU&O!\/6N"BR/;]R3/=6=^=P<C`@Q-E'8!_3=9JV;]QP\<:I0,0UM_F(>D
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M)ZOO,EL"Z_X6UTC*2N9:^509;UMP]A8'AE<6X"@)6X>(JYU0)>Z`B;A2/G&*
MZ9/%@P(MF,]X;2T9$8BE3PW/PX!,4D/?PB]^4)W9P.=CQN+(P0K]`.U:TV'H
M^02SH`02CJV?%#^*)7&C=RXJZ%*P$A7+RJ$1A;-&Q;9,$1'+*XHER]B.^-T0
MCS<PU4)2H"Q8+E`2&J=P6E')5J(UBF!GI#YV#2>1@T7)OF-IW'4>U:@\4U2L
M=HC1P;*P5#0V/IVW6*A,_0+K.J'=RRNX,8KXC:`D,;ZZR@N332T;0T@=$;F+
MQ:X0S3%ZSQ<UU<2(PIF(]Q7%>44V'S-&3W%3!`GBQ#W[*IU?Y$\>(X&=&($G
M.ZI@+3-9#-DD,,@AHVQ"]^4W'C/\8OF,`FHC6LH.)?6P2-;$`DZ0"P44Y"7V
M#(R>IEIV*`QE-"Y%>T^IOF=<MFWEZAN^*$G-Z\\%;H"!YU%18Q$;+MJA..HX
M!C[&]925O<8>CTN3"\R;DXW@[.02T035);^H'1P#H$;\(9>&$&&XQ%2J'E:4
M!Z6=KEWS&F9(V(Q?,2$`6?R&2$@:!=(T-\Q?E;UI\6'XT:"0P]]"US?)X?-7
M8*-@/JSY&SP`3R@EOU4F=(>V->$!W#SW092ADUP13X;]M/R`&K-P&K;-1K(*
M(183<+$(X9PG,V"G.*5KZ_DFSI+`3.$Q=!SP"MAJ`48QUF2/N5QVZASU.;D0
MF(=@`8\ATI!""Q"CF"XM]N78Q7*5R#Y*\71\&UCQ[:$)$=#QD.BD^OWAZ]O-
M.I%;O_KNX?OWA\_T-JBQS+9]A`AU)JAUT]\SS!SA?\=C\!)"9?#I_B/,%(-F
MK?'\-^T?[[]]O[\=?)(_!.Y,>=>4[_YY?_?]OU$4Z2"+LG2NP,QX"V=8_3#X
M?/_IGV^UQ_ETZ-J_:>HP;#9&[6JA<4[2J66:;K!N^RMHF#%[WA4O%DJY.`XF
M$`6,;V!FT29'=4_=Z+#+IE@V,;FI72[YF/-DB$1SR9"8TQ\I#2:S@661@ZV`
M3?$MBP#!C&1)2D,>&2/H/J!*D^IY`SIGQJ@R]WXE3;PW@:=\)CBW<CN4VR&Q
M';B>YTL\-^"MF0'&B<)O)5N5;+496RV(PEAVJHJ/,#+P7$>1!N>Z(C8YGB#5
M5N8*H;"/%)V1YR;.W(#Q=-*X%ZD]D(YV0R)>:..*DEC;AJ_/45F_QT,FL00F
M8YC<B-`NW'Y4=*QDL8)(A_9%&6U/-8P6M'95T::<V)'K20D#/;VXWE^PT,`!
MYCQ.LOQ-&%E3T/%Q75=VHM9%IM3+3$7?\!,S$28Q7GB"?9"CSE^4D28]=D#*
M3)^2=HT;`Y2.A(JM6D2^8MP;0_>9W:3<!<+=`-1$:"=CPM"=K#@?N$W(G2HK
M'E)9353<%BL8.4W`SIZ`;H1@(M?<18?)U-)3D>T/@GT_(X`WZ1>(4J$]1B&C
M,L=7[>F&CSCT(PFV:O`\X]J7!)%UNE&!-/YBJLSC3])'Z8;P(VC8,4Z3;QS+
M&X53?D'K4\T0;OQ9F+<+>B$,'K<",+OE2S=/U)SIPO_A[K8<Q)D-Q&8,GA)]
M>H@B!=2SN&-+J+6BQ#G]S6N5P[=S_K3/S(O:(8.D*JYZ>Q7?!0@DVQI9RC(A
M3"Y)*N0LG\S.A(]"U&.7[E[R%%E3.K/&$=ZP;(6O+G<LQ^5@XN?EOL`_Q>AJ
M&J^G@7S^[%HCSOTQD#$,@?U$;LGPQI"4)._(&+T1\29.5HHW%!F[T&NVP$WT
M:HA'!:)P8GCK=;^T8,TE<2'B;#B&/?]?QCVU.;<#2,/(WXQN+%)_7I!B;FCC
M*N'!B>`63]';TAL6+Q+L:H/<X>YX[#-JE"`@(I0F(3AKV@<A$`(JRC#EM2T0
M5L+,0I[F8-,OG,T\?(B@,'Z2L`$I_4N]5M?Q<+$E1`M\TY9?5*0+#4X@!&*@
M:Q6?EEQ,A-S#.!P%BR$]D5S7H)S=GN`65EY%)N\W,=S&##'<!`'TO^.*)J\V
MESU0WFH6<*OY753NTFP7'W`8B7_3\DG0X.=?FOU*N]>M2'V'.%I(*N+Y'-3%
MA!2+6X9EC9KGER?DNO1SO92'E&,)FUI8CNW6K[]I[QZ^W;W_5KU]^/1I\/7Q
M_5OR8!LSGVW0]196];O![=\_?GOX\>6N*J`WO<GP6J^W*GJ[78%_;Q:-[*$;
MP.&296?G&L>M^J^;DE#FH2@6BNTZDRKQ$BYROF$M.M4W[G,=KT#N'!L;=_?+
M>KUXUN1)Z69S4O;[_4J_WSG(G/))J)K\RQ@0%.&`[<9UFPWY4X*M*M`&J%6C
M)/LM]^)L&U"QYF(4R56;M=VHM#KU2JO1+6[XZS%0RF>TI7*Q3!G(TRO>"P"O
M1V[;/CZ!AOT.K\C1^0&G%$=/@1-G)&"@OD4*_%>Z)J?\V3RE9,^MEQI-ED:3
MZ4K>\<2GE1*1)"-EK:0^'-G\ZZOX>`V]7&G9\QPVTEH:]?KQU);U#P=RLC_>
M_\][/I2-G/][%>N"4O(6A!#.M08T3PIMTL./[B_F;41"%RGH_'[5H0%]7\)D
MA<\Y^Z`OERQOR70:$&[]`\[M[(FE7S0?;_->CG:G-I6FXUH6SZ'GL6K0^^][
M7=.D$-NXN[F=^BW'^5::Q.OVT^M5.LW6D2WB<GER[<Q&MU+O;&1EOB:/Q4=^
M(<MCJ,VIY5A^X%%TQXD>^/MU!&PWAJT<'GJS7^FWCN+N*)=NMZ5K@:W3[A_=
M4W4X?6+#>QE*I_!7N"V.S91ZK0T=F&XXM-GN?+GD^-JP]ZTXLJGW*NU>XS4(
MDXM:MW8+M,7.1MKB.?B\]^QKSG.8?S`L[Q\8H<HQV@:.J8`7?^;54,P'!QH/
M/<PH@R%8_M*;^SVT6#K&"[KJC_.$`A%V/.-%,1(1HDIU]#$LIHA@?K)`JP6S
M=D[.<@P=C>L:&K34I/':\6)KHIH.J,&!VA*&O6`L`5]_3&&T\EWII==\;ZZ;
MKX.[N_LO'R-Q#/K<)ID":O7/8C3)33V/J3'%KJA&BP8XH`"\Y`7.29#G6,[+
MU\,!W!GY";UOVA*=[B@$>9VKL.1*H%R%@ZW":<B_U[L*[WA8Y$D09!^GT+:C
M4FR"\JZMG$<YCS.Y#VVU-KC"R=KX=_##,]V&8(J%'W@A96;D$V>+V[=MSX6]
MW%ME=5[\S5Q6K]4CS+2@^]1R1<L5O<@5U4$T-RK-?KU<V7)E#["R)POM<.P\
MK]+W>R%V=L+W>\=&;#IDGG3_GH83JG3_EN[?U[8*I['S7OLJE.[?TOU;NG]+
M=V,YC[.=1^G^+1T0I;.P7-%R12]@11L5O=^N=):%I94K6Z[L(=R_.T>L[R'P
M.R]*_;,1A!ZU\S!&0*#OS)NNA)!;[Z4RUER)-<]RC#?;Y^`7?VV.A'\RPSL)
M+\+K60+J_2M(KI$U,VP<QM#3WO!O1:F>8]AJ!]0&CJJ*9*VD[+Z]ZUWMTL2`
MUZB!I;2A70G\2[>%*(<+^;Z%)?$??BL<@_]WY/E"DB:WG=\1N'N7+G-@.P\A
M\8]RT"XRQ-&'(7?!W@<"6Z-]\I0X>75K#YNLVZY7ZO7#G1IIFE*J^J*7?YL+
M@VQ.6=+!MD*MR"Z*F<22]@[.RWL#)\C4@O1*NXX<O1`36*1?9CT_2)[KY3&`
M'Y]<VV2>__X_H17,O[@!^Y/*1P7^@_<-R9*+F+OAVZ4SIH#$_T&0BV&+A3.8
M]D+_)]8$:R]BL1U>)LC%*CBC)\-G6KO2T>N5AM[CL#2^K!.#-21=!\8*ZY>L
M7L%K!V4V;&1D9BO0NCB@-6H#E/&AI^22^A)2I"6LZRUGB4?.)U0BV9[CLLN-
M?V):S<FK4ONP]^Y]/V3:G1&P-^]_,F]D\8HZ^,7KI4R:AP5E&/KY3B1,Z_4L
M!O7^_N?,XN4J,UGSJ-$OAW9S)IUP^JX^0#C"*MUN[PB.SNO&S<EY.%,^9'W7
MR"909JKUKO9&?#BY^1[_3EW?M==F;3/$R-?FIM>;>^#AQ?(Q)XBT>R).X&Z]
M76FV#^9&O]:7B-%SNW\@,=D'>?G(9O#A-":V^QH54^`I6QHN^I'*"YRUNT2V
M6[P!.VUPX!,AG5YI=W50)3>Z)"E,?SPWP?>WT.:"[V^&4VTLV<*EX,MAOUJ[
M%'P[\!^RW<+6+96\O"YSKFQ*)6^-/@<S,"CJ(.L>1D$IZ[;QV=1Z2U3C4M:M
MZ)+8;FM9]ZJ5O$:EJ3<K^N&"Q"Y*\*&21X*/3MLE$!2EX,L3?)V-0G)+P;>H
MY)6>O/6=*=U&I:4?C.,N3-:AB$-9%Y:R;CM/7FG0[LI_1XG$+JY4VYD$Z+8Z
ME79O(PUQ[T$,2WV#EQNC3E=UNKAN/A%<NX.N^V;B>>_=@WZZ4:VXUQ,Q=`CJ
M(]/K"TQ?F'I;:!6]\XE?CT*`=V'\`T7W[SF5X[2;*Q--SI8G3@V0^>1CWP-W
MEB6B)5K%KVLOGRI7-I%'HJ?VKVOHGSOVT==%)]^?F*^D4JAY&6K^A69X\(5M
M^+XUMK#NHJ\QRKJIE6QW:6RWS(-T?+8SF<3Y4RN"\HP@M13H&'.0_,1#VK7/
MF.:X`=.:-YKE:QY3"XEBH5+FF/@J>V;>'(N8NEZ`Z24SAH5O*8\(GX*!.A.F
M68[:([6'+T!K\`L^%SI&:%H!%=EV3"RL39_(8C;P:S^`?PC@@Y*>H!L#`]1]
M2F/"'"IH">C!M&M1F/MFD_VV<X+?ADEVJ4R_S,+"/(TO\Z?]Y^C!`EC\W1^/
M=U?`.B-K:M@^;LP_FGJOW6LHL\X<TSZFU%@])3TQ)5V94F.#*;5;O4ZGM8\I
M#7"%)\29[^;Q(P*-9@#[UN1)6<`CE(LU"(,GU\,:T4NHL4.K2(M6KP8KUF[6
MFKUN(YN>AE]UQRFN@-?JF2]&E.1IARHQJ^VK/_K-.OZWBIP[3*J8E7@V+!O%
MP`?7^XC[=*\+DF[\".NB=PI:E_3<]K0\#S,2Z=2D?^_P&NH?/=?W=UN9_':+
M%*2+:P*"I[.G!<F?TGFO14$G0.9:--K]5N_H:\'?'CCFO8..:M#6OMJ&XW\%
MS6<T7T+KI>^52?P%)/%C6VR*'VE%JK0DFKHFI"7R1U*VU7$+.^W8P9^@[7.E
MFFO^?@";")7RI!5!FZPZ)*H8N#%\;8)[`OX$JX5-9[8[9]!7B,GHA%O`+9>1
MJB'.D(FS;!3^K,OW&IH0)@N8-[6<V"2AWC2T%[30)X@#1[R@S3P+#4]MZIK,
MKN&,GHQG=2K!0H?,&#TE>N63$DWC\^_0MJN"$>#:B,60V=/WA>?H!S)N++06
M*IH!1MQ$&#%C8Q2X^"41^B?B.,#@;&LL[30Q"&E?18\\NS80$*RWN02%X$/'
MX3`^#-7<$\T$3T`ZH&5H<SK8\[A%6+-GH`^WUD;NQ"&=%=T9@A>0(M"+9Z!M
M`V-TF#9$/%G-!9N0CTZL.7'H_VGV?\.FP#J"O<TTGWG/,#9A,=8N:<,L<B^<
M/@&L!+=D<5TFW)Q/\C'?.RXWB4>V2YQ&*YB%]"$?Y$M);(]LD;M>8#&#TC:/
ME^=5K,5[P8,)\900.1%]8JH)KT3PY,&+0/#@R4>'!_R2BY<"A!X9]BBT29Q$
M*RD$X;(-AFT\P>M#QAP8A!F.4+2ZGBIH76_,K"!$+`_8L0:N)?&$,9MY[D_9
M=$/_M1)W_60!FP#S&+;Z?N[B'J:\H'#E_3N$N8WG.[//XZI%13INOI2Y<#=%
MS.%\';+[+X^W$>6.C9VA0)=T:$#?ES!9X7,^5D7#<UTRCC:S''9X[W,[>V(M
MB7*Z`#X^WY)4^W\O/>@+*Z/5W00GA+?\C?F,Q#FJ"B86<W1GZ&O(I\<6D"2[
M!&ML`;:R32#?-O59>#^]7J73W"A6=>LI%808<]'+TVAT*_5.T?@^JTAX@ADR
MO+6/S&$>6%.X_0T33'8+O1_H>CW1`W^;21XYPEW`"S3[E7YK(T;<_RS+I=MF
MZ5I@Z[0WPP@[M.`X3DZQ<`VZ`4B05;ZH8S/EON*J5QY?Q090B]0NO5=I]S;*
M%#A787)1Z]9N@;;8*23W?1-)DA>:>>J.[[O0DQ=5*YV?%>V%19=U'<):B:[:
M$G=WJ/K@U55H!W1_@7]/#1-C!?/N.&J;C$1/C*31!BV@ES^2E3TOX*Y3\T\&
M.M]1#H>.XO1?XX*`._=A'*&#KOOXHG/!%?^+7JMK4\NVL0&'!72CF.7/KZ`>
M"R-\D9=YV'PTJL1]&][;&/`@;B9F5@WXVYC(2QOL0*_I;6T.-NJ"EW_;`,?-
M0P\R8AX(R#D.9:`_*:ZI7]/KNEYK]/HMC&^JM_%CM]9NMF`FC68S)S1*K\+_
M1&A4OU9?V8@:"/@OH-:_:*75:!#]Z@]H3D]-G`:Z_GQ:>F/;^6#<15TTL;?Y
M=+N[S:?;[FPW'XHCT7NBB?W-)QTXM?%\NMO-IT'\5A=-[&T^^EKKXWH!5@MY
MYWJ>^P)B5,9?+7P?10KFQ/SD1A:N&S0+S_?U9E,=],(@=AM]?XW1IS?_^J-O
MUMOU[B:CMT`$CZT1'"6#T<@-'0QP)R%GL72UE;4>+:.R"HK*@M/?=2;X)T;=
M:[I6U1[#Z=3P*!A&61PM7AU-+@^=?'$+2V]^SRSV`=OBX6CO>&#.6/L**@<L
MQ"6'JSV$WNI\DK'E&,[(0EL\SBRQG)$=FCS*S>"<PHD&TGDZ@&\=5M%`Z:GQ
M0!OX\>7)M>UYU7W!\!T_'/J6:1D>I=D,;&A;83T++]]0KS2<N49[R1B)%!8'
M`T9`A1K!U"@NC4)!F&U-890B2R8>/69+[##)N(.9QV:&QYO'Z7HF#D%[L8(G
M;<)]G:#)PB]L1JINO'=FO`0OAK.)4)D?#@WD$?OQM>NK'[7'FO9Q,/AZ=5,#
MDM$S[LQR4!T&BL+2&3RJMA)1FRB#K>^V>#!HS3`Q.(.^K_!0.Y_&#3T[K@=G
M`FK8O`1Z\EFNBV,NE<-@-7P4(9ARQ7<-!75A!!40/Q[#S.52D2HO@6&TD*&$
M-I/A/VECK*3$8_%63E'P`Q@E#(P'(]#N8#Q4W$=:2G',$"5Z(5G@_-"4=E<0
MC*(F#1XPR4=%+&I-\^;A44I81!D+*&$Y)G`WY9B)P$+Y+C4]-8!8HQ&22\3A
MC$-8GK'E8U026BHU[99Y@0%<9#EC7!H>:>F@C>0&E(%FPM.VB\EG8O&H7UKL
M*%(K<X++^#OB3V4_Q$L!@W6G5H"DFX6>'^+^!3:P'#@G0KYK8;5#6]BA'IM@
MW!=1"5EEY%E#7,,YWQK8U2/R&\^MPS?>_Q29<5BGR?)]VM-_XCALBSTS3CU\
M.9X\-NT^6SAI+!F&<\(272;[3XC!8#"\J?$7EUTJ*07KPENX=M"7S0RJ__4"
MXDQD_FVWX;![#QH3TNG?H4.4X?3%8=RJ37R(FGA4F@!2X)'M)Q84M]?`<4)X
M]AOE"6(TVP>8$1P!U;]'K(3L(WP("YNC`D.VX8=H+&O2'X4"C`SW.#$^I2ZZ
M&-F*8;_`]IK/2),Y7AC=WG2"'SYMVO?"*^%?J#J`@HU+`KXA8,HYYP=R,6X<
M#*)."0D*E<4]&!]<T8Z3;AW.68;OAU/IL,)=;(S'Y-4AV2BR7HUII%O`\TSL
M!"4!MZ)*/7@*S038M-AM]@LR!MX4@:%Y0K$2A8YG#<8#V>.$8B;"[^1K9NR_
M2R?Z[J*(R`-;59)B6LI='H7+,F@1A/*(1\/C`*/H:A08<';!AK8P8I)32"@6
M-#GY$#GB^(D&4P#R^DAJBI;/<?[Q5A(]Q9/AYX&DJQ+&'SR13:N]8R,C]*,%
M$1_C25H.BG)2#E,KIA#:<_&\A0Y&04B_\`,6E#';!#8!]O)4&H+L(D4@>')]
MA3EQ2XV!B[:ZD.#2#E]?)AU.71+$H@\.$P84TVY)W(_FW"JV+]DJHIP$<40#
M%XWDS`53<T-&XX;,6)!'-6@PKP!8U/)@VXR4!L#0R19(<K=DM86J0R!(3F<^
MR-*D!6%B0+/GQ]'L3)[8'A>U"12";-%TSQ$!%%D&-AN;+G0OVI*.=4TZUE-=
MPB&"B:_8PU*)F-YI"^!)"K.IU@>)O`29Z/P@_11U-])10:::%7H*+V`L4H9M
M"PXG+FA1<44)]((%%.$(`=L$OQU7N+((JO@TE#07L@JEG<=`&?11BY<H"B@;
M;^`M^AD4("Y#?07F($KJ2>";2!FAR2T6,5J0,VM:#"`DS(PE>U.'FS56'",N
M7D8@_X)"N.ZR<)M<FX!%XB,U^1E!@TS;'#)Q)U(K\'3!YR]-6MXFJ/Z)J`XT
M'BC+\T#+DWR0;[\UQ.EN`RV<$+>+3"=8P>=WFG25J&@8MJ00NB($XY(@(263
M[Y9(43"<I#.(%$\4PY@%R/M!X7)MW60T@A)#+`*.+6^+<94!FQ&:`4NZDT@G
MSI33?KYU+<1NXGD\&FBWA@%F-\IGDJ)=2"+4RT2B4YQ2F3Q;HOX7SRVNQUY;
M0!:\Q#5LNL+EVY9.(KYO,5<._?P:;E40[`*XH`J]5GW#QDV-%[DTHPLPZ6[1
MS833IP\(1`.:*Y/5GB]/J8GF2_XU%L^7F(R8E8[WJ>']!1N3U'ANYXOT6]JB
M3W#N1\>HRA%B,WK6Q$+>`SU:^A"(L950!CPIT#L`>LR0+8SFHA(J8V[[QIY=
M^QFW[B=,_L6JXQX#.Y!6!&_6X*PP+E6?'OADHH<^*ECCT!,85.3.TCH49T+I
M-E*]-4`D@:PW)L`UY#X@WI(AQ>]M,'(],&YOC9F%Q\FMZX%>R:7S]=7']_*'
MJQOLA&L\7*^!@<P,+^`LB?X&V0.-P<*2XS(L)D(.4^'$XK;Y^PRK/S.U%UW/
M`0V+VZ'T5S"A)SP\!K,(A<">&999M9SJB/=140XC=&&"%C4,B))DI\.[V&[$
M/&FW!DX'G;A\0,EWI6-#G%;0P<CU`WZ*XJDA'94.4X]:<A+$)$.Y,61T+S!%
MO1Y/E2AAF@X1,75:S?C@8N3EX1HTKKH/0H>!"6[RD8K&HM-VZ(JN%Z=@,C#H
MO=AI(N>QH(-&'47&S8Y8:NN)J3X";)[Z[HR%E'K[>PL:$:BD7J2_<L?7-S`6
M0%1CE-]ERBKTT<T\BR[$1S$-A.%%7LX[=)#2J8<\<0<\B!QUC;]?W;EW(':J
MVNT3FU(Z^3O+M=T)??S,3/KW<>Z3:7U]=?ON\^/53>QGA(>GXJ&!^8R;UTQF
M4MW%F52:@/P"U?;ZZMW@V]T`KP\'Q*?K6'D5<>]`5XD*Z@0HQB8E^(MUIK=#
M9VC9>$F@?!]=P[XPCUNCGH7[!XU3>\Y=I/)AGVO3.%]JC\9[H4?]1]<U7X!:
MYV_-R9F@XX9?C?G"SXQ>5ESAZ)04R!M2^B>//S3T0(-T`A`N1NQUQG]<,)4"
M>?EDC#C(!@E85#T]]FS!`+GO:(2M<Y\9<==$CLZ@^R^;3"#:D!&G4\!+2(3Q
M>>JA^`OO&^D6G7Q3:(RJ:J]V#2U%()[#>1HC1IOBJ3RSK?CBTB'4-V[9!NAO
M(DN48VF)<:5\<'@E=R,/<:30T'7_2GK/A;-(NQ\O#A'7@&$TK3"DX[<K&.8K
MM2P#](HYQK-8OKR8@6/V-K:.\?WXP@YSM-ADCCJZ80*Y?:9:TF(`>%3R11*.
M=0L(*:YM\*/ED7SB74?7OM1WM)1PT,CS'70#Y2VN&>'44<ER4_Q&YC@H4A3[
M(&B%/(?Q)5E82\*`F<YLQFUML#T,PA&A*U-UM&@#^U*HQ[R59BD14,"UCPB-
M1MY!>XS4.UB`1-.1PDGQ`^=O.W_C=U^H#<B5/(HZ<`@X+Q[=@RHU,(^X]..G
M&;]/HNO-^8P;NGCWZ(G+)R.&P_/?DEY:G=FA7QTS%CU'(3?`CQZSIL/0\TDZ
M"KPC"NRP?F)<!0F=Z)V+.C>_R6M4U\FCD8B>4!&'T-KAMY4)0<&5_\B&4:X>
M1.`_-HXO2UD107S-0)J/B/K8-8AFAPES9*U'T^!4"/-,O#%B\=CX=-YJUCCQ
M!5HQ*'[YP<FX;0(M\5MFR_]+7+5.+="C`M<1$M6?L1'B5T?O28^*&%$XD^!8
M7/P):4M0;5%3I`0Z<<\)/"P9]1(E<Z@C\&1'%91O\K@QXX`>T%-??HMO6+B5
M+VDI.Y340^MV`A:A(Q<**"APZ?!2EZZ-N(G,/(K70<)RHS&^]EJY^FAXTZ'/
M+6_NC(Z/#>CHWQA^($Q(=$KSM9:TBV.VN']87("(!>;-R49P=G*)HFL0N>07
MM8-_$$8A3B_B#[DT<9B$>NA7E`=G'!P4C*'8?Y_Q*WJ^D<5OB(2&)9C&RT&9
M2,C>M/@P_&A0R.%OZ;X@,7SI=W_"^#+S-^XZ5Y0JE0G=H6U-#,5)`F.2J4E)
MFK"?EA]08W@_X=HV]ZWP36?XP-Y#TF%)Z_Q-^.R?;^(+S&=RG:"'GG0,->A2
MC#79X]DJ&I^3"R$=T")L6-("Q"A=&HD`'B`H92:HZBF^#:R8"U%V$#0RWDGU
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MKY'K20D#/;VXWE^PT)@5,9<B!O5>;F1-0<>G0,%5G=`,Q"T@=S1F*?HB.$;.
M1'H$?7(<YJCS%V6D28\=D#+3IZ1=X\8`I2.A8JL6D:\8]\;0?68W*7>!<#<`
M-1'IP)@PS$)6G`_J'>^*AU16$U&68@4CIPG8V1/0C="_?!TGX"FP$QG^(,L1
M>4'2+R"PO&/7N`#<5WNZ$5EH<6CZJL&;;,8<TX\PQ\65A<R!4&0>?Y(^)C,C
M^!W*2&2=C2QO%$YQ54:45C$7QI^%E].@%\+@<2O@;8DOW3Q1<Z;+?-K=(O],
M29A2^O08Q8;9_'Y&)A3,0@^C8NEOGNX'W\[YTSZ[+/#S05(55[V]ZH7%3*1"
M1\N$%Z,B]X"3WT_Z*#@4?>3N)4\1)JM2AJ6\89:M\-45B0I1`&+\O-P7^*<8
M74T;B*04RWEVK1'G_OCJVG*4^Y/4C$A*DG=D;//,$<&SJ91*1<8N])HM<!.]
MRJP9<8><&-YZW4?WSU&J<7RW?%%<^"?C]V;_R[BG-N=V`&D8^9O1C47JSPM2
MC&[D>*0]R/+14_2V](;%BX2W?.0.=\=CGU&C=.THDYFDX*QAA#KGQ+6AX<G?
MB[SAX4,IP)]ZK:Y'B#_X!GS3EE]4I`L-3B![7N'7*CXMN9A(=.LZP<L_1RH;
MB8GDN@;E["Z*;908GK+>3EEOIZRW4];;*>OMG/Q:E/5VRGH[&R]E66^GK+=3
MUMNY["4KZ^UL0ZRRWD[ZO;+>3EEO)X\>94&79#]EO9V37IZRWDY9;^<DBK:4
M]7;.=NG*>CMEO9W3JMM2UMLYSW4KZ^V4]7;*>CO[J;=SUE<XV!:_51<(BM^-
MGQ<+#_QG!$9&=Q<B,B_`&2M7SY3<GX"XG',&-$9/DJ,BC.",?/!QB,R'S6I#
ML&K&&**)F%$J7J:X`X,MYWJ8`B53<3$^;LB"%\;R06+I?AH;-WP606]F(P7#
M+J5[4K[7#,PPHK@DB[+-0?9:_I-,E$SD8_&KLCAJ"OL378C01!D3I5ZY#2DX
MD.#9*`[`L/W$?E-IPJ/#0A@-AX3'GR2Z/A((@=_'(L?E:NH"06WK+XKJ1Q@]
MQPVNXCA`^1X^ZX<^MB<0/L1U'2Y!P$9/#MW838$C4((15`H5LB+`4W6H$=X.
M!6TSQ[#ENN6-F#)A$I"6,7M),7-1DN-^87IT4?M+O])M\1N_7QKM>J55;ZN9
MK)L$8*EA5+6L_JQDR"-%W$<;*;&/`N#+8`$<(2D$9+2HR%R'WR),\`PD*V5C
M1&)"2H>1X6#`J@CFRMA$&#2B!GXG6L%II2'RUZH<$<&\VJXSJ1*`E2H+CG8Y
MO=?*-B..!F39(1+@"TR;0$J_PK3IPOI"CZZ%<YJC]J*"PI6KM\K$-4XH*_M)
MD34X(P(.\>P1$>4)UB+,FT0#(F9Q`3HYAHZ1$30<-48%DEG(9:]@>*W(?8D4
MOK2N>5'R$D-0^=S]"%.(TS?"*>#`<G'U%<QBJ)K(ZI3+8@JF1]`!BK5>O:02
M74?TM'H),]9.QL,)E!R7IRW'J4IR@,GE3]3BX8!D%D?52D0;5O)7GZ-$9(,9
M"DQ`V7,\-)QP]'4\QB1GIG)2D^&/2WI=1,E`@(5Y=+9Y!+DT%Z^+?)%+X^%X
M#T=\C/(A9D^"1$ZR9AR\Y5M@N!D>S\X<DIA*/3\4=10666[ENJ(^H&X9$#L1
M?(D<)U>*(QSG5)!7H]9)Q'7#%U%<=Q;+^W&I&:68U\\D>+B<OK`/))TB^&B%
M5IO&QJ5CS17B61[7(BBCYH6BZH<L29^+XLWXA$2,QU3]/\]UW%`DN)^L=:NB
MU&^>_QL-++)U>1@VM_\81RA7:/*(\IT<+#]F)D]J?/+<<"*P2B7*S7;U7@A2
M4>#14LF[J-85EK$2X=Q<94?YBLHX'G@T8@/!EV%F`M]L1"6A>#I31JFR2F9U
M-L1*C\NPI0B^;8'DM0I_INJ**D44WG,<=ZHANO!UX15=^_V6WNVTE>DLC&&7
MH1=:SK71Z39[K?HN8T>HYKNHS%*JHNNZ3Y=%70]3U+6-15TSRX_PY:']N;J,
MZXEC\\4'UB>TUPD'.ZJRKF&9]5,]J';V'('N4N_F`?BJA6>X?O8LDHCP+2V+
M6&JB&%%.H!G3"_CWU8UPS8BZBG'-,;K.$-FI5M0@GEF.ZU01G(\CH*6L%F&A
MP.@8(L!BOW01!S^IZ?@HU?R*:MH(C57<;7#W8OS\T'5"2@F7^%JHUFE7_.DK
M@EN5&`#N&,XBB6\=W=V`<AOAL:-"&)&-J&)PR&6)@*#.?<EL!2Y!VCKC,U!&
M9%I`#$RQXB8CUM#D">*$BQK?;%V4VLF9N9?+S*C7+S"S`;+4Y)J2,$^B-2((
M>S0D(_.TJ9@@PM"!EUJ*I2*_18`)`XR9<+IHT4=+SUV;$EQ?`0R8$8=0_)6P
M^T%Y9![BY3MQ=GBB2&J44[]U?Z3ZB1DS?,G%6J8C@Q=^Y8F">.N&ILW$<ASA
M@05R]>6%*7!PR$UPKK["D=NNB"*P]+VK29<]5ED.L*XG70`%3]+@BJB?>:W)
M<7$)4B]A+?9KS?021"N<,V?J:$;+#*02%8@3C>J+ZTH]RW(VXIZ%Z]8B!]+%
M)#6$^8TV8%:9UFE<SC)R8E!5:Y&+CCW1GA9U$!GWW:AP=%%F)/-&ED3-KFD/
M0DY@[G^DPG,^C,HH``\MOSW=PVDZ]+0WJ:/U3^FZN;4-W^?"S?!5/>(BS]>X
M]$5<^>)O(;(7;AQ8MF>T[X`11POE0]1Z(9$'C*J9@"28B-PXO=+NZI5NMQTY
M#,<Y`C"158GY=4Z*??#57_1:NQ[[03A;QP5'4$:(4B70U-\,)\1K2KU'&[2-
MY==]-^FR]-AZ\VC4ZS"+GC*+]'A_:=;ZW7AH44A!<DQ"9-1I1-U+.^"RN"DQ
M8[W"BYO$94RN?<9$?9R;C;FKU:FT>ZT]L5:CUFDH+K9D%1QAV-['=:`JJ%9R
M!HP0O91\8R,`+6@8!E(4!RJC8G>=?J77[=!5:(0>$1=Q4^Y!0-GR0#IF1NHL
MWP`JZ77]`N[UI)`^BCPN'I@GLVHEI<-RS>*%J>)*E6/J)FE7.GJ]TM!5895.
M6T_?F2>X*"$@\\JL\"Q=TG=\@4F;G[%;)N?N%`.^:<[@;UJBCFDZB>Q+I(+?
M<I9XY'Q"^-;\EBJQT3+C/K\.[N[NOWR,)M"8;1#ZF1K@V@&\1^GT@"O%SU$\
M`+4[..+>O.>G%'$Y?O%Z*9/FX??R_/Z*Y_>)T>72%X-Z?X]J!G=H9;'F4?-*
M-\F$VY;>^4E_^B:YC%G="V-CDZ#[/4W\NG&3W^L6F9K[(*YD5ME]:\?^09FI
MUKO:&_'AY.:[UP7=*FM5W[57-(6/,-F"THT+D!#-/?!P8X'$)YBTNT?:[=)E
MM]ZN--N%I#%EBE%]B1@]ANS<65[V05X^LAE\.(V)[;Y&FTG&W:1AO7ZH6>TS
M#?)$]BZR76-AZYYVGO&)D"[ROA],\"W3'\]-\/TMM+G@^YOA5!M+MG`I^'+8
MK]8N!=\._(=LM[!U2R4OK\MVG9*F2R5OBSX',S`HZB#K'D9!*>NV\=G4>DM4
MXU+6K>B2V&YK6?>JE;Q&I:DW*_JBBEP*OC65/!)\=-HN`:@I!5^>X.LL`6\M
M!=\Z2E[IR5O?F=)M5%KZP3CNPF0=BCB4=6$IZ[;SY)4&[:[\USF&DE<<ZN,A
MKNOW0'H>*;D)[^X]B&&I;_`H(1-9\G7O`Z&K.EU<-R^#;C\Z"0I:]\W$\]Z[
MQ[#>H\[_9".&#D%]9'I]@>D+4V\+!>3<JZC?&TYGIB=4A@#OPO@TPL.SOM+M
M-A443KNYC:B>[F!?FWJ?710SB5-<Q%,KE'[RL>^!.\L2T6*HS5_77KYMX4Y$
M3^U?U]`_=^RCKXM.OG.<DJSDI606DH?%!=5,0Y[X4RO9[M+8;ID'Z?AL9S+*
M\<3LM00>[&+Y3`[!HZ+34NZ>@[E[S1M>\G)*P&9Q-5CF4+XQIH?/%61:@98L
MTX1AH,Z$0*V4'JD]?"'&QUH),:0`"R6P?RB-B1`O)5*A0`:]V62_;0L'M"YJ
M3`8T#>6"F!R[^RL1C>?J`&/03WZ,2[/R48$KTVNWVGWZ_\XNX#29S438/#SS
M+`W/T^_7T]@\*T==.%%:O6:_UJ[7Z?^Z*TG22I"D7857>!/UK$96$*3>K/>Z
MNY(D'/IP=@!'OG]&SD]!%N7]6D(4'0:BJ(L01=$B:'P52%"</2Z1,BTX<#(P
M_D$PFUJC`EQ>`39?DHZJ`%\@#WJ(:6/*5&@7@9IA+\20ZH@/PT\%A$:<>>Z(
ML4S\?[R;E"`9->WZ,4XUKVD#),48>LLZBVF"4:;YQ"/T1:6?<(933O?6K.G]
M"),##D-$$HGQ.&B.M!38*U&04.[PS.9P&_O"G\O;\TG!\<.!@QSH?(L4-T:!
M_XW0/6BL*#J6_%XX"%VSVVAV^]UX3DL&L]]9%8E/UVHT6JV6OM6L)%[^1V`J
M!+)^<.XBS<T7,UOZS/X%_K*I5OOU=K>;6,"EHRMFNHW5T]43T]65Z38VFFZ_
MT>GH1YYNO48X#XU>OU5K-UMZ36\TF]NN=&Y39[#J&Y%A.0=L1X:=N,%G#^/W
MHDR-F'7BJU)U*TAUXX@B/WPR=R-RTR%[>>!/:.#/P,(V1!(W%J3)0NCE"&$(
M/(C*&,'Z1.4NXO(V"F88*$93XR\655KB<&`&F"Y364,*Z[$8A&$OZN((.U_6
MBD%-+K-.#8*'2[N9@S`1+B%VF_V"=$28`C$H62LGGF8E<D9D#<9CH$B%8B;"
M=>"K&#UIUP:O&;,=)+(HZ:'Y,8RP0DL)1QF5TV'0HCM%>'1KS/$H(X\-JMF6
M$X!Z::'ZPRE44:KRR(>H-A;WEL`4./IYA7[)J\<EH-_4GN+)6`[8-J&D*VCY
M$^%]"9ZP'$%->R?0Q\6"B(_Q)"T'\6Z<0#I^LJH;D3J.</*@-X7T"P=]'A&"
M.2_OHM(0-'1"20R>7%]ASK05L-$FJB74^?UH[TE9GSP:_A3U&`:\'`,'<GD8
MDW_@(4;MH:H>`\>4Q4_P"-GNU2*5QDR72*O7;/<;O49,C^T&?@IT*TC[S*&;
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MT%%,EVN#"T1`6P9!D_Z(%R]J._HM]1(#&1V_`BO<BSLVE1?DMTK7\BO!.VNP
MTY+#O`_G5+?6[YP].Q'0[\-80-T]>-_PO-R8H5!XBB;0)(:Y/:*Q<%R&:FS.
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MYX:STC;8E(M`9#::_7-G(XS!O)7!8UB7_=W\BQ&$'GL8QU_/=^"KTHFQ,6>5
M5N<B'Y7&YJ9<5"_ETQI\53KM-V*L5K,'5D*G<?;BZ1'&888VAIB*2O"/S'NV
M1HSB`M]AG.^M$N8[L&UW1)\>QM_8R)TXF,3`LU)O73\`MOQ&$;F?+&=[=?X;
M\QEF#V(8(ABRMCO#^;WG<=8EEZ[-I<UZNUW3>[VSY])/KC/!@N!W;+A;F-<G
MUW#\K\8<,^I*1MJ`D1JMDI$2C`3R#8Y>CYFRNY*1UDDB;+9;Y;E9U+GYD3G,
M,VPX-@?FU'(L/_`HH;`\.3?FTYPLSS/EU@^&Y?T#<[/>S:./_PU]H)(U_X0J
MUM8\%[5W[\S"P*?&FOOW#W^0&5_W42[9UD,6MGBY'=;>#HG<X(-O@8LC-N5U
MI;*\ZIB?T4IG>9T=L<74-B&VF'^!Q%Z24E<:\J_1D-<W%PEZX2)A&>A$J3:_
M2K7Y[/BT5)M+M;G<#EGY^N>HR9T8L6$X_9C8]!>JS<U6O<?O^IK=6JM_OG&E
M,>JGP'YY%_IPKOG^(V]LNP"NKW"R3@?!$SOJS;%8NTVX22SP<;@I#@-,\M6Y
M\M0!X^M*5C\Q5L?A="-6YW_1*=6JI]$JS^V4DE/;@-AR_OLFMHIQ*O$V6O42
M;^,$\380CPPTV0SH#/G+GIE!1Y6PWS[#S;9`*KU(4B6P@4M@D=,#%DFR@ZKL
M'X0=2EB09>QP:%B0(S-#">JQA!D.#^IQ9&XH(3F6<</!HWN/S`UE:M,2;CA"
M+LJ1V:&$PUC&#H=.>3LR,Y1I14N8X>#Y14=DAA**XA2@*([(`"60Q"D"21R7
M(4K5\12RXH_,`Z6*L,@#KTDS*!/GY/(?/W'NJ&Q0IKV=2MK;$=E`K^L='M4(
M"X6?SAL<ZL!1C7H!48WQ##[SNAI(C`\>72AO@8*PT*[2*I;@#+U7918!O[=*
M?M^6WQLEOY\?O\NH]5ZCWL:/W3B`O63[M=B^B.#U>`:?1`7'.1DU6QDQ<7W5
M3W$YR#+B_D0W8ID^<A([L&3F/3!SJ46=!C.76E21_)[@\@OA]))/]L\GYQT!
M73RI]!Z0JDM7TJ5A<O(G26F8'$UFZ85F;4#[L.&:/=B!9:3(:4:*Z.W"&$"O
MPO_$H=4OKP#**X`C*VF"'P_)[^450'D%\)KXO=2T2TV[U+1/:".65P`GL0-+
M9MX#,Y=:U&DP<ZE%%<GOY15`R2?K\,D97P$43ZH80E`O#9-S.$E*P^0X,JO8
MN[@E&[$T3$YB!Y;,O#4SG_4!?`A2$1"HWBA3P4XU%2Q5-.(`;%"F@J78X!12
MP0[-!J4Z?J+*0*F.GX(&<[B->/8:3'&D:L3>EG:SM%Q.4%A=T+YO%.P/2S/S
M&>_[PY"J3M'#W5)7.=WM7^HJIR"S"CN`Z[U(9K4:)<Q8Q*DG"S,F%ZPPAN@J
M#-$O&>+T&:*[#X:P+>>OMV/7#1PW`.'L_*7]I*^"^0Q6#AYCCLG,*_&MY]K)
M]53IUGR#/[_!!R-.232?:-ICOAMZ(R:;MHTALW^_^B">_9?>:OS+'MJ;]"S[
MH36&!IT)S,"I_GB\^N/[$_.9]L)ENJ\%KC:#SI\,^'+D3J>NH_FXSIKAP1=X
MS"$3FIKA:XQR"6K_]28QE7W,3S^)^9G1T:S9\=E<TZ!%;0Q*@/:,6H#FCK6`
M^E`>TJY]QC2:>?-&LWP-8P4H9`!:#O!Y#;@'7X5]XLWA9ZR":3D3C7.E9L"O
M^!0,U)DPS7+4'JD]?`%:@U_PN=`Q0M/"+X"'32Q[29]\U[9,`[_V9:4F'WMU
MH1NJR^GC1%UHP8.6@!Y,NV:\;.;-TH6UW5%B3:G.I^O)-7ORV/CWJ_^3"6'W
M)<3M_S!^Q+@)HM:M8=O,?#<7S_GB05_D'"Z"_B89IZ!>_@5SNM+>9/+SP$M.
M'[17.2CXN()CQ1-OQL8HJ"J<RWOPW&G!4Q(#=[-$BNL!U_]^U4`BOSGJBNL'
M67']\E8\8TJ9*ZZ?VHHW#[+BS<M;\8PIG<<>;QUDQ5N7M^(94SJ//=X^R(JW
M+V_%,Z9T'BO>.<B*=RYOQ3.F=!XKWCW(BG<O;\4SIK39.9ZRV-!I`=]S[P9\
M^/\!4$L#!!0````(`#V(J$(Z0?,;!@X``"6K```4`!P`<&EP+3(P,3,P,S,Q
M7V-A;"YX;6Q55`D``T:]BE%&O8I1=7@+``$$)0X```0Y`0``W5U;<^HX$G[?
MJOT/+/.R\P"Q,==3<W:6`)E#+0DI(&=VG[846P3O&(N1#$GFUV_+^$:P028(
MK'E)`A'TY6MUMUHM^:>?WY9.:8,ILXG[M:Q7M7()NR:Q;/?E:_EI6NE.>\-A
MN<0\Y%K((2[^6G9)^>=__/4O/_VM4NE1C#QLE9[?2]]MUT,ON'1G._!95OI[
M^?M=^<=*)1BYHL1:FS"4N*6:IAL5K5'16J5_EEI?M%JI>[\="!_][0O_\8P8
M+@%K+ONRLE=?RPO/6WVYN7E]?:VN%H@ND;?`+JZ:9'G#OTTS#+T<C'][IH[E
M11_A+ZN$OL`XK7&S_6<TE)/:^?)7PQ^K=SJ=&_^_T5!FIPV$+]5O_GT_FIH+
MO$05V^6*,C%\BME?F/_FB)C(\[6;^'B2*^,FDCAS!']5"8=5^%L5O58Q].H;
MLT(6]X1))U(&19=*6U53XN`)GI?X[Z?)\*">^9B;/C'72^QZ7=<:N)[MO0_=
M.>'#0$#@P__2!<7SKV6`K1)"P[G\@;]A(6R'P[SW%1@3LY<K!_1U\QFN>L2U
ML,NP!7\PXM@6-\I;Y'`HI@N,/2;`FVD^LZOP]H@H:'2!/=M$CB"C*PF</KEH
M;=F>S^D^RU,/?G+HV7@^7F'J0RZBU[5I,D*NRR]\DO;(<D4Q?`6S-WA$F#CO
MIG-5[GN(+>X<\BK,L#F7P.^8OB#7_L.''6;_[9K9+A92(D'/$OB9KI=+1-_'
M\ZG]XMISF#O@E4R3K,$MN2^/H$C3QB+L,<*0C.ETAVSZ'3EK?(\16],MF@+\
MS#=+*6YHN;0]GP=`#TR-:PDBO9B.3&3*@-`CYF\+XEB0?@Q^7T,T$8$+R\#*
M=L$?@T9F%+D,F:*^;>Y=S;+]WT(*X_8MP\#%^)RA9T=\'LK09^I$%&8+IJ,4
MIM(L3IPI[WJ&]X`H#_X;W,<>LAUA:%U+OQK//#VWU@Z&8?`EF*?!%L\'(.[Z
M`6WPQO_,*Q'\@!7-I2PVDK2W0."ZV="-AD&&LZ8CO,'.#'C&(QL]PRK,`\'%
M)0([A\S!GF\(<9R+"76",0&CK@S^#D1(<>8@4,K@;3]2GC(+L9PI>,JZ(>^:
M9YN(RXEBSPS_O@9N!AO!#(UAO69<*B;DF!C>Y7Q1Y$\3OB888'6]Z#,YW8^S
M1/.-I#"QBW*>62.'H;T9'>OT5SZW<S+)R.ME'(]X/H<]`<7!]#?7CN\41O`Z
M'&][#GQ`TVJE2BGR(/!W;_S0'SQ,!WW^UW0\&O:[,WAQVQUU'WJ#TO3;8#";
MAE2Y!.<L'FVEP&\>.%*(^[X4H1P.,8-1#GK&SM<RO/'?+@,EL-Z:<F=7;;1;
M]:I>KS9WE9>L4\X1>_8K=FM6>4%HQ8N;M1OL>"Q\A^NY5M'TH/;W0_#V+JE=
MAAU>@"0TU/M!CGFM@4<_^,7AWB#'CX=>#TSR'3R3/ZNKS4:C*4T2(1:$)$S8
M5I>&PLXI60JAXY$354(HS!:_EJYKFE8NO6+[9>'Y;\"K%;4)A7D$UETNK1EP
M3U:<PS@,(FKN6>YN*3<8<<-X2L@_7('P^Z%J`&.$$+^U'<>W?8]"Q)E@$X.(
M?(I7FUI'GKUFDKT@LD*BQVC6%$#SR7W>$8K%4E7UEEZK20/T`.4+0BHJ?XRJ
MH0"JCQ2OD&T%JU1P1GY!>U<E>KUFR)NN`AQ<$.6\^HC1KBN`]@0SC]HF7U`)
MA1Z]8=0U:<CGY.:"5O`9/<46T5#`(K8*`4VTY>&\I7$^^/:Y#7'+A#<&I:D`
M*(^4K##UWA\=M-T/!\M;\67*`^;>I]EI2?3&V:0O@:"PZ#&B+0403421!^*:
M82`Q:C5Y4*;2O`2&QX6-P6LK`-XOA%BOD/M5=<W0=6EXA60N`5&J2#$J'050
M290'H\1,;S;;TO#9)WAZ,2381V*/Z)TO(**(59?(?SK-<UB;$!11C#XJ>F2'
MO,A1>#L$>>@:ARL&%BX9`KD2JH'9J'725LEI-4[QK[T&@"<('(.J0NEJ1-R7
M&:;+/G[V(HW4:FV)WF6?XL61/29UC*$*!:OI@E"/BW-+*"6OO'6XJC?KAKR,
M*X7BQ3$\)G6,H0KEJ3Z>8Y#8FN`-=F&AW6JTY25@'XA='+H#PL:IF0HA,1D#
M=+VER2L-RXN#*8Q';O(PJ/$,4Z$DZ,?NA$0[*[9Z75[`RR9\.20%A8\15:&D
MEXSB28$@D'<NDKY<`TD!H6,45:@!]C&U-WX;5KI]MO6:O#V9(\0O!VL.+<3P
MJE`03(@#"ZC]7ABN$T->JG.,_)D1%A4Q)<+N&$>,L0IUPS21F\VFQ/5'T7`\
MHH$(SIH*:Q'>Q4M<7Z2@,4=FU]5':N=`4L@@H^:D`^+&\U"%2G'7LNPM_4=D
M6T.WAU:VAYR$@-5&4Y<W+8_3OSBX^502SU,55I]=TUPON:*PM7\Z<^B:9.F?
MT;PC%,1PMRLX\]UOC`ZT:_UOS;Q@TW$\GZ&W:J/1DI<[2V#X\@8E5^FQ!:I0
M/9[P[FH76P-$75Z`2RBGC^>V:</"I%%OR/,XQQFXN('DU$D,>$%*S3_=?%3)
M"%Z+MYO7/[2;/SUTG_K#V;;=/*WQ?#J#7_>#A]FT-+XKC1\'D^YL"`/RM:!_
MYN1][J;TQ#P'(]F><UH#V/%7W^(Y>(#M.)CBF-W;KH_DT/4PQ8RW?.Q^R]:P
M[K&W(/"?#=[Z"%@6:,V&/)=\04E.WT2&=3#9\N.^;$D%>W)5O=;NR*O<9=(]
MAU.YK@V%WDI,M6I5Y<>[`G'E\$T@B8U_*13_/"9R3)V!<=34,`Y(NI)RU%HM
M><6G'5JGN[]@[R5".9BAMQ#_YI!-M&H2MPH/TSZ'D1\#)%JF"VLARUM5KFZ1
M9U+%M?R"6C/=7YX=B&]&O2[O!-YAXF>9-SF2HIUM0#&5J!7RGUR*D6/_@:U?
M8/'%;7KLQELJC)];:LH\MW60^K70SJ,4!:?VX6++]N@_N+E$Z66"30<QYE]Q
MLEN*F02*>EH1=XH</*8C&QRBY0^K-MJZ88CV,UZ6MZMZDNL@$)BJH8:I)J:>
MS5:$^=7H\3SH6]<UO2-O67*0]K4L1UPA`=!U-8`.,ZM(`[K>DE>:^$#M6F`>
M$CJ`KU&\-#P#OS#IW0H?B@8RU0UYB6(6V>LA*J"&`-JF&C,S*F"$G?R\?-&\
M0#4HI'?ZTG^"&08Q^<G</K^;C/A'!",4&[5.6EYRME/+V;3/89XBN"0.*@LJ
M0JV%RR_8!24X(%;76MJNS;SME6219%JM+:_WX@CU2X.<1QEJ98%]O*+8M,.;
M?[M+0KW@(N!J6ZO+;'#,)'QI=`5UH-9*-'%)2G"6`6Q48J_4+K6S0GAPMR1N
MELJ6M[">]ZP:.&SR6=9[O:3WL_OYS4_NY\^^#28PX/YQ,O@&HX??!Z71>"IO
M=__@/?6Y=_H/]?A$_3NZH<L^/W*$A=,SS+Q-3&E5G926)MTPM,955'(ZTV?Q
MIJ?9RTY932X:A?72"F[7RC6&;-D+ER-]-LBT/A=D>MWIM]+=:/RKM+"R]P"1
MW)$D_8*M1PQ@\:U8BA&_/'W[N]IL2#S"EH>3TP/+8#[')MCXX,WT+UN?@#+'
M;CKM:KNERUL#Y>'D'-/^<TB'L_]4_2GGW[DLCY1L;)A'M^]/,`F';G2-=Q<"
MW"8X'U5K2;RC3YR1XIC(B<HK7/0XQ4*V=>H](24>)11GI/`6<DQY:A77,H2,
M%NJ[0DK<E!-GI/`6<DQY:NW-@G0FQI;?Z.8W%\PSKU\$^1J:U&LG13DY4W/E
MZ<XS<57E2=I3*Q-Y1._;IUJ1K@GB4'Q`2*,E\92<."/%L9#3=%>\8JFP%PDE
MOB/47^6GYEQUHREO>S8G-Q)M12Q93_,F>;6HF$=)2#ID;,V?AC*>)XX>P\0(
MGU/C=[BE92:I/89YOKF0P.=2A[JYQ@2O`@L?SW>O6L^P=(GW+I[,5R$-Z'3-
M9K6E%=2:(BDCN7J$\49)HRVQ;2"+;'%L040O66UJ"N072?L>\:=$@Z>DV.*'
MQ^MUB8^@$>*A.%:06V.!2;04F?VI(3-Y!=R'F)E:(,V10F1\=2$!SZ>0`/BV
MRL`G;ZT!HZY+7(,>HU]PB\C2E%J%S3C(^9*$XH6!KM62MQURB'1QL!?5CV*%
MAH_5VZ$;7$6_>T.=OV2."K4[5PEJK9:\[IO/LB?1?L1J_HESU.?3LUJUB531
MDX^K`-G:$CNXCM(OMI%D:DJMO=5]V8+'`H8WM*<^'A`$[ACREB"G,55@>\FM
MTZPL19EP%3Y"-/D\6%W7='GYBA`/!;:18QK+JH$J8Q*ATTP^3%9K-^3MCXBP
M4&"#.*(OQ0[7;B]?_9?-;YT)SY,:C8Z\9IU]@H7!^H@NU#I;&P:US&N9FC7Y
MS[&1>SO5YQ'/H22UZI/3!:+X%OE]TTLNTO8TG]ZL2=R;2"=:&+`%=*)6+3*^
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M2E1KFR^_P*_$%U=>7?84EE2RF`\*5&M#,)>X#^".9Z_8V>![XGH+YC^$5.(C
MD#_#FR(6=%"EA6M>RLPL@G_P'\^0,<$[_P=02P,$%`````@`/8BH0@&!MR!$
M'@``'<$!`!0`'`!P:7`M,C`Q,S`S,S%?9&5F+GAM;%54"0`#1KV*44:]BE%U
M>`L``00E#@``!#D!``#M75ESXSB2?M^(_0\:S\-T/U@6=:MC:F=EEUWC")?E
MM5T]._NR`9.0Q&V*5//P,;]^`?"4!%(@B22AZNJ'ZBI;`O++_'!E)A)__=O[
MQNJ\8M<S'?O3F=;MG76PK3N&::\^G7U[.I\_7=W>GG4\']D&LAP;?SJSG;._
M_<>__]M?_W1^?N5BY&.C\_+1^=6T?;3"G1O3(M_U.C^=_7IS]O/Y>?3)K>L8
M@4X^ZMB=?D\;G/=&Y[U)YS\[DU]Z_<[\:_A!\M7??J%_O"`/=XAHMO?+UMQ^
M.EO[_O:7BXNWM[?N=HW<#?+7V,9=W=E<T-9Z@X%V%GW^_<6U##_Y"OUGUW%7
MY'.]T47XR^2CM*N=QM\&[+/:;#:[8+]-/NJ9O`^21K6+__YZ]Z2O\0:=FS95
ME([)MSSS%X_]\,[1D<^TF_EZ5JK!18(X]Q/T7^?QQ\[IC\ZU_OE`Z[Y[1BSB
M`1A^)V=$T9U.J&K7L?`C7G;H_[\]WA;JF7[FXK.C!QML^W/;N+9]T_^XM9<.
M_1@!2.1@C:Y=O/QT1LQV'IN&2OEG^@,#83/^F/^Q)63RS,W6(OJZJ"/5E6,;
MV/:P0?[B.99I4%)>(HN:XFF-L>\)R*;K+UXKLCT@EVATC7U31Y:@H%L`2;_9
M*#!,GTEZ*/*33_ZDIO<6R\46N\SD(GH-=-USG';E)=]TKYS-UL6D"<]\Q7>.
M)RZ[;K4J_17RUC>6\R8LL+X$D'?AKI!M_HN9G8S^R\`S;2RD1`>]`,CS%&PV
MR/U8+)_,E6TNR=@ALY*N.P&9ENS5`U&D;F(1\3S'0Q##Z0:9[J_("O!7C+S`
M#:TI(,_R=0,R#6TVIL]D(-8C5*-:(BN]F(YTI$.8T'?TW]:.99#MQ_7O`5E-
M1,R%(6QEVF0^)AIY=I'M(5UT;EOZK3&;_5](893?$`07D_,9O5CBXQ!"G]R!
M*"P6&8X@0O$8)RZ4WQ[Q[I%+%_]7_!G[R+2$36L;6FLRT^VY$5B8?(PT@NDV
MV*#[`;+NL@7M^IW^M2PB\@<YT33%V`3IU1J1J=N[M9./D1U.X-[A5VP]$YGQ
MG8E>R"G,)\#%$1&>DYV#N7QU',MJ#%0%,A%!;0CY"E9(<>'(0@DAV^%*6644
M8I@A6.7<4/;,$V[$85:Q%P__'A!IKE\%=V@>UOJ#IM:$$@/#;VXN2N;3S%P3
M?<"8^\EW2DX_U@8M7X&6B5TKEQDU,`(=C.A4I_^@8[NDD)[SULS$([Z?P[Z`
MXI"KQT)%?\W*E7BP3-N_,,S-1?29"V3MS1HY;J_8XT==9B,F6N:;TJ6R'7]>
M6;#=+TN7;4T:=/7@!9^3GU(GR+[#3EC0@I:D2YWT<&XX&V16%3FO&?GRLN;/
M-WCS@MVJPO+:@-0L7J+`\NNK=K>=?(G)!TW;I*O;'?EG_''3M\CGASTRD73.
M.Y]-3[<<NIZ0?T1;WXZS[&2V^9UTG]^)-_J=GY*-T<^=GZ()].=8)`H<^A@4
MPL;O/MEMD<,!@QT#MQP]^I2%7K#UZ8S\X'^I>X]N.,G_Z`S[BBRV!7TWO>YT
MTN].NV.N99A5ELA[8:8)O/,50EL:#.E?8,OWXI_0>;E_WM.B6,&?HQ\7]+H+
MQ*+1"\>-#5B(Y!%[OFOJ="?(;9W_TZ^,Y]WA4!M`@:TCF)`Z4D;/W5@Q2]?9
ME+6P[TC5I..2=9M%]>A_9YVM:SHN6<,_G9%_!![!XVRIT.D6/)H=:DP?H9[(
MQX0H<T0UXS\2^8'`JDW^,03YQQGR]V')S]E.B'+_D;IQF"*&VG0"9OZXEQK4
MIDW$^M6F4U!1I1$O7[T)T;BXFIDTZ_(F*_9$#7-PA?V*WLU-L(G$'?2'&I2X
M.SW)XD^.FF,&Y:%+.*2-I',H_W0@3*#:$RP4XZ"7*JXZ[DS2ED&L,Z=NEU7H
MX8K0CJ9:?W8(E^?P*&I'!AUE&BWFKR#TE,Y#!>E<>$PC)TQ\Z^.-1_$,9]V9
MD"G%FJQ.N>,14RKNJ"=#7-:<!`)657/,M7*88\KU>O$Z'#H>?J%>`6Q\.O/=
M`*<_=&R?'+FO+<;@3V<>7M&_2&7J@>,0A)]B4PTT/^\#.AR3@(V]>@H5ZG7)
MG#">0,W_N=TV35_.5"FDDG3OV%=PHMQ?&Y`?4.$>,)'2(,A[LZ$@_PI;4L!8
MPDA3@ZFXLETYGK]8/F)S\Q*X'ITBHT2%[D0;<^8*2=Z1O%Y5,*R`1E*;CA6T
M*4M`N=Q/0,GLORX_TH\\H`^6;?V&7",)JLX]+]@P!-[<M@-DW3CN$IN$XO@1
M^6P5'7*F:/Y"`BV-`IQI5.,I^28*DN]ZL[6<#XR?L/MJTOQSGF;N'?N5'#:P
MP93@/3L^LK*_IV/PWO'_B?U'K#O$-O_"1G<Z[?>@)B0PJ14@9Q,628]O\CU:
M"G,R7.W)4(U^1#^G$;7`^2^:A?(]L_>8[5)*:PI2^M;6G0U^1N_1YN02V\0,
M/AE_8SAW;4ZG"K!$0!VI/54\.,T)8L.T`AKN?\(Z/4L0Y-?ONA48V+@ABJ)\
M#GQ&Y\7R&KDVO0-)2,Q&Q'Q#=4;U,X8ROA0)%:"*;$VGO!HHR*O*.]-%N!G]
MPM($;^UPMOSB.I[7U<;]R0B*9@`"*T`Z8#-$')QT1RINOX3=LJ,F7=%5DD4.
M!%0B6:0&=7.TGW5R'5,'8!+$T330BGD00&8LEP<!9S4>VLA*@Y:M]->+/>QD
M[ORM1-YFOT[>9IS^SCY,9]MS=DNKDYV2.]$&$CBUL]IML=*)GT*'I[EE1?4C
MJ-MS]WA$#TZ9]4V;:)R`88,G6W%9:T1.$]O($2D<K<.Q-H52'8C$$B8Q:/HE
MNRM@BWU'D6(0D[3IZVIB1HCZP`9?A#@^-)KT.=%-2:=O(1%4';.\8WA9G:H=
M1Y6CMD>\=5R?*N\S$XEJ#^RD#2-RK?1V3-1-#QR?Z45S9TNGS8@(<9;98`J6
MW2G0OS+CZRA1,IGN)92J=G+)%[+1=I%%H,R-#5&QYX?7HW;1]`<CL%E82(+3
M(TE9Q:8T4=+E*7DW>/F1*C(\58^U"=0],FCAJT_/D)P$4F:+*]P1[T[3%"T5
M3:UC1/7O`S:C>Z#[2W_,Z0%(F7_PZ8%S70W<B,K?F`1T)0%%'=IS_K4XO9Z(
M+BM-K\W.#7R"0GE6"ZRI2!RQ7H1J<!BAHBF^'9;CV\G6M^K\E`E=1?7V.J:=
M_3CYQ2)P.ZSJ7F?0R=3!JAR=`BO[5SHTE71Q^9'\]>\F.8:Z^OJ#]<CXH4UG
M0ZCU7TR$ZE,A5]F'/<6+Y&P`MFTL)8F$2:JB<>-9IZKBE+]77P$8D"=+/B.*
M`=_:V\#WF.D'L3^IU^^#PSOL5R:]*YGQ@.6%NE';)9M@X!1I7-B/-+W2->T5
MV2B8WC?;>?'([H%N.!ADND.P=?(M%"VG4<BHWQMP;E%+)H9$@24,C_K2A/NX
M?F\X/`'5R4HP:(1^!^-5OK'V%ZZ332^`,PCT0J'$?/"9G)1>6>@E*M2+K%O;
M(^9G*TQ&Q+3\;7+4Z$ZU'MAZ6D<PI<<Y9UV69`1(5U?]A?N;[6)DT=/Y%](4
M?:MF8:?`6=K&&(Q-1SH_-<*4T"5@&JY:N[G,"@?DJVME.U+;E0&MC/JNC,8&
M%I\B![LM4:4"'OZEW4/@+"@,15\;#,"HP>_SI+AP5&V*.(^K&Q_*\5?#^%P0
M[-V()7;I`R9A*(!8>+'D[92>2>,>_U>19V2D#<&<NS(%E3%6!(T?4QY(S\I[
M2.7C!MK#-LXOKKJB=SSB>HJ#(=B>?:<G"0,"U-#Q*,I33^L)C'6CC`/A*&/]
MQPI*O:H%&@<$2A-4,`X(C53!."`G6[&JXM1/0OP1_?X1_0:*?JN;6Y?12WQB
M_+BRD.?%ZH"?]W@]*Q&^VQ<LL6Y_!JX4*.GE#B4!R@!$ZH[:Y:36FCP=PB\Q
M)SCLH)5RVL.N:.%JP"ZGL]C!*D/]L'@-DAZ)D>_(%C\HT>/<E^:6D2IH1RW?
MN*#Y#\/7A?I1^SK]CT3)'XF2E1,E5:S)7NC_A]K@JQ_\`4)^2L$?SOD%2,\G
M<%3Y$2+]$2)5(T2J[LGB1XCT1XBTR1"IBN]+<C>6=]DZS-I$\&6[XJ8DQS^2
MRJV\8I#BXDF_/R&HQL(0Q0&V[ZALHI"BQ/P.4'QCOH'%,AK/"_?17*W]!3DO
M^<@VR,31'4]&8*?D8YTWQ57>>U[B>DGG/!6?_/BCI.R7M&_Y['M%[U*RD@H/
MKJEC6MJ?]U"BQ!<66#\M6HT/-KT>H:*!CJYZ8N\7U%S1?UQ!*&&&NK<)3C>A
M_'1O$Y0QJ^C%@+;?/:@;H(<?LQ4#]*!#M5`;D66')UTO:-C3]C-YKYS-QO3#
M[%VR0R7_9B]'8#M\Q*):#F^F4?J>2[;)N@F\=,>UT^#EQSU]#!DOENF//YCQ
M!MH`+)M)7(SJJ^QN'U'[D7]EH`VGS6#;Z5?"(*UAP'C,BBE&_?A#654`.>:5
MX'(CV-KF,B>L(*88Y:,$1V$`G2[KVI<+YHOK!%M6@2Y-9.'E1'#/6_M?EDZS
M8N4F1=8+,*C]-BF3_,8)W(S@G$=?\I6??K=-W?,1J/U\Y]Y3;D#[BW(/U^4+
M&K\GH4W!MD*9?B1P*5^].V_I'>!2?R>SAPQH,8<@#J2H4,3A;"/XN)3?-AR(
M#?783DES<(7]BM[-3;")Q!WTAV!O`^WT)(L_.6J.&92'+EVQ5*PA]!2&;:,%
M>3B9@CT/M]-3=1(]4'_)G/E+TMT!+Y^8N[\Y^+8$<A2K,*9'H=SI`C53D2,^
M\L-7KP//M+'G18A#%]]P-AJ#/:]3U'-U#G$L!@6@-.F/<*V4*9+H70Y>]?=%
M`GBAGFYIC'I0`)JG'F=?E8=7^9U5ZH+?]\#'`9'>;"P80C[25@TV';<)U-,;
MM8=',=M*JS\AG*!*3B%B7-8]"F1KR?YM(,-74M8IQ)OW#J]`1B[G&P"R(0]J
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M%EJWR%%<:E>(R"[F\]7*Q2LB_H-K$OA;9,TW3F"3.<+`&R8C&_:<*R)'-S''
MFV[=D-4UD5IXHJ"%[QT?>P_H@QX3#G$]XBWZ8(L^`\A@B:8XE6JY=?M6UD-J
MWNDIEFT>'29[/_F._MO:L0@N[R^=Z]\#@D9&S>9LNV&KT@HV<^]31N[XV1CL
MUEI!MS7S"A?9`&J?DT*0G]BVD!CU+:'7G;0VKOAJYPB$J9!O3D9NT7/=[E=;
M5#M7_%3M*EX@YD)ESM'9&"Q%++?3&M[&(R9K$HFT:*BP<0KOM>]K0?GW/HIA
M`R51M,#))I$TQ$E.7HB0%IJ)U-=)$GFPD'V/-DE6^70"EL2VVU6=P#W9\-W:
M]-Q$]GBTU><W\O>/_\&N\X1?L9TN5B/1M5:P30E$.Z+P-!1?&B3D!"CAS!_A
M#H/(TXD&M79E.ZH15>&8"5A@:7-9H:H3ST,>0.77T4-X0"L.').`!09D$F<E
MS`6H_NIWZ#O(^G2TD288R"]HI^8ZM]-H4DY@U*\LF*S,@E*JVUG5BB%]1XD$
MQU548G,BFUW4K^G8K.DKM#5]9+$Z1=XCIO79L7'CN#<!30&[];P`D8U(=SR=
M@ETZ*2U-(PSFQL*JJTWMW`2&XQ*1,48P;LGLBD+%N32OC"6%?J0?>8C\UC0H
M>!_03A?+4!'SP%\35/_"1E<;#^"*U4L7MRU&@>I=[3"Y+.BOR+3H.D(&WQ=Z
M&F<:X!S]U&+>OM2G3L`B*ZB=)L#UY23HZ`,F[&61*[(3P,;E1_0Y+_J@UQU/
MQIPD.T"WE[ALK:V3TE2J=BH#%^?U.W9UTPN+/B:_W`'7;/#PB$!*D41<>6JG
M0*B;>U3)5B52CEK*6#A^%ELP`;Q,_NDS=C<,A&A^44$[K:W?8M"2(H(C%=W#
M3\%V&Q[BD151C9Z@L'%K$TPVUJEH_S#]]9UCKRBTS_B%)<R,1-/;*_70FDWK
MJB.R]E3-8$"Q'TCL8F@=UU:%^"S0U;%Z\=FRS,O1<N%ZO*N!4[CZ>>BU!C)>
MZ0"!9'OE`$U<J`!3?7/U8L>'*811#61[U6'OQ2`V"U8N%)NTEFVL;LH@G8?3
M"LWI3*_U)[-#G[T<&N;T67TFW&TP)*'6G_::`2`K0B%JBO0UT2+4^V'1DXU*
M%*H%Z%`JG:&TB<7RRL6&Z=\@G57.CHI(73JNZ[R187V%MN0W_D=7TV:\7:*D
M"_XE)($F-6<C6551@"7')>P?>:BN`M>ESDH>JAG88S%E)%'$_"**`BP<`&3^
MI);^8AG>ILB^>T20P7G<RDJC"`U$%19187PZ5#A@]F?LZ:X97J&B)`<+8Y>5
M1A$JB"HLHL+DA*D07;A;+/\K0):Y-+%Q:=(0Q%S7Z1CP'K&.3?8\?7<Z&LQ$
M7;62^U:5%]6TI[8OJB+P;_8+'SI#+GK76W;GIT,<(?U%S)FIR9Q=3=V2,Y^+
M/?\1^9@54C/2R[W=R1!NT1$7HP5V5-)1ZL`Z`;M?(L_TGK8N1L;"_A6Y)IW^
M*$`"2`/;=`K*T+K%1;03FUO1FPN[@+[2NGATBQ1B&(Z;L7"VV]:-FJ.#V(Z*
M.@WRIZ+KY9)&U%[QSFPT!/,9E9*D=6N+:RHF`$1)2/D$B!)T*8G)NC,8@Z6J
M%O3;OG%SM`!8W%/&GCT3]8XF(Y/F8$?E-+S%,JFQ<6O?XW?_^0U;K_BK8_MK
MJIG^%,XA6$>T-K;OLE09#WY5?89E</X3(_?YS:'P)F!YQ%4D4IT@',7%O%#5
M@5@:'GW7C`&$<R-6DNDDN+&OO)@=JOH4,P`?W!@7^=O&##:)4R,!V9V.ACW1
M>HXEVV[9O"71QW95U>E7#EE8EY1.;!2BZ+V]JIVH;VFN/N+4,$6]-G$B>9A'
M^>P\!*Z^1A[.W.C+)E<^.W<.LN<K,E]153"@HC7JZG75@OGEZ28F@:*^G!_7
M-:H11,Y-C;ZBQ\F0X(S[+").F/Z*7=]\L3`KX#BW#?:1>%C$2!GQRY68*=])
M"]:6H8_8Y(HZ`S,0/Y-MJ[T*E[0,7)K:RFI/Q]#36VM=;3S6X![[JR-:NVRI
MI\J8,HIZ$')PAK=?A8#RGF(`Y8R@;.J0IH(R8]8HZE_854P&30J2K9_4^0J7
MIB@L1>L.:3$-Q497U&UP:QN!3N_3<WE,`5^_TYOVF%9/A0L\"(O1@M4KJ2@V
MNZ)>A0R`^$"=+0#>G7`?@9!50:>P[S;.#,+:B,VJ:)Y/'`"-",FN6FH:H/^7
MTV$K([00=APA5-3=D_5H11GO+%H%]LP[I\.6'7D<V+'1%'7/9*6_=VP]`P!L
MXN3WV;+I^.!CZX%45)1KO>1V`95?:R2&FG39LNVXT&/3*>H!HW=AK:BVTPW&
MBR4%0YV\E\BBZ2%1"(`Y>$1+90BVV8*U*J"-MRB*#KW\C*T;RW'<3+86Q21:
M,D.XU=9/C8*(XZCD25CQ"KGNAVFOHL>!)H-Q4^Z!G8Y;MVVN'M+,$B5+VNRB
MB*8;.M-XW<F05YD>PI;9;ENW9(X.DLNF)V!&+YO[S)+@YK9!,UMHE0[AI5&P
MS=8-)H0VN2!Z`N;[9J.-X_JT3"JM+!).*$.X\.[1WELW<;%&4L_,"1@W4[(#
MJ.!/U4(EN<<E/SHS/)-OLRH^Y*0.5FN*UZ%T_O&-D#TG%6!.BJRT6[BHE-FB
M9P\("+@:(]PN:S`O<V4S>D=FT(.[JW;8G036"9J!=TOU`++:+^?0@VGL-$]$
M!RQH<]!="]8J@@SYK(@<)QA_A@-Z/JCRK%YZ=FL(@+37:X1,D;<R'0!7_EVD
M?+A`SPTUQ[R&`#3`/,[[24>!J_^.4EBM<K%<8IK*P]!.1\/1^-!PW./PX=>K
MTVBWK4B75)AI)6&D44)$13$CCF%H9BH"(<3!&M(F(:H(`T\(SN)T#$,S,T2-
MM:D`@)C'K+(1!,2)=IA4'-&Z/;P&I',B3TU\5ARB4/M8LRO]<U0T:CCF.&\$
M3%#3%Y,[&*O((LFO(J0@/A?V`0`R09I?91=!ZL:DD$7?8<QI0Q8OLC:H(I"L
MRL;"JN*SXP#&=U/;N%@Q5:9V"1R*RNU&M3:3Q'=JA&\V47SX?D?4'Q-5])YA
MJ9;!><=9H2I#5]O'0Z]%FAY+6GZCUR6?D(6]^0JSYW%<[)%1,_?2#(3%<KY:
MN7B%?/S%=3SOP75TC`WOABCV&NEK^O7X%36F!-$K98!RM,&6AM2J=FF;+(JX
M.`]-C4\NXG:UX7`(E@UYM/LVB%%*)VJ7KLX(S9CY%+S04KLOV+@,_&^VR6Y$
M13\,GW3*U%0=3^'2E^L(UM9D(4&1:E>W?L2T":(0T15T,M1$C[`EVV[#QC7@
MJUUSN/#VXSU^8[]BMQS[8`->3(8VS%Y>.VH7)I\;_Q=X/LNG>G;FAF&&HCP@
MDS[G%KTBGF*.5[@KQ_.][F@\`DO[K"-8&\20I,AD`]A63E.]A[$&G(>QD.EV
MV"39^8H1_2%34N>G)WV-C<#"'6?9N3/1"ZW.;6(O_I3107[FRS]7?DHKOO*0
M[3WN>[',]!QW/$^O2=1]<BMIZ/(CT_V-BW\/L*U_,%^8!A@&%>B_NO.`I]FD
MZ<A!K,TT>'#Y_4N8":J8,+G,44I#ZH?.A'4!E(ZA!IVAP:E!9TZHKYR&E`_\
M9521_/7O)G;)]]<?=_@56Y$V9L,&YN<"$>1RVCOL*;'=H-').E<2N3PO8]PB
MJHLH[J3F\*.*@9_&56%]@W.Z*JP7G.!%%'<Z4_VQE0OH-"MK;1>G^R,M2)7)
MO=!F/;#G0$0$D$GN$D8L9':^CM1.3TG`S#T/^[3D(><4N[`3>.0#]X[MQO]D
M[]Y$=V%F_2'4E1YI4DH8&<<VN]`JJ'E>$1P7TNEP,'J$]'@*&3UE%DIX<M3=
M!2G$#S%M`FX8Y%-$?#/4Y/I::Q=9#/C6W@:^Q^RF14MCO]<'NX-7T"_0KD'<
MC`<,+]3-B6P;,ACZ*0;X[>%AOTK;]U`W:J=^\3`,4@Q@H;J"?I6V[Z%NU$Z_
MDK&.WZ4E&&;#V6&FL#I;_[OZV:V2-SX**TM6]C8LQ0X&HT2[?#=YX@`F@)[W
MVQWEG[%KOB+Z\">MG6?K)GW0*ZD2E!$IC>HG^0G=J<9[.4=619;J@JDYEKD5
M>Z1HO_6=5;V\E\EAW@O-[V3^$;]S_1IFO%1+8$D;"MNIFY.RUU[F6O>HQRN_
M*"FE+Z_7Z@-_K\EH-T=`@,UXW!XE#%5QDR1YB$>PJWT2W9,^G64(@#'4/BNO
M4VD$#+<D!,*T(0BR=GW"YLAAWS[P_6/4R>[%BA73S"0C@Z=_I)1N89O53ND>
MJEEX\/NZF%':G/4O9BA:[/7']2Q)#)%]/4M)MOP![FJ6-GR5NYH3-<W+.3&P
M$"L1%BR9+:=/>?OGO6-/<S"DY=^)FB5O(\W3@/+%_0I!`Z43-\W%YF`TPT5.
MRK.(!M0O]Y=_-`5*XZE\)B\_EAI"4&8LE:,@UQ@%_-N#KDAB63U7\:C7/W`5
MT[W'VK$(.N\OG?#JZ>[]R/@5Z\JW(+-=A!VD5R#CQNLZEKD/L8<VGXUF4.S-
M[[7Z*.2VR<@X&X,-P]Q.)0Q$<=,DAZ3C*E!D.!9:,N;V,_G3(R=^%QL$`*=F
M&Z`-)7CPCMBO232RG,X"EBGDXA[Z[R;^GZ<7*.=-DXR]#^B)=[%,7TN_(GK"
MQN5'C#KZH-<=3\9@L<B:L@&2G^>MDJ9(Q:M/\7#&7AKZQA/UU/9[HN7GCK6F
M@!'SP*E=]XD'Q?,I!NI6^\?:U-?['+Q^)XNYZ87^TPFOA"#<N!87K7U&5%*C
MVO6%N,2/@.`'U]0SYX_LE`5VV:"*0.TSHX3*U*XN%@E^_;XU743%8)/?:*H)
M5UOGMM"LA8Z"B&PP4],&7()%KKY9PR.O;@Y8U!HUFK[&"SM^DFE&9!"MJIS3
M!M2QFZ_I/6X5`5([MVL7P/.;DP$@6CPZIPT5+,(%U'KV:AF+$+UG225:T#FW
M%26LP@>E]GV>70@W3N!F$(@^UYO7B`I6X4-*LJ=.P2CF:Y96HH_3YS6BA%&X
MD-3V#>PB>#+?,P`X>9@"-DG:4,$D7$!J>P'V`.!7;&<@<&["B]@D;44)J_!!
MG>!Y.PG;`&4QU(M<53JC-(E$6D:&L'$*70'[6E"_Y%PQ;J`TKQ9(V222ADC)
MR5D3TH(*%>'R\C2BG],_7I"'R4_^'U!+`P04````"``]B*A"T^O1KW-U```+
M.@<`%``<`'!I<"TR,#$S,#,S,5]L86(N>&UL550)``-&O8I11KV*475X"P`!
M!"4.```$.0$``.V]:W/C.)8V^'TC]C]@:W>CJR.<*E%WS3O-=YVVL]H[KI0G
M[>S>V8J-"5J";';+I)JDG.G^]0N`=Q$D<1=4U1$S74X1E^<`SSDXN!W\^__\
M_KH#;S"*_3#XTP_.8/@#@,$ZW/C!\Y]^^/KPX?+AZO;V!Q`G7K#Q=F$`__1#
M$/[P/]W_]7_Y]__MPX>K"'H)W("G=_`7/TB\9P@^^3N4-P8__O"73S_\\<.'
M+.4^"C>'-4H:!F`T=,8?AM,/PSGXO\#\WX8C</E+FA!E_?N_X?]Y\F(($+0@
M_K?O3]%ND_SIAY<DV?_;3S_A?P["Z/FGT7`X_2G]^$.>%&<M4G[[]FWP;4S2
M.LOE\B?RM4@:^[2$J%#GI__GE[N']0M\]3[X`19\#5&NV/^WF/QX%ZZ]A+16
M)7L5U?BG0H+6%/A?'_)D'_!/'YS1A[$S^!YO<H@-8>B5_(`:#H"TZ:)P![_`
M+<#__?KEMLB]]>(GDO,0?WCVO/U/.,%/.^\)[G[ROOOQ-=QZAQUN1U+,2P2W
M]09O%(#Z</03W"4Q_@67%G_`/WT8.ID4_SNEW.1]C_@3^Z_['6K2GR2!KU^\
MX!G>X;]QU4K!MY2M5H!MY#V_PB"Y#M<'_%]"*Z5B=-:@1QC29EJ$J)7,#_Y8
M@Y8I^@W<1W"-K5@[\EK6710=Y\0*O,0*[,P(XI8R-6"^1O^C`W>C7&78`_@L
MTMA9MF/$M-)40[V'D1]N;@+%F.G%Z@'_D'A1AV:*PV\6K%J`QS#Q=FJA-XM4
M#?HS5-S:QP4J;V7D`7(;DIY6;A2I$+1`\R9-G*QM2D:X._17EA*7V.&9I:-B
MZFQ62H;?$QALX"9UV(JRPW66BM3RIQ_0#_]]B<:[#1[S/NV\YX$SF0P<9S!K
M'U5CN!X\AV_(M/OI@(K^.!Y&T4_U<NOH=MBM#:-<\)KHEU&.<1N%KRP0D_!/
M/S0J_._=TVXPFLVGSN0'$$8;&*$9QP]@CPQ)Y"?O?_H!33X.,<(2[K&?XA4]
MXT7KGB;/4ORT#I&WOD\^[)H=BY)0A:NW?C=HCNYO`HA@'!XB,IEXW:'Z\`P+
M!A^^/OP`_$U/S6[Q!>!/__Y3B5F037/[V31G9-/T'-DTY6%3TF)+Q2DUE:/4
MU2&*<)E^O/9V_P6]"/DQV&<<.-.I(EO55H4<T9B!YYQKRY`WY6QHMS%CPJ_;
MKK&`<+-$($T%<#*`T@&<4"T[%=B^T["S81'[&]9NX\B$WXB=9$&BD*+YBDQ:
M4CJ9^H1^BP>CX4*1!6VM0XZD[-!SEK;F*!IW;C=-V030;4694+AYJIRD:3I`
M$BKFJ`([>BJ.-BPI0^/.SIVC,T.VE`F*-J)BJYSW]5R+*2UJ4$G2=MATBA;I
MRT:=GQ%!Z?#-FE`JA@8OR2BOGI7*C:<95O883DJ3+LZ;E8N3&$TJ$.74+/8@
MTDG&S%%L+FOEJZ%E-^1C4M92%TVY<,Z"DNW@39G)5@0E$[-16VX61.U4A0;2
M%`];C6-+0X[.F8<CPX:Q%89B,CXB8(.1,U)L"W&Q:JA'!7C,.)RH;*3Q61"M
M@=F4G3NNN&04_B)/(X6F3`^-6@U7O67L7NINQ6S43!W7+L.EFR!!#7R%,D?>
M[C;8P.__`=\'SD+5"B&U?#EVL4'.:49-G;?>?&BWG]8/7K?]ZD7@IBE`E@20
M-``E4LA#!<;--`\;YJZG(>WVT_K!&S&`O3#4DC%\?0V#AR1<__WAQ4/P5H>$
MG%+W@^>!LU3EO?57IH2F/,(<<;8C:]GX=OM_G)(8LJJ,<`I6D_2`9`!I#E#)
MHHOCZJRO!1QOL\M,76&W<\HIB4F+S8B)1O0+14S_Y.]@=(6F[,]AA$=I58>(
M**6KX'(WW#IY:VG+]K1[KZ8/NAD3W%I_3D62`.0IE!%/F4TU0[P6J]G2>G9O
MQ_1!-V@76T&H8]\7^.S'R!<.DL_>*T3]J6J_FE:\"O[U`*X3L)ZX;,'E&3"P
M`[L9V]<.(*=?F0+@).KXI\S\F>)?BP%L:4)G>+[\P]@-FL!V%$I(^!AYV&%\
M>']]"G<#9Z[*^M7*E:-=-\2<;[5463,MAC.[?;QVT+HM7&O-;O8%I)\4L$F!
M+=/-IH;U:FD>NQVW=M!&[%5K]5*4RK=N+H--:N]N@VT8O9)K])=/V.ZMD\%T
MX3BT^>K>WV,ZC8?CC$SH!Z82U6SO<6+&Y$-ELF4GYY'L75/DED.GP>,%4^X7
M>@$^RD"&V4IZ\&N>X__32>;C@!IGP>9*I(Z00"[R%Q$P.LHIC]K9N]\C)1,[
MS3?M`4-ZZ"X#4!OU+]?KZ``W-]_W,(AAC,BT2E[0Y#Z]SG/G>T_^SD]\&",J
M#:E[1U3Z,Q<KIP,RZ',]8"ZCN")J\7JZN$`Z#;TP*C?+!?)L`.4#)"/(;YQ5
MLFJG_ORLJ3]70'U[;Z.)"Z3=#1>&5O`?YOS'YC\D_-\9Y#V3RV,O\9O.CT!O
MV.O4BPMDRNT10N=>>5'TCB>H;][N`($7@W`+4#[PY.UP[$$0OT"8@(V70/PE
M?-KYSP1?#/Q@C<O>$'W9>^_>TPY>@#V,$L\/<)%)"-9AG,2H/`\Y51'$@1R3
M`R+B.\H,`O1WA'+@#T59R,U"?46\K(.WJ]9W@:@!O#5JHL..H'E#"IKXKY#4
MC[PT\.W%7[^@HMY"?XW4^,5[@R`($_".!'B",``17$/_#=>"$ON['?GZ!-'O
M`2(=W`S0&.CA`#Q$N-UA`T'B?8>H:C]`9@G&R06(<@?QD.0Z`+[&J$PD+=+;
M'5PGI/W6V="Y#R/B/&;-6K$HX,<-:O%O?O*"&B,,(,+I12DT\A-.'F#G$S4#
M:E74"JA-U^_K'6JN+=B%P3.,_C@`E[LXS.'&))/W_!R1*$A@G?>N]QH>`H2^
MJW\O?OL=G)KV;:T7<)(8[CW4P'#W#C9^O-Z%N$.S+J@UU&G[FGL,PIT>WZ<]
MEQF"P70RZSO`VQTF$?]RO%*9_=Q2I_1@Q"0''G>Z<926S]ZCO1P2Z)Q.L,-P
M\R0@2Y//&I2RM6,E_:S8.A=AJ[T+0AP2:)\!L&,I*9N-:MQ4S<:HS,4*7_<1
M?$%N%QI[;H-U^`KOPCC^%$;0?P[2^M?OCY$7Q+MT]6GSMT.<8%?O,TQ6VT?O
M^V`ZG2]U6F75@*651'\+'FF8Z@I+0MD;F<.4^(9&(ITRN)7R\]6O:@T@K0+@
M.D!6"<AK`95J0%D/0!6!U1:@JNRQ,+I&TM^/A6D;P_71T]ZC'*;$-^D]Z!2D
M9F;21<9US<R@N2?O6N-FXZ?]?^_YF]O@RMO[B;>K'*P?3&=.W^DF"=WOK5]2
ME07DJVEF;_ZR@^P]Y2(HC9&1F0N26R8'.#T:6$&6HW:Y0YL2Z!D`[5$"^O#$
MT4?VGI`6E,;<X,&%JZH)>Y3^@Q]\6*<Y.,D?QS#!>S&+H3XK3^J0)'$+SAI1
M29HR5/096.0F8B-6MU&MF_XDQ9WEF7!GR<*=,S!D3<0<QJKE)1%!`B&#1-XF
M`9XPC<HS<<N^.Y2R;%)SP*\'=I-<QP?'IB-[[W,P(#=GJ&C59P9+_&`=M??T
M^'?:24=WVUK:[@SVK]J1FW/'6C&XEP\/-X\/(G0K=G06\[Z'<63IIF9#JAMU
MDVW'&R:C,]A^:@5NSL!1:L_MF]B&*+7?-/IG&MG6X:TUFLW>,V#]P`W[;A0(
MF0N7GT@1=^6RLBNC5%]0(T7\4SG&]@G12L?FF&'O>71V`8P;0QJ*(Z,HZ?RU
M]+!&']`<33L\PM;VM??L.+L`AOW##BC%DSNI'?TW/H9^]'<[N+G*3CM^(6<3
M\6F3>#`;+O7YCJW5RE&50YHJ7UNSE>UL_Q(?FQ`FS"L3$C=-!?)DH)).-86U
M6-J349AJ<AG:W/Z51C8AC)E>)CCE.;VH2`!^?")9_\CY*)\7OUP&&_R?FW\<
M4%$[9-;CRR2___`7?/UA,)M.9]KL,A,$.8(+2EDE.U,112>-[3^9PB^0"3O.
MC<K%2<G53/)')1.X3$!QC8?DTZD:6NR]=:I!'0?X^FQB_\8`OT#&Q@=N:*E^
MX/L]:_P'+#-Q:D.Y5Y]10N<Z[W%MDASOQ5ZC\U'JHC47]A]H[L1NQ'YW`'!K
MP9A%+');/^HQOF8X2#>IK<UX!HY%%W9SAK(#14[$.`V6_'\,!\/AT`%[+TJO
M^_X/X`R'%\/T_T&<QE+V#LD+:NQ_PLW_`)/%Q<2974P68V)9T3_'T]'%;.KD
MB?TX/N37*LL8S,!+P"^H,5_`V+D`^!([27&-G/C7)QCEOX[P;=IX#]>)_P9W
MG"%,K^$6X@NE7^`;#!#-D,!][\>)J\A197(:THN\JB!'B8MX-6/[-^6ZH)LP
MT1WUN_DWD'U4PSTMYMD(]ZC&N;4![=^BZX)NS#1W@"@)&(D1,$+>+3:;E;@.
MG\,@V_8;+)R1/I^UIW)9@G)*5B=L9^:B`R;G0&!V4<P84V8\;IFV&C@*E*GU
MD%V3];6`["W6F;%'[-^YYA'%H/5F!E5EO!_$243"^'`N//P<AAL<LV3@#,>.
M/E<VKT:.N1U@JQS-DQ6QNR?V;Y10,9LPL;2*W?Q'62YI,8ZZN$2U=XWFF=J_
MP$K%;,R"T6H7)%0UY)OCS(?ZSH(IBV'7#;G*+$ILM/G2?D/5!MN$K6JIVQ4.
M%$KM+2V'7?42C'K2E=):BZ']UJL--H<!DSOEV@(@.^,J')RS4NQEL"%+IR_A
M#G5%C+>:DG?<FV-]'EA?]<I8R2I<"U6IV<M^L/\*"I<LAJUF+Z"J*27;_M7D
M($VOB_:Z[>Y):=]GH7MZQOYU=RY93F'+>U$U#3S9/XHKF?Y`=OA5JT#Y&L9R
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M=N`I[BI7+#+GA>6[,'A^A-'K-7Q*B@%W-%IH=&*;-4HRETF$&F>;.8IF/8/K
M;7WPC5C<;@PN_@YP`H!3"#JS71VKQ[@:Y2;=GG8U[!D8TA[XYBQH-Y#"=%8>
M<,)O+GU(,&<W*),X5RO'^7!?ZWOD@UZI.L9V"M)&VN9YN<7DO&QJBP2FS2H=
MQK%E%3UBV]?/VNVK*<+V6EE:.Y^7H6V1X"2VEHZ%L+:TK1=@!^/X^!$]/@*3
MIQK2<#[5;A^/1OK>/:#6*4=?5C&J[*7F*9I[:?]*;+\`)HQM+PHW?10HBUXF
M:FE[>EB+H35/5*J9[6EA^]=G^P4P9F1[H61L+;W8-((9.4>QR>^>D<=;!?A+
MOZWBC"<3?2L%[14K8#*K0`TZ=UX-69[!NBVC%,8L<"^4C-@J+I:Q=+T^@WPB
M+K>;YIZFM]\+9I3"K)'NQ=.PU,([:O<1Q,_(9"_`YP_`UR,R.Y/16-_58`8$
M<@P7$[%*=882BMX9V6^_><4Q8<@Y,;E9>I!E(*?8:LZVT((Q%U6TF'F[M(%J
M^+FZROX1@%<<8T,!)[!")6":(?7;L^<B)4*[WT?A'D;)^ST"FB`4^(3</GNJ
M$C%EMM2W6M)5M:P6<`E5IW][UJ(_)O;/3)GE,&/^V<"X>4)`4A*S7Z3%3R?K
MX+8F0W]:;K>8=I9N.`</AU$.@\:<#5%)<&R]89[J`@2\W/X"XR3RUPG<L(4Q
M=:9CC?=7.-'(:8"\Z%6EX"RMZ,V9_=>^9$0S,2Q(X'/+O$!;&&1AHFD94LY#
MQZ@#CW!'VW]S3$8T8\.3!,BJHN$PRKP:E'A^`#<W7A2@TN/*4_?7<.NO?>2R
M3"=3?7.,?@"R>B(@8%TU^@HH>\/^60>G-&8&&1Y(;IX<Y.E!)0/(<NA3`DTC
MASU*T#(^L/>1_=,33FD,C@(\N-PJ[S<BO']X":,$G_OY&$91^`U7.7!FD[$^
M:T^I48[9;")4J4S)D;7J`F&VGKM]\$U8[!X,+OF>'G$L4RBDIA8;;)::5"O;
MV:[V>]I]\(W9T1X@*3]%#XH_),C@XC6AU?:3'WC!VO=V]V'LX^8O;EQ-EE-]
MQVI8$$A25TC&&I492BCZ9&Q_7#5N>8S884Y0[M7J\_7-YX>;:X#^>EC=W5Y?
M/J)_?+R\N_Q\=0,>_GQS\_@@?*.2%L%I-IMI]"84!Z1B$J#.\I:02*BY[9\+
M]J`WP^`N"*YT_+2N'M423L$D):GA%+I:U/Z960]Z#@]"+IQ"-XXLG()\;+..
MB$63Y4+?LY:ZXC'QR---VN;P9?])%D8I3F-7:5!H]E7AZ-_H>SWSMM-QF3Z)
M8VAZ^P-5,TIA;DK'A*=&Z-PD<P94^!H\U=XYCLN'C@?.W!GI"Z/>4;,<E?E$
MJI*Y(V?1[G/[HPJSBF'"-#-B<?-TQ8OP<>5)>`V4UF*<3TMIJGUF:G_[UX%9
MQ3!FH1D!E;SVF@_%"S^Y>N]%JX@LAVS(!OD]C![P:Y?X)5-]"W$,`.18+B1A
MRUNM;044CX_.[8]JRBN."7O.B:G^T##*`5812/.D)Z``R@5(-GW:H/M-XM-K
M0]_+Q?U=9?\E?%YQC`T%G,".GCPNGCH6YC^I(;XL'D7&K-`7Q*>C8F5\[Y>H
MA>?'&<MVMW\.RBJ&82O?A:5NW=.4H$RJGM&Z+;EY1O=9[M;F7]B_B\@JQBDL
M=1>@(PO=>'5>DM>WY$5ZS`!](81;*E7,YS9).KF<9BK;V_[U%!813F*5FSBH
M%CE-II:UB]\,:Q="K+7_?!*+".RL?8/14ZC4]C;AT.VNKX*]JT,2)UZP\8-G
MU/$S??$ENFI6S.-.F3K)7,E9MO]9K8=TRW$28]P"AFJ1*VDU$-N,EVR6V&Q^
M,K4/SFIIHUN.TWG*+8CH)CL4IG<:.>(V6(>O\-'[GD6C^`@#N/63P7RTT/?H
M:7?=DA3GE`N3'!76EV\\L?@M.V;\.JTU*X@BOG::"J!D1;"?'[.4?]3"Y<GH
M-TKF4C`V-D]&@\EL-IO8ZX=PR<#`ZF7*Z@`^XP5C?F/-@\?-B)T@8F<A>_CH
M_+/G!W=A'*^":S_>9\>N5]LT0-#`&3I+?>$<.NN6(S.O6#F7N_/-YXZ]!_A8
MX>NVRPP87)P&_(A3_1$@-Z.2$+^`<"D08(JQP[7XT*?G\9R/Q\AX3)?VG@YA
M%T"[X\P,):4TXF_R`D'L[2`F<A;Z^`7N-F`;1N1W/EK?!@@XC)/,_J.^=M*M
M83W^Q5%U<MQEP)[3]3CI:+9P+#[)T079D(/04KV;_R[F#9#@@*E+@1G_*8R@
M_QRDSLCZ_3'R@MA;DXM9P8;\:^?A?WV!ZQWBNK_UU^3?EYN_'>($W^GZ`KT=
MWEOYND?33L3^573G_^/@;TBRP73AC,<4]V+O$X:.A^.,G^@'P]CDJ'_R=LP5
MRS`0$EG8;KT]48OH]KI.(U860CJ;A."*058SR*L&E;I)^*Q*[>"X>E#6#W(`
M`",`&`(^9%8!<1ZF;?$OTZ:V';%I,]]H9>!T>Z_$GKA5#.PZGE9"-TWIY?/4
M+'"-_P9!4C%J7E'R>5@H9_0O$Z6X(4]MH^S=/CAQJ[#;J$V(U!N53>&CQ49J
M7*P(QWE8#>"_[E%=V&#AM8GHV.4JS159HZA:LF>R3+<CRW11[HX=]K55C@B@
MZO8[F)"_X\,3WB),?&^W>R^_[$JL9%TD`'[P!K-:41T>KIJXC>@''!Z`=_N\
MN*WS!H,#',R'(YT79NJUR6Z3]V&O;XW74Q>;MLMS.#?:@=W,V8YV`&[U@B+Y
MJHB"FDYM&*%@R^F,ME8\AR.?'=@-GL)H1U'P$!E<`1I>PSTR\+Z7#2V7K_A-
MT]1C'2R&$WWGB#HJEB,GET15GG9DS!M\-K;_$!&K&,;8RPC(K:8C[Q!XE91\
MK,Y#B>;WKCYZL;]&=5_[NT,"-X/%;*EON.^I7([=W))5&=Z3N>B-,S@JQR.*
M"5>!`X];A'`N[KP"DIRL=F89]/!=BR6W@N]4B\[<*?8NT8F(8LRR<X!R4X:3
M1WW3K_AM&8"GBF"/U"#FO_K],PQ@Y.WPD+)Y]0,?!\;!:VO%]C%R2O4=\.^I
M7?(4![=H5=KWY,Z[93ZQW\SSB&+"S'/@<;.TQ*K74^='2C7Q7<^9)2OX3C7S
MS)UBOYGG$<68F><`59">^.^UU+SGF(JE4,02/,?U@P,::U9HL"`3@O@CQ$N`
MQ8%7&/_B!Z1#\Q,M"&^]E#2"VB\P>0G1EWPY$9^*FTWU!4HP*(GL\:M3-GE5
MH0TB*<A[!J_8G*I93`RL)Y+-K9U$07E`634HZP9IY95;(3`&>?V@.$*'1_I&
M@5F`T10&J.`X`X.H)5CTOPPB4Y.?W"#:'S?[5,W"X7G)!>0^D8#NYWQJ_I3:
M/;^X-`2%S%;Q9$,13'@T=72[7(U*55@#!DF:BMO(5#:VO=>#>$0PYR%TXG"_
M?K[\>GW[F+[T07OSX^$1_>>7F\^/#V#U":SN;[Y</MZB!,+QOUOO+&@BMHGK
M%BU,KJ4NFOT,UDZ[H)MA;FO]Y?4+H26ATGZGVI&7AGIQ,M;WD$);M;)\9!:F
M3DQZMJ*9E_8O<S+)8(:J_4#<,E$^V\F3J6:OEI7,4[&7NG;9W^#G8%\99#"V
M6LF"IC2[J6?+QUOD'9<N]<`9S>>.MLERK2XYAO;!KM*REC9ON<49O'G0#MS8
MI*T50C&MXJ1;&(3I?"]X3@LN/+;10N,YEM9Z)6G((4Z-DFWYRB:V?S+%)H2)
MD9X)B5M-E0_V0IXJ0Z_KL9\G(S'=KO:WNOT1JMF$,&=O6>!DC]>%Y/IIMISU
M8W;EG3.@4VM]Q9+0>#+5]UY2;_6:F-TN'1/!C]=K%F<0N)I/F)-:;1JB+NLM
MO.#%S@\MDS=KV$^=S7%TSQFXTES"&)O?<<'*X@T<&WS.Q_%6>7U936CV-![.
M],4Y:]0G1VH6^%46-]*7+6K_GF`W>!,VNA.!6WS-+3'G;+"C,[4XT.:X2'68
M.QK3_ME>-WAC#G(GC-PQ+F@)U="R'#"G8WW!>ENK5<S2=FDZR=H<DNR?W;$)
M<1)#2D-",:C"OFU_MVOQ:4]&8JH/V]_J9W!UG$T(8SXK$YP*DW,;+.JG5M?Y
MQ\.%`4]5U28%FPA4OE(6W<_@AGD??*.&EHZA0LS*Z5:%U-3KN!JA9K?S2FM7
M>\/ILL(W[\#2@;CDL#7NJ-R-#0->>N)E@HY%_?%DHN\X37?EDJ3E%:S&W\[,
M91"A,W!JV24Q8G"9X60+6,KVX5CYH,?1M8#H=)^7K3^<,W!\V24QY_TR8VI9
MKN6C^!<80]1H+_@B.GR#NW"/#P,51)B.EK00TFH8WEFW',%YQ:KRNS-OT0%3
M^U?4V`4Q8<:9T;AYRC3$1YE6S(@S4D&+#3\]PZD6G+$K[/=4V`4Q9K^9(94T
M)W$^RK1\]/X:Y+$C*R]IP,A_(_?(T:1K[LST[3#WU"Y'<7[1JB3OR9UUQ6(X
MM__$.X\HQHC.`<J]>D&EX)MQ8.OY$7CS=@?RA,NF2(^^Q4ET$+CK^U?H/[\D
M<'/YAARF9_CY\/H$H]66Q-BI/,!X'`O)F8^7^IX2%P,EIR[*&J*J16*%%IU_
M!@_D*I#0A/LD#]/-BP!9&2`M!*RV66"U2CFR0=9DR:AEM#I'K:2.;;)DL'_(
M4R"AL9%0'FNIFEZFFMFCP*@[-GC87'N[]2&+&X[&S2?E\>'(6L)5^+J/X`OR
M5-&(7"X??X;):OOH?1\X8V>B[PH%"P0%RU[\0M:>>^K-/II8?$^=5PR=(QLG
MEFRYJY8X7]U-'[N\`/C.$%(/E$DG^_7LP%G&_J40^R>SF<VG=;GET+YKQXO(
MK?.?_X(<2V7W:%J&XYVLT0POAM<P_6]Y(F9VXE&@&Y]^+>%M'QX5ZBG;&2T<
M>^=4:H6T8?!A0LHW-(F?N%-'37T[EK\-U:W-NA24BZWWW-[[``HEU#[K4H<U
M4]MU36WS[53R+A/GD<*6H`%Z[G9ICW5`O[1%OZ]O_UY_.W!CZP2M$$BL`X%C
M@AV:P/HF6OD&6F4*,![J6QG7`UK?P*&T(1O':)176A[ULW>T,=@"QLZG:16C
MR[_D?Q:Z\@HTMCLKQ>LE*A3&N'OZ6[4\[0?X-!+6WN5/@RU@]L"@5EG<W+RL
M<_.BXD'F(CCI:IL"1I`H8I1.^U+C)7).,')*+RUY59DY"RMVG<;V7ZF0$<W$
MP"^!CSOX[N.?;[Z@!+_<?[GY,TI]^Y<;<+=Z$`_%>PV?DMLX/GBHKZ[".(D1
M5JS=F^M#Y`?/GU$?>O'+*KKW(OS<</;OB@$9S"<+?4>#I>')::B&ULG7@.6+
M'L]F]KY`KE)$W>N_BG"ZN!R0%P1(22`O"J1E@2PS?L4[*Z[XJ5+@J718TZ.U
MOQ$=GJO7X<ER.+3X9KA:(;6[PDKA(G7>0J*Z6S]`I6'M71.=#L($[#U_`[P8
M;^7\0@YOCQW>2,[E<=D';P=7V_L(W_5)WN^17`E^<(*<`A\X0V=)+F%-1CJT
MDPV%G`J*2YIK&EL)DQ'VJQS+%8I;%@:]6:9Z$\!GY(INQ#2'%Y>+,P`T\T,3
M3[#QXWT8XY@X6]3B:49R,`WF&;F?0*GMV=P&E^MU>`CP<^YKZ+]Y3SO\PN%B
M.M:G&BP8Y!1#5,I<+5CRYQUF]VD<3DD,J00?*C?_"*+BJRSK\T'H"WR#P2$E
M@[[EC][Z5=.]7[QVJA_G7<P7]JYE\(B@>[[#B,/-TX$?\Y1_Q&>0"[\H2ZV-
MXIH>LK"%XHWI1']>?&#!<N^&70@CTP%F.*6['ZFA]7T$\20A+S:/MQILR$+]
M91Q#\H+A<CPRZ<&PH%*M`:(MT:X7+"7FX[+=IR2E93N9)\2'T\V2%U':R.0@
MC2R?;B<E:#J-\\CJW=?@R=_ML'[G/A@B%YI:#DVJ&06$:JUBE+-=B6@%D-XZ
M-R^J2Y"3J4<'*#?_!CS9"4/+D;V%#I;K/VFX."9M/1U9F+,W&$4[8'9/YPU&
M3Z&HKT.M7/#]I'OOG=S!7VT?DG#]]]J*ZL`9S^?Z)J%=5<O1CE.HG(4]V:9#
M>X_8L<+7/>5DP.#F:?`2(DEUM)>F@\!Z_(%3,[@Y^G?FFSJCT<3>%Q.9\1L:
MZUFPN/C9<505'N0A>3L<L1HYRG@3R<]9O19G]6-XN4;%1K"V2(^<[\IN"F+#
M4C_'^Y&H8;R8Q,?\[R\EG;(@H<]"'[CD,:P?/-C<>U3H"UYK5+1_5"KIIWSW
M-C>2B\G$A.FOUZO*[/=+@RG?FGXT'XYG]KHKO;@-4+@/0^NY`.XGP:Z\^*6H
MXW*=^&^H'XK3GM.%0WT#9.\3\HV'XXQZZ(?>TB2G:_Q8,0M9@)77G^QU0+CE
MT.E-\X+![]D!G!H4R4&>7N8].T9"S,^(O'-Q\MIK4KGET+XMPXO(S0](EO;6
M2Y/[O`\NL7/!&9T1<9V1.'/M#0'&+0<[<S?AFH28])K'2Y62=ZK'_"*'>@WA
M)OZ$N))//U?;J_#U-0S(G!0YV7_UH@BYVS%A"2U,"Y71/"5+NK1R,N1$YRFF
MB+H[MG<+74HFW7Z'*#`WSPAPSG)9;[4%:>9LO0_?4,WSF]`(%N?$=HUH."UB
MG63O<H>43$:<&5%TI5J09WB*=<%PBV.18+6(B5K@99!O!M6"R?>Q72^:/I%0
M-XWLW6^4DLF4KR0*\$@W\!'S5OT(HW9]&:A0F+LP>'Z$T2N^6W)$M@EM'Y1#
M85J*UJ$Q[%)T:TQ+.:5ELWLE1URHT[A7#,@Z_"N<&^#L@-Q.5.UA]7)*W,6R
M23,8G:S>KK)[F4A<J!.Z60SP.ORL'<K](<'JL4'YC6B$A'=EDTJP^E>]_6/W
M`I2X4*?UL!@0'JG%;44MCD8-3WC4*`/*Q(_A%XB[Q-_!VD&UQQ`OCR$L;_X&
M;CZ^?XWAYC8H7B^]+)9ZRS@H&M]FU@%83C^--&$UDHR."G/>3<_@-4CM\NOT
M(TT)X58J`(\A**H@L>2J,>G01[+^G5<$/KX#7!5*!,HWLLO:A%?%=2J*EJMH
MOR];0PU!IY>F]BYJ&I-?NV=N2I*:P4E"?&,B,SC%DS?H5_PWV2O.'\PI'X`N
M]XPYHSECT#BB%_H//KGVYNTPALOD"GE$[ZCDO^!7[`:SZ93$KB@-O$I3P81!
M3O=%Q:RJ,U,91:^.[5U;%1>(7>'V)#CY0^)%B;C:<0-TR6",/7JB)[#,=`&\
M!#S!9S\(L+[@@Y@$H59M<7X?VN(HT!;[PZGR"\2K+3>!P(E.87@]N@+Q#5:5
M6D)_K@"Q:+'4-N'E0:)#95AE[E<<>DE%?T[L#98H+9>)&:4HN%2)\,8#^:.2
M%Z2901%G),]N0)>TO-UFN2XMU>F2O4$5I.7BF#&)/?4FB["(RQ.G+X*V#%&\
M,4332PWI;.W1^Y[%<_@(`[CUD\%\-J)=1E`5(;2S<CE5X9:LJAT]F?-NF5E\
MHE!$%!/C"0>>\LI-MK"(7T_+DH,LO1ZZ:PJ(:P'=J<MQS'UB_\H:CRC&%LDX
M0)6<SUXB2Q#G\^`YO&3?1W#M>]E[#Y>O893X_R3_'"R&Z?U!37:]M6)9DG-(
M5"=X:\:R\>UW;EC%,&/'F;"XU71D.E!-J9[06D+@G)30"V%"VWL@CU<,=D(+
M1]+AA%3G-7;$O4K*W&+S\?MFNX7K9+6]^;Y^0?#@%R^!JX`^7Q@LYHX^"\Z#
M1$X#Y&2NJ@1/245/+NS?BQ"6R\0H(`K.33/BHZIY5H#S@E5V;8ZV<&1`F[0X
M_I9K$W5*(-2Q%L>HE9;+V&1!%&&F4B2.%LQU*D*98QRL'R\3Z7VG0LM`9.,S
M%=31AZV0O+_F9["2*B"1B1&''U;Z8`4YE(9&%YP+#SMY/D`R@B*GJO<J[KWW
M_!D'C<\I]]8OIQHBXE6UHC=_T4]S^Q6"3Q@3NL"%R&WLM^&CF,7;%5D.;?0W
M%-7_5/2G.E$<_6/O=0@Q88RY2URPRJ=:]FKI3GNWQ[#!/\WC1)QFORRB[!;[
MEZFXY3FM\:>#ZK'_7Y2]782*C`YP<^=[3_XN/=B;O0Y0G/FM?$-40III5E\X
MX&G0);G&Z=4SCN)+>MA[0U6+K"?33T'`K;J+RP.53&3=C!19N613^7XJW3;G
M_9VA;K/[CD+TL?\`L5)93^MY"J)V<UVFO).S4Z>^!8PK;^\GWJZXK#6:.?H6
M\=AQJ-9(=GF[5:^MG+(+[=]'$I3J-$,E"S3ZH%@.>UE6X8NE`G0R-,Q9HSZ,
M(U=O;R[LWS@2E.J$HQ$+/O>*[!/%1W<FR8ML9`BJ##Z<]R=E'P0T-!39_S(B
MXQC%4FC9]?:?Y%0@X6G&+EZ8]'$L?SBQ.`^:'WPN9WB7^A].-*2$IWXWD5'%
M*&64'6GO\XGB`IU&@7I0T?6E>%RQDHM7-=`0#./D'JD=(L5XHG,8*JN2)7HG
MZ#J?RZ1E>Y[#RE\+;C/LI%?NYA\`_J*":)KF#GJ)UC(!H+79.2Q#M>`VZ,33
M$:27:8D_L`TCY*RGR;@?C:4%8CE^SX`L38[FU`BWREZ4900B1UDI@:N$9B^H
M>`-B:K]=%93*A-45@T;>O&T-.M9XB(/_&1D!/FFY<&ZS`E%OFXOTI_WCA:!4
M'*.)W$US,7Q$B\BM\A]Q-*T_XG<94V5Z>E?Q%A,SJ&*U<3R>Z3L@P(_'E$ZU
MRR^F6HUWBJ;V;UI(2F?76$6#R#]FB;_>)\X\+7.3,](\ZC1'HN-G]N]W2$IG
M;,HDA]/]I&M`NPW>T`RMX211WW;5JD\4(%KTB$U@!@6B%%1VF?W[%H)2G7"H
MZH'6/405F55/JSKY9'):984"\4RK.OO3_FT*0:E./:WJP5=.JXKY5#:_0M,J
MOU`B_:-0Q;E9&)]6=>`QI5/M\HNI5M.ML#_BI*1T=HU5-(C\8Y;J:14+\TQ.
MJVS4/)YI%5/'VW^)5%*Z4T^K&'&ZM[H&-,JS`=A)FM.>NM:J3Q0@6O2(36`&
M!:(45':9_==/!:4ZX5#5`ZU[B*(]D:-?@4Q.JZQ0()YI56=_VG^)55"J4T^K
M>O!1IE5H/D5[_D67]E2]&GUW:/CQF%*F=OG%=*KI3YSM40I6Z>P:I&@0^0<K
MU?,I%N:9G$_9J'D\\RFFCC_;,QBLTIUZ/L6(TUVI&-#*)]F(`Z1U)ZJL2UH;
M.F$?,;U,6S;?69QR:`%N:&2@U^X>O>G)^4ZVYR."_X<?;/)3K0-G/%WJ8UVS
M0CGJ,0E0Y5\S0_'N\AF\2=F#W@03NR&X^#-V-W`"<"MT!KJK3[5X#R9)21W^
MN]K4_KW`'O3&AN]N'.[G,/A`)J'YR7RQ`.#WWCMYZ'2U+8ZE7(4QO@LZ7FA\
MKZ&M6EFF,@M3YRL]6]G>]F^O,<E@QJ#V`W'S1#@J:GD<BJ03H^]C>+G^Q\&/
M8"TVZV6PJ033'<_G^AXW9`>BAN)"`M-(WU]0V7/V[W4)2F52,?B@E:KR&((L
MXW$@87P]6S"8,"II#>$F_H0(EM?T*8S(96_JG8O)>*8OTB0G&DE-DA:]IDY\
MI15=?`9O[<J(9D2QQ/&Y>5Z`,X-"UU#V+."!_!4N89[IF1R<A8K1IQ6B_6S_
M:HR,:.8F).(@79)(7&^^P'WA5M[Y`43_N8K@QD=.SF0RTA<T@0F#.AWA$;--
M,UK+*/IC8O]-$'Z!3`\T3*B.AI<R#Y[WD%SXCS2?5N70/I38H1R]PP9#KYW!
MJBFW0"<9(IB@D?7^'Z,\*0BWY/)OJC28!R"";^'N#3M@:Y(;>,\1A'(SG2JT
M+S!.(G^=0/+048M7LM!WUD\8EQ[-$FD.%FWK+;=DQ1DL$2L1\I1#%A?2SF&L
M+"D]K*%VPB1(3:/CG?V:RC4N<E#C#);%E0AY\O&3"VX68!7'5XU*Y21[11$D
M"XBO_$];5I%17D&K+SQ/IL.YD0&S!XDZQ>,7N4W5>DHJ._(,%ML%Q3(]\'%@
M.QKJ6E[N4[3@SDPJ[<.9?7K4.V0Q=ZK]]TQ$Q3K)L,0!L%0F,I-+7B"(L4*%
M6SS'2Q4*!_R&8JKT\.)%\*,7HT$Q?,5''])'[)W92./!!7JE<@K"+$A5%^B9
MBN9?VG\[A$$"$R-%/PR7)`$D#:@F4LM7+5;^%'REVNZ^9K;_Q@6#!,8L<C^6
ME+0?G@AIUY5$8N?$'A(O(?.&U99,07;AM_(RP&0YU1?6H:MF21YSR50C<T?.
MK!,6PY']6_O,<A@QQ(Q@W*^?+[]>WS[>7(.KU>?KF\\/Z5\/J[O;ZTO\\\,C
M^L\O-Y\?'\#J$[BZ?/@S^'2W^NN#\`6AA\-^OR/8O%V.[3;8AM$K4:F"--/A
M1-_I&$80DCHA*FE-/=@**3IU:O]<5T0D(TK#C\NMYLD6;5$N4,EF3%'T^#PV
M*@K=*>+M/?LGLR(BF7.;^,'5M67CQ^M=&!\B,HLE:ZI;K#M^60B?PJRB9R_P
M_TER7H5!'.[\38HEV-PCJ7"U^)_%<6IO5XR3E=N8TYF^*:\2B'+*IJF5L"JB
M.A45/YH/)Q;?%%`OJ,[Q33E:MUH:67;Z>(CQL03Q:^-2^*X+2_((OR<?47E_
M'SAC9Z3OI(%JN"=4:;;&JXZTJJLK+JTN[=5X([*;<')U"E"W"[72R3Y/M?S*
M=27D"Y15@+(.\"NN!9!JK#$G6KSLWXLYH3KN^AAI_U18J^S&I@(ZI6CW-?@L
MPN5Z'1X"'(/C'L%;U^*O:`RDVUZMG(YRB)-[YAU9L%\WMW<^S(A>MP_=#P%-
M<%]?O>@=3V@?_.?`W_IK<LBAR`GRK.++0F6Y34`5FSN;:+Q=R`9"<E5(5-#:
MJA!3(>62N/T'9@4D,K)XR@W+[=408?>/ESIZEDXMU!'ZRBEGU]D_2Q.0R-RZ
M*3<VCE&%3TT^>7[T%V]W@*4/5@YISG*J+]A35\UR&L$G4^X;=>8B@[N]%U^9
M\>OVCUA`N#@1(*G`+]##:=)IOZ@[1*NT-'Q+-(LP2F)%=IU3JJHU[\Q:O$H\
MLO]N'KL@)OP;9C15AE?22G@S;&30XL.<G.)4AX6Q+^SWY=D%,>:>,$-JL^1\
MW+X*7U_])-UE"C97(7%G8(!]F1)`.7X/1_J6:KB@R'%?4NK<:^$K!H_`"WOC
M%8@+I-NO$4+E5G*19<M:/F%WAPE+:49GB[&^35`^+`8TID/NZO#!5U9N\Z9G
M$,A>0C(3/I0XO)HV73:T2<F>H2#%M/A=9Z!:5,],M(?M/]XM(9DQWTT<8_=H
MQ7N]`17^$NY0=\;X+EOR_CE,RO%QLM08`:2[;MDK#GQRY5Y:3S[B+]@[&^>0
M0+<?Q@;#K2;[`T@3BN^V4>ND'G*8S>8:-]Q8<>C@.)NX]4L]C.44Z]QG$`!#
M3"@CFV\BR&J*DNL)SJ?&G1*@DIYM.&LUA[X9Q]^5]A]S$A/*W):<"#SJ.,-Y
M)FFS\=.^*<Y%56Y0T+@SG8WT/7;!#4?R").\]%AQ^(N9+(?#I;T>E[A`VA5&
M&)I;AC)[C+P@QL]@A0'O$3YAPN@YVG<NZM(\"<A=U&QN[PQ=0B+=,Q8Q6&Z9
MK7)$OGJE5(F#=@V?$MINPVBA;QI#KU-.,5CER-G?DIY,'^W=,F1`KIO-W=6W
MF'B9G8Y]!%]@$/MO,'W&CIQR>D__MZ(R2T??P[VL**278`5EK6P%LI4P6HSL
MG2\(2&)@\X\#CEM+GKV^>)$>SWL'OV;_E=FBX..)KLT)&W5B+JP3Q$FUV_1S
MRZ)]+B""ZD@]\*ND9+?A<KT^O!YV'@ZNFKX50],C/EWY.0PWW_S=[I(\^H?0
M^T\[>!G',(GS3RG*@3,<C_2=$F3&(:<N,N+F"L->AM4OP8B(HGL8X<3CYC\2
M]2AS@#3+!<B_JQM;!`BD972Q5U\:`PQ[&<3^V;O#(2:,D2&&&U:A.GST_\7[
M6QA='>($#3113!_%G-%DJ._92P8$<I07$S$G.U-N9^38&RR54PK=0P([%)<D
M!45:=4:?BQ):S+U=K&^8>);<9`'$[O51'C&,F'4.0+5[HD66?-Z`;\#%X`M<
M0__-0T,#'_\_PV^52WA1&*`_U^DY]C:FS#5&"^"%(Z<9"H3/U82_*&>QL-L?
M$A5)][`AB,M%^6HW1FLYU8THXJ32,KR<BT8U!A[NHHBUM#N&A[!,1H8D470N
M'GR.KF/7<O,IT$<O]F/\*D09-P?-?1@O^L^&&D<G&61R>J6V3:K'K61*+@Y0
MC^R=\RB74^?PIAJL2PI*'QVJ1)[#]T?TQ1Y1PE4M8^&9ZR_UN*0:JMA_LTN9
MG-J'4M6(,R4.ZTK,N6_JQ2_X1@SZ#SZG^>;MRE&]0K3I7-]I,28(DCNF8E+6
M[F^Q%%'TSAF\!\8OD(D!CAN52YX6(!<?\1^53,7$3?Q0`1=M])PHL$TYZ)<;
M^7K-?J>07R!CHP<WM%1#/(J&\)^*/&;%?*+Q%3Q*A?+G(7LEJ/*:DB%OV=D9
M3&WZX)LPZ#T87/Q=WE)W]:P6NVR4FU2;V]FP]KOM??"-V=,>(.X7^!;NWO`4
M^,X/R(,L5Q'<^`FQJ(\P>@5WH<?I==]X48!*C.]A1![0.^[XQ7RHSZSV5"Y'
M8V[)JI3NR5QTR\)^>O.(8L(,<^!Q\[0`)0;IJZ32!IJ5%UJ,M16,IQIQYFZQ
M=Q-=1!1CQIT#%%E-61.K?NWO#OC`[6>8I"=Q"T7@#$\81M!_#JX.400#5&WE
M\@?RX,D_=V3-IC';<H9#9Z@O/*<H+CE-4=D<M:"'HN460?LF]AYQ5RNDB:%&
M"5(W*P7DQ=2O3N'UGFI)\@.4`G+JB3-ZMKI*#U`J3PY[#\>H%=+8(*D$;HO"
M[@3V)-([+8_>]R:UYAHCK[=5*Z=(',)4]:0M6]'D<_N'+"893(Q(+$#<-!%`
MJ>0'D_Y.US)6G(K!5$O?W^CV&W(F&8S9:18T%1KS1B?\`M]@<(!?X#I\#DB4
MA4:'3Z>.OD-4O?7+T5A$O"J?>_/GW;`\@YB=?,*8L-%<B-PL-:@DE[?:'`S1
M8K[M40"J0>?H(7MOP(H)8\S$<\&B:0%G)$*\IO71B^$&WRJ'R.TGCU'NLR-)
M:"R!0>*_P7L$.'/^!\YLK#.:)S\B.:U0TP2U.(7\)1;1\QQ[7R%0)9Z)P402
MHYMN>I`"0+4$D!9!EI^*0@`I)1M^#.J?GIB@9Z5_]#BA,IUO;_!#5>(9&\LD
M@:9*^*&IA'PJ]C6&J^U-G/BO7@+C@3,?C?5MK=<KDU.,7N!5SM<3%\TXMW^C
MO`.YB9&BO7H7?<(7)(J/:GBGQ6J;X!W5UK8UG_TSX`[DQBQD.P9"OE"8?`_K
M%[@Y['#IK_M=^`[A`XS>_#6DV^3+'2$)ML[;;"[Q3[BYAZC?4+HXJ;Z7.UW,
M]`7ZT(9;TD<QV)PU3T97O<4LTN+'6\TV@I%9B0E)W+P6,G9E]8"L(M`ZL2DK
MP_G*ZD!:'R`5RKQYH%^%],R'?K<6B3ZWTDYAB]]A--L(YN9I)L0IS1)^JIW,
M[)Z:5NCF._Z;]Y1=_B[K;;`_)/&=[SWY.S_Q8?R?!P_-,/&U2!R#LP@2_HBC
MX92,7XZF^J(D2X*3/,2CNF4:C\(+%CP;C^U=:%$GH$ZG0AG*ZFO%:3D7H%+2
M!:B658NU_RLI3CP@CBIZZGW?^YP5MQ$[1[9@$DG2WKO-*D74/OXJ!%L;75OU
MU7L*#PFX@V^HV<9`R2/E!?X*\JRTS2I`[L$ABOS@F00J^!J$3S'R++`$1%SL
M/01KE"N5K&0ODDK_@*P0L2)EU]J&#0N@LK;9;&KO<43-4AL;Y)5#KXS\M2$_
MMP<;@(Q&40$@-5R`:AVIPP#JM:CS"W0HA%YGX?=A5-K="I6UD;'-[A=9M,IM
MU@'1(('[<'A]]:)W<F?Z!=6.3(L?5!T/]"%W1RKUBZXL%K*D0=`O@PV#4$<.
ME3.=._I>O%"*5=4*HIYF*][X5EO/;&KQ_1]M\NKV,72`KLU)JIY&6C*Y:,OH
M=$A[%)K(KGG'X;=J(QKN@]IZT.CC.';[#7H$-N(P:(%>LQ54H^`E%1LBJOS7
M,/+?R+I(I8[+I!"D25B=)YT%8:E2:>G&H.\+\A5;[ES;.ZHKE='L.0-QH+5C
M!&4Q->6\K.HD2(=H%2<$1)FI>3@^+S7MV;X798:]XZI2&4^P^2Z.MCK/KBCD
MGWT8H:9[>0?;,*H\ETWWO\65]2EI<G"F;P&_JVIU2L<@5--[I66;32W?+V.!
M;V[^V8JAYB*2H)'J)H5=W:U]4#D%ASMF8,UL\\%D-IM/[3V7Q2Z`X1E2!Q2W
MB!QY0<*,Y:3&K\CCV.^B5/[%2PX1,>BK[5T8/.-J6IA@8IF3#8XJR@L+WU0#
MUJ)FL^&YF'<^D<R9?"Y<M6&@S$G6#5#>#PE6*\7#`R^M-`\9=NM4Q]#"6!2V
MD!-[+Q!)R61X`.)#Y]Y'/IHB[-$<X=Y[)Z>!P"H`CR]0-,XQ/5;]Y7<_'BSF
M(\,OBN!JY;2"0YR<_1U91B/+AXY>[+K'B#X`[2\;@%]Q*N[X+W$2^>L$;N@5
MTW_]!;X^P6@PF3CZUHIED,E17FV;Y%HA5:J#IH/VOKV@2CS=NJ4`8Y?Z78>O
MGA_PNEST"R=1A,^.X/'HXWN9)!NB+K]YT28-*A#_C!(F\6V07D;Y.0KC&+F-
MH[F^F&4:$$LZ;D::L/#M=-0VG]CN_>F36ONL2QMTM_525Z5T\/1>N_R5U0!(
M%1=9=)WX`J35X,-B:47X%U251=;$8/"=WZHU:<X4-=0VF<W'%D=!T2VVF?FF
M/@&R2%QI#\7@&:=$=B,)`<SNJG(:A6-_)IT@OZ=5#Z:+X9(6'6CO$YT=#\>9
MQJ(?NHN2GVCRH,0:U`NI?!/.WN&53PB=HR47$K?A`.=ILP%,"TGG9T'2N2!)
M[8U,PB>$=A/,!2=EZLY':3>8GJ\Y3_?Z>.J,SH*H)4Q.IMKK7O`)P<[43;@^
MO.8/3NLBZ[QI5B_D[.I=3ON*;Y(O:4P7SH@6V(I*UHZ"Y*C*AS#G:4>NO#D7
M8WOW[WE$T#WD,^)PBW35Z6T,?DV3<JY[,?4ZRVA_6EXV1GJFQK0W$`B/"$9&
M>48P)R`GTQ!_6G8VAW>6YAS9[8:RBF!J:&?$HY:APNL/U1LLA]=TC>$R"`[>
M[E,8;:&/7`WXQ4L@)M&$=ER*2G/M<$ZTIB?16KG&::^[.!:]M%MOS3:$;J?)
MJ#3MP?FK&PT?WVNQ+FL;#=5#\I6*05HS**L&N&YK;1&+0_@O6]1H+=.V:#$<
MVCWU,ML01AQEHR+5=C[758.T+?+$(++9E#"Y[_^R)<WF.H%C8_?FC=F&,#6M
M,2I5YN`PGJ0`U),4=`_G0HV+XS\'_M9?>TC&-;FLX@?/Y/T6'\9W?@!O$_@:
M$VUA7E!E*U/20(CB+I2<J8#R#1N[]P4$I-$^C^"&Y%:R@#(/R#.!7W$V0/+Q
MKBIPTH5M#+60YY31C+,?[#V-*RB-L7&%&YI%A&>:?UK(]^9,D+,7+/?`^*4Q
M,R?CQG4JKI/;49@O4UH4`WZ>D_(T<KP-+Q._2>:BU4>6+U7P27)2?Z4!IY_.
M)(M&)DM;;,-,YK/41PUN][XRIR2GM]`-3*>GL[S';9C/G)YVO<D=RW>T^"2Q
MPL-NP-+#Z4M4R,;?'7!LIP<<#9'<R+[YOMX=-G#S"5$)K_(<DNQ1I1LO"E"E
M\3V,R`K/Y2N&@5FD[YDB)1#E%$E3*U7#GRFIHCB@:/&T5Y_`.ETJ;:C=:HF@
M+!+D90)<**B42AY/S,K%1TVSM=:TZ%-JOY9[9[\Y[:<&/U1,*WM7=_4)K-T-
MU0:=F(`/A0V(2QL`<QN`R4CV;W,;$&X!S&W`'MF`&!?->4,BC!/\3*+_^G2(
M8NP[9$\<#N:.QG>46ZN5O$C!+DU5\5JS%1VTM/?U(#XA3`R/3$A<G"I]RK=,
M)_:^9G^O:QF43L9AZN#!T.CV1[!F$\*8D6>"DQ(YRA*E=W_#[3:&^,<8X@"W
M)`3)!K\C$^[))CA,B^&\&LST^NWG,'B#<0(W9*,]?@P3;U?]CM%^#I/_@DGY
M-NY@L1CIBX>K#;:<GAELS:J>:JLVY^3,XG"^9AO!Q%AG1!(WKP5DU=2.#M=.
MX!15I0=M8D`JJZ<A!@O5!U"%H*S1-F.D9=#^W1HCJM-@@+WVKT&9:01C3HL1
M<=RO051\2.>=M//%F9^#'*&=EX5%.>3VR2,U6V)TTLO:G\(H^PFG<Y#N:`R9
M:%862\T38[L;L5E4+"7I[5]..V'+G+6KU2N>&?\KBQB!SSZ#"A+@G(6-/"]O
M[;=C(\WZ=3VJ8N_!0PM:YOP]P%X9E;F%),DZ^_:$4Q:E^@%(7J!0.*C;`,&`
MC][W;!GO(PS@UD\&SG"V6&AS]%IJE;,V[*)4[4)+KKP+YW-[3U?RB&#"&V'`
MX:9I`$J4;VR`+)EBWFH9?$_#6^IXUMO8]IZEY!'!V`C!`"8G;X+("T5VY3X?
M<*24U7:%++6'#ZD]P&<21&7@C)8:WW9JK5>.N#SB5*G;FJ\(-[.P?[V>30@3
M9I<)B9NFPKO+13J0)U3.8BW&]W0LIAI@AF:W?Z&730AC1I@)3D[E<`O"@LIQ
MFI#SF-^.D`5NZ/.!_)#!=#ZB!9A6=(Z/"8/D03U!.6LG\9C**(]OV7\Z2$`B
M(R=IN6&Y19;V13BA4T2<O-%SSM4^_:"?5.7L-OM/'@E(9.ZL*3<V-UUU[EN`
MT;"PG&$EAUZ/%X[PDE+EOK,S=TY\Z(@=K(&E89F6XU[[9:^L7-ZS?XZM4W1K
M=KC$\'-L8945I,=SC_>G2"425]MU:</I=J#.W8Z([R&)D-%^9UFGZ';M`HD)
MT6),*&^K752M26BO-?D"]V&48!#INY!8-?0]RJ@'LPVVI;\=U9N8XSI+IMH_
M[3#0`N?CN'2)H=Q_22L#Q.Z(/0:K66,L=F?.RO)H=&[:"3OYW5N>R=FY.EVR
M*/=X+A08H)]A`"-O=QEL+C>O?N#'"=X?>,LOJ67OBXS&4WT+^DP0Y,R#H)15
M;6<JHMC\MOBY-'&!3'@!W*C<+`=`64`]3W%@1NS%%3[2:!EJK5,-ZD#(V6?V
M'_#D%\C8,,4-K=`/3[5^?,EN)B,LU^6]Y#IO)N.%HVW@8``@IQM"$E8U@Z&`
M(BCZS/YSD[SBF!@P.#&Y>7HR7E1R&%0&+4.%5<I`'2:X>LK^C2)><8P-$9S`
M2HWPCC1"\*&Z]0O<''9PM54SI?KX7DZJ+K_[\6`R<_2=_-2-7DX'S;=M58%U
MUUZP<F[_:5:C;6%B'#4ID)M71B(0*EZ4_?A>7Q;!E=MJPK1X`O\R8>UGD,VQ
MW/ZCS$;;PICW8U*JTHZ%;79,9G7WR3Y+EL;Z1BJF[ZJC%LAVV:R65M1IJ*I1
MP!%W[5^>UM\`Y^A5-:30ZDJ)/6Z@55G.PF.RWN08\8V.N&K_LK_^!CA;+Z@A
MBE;71\SP%,^0WOG>D[\C@:]_@5Y\B.!F%7S!P;`C/WA&POOQUR!\BA%87,UM
ML#^0`!7!&N4BV.Z*XZVCX5A?!&L=B.7,CIDVQ%8'0=!3VVQF\?*19JEUNC1Z
MH;OE8[X7H%(ZR(L'R&(4%0!2PP6HU@%():!>B\2A8(6RIH/O:#C1=XA&-5IK
MS$A+VVDP(6E-L]G2WC>H-$I\1J:C`EN;V;#.`=$R\?F=.2#S8^NALQT&X]ER
M,K/W^H`Q^;5/>DQ)8I^/<HTF36_D+-<G/_!0D=[N-HB3B+PE&%<@%LUR[<?K
M78C1#A;.<*3-'Y%!)F=!U+9)=8%$IN3B(/C8_J5797*:6&%5!=8M"P)%2:!2
M5$WC2TL`RN).H+O.\%_*V]$HZK77WKF!<CG9M3>-H_J0>%$BOF2I"K?[$3[[
M09".P*BV]4GTTOF77G8TBGJ]M']W09F<O'IY$VQ.K96+'UR$0E@E<41H;X>W
M"7[V_.`NC.-54`(C,2AFA&$+'5K74[N<8O&+5M6=GMS%J]]G<!J)1Q1V#7B#
MT5,HLY'&`<LMTP*<.`8_XO0P_B/G!CK>/+N/_#4<H+Y?ZELS+BN2W*ON`IPO
MM503S2>6;]$TP>I>'FW4Z*9G-\A/\OS1<VQ"(W\:2W651)/ET!G:>T&D!:V1
M9;!FO>X5&HQ)P-<D7/\=M]0:7HB^],P\6DU&O]V1N)0MYV9?5C1`.`M[9XX\
M(C"P>)FR.(#/.-ZD&(\9X;A7+R@WQ.]Y;/&*S!M9D0FW8%,NYOBENRHZ$:RM
M)9.+;E,TIZ'%=MK[A+SCX3BC+OJAJR!5LS(6A)BM/7`*CWUBKWGE$4'GJ,V!
MH[JV6%U%%+M@Q]3K<^MY.1?BI;V!_WA$T.X+<(`Y`3F=D?7L=$9"]+3W#C^/
M".STW(1K,K22C4P]#!TJ9FBQ4)7MVF8+6?E>+V(`]7HQE:/=92DZ"<&*,R=J
M=\8B-LC8WBDXIQ2Z1WEV*)43`J":6,4QQ!X:,-E4&_C:M*RL[6MO0#Q.*4S9
M5W9()R0NBZ=J`V\;_BIKZ]J[]LXIA1&OE1V/*<ZFQTTQ#VB77MGYJO)<-0N^
M3I[6+O3,+=X^Y9#@)'Y``T8[+:7.%'?TN+`%-<1(-LMYU)#V+I=R2'`ZB]G`
M8IZ6XAZI(5XR>J)'36GO^4T."4[J@3;@J.7FU<Z+X]7VKUX4>4&RBK[XSR_)
MZI#$B4?.H`QF\ZF^`&)]M<O1FE^VZG&1OMS%\U]3>ZVOD"PZ/0,10"Y)C$,O
M9,G!*@(D`ZCDT$1[+6<!+*$]-;`!<\^<00A6+EFTNQ\BJ-PL50R2$.Q1X2]>
M#/'3@J]AD!Y2$'1%/KX7?_[9AQ$.:?E^A\-9DK!@SD+C22HV#(H\&DXYJYK`
M5D8Q-#OV^CH2$ID8#/AA57V@C^_5"R9%/D`R"L4!XR2/WLNF]B@)=;C@[3M[
MUTXD)#(V=/!CJUW#+)5#4BWRC<5W,I;E+-$W3^BL6ID2L$C5POUFUK(3[)\>
ML`MB>#CH1G,T"A2)03IAT,=QW1;_-!SOL^\=G3&R?R[`+L@IK'DW)%<IM<FU
M^IB,%N/\Q9KA2-_M]HZ*%=&:12(JJ9L9RV:W=R>25PRC1KL;2]5DIRDS/WTL
M>T"I@P-ZS?4I6-UMJKNZX(PFJ3UBF#?3W8!JGG::]$(5N>7CLQP/,?F;G<O1
M641LI,-7I&CF6I>JKKJJ+S>-SL@[,](81@=$$Q)5AU5JK*55(]820Z@EVIQ*
MZ-U4<YIF>^"W\[9CW6Z'?J+;>\_J-(UAW@4R(5;5F#TI-T'5(Q/--=2"\&,#
MBYDL4#0<[&&7FJKF+$65W6GO%31YP8RZ$;SH6H\)43?+3"J5WC':5J7J'COY
M>M?>.*GR@ID?TW@AUB;ZU<P72G6K&4&*K-:/G/%8W]!$KU127U@EJ6D&/5/Y
M6/<9S&D91#`RA/3C<&E!/,5V&7HZ6X_Q/P5MZ0:]KZW/8`K#(((Y(]T/1AUW
M'R,OB+<(\&6P21_G07.:U986R^\1"1'3/V7C_M31^("%2J1R6J*WS:JJI;*F
M(A+=S/[#&=KD-C'VZ`+O%@4#5#(HBL:GQ.D!J4GQ[9_%G#0M[-<R1/[&+09U
M,-9"OKG]CJ<VN8T-^[HD<%,K$*JU`LS!\+3X`G;$^:,.V<SQ8.U?T.`1Q<3`
MRH'G.-0NP*GQCF`E/1_ALTLI>1BH\40?NVM5R7&Y!W65N+6D15LN[%_,;@=N
M@I2MM>?7F`3/P=![3HN?I)UO5$^EI>'L-XOMP(WY"JT0RKMS8JS[Q?ONOQY>
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MW57X^NHG9"/QFQ=M[LFK7ZASATO:L0HJY5A+E6.A!/8\0A=K$47$$8M/V`K+
MHY/&HJ#<-!/>CJID`V4^0#*"-*=NSK.$1+25\XUPB?S=8>^JGK`\VAU-463N
MP^W/E^`I97^X!>L*^\.GG?^<6GJ/L#]]D1%LP]TN_(8W=_W`3_"6#8Y_!".R
M>Q-[.^UC`E-L1EL5I!FWD;_?[/5BA.5AUQ"YF(XBX/+1X4@_UN7H4-./#R`X
M8+\<IW^'7A3W:PQ.>HG0)V_OT>,O`\[8>27^8(/E0A7!8.W#(F3H<#EC]:5Z
M"I/3%GZDN8[TY"Q#M-G]+@2/&+K])`XL;M41"C:@EEHPSBDK%5B<(3M(VW!]
MF%O8WC5^7C&,.#H<@$[)7"8WQ0[J-IT2YC:V=X&.5PQ3+@@')JWTC8^KOZN\
M&S*D1H_KH7![B:IXS(6YR>7V[$6K6WR>4$@6<VX$&Z`*I6,:I^]$GS_A(PF?
M6V$'L3L<#):VMWLMD5L6PZX&&ZH:N[V3L9O3];"#WEU."$/K6WQU1$@6\^X(
M&S"-%#]$Z1(,W'R",&4&+1I6"YOKN669VXNE)&D]:=%62]O7(CIPZ_<:VBMW
MR4>0?07XLRHBL8WZ9HA$&<W;VL3V]8$.W(9&Z78$;LXCYZ<QB*`7HY;"$;:\
M!'5C`-__$(,MRD(L&?R^AXAYW_PD@''Z^P78[PXQ\`,$#\8)]])L6^\SCM!F
MJ$@;>=M:U/;Y?@=N<R-J.XC,N'D9*3'%.#GU<Q0>]I]0*>6KWZ,AZRAYE%F.
M4/U(<CH=I2RNBT_M'B*[8.L>(3OJ=LDW@#\*'G!N[3F6`=(,AQK#8VN#V#TZ
M=L$V,CAV`'!OWF#T#L9#L/'>8W!`?OP.;#U_=X@@\&.P)K$J%5.,:>0SP['F
MN-?:6'8/>UVP38UZ'1@4&:Q'1!A8Z4/:+<=V-E5R*Z!3-Y8:G2I)BT:9V;T8
MUXG;R,C74GG&)/)5.968!S\#5*(/?]16L?N\7"=N<P-@"P+W-CN0DU\8^\7#
M4ST<BP#BZ'%D)%R5!^%44XY],#3`N9;AD-IT=N^2=>(V.B"V@"AX]YKQ[K7"
MN]P#JQ[`##;`VVS\M%6+7)44,'/EDA?DS/F[=^!MD<X4!\XHY7/..S_#Y#X*
MMW[R!:*"<)V?$*<>O!V,/\)M&,%K/TXB_^E`/H71\4D[S+,Q\T15MC8Y'=$@
M:ZY2LD7G+%I8'*1#N9RZ70Z58%U4&$A+`T5Q`)<'2($@+1%4BT2N<02:=Q!.
MI:`LCM!O14$;CI8Z+M@]9U0JIQ%'3B7B].)#@%1U3XJ,P8]>##9PZP=P@T9-
ML,;KM'ASP,<#[M\.FV<25/B/X"E5WTU5?=$OE$L4IU)?)J?RMZ*_3:=5'4WL
MGEDIE=.44ZP2-!EI4_4%2`G+"Q0:=)G760X3&-][[WBK\?+Y.8+(2X?WD1^L
M_;VW^P+WWCLY`/H:'H*4S,R+65Q%2VJII!2%1O*44_2PQ>&6Y(32[LV*(G-)
M3I!E!45>4&0&16Z09C>B%DS^J/5JT?0TQ?K)<K=26"@S/J0H/+?4AGVA#1Y)
MAL>)<B7&B$:PN7C6JP3%>1/K'\L]-6&AC+EEH@C/<"'S'J*V0`WU#%?;IJRI
MB%_@!KX2TA"RTEX.H*H<7]ER.B<M1ZYS?`7EO;]T[#YX(2&5;@=-')I;9L4+
MA30/+<T.ROQFM(/%1SL'[6AX::*=9>_+WI)2&?'3Q/%5500Y9EZGVX;:$@TW
MB8^G.V0,-*,L3.[;.6A+TX$3[3B[3X)*2&7*A1.'**PQ`5DNB.#.PQ>`0!*"
MY`4B?VT+UPG<@/C%B[B/-U?%*!8+L\/4A'=3$5_LN"1UVL*`D:8:Q]G*_K#[
M&ANS#"9]J"X@1QY397,V2ZR#GKS.T"GHV>GHM+;HR.Z#/\PR&'=BNM#P1&&#
MFPL<:*IBKP4V,75PGMNG.07IN_V5=CNR.'_68QE.X8MT`3KR/$2VX_.;5$@_
ML/,1DR,VM7!J9,V)."DH&2I^<U@GW%X)<F5>+U$%0>74)/5->CKMC[-+<IT!
M3<'OX[2EX;'<Y>X$KMV]Z*K=)5]!^EGP3'!''S)Y#\88U?03VIO&\A7!3N!F
M/((N"&[EJWI6L8W/QFA%&8G;V\;N+<]NX,;&W"X4"JC5$X6?Q6B9?QN@8;RH
MZ<M7JNR^EM4/WH@1ZX51/!8`R\<"-MR/!?1T+9,],\^XIEWK;JZYW>L]_>!-
MV;=>)#GK+N3>J,"O<=9"&GU\_^PEAPBFAQ#3G]_)"U%C9TR+3Z3F^1UV'')\
MEI&W^F8B>SG%^8&IO>964BJ=TQ,Y:"YY;;8>L^OC.TASYI=/LKQ"SYT)\$G+
M:V@6ZP_US5&1[K3WV).D5-K]&#E\QTI4Z(^\PF35I\]W(<9,]#WPUE&Q2I7H
MD:A=!VH9R^:W]U@XKQCF1XE6+.V,%GI(CH4!!JR^84XSV/66#K!W@8-7C!-9
M[E9`#6)?R#&;_IZS%BYK?X6:RM=:TK(E[5W:[0=NC).M$)0_2*WO`6$=#U)3
MB58D*Q8JS\"?I8,V1C!J]1)O4S_`9[PBDXUCD_F"%J!##;EJ5<D1K`=UE62U
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M9V>/JG[Q8IC=UTD/H+^^A@&(DW#]=\X#:`C]9^\UG?Z/%W-'FVM5K4GRE%HG
MYEPG:JF<\7QL[P7/-K@ZG:"6.EW\&\`_"ME^:M=H\6,TTVG>3:?IU)G8ZVZW
MXM7N<[35K(A6^?[-8JYOW:M>EQIJM>$^)E>6#JGBR-YC9NV`3=FK6JU5:@DM
M-[1TDE:KI9%<K98K;S6LD><Q%AXA-FJ]ZG5+DXP$%U]5C]6/:*Y6>SSYE9H3
M_KTX:J'D5\=GT^=3NV_6=:#6:9RZJ\X>P5@)'^5OZS3F!S`TDX?^^`6E+>P=
MU'I0:S<]W?6[E1/2J(>GBGG$_JJ%9B*UO&A!:1-[![`>U.Q,4O":!16"&G/T
M^"VL]-Z8[VFG/*\"%G7AJ#^+DB<LW_6P=P;7@]K(6$:M.G_0Z5NHF#SLCSGI
M)4_+0T[-MK!W+Z('M;FQC%K_T5@V5\PCCA>:]!*I[76F9IO8>T"Z![71L8P*
M0=H</>`E\Y=PAYH_OOG'`37\G1_`VP2^QN2.(/,DK:,@V5U5'H0YUSIR%5M^
M$WM/5?&(H'LP9,3A5M.!-"'X%2<%)*T.8C(9N],RLVD&F=K3[K!5K"*8,I",
M>$Y!41:_[K0,;7A\3*UI[PE!'A&,^(*,8+2S\Q%'2R?]SOQX2TLAJEG9AJR=
MD21'V7KVGMU@A6]^%&]@H!.0)%/-/3&K:()[#-;PJ.'L7HIC@7\B*]@`4B/@
M'_0R4-!U-$%!%I?QJ.WL7HQA@7\Z5[&!134-;P,<,])_@W@3]?$;^OO]_X51
M^`#?8%"NFDR9UY`9"U7`4B'D-=+VEU"VO-V[8R+B&!G4^3"EY`9%)D!V]M-L
M`.<#)*/,<A(/:Y@=`>OX3G<4.#IC>@9S?$YQS#D2?,!<5/$<W(7!,WB$T>LQ
M^PUQG=WEL([L+2X)C^FQ^^",B#A&718^;'0K3[1`@NPKTD=Q_K;MP=MA;2(L
M87YQK*,@!9QF1EBC,3U7:4#.8*V+000CSD@_CHR:64)024ELLP9:,OL8)Z,E
MW9?H:TN[]TU913#G,_2#<7-6DBC](-'#1W8_X&2$;!GO^UKP##94&40P.J[W
MXU%K,`_[_8[<AO5VV=VZ6W*S[C9`!0=PC2OYJY^\8&<9%W\-G\@#N%/F=ZR$
MJI#DM"*I"K*+E%?VF>4KPM+":?<D9!&ZU1)`'MT[+0,YQ:`L!>!B*C-#7))1
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M0]23#3%B>#N&H;1`_*DL$J1EXN?`BC"!>8:84ZU)`$&RT7+E[7TT"W\@P06_
MP!A&;W#S*8P^'?`K''A>[Z&>'LP6"WVQ`KGA2*JNO/0U9>4MKN#`_`R\.RGA
MC"BD#$(WS0W2/<<L/T@+`'D)`!4!TC)`7H@I?=/C-IZ+OM%]3/$./P//4THX
M<_ZH#,Q<Z4C\6A!E63BW3'!U'[T8;E!A>QC$9"G[$@^+SVGTZ_<RR;WWCG^Z
MQ*=<BJ&:X+T\)"^(!/^$FX$S&X_U+0@KQRNY-6.@^6H!WU775VPG#.U?]-,K
MO(DQ5JL$+OD(2%Y0+1]4*L!>;S5=5@D@M53=Y73H+FNRQJSH>=[A=V-6Z.](
MZ..E_:ZY7N&-N1):Q7`S>^#M]U&(7?DM<N5](1]>%<XWS]_AJY7(1?H93^()
MQ6F7(>VR$,>P[3`4#(VIPUX<5UM2SOX9AI$V.">GI$L0+;Y)7B%95R!5VF:)
MK/95SLT2:?5<VLEK;[13HVUP=GY,ES2%.U.8D"0$3S`[.L=G16Y?]YX?812K
M[6V0()0^*O`RCF$2WP8;N/4#/X$['WE--]_7N\/&#YY_#L/--W^W&SC#Z5*?
MSR(#3<X:*&Z4_$T&J6(78XO/@RN23J>_H`:B6Q:!]]?+0D!:R@4HR_E`"@(_
M%D6!O*P_GD)'M8SFYZZCC7=3I(J=S&:SN;T!793)IWTT586TJJYK-&@^0\XM
M\H?#4PS_<4#Y;]X@?CWS*2;W$`=3-!#KFZVWU"I[$8-5EEP96G-,ED/'L7?)
MG0F[[L&F#X!;)@`D!?@U3\(;IN*HID?X/?F(/OP=S3YF2XV[66WUJN5IESAM
M3*WD60P7]DZ"F+";9NHQ@`938_`K3@-((O5DU;/N<#*R-GR,CCSCR7QN;UA#
M-O!&O(->&$W2\A_601-JU-2K;W#S&#YX.S0M?\85?M\C@&CZ?AG?PPC'&O*>
MX6I[^?P<P6<O@3]'81S?1^$:PDW\"3'EQEN_X.SYY'ZPF$YFS('@-`*1/]!C
MKH6P\NBL<3)WQ@M[U^U-B*Y=<0T(X99U@/!;>DD[QM4`#]=S`6!>$_!BL"_J
MPK-Y+Z\-/./J$`'2^@#F/("H1E(43JKB%6XC^L-T*_SW;6+J-\RU<]3>(P4F
M1&>W,>*WTPW(8=3,#/CL2AJZ>;7=PL@/GLF-6L3UZ8S9'#0+D--B-D!8^2@I
M<8-;?/^Q`[$)JK=7[V81O/-O0K=TZ\5G-_]PWRT$R:3B5B(KJ":ALK2DA>R=
M975B-D^J.H`FK81N%-:KN"O>Y\&#,OLC5RVEJ*17)[0FP\KDN+TL?N2O#[9Y
MGC4P-*EV)_HL4+VF+,XS-AE+0:ZIB$?-"JK)LBPM44E[-X4[,9OG5QU`DUQ"
M$:+K5:1/FF!#,13DE8*75A@A-5F5)B7*9^_63A=D\YRJU=^DE,CC*9>;OQWB
MY)6L:8:7FXV?-O6]Y^/`6MDM*Q(;/0VVE9UBO@KC)!Y,9]17SM2LH,L@DZ.T
MVC;)E^&E2IV/[74@U0BG>]=)&J%;*0'/O\LR`"X$AY#+BKG(;O:F)5T4UW<!
M*>P$^JEEA^O,];.Q3293ZGPP=293B_UO=0(:V6Y3`C4?(,-L@+PH[N"`-;\B
M&ED;9@G]_?M>/6\,J[I77V=V#[PFQ-<]-!N0H;J`CBL!CR$@U0!2#R@J`I<Q
M**O"%VB*R@"I#>35`5P?P!62DLJ[-L)1.DAV?(Y@'?E/<//QD'P-TD/VV8_I
MZP1?X!KZ;V0J,%LL%B8"Y'`CD[<DZMJD:BF$2QW-IW8?ZU(@G0D]EX-8BYQS
MD=U_*XL!3X<$Y`5=@%I1H"SK!`JJ.Z+..2IHPP.7*G6R'`Z7]@9;5R:?$?];
M!=)ZP)T/(!+6O^`-1@D^C9^'=O\<)C"^]]Y)=?/A<JEQ#.RL7%:+."4K%:4[
MX]AQ[(VMSBZ`_O&(`85;207(9Y!]OT#_#-:'*(*\=ZE9.U[3J&$!I2FVOSOC
M9#Z<6.^!L8E@R((S@:FQ.T`)P#XG]]J+7]"_?,X;OOC9C=L@3B*RX_'1B_WX
M`<VMO,TJ^(L7^;CL+V@R-9A/''(+:*&#XXP@Y+@N+&G.>=8"G.EP-K$WJ*Z(
M*.PZ@-CY%(IJ`2<L]R[T@E(#_``I((P3$.'9?TPRRBC#E1=%[_C<U&MX")+!
M?#PC*]%+_1I0KUDE[?MDHG/]*)<S<19+NST6)OP<ECU,O)T*3M.1N(^X?"FN
MEN-"^B=>.KN/_#5$@_=XJ6_;EQF&4A;S2-M"Z8XBQM.IW=>T>471[9ESXG%Q
M>E!FN`"5+/D_R-HOR:5;+[2X[=;J1<.59R_"&>-]G=^(9N3"&''ON6&E*K(N
MOE[@IEY#?%<@/?8OHQ2WF:.$?:F;[1:_HO<&RUT4Y`%/]#W(P05%I7)P2TU7
MD+YBQC/GG`8/-G',#B!,F)J#2)X-X'P7H,A9V2`TH34&9L@6:DW/;+FO&&<Q
M'^$+\6/'F<[/:8CA%>PD,VE.D.YML([REU>?PB@*O^$#JV1:?8C3ZVQK;[<^
M[/`O&S]>X\F,*MWZM`O#J`(.C8=#VG!$/6W#7*PN'>E'WZ\@QV7@Q;^)W8NI
M_,*<;DAI070\H-3'$T!R:1A*6@G#$OW!7KKW3#-Z^^-<QX`V84XPS6"`Y>;+
MJO7%TXOT2>TMH7RX!<Y@^G]JYSO3?1A["5^_.R/0&W8?7.07AIWQXO=MA)"Y
MCR]H(AU&)$0W8G>"_KG.UF6!1Q9FT]OU*$GZHGSA`\4@/"1QX@4D8*<7Y]F?
MO!TYJ!R_0)B`3:I"+_[Z!7CK=72`<:E?'OJ_;(?B\/0WY(H1;^H%!P!.K_@G
M_BL)V8O_>P%>PF\0>8*91GIUG>2\^M_>4@^H[>&FYM8O]3WEQXY#EQ;WR]NO
MQ(TRQC/+@W-QRW(Z'XT.J'?.GV;3X*6U$L;`XK%5"L+AUS7*(/;W7!?'6J4Y
ML6?7ALO]Y'^'F[I?)Z4-V66<:U0.WDV8Z8L<VE&Q4KYW2]1"\%JF\71\3OO@
M-/"&;7P3`<6HY_>^KB4Y>U<$C7!&<WVG3ELJ5<G5#DGH/"TSC*<C>Z-`]`,W
MR\^CVAMK0N)!1NKU_.(E^,7N]^OTQ-ED9HB<U7I5\K-;'CI%:WG&LY&]8268
ML)LE:A-`TX[F::3M*+5W#>QS&65KSPY6+8\SGH]&]H:=8T1_DKTH&I*4NGZ%
MNJ\Y=3>2U$UCL#BCQ="0A540HX=)`CI+T\1H[#JG:585M%DK6JG9?5B_P,TA
MC:R)S^"G2W]'1C46"]M3K_5KX+WBY<=_PLUUMGF*K-!,WXLAO=6KY"N3='3V
MTK*.9Y-S<@S:13#+[%8<33>ADA1<*]C,[R*`@>6R$]*[9W&,EG7JC$;S<[HL
MTB7$"9;".N"D3!<[GM(5E)CE'(K)(,D-H]H6]M?NI:H.U+I-9WO5!N(D\]-)
M?YCD'DI5@_[:'42K$[=96M4K-Q4IF9]=BM8OV9'1.797#_AK]V2[#[I9IC7J
M-Q8KF9]M^D,E]_"L&OC7[D-GG;C-,JQ>N8EHR?S,TATLN8=7E>"_Y^1WU6&;
M956M;C7QDC_Y)`XE>4C]$X2K+8ZL@*^-?TQ/;&7[YN08'VW]A<HSQD+EN">.
M/.<C:PGDP(#=:RR\HNCF+2<>EZ0'60:`<N#P@S@/("$,LESYN27-%&<Y6&XG
MQ1OK*US]8/=,A5<4(VLMG*`RGN\SGF]A$9\&A`$@Z^D[S/?LN.Q%_O259L(S
MG2RWD_'-4^5<76+WK(E7%';*RYTHY\0ERGK.T]NWP>:PAIORQOAJ6[E(CM<Z
M;[[O81!#Q)NAQM-YS#CD5$5&W%Q7V,M8.H[=NL(KBFX/B!./FZ6O!O<(M]6X
M'^E.:Y9)NV9HV8>R5S,:CA-[&23RG-VN$[\P1IPG;ECNC1?MWNLJ@B:_^+50
M$:5(#WYG=>#J$!-&<WW7>B@URA*=1822TLW4R\G8[HEM.VC]!KRE9K>X4Y-]
MNB"F62'[-!E?D^RC&-1F:J+6=E\)ZX)MR$BV`BB)F!E`$,$=N=^%;TP>!4+E
M?,;AS@^07W\5P8V??/+6_@YURL?\EN>5MT<_)>_7L`B8C?I\J?%&)"\<.68K
M$#ZG/7]1PZGE>WFB(NDVV(*X7)R/^-HD)\BS7H`B,\AS8TM?Y#>E4%I&@W-1
MJ,8XPET4682P^X*/L$Q&1B!1=(5BK5/%*@,EK;-,8*-5F[)EJ-7V/P_>SM_Z
M<//1W^W@YG)-#KQ5WWA83,=+YL-&BBLWH%I2+<&E>1PU89J,[)XXZQ+9BJ&0
M'W>JT:O&4$D9*?.M.IRZ*!^D%8"\!N$WC+21GF7K[_>A_F(#+R^G[)[\Z1+9
MGF&;'_SQJ+[-;4!S>+\`_R@T_RG5?"_7_/+U),%-3FW$9]H,_7W8@.;FJA92
MV1VY49?(IC9K->'7Z`MP[OL*"O@U>**+2/C/?%I7=>TG,04\;2%I"MJK(L2R
M^X2Q-IDMG1#T`I>V`GD-%#M@BQ70."<X.RN@:E;00ZS?P'*=B,PVSPMZT0M.
M#`Z!+5,#!OKKG!N<G2U0-COHH9;=E[^UR6SY_*!7`)VN@8HIPE7ZTFU#5++W
MI.\].!XHZC6?0^@NI6XO9CB=G=^2?I\XI_#.>S"U[UIG&2EJ9D)GM`0]LUUG
M&I'1^(J93&>+\UL#ZY6'76NDHJ>)8'-S)6GZIO)*\LGSH[]XNP/ZD+YBNBI#
MXF/.:(QCQ0M'O;)P"M^E,-U%#:>6GUP5%>D4@PT#KO8!!V<&)#?^G.8'E0),
M:92QH<=&C6(:@CJ+(J=VSF^NQ233"8<B%GSMNJ52F[*8%..A8V8`4A&YA`4_
MC?%96F2Z++^:TP[:Y#A0J_F8C6+!2O!UT/@^O>99]-Q4W[.YS?HDF<>`OV!>
M,ZTSG,_M#FO2#EH[\]IJ=LD7D'T2)E[PC.\CXYL2A?$=.*.1,]9(/DJ=LOQC
M$Z/D(#7]<+&T?$SOPJV?B>V5N_48QU4_5RDA]1SO-T[(YLX@/?UD9K]A[`)N
M9H^N"T*%F.6[>^*4S.+-^S#^`K,0#?%J>Q_YP=K?>[O;X#/\GCQ^@[LW^$L8
M)"_XA9710N,"N0PV=117T2PT51`HUQD.+=\05R&?25LO"K(Q)I0%78"R*.P\
M%X4!/P"X.)"6!]("3Z*O>E9(SEY?FVLG<N4NYN/A:((?BQ^-[7YF0JV@IE99
M5()V\?$-C<KX7]"+'I&Z$4\IO1I_>BTL0!E4OZZ&$-*[LD!R'?Y\?$H!R6S4
MK`9*K$I3W:KT+23\&5ND2-]"TVI$;01Q)<+%$:LX)5;1]DT`%?)9JU!-K%BM
M)N)J=1_EM:&_7OW#:W&4JZB:1%-D#B+-6;@ZW1"3A*86+"614VSGX[WQB&1R
MIL6!BTRNTJ"_)-1=F15D>:OG!(OLAE2#Z1;`6:A&YTH=:W_9?OA"4"3CJWL<
MX-R*0NS3Q!?`WX*]YV_`-S]Y\0.0O$"P]:,X`<FW$+RC$84L1N"?BSBKHJ?J
M1?G&=FC^+%2'<N1=I"_/9Z["(Q*[[D@>6!?#IUQ]>,^@\\%&O_CA!ON#F'W,
M3Q6)UF)4H;ID$U2LLDC2W99'4).5S3(/K@%0T)4#:4$`E61:MS2X=];HEJS#
M=]2]EA]5EY7-1A>P@;)S,/.V")E%KB"%DCI\0FOT3=I+/.INRT\PRLIFJ=_8
M`*I:YP3\QR2#_XAD)J^PCA8+?0]9T&J4UZU^&:I:TTB]7-I^P;`=M0FWC5YU
MX^`"_BST5N]Q'=FKK:@3=9[MI=6IEHIM<K21,4N/6M?^E;!6W*8)6:V\A9)"
MK_S^XGWW7P^OV3V+AR1<__TVC@_X%/'7`'4-^25_*)&\4$D[OT9U0KB*EJ.D
MK!0Y5?G*(<])VNW3BPFDF]Q"J-PL5W9A#LU^23*0YP0D:_9CGIE/&>ZC<`WA
M)OZ$B$6*13V`7U9Y?0T#4N[`F4PFM`!G:JQU;_UR6B(B7JX9+'F16EFM#,PR
MZ.8_*Q`W3PAP)X(\:?J\%4Z<LET;R;4<L+>'Y(W5G?Z\D^5PN+![;YM=""/K
M-<QPCLCN5\B^3LD>\Y/]"\0^$1H(6%V#^<1A#F#)6;@<K^4ER5G.6Q+J'V=H
M][:`J$BZ#;T@+K?(I]'9$284TPKD>>A&<[V1LRAGE/:9W0LKXD*96F$41N@^
MON#'NW)U><N#:52'C'0LP5IS(%J#%Q51NR8(-PZ2!O]QP)'4PIP=AM2(9=_L
M/+2HX4=QEC1/.]/NF;2P3$:\+%%T;A8FH]0@[\WS=T?*XD41JA2^<F]W%3#@
MYOJ`*TZW!AY>/"13R^NE#W"=G?8=.+/96-_:J!PX.5U3WC"YZLD6/%\N['Y9
M1(V`NAT_)2C=TN=#PU1:3G;0XP*D15UTO'I=EJ=0:3_#;^03X>"(]O"7`>4L
M0&A4PBY!F92M4L!\.;?[9@B?("=5GF,T3$J",J4I-*N"E@4S&U6AX?(Q%H#=
M#L?NM01.28RX=WR8W,\''/T'CP<Q20'B<+=1PGSB7C+Y)P[M6I16A6##ID5/
MA)NE1WU8RYTOIW;OI2N1[T3C#A?(SN&(E*399:N@)65^QB^87P8;DN0>M<"+
M%\._DAE=$I.3=[3@7M35"-%:E*F<K&P4;>,KDIQGLSNBC+1L!K5,"&!=P]+U
M\:H.D4(`*B5;'<_+`7E!IE6+9:'O7%6KRP_D[]V)W=>[I&4S[2L*H<STRT_U
MBRREE\H5$.7RD'*E*^O[7+F^9:5<B,3YD^<ATY[4N2I9<Y=*SH;:?7Y!6C93
M>U:R0*4',LZ=JCQ;6N%CF)=7.8MQ&R```5SC]G@,<4S9R^<(DH5_0D?FLY]R
M=<DIG'(Y<ZV3+)ATN]V+ZXHDU.U"JH'IYL7D*O@8ECI6/5\';@-0EH:3X?)`
M4>!IU)#%K?PMJ&'#Q531^W8OQRN2T(B[J09KJ8N9WYF$I6]9/<MQ@8."KDME
M1.GPU3#@G589F?S/WX(V-GU1%02P^]RX(@E-^:5JX"H;'3F]5,&K/"RCH?T7
MDFICG<`M&7N7)L6$T3Z""<$B9PY?L]M("DX<&E$0IA'*?@VICS\"W6>OYR<F
MC(E110B9:BWA'$?PS=C;($XB(G.<Q1!]O_:2-)[U9;#!84,'TX4SI+WJ1=4/
MQD+E-$,<.58)#IC_O7O:#4:S^6QD[]%;47%T+D$(8G))0*=*IOP-A'>`LZ7/
M&Y#U/IQ3,]M9_"4[V3Z79KN]:W"BXFCWDP2!N8]Y[!:R9[3+GL=;D^?Q+M#H
MD/%_@\K03'@F_\=.QM=]'J&NL/=^DJ@X)OP>06QLAMX3,O17.R^.5]ML<KZ*
MOOC/+\G-=QBM_1C>1SZ^7)O/W+.O\0#!TO=PJ0@B.052TP98EV1DR'M\.K77
M>U(FGTYW2A5(EQ2`[\IFJ<`J`B09R$L!I)A*DKA(PWDL2(J#6I[?.#,]7*C7
M0WM7D97)QZZ'PJ]OJ,*:+R`#F"O?'F>2<?,^>K$?/^PCZ&U6P5^\R,>+!U_0
MD#J83S0^S<T(0J57R"%I57\8"RF<E:&]1X%D1#(Q6@G@.O8+`<D%TFQ@%8`\
M(_@B.1^Z0JKW[@?/Z>W>P7Q,C=JF0SOJ-:M4B3Z9VO6@GK/H$<?>*Q/<<IAG
M?#N8!LWSI"!-*T/L^S2*+%Y6B)$IG.I[S:R]7I6D[I:GG=*U?.05.?N='P8)
M#+HW_6C*Q:L+D$<OQD$W.6<*#!UNP"X;)3"#3:[F*XV'O2NSG%*8M\=M4!K6
M.$M(WIC@?4S9#W#L-K)Z^\E;^SO4.]G>X,?\/?4K;X^^).^(!\NIQL#&'%#D
M^"XI=%4%>(K*^W!A\=JMM%PFU$04G(LSXJ6B-"O(\X(\#FV1&^3936B3EA`#
MMFO37)TVV;]8*RR7]EU`682I2A4;@&";Y;THSHD\%3JU%M,IR8>UM07A/[<7
MQNGCEU"A!0,F]D^X%4AH9$R3AGG\SEA9"BB+J3\Q=AN0_4I`RC+Y6KDE2GG:
MU\H5*>2WL&3!&3B6LO+9J8QUD#*JR/O<GZJX@^8#79U)0$:JIRI7..$*69.R
M-W"6!DF->;/J,+OUR#[_]V'W#A#,9>U:-]'Q'_T@B\WUQY/$Y3*IOV<4EXM'
M>]G*+NEAO_.K3M!3ZRX_9&;5Y5/73YX?$3"WP?Z0Q'?P#>Z<7R`.SS<8#4>T
MH]AJ=+&C8CE-XY((JU%7!F?B."-[%8,%NG:J,X!PR8_``;^FOW.^`7>-=.;-
M2_PW^,D//.1B8D>U.+QZYWM/>)4&*4P!Y=J/U[LP/D1PL'#2B\&:-F'%D<GN
M<JELD_RNM%2I^)V<I;W7UY3)9V`36!56MRR$<RNM*/0RCF&"8P55:OP%>KB6
MS2KX@@<K/*ZA!)_#(,K_24X.X=74VP2^(@=FJ?%5.J50%0T^>EHM5U.UU<S&
MEK]#K4-<G0LOFC"[N,P\1FM:++FD42D8Y"4#Y"8699-4U=*S@WV_DNT.4@/G
MB*Q"ND=\DA!Q?*3O8*PRF*>W"BVMI=(BI%7,1E-[3[GH$/4<+$$%;\4*Y-I.
M'(*++GW_E10@JN0?WRL5?8K@/PXP6+^3)\@=G:_4,P!0I)@\$C94KB/S;+BP
M.V0LNQ#&U*0/B5OY#(KO0B_>LZP5Z&7V*58_VIE,R32;#>U=_V`#;XRY;0AJ
MCEN:Z`+(+8G0ZAR5_3PSRMR1+N:V2M3%W%'1]!8'4F`#?PKFUA!T,'>DD;G&
M5IR-,;<1)+0KDS->C"Q_Y8X%OO:59T8@KB+"TMR2ZQ"_2XGF98X!-[@=@"("
M\TC8(')'YMEH;._1`#XAC)GD/B0UT]SB$J?I%?`]+N:6N6HMAP9\C`X$ZAG?
M+V,7Y1NY9\[\_#C?(L4I2$^'TL;ZVO*'.CO?R@F]'HH=O&_W63IS3\:3^9DX
M+RQRF/5B&!"YLD1_.#S%9(A(;M[0_Y2[#-.A1J/>5JODN2IF68JG:=IR.`MG
M:/=B71]TW6:ZIWZW_`Y(`HD-IJ.J,@U`G:IO&YE:I5)VMDG10LU<[5'CVAL&
MI1>W85+6*J<P4H7%3'=C4#=J?%Z<4J-2+K;(T$+%;/<1-:J]$=S[8!LF8K5N
M"@]%-N2.:T#(R+8(ZD5]JP\ME:HE8ZLD;7S,,^#VM??&+`-RTZRL5]\D)DX@
MM)=&J2A;KD"=JB_.0FNUR@G:)DT'1?.ULX7MYR)[L9^`IC4`;4056N&B1@XD
M#P:@IL01<`>+^60T9([*W%N>'!>%X&)6]F><+(?.T-[(3.P"L/-3/-HR,YKV
M0*\7($]/(BUS/AE!`Q`GN*!/B"Q_??'7+\<!+[-XF.GQH?E,WW5E.6SJ%42F
M77*++EGN:&KY:YI*Y-,],J@`F2ED6"ID6"@DB7B.N02^X;+*P,MYDAA4RCN)
MPFI9;/X-*&QC@5JRW"D.9F#O:*A00B.+VFJPNI7?B+(:C(->7A7]'0="+QNA
M2\WZBILZ:8>>WXC((1F[6NW#V,>WLA[5JA<[5K?^Y("V"13+JV7VS)^87$"*
MSW^&K*8*<0IGCHJDXZV,V@Q*&V]9WA^SA[=,GE`M[SQM:;N7I3BD.)E'0\?C
MDI@/`A3-+?8C^M]X"Z,(;@;+F;[8?U21[M1LSK/(TDG8`@>:QCEV[X$RX3^)
M>3T"T3X7EMBNIU:<[H`MI_JV[-NKU6!YZ>)T\O<Q6X)P[-ZBZL5^$MY6`'1Q
M5F0C-2OEYOO>C\@Z,!E-IPMGNJ"$"J&._=0BE)C+7E0YY:CI%\C!GTRG=AO+
M'N3L=),*L-&-PBU_%Q_&\<BW?H&?T$PO.YB"W(,1;3>TBV2-4I3PC`7;$=6:
M6?!L<G869&O'KMNZ]0$H'B++4@"<1/"D4G_?,NUHGHIX]?W+KL9S1NE*AMTG
M-AG0F]BY9(.BD8<(7*6KF9^S;RM%*0V[L+6PL,Q"5-CN,W&]V`W;OP:`)N]0
M$B6\6P55"T.;1#/0KBA$)>NZD-%)5^;`S6;QF[XLT,U2KE%_@W$HA1+"/<`W
M&%0ZEG8LDX%RE6)4DJX;'9UVU3QDG+`[5%@_>+/4HR!HD(^DT4<_`8?/)/_Z
M7+Y*IMQ5.2?;1X=_&J>/BD4G'?WOE=ZF72UCX6)>B%(F=B!KH6&1@[2;W3%Q
M^J`;MH'']3<IYW_713@1ZV>(<;V6+\^2*ZO=]\G[P9_(ZC61:",@>7JHTL^T
M\[8,#*P4HY*#W>CH)*SF(?.U<UIPH8$W:_LH"!KD(VG4T.];6.E>VI/J+.3+
M"U%*O0YD+<0K<I!)F]T'%?J@&R;=<?U-RGT+!0E'W:K[?,`EK;;ETQ57WFX'
M-Q_?::<*]3W0)`E.PZ:Q3,M4WWB1+#Q_SFLZM7>M4H>H['HG^<Z+0M!NF@WO
M=E^%KZ]A`-*7GL#7`/7;[AT'_LCS*UX<%7"63:V.UIWEO)V+=,YTN!PM4WMG
M[PG^/M@F'.0>#,50H6I)E-*7+&<K3\.R>2_)QL.TI>P]\=L'6[M-[`&@;?&=
M.KT1,&DF9U]4LU9-2=INFLX=[)W_]P,W:-K:49344S?EHO4JOX$SR3F:D6NT
MV2QM,WO7.?N!FS)T[1#,3O5%3)VAN3[=S!7I2*NEJW,6GUSL@VW2Q+5@*`DG
M/,'O[4L!XV:(953#5F^I<=I2]LZ"^V`;,VHM`!0N)3V@[)O##J(),GXE]27<
MH1Z);_YQ0'WQ.4S@\23Y$7Y//J*,?T>0EA/:[4)%(85$<<G16V5S%#&)Q,N<
M+2R_JRLMF^Y%65F`;EX`7@JJ%O$'D!8"<"D7M(@5Z:T(@$L$I$CSJJGG!>^S
M5<W&#4WA,N?I+J:]0Y@BZ;2/=&IPN@^'UU<O>J_<3HK!ZI#$B1=L_."YH7C5
M'^[07^C'_"?T/T]>#-$O_S]02P,$%`````@`/8BH0E#1%.LF,@``L`X#`!0`
M'`!P:7`M,C`Q,S`S,S%?<')E+GAM;%54"0`#1KV*44:]BE%U>`L``00E#@``
M!#D!``#L75EWZS:2?I]SYC^HW0^3/%@61:WWY$Z/O"4^[6MYO"333WTH$I+9
M39$*%]O*KY\"=TF4")`L;C=YB)<K`X6O%A0*586?_O:YUCKOQ+140_]Z)G1[
M9QVBRX:BZJNO9Z_/Y[/GJ[N[LXYE2[HB:89.OI[IQMG?_OL__^.GOYR?7YE$
MLHG266P[OZJZ+:U(YU;5X&^MS@]GO]Z>_7A^[G]R8QJ*(\-'#;W3[PGB>6]X
MWAMW_J<S_M+K=V;?O`_"G_[["_W?0K)(!TC3K2\;=?/U[,VV-U\N+CX^/KJ;
M-\E<2_8;T4E7-M87=+2>*`IG_N<_%Z:FV.&?T!^[AKF"S_6&%]X_AA^E4^T,
M_B&ZGQ6FT^F%^Z_A1RTUZ8,PJ'#Q?]_NG^4WLI;.59T")1/X*TO]8KF_O#=D
MR7;1C?UYG"KQ(ESQT4_0G\Z#CYW37YT+_7-1Z'Y:2D#BP6*2)SD#H#L=#VK3
MT,@367;HU]>GNY,XT\]<7!NRLR:Z/=.5&]U6[>V=OC3HQV"!0(<[Z)M)EE_/
M@&WG`6LHE7^EOU`DH@8?L[<;$"9+76\TP.LB#U57AJX0W2(*?&,9FJI0H;R4
M-,J*YS=";(N!-EE>6)70]BB9@.@;L559TA@)W2!0^JI+CJ+:+J6')#_;\'_*
M>FN^G&^(Z;*<!5='EBW#J)9>^$OSREAO3`)#6.H[N3<L=MIEK5+JKR3K[58S
M/I@)EI<(],[-E:2K?[AL!^V_="Q5)TP@&M("@9YG9[V6S.U\^:RN='4)N@-6
M298-!\R2OGH$(&65L)!G&9:$H4ZWDFK^*FD.^48DRS$];C+0LWQ?HYBA]5JU
M71J`>R!J%"78Z=DPDB49@X6V(?_[S=`4<#]N?G=@-V%A%\'@E:J#/09$7DQ)
MMR29U;8M[<HDV_W*!!B5;PP!9Z/S15IH['J(@6>B(C*3!>J(0E22Q+$395<G
M>`^223?_=W)-;$G5F%FK*T)E-%/W7'$T`A^#00AU@Q7J#\"^ZVYH-Y_T6]X5
MP?_@1%.6Q(8KO7J3P'1;=WKX,?!P'/.>O!/M!6@F]ZJT@%.8#0MG7Q'(.7@.
MZO+=,#2MM$5E$"8@5,>@[\0.R4X<;)08M!WNE%FTD."H8)9S`^^9QW/$<7:Q
MA45^=X":FW=&#\TB0E\L:T_@4`R[/%L4VM.8K?$_H,SL\&\XS8^VEI;O2-O$
M+I=YM`:'H`.-CC#]C>HV)Y&6\5&.X6'WYXC-`!P<R<$NV:Y5N(=?!'^@VAK\
M1:\G=,X[0=`I_JVD*QTO`M5)"$%1VHL)9GF4DT\;C"?L]2[E`>V:(?N?TJ0%
MT;Z>P2_^>6K0V<*R3=#K[G`B",.NT.^.TX%D&G&77(V&'`TS0)J)WA?XRVX?
M2#JD*AY)M8C<71GO%PI1:>2U3[^A)/?/>X(?C_PK_&IG6";BXH(P,P-"EZ:Q
MSH6K;9Q<IF&"9'\]$[L]^M]99V.JA@F#@^B==1P+R#4V=(9HDY),^4"Z=@.M
M_B<N-NX>=RZ_J?O^%'R"3D66Q`1[>>\QX^AX[F`V*"!Q/\G$U1FL5:'KO=6D
M55<8#`IBZ\ZX=>#KL87ZC!VTC;$!7(\$%@2(*=?@7G6%D5"PWNZ,7P=&IRW<
M9_BPK0R_52UPE?]!)/,6?F-U^[UQP2S?FZ%.3#^^>)_MHW:SW1/Z8.T3%,;'
MYJ@?ZY,!\)D_;AOSX?Q'+^"?M^N%H76%<5&:OC-N'9A\;*$^8R=M8ZR'T1-9
MJ10:W7Z0UK"'38KB;]+P=6!SRK)];D_;R>TKF-^4M#LX/W[^G6QAW479[\3Q
MZ\/OXPOW&2[TVL;Q*\<T=]R5T$\=)AWWLS#]V!1UX#O#\@/6"VUCO8?7K:H1
M\PJ6O#),*O%%<3UA]#HP_/2B`U[WV\EK>F%DZ&Z$U+U5M.:.[>9)@D?3%:9%
M1=+2)ZN/)#!"$@A&$\-N/UTDQJTY0MK]SGDGO!6#[Z_F#]<W#\\WU_2[Y_G]
MW?7L!7ZXG-W/'JYN.L^_W-R\//-%MMD3(KGCVS/+@C_W+7TD&*GBOI2LA0NN
M8YVO)&GCR3S1;"OXS;[P^[].GC%[P)NFT]$+7OA";S3>)<V]\K6O)-/<@IRZ
M%U?=T7`X0EL1$PF%:#4;M\+]FQ>:0)$;J,<G9>12U317>5R\GHA,``QZ[]4=
M]:9IL?3L<G%TV@ID@0D"G_^MV^!?]<7.\JUH_5UA+/3QC-V)F2L0`E8<VGJ-
M]FB2C:0J?GH8F$8WDWP'PZXPZ(MX)H&!@@KD@A>7MM[&/1$`2I5I[A/3UBD,
MQ4$/358XJ:E`;O+@U=8+OI,(3AO@4.^J_7`R'I1#.;[\3O?E]^A2FW,-:=B2
MQBN<,5S2`EIY><LECFS,/4I](E<3;%A;3SF/IK$AIKU]U"0O[@.&>$.#$@^$
M;M^C:=J]5!ZWYOC49;*>&8*VGG1BCMN#H<N![R;V^WC,3YRS3*ZG+[JM!YJ?
M#4/Y@"-=5^B)0EK.6'8.!].4R=3$I;7UX)&,":+/592;"$[3I(=,*Z+4'?$(
MXZMJSCF%SQ6,57KLNTK]J8CG%QZ?-X<L>A6"UJ.TI;&LT*$?C-)R,W+(9N*<
MA<@J#VM"P4V%H*UN+ZS<=$@0O+*"Z)6/0`Q+T.I>XKU68ID&\[!5LCS#PMOJ
M^=X;^NJ%F.MKLK##F&6_GYJ=E<.2'<Y8F2RDK;ZM#O#SFV':=.&7AFD:'[15
M55<8#42\TT["C)5Q/6WU;767&;!"\4<Q?)?#,;N",/)V[9(649;\'GC;*6MO
MJ^M][8_]1-Z)[I#N>#C!.[OO35:9K3JQZ-`E&=:=SYG-%#AGA[77,=`0KQ%9
MJ2A:,CB7?-PF),E66P\SK@<?@V`GGCD8X#FSQR>NB5PP(O,]'&_B2P<??UK*
M":=V`L&`2%M//=?$5-_==D')"C$1^G@I3"F3UT0Z."#Z#DY);"!B'S?RNQ]I
MZX3CP[B'EVF#&/7CY%""M[2S]K8>G4Y@-)A.\%+\:^\VLP'3G+RF8DT=U0U1
MJ,S&U<]8I*/4G&8,O!;$+]6:+_T&?9+V:%CJ3F'<8#K$.VJQ4%"(Q&1;ZNY5
M>$*>1@O.WKC(9;'F;3VWQDI(_7(S/\L6IQ)O;[:"U(C=YPA+[TXL.]*??JM8
M/5,4U:/[45*5._U*VJA@FF-0=(<C`>]F+GW^RL2!#YK(%HCM$A!9=M:.1HN7
M#Y_PN--E8^T^Y'%KF$1=Z5[T5]ZZW7,UCQW*OQS+]O-YY\L7Z;,['([QXE\(
M!%<G@KC@1Z&V0:MD]HDV[=6)<B.9.KU?C\%X39:JK-I=83@8XEFU=`(J$RE.
M;-H:9V.`#N74B1%+2SH4CD:C<8F+*$N<#X['*6MO<$@M?Y,3,4N3D\X/.^\"
M_!BLK*BF)XFO#G!W0&E10"#M!`:`S4UW-L4]E3P2T^WK0T\G>,MC(*`&X0Y.
MF-IZM7C0\FGFV&^PLC^(0I>/YVN?F+A>TG$*EO:Z.!S@31IM(SWVWEF6X[%V
MB+:D(Y.6+^V35&D_A*,QWM`[,1=&+@L8;WHWFHQ*B5[B-`4LV`8>`:;!EXSY
M'>7!GJ/\^C![O;Y[\1SE))?Y^06^?+MY`'=Y?MN9/]X\S5[NX`-\SG*>QWZY
M/68O6A0.&EUG#(4IVD'QR*39;;X/A+Z*@E]=0>PAEK,FS%B(6C/S(\RE3%EZ
M8XP[Y]UO&E`H5KUPP8UU;_-3Z7M]S-/;[FRE2&S"WG-\S6T]BH5:&E9X!C")
M0Q&O8.3HM-5PG@F%MIZ['@S=V+7508^^$(3!$*][9>KTU8@$%RH-]D89]C+W
MR@Z0]-ZW=0"0R+^[)$O#]*_V7J1/8GU3=7?I=SK,12S:(&EW%"_J_8W8;P;\
MRSOQKOO`-^B-AMB>72DKJ<;=JHI5;4WA>R!VW''MC\=XJ9T[<U4C/L>7VYR7
M=O@8'%PH!X'W2\E295"!:U5SX#C;G8RF>`YORN35;'D<B+3V-9[?B+IZ@\7.
MWL%LKLB#LUX0<[YT\8B%HO:A$<8B8IO+;$15(T0%`-C:]W[2P!STFQ$;\,K;
M0D_"=XPOB4Z6JMT=][VB>YS5G)Z\%)F/%K;WB!4+(O5_IG#JR;9.5C2LRR/=
M@8?HX1"XE5U!&(AX55/'IBU$%#*<C2.'G`&.%I0YY(PIX%B)8H(*1\3<XZ,_
M(+!3\!(VL*SWSG0E2_6AJ3NY_/H7F&0U;NR0H5SC(\JSFZA].C<;QJ>2I"NQ
M3.TG(FN29:E+5=[+W'XBDD9S5EXWAOXL:61NWJN_._22$#Y&GX,3Q02<$OLC
MEDM;R;IUD!%1(2<:<[W!G6GQJIL^"C]+JDYQG>M1WP:+/DDTPGR:Z>3L5?LH
M/.`TY[XV0S>DHQBZ?7_PG-?3DU<M'AS0_'DYAA,9QMOW3_"U/YGBM8:LB[0?
MAL"9`&G.51]?.#RV`:C6QL_7FR_]7O5"3YCB=0\\.7?51I`=F+:VF'P";&$6
M^O;:-7DGFN&^=A,JQ[`_%1$K$T_,78AH<&3`Q)ZD8P2DK?&=GXD.J&D`P$Q9
MJ[I*$:,N8XA!KS_!RV%.F;TJL>`!I?Z1$JQ\,MRLUTSY9&PKH=FKHQ(2=X/Y
M2A+CXXF[B0MOCJ//VR\;AI=5R8^OS-:&::M_>)&226^`V>KRZ,15&3)&+!H3
M-,*HP1CEK,%X^>7F"3[P[?'IYA?X]-VO-YW[^3->1<9!.X[#7"..ZHQ3W3V"
MSAV/!.2!9I291++(-?&^1M(WPNXTG8N^G`%UCLXG23'=A#XH@BCV\%),<(@N
MQH`AR-I.A`N75VT]`L3J_#S,Z-/<ATC&2OY&>!$$3F)R1,V2\R1Q,N,+3PO-
MS;.4=-%F.P6EHUBL96N.9UZ.H4%J)522H6&1#=AGA`%>I)Z%A$K-TN'1E1>T
MYEQJ(O1;&N<[PES-GG_IW-[/?T,[M%Q)UMNM9GQD/Z=$OIGU8CP1V=!E52,[
MN]>+0:=Y-(UW%<:\W+X"07=Z>&J>@<?W[K79#<7/JV'&R??"H#B[%6).$,`!
MHXSTB7)$A#OC(I9.5V-?*FLZ'2;H*`EX]5)+E@`="@S8P<I2Y((GS#EID%_-
MG1L7F2`W.W`)H`*,]O91DW2;%G^Z]YKN'?<(S\BS45%[\3JT]5G@K;]#6D>3
MC]3JO4XF/ZC().[)"-QFSTZ!MX!X-Y4\:>U5,>$-ZU3PFE/FS/N,GS?VT=JT
M41__76#,:KU2!8D#S>8T1N`3*.]QB;^KM%E$4-$F#J=X0G0X8?/D)@6T^A>%
M9BYXW@E;Q\#S7R>)BFM'`F:-*"L=S1.M;!BWMH%#!CC0RNZ+E#G&Q<YDV7!T
MVL).)NJ[M-!HVN%D*):YSD,:"M&J7)P]KBUIB-7__CY[P?X^%J_Z0M4THD18
MT!=?>P)BO)N)B#K+3RIF]4_U+4Z`'DVR`5<G<).#(@O=>PXJK)F8BHB7!MFH
MJK.(\:/:WIN#XP;\4=H&UALQ42YU_JH$B<$Q/(548Z+<N?U!0,%T8+*=!U1=
M30HQWGGQO#<>ERQ.'.356]JRXES_*'A1PAC8]*#E-'4]\4+:J?/76)Q.(=6<
MHES.ZG-B)X4)_'<U$L,$HCC"LU;\]&0_V\(D,B&*VXB6/@U#GV2;+^\-??5"
MS/4U6=!^M;])IBG1EK3#B3!(TIO$MC)<0Q>B$D4P,HPE9@:F_D?9C"'I&")/
MX"IO_?RQ>U4G-(T,IJ7/A`X&?;Q.+TPTU%J6V)"K_VFV=%.+U,*N3%L;,CX<
M_LJPZ*%2G'@WI#AK/#9OU7IR>"AG0ZB]Q^YCAN*)`'2J3+-Y:;+N(;9@/,0)
M7J%?9KJJ%C%F4\R'<%N/\<E.SU7T6MR>SR,FB1R',Y@\<JV%A@N6MIZPXX`$
M-OO6,-VPPQ'=&>%UK^&DIM;BQ8OFGV?R`WRQ'@\IS4]DGXO6A`[PRO#8":E:
MIY)>6LF"87/2R?CZKJ3N8/3T.<![.3%U_JH%B'_/WT$LW.A;UI0N.I"Y:PZ`
M"`YEXS%BSL*IN:L6EU-'US2DPN-K;64E<_OV9$"]-QJ.`3HI/[IS@J#\T9T7
M8R;_[J@FV2E$@1-"K!8%Q`'Q*1IV2C#5B(_K^VK$BV+]@^X5*%69MU,X.A7;
MA!.JNW;%83#LC4MQ8%(HJ5JI3KHR/"A^9Y<0+-B6><Q"T2CVN>BY"+&7*#LA
M5>L3Z]DR#</Z7UMD?L.5M\H"H!VA5<_STY-+G9(Z=&&MJ^!&945P+J57V:0)
MKEG6ROX<^)7IFN65?$0Q.O!5D(NZOC.7AH4%9>[N6#:8<2[7+"&^N<),2-5J
MQ^K2I&'85I<FUBHO[(X6ZXLWQ#M=GYJY$*GA6QJ_?"29^.:(21'=2O/#RGC*
M;T$62JFP,MX#M35IXV:Y)#(`>?,IOTGZBCP!M'.=`D4;@<(7&@5ZES3J>W4G
M8P&OX0T/)14:O:R`M34G@PE%['[`V7;%Q/4D<S*Y%71W-)Q,T=;'0TEY"G'@
M)68%K*U9%4PH"KVF:\0,=E/3W,+&^:ND.92SPQ'>RIAH*$\)HD6>UH)3(#6F
M\=#&567`Q;2+U@*AM5J`LK*Z:8&04PN$!O7^\[3@1N>XI']V-AO-15'2`A3O
M]*5!^[)3W`,\A[T!7AXT(Q$5>M098&IM"ZT'0T\J-=E&($P$,:G?7V)]1=IH
M5<:.>!8:L+O^MT7<30F\CH2T1R&80W&`5R0;GZH8OF>U;E&?@2.+C^X&^ZWB
M-JT/WTD!A>,1?>%,N79,4`%0"1EPG)N/X&FIDN;_''O\K#L>3/!VBMSDU4.L
M"D4YNAILERC&4?:+U"AF-"!Z9>@Z<8'X3;7?XKT-J$U.O.5(W'PR35','1C_
M)IKDBV3#)31>XK1I$I/W62.A)W3..]>J)6N&Y9@$?IB;*TGW'W;H2+K2N70L
MVM\@C."RO5L4'P;.%_N#\+^A&ALO>@')&_PQML:PY%S2HL>18H_XCO#"X860
MF/VXFVOZ2`1>@"F7FEL8(PI]Q$=G"R:W$#N$)&7ABVN8+&I,?A:&&>OOF[%G
M9[V6S&W'6':>U96N+E49=H:.W]0/MIC.(Z`OQY(XV.R:/^Y\&1LU&G1_3/XG
MV`Z&BJ0*L1C@^+39[=%)@&(B/!H@UI2S$5&([>!@7>B[\$/T76NYN*_EMY)J
M=MP09><;D>@OU_'+9C:5IH.X8R0-P:W!X6@1H9$@"-,AWM,/IV;.KL9)HT:B
M.>V/\(IU3DY=B,[R,2M06V9(OFME'>PK*RVZ5KV<8/=@`1X0M7=$Y]^%8T.Y
MK]\F#,2MN"?&C)81"4>OC[<=<Y&2XX*,99I(L$>3Q#Y!)2ZY6.7/R?#P!BTS
MBM^U>1@>>.RTWO[-T``3Z[\Z]#+2WG+ZYK$1=O^>VQ@<#O5@V/$WM1&[M)V>
M.X=#GCANXK%R-!HC^N2L=!1TV<7'R=`WSX36=ZW2HP/W/(CG=F+!>E[O/!@C
M:0ANO:;!WR3CWD>^I2ERVYXIBNK)4!@EBEVW)$GH$//90FYR"E%K5D9&!6DY
M0&MPN5E>K>[G":UU?G"_V_Z($6/SAOXSTB;_\U*R5(MV@XBIC*XP!I=&/<35
MYJ&LJJ!<46BVH%HJ4=I>+3)?WEBV"GI+ZPC'?1'O3FUWLJI$XL226U"\E1SV
M,TP"(G]%\S!T>1MWOD`;W!\U%V+?#L?<X9[_G!M.3#`K757)3C%`MK68[4@I
MRAX2H^$8SW]E(J$JZ>'&IZU%:]3?WU_V>##`VWD2)JQ*"%+6WIRR+#Z6^V]7
MT>XAX'O1%1Q8R.%0P'->4^>O2A[X@&E,O09O0B0<'0DXZT2Y,M;TC4\O=6;C
M.^QWN@RDJ>^$-L?S+697&(F8@4U^BBK+/,@)7FO+.;S^1"_2YZ$W-D:\NS\V
M;57RP01#:XL\;B13![1H2;2K*/L@3,8]Q*X*IR>O2B(X,`GDHHGQTI0651\Q
MY$Q#AV]E+U_(@^-`6_ICU!:^?.14)3JY8`N$J75QM&_2OPSSRK%L,+3F42`&
M/;S7'!@HJ$ID>,%I3&D^;WP$O#.3O(&#!LZ8MRDG@S&:"G@-*5FIJ"Q*D@&E
MMC[U\;-A*!^JIKE>O"WI*W6AD9EE$=L*_BGPYWMB'R]YDYF.JH0F&U"AH6F>
MV.2]"A;S706_2("OA7(5[`W]YU4PG.OE-Z(X]&V`F_5&,[:$/!/S795)\H%_
MIKF#NR5'?CCI#Z)XG:#<2MQX2&DRPG-%T.BN+,!2"B.^XW0SD;D:)*/I22P+
MR6EIVE8<$DGY-8CJNT1#AO>JM%`UKRVG'4[K`A<7XC%F(#8C6176E!2"9(/-
M`9O:Q!#QM5*9ZV`O'9,VBG`S=UYU8V&!J:4HW>D;QPZZSZLNQV)U.H,I8IH"
M`L5UJ'A"8D"#$RS9!-<%PHJA][\.>+*J[>IY+!%U3[FG_2'>J3XG<740Q_RP
MMC5++]I/0K"\LRT<=QF4^'"3$?!"!8726HL]O&C,PXW]>XPZ,):59'7SD^I+
M<KKY;:@RB83YFV0[IBNY\V6\B=*AO"+6@O.24TF122[,VNJ\QT\VB0#@>>&G
MIJY80%*P:+!#G-?@#WK]PZYD/('F!]H%CCJ`/W9^N":VI&HX4>=P'G^2/^//
M:1UMJ+R[K?>25#ZY)6'J>)4%>/E6VE;K?J1_^*=*GU)QV\..RDO:I]-FE]TG
M`BQ799LHR:,G__8;62^(V1T,!!%MM7DH*T0_.+@<)2D7@V:%BL,B,_1!(1>'
M@3`9XPE`,$T.Z:9#!/`*7M,#/%H+E+T3$(>REKRV!HC.'M$X=0R<##F2K?:I
MKIVU3Z_8'^!=5>U,59P('8,Z2CD[LL)0C(1AJ[;N0BPT4N4-\GZ7B,>]"F,I
MM.LT[2*]\BY\_>6"*]=/RGY(=%I/#%2,.!?*N$#^69<?J<.@5>IPTJ&'8RJY
ML\G:HE`,F"6!;<SL(OO@4/;,E^$#KL]DY?(-")PB1N..SEN(?&?F1)APS@1+
M6Q^MV-=[+Q2Y]9*)`+7>-*EX)5%^3PY5#UZSKS:ZZFN7X:+Y831K3%TO'-.B
MD8>;3YI81KIC`3%E[^BT-9$+%E3:VE;A2))AM+%?;J.//$I;^JO9AV0J\8M+
M9[WQVU3HCJ3=&N:2J*!<[ONY+O!)^TOR-HA-3CU$KES4V]KI@2E?]L%PWU8G
MBHN?]4(??(W_.]7^!\/^![&C;-KN9-+'NVM"([L>LET*5]K:J@`-/,_+`2,1
MZP4A`**(9_-RU])RX4_E7_O[+/A>V271R5*E;;9'B*'0([/60\I8(&EMRX49
MP*6HFD/OTY]I6IR;/'/S*6N.0I1;0)GJDA.\C[3?C6"VIH!3</^_O:OK3AXW
MPG^%NVTORL%\<TD2DN6<O"%-2/>T=PX(<-?8K&V2T%]?2?X$RT:R)5M6<K.;
M-P%)\\PC:30:S8B+E^4R1#FHQAUM95,^%+;I_5PZ[@,J2.C.+7^E?W!LUVUK
MP^Y(7%B'@!'+05K1JHCRJ#4OR)9;3,Z0YC1?34Q.H6%?*6M_'K!0IW%5*+9`
MW/4P=6P!3ZVE$]N1)%;!Y!&*6H&%-6)^$\\5/`),2V4R"*-X\8?1CO./=[3E
MM)+;4BLPX@7'H,8!Q7@@[Y>[8S"*GPA5<1D2\.SL#S6!!8%$#+FVN%G1^*L:
M:<L'KG@_T$8"T[1S'FSQZ1[T`=;D(81W@H-15UQ&1[HQ<)F0PDD2>1"8<8WG
MI5K7[WP@?P$'V_$0\'?V7C<LA+RXC57,F$N%W@.H*71DNP,?P+0/Z/`>D"@,
M7.N-Q<6<4@Q`HOEYG2R)*'P68%4-B7J`IK6CHU1OT_7>L`QDHR#?YSD0W=Y`
MW"9`-81&<HP9W)AE/:58QMNTO3G%2O"](L-*LC"(&3T?]U+E$#/=`9>:50H<
M7*I67\;A6]19,X\M*MS42Z8^@8>9;^X`):1RS4R>F/",WNZ0@]YM&5;RX_`/
MBZ/3>D3V9:O72F2Z*>S\).9>C#RBP3#F5O2QQ0:.``]@";?$9):RLI[/J(N;
M4_3C[P:T=Z!1?<(]XH5`&Q.#ZCDGZLH=0_'3%Q'M=$_ACC7IB3-"F(;"Q:(H
MJN!4+C)6\!38[O/9%"1G0Q#VPD-`I]NM+)]=HF.^3"DV3;*2UV7@H^I1G"JU
MFI"'Z6)2X/),C8G-H6['K^PG%@-.H^4[L:@H(2(GZ27P<F<.X"AY;!QW.ST<
M':!U).<=ATNA.,5RD/U/-^<6Y-L1+^F)(1*8V1YKG:XXH,H,C>]D%$NNN+8I
M)U4TQIPZX*/IJZ<[7BT9L--:&:L_X]\L!^@F\@P\0./LT7;=A153#[L&AEUA
M6%SI7?YY.[Z<MBQX-B:7X0=PWNV:\M(3UDI-_6G)9_47`I3B&[$F9B/6&I11
MW=^(9]:ZGD(49V<.Z8M0\#_L"8,P=4"D]NPUQH9D];FD9S06O:OUQ#T4SNBT
M:22Z#EUC[)OZJNZD-R#9%SPVXT8BO@I66F-V=T:RX^H/L'E4J\._;X8H+38D
M6V@)A^22_Q3X_@>:P%V=YTCYD)MV=PDY*@IK5;?O/U"B><L+<S'V^N+NT,ZZ
MXL(.L1,KI%0F1`V.->01YD%?([-\U03B_2BW(@D_@1@_@1@_@1B%[/>;4V@,
MGFY-W75#'"M@#ZEK*>[:+P<6T8*8YEFZXPEY^+SG(0UM!!P\KNM&U2E+K/T;
MY^#ND%Z$$7-TY#0DVX&6=B:F'=7Y&*GZWO`GOHYS?-U037HH4F*>R(HH)0HQ
MZP)Q1<QNI[H8-CJ;-2V<JMM=X^XE?ER'/Z[#1LVP']<A#]>A6G6?B)O.8S)/
M&/&5,?VNRG9W1APC/@DL-H%N%LZ+L=UY"VC.>;JUABQH#T<#<>Z+:[V+,W?S
MU!#E-F3`)N:P]BTYW._62&+J(,G+438PZI1:#\P1I.BK<8B%K(^A)CZ-+;!%
M29$8\PL_.\8*H%RT`N\NXH[J7;TR!([C"F35<.G7\TPGV?)!;$VV9<5`21W*
MU>@TYJ)IF'\I$"+8Y``AL0A>7S"_>7**?D>[C%JXM?=[P_,C%:"1"_^-DXX"
MRT_(6RQ>(=$H2A6>;+)LL$)>TY%<L7NPTQ67ZH]I*"4.;%$WE[V$$Z,S(97F
M()>=S&^,BP%34D5QF4%ZN55U,B'C_4STF],3*L,)%IOXUR>\4_0T@>&_].,H
MSO/S/H+V`Q=33^N+2P*=TS&7^5!&B5$):3IP5)T'#XY]/.`$1(FRV22'*W'1
MN_RV`*U>H6N4T#%/CKC\=V,/:MG*N[>/3D)F4G[L;-W%7ZY9=1E2Q)IK7"AL
M\^JD9(\TS+JK":QSE^B("Q=S(#ZKW9*63=6U_I?^9>R/^T#@7K<O+J[BK"M^
MZLSB8:C03`GC=40ME;Z"+;+C@R6V/QJ+*X]PUE7Q]>09'6NG^%@;K_?$H'#B
MKI7Z.A=R78$QI%?^V.-E8Z(6QR!N?JVZHVM8P'4#M'P_6G\R$%>^,K=K/IIG
M$RZZ$<@BC`)[![T7@M9M$J%&"_9W2$Q<',9BQ][O<,=2'-/<,GY-OAA@]?4F
MW?L=XG.;*^[/[!8Y^T!95<PL=*/O-/*-,."L$,A;N&0\`>_9L3>&7W<6K+%-
M0_UH(Z\ET3[O/*I&)ANMI*KFKKUQ@+[:^3L#NA8XZF9B"B$@_+SS&$-2!#-1
M[;2MRD"!0@C$T3MJ.9ZB.?`"/#@(*`&JG/ZJF]"*`!O;06\!/,=X/^(_V<XE
M>'C.4/L8R_8F`WVX(A:'#*GUP.O6/CKALGH/@(\GZ=8LPW@X_[8,:L^5*%!C
M7S6[((C/G7T=#`<#>P</;+B,,_6;)6(3,BCTNFR!5@>J:35I`TVW6P?'>SX[
M!H3NH)O3/2J'^P+68(^EP^L5*:;SJOUWO6T9>%`"C8`@0]4(\F1[P'W63^@`
ME8;D!1ST$[:5,#88$>H;8J:F9:!'<2P"=HP;R([R`7"#=`#<JV>O_MS9)D3%
M_:TU^^L(L>"1LR?9KM\JMX0]Q&<J@9-W,A07Z)[3;_&;%GROODA>571)%W[9
MP0$+KG<L+-B>A0:015#U1L\/9/FT$R)3G\K/OUNOUL@B1,=J3:VW7428L#MY
M,JSXS1^WJS%ZF7)?^:7(HL`5&=G,-G7K2=]'\4[CD;C+^/.^BN\1>"^=6\@@
MAMLG:G7Y"7\^_0<X]BOX`%8\AP?4RQ!EHUQ(>@WT^.J175#5B>K?$(Y'XL*`
MDCUQ53=YZ-$1+Y,4JJJ48!/#<TST%*`_$1BXE]]WR;7IK-WHO=*`^OR9T0BG
MV!$VT,_6HBN"?1^B)@_E&C'5$Z5B'SFD<+#W>]O"3=_J!\/33?STUWT!*!D<
M6-_;SOT115K,7?>HP]VD/1R/Q2V?S,,11.L\%25OUPM#I^KE*X9C@8?N)JX?
ME\#98RBIW:PY#=6H<UKQHNN2@6*+&;FZ.SK];/TXMU/\D>?`<8BNE)Z.R-A<
M;/PI,CUZ.XC'_\"ZK0U[`A,D<Q]OG=P3BKVJ][2\4/O0#1/9+'!5?T!G?0R>
MN/QWHH:M`']S-:'J/345Y./:K$B2&RQ2&\HSC//_WNJF"=8WI^!S;O!!MST<
M#0<$`03Z#.D'5]V,2=7OY`AK8V[ZF<M[$D&:?0%G9;A^"J/HCV?(]*LEW)41
MR<8R!@`;$R/`3"VI@X.*;<+4,4$CZ=7)NH,>#P<3VQFZ&:"`#N9@/;?@2<X"
M*R34'X:W>[2M+3K0W8%W'.XPH`X-+]1%G199:4@:'`%2'-HLIVSN@GIQC?@=
MWGNQ(T=+8R7>J?"'+^NN*"9;\]Q190.U.IT!CLP*WF'"G]^>IF]W\^7LKG6[
M>+J;/;WZ/[TN'N=W4_3KUR7\WZ_9T_*UM;AO+9YG+]/E''Z@];=G+.L.>,9*
M-QF#N-XL_;@V/'3ZM=;P](M_<&W36*-<I-$`X<*Q.`!_;W;/^BL<XS6WX"!`
MU$-T7=,=:.+2/&5T6OR,.=\?=,-!;2TV<ZAN:VN@@$77!9X[ATAL#`NB:QH?
M8#W[6IE'E&3YP;;7GX9IMK7.@/C4AY.L)8;&9?NGUG"X4G`#L\&W=F57%JTS
M2@6`'M]=\-<1K3.S#S29&>,\HZ^??YMYQE\V%!$"KO\"DQ=G]%KB0ORBQ27$
MX`;^X<^V-AP*K(R7V2\?8YU:.[&A3H/#-YZ+_<XP'8X=I!*VMBU<HT+'QYG"
MB4BCUI*-E0V_1@>J.-%Q;.QJW9&XK3FCT^+3%#6QV-Q"]1O>O;[">8>#Q$0W
MMN/8GQ"U6_T`_^*=VIHV(9ZH.25@9!@*E\E,K<$HET51L%0MZGX-02$^VDKF
MP.W10;`2U3KI"I.-92B5S(&4R[DP6(VYWF/V-9,@B;*1+S;^ZZMD_1@(B\`[
M#-;AR,,C:M#4O1(CP9*:5W?`73F&_^0333%Q07VLPY%G7Z8&K3%W8*Q)PVE`
M"=X7+S;_/.JFL3'`^L9`-]+3U0K-/_<%K("!"PNWQX/>A/KNC'/G$M.J((*J
M7M45Q.S->B>CAD&CSLW!N_=&\8X.0P6N_2B.(G,+?AVXWHON^;[5=9Q)H3WJ
M"]PQZ<=1#[F*X12P9J(V:VYTUW!?88?Z>F']2W<,M&PC:"`4FCB#G7(0]=CI
M!1!J3O).9O/\'(U?*)$I,BU]`/K#BBB2[%<&5F3AT)R4I"6)D%Q&9YL-BK[Y
M`&<K:5]<D"S34&2@"P-:S:D76))!:1"'C?"=7F@V>"Z'%@*M/>KY,5,52'+6
M<24<'U[A>!82<:[.R@E-57TKCA8,5G4#/8L,$DFYBTV476IN/8$O;_D)S`_P
MR[:\'<*F.Q;H&R\SMIJ<G-S@#!="%=WG+"#]&^C.\M-&V(QZ<E`M&%(#&$8"
M+R26BKYT9FQ023:,#NE-5EW40H-J"KE2`(;TDM^]7HI>STX("OQI;QSWD7LN
M0J@]'O0[U,FH&1NOR5%9`H&0&,HY(AE!\=.YHU49H4.=4:1H+XT@"AF3D#'*
M.2'#%WK^`YZE_7QT5CO=!8DL)<E7/4O[T=:MZ18NM0A%C!%UBJ%R?=7#'H[X
MA*<O^5V3/'(Z?L^GM,QF#J=7M%T%G53^Y,+S#@?FP%D&V_#0BP.<>WIJK?%'
MPBD9PH0G'6,.1O9>ZEF.N&`2<D9^UWB1;!<^.G?PP&!M_<T\@90+I<(51T+4
MXG0(*"9>$U@5M,S8:B=;23A#QLGO0>+#.#_E#!5&Q`IB0BE'.3BI.%<$T)!T
M\GN72@4.)("(\<&6`_+]3TC6N8A;D)QAR!!L0HE2R!GY74:,G)E;Z^,*OQTF
MS2"$U>P+)=<"*.&\P$SLU..HAS3%8`I9HUQ$94+VT(V2+/O2'I%KE_%*ZIK;
M>3T$84`D9(5R7L8PAB*8"CB[BZ9U!:9')_18U_J0+WJH<^7\A$DO:O#D"M\1
MB\N63NBQ?@<R2?3P@663D\I<U?F3;:T2LHM;]<F=UJ_Y#`!"Y2OGU$W*'KV-
M0Z)KXA*B$/NL7_5D\4/-R^]Y9=0\REA@!HET[P%8;!`.Z%KC1C=16%EP9X9=
MBM1YV2D;K4?9120.=WKE5OWL>-E[T[:=1*PL@H,ZR2%ULS)X"VBE5B$=7Z$`
MX4D#`X1O=<<Y&=8VJ$@ZZ@V[%8ERWG,E!)_D$SP;BSAH2OJD?[:GFT4I':SV
M:*%WVZ/^0%P\9W:_,KR'R,(ARG(@.PM*OGUPD^^'<.SSU%JC<$*4+Y/>O*%L
M5(:]C4[B*#.![/HOM;&]6?K>=CQ4U02E`//7PK[`^L57NY>!(5=0B7U<2G/#
MSYJK=<>=BMX1\:NW1R4(6?=ILC3BW9`7'-67\)LXC7%W/!;W_HO48_6*NR9W
ME->Q^FE*.=GBM(M1+DLH;4_H?$OWR4US-.*09UU*TS7FY*30G9]6?+&!2S%*
M;!DDF.D/22LET5PB-%"+%JX)TJR%+ZCB"Y>`065+7]FZVH^)?#-!9>E>Q\_F
M(&;\J?ZX$(]6%:0T.VFQY9[]R#$:WG='8Q^(I-QE?_6H+%=L:58*5K')UE*6
MC9$&26ZNGB_P6%:XO@^&Q38J:CN/8BP!DF@TXV*C85AZKY&""B;RIDF0HTF4
M"&8R&CXI\P6%&C@N290,(2N"((DTBF`3/,N@),N=8JLT4E/0+SYN(W&U8@Q\
M9+HI$:D+LCC2[(W%%$+C_RVC$.*H@M3N04;B*"H>:>/-@G#Z%<6#_O!8J9]A
M,C4M@%)Y$(>T*BY^@ZM97`G%W>\-%X<D?Z*'J*^Z"=SI%N"BC!!_%ZRG;GQ-
MO=A,MUL';'4//#BVZSX[]@J`M7L/E3+35SOT];`T,L:/^L&<P('41+:JH*UQ
M'11*S20`8>XI%#<?O9!N:_U^7US(X-7^:^(5&RZ-J5%08.$*Y,5S`A4E6CG&
M.UC?'+TWR\!OO8)?8@&3::N'8X$1QF5&5N-2Q0/,QA0Q8"3;"T!G)@@FK>4P
MZA.+&1)W/L;&:Z)(&0A4K4>0^ZKT"7SB/^'7HUUQRPW=(&IB30&$&A,BQ$B6
MZ?J_1]?#H3)+>[I>&[X0S[J!"ESK!\/3S01<X<Y^:[N>VQX,!^)>W)8964V\
MX@5F5,6L>60K7Z2P1RA2J!M."Z_PK5]`1[_$&+?^]KK:@?71!"U[TWHT]'=4
MP<$`;OBI=4OW$E_^>^&RAN&;B&3O8=^+3:+GL.-I_(ZB;/G#J*&;4Z+[>P?7
MNER=L$=0$QD`0C&`XJX?$K11TX%36)MH%4B7/0`NJTDA-49O-MA0DMLIG$`B
M^O%W`SCP^[O3(_@`9@#&1-S-.-T8^-+:3?<4J:Y7+<$SA\*;ZDP*SF,[%7@-
MX3W%)!9B4?%:ZN@9_X*2U23NZ[1)9UBI>)<CX,MO%D7FDCL')U5=_!$.4]<%
M'LKE1C"C%E:$#/S`DVTYX3]Q?9P@DG#2K6"C*#M,OLSC#UJ*GW1VBC1+KES0
M4>Y[<E\6\X`L/C9KD[ZX<BM<A]JXJ<I;/S5641=F6U=G<I2RK?,EGEN'H^?B
MI40+3(5NIRON!5=.Q\(L*095IB9"/C[*FU()\;NQ^!58W.F.9:<'`1]5(Q9(
MXO=B\<5Y\',ZEIT>!'QJW!2E/XBEK0@AV06JM_*(B-T!Q_C042U%E$O'6AFH
M*D_TXCPQI/@.(+K-:(^UCKC*;65&)HW5FT.F^$$A'PTTQB)@3OQ`$-R-GPA.
M!J3H:\Z3E-`S7XY1B<;SL)0ZC]7N_2A_W3I*7[>BD"KL[O%:LP__HK78O6G<
MD-].V:O0R_8BK0\Z'7$NP*Q>BV\@%RWZM((RD-Y&"9&!GT>27B51\,T5X6N?
M4TRJBY\)0A'$/0O-[)8;"0.#%THASDM'[%($#?/4DL'#M/R-(F)L-$$)Q)WX
MLWHM0<-O%JU(K[?RT8K]!@:0?:^(9W8V<(AX5BZ(]>?5!4>"<7YUH5Q2O>_Q
M`(R=-X4>@(U48P?!$,67_E!,<2%^&9V*LJS)`F6=[XBFN#2V-:OXY*-ZCNR7
M8$DC>;%3117\93M5"-4@$8#:HW;*>_T&G6[*ZX?6Z)UM0MG<WUK^XY?S%Q9A
M?=7"[RB27?@=Q(\HPL;+^@B)-89]I4^(66\X&7J9W18_&A/;Q.O)9"AN,\GL
ME<ML9%!/;M7H"QCD7E5#;B_A?UW?]H!C%W<%0T2,[ZI:0(_Y*-2^J!;5H)AS
M8WD-TB\I3T?D^EQLXM*RM[IIPO/>B52,75P)WY*#X\)K&D7G+DS%P%0U10$1
MHO!TB'+R(_]4EU2(G)R.YUIS<G`@4T!54PZ04'`])#[R!ORQ,U:[2_;/OH"S
M,ES?:S0B9F02MZK0CTT*0A6#,G*Q*$:V'#0'6N,WXT"9`)?KCH]%R4VC7[&H
M5X8D>HK$DN8NNBS`!5-#_F+%!]LU4)C;DML4$1)W*&J&!`W.O@Z&@ZF#=]3!
M6/.3Q(XI3`9B$Z(IFPI8O"Y(0$GY:RDSAR(2R1&XA"<"RP_E]%N:D4CGJQU8
M6&%V]`D<`W4"U8Q&Q!W,,]"^8&>N4(T)E2UF302R+S_MA.S4668S&I%$H62A
M5'WN<B$[U%J2SM297S.;D46I&8*I^DR%`K'J?*E\=Y%[^^@D-$F2A8*B<2M5
M,33+PYLO5HVI7]DU`TWOA`BD^%X:S42MR*(9LE@U.B&9-?-J?"4DH"YQDM&(
M)'HA"U6CTY!=+>`#6`D92->4-(J)FY%%-1F"U>ADXP`!\3(YU\N2`DWNF]=T
MQ,&3[<6U\OJ3L<`W-[E]\XEM810O5[67M[>U:[9LF$NO,Z`+<L&2EP]F\9LI
M'+E"J4QQ#R#*<94L4Q3?0^[ATDN[A'C=F#A8=##ID^X%.<E;=%Q53MOT2Q`N
M:#;8DY.](@1_0?]YUUT`?_-_4$L#!!0````(`#V(J$+S$$(N8@P``(Z"```0
M`!P`<&EP+3(P,3,P,S,Q+GAS9%54"0`#1KV*44:]BE%U>`L``00E#@``!#D!
M``#M7=USXC@2?[^J^Q]\O-SL`R&$R4Q-:K)[3@(W5"4A!V3V[EZVA"V#[FS)
M*\DD[%]_+=D&?T$,<1;GUB\S1NZ6NJ6?NEL?[GS]Z=ESC27F@C!ZV>J>G+8,
M3"UF$SJ_;#U.VN;D>CAL&4(B:B.747S9HJSUTX]__M/7O[3;UQPCB6UCMC*^
M$RK1'!L#X@*O,#ZTO@]:/[3;$:7/F1U80,JH<7;:[;5/S]NGGXV_&9\O3L\,
M\RXD?!;VA;`6V$.&1'R.Y3WRL/"1!<TNI/0O.IVGIZ<3?X&XA^0"4WQB,:^C
M*CSM];H@NXL]3.6`<>\&.RAPY67KUP"YQ"'8;AF@+!47/O%+5A?2/\^X2U(<
MJN2$\3F0GO8ZA*KNL7!,3P.OF-J6O"-7/NX`!>;$2C9@RS5/LO;S3OAR73>C
M):IGM)UM0M@IIJ=>W$*W\\^[VXGN]!:,@6'H44"4,HDDH$*7Q:6^3ZC#HB(H
MA+'^[X7Z9X8$'F/'>-8EG+EX1X>IUQT+N5;@ZB9N-Q6THAH6'#N7+1BI=CP:
MOP##"2@34RA-+UN">+Z+XS+$K5S3D:;=+U^^=#15![#H8RX)%IU8]'4WJ8+=
M[#%ICC*MXZ;F3B7=96.'4%*^MX#^#]Q;+IIAMUQ'`>D?N*-\C@48S#VF(7#\
M7_27DG`*PAOJX7$\W.D2=%]=,\\C4OD785+[FE$)G@Z\)6C0,H@=]I.%K'U%
M6PL6B[:9ZS]V3S\:;>.&",ME(N`8?B3$,,`K&RE!OG:R-60K#P2V1_1'_9RQ
MP1%S1+&+,6V-RO-EX5:><SVCR[,`=C&';L';V:+2&`MO"9$;+!%QTTBQJX3*
MQ]./I]V]P&)\B(3ZH8'-D6%#;4RA#7@0S"6VBJJOD*NBRLD"8YF$C3435<+F
M%.+OMC&!SM6AL\+,Z/ZF?S_IWZBGR>AV>&-.X<>5>6O>7_>-R;=^?SII$%-S
MQ#P@$`FX)('.3\/'KQ8_O4/P8WQ("=A8H./BZ899@1H^\%I]\!!R-81UGB(#
M?3?@L1$FU6)'.ZRH[>2C\E6A($9"D@8D1P7)@%"P+Q`^3#FB`EE*SX1G<F2U
MD>^G;#"S;M]("M"`HGZ@R`6[CJPXUOV4CW6+X=$$N74&RA3-7)S"2:5&I%?6
MB!@?0DD:D!P9)(CP[\@-\!U&:L#TRC4!CZ57K8_IY>`!`AA:`B,I0@.+^L'B
M'G$.&B]QWMLL/5JQO^F5AHKQ82W8#XWSJ3.`)H'G(;X:.=<+1.=8#.F:;.2,
M`GZ+E]B=+C@&0=&,N$06[>,!V`2SB+-DS'4K1]U9:=1%VAC,,2)]#$*3Y/`"
ME#*T5D;/2.C4X+3>.+46V`Y<`&5BS"("VY1KGF)HNAYREG:W:F#FP^^MP(S$
M5P!,*!!3V0:2">8&B[7&8BY@7WH51^SE_6P3LM<!)B,^1Y3\IO4SJ7T5"$*Q
M2$"$H5FU07O.]"1%T%N'L1`--(X*C8EDUG\7S+4Q%_U?`R)7&U1L3ONK`<5Y
M%A3)QO]JA,TW>#@N'H*9P+\&H&)_F5[8"]P]ZU4+B,\Y0*Q;-\+F&S34"@VY
M\!6:KSAL_9SW'3E4-/%G7?"1\Q[;=WR@(ZK&RGD!5@I<2K/=\RZ@LUE#_ZR&
MJ]C<"/94\0;.>7X#IQA$R45R+&&#I_KB*;L.%EA6:G]ZY0+:9A%<$X#$6\D3
M,J?$(1;,7].R6*"O6SXPEZ2O"0LF4*77L+H%AF:S(9R0RMB(9<1R->!Y!^#9
M$?PH,%4>_YP5Q<IE$=5$1>\69_K_509=E=JJL]?8*N-#*&`#IO<`IDW8/8%*
ML(*&?<T\'U.A>Z;_K!ZWF#3XQ\(5!^2OQ%XR3-<:M;5*1E(G(U*J,7SO"ZNY
MD%YAL.+#K5>!KPGUZP"F1XH"FTC]Z47^&XSUAQ!BY%PCL1BX["F!J<"R!+.<
M:B_1?\Y\@/%X;S[>#*?A!QA%GV),IO#?7?]^.C%&`^/:G'PS!K>CGYN/>MX+
MLD8^YBAS_5Y#BU6+K(^O0];HH3\VIT,@:)#U7I`%G%Q%,QQ#%0+6;[=,Y%!F
MN=7B[-,K<3;]UA\#P=W#N/\-J(??^\;M:-*@[MV@;FW/MGRV&,*NX@\7SZNR
M;LW'C&^`NZ^=;,J9J"2=FD8GIB&>S[@T:&&ZH&W9>L),0[?,TI7M8%&_VC%?
M6Q6UNV?M7O<$FHX32^PKQAJB>XH1\QTDAJY/8.MDSI8=&Q.5ZNBL?=IMJV1'
M6^0HY%$/[0WSGA+D<AN5[(*80>E^?F#G%R=)*B-`DO,^9%2"?%&#T/WT:G$.
M$^45<J0&EM`E%G)O/"38HN>#4.$@,=.*!:(]1\@O+4<A8P>[4L0EKY9'];.H
M2"!=U^'S)NYUO37`5WN/5I(O_G&0--F)^27T]Q3/E6,OAV&7\Q37+@Q':=VT
M))<MT[)X@.UHETTE6@F#UH`K'YRX8;X.'W[9@X42UU7[+)<M"2P0<*CL;Q>S
M,+7"9<OB&$*:N!C"%L+LJ<Z!%#H(9<V"F9!$!DKWOW,6^)>MD!I"(:]EA!F3
MPA*/42P17PWAC:IEA]97'"-K,7)4!A>.+!D@=Y/<Q7Q"W'[0PFR4+L]1K'-2
M.3O@42Z`/;2+F4IHI[9*U(GV$KDJ(KQ#,N!$KK(JO4!6`SU<),3ZCLF(C\E\
M(8="!`H]-X#SA"XOD[Z5/E!Y&5T46(3*##EZPO:43:#3A3E7]_6>50@)09PI
MH.LMK%,_CAQS/N=Z,D/[0CQP9F%LBP%G7A^`J-BC8X#$S'S31E[NO_TF+;A;
MQ:UD*=M_,LJJD4J\I#=R,WVPBS"K!P)9U8Q^!2YL>;%8*5V"F<9"&B%0/<BP
MEXZYA%<0[^N:LX/](O4;:%LT"_;0,>"AO<3V`*?!FWUSL/<X2(4]W,<-GLDA
M@)WK_"I#*F%1)N08YM'`98QO9MA&NSU8CCO1TH*NO8*RH7>`L05@[5\8\6V:
M[6!X(P,\5[7KEDIIQ\'?J9L4J:__O!E.:;2#Z,TG5)B5]L)F'B)EO.2N;$-F
M)%Q"MU+4=;,:X?V\D>-@Q6`^DX3=*'KW-C;>)I[:Q0UCETHTN=&#O$V7^&WM
M()<6L\`W;26H-["RAJ#X;<V'(Q,/%;ZL;PQ4^)UL`<)>HJL;T+9___N"3O4?
M,4*1^X!6.E<\A@7#%'/OEB$:95",0IN$FF49*@\8]HN$=#4#B$JS9B'WHG86
M05<THKA0\D1Y/07764(*14^]J:GP3ZQ8]$UY[017=G/D7.OUU`!9*N)=73'.
MV1.8@&OD0Y'>%U(39^3\(_X;$%>@![:CVU5BC"T,87/*HE5>\9%-PH'Z/-)9
ML4:O[JD=-1^]JR#P`&56IMJ2FX?.+#LS=A+5;YHP"*"P^FLH,_G`L1^Z,'CR
M2."MQ^8!_*9%?)0<W'T9CSUV^\D;[AB#@3M8XT0-1U;]#CT3+_"BO%7Z*S&]
MC0P2/5(;<UT21],;??=DJ^NYR#V&,6(.D6,LH13J5GO!>AOY"CN,XQNBXL*9
M;G;`>/949-,AKZ^IMKM_]XSJRZAQ[DO3DF2I;%ANL^5ERKHM4^Z9Q`)B<R73
M^G!@/4W'\40V/>5MDHKNQ?;"T-IX=IR1U>>80VHQ3U_4`UAB,J?AP::U2J0X
M-:FM?X47C<#IJN,G?=U<O[7_$PB],S_&X*=_`S?M,ZI/4WCH\=*IP'_YO=NM
M[=0J/)M:XRB$SQC;V//3';@OWY&=3%+<M:&,CCZ*E<I3'5L%=4?1U'<4LT%=
MP:O:A7+)H\[XF%@Y'P_`JGTUS+0X<T!"L[VXZFKEBK5(1FQ[*+^5K:[:C[&"
M"'C#?4.\O1GK&N3I`_VK[,>#B178U6I#$NW3:;.SWI\T0>O0E`H3YAURP6,Y
M&`3E>)RZEO$[-'5D.[CS([B"?>NR]'4+#%_^V*^DCK7?S\ZG)RD:QEU$M1N[
MXH0KN[1Y'Z,$(;-:6R[Q`]C4Z1,\K_Z-.9O@):;9J*0T0^UBE;6CP;8VB;!$
M7JJ_]0@RZG47N%U-\A!P:P&&-.^Z#Z^AMBN%T->&CB%Q)U.%(AF]MQ$=_W[C
M)/#]L`"Y49>'@S2D("W%>LGW,Y&+9)"5T.XP]KH&9I$*_6>?A`VE;WAN>7W<
M6YWQ1`G[?<KB"918$B0'8\K4,:<)ZU-=24ZY@^MYHUX0^NIG^7Y0>Q/6`@_`
MP&;-[W:*VMG;C*@%!\#;*6JN3,&1\%:"FJM2Z.1WD-1='?+\@C(;@IJK4GA\
MOX.D[NKD#_2W$AQ3E?"#SO!K(?CY/U!+`0(>`Q0````(`#V(J$+(%(K\27X`
M`![-!``0`!@```````$```"D@0````!P:7`M,C`Q,S`S,S$N>&UL550%``-&
MO8I1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`/8BH0CI!\QL&#@``):L`
M`!0`&````````0```*2!DWX``'!I<"TR,#$S,#,S,5]C86PN>&UL550%``-&
MO8I1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`/8BH0@&!MR!$'@``'<$!
M`!0`&````````0```*2!YXP``'!I<"TR,#$S,#,S,5]D968N>&UL550%``-&
MO8I1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`/8BH0M/KT:]S=0``"SH'
M`!0`&````````0```*2!>:L``'!I<"TR,#$S,#,S,5]L86(N>&UL550%``-&
MO8I1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`/8BH0E#1%.LF,@``L`X#
M`!0`&````````0```*2!.B$!`'!I<"TR,#$S,#,S,5]P<F4N>&UL550%``-&
MO8I1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`/8BH0O,00BYB#```CH(`
M`!``&````````0```*2!KE,!`'!I<"TR,#$S,#,S,2YX<V155`4``T:]BE%U
D>`L``00E#@``!#D!``!02P4&``````8`!@`4`@``6F`!````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E5WAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (2,111,385)<span></span></td>
        <td class="num">$ (2,679,888)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of derivative instruments</a></td>
        <td class="nump">905,777<span></span></td>
        <td class="nump">991,662<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
        <td class="nump">52,602<span></span></td>
        <td class="nump">85,910<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on the disposal of property and equipment</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(66,626)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expenses</a></td>
        <td class="nump">9,743<span></span></td>
        <td class="nump">150,405<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
        <td class="nump">32,431<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
        <td class="nump">328,581<span></span></td>
        <td class="nump">548,664<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
        <td class="nump">566,725<span></span></td>
        <td class="nump">3,278,062<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInUnbilledReceivables', window );">Unbilled accounts receivable</a></td>
        <td class="nump">400,645<span></span></td>
        <td class="num">(1,254,867)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">39,486<span></span></td>
        <td class="nump">137,362<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
        <td class="num">(407,653)<span></span></td>
        <td class="num">(35,280)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
        <td class="nump">950,800<span></span></td>
        <td class="nump">131,338<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
        <td class="num">(507,351)<span></span></td>
        <td class="num">(495,372)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
        <td class="nump">260,401<span></span></td>
        <td class="nump">791,370<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
        <td class="num">(25,468)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from the sale of property and equipment</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">67,400<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided (used) by investing activities</a></td>
        <td class="num">(25,468)<span></span></td>
        <td class="nump">67,400<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants', window );">Proceeds from issuance of long-term debt</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">2,500,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit', window );">Net (repayment of) proceeds from revolving credit agreement</a></td>
        <td class="num">(1,274)<span></span></td>
        <td class="nump">857,808<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred financing costs</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(220,234)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Controlled equity offering issuance costs</a></td>
        <td class="num">(112,500)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities', window );">Change in restricted cash requirements</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">100,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
        <td class="nump">53,413<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(32,960)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used) provided by financing activities</a></td>
        <td class="num">(60,361)<span></span></td>
        <td class="nump">3,204,614<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effects of exchange rates on cash</a></td>
        <td class="num">(2,678)<span></span></td>
        <td class="nump">4,034<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increases in cash and cash equivalents</a></td>
        <td class="nump">171,894<span></span></td>
        <td class="nump">4,067,418<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, at beginning of period</a></td>
        <td class="nump">12,701,517<span></span></td>
        <td class="nump">11,236,771<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, at end of period</a></td>
        <td class="nump">12,873,411<span></span></td>
        <td class="nump">15,304,189<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid for interest</a></td>
        <td class="nump">67,360<span></span></td>
        <td class="nump">3,028<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_NonCashFinancingActivityAbstract', window );"><strong>Noncash financing activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt', window );">Value of warrants issued to lender in connection with loan</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 69,876<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_NonCashFinancingActivityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_NonCashFinancingActivityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from Issuance of Long Term Debt and Warrants</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_ProceedsFromIssuanceOfLongTermDebtAndWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Supplemental warrant issued in connection with long-term debt</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_SupplementalWarrantIssuedInConnectionWithLongTermDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 8, 9<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7, 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7<br><br> -Footnote 1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 289<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 45<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6889476&amp;loc=d3e330036-122817<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 6<br><br> -Section I<br><br> -Subsection 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredIncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The effect of exchange rate changes on cash balances held in foreign currencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 25<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The difference between the sale price or salvage price and the book value of a property, plant, and equipment asset that was sold or retired during the reporting period. This element refers to the gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnSaleOfPropertyPlantEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of accrued expenses and other operating obligations not separately disclosed in the statement of cash flows.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInDeferredRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInUnbilledReceivables">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period of the amount of revenue for work performed for which billing has not occurred, net of uncollectible accounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInUnbilledReceivables</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 29<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from financing activity for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from investing activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e565-108580<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaidInKindInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for loan and debt issuance costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18, 19, 20<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfFinancingCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for cost incurred directly with the issuance of an equity security.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18, 19, 20<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfStockIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 17<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from other financing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18, 19, 20<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3095-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3098-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -Subparagraph c<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3098-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromRepaymentsOfLinesOfCredit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from cash and cash items that are not available for withdrawal or usage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 16<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SupplementalCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrealizedGainLossOnDerivatives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E2NAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Measurements (Summary of Changes in Fair Value of Our Level 3 Liabilities) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized Gains (Losses)</a></td>
        <td class="num">$ (905,777)<span></span></td>
        <td class="num">$ (991,662)<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value, Inputs, Level 3 [Member] | Warrants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure', window );">Beginning Balance</a></td>
        <td class="nump">1,295,613<span></span></td>
        <td class="nump">1,886,652<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized Gains (Losses)</a></td>
        <td class="num">(905,777)<span></span></td>
        <td class="num">(991,662)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure', window );">Ending Balance</a></td>
        <td class="nump">$ 2,201,390<span></span></td>
        <td class="nump">$ 2,878,314<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative instrument obligations meeting the definition of a liability which the Company is a party to as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 15<br><br> -Paragraph 83<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6913464&amp;loc=d3e34841-113949<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 133<br><br> -Paragraph 10<br><br> -Subparagraph i<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 133<br><br> -Paragraph 6<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrealizedGainLossOnDerivatives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EWUAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies (Details) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2009</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>Initial Maximum Maintenance Failure Obligation [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>Every 30 days until failure is cured [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011

</div>
          <div>PharmAthene [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011

</div>
          <div>PharmAthene [Member]

</div>
          <div>Maximum [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_PercentageOfNetProfitAwarded', window );">SIGA breach of contractual obligation awarded, percentage of net profits (as defined in court's final judgement)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_BreachOfContractualCommitmentAwardPeriod', window );">SIGA breach of contractual obligation award period following initial commercial sale</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract', window );">SIGA net profits (as defined in court's final judgement) before distribution for breach of contract</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 40<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_CourtAwardedFees', window );">Awarded 1/3 reasonable attorney's fees and expert witness fees, plus interest.</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2.4<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_WarrantExpirationDate', window );">Warrant expiration date</a></td>
        <td class="text">Mar. 30,
         2022<span></span></td>
        <td class="text">Jan. 28,
         2015<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_PercentageOfAggregatePrincipalAmountRedemption', window );">Percentage of aggregate principal amount of convertible Notes</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.00%<span></span></td>
        <td class="nump">1.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_NotesPayableAggregatePrincipalRepaymentAmount', window );">Aggregate principal amount of obligation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.2<span></span></td>
        <td class="nump">$ 0.2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_BreachOfContractualCommitmentAwardPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Breach of contractual commitment award period - number of years following initial commercial sale of ArestvyrTM.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_BreachOfContractualCommitmentAwardPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_CommitmentsAndContingenciesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_CommitmentsAndContingenciesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_CourtAwardedFees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Court awarded fees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_CourtAwardedFees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net profit on ArestvyrTM (as defined in court's final judgement) before distribution for breach of contract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_NetProfitRetentionFromSalesBeforeDistributionForBreachOfContract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_NotesPayableAggregatePrincipalRepaymentAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Initial maximum maintenance failure obligation and additional maximum obligation every 30th daily after initial maintenance failure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_NotesPayableAggregatePrincipalRepaymentAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_PercentageOfAggregatePrincipalAmountRedemption">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of aggregate principal amount of convertible notes relating to the affected shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_PercentageOfAggregatePrincipalAmountRedemption</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_PercentageOfNetProfitAwarded">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of net profits (as defined in court's final judgement) awarded on the sales of ArestvyrTM and related products.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_PercentageOfNetProfitAwarded</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_WarrantExpirationDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrant, Expiration Date</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_WarrantExpirationDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.1.0.1
 *
 */

var moreDialog = null;
var Show = {
    Default:'raw',

    more:function( obj ){
        var bClosed = false;
        if( moreDialog != null )
        {
			try
			{
				bClosed = moreDialog.closed;
			}
			catch(e)
			{
				//Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control
				// that somtimes causes it to throw when checking the closed property on a child window that has been
				//closed.  So if the exception occurs we assume the window is closed and move on from there.
				bClosed = true;
			}

			if( !bClosed ){
				moreDialog.close();
			}
        }

        obj = obj.parentNode.getElementsByTagName( 'pre' )[0];
		var hasHtmlTag = false;
		var objHtml = '';
		var raw = '';

		//Check for raw HTML
		var nodes = obj.getElementsByTagName( '*' );
		if( nodes.length ){
			objHtml = obj.innerHTML;
		}else{
			if( obj.innerText ){
				raw = obj.innerText;
			}else{
				raw = obj.textContent;
			}

			var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g );
			if( matches && matches.length ){
				objHtml = raw;

				//If there is an html node it will be 1st or 2nd,
				//   but we can check a little further.
				var n = Math.min( 5, matches.length );
				for( var i = 0; i < n; i++ ){
					var el = matches[ i ].toString().toLowerCase();
					if( el.indexOf( '<html' ) >= 0 ){
						hasHtmlTag = true;
						break;
					}
				}
			}
		}

        if( objHtml.length ){
			var html = '';

			if( hasHtmlTag ){
				html = objHtml;
			}else{
				html = '<html>'+
					"\n"+'<head>'+
					"\n"+'    <title>Report Preview Details</title>'+
					"\n"+'    <style type="text/css">'+
					"\n"+'    body {'+
					"\n"+'    }'+
					"\n"+'    table {'+
					"\n"+'    }'+
					"\n"+'    </style>'+
					"\n"+'</head>'+
					"\n"+'<body>'+
						objHtml +
					"\n"+'</body>'+
					"\n"+'</html>';
			}

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write( html );
			moreDialog.document.close();

			if( !hasHtmlTag ){
				moreDialog.document.body.style.margin = '0.5em';
			}
        }
        else
        {
			//default view logic
			var lines = raw.split( "\n" );
			var longest = 0;

			if( lines.length > 0 ){
				for( var p = 0; p < lines.length; p++ ){
					longest = Math.max( longest, lines[p].length );
				}
			}

			//Decide on the default view
			this.Default = longest < 120 ? 'raw' : 'formatted';

			//Build formatted view
			var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ;
			var formatted = '';

			if( text.length > 0 ){
				if( text.length == 1 ){
					text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ;
					formatted = "<p>"+ text.join( "<br /><br />\n" ) +"</p>";
				}else{
					for( var p = 0; p < text.length; p++ ){
						formatted += "<p>" + text[p] + "</p>\n";
					}
				}
			}else{
				formatted = '<p>' + raw + '</p>';
			}

			html = '<html>'+
				"\n"+'<head>'+
				"\n"+'    <title>Report Preview Details</title>'+
				"\n"+'    <style type="text/css">'+
				"\n"+'    body {'+
				"\n"+'       background-color: #f0f9ee;'+
				"\n"+'       font-family: Arial, san-serif; font-size: 0.8em;'+
				"\n"+'    }'+
				"\n"+'    table {'+
				"\n"+'       font-size: 1em;'+
				"\n"+'    }'+
				"\n"+'    </style>'+
				"\n"+'</head>'+
				"\n"+'<body>'+
				"\n"+'    <table border="0" width="100%">'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            formatted: <a href="javascript:void(0);" onclick="opener.Show.toggle( window, this );">'+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +'</a>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <div id="formatted" style="display: none;">'+formatted+'</div>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <pre id="raw" style="display: none; font-size: 1.2em;">'+raw+'</pre>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    </table>'+
				"\n"+'</body>'+
				"\n"+'</html>';

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write(html);
			moreDialog.document.close();

			this.toggle( moreDialog );
        }

		moreDialog.document.title = 'Report Preview Details';
    },

    toggle:function( win, domLink ){
        var domId = this.Default;

        var doc = win.document;
        var domEl = doc.getElementById( domId );
        domEl.style.display = 'block';

        this.Default = domId == 'raw' ? 'formatted' : 'raw';

        if( domLink ){
            domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed';
        }

        var domElOpposite = doc.getElementById( this.Default );
        domElOpposite.style.display = 'none';
    },

	LastAR : null,
	showAR : function ( link, id, win ){
		if( Show.LastAR ){
			Show.hideAR();
		}

		var ref = link;
		do {
			ref = ref.nextSibling;
		} while (ref && ref.nodeName != 'TABLE');

		if (!ref || ref.nodeName != 'TABLE') {
			var tmp = win ?
				win.document.getElementById(id) :
				document.getElementById(id);

			if( tmp ){
				ref = tmp.cloneNode(true);
				ref.id = '';
				link.parentNode.appendChild(ref);
			}
		}

		if( ref ){
			ref.style.display = 'block';
			Show.LastAR = ref;
		}
	},

	toggleNext : function( link ){
		var ref = link;

		do{
			ref = ref.nextSibling;
		}while( ref.nodeName != 'DIV' );

		if( ref.style &&
			ref.style.display &&
			ref.style.display == 'none' ){
			ref.style.display = 'block';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '+', '-' );
			}else{
				link.innerText = link.innerText.replace( '+', '-' );
			}
		}else{
			ref.style.display = 'none';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '-', '+' );
			}else{
				link.innerText = link.innerText.replace( '-', '+' );
			}
		}
	},

	hideAR : function(){
		Show.LastAR.style.display = 'none';
	}
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Organization and Business<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization and Business [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Business</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Note 1 - Organization and Business</strong></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We are a biopharmaceutical company focused on developing biodefense countermeasure applications. We are subject to those risks associated with any biopharmaceutical company that has substantial expenditures for research and development. There can be no assurance that our research and development projects will be successful, that products developed will obtain necessary regulatory approval, or that any approved product will be commercially viable. In addition, we operate in an environment of rapid technological change and are largely dependent on the services and expertise of our employees, consultants and other third parties.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Historically, we have performed under government contracts and grants and raised funds from investors to sustain our operations.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 852<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2209116<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122150<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7668296&amp;loc=d3e288-107754<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2134480<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 720<br><br> -SubTopic 15<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122524<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS140-4/FIN46(R)-8<br><br> -Paragraph 8, C1, C7<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197480<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Statement of Position (SOP)<br><br> -Number 94-6<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 46R<br><br> -Paragraph 4, 14, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 272<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7880789&amp;loc=SL6228881-111685<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 2-6<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 235<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472506&amp;loc=d3e38932-110933<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E6FAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
        <td class="nump">$ 0.0001<span></span></td>
        <td class="nump">$ 0.0001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">100,000,000<span></span></td>
        <td class="nump">100,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">48,416,483<span></span></td>
        <td class="nump">48,352,651<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump">48,416,483<span></span></td>
        <td class="nump">48,352,651<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StatementOfFinancialPositionAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Summary of Warrants Outstanding</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> At March 31, 2013 and 2012 there were warrants outstanding to purchase 5,620,128 shares of our common stock, respectively. The warrants outstanding as of March 31, 2013 and 2012 were as follows:</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Number of Common Shares Underlying Warrants</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Issue Date/Exercisable Date</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Exercise Price</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Expiration Date</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 22%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 100,778</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (1)</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 24%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Mar-07 / Mar-07</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 21%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 3.97</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 23%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Mar-17</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 705,354</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (2)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Mar-09 / Sep-09</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 3.00</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Sep-14</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2,572,775</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (1)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jul-09 / Jan-10</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2.50</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jan-15</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 500,000</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (2)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Apr-10 / Oct-10</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1.89</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Oct-15</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1,323,214</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (2)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jul-10 / Jan-11</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1.63</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jan-17</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 371,423</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (2)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jun-11 / Jun-11</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 3.50</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jun-16</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 46,584</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (1)</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Mar-12 / Mar-12</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1.61</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Mar-22</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 5,620,128</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 3%">&nbsp;</td> <td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 5%"> (1)</td> <td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 92%"> These warrants to purchase common stock are classified as equity.</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 3%">&nbsp;</td> <td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 5%"> (2)</td> <td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 92%"> These warrants to purchase common stock are classified as derivative liabilities. The fair value of these liabilities (see note 3) is remeasured at the end of every reporting period and the change in fair value is reported in the unaudited condensed consolidated statements of operations as other income (expense).</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 28<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section S99<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number D-98<br><br> -Paragraph 2<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E1CAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>May 02, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Mar. 31,
         2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
        <td class="text">PIP<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">PHARMATHENE, INC<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0001326190<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Accelerated Filer<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">49,460,686<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Trading symbol of an instrument as listed on an exchange.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_TradingSymbol</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Financing Transactions (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Financing Transactions [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Principal Payments On The Term Loan</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <table style="WIDTH: 35%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Year</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Principal<br /> Payments</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 15%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2013</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 15%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $749,997</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2014</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 999,996</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2015</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 750,007</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $2,500,000</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Term Loan, Net of Debt Discount</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The term loan, net of discount of $39,587, is recorded on the 2013 condensed consolidated balance sheet, net of debt discount, as follows:</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 54%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 40%; FONT: 10pt Times New Roman, Times, Serif"> Current portion of long-term debt</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"> 999,996</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Long-term debt, less current portion</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 1,460,417</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDebtTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EYSAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractsRevenue', window );">Contract revenue</a></td>
        <td class="nump">$ 6,475,138<span></span></td>
        <td class="nump">$ 6,149,052<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
        <td class="nump">5,233,475<span></span></td>
        <td class="nump">4,705,357<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
        <td class="nump">2,279,795<span></span></td>
        <td class="nump">2,948,481<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">52,602<span></span></td>
        <td class="nump">85,910<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
        <td class="nump">7,565,872<span></span></td>
        <td class="nump">7,739,748<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
        <td class="num">(1,090,734)<span></span></td>
        <td class="num">(1,590,696)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
        <td class="nump">783<span></span></td>
        <td class="nump">2,988<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
        <td class="num">(99,791)<span></span></td>
        <td class="num">(3,028)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
        <td class="num">(6,123)<span></span></td>
        <td class="nump">52,915<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of derivative instruments</a></td>
        <td class="num">(905,777)<span></span></td>
        <td class="num">(991,662)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
        <td class="num">(1,010,908)<span></span></td>
        <td class="num">(938,787)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Net loss before income taxes</a></td>
        <td class="num">(2,101,642)<span></span></td>
        <td class="num">(2,529,483)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
        <td class="num">(9,743)<span></span></td>
        <td class="num">(150,405)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (2,111,385)<span></span></td>
        <td class="num">$ (2,679,888)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share</a></td>
        <td class="num">$ (0.04)<span></span></td>
        <td class="num">$ (0.06)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares used in calculation of basic and diluted net loss per share</a></td>
        <td class="nump">48,359,181<span></span></td>
        <td class="nump">48,269,894<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractsRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period arising from products sold or services provided under the terms of a contract, not elsewhere specified in the taxonomy. May include government contracts, construction contracts, and any other contract related to a particular project or product.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ContractsRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The component of income tax expense for the period representing amounts of income taxes paid or payable (or refundable) for the period for all income tax obligations as determined by applying the provisions of relevant enacted tax laws to relevant amounts of taxable Income or Loss from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 289<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6889476&amp;loc=d3e330036-122817<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 45<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 6<br><br> -Section I<br><br> -Subsection 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CurrentIncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 1(i)<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeStatementAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 9<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher OTS<br><br> -Name Federal Regulation (FR)<br><br> -Number Title 12<br><br> -Section 563c.102<br><br> -Paragraph 9<br><br> -Chapter V<br><br> -Subsection II<br><br> -LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy.  It will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 34<br><br> -Paragraph 21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-04.9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 115<br><br> -Paragraph 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 7<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentIncomeInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e565-108580<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 7<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpenseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 9<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 141<br><br> -Paragraph 51<br><br> -Subparagraph g<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 86<br><br> -Paragraph 11, 12<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 985<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 2<br><br> -Paragraph 12, 13<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrealizedGainLossOnDerivatives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Financing Transactions<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Financing Transactions [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Financing Transactions</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Note 6 - Financing Transactions</strong></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Controlled Equity Offering</em></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On March 25, 2013, we entered into a controlled equity offering with a sales agent pursuant to which we may offer and sell, from time to time, through the agent shares of our common stock having an aggregate offering price of up to $15.0 million. Under the arrangement, the agent may sell shares by any method permitted by law and deemed to be an "at-the-market" offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, including sales made directly on NYSE MKT, or any other existing trading market for our Common Stock or to or through a market maker. We are not obligated to sell any shares under the arrangement. Subject to the terms and conditions of that agreement, the agent will use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable state and federal law, rules and regulations and the rules of NYSE MKT, to sell shares from time to time based upon our instructions. We are obligated to pay the agent a commission of 3.0% of the aggregate gross proceeds from each sale of shares. Total expenses incurred for the offering, excluding commission payable to the agent, were approximately $277,000. Through March 31, 2013, we sold 19,900 shares of our common stock under this arrangement, which did not settle until April 2013, that resulted in net proceeds to the company of approximately $33,000. As of March 31, 2013, aggregate gross sales for additional common stock of approximately $14.97 million remained available under the arrangement.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Loan Agreement with GE Capital</em></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On March 30, 2012, we entered into a Loan Agreement with GE Capital. The Loan Agreement provides for a senior secured debt facility including a $2.5 million term loan and a revolving line of credit of up to $5 million based on our outstanding qualified accounts receivable. On March 30, 2012, the term loan was funded for an aggregate amount of $2.5 million.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Under the terms of the revolving line of credit, the Company may draw down from the revolving line of credit up to 85% of qualified billed accounts receivable and 80% of qualified unbilled accounts receivable. As of March 31, 2013, the total amount available to draw was approximately $2.3 million, of which $1.3 million was drawn and outstanding.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The fixed interest rate on the term loan is 10.14% per annum. The revolving line of credit has an adjustable interest rate based upon the 3-month London Interbank Offered Rate (LIBOR), with a floor of 1.5%, plus 5%. As of March 31, 2013, the interest rate was 6.5%. Both the term loan and the revolving line of credit mature in September 2015. Payments on the term loan were originally interest-only for the first 10 months, which has since been extended to 12 months pursuant to terms of the agreement. Subsequently, the term loan will fully amortize over its remaining term as of March 31, 2013. Principal payments on the term loan are scheduled as follows:</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 35%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Year</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Principal<br /> Payments</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 15%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2013</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 15%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $749,997</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2014</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 999,996</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2015</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 750,007</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $2,500,000</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The term loan, net of discount of $39,587, is recorded on the 2013 condensed consolidated balance sheet, net of debt discount, as follows:</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 54%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 40%; FONT: 10pt Times New Roman, Times, Serif"> Current portion of long-term debt</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"> 999,996</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Long-term debt, less current portion</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 1,460,417</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> If we prepay the term loan and terminate the revolving line of credit prior to the scheduled maturity date, we are obligated to pay a prepayment premium equal to 3% of the then outstanding principal amount of the term loan if prepaid during the first two years of the loan and 2% if prepaid during the third year or thereafter. In addition, we are obligated to pay a final payment fee of 3% of the term loan balance. The final payment fee is being accrued and expensed over the term of the agreement, using the effective interest method and is included in other long-term liabilities on the condensed consolidated balance sheet.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Our obligations under the Loan Agreement are collateralized by a security interest in substantially all of our assets. While the security interest does not, except in limited circumstances, cover our intellectual property, it does cover any proceeds received by us from the use or sale of our intellectual property.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In connection with the Loan Agreement, we issued GE Capital warrants to purchase 46,584 shares of the Company&#39;s common stock at an exercise price of $1.61 per share. The warrants are exercisable immediately and subject to customary and standard anti-dilution adjustments. The warrants are classified in equity and, as a result, the fair value of the warrants was charged to additional paid-in capital resulting in a debt discount at the date of issuance. The debt discount is being amortized over the term of the loan agreement using the effective interest method. Financing costs incurred in connection with this agreement are also being amortized over the term of the agreement using the effective interest method.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The fair value of the Company&#39;s outstanding borrowings under its revolving credit facility at March 31, 2013 was consistent with its carrying value as of that date primarily due to the short term nature of the Revolver&#39;s repayment terms. The Company determined the fair value of the Term Loan approximated its carrying value as of March 31, 2013.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalFinancialInformationDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Note 5 - Stockholders&#39; Equity</strong></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Long-Term Incentive Plan</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In 2007, the Company&#39;s stockholders approved the 2007 Long-Term Incentive Compensation Plan (the "2007 Plan") which provides for the granting of incentive and non-qualified stock options, stock appreciation rights, performance units, restricted common awards and performance bonuses (collectively "awards") to Company officers and employees. Additionally, the 2007 Plan authorizes the granting of non-qualified stock options and restricted stock awards to Company directors and to independent consultants.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In 2008, the Company&#39;s shareholders approved amendments to the 2007 Plan, increasing from 3.5 million shares to 4.6 million shares the maximum number of shares authorized for issuance under the plan and adding an evergreen provision pursuant to which the number of shares authorized for issuance under the plan will increase automatically in each year, beginning in 2009 and continuing through 2015, according to certain limits set forth in the 2007 Plan. At March 31, 2013, there are approximately 9.3 million shares approved for issuance under the 2007 plan, of which approximately 2.6 million shares are available to be issued. The Board of Directors in conjunction with management determines who receives awards, the vesting conditions and the exercise price. Options may have a maximum term of ten years.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <br /> <em>Warrants Classified as Equity</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In connection with the July 2009 private placement, we issued warrants to purchase an aggregate of 2,572,775 shares of the Company&#39;s common stock at an exercise price of $2.50 per share. The warrants will expire on January 28, 2015. Also outstanding are warrants to purchase an aggregate of 100,778 shares of common stock at $3.97 per share, which will expire on March 30, 2017.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In connection with the March 30, 2012, debt financing (see Note 6), we issued warrants to purchase an aggregate of 46,584 shares of the Company&#39;s common stock at an exercise price of $1.61 per share to GE Capital Equity Investments, Inc. The relative fair value attributable to the warrants of $69,876 was recorded in equity during the quarter ended March 31, 2012. The warrants will expire on March 30, 2022.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Warrants</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> At March 31, 2013 and 2012 there were warrants outstanding to purchase 5,620,128 shares of our common stock, respectively. The warrants outstanding as of March 31, 2013 and 2012 were as follows:</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Number of Common Shares Underlying Warrants</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Issue Date/Exercisable Date</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Exercise Price</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Expiration Date</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 22%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 100,778</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (1)</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; WIDTH: 24%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Mar-07 / Mar-07</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 21%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 3.97</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 23%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Mar-17</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 705,354</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (2)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Mar-09 / Sep-09</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 3.00</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Sep-14</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2,572,775</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (1)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jul-09 / Jan-10</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2.50</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jan-15</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 500,000</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (2)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Apr-10 / Oct-10</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1.89</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Oct-15</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1,323,214</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (2)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jul-10 / Jan-11</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1.63</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jan-17</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 371,423</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (2)</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jun-11 / Jun-11</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 3.50</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Jun-16</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 46,584</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> (1)</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: center; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Mar-12 / Mar-12</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1.61</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Mar-22</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 5,620,128</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt"> &nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 2.5pt; FONT-SIZE: 10pt">&nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 3%">&nbsp;</td> <td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 5%"> (1)</td> <td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 92%"> These warrants to purchase common stock are classified as equity.</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 3%">&nbsp;</td> <td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 5%"> (2)</td> <td style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; WIDTH: 92%"> These warrants to purchase common stock are classified as derivative liabilities. The fair value of these liabilities (see note 3) is remeasured at the end of every reporting period and the change in fair value is reported in the unaudited condensed consolidated statements of operations as other income (expense).</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable).  Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187143-122770<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Section B<br><br> -Paragraph 7, 11A<br><br> -Chapter 1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 5<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 20: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 21: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 22: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 23: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EP2AE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Measurements (Narrative) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="4">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>Fair Value, Inputs, Level 3 [Member]

</div>
          <div>Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012

</div>
          <div>Fair Value, Inputs, Level 3 [Member]

</div>
          <div>Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>Fair Value, Inputs, Level 3 [Member]

</div>
          <div>Warrants [Member]

</div>
          <div>Derivative Liabilities [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 28, 2013

</div>
          <div>Fair Value, Inputs, Level 3 [Member]

</div>
          <div>Warrants [Member]

</div>
          <div>Derivative Liabilities [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Fair Value, Inputs, Level 3 [Member]

</div>
          <div>Warrants [Member]

</div>
          <div>Derivative Liabilities [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012

</div>
          <div>Fair Value, Inputs, Level 3 [Member]

</div>
          <div>Warrants [Member]

</div>
          <div>Derivative Liabilities [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 30, 2012

</div>
          <div>Fair Value, Inputs, Level 3 [Member]

</div>
          <div>Warrants [Member]

</div>
          <div>Derivative Liabilities [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 30, 2011

</div>
          <div>Fair Value, Inputs, Level 3 [Member]

</div>
          <div>Warrants [Member]

</div>
          <div>Derivative Liabilities [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_FairValueMeasurementsLineItems', window );"><strong>Fair Value Measurements [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,899,991<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,899,991<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of derivative instruments</a></td>
        <td class="nump">$ 905,777<span></span></td>
        <td class="nump">$ 991,662<span></span></td>
        <td class="nump">$ 905,777<span></span></td>
        <td class="nump">$ 991,662<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price, per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.70<span></span></td>
        <td class="nump">$ 1.12<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.77<span></span></td>
        <td class="nump">$ 1.27<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_FairValueMeasurementsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_FairValueMeasurementsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate amount of each class of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Price of a single share of a number of saleable stocks of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrealizedGainLossOnDerivatives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EFLAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Narrative) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment</a></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfReimbursableExpense', window );">Cost reimbursed to offset research and development expenses</a></td>
        <td class="nump">$ 20,000<span></span></td>
        <td class="nump">$ 500,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate', window );">Share-based compensation forfeitures rate</a></td>
        <td class="nump">12.00%<span></span></td>
        <td class="nump">12.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share options granted to employees</a></td>
        <td class="nump">60,000<span></span></td>
        <td class="nump">15,948<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized share-based compensation expense related to unvested awards</a></td>
        <td class="nump">2,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized share-based compensation expense related to unvested awards expected to be recognized in the period</a></td>
        <td class="text">2 years 3 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
        <td class="nump">$ 9,743<span></span></td>
        <td class="nump">$ 150,405<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
        <td class="nump">11,600,000<span></span></td>
        <td class="nump">11,500,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Liquidity Arrangements [Member] | Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_CashEquivalentsMaturityPeriod', window );">Cash liquidity maturity period</a></td>
        <td class="text">3 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_CashEquivalentsMaturityPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash Equivalents, Maturity Period</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_CashEquivalentsMaturityPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Share based Compensation Arrangement by Share based Payment Award, Fair Value Assumptions, Annual Forfeiture Rate</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_SignificantAccountingPoliciesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_SignificantAccountingPoliciesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 07-4<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 171<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 40<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 13, 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfReimbursableExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cost associated with reimbursable income. This occurs when a services entity incurs expenses on behalf of the client and passes through the cost of reimbursable expenses to a client.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostOfReimbursableExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the aggregate unrecognized cost of equity-based awards made to employees under equity-based compensation awards that have yet to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph h<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 45<br><br> -Subparagraph a, b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NumberOfOperatingSegments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-based Compensation Expense</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Share-based compensation expense for the three months ended March 31, 2013 and 2012 was:</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="6">Three months ended March 31,</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">2013</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">2012</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt" colspan="2">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 72%; FONT: 10pt Times New Roman, Times, Serif"> Research and development</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"> 88,634</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"> 117,067</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> General and administrative</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 239,947</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 431,597</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Total share-based compensation expense</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 328,581</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 548,664</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph g(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 64<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6793087&amp;loc=d3e301413-122809<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Subsequent Events<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Event [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Note 7 - Subsequent Events</strong></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Subsequent to March 31, 2013, we sold 1,030,870 shares of our common stock under the controlled equity offering, which resulted in net proceeds of approximately $1.63 million. (See Note 6). A<font style="COLOR: black">ggregate gross proceeds of up to approximately $13.29 million remain available under</font> the arrangement.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EBOAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policy)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Basis of Presentation</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Our unaudited condensed consolidated financial statements include the accounts of PharmAthene, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. Our unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP"). In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly our financial position, results of operations and cash flows. The unaudited condensed consolidated balance sheet at December 31, 2012 has been derived from audited consolidated financial statements at that date. The interim results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosure normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the U.S. Securities and Exchange Commission. We believe that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed consolidated financial statements are read in conjunction with the Consolidated Financial Statements and Notes included in our Annual Report on Form 10-K for the year ended December 31, 2012, filed with the Securities and Exchange Commission. We currently operate in one business segment.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Use of Estimates</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our unaudited condensed consolidated financial statements include significant estimates for the expected economic life and value of our intangible assets, the amount of our net operating losses, our share-based compensation, the value of our financial instruments, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates<font style="FONT: 10pt Times New Roman, Times, Serif">.</font></p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Foreign Currency Translation</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The functional currency of our wholly owned foreign subsidiaries is their local currency. Assets and liabilities of our foreign subsidiaries are translated into United States dollars based on exchange rates at the end of the reporting period. Income and expense items are translated at the weighted average exchange rates prevailing during the reporting period. <font style="COLOR: black">Translation adjustments for subsidiaries that have not been sold, substantially liquidated or otherwise disposed of, are accumulated in other comprehensive income (loss), a component of stockholders&#39; equity.</font> Foreign currency translation adjustments are the sole component of accumulated other comprehensive loss at March 31, 2013 and December 31, 2012. <font style="COLOR: black">Transaction gains or losses are included in the determination of net loss.</font></p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss and Accumulated Other Comprehensive Income</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Comprehensive Loss and Accumulated Other Comprehensive Income</em></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Comprehensive loss includes the total of our net loss and all other changes in equity other than transactions with owners, including (i) changes in equity for cumulative translation adjustments resulting from the consolidation of foreign subsidiaries as the financial statements of the subsidiaries located outside of the United States are accounted for using the local currency as the functional currency, and (ii) unrealized gains and losses on short term available-for-sale investments.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Cash and Cash Equivalents</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Cash and cash equivalents are stated at market value. We consider all highly liquid investments with original maturities of three months or less to be cash equivalents.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Revolving Line of Credit and Term Loan</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Revolving Line of Credit and Term Loan</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> As discussed further in Note 6, we entered into a loan agreement with General Electric Capital Corporation ("GE Capital") in March 2012. As part of that agreement, we issued stock purchase warrants to GE Capital that expire in March 2022. The fair value of the warrants was charged to additional paid-in-capital, resulting in a debt discount to the Term Loan at the date of issuance. The debt discount and the financing costs, incurred in connections with the agreement, are being amortized over the term of the loan using the effective interest method. The amortization of both the debt discount and deferred financing costs are included in interest expense in the unaudited condensed consolidated statements of operations.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersPolicyPolicyTextBlock', window );">Significant Customers and Accounts Receivable</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Significant Customers and Accounts Receivable</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Our primary customers are the U.S. Department of Defense (the "DoD") - Chemical Biological Medical Systems ("CBMS"), and the Biomedical Advanced Research and Development Authority ("BARDA"). As of March 31, 2013 and December 31, 2012, the Company&#39;s trade receivable and unbilled receivable balances were comprised solely of receivables from CBMS and BARDA.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Goodwill</em></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Goodwill represents the excess of purchase price over the fair value of net identifiable assets associated with acquisitions. We review the recoverability of goodwill annually as of December 31<sup>st</sup> by comparing our market value (as measured by our stock price multiplied by the number of outstanding shares as of the end of the year) to the net book value of our equity. If our market value exceeds our net book value, no further analysis is required. Changes in our business strategy or adverse changes in market conditions could impact the impairment analyses and require the recognition of an impairment charge equal to the excess of the carrying value over its estimated fair value. We completed our last annual impairment assessment of goodwill as of December 31, 2012 and determined that there was no impairment as of that date.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Revenue Recognition</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We generate our revenue from different types of contractual arrangements: cost-plus-fee contracts, cost reimbursable grants and fixed price contracts.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Revenues on cost-plus-fee contracts are recognized in an amount equal to the costs incurred during the period plus an estimate of the applicable fee earned. The estimate of the applicable fee earned is determined by reference to the contract: if the contract defines the fee in terms of risk-based milestones and specifies the fees to be earned upon the completion of each milestone, then the fee is recognized when the related milestones are earned, as further described below; otherwise, we estimate the fee earned in a given period by using a proportional performance method based on costs incurred during the period as compared to total estimated project costs and application of the resulting fraction to the total project fee specified in the contract.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Under the milestone method of revenue recognition, milestone payments (including milestone payments for fees) contained in research and development arrangements are recognized as revenue when: (i) the milestones are achieved; (ii) no further performance obligations with respect to the milestone exist; (iii) collection is reasonably assured; and (iv) substantive effort was necessary to achieve the milestone.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Milestones are considered substantive if all of the following conditions are met:</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"> &middot;</td> <td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"> it is commensurate with either our performance to meet the milestone or the enhancement of the value of the delivered item or items as a result of a specific outcome resulting from our performance to achieve the milestone,</td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"> &middot;</td> <td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"> it relates solely to past performance,</td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in">&nbsp;</td> <td style="FONT-FAMILY: Symbol; TEXT-ALIGN: left; WIDTH: 0.25in"> &middot;</td> <td style="FONT-FAMILY: Times New Roman, Times, Serif; TEXT-ALIGN: justify"> the value of the milestone is reasonable relative to all the deliverables and payment terms (including other potential milestone consideration) within the arrangement.</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> If a milestone is deemed not to be substantive, the Company recognizes the portion of the milestone payment as revenue that correlates to work already performed; the remaining portion of the milestone payment is deferred and recognized as revenue as the Company completes its performance obligations.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Revenue on fixed price contracts (without substantive milestones as described above) is recognized on the percentage-of-completion method. The percentage-of-completion method recognizes income as the contract progresses (generally related to the costs incurred in providing the services required under the contract). The use of the percentage-of-completion method depends on the ability to make reasonable dependable estimates and the fact that circumstances may necessitate frequent revision of estimates does not indicate that the estimates are unreliable for the purpose for which they are used.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> As a result of our revenue recognition policies and the billing provisions contained in our contracts, the timing of customer billings may differ from the timing of recognizing revenue. Amounts invoiced to customers in excess of revenue recognized are reflected on the balance sheet as deferred revenue. Amounts recognized as revenue in excess of amounts billed to customers are reflected on the balance sheet as unbilled accounts receivable.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We analyze each cost reimbursable grant to determine whether we should report such reimbursements as revenue or as an offset to our expenses incurred. For the three months ended March 31, 2013 and 2012, we recorded approximately $0.02 million and $0.5 million, respectively, of costs reimbursed by the government as an offset to research and development expenses.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Share-Based Compensation</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We expense the estimated fair value of share-based awards granted to employees under our stock compensation plans. The fair value of stock options is determined at the grant date using an option pricing model. We have estimated the fair value of each stock option award using the Black-Scholes option pricing model. The Black-Scholes model considers, among other factors, the expected life of the award and the expected volatility of our stock price. The value of the award that is ultimately expected to vest is recognized as expense on a straight line basis over the employee&#39;s requisite service period.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The fair value of restricted stock grants is determined based on the closing price of our common stock on the award date and is recognized as expense ratably over the requisite service period.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Employee share-based compensation expense recognized in the three months ended March 31, 2013 and 2012 was calculated based on awards ultimately expected to vest and has been reduced for estimated forfeitures at a rate of approximately 12%, based on historical forfeitures.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Share-based compensation expense for the three months ended March 31, 2013 and 2012 was:</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="6">Three months ended March 31,</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">2013</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">2012</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt" colspan="2">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 72%; FONT: 10pt Times New Roman, Times, Serif"> Research and development</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"> 88,634</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif"> 117,067</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> General and administrative</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 239,947</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 431,597</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Total share-based compensation expense</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 328,581</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 548,664</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> During the three months ended March 31, 2013, we granted 60,000 options to employees and consultants and made no restricted stock grants. During the three months ended March 31, 2012, we granted 15,948 options to employees and made no restricted stock grants. At March 31, 2013, we had total unrecognized share-based compensation expense related to unvested awards of approximately $2.0 million net of estimated forfeitures, which we expect to recognize as expense over a weighted-average period of 2.25 years.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Income Taxes</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We account for income taxes using the asset and liability approach, which requires the recognition of future tax benefits or liabilities on the temporary differences between the financial reporting and tax bases of our assets and liabilities. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized. We also recognize a tax benefit from uncertain tax positions only if it is "more likely than not" that the position is sustainable based on its technical merits. Our policy is to recognize interest and penalties on uncertain tax positions as a component of income tax expense.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Income tax expense was $9,743 and $150,405 during the three months ended March 31, 2013 and 2012, respectively. Income tax expense is a result of the difference between the treatment of goodwill for income tax purposes and for U.S. GAAP, resulting in a deferred tax liability, which cannot offset deferred tax assets. This deferred tax liability is included in our condensed consolidated balance sheet in other long-term liabilities.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss Per Share</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Basic and Diluted Net Loss Per Share</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Income (loss) per share:</em> Basic income (loss) per share is computed by dividing consolidated net income (loss) by the weighted average number of common shares outstanding during the period, excluding unvested restricted stock.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> For periods of net income when the effects are not anti-dilutive, diluted earnings per share is computed by dividing our net income by the weighted average number of shares outstanding and the impact of all potential dilutive common shares, consisting primarily of stock options, unvested restricted stock and stock purchase warrants. The dilutive impact of our dilutive potential common shares resulting from stock options and stock purchase warrants is determined by applying the treasury stock method.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> For the periods of net loss, diluted loss per share is calculated similarly to basic loss per share because the impact of all dilutive potential common shares is anti-dilutive due to the net losses. A total of approximately 11.6 million and 11.5 million potential dilutive securities have been excluded in the calculation of diluted net loss per share in the three months ended March 31, 2013 and 2012, respectively, because their inclusion would be anti-dilutive.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Recent Accounting Pronouncements</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="COLOR: black; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> We have evaluated all Accounting Standards Updates through the date the unaudited condensed consolidated financial statements were issued and believe the adoption of these will not have a material impact on our results of operations, financial position, or cash flows.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Financial Reporting Release (FRR)<br><br> -Number 203<br><br> -Paragraph 02-03<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7, 8, 9, 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Technical Practice Aid (TPA)<br><br> -Number 2110<br><br> -Paragraph 6<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 305<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122427<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for costs incurred to obtain or issue debt, the effects of refinancings, method of amortizing deferred financing costs and original issue discount, and classifications of debt on the balance sheet.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2208565<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 22<br><br> -Paragraph 8, 12<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 40<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 6, 8-16, 60<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144384<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2175892<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 52<br><br> -Paragraph 5, 7-20, 80<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2175856<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2175826<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 142<br><br> -Paragraph 18-23, 26, 34<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 17<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 48<br><br> -Paragraph 20<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32247-109318<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 4<br><br> -Paragraph 11<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 19<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 6-34, 43, 47, 49<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32280-109318<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 954<br><br> -SubTopic 740<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144749<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144681<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 280<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 42<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6534315&amp;loc=d3e9054-108599<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6404-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6327-108592<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 18<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6351-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MajorCustomersPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of the adoption of new accounting pronouncements that may impact the entity's financial reporting.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.B.Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6600647&amp;loc=d3e214044-122780<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 22<br><br> -Paragraph 8, 12, 13<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18823-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section B<br><br> -Paragraph Question 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2228939<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 06-11<br><br> -Paragraph 7<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Statement of Position (SOP)<br><br> -Number 94-6<br><br> -Paragraph 11, 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EKH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Liabilities Measured at Fair Value</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table represents the Company&#39;s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis:</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="14">As of March 31, 2013</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 1</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 2</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 3</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Balance</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Liabilities</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 44%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Derivatives instruments</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> -</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> -</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2,201,390</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2,201,390</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="14">As of December 31, 2012</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 1</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 2</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Level 3</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Balance</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Liabilities</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt" colspan="2"> &nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 44%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Derivatives instruments</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> -</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> -</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1,295,613</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 1,295,613</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of Changes in Fair Value of Level 3 Liabilities</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table sets forth a summary of changes in the fair value of our Level 3 liabilities for the three months ended March 31, 2013:</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif"> Description</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Balance as of<br /> December 31,<br /> 2012</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Unrealized Losses</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Balance as of<br /> March 31,<br /> 2013</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="WIDTH: 58%; FONT-SIZE: 10pt">&nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Derivative liabilities related to stock purchase warrants</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 1,295,613</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 905,777</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 2,201,390</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> </table> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table sets forth a summary of changes in the fair value of the Company&#39;s Level 3 liabilities for the three months ended March 31, 2012:</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="FONT: 10pt Times New Roman, Times, Serif"> Description</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Balance as of<br /> December 31,<br /> 2011</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Unrealized Losses</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif" colspan="2">Balance as of<br /> March 31,<br /> 2012</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="WIDTH: 58%; FONT-SIZE: 10pt">&nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="WIDTH: 2%; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: right; WIDTH: 10%; FONT-SIZE: 10pt"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT-SIZE: 10pt"> &nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> Derivative liabilities related to stock purchase warrants</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 1,886,652</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 991,662</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> $</td> <td style="TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif"> 2,878,314</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock', window );">Schedule of Quantitative Information about Level 3 Fair Value Measurements</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="7">Quantitative Information about Level 3 Fair Value Measurements</td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right; FONT: 10pt Times New Roman, Times, Serif; COLOR: black" colspan="2">Fair Value at 3/31/2013</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Valuation Technique</td> <td style="PADDING-BOTTOM: 1pt; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="BORDER-BOTTOM: black 1pt solid; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Unobservable Inputs</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> $</td> <td style="TEXT-ALIGN: right; WIDTH: 20%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> 2,201,390</td> <td style="TEXT-ALIGN: left; WIDTH: 1%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 42%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Black-Scholes option pricing model</td> <td style="WIDTH: 2%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; WIDTH: 32%; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Expected term</td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Expected dividends</td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,255,204); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: right; FONT-SIZE: 10pt">&nbsp;</td> <td style="TEXT-ALIGN: left; FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT-SIZE: 10pt">&nbsp;</td> <td style="FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> &nbsp;</td> <td style="TEXT-ALIGN: left; FONT: 10pt Times New Roman, Times, Serif; COLOR: black"> Anticipated volatility</td> </tr> </table> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of quantitative information about the inputs used in the fair value measurement of liabilities. This disclosure may include, but is not limited to, the fair value of the liability, valuation technique used to measure fair value, the inputs used to measure fair value, the ranges of the inputs, and the weighted averages of the inputs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (bbb)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19207-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19279-110258<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 157<br><br> -Paragraph 32<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7578670&amp;loc=d3e19190-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EGLAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Fair Value Measurements (Schedule of Liabilities Measured at Fair Value) (Details) (Recurring [Member], USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure', window );">Derivatives</a></td>
        <td class="nump">$ 2,201,390<span></span></td>
        <td class="nump">$ 1,295,613<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 1 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure', window );">Derivatives</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 2 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure', window );">Derivatives</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value, Inputs, Level 3 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure', window );">Derivatives</a></td>
        <td class="nump">$ 2,201,390<span></span></td>
        <td class="nump">$ 1,295,613<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative instrument obligations meeting the definition of a liability which the Company is a party to as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 15<br><br> -Paragraph 83<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6913464&amp;loc=d3e34841-113949<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 133<br><br> -Paragraph 10<br><br> -Subparagraph i<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 133<br><br> -Paragraph 6<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EIIAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stockholders' Equity (Schedule of Warrants) (Details)<br></strong></div>
        </th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="14">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2009</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th" colspan="2">
          <div>Mar. 31, 2013

</div>
          <div>Warrant Tranche One [Member]</div>
        </th>
        <th class="th" colspan="2">
          <div>Mar. 31, 2013

</div>
          <div>Warrant Tranche Two [Member]</div>
        </th>
        <th class="th" colspan="2">
          <div>Mar. 31, 2013

</div>
          <div>Warrant Tranche Three [Member]</div>
        </th>
        <th class="th" colspan="2">
          <div>Mar. 31, 2013

</div>
          <div>Warrant Tranche Four [Member]</div>
        </th>
        <th class="th" colspan="2">
          <div>Mar. 31, 2013

</div>
          <div>Warrant Tranche Five [Member]</div>
        </th>
        <th class="th" colspan="2">
          <div>Mar. 31, 2013

</div>
          <div>Warrant Tranche Six [Member]</div>
        </th>
        <th class="th" colspan="2">
          <div>Mar. 31, 2013

</div>
          <div>Warrant Tranche Seven [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of Common Shares Underlying Warrants</a></td>
        <td class="nump">46,584<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,620,128<span></span></td>
        <td class="nump">5,620,128<span></span></td>
        <td class="nump">100,778<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump">705,354<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
        <td class="nump">2,572,775<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump">500,000<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
        <td class="nump">1,323,214<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
        <td class="nump">371,423<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
        <td class="nump">46,584<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_ClassOfWarrantOrRightIssuanceDate', window );">Issue Date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Mar.
        01,
         2007<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Mar.
        01,
         2009<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Jul.
        01,
         2009<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Apr.
        01,
         2010<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Jul.
        01,
         2010<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Jun.
        01,
         2011<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Mar.
        01,
         2012<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Exercisable Date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Mar.
        01,
         2007<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Sep.
        01,
         2009<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Jan.
        01,
         2010<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Oct.
        01,
         2010<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Jan.
        01,
         2011<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Jun.
        01,
         2011<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Mar.
        01,
         2012<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Exercise Price</a></td>
        <td class="nump">1.61<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3.97<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">3.00<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">2.50<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1.89<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1.63<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">3.50<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1.61<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_WarrantExpirationDate', window );">Expiration Date</a></td>
        <td class="text">Mar. 30,
         2022<span></span></td>
        <td class="text">Jan. 28,
         2015<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Mar. 30,
         2017<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Sep. 30,
         2014<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Jan. 28,
         2015<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Oct. 31,
         2015<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Jan. 31,
         2017<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Jun. 30,
         2016<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">Mar. 30,
         2022<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr>
        <td colspan="19"></td>
      </tr>
      <tr>
        <td colspan="19">
          <table class="outerFootnotes" width="100%">
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[1]</td>
              <td style="vertical-align: top;" valign="top">These warrants to purchase common stock are classified as equity.</td>
            </tr>
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[2]</td>
              <td style="vertical-align: top;" valign="top">These warrants to purchase common stock are classified as derivative liabilities. The fair value of these liabilities (see note 3) is remeasured at the end of every reporting period and the change in fair value is reported in the unaudited condensed consolidated statements of operations as other income (expense).</td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_ClassOfWarrantOrRightIssuanceDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class Of Warrant Or Right, Issuance Date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_ClassOfWarrantOrRightIssuanceDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_WarrantExpirationDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrant, Expiration Date</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_WarrantExpirationDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Date the warrants or rights are exercisable, in CCYY-MM-DD format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(3))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 3<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exercise price of each class of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The specified number of securities that each class of warrants or rights outstanding give the holder the right but not the obligation to purchase from the issuer at a specific price, on or before a certain date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EFFAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE LOSS (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE LOSS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
        <td class="num">$ (2,111,385)<span></span></td>
        <td class="num">$ (2,679,888)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
        <td class="num">(1,684)<span></span></td>
        <td class="nump">13,369<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Comprehensive loss</a></td>
        <td class="num">$ (2,113,069)<span></span></td>
        <td class="num">$ (2,666,519)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e565-108580<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net of tax and reclassification adjustments of the change in the balance sheet adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency of the reporting entity. Also includes the following: gain (loss) on foreign currency forward exchange contracts; foreign currency transactions designated as hedges of net investment in a foreign entity and intercompany foreign currency transactions that are of a long-term nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; and gain (loss) on a derivative instrument or nonderivative financial instrument that may give rise to a foreign currency transaction gain (loss) that has been designated and qualified as a hedging instrument for hedging of the foreign currency exposure of a net investment in a foreign operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=SL7669646-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 20<br><br> -Subparagraph (b,c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32211-110900<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net of tax amount of other comprehensive income (loss) attributable to both parent entity and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=SL7669619-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Note 4 - Commitments and Contingencies</strong></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>SIGA Litigation</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In December 2006, we filed a complaint against SIGA Technologies, Inc. ("SIGA") in the Delaware Court of Chancery. The complaint alleged, among other things, that we have the right to license exclusively development and marketing rights for SIGA&#39;s drug candidate, Arestvyr&trade; (Tecovirimat), pursuant to a merger agreement between the parties that was terminated in 2006. The complaint also alleged that SIGA failed to negotiate in good faith the terms of such a license pursuant to the terminated merger agreement.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In September 2011, the Court issued an opinion in the case finding that SIGA had breached certain contractual obligations to us and upholding our claims of promissory estoppel. The Court awarded us the right to receive 50% of all net profits (as defined in the court&#39;s final judgment) related to the sale of Arestvyr&trade; and related products for 10 years following initial commercial sale of the drug once SIGA earns $40 million in net profits from the sale of Arestvyr&trade; and related products. The Court also awarded us one-third of our reasonable attorney&#39;s fees and expert witness fees, which amounts to approximately $2.4 million plus interest. In May 2012, the Court issued its final judgment. SIGA has appealed aspects of the decision to the Delaware Supreme Court. In response, we cross-appealed other aspects of the decision. In January 2013, the Delaware Supreme Court heard oral argument in the case.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We can provide no assurances that SIGA will not prevail on its appeal, that we will be successful in our appeal, and that the Delaware Supreme Court will not overturn the trial court&#39;s decision awarding us a 10 year 50% net profit of the sales of Arestvyr&trade; and related products (once SIGA retains the first $40 million in net profit). We have not yet recorded any amount due from SIGA in relation to this case.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Vendor Litigation</em></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> One of our vendors mishandled the storage of certain biological materials. While we have been engaged in discussions with the vendor to address our concerns, so far we have not come to agreement. The vendor filed suit against us in Delaware state court seeking a declaration that they are not liable for damages and seeking damages from us for allegedly not maintaining the required amount and type of insurance. We filed suit against the vendor in Maryland state court seeking damages related to the loss of the property. We believe we did maintain the appropriate amount and type of insurance, that in no event did we harm the vendor, and thus their damages claim is without merit. We plan to vigorously defend against their claims while pursuing our own.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">&nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Government Contracting</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Payments to the Company on cost-plus-fee contracts are provisional and are subject to adjustment upon audit by the Defense Contract Audit Agency and BARDA. In our opinion, adjustments that may result from audits are not expected to have a material effect on our financial position, results of operations, or cash flows.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Registration Rights Agreements</em></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We entered into a Registration Rights Agreement with the investors who participated in the July 2009 private placement of convertible notes and related warrants. We subsequently filed two registration statements on Form S-3 with the Securities and Exchange Commission to register the shares underlying the convertible notes and related warrants, which registration statements have been declared effective. We are obligated to maintain the registration statements effective until the date when all shares underlying the convertible notes and related warrants (and any other securities issued or issuable with respect to in exchange for such shares) have been sold. The convertible notes were converted or extinguished in 2010, although the related warrants remain outstanding. The warrants will expire on January 28, 2015.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> We have separate registration rights agreements with investors, under which we have obligations to keep the corresponding registration statements effective until the registrable securities (as defined in each agreement) have been sold, and under which we may have separate obligations to file registration statements in the future on either a demand or "piggy-back" basis or both.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Under the terms of the convertible notes, which were converted or extinguished in 2010, if after the 2nd consecutive business day (other than during an allowable blackout period) on which sales of all of the securities required to be included on the registration statement cannot be made pursuant to the registration statement (a "Maintenance Failure"), we will be required to pay to each selling stockholder a one-time payment of 1.0% of the aggregate principal amount of the convertible notes relating to the affected shares on the initial day of a Maintenance Failure. Our total maximum obligation under this provision at March 31, 2013, would be approximately $0.2 million.</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &nbsp;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Following a Maintenance Failure, we will also be required to make to each selling stockholder monthly payments of 1.0% of the aggregate principal amount of the convertible notes relating to the affected shares on every 30th day after the initial day of a Maintenance Failure, in each case prorated for shorter periods and until the failure is cured. Our total maximum obligation under this provision would be approximate $0.2 million for each month until the failure, if it occurs, is cured.</p> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6952336&amp;loc=d3e14435-108349<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 14<br><br> -Paragraph 3<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 5<br><br> -Paragraph 9, 10, 11, 12<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ENKDI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Financing Transactions (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 30, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>Equity Offering [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 25, 2013

</div>
          <div>Equity Offering [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>Line of Credit [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 30, 2012

</div>
          <div>Line of Credit [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>Loans Payable [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 30, 2012

</div>
          <div>Loans Payable [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 5,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Current borrowing capacity</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Amount Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Term loan, payment terms</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Payments on the term loan were originally interest-only for the first 10 months, which has since been extended to 12 months pursuant to terms of the agreement. Subsequently, the term loan will fully amortize over its remaining term as of March 31, 2013.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityBorrowingCapacityDescription', window );">Line of credit borrowing capacity description</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Under the terms of the revolving line of credit, the Company may draw down from the revolving line of credit up to 85% of qualified billed accounts receivable and 80% of qualified unbilled accounts receivable.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_DebtInstrumentsMaturityDateMonthAndYear', window );">Term loan and line of credit, maturity date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">2015-09<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable', window );">Line of credit facility borrowing capacity, qualified billed accounts receivable, percent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">85.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl', window );">Line of credit facility borrowing capacity, qualified unbilled accounts receivable, percent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">80.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10.14%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_DebtInstrumentInterestRateFloorPercentage', window );">Variable interest rate, with floor of 1.5%</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.50%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate', window );">Loan payable, interest rate spread</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Incremental borrowing rate used to calculate discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6.50%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2013</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">749,997<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2014</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">999,996<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2015</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">750,007<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="nump">2,500,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_LongTermDebtPrepaymentPremiumPercentOfPrincipal', window );">Prepayment premium, if paid within the first two years of the term loan, percent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo', window );">Prepayment premium, if paid after the first two years of the term loan, percent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_FinalPaymentFeeOfTermLoanBalancePercent', window );">Final payment fee payable on term loan balance, percent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement', window );">Warrants issued to purchase common stock, in connection to loan agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">46,584<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrant exercise price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.61<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.61<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">39,587<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
        <td class="nump">999,996<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">749,997<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
        <td class="nump">1,460,417<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,704,108<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_EquityOfferingLineItems', window );"><strong>Equity Offering [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_MaximumValueOfStockIssuableUnderStockOffering', window );">The maximum value of common stock issuable under the controlled equity offering</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares', window );">Commission owed to sales agent, expressed as percentage of aggregate gross proceeds from each sale of shares of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Equity offering, issuance costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">277,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
        <td class="nump">53,413<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable', window );">Common stock - receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">33,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares sold</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">19,900<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pip_RemainingValueOfStockIssuableUnderStockOffering', window );">Amount remaining available under the arrangement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 14,970,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Commission owed to sales agent, expressed as percentage of aggregate gross proceeds from each sale of shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_CommissionOwedToSalesAgentExpressedAsPercentageOfAggregateGrossProceedsFromEachSaleOfShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_DebtInstrumentInterestRateFloorPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date, which accrues interest at a rate subject to change from time to time, however, with a floor of 1.5%.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_DebtInstrumentInterestRateFloorPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_DebtInstrumentsMaturityDateMonthAndYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Debt Instruments Maturity Date Month and Year</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_DebtInstrumentsMaturityDateMonthAndYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearMonthItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_EquityOfferingLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_EquityOfferingLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_FinalPaymentFeeOfTermLoanBalancePercent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Final payment fee payable on term loan balance, percent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_FinalPaymentFeeOfTermLoanBalancePercent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Line Of Credit Facility Borrowing Capacity Percent Of Qualified Billed Accounts Receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedBilledAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Line Of Credit Facility Borrowing Capacity Percent Of Qualified Unbilled Accounts Receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_LineOfCreditFacilityBorrowingCapacityPercentOfQualifiedUnbilledAccountsReceivabl</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_LongTermDebtPrepaymentPremiumPercentOfPrincipal">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Prepayment premium, if paid within the first two years of the term loan, percent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_LongTermDebtPrepaymentPremiumPercentOfPrincipal</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Prepayment premium, if paid after the first two years of the term loan, percent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_LongTermDebtPrepaymentPremiumPercentOfPrincipalPeriodTwo</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_MaximumValueOfStockIssuableUnderStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum value of common stock issuable under the controlled equity offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_MaximumValueOfStockIssuableUnderStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_RemainingValueOfStockIssuableUnderStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The remaining value of common stock issuable under the controlled equity offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_RemainingValueOfStockIssuableUnderStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pip_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants Issued To Purchase Common Stock In Connection To Loan Agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>pip_WarrantsIssuedToPurchaseCommonStockInConnectionToLoanAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>pip_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Direct costs (e.g., legal and accounting fees) associated with issuing stock that is deducted from additional paid in capital. Also includes any direct costs associated with stock issues under a shelf registration.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Technical Practice Aid (TPA)<br><br> -Number 4110<br><br> -Paragraph 1, 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exercise price of each class of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of subscription receivable from investors who have been allocated common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 85-1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The percentage points added to the reference rate to compute the variable rate on the debt instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentBasisSpreadOnVariableRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date before deducting unamortized discount or premiums (if any). May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 16<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number APB14-1<br><br> -Paragraph 31<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentCarryingAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22(a)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentInterestRateEffectivePercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Interest rate stated in the contractual debt agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22(a)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentInterestRateStatedPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22(a)(3))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 470<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentPaymentTerms</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 21<br><br> -Paragraph 16, 20<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number APB14-1<br><br> -Paragraph 31<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 55<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584090&amp;loc=d3e28878-108400<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentUnamortizedDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityBorrowingCapacityDescription">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of the credit facility's borrowing capacity including discussion of how the borrowing capacity is determined (for example, borrowing capacity based on the amount of current assets).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityBorrowingCapacityDescription</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(b),22(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of the amount outstanding under the credit facility.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13433-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7491637&amp;loc=d3e13476-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(b),22(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount of long-term debt, net of unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19,20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of long-term debt, sinking fund requirements, and other securities redeemable at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 47<br><br> -Paragraph 10<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of long-term debt, sinking fund requirements, and other securities redeemable at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 47<br><br> -Paragraph 10<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of long-term debt, sinking fund requirements, and other securities redeemable at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 47<br><br> -Paragraph 10<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.4.0.6</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>72</ContextCount>
  <ElementCount>166</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>27</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfOtherComprehensiveLoss</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE LOSS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>101 - Disclosure - Organization and Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/OrganizationAndBusiness</Role>
      <ShortName>Organization and Business</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>103 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>104 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>105 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>106 - Disclosure - Financing Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/FinancingTransactions</Role>
      <ShortName>Financing Transactions</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>107 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>202 - Disclosure - Summary of Significant Accounting Policies (Policy)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesPolicy</Role>
      <ShortName>Summary of Significant Accounting Policies (Policy)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>302 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>305 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>306 - Disclosure - Financing Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/FinancingTransactionsTables</Role>
      <ShortName>Financing Transactions (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>40202 - Disclosure - Summary of Significant Accounting Policies (Schedule of Share-based Compensation Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfSharebasedCompensationExpenseDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Schedule of Share-based Compensation Expense) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>40301 - Disclosure - Fair Value Measurements (Schedule of Liabilities Measured at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/FairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueDetails</Role>
      <ShortName>Fair Value Measurements (Schedule of Liabilities Measured at Fair Value) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>40302 - Disclosure - Fair Value Measurements (Summary of Changes in Fair Value of Our Level 3 Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/FairValueMeasurementsSummaryOfChangesInFairValueOfOurLevelThreeLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements (Summary of Changes in Fair Value of Our Level 3 Liabilities) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>40303 - Disclosure - Fair Value Measurements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>40401 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>40501 - Disclosure - Stockholders' Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>40502 - Disclosure - Stockholders' Equity (Schedule of Warrants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/StockholdersEquityScheduleOfWarrantsDetails</Role>
      <ShortName>Stockholders' Equity (Schedule of Warrants) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>40601 - Disclosure - Financing Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/FinancingTransactionsDetails</Role>
      <ShortName>Financing Transactions (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>40701 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pharmathene.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element us-gaap_CostOfReimbursableExpense had a mix of decimals attribute values: -5 -4.</Log>
    <Log type="Info">Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -4 0.</Log>
    <Log type="Info">'Monetary' elements on report '40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Shares' elements on report '40501 - Disclosure - Stockholders' Equity (Narrative) (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '40701 - Disclosure - Subsequent Events (Details)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">Process Flow-Through: 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Mar. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2011'</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</Log>
    <Log type="Info">Process Flow-Through: 006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE LOSS</Log>
    <Log type="Info">Process Flow-Through: 007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</Log>
  </Logs>
  <InputFiles>
    <File>pip-20130331.xml</File>
    <File>pip-20130331.xsd</File>
    <File>pip-20130331_cal.xml</File>
    <File>pip-20130331_def.xml</File>
    <File>pip-20130331_lab.xml</File>
    <File>pip-20130331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E2BAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Schedule of Share-based Compensation Expense) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
        <td class="nump">$ 328,581<span></span></td>
        <td class="nump">$ 548,664<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Research and Development [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
        <td class="nump">88,634<span></span></td>
        <td class="nump">117,067<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">General and Administrative Expense [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
        <td class="nump">$ 239,947<span></span></td>
        <td class="nump">$ 431,597<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph g(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 64<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6793087&amp;loc=d3e301413-122809<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
